data_2koi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2koi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.82 0.343 . . . . 1.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.51 -33.03 68.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -77.51 -48.17 17.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.788 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.0 mt -56.16 -51.2 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.056 0.455 . . . . 1.0 110.957 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.517 ' O ' ' OG1' ' A' ' 38' ' ' THR . 71.0 mt -58.34 -30.88 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.986 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -67.73 -39.36 84.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.408 -0.517 . . . . 1.0 109.732 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.469 ' O ' ' OE1' ' A' ' 41' ' ' GLU . . . -70.39 -33.24 71.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.769 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 53.4 p -63.65 -37.15 86.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.305 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -23.34 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.4 -51.71 33.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.341 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 18.1 mp0 -69.7 -34.94 74.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.745 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.74 -55.35 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.337 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.3 tmm_? -53.9 -43.65 69.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 1.0 110.669 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.63 -43.41 72.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.321 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -65.41 -37.28 86.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.8 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 mt -96.65 -15.06 21.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.763 0.316 . . . . 1.0 111.697 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.85 25.04 35.84 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.505 -1.038 . . . . 1.0 110.505 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 87.6 m -78.36 146.07 34.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.8 m-20 -52.17 -41.98 63.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.543 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 49.4 ttt180 -152.45 132.29 13.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.549 -0.86 . . . . 1.0 112.802 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 t -136.76 131.64 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 1.0 108.702 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.88 151.74 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.628 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.85 140.36 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 13.7 t80 -129.13 132.57 47.38 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.431 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.993 0.425 . . . . 1.0 111.206 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.9 t80 -100.47 128.49 46.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.696 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' OD2' ' CD2' ' A' ' 61' ' ' HIS . 40.9 m-20 -97.75 151.97 37.88 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.93 -22.45 30.43 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.029 2.486 . . . . 1.0 114.488 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HB2' ' ND1' ' A' ' 61' ' ' HIS . 96.2 mt-10 -91.16 -3.51 56.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.07 -19.59 37.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.67 -0.776 . . . . 1.0 111.901 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 57.2 p-80 -80.49 151.45 29.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.404 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.45 162.85 26.14 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -134.57 154.99 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.015 0.436 . . . . 1.0 111.504 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 t -90.9 113.42 26.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.338 -0.986 . . . . 1.0 108.338 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.28 -3.33 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.92 125.92 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.31 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.543 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 79.1 tt0 -155.34 138.69 15.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 1.0 111.676 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.28 138.95 53.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -113.28 136.48 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.019 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.781 0.324 . . . . 1.0 111.35 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.93 10.86 37.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.978 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.93 129.16 38.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -4.04 86.54 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.847 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.79 147.36 27.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.3 0.55 . . . . 1.0 110.422 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.3 m -107.52 135.81 48.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.611 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.45 112.92 62.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.248 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.08 137.95 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.561 2.174 . . . . 1.0 111.464 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -60.52 -37.6 81.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 1.0 110.432 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.06 -16.33 0.47 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 84' ' ' ALA . 86.9 m-20 -71.76 -23.22 61.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.687 0.28 . . . . 1.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' PRO . 44.7 mt -116.83 101.57 53.44 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.542 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 87' ' ' ILE . 76.9 Cg_exo -45.63 -115.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.575 2.183 . . . . 1.0 111.653 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 80.3 tt0 -157.0 -51.68 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.93 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -49.53 -39.97 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.608 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.85 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.669 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -63.8 -33.9 76.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.819 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.69 -37.15 86.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.947 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.44 -36.65 83.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.484 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -66.85 -35.0 79.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -77.24 -31.15 54.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.284 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.51 ' C ' HE22 ' A' ' 99' ' ' GLN . 79.1 mt -94.55 -38.99 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.58 -13.12 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.595 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.4 mp0 47.71 56.7 6.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.669 -0.813 . . . . 1.0 109.926 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.5 m -159.09 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.875 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -165.57 133.88 3.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.888 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 78.2 t -145.68 156.3 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.703 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.546 ' CD1' ' HE2' ' A' ' 139' ' ' HIS . 62.4 mt -112.5 127.73 69.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.265 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.1 m -86.96 170.62 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -49.53 114.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.906 -1.043 . . . . 1.0 112.249 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.25 -21.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.512 -0.767 . . . . 1.0 110.674 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -80.36 -37.86 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.2 -14.55 2.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.18 0.514 . . . . 1.0 110.453 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 57.32 59.96 3.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.849 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 t -94.97 124.94 39.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -119.72 143.73 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.5 153.74 28.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.764 -1.107 . . . . 1.0 108.668 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.325 -0.484 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.468 -178.909 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.491 1.375 0 CA-C-O 120.835 0.264 . . . . 1.0 112.348 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.81 132.89 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -41.68 160.86 0.15 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.401 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.11 -23.67 45.66 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.159 2.573 . . . . 1.0 113.666 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.54 ' H ' ' CG ' ' A' ' 136' ' ' ASP . 7.3 t -58.89 -58.76 7.22 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 1.0 111.298 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 103' ' ' ILE . 2.1 t60 -68.38 -27.23 66.06 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.616 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -62.25 -56.95 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.608 0.595 . . . . 1.0 112.608 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -62.23 -38.78 90.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.376 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.463 ' O ' ' OG ' ' A' ' 145' ' ' SER . 74.8 t80 -47.9 -36.58 12.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.9 mt -73.64 -42.73 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -58.24 -44.84 88.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 83.7 p -61.9 -17.73 57.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.687 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.3 mmm -100.48 -0.02 38.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 1.0 111.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.38 18.9 77.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.538 -1.025 . . . . 1.0 110.538 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.29 142.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.696 0.284 . . . . 1.0 110.298 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.2 -26.73 5.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 p -153.78 121.35 5.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.701 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 m -126.77 138.66 53.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 1.0 111.385 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.99 134.27 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.1 t -113.96 127.76 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.332 -0.547 . . . . 1.0 112.291 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.65 126.18 17.91 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -90.51 161.42 4.41 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.351 2.034 . . . . 1.0 113.704 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 24.6 mt -114.34 114.78 26.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.435 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 23.4 ptm -141.9 150.56 41.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.489 ' CE1' ' NE2' ' A' ' 159' ' ' HIS . 9.1 t-80 -125.7 126.29 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.809 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.489 ' NE2' ' CE1' ' A' ' 158' ' ' HIS . 84.0 m-70 58.34 -122.47 1.35 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.105 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.56 2.72 50.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.811 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.527 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.2 tt0 -106.22 145.97 30.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.755 1.02 . . . . 1.0 113.755 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 44.9 tp -101.26 123.8 45.94 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.527 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.7 m95 -101.87 -32.08 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -176.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.88 -167.75 22.77 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.719 -1.229 . . . . 1.0 112.398 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -143.7 122.94 12.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.417 -0.392 . . . . 1.0 111.664 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.4 tp -94.76 150.5 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.31 133.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.822 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.578 ' HG ' ' HE2' ' A' ' 170' ' ' HIS . 87.9 p -113.24 139.73 48.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.249 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.471 ' O ' ' CG2' ' A' ' 48' ' ' THR . 18.1 m80 -111.92 124.38 52.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.578 ' HE2' ' HG ' ' A' ' 168' ' ' SER . 29.0 m-70 -117.44 116.88 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.09 -15.33 62.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.747 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 . . . . . 0 C--N 1.326 -0.417 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.611 179.817 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.65 0.262 . . . . 1.0 111.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.7 -33.57 74.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.937 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.27 -45.57 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.633 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.33 -55.31 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.724 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.1 t -45.37 -39.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.638 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -74.56 -49.37 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -48.54 -36.59 15.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 190' ' ' GLN . 21.6 tp -70.69 -46.39 63.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.082 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.05 -46.83 75.38 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.43 -48.23 81.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.22 -36.66 75.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 186' ' ' LEU . 7.0 tt0 -68.61 -32.41 72.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.47 -48.54 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.342 -0.985 . . . . 1.0 108.342 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.4 p -50.12 -31.6 13.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mt -74.65 -34.9 35.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.27 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -43.71 79.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.95 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 196' ' ' ALA . 31.7 pt -63.17 -30.77 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.406 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -72.79 -50.12 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.411 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.8 -40.79 95.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.275 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.472 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -67.51 -31.39 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.385 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -57.78 -43.39 85.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.93 -36.17 48.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.965 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 83.1 p -52.17 -57.49 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.647 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.486 179.414 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.835 0.35 . . . . 1.0 110.546 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 66.6 t0 -48.06 -36.05 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -74.4 -49.95 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.808 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.7 -44.98 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.022 0.439 . . . . 1.0 110.92 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.495 ' O ' ' OG1' ' A' ' 38' ' ' THR . 45.2 mt -58.4 -30.7 67.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.98 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -66.81 -38.35 86.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.78 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.76 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 76.9 p -68.67 -36.65 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.273 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -74.34 -23.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -72.76 -48.48 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.305 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.76 -34.96 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.742 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.7 t -59.98 -54.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.609 -0.269 . . . . 1.0 111.287 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.6 ttp180 -51.45 -43.43 62.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 1.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.17 -42.49 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.254 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.4 -37.19 86.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.793 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.2 mt -97.13 -13.93 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.864 -0.335 . . . . 1.0 111.701 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.65 25.59 22.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.6 p -81.29 152.21 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -48.71 -42.93 36.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.516 HH21 ' CG2' ' A' ' 148' ' ' VAL . 36.1 ptt180 -160.17 146.25 15.52 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.568 -0.853 . . . . 1.0 112.782 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 20.2 t -137.44 133.92 46.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.957 -1.019 . . . . 1.0 108.675 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.595 ' HZ1' ' CD1' ' A' ' 77' ' ' LEU . 17.7 mttt -135.91 144.62 45.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.604 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.43 141.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 18.1 t80 -129.78 130.62 45.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.509 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -111.86 154.11 25.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 1.0 111.239 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.66 136.89 40.73 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.661 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -97.17 150.94 37.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -41.54 -22.03 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.962 2.441 . . . . 1.0 114.468 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -103.85 9.0 37.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.185 0.439 . . . . 1.0 112.185 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.03 -15.81 62.29 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.598 -0.81 . . . . 1.0 111.966 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.585 ' O ' ' N ' ' A' ' 57' ' ' ASP . 35.6 m80 -77.52 151.27 34.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.78 163.56 25.54 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 p -135.63 158.85 43.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 1.0 111.495 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 104.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.78 -4.75 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.0 125.68 7.63 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.33 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 75.1 tt0 -154.45 138.99 16.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.158 0.504 . . . . 1.0 111.684 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.7 131.41 51.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.562 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 34.8 ptt180 -109.03 140.2 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.02 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 178.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.77 0.319 . . . . 1.0 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.617 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 35.0 mt -103.98 18.09 22.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.968 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 24.5 tp -65.21 131.03 45.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.6 88.77 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.843 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.78 151.01 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.352 0.576 . . . . 1.0 110.461 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.4 t -104.41 128.99 52.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.603 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -106.69 107.3 60.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.286 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -43.37 138.89 4.66 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.592 2.195 . . . . 1.0 111.522 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.427 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -61.55 -29.29 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.21 -17.71 0.24 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' N ' ' C ' ' A' ' 84' ' ' ALA . 89.2 m-20 -67.52 -16.55 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.665 0.269 . . . . 1.0 111.032 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' PRO . 16.1 mt -134.55 99.47 12.97 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.53 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' ILE . 40.9 Cg_exo -39.6 -97.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.521 2.147 . . . . 1.0 111.704 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 22.8 pt-20 -165.71 -39.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.003 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -56.97 -43.35 81.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.625 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.12 -35.66 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.686 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -65.01 -32.23 73.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.806 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -64.6 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.541 ' CB ' ' NH2' ' A' ' 101' ' ' ARG . 10.0 mt -60.18 -38.31 82.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.546 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -66.56 -32.5 73.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.168 -0.679 . . . . 1.0 109.168 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -79.74 -27.53 40.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.172 -0.922 . . . . 1.0 111.305 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.85 -40.43 8.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -119.08 -11.57 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.422 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 4.0 mp0 44.77 64.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.669 -0.812 . . . . 1.0 109.91 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.542 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 11.1 p -168.8 107.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.905 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.542 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -159.15 134.4 8.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.895 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 103' ' ' ILE . 53.7 t -149.01 155.76 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.707 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.408 ' N ' ' CG1' ' A' ' 102' ' ' VAL . 66.2 mt -111.9 129.14 67.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.238 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -87.28 169.58 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.16 115.79 1.58 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.975 -1.011 . . . . 1.0 112.274 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.4 p -51.24 -22.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.644 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -76.38 -38.83 55.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.822 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.87 19.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.234 0.54 . . . . 1.0 110.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 56.33 62.79 2.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.838 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 m -95.43 125.59 40.15 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.777 -1.564 . . . . 1.0 106.777 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -117.62 145.36 44.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.661 0.985 . . . . 1.0 113.661 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -111.97 148.8 33.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.77 -1.105 . . . . 1.0 108.62 177.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.438 -179.074 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 120.784 0.243 . . . . 1.0 112.422 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.63 125.44 71.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 178.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 138' ' ' CYS . 3.5 p30 -45.67 142.55 3.47 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.752 0.31 . . . . 1.0 111.317 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.8 -20.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.15 2.567 . . . . 1.0 113.634 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.5 t -61.59 -62.78 1.57 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.209 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -70.26 -24.61 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.631 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 135' ' ' VAL . 61.4 t -60.6 -60.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.61 0.596 . . . . 1.0 112.61 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -61.12 -38.4 86.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -47.23 -36.64 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.9 mt -73.33 -43.65 60.39 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.22 -44.63 88.28 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.644 -0.873 . . . . 1.0 108.644 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -62.63 -19.0 63.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.691 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 23.2 mmm -101.27 -0.98 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 1.0 111.052 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.6 17.62 79.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.516 ' CG2' HH21 ' A' ' 50' ' ' ARG . 73.0 t -107.29 143.65 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.655 0.264 . . . . 1.0 110.335 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.7 -42.74 2.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.944 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.7 t -136.87 118.16 14.59 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.77 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.3 m -129.12 143.39 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.998 0.428 . . . . 1.0 111.405 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.45 132.54 45.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.74 107.17 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.304 -0.558 . . . . 1.0 112.258 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.53 132.68 21.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -91.63 163.39 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.386 2.057 . . . . 1.0 113.701 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.5 mt -116.9 113.86 23.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.569 ' N ' ' OG ' ' A' ' 192' ' ' SER . 25.3 ptm -142.69 150.3 39.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -125.66 124.49 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.897 -1.047 . . . . 1.0 108.842 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.615 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 79.5 t60 60.17 -122.04 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.165 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.615 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 41.3 tt0 -97.85 1.71 48.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.808 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.8 tt0 -106.43 144.24 33.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 tp -99.31 125.74 45.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 75.7 m95 -104.37 -34.84 8.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.5 -175.05 31.08 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.717 -1.23 . . . . 1.0 112.417 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -137.44 122.02 18.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.471 -0.365 . . . . 1.0 111.644 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 47.1 tp -94.95 150.02 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.5 p -156.62 134.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.004 -0.678 . . . . 1.0 111.843 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 90.5 p -116.03 132.74 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -104.96 126.83 52.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 5.7 t-80 -118.8 115.35 24.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.79 63.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.799 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 21.6 mp0 . . . . . 0 C--N 1.326 -0.42 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.535 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.647 0.26 . . . . 1.0 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -66.37 -28.88 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 1.0 110.902 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.98 -39.25 76.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.651 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -78.92 -54.19 6.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.618 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 184' ' ' VAL . 9.9 p -43.67 -42.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.669 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.443 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 34.0 m -75.09 -48.36 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -48.26 -36.49 14.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 190' ' ' GLN . 24.1 tp -70.85 -45.72 63.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.023 -0.989 . . . . 1.0 109.088 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.08 -47.67 77.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.8 93.54 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -62.78 -37.12 85.42 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 186' ' ' LEU . 7.0 tt0 -66.89 -31.7 72.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.647 -0.871 . . . . 1.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.62 -46.79 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -50.8 -32.84 21.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.2 mt -74.73 -34.32 33.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.198 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.94 -43.53 78.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.984 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 196' ' ' ALA . 24.2 pt -63.06 -30.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.72 -53.47 7.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.392 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.84 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.224 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.452 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -66.05 -34.05 77.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.467 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.7 -40.92 73.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.211 0.449 . . . . 1.0 112.211 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.0 tp -51.45 -34.65 36.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.928 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 94.2 p -48.3 -56.41 8.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.696 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.986 . . . . 1.0 110.482 179.507 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.362 . . . . 1.0 110.563 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.2 t0 -51.69 -33.24 33.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.728 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -75.98 -49.44 17.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.779 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -55.38 -52.69 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 1.0 110.976 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.7 mt -56.36 -30.94 63.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.988 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -64.6 -38.93 92.7 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.754 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.09 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.844 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 67.2 p -65.8 -37.4 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 1.0 112.311 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -74.58 -25.45 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.58 -43.17 23.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.283 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -72.24 -43.99 63.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.785 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 7.2 p -61.69 -47.63 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.306 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLY . 70.7 ttp85 -54.97 -44.21 74.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 1.0 110.689 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.82 60.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.351 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -70.18 -33.59 71.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.813 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -97.52 -18.96 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.759 0.314 . . . . 1.0 111.695 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.8 25.21 51.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 91.7 m -77.36 144.01 38.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.981 -0.377 . . . . 1.0 109.981 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -52.83 -42.45 65.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.635 0.605 . . . . 1.0 112.635 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 2.9 mtt-85 -149.48 128.35 12.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.507 -0.877 . . . . 1.0 112.797 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 10.9 t -136.7 129.89 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.968 -1.015 . . . . 1.0 108.739 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -137.95 152.39 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.658 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.3 t -99.12 141.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.445 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.6 t80 -131.85 133.24 44.44 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.468 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -113.66 154.06 27.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 1.0 111.205 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -103.87 137.64 41.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.68 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.3 m-20 -101.75 154.95 36.97 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.54 -52.3 2.04 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.001 2.468 . . . . 1.0 114.481 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.12 -6.31 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.561 -0.456 . . . . 1.0 112.141 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.07 37.42 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.689 -0.767 . . . . 1.0 111.887 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 57' ' ' ASP . 72.8 m80 -77.56 149.29 34.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.445 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.47 161.06 24.95 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 155.48 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 1.0 111.559 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.44 108.68 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.89 -4.27 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.41 123.44 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.25 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.7 tt0 -151.84 136.62 17.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.155 0.502 . . . . 1.0 111.705 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.82 134.36 50.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.061 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -179.714 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.864 0.364 . . . . 1.0 111.284 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 32.6 mt -98.23 14.69 26.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.484 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.7 tp -64.53 131.79 48.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.61 88.15 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.781 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.81 150.21 24.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.344 0.572 . . . . 1.0 110.479 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 p -108.63 137.17 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.566 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.55 149.57 39.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.235 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 78.5 Cg_endo -80.12 136.66 11.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.493 2.129 . . . . 1.0 111.507 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.67 -35.05 75.28 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.81 -14.7 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . 47.7 p-10 -68.71 -19.61 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.624 0.249 . . . . 1.0 111.016 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.97 97.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.538 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 41.3 Cg_exo -39.18 -95.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.565 2.177 . . . . 1.0 111.683 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.482 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 41.8 tp10 -162.91 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.969 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -51.03 -40.9 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.646 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.48 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.726 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -64.7 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 1.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -65.21 -38.8 91.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.05 -36.95 75.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.549 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -68.7 -35.37 77.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -76.98 -32.08 56.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.24 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.522 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.7 mt -95.84 -39.24 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.41 -12.94 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.2 1.185 . . . . 1.0 114.2 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.574 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.8 mp0 47.17 48.12 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.0 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.6 t -149.87 108.45 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.912 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -160.91 130.9 5.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.84 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.2 p -150.06 155.96 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.683 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.431 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 95.2 mt -114.32 131.18 67.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.245 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -87.99 171.13 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.028 0.751 . . . . 1.0 113.028 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 42.9 m-20 -50.74 115.4 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.932 -1.031 . . . . 1.0 112.231 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.0 p -49.66 -19.74 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.642 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -76.76 -38.79 53.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.821 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.577 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -61.78 -8.94 5.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.167 0.508 . . . . 1.0 110.43 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 15.8 pt20 46.17 62.03 2.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.435 -0.802 . . . . 1.0 112.891 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -93.35 126.94 38.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.752 -1.573 . . . . 1.0 106.752 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -119.4 147.01 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.666 0.987 . . . . 1.0 113.666 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.529 ' OG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -111.44 149.32 31.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.789 -1.096 . . . . 1.0 108.636 178.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 C--N 1.326 -0.438 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.445 -179.314 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.529 ' C ' ' OG ' ' A' ' 112' ' ' SER . 49.6 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 CA-C-O 120.83 0.262 . . . . 1.0 112.401 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.509 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -117.61 128.17 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 138' ' ' CYS . 4.5 p30 -45.03 140.77 3.41 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 1.0 111.376 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -37.91 -17.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 123.053 2.502 . . . . 1.0 113.748 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 136' ' ' ASP . 42.6 t -63.28 -62.21 1.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.267 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.407 ' CE1' ' CD1' ' A' ' 103' ' ' ILE . 51.7 t-80 -71.1 -25.06 62.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.667 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.36 -60.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -61.41 -37.45 83.52 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.394 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 61.1 t80 -46.17 -37.93 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.16 -43.4 64.68 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.36 -41.49 89.39 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.631 -0.878 . . . . 1.0 108.631 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -64.16 -22.18 66.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.441 -0.799 . . . . 1.0 109.642 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.598 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 70.9 mtp -97.97 2.09 48.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.101 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.97 19.44 78.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.6 -1.0 . . . . 1.0 110.6 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 78.9 t -110.19 145.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.679 0.276 . . . . 1.0 110.276 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.3 -23.9 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.027 0.38 . . . . 1.0 112.027 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 20.2 m -152.36 120.21 6.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.747 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 p -128.17 137.58 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 1.0 111.419 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.0 131.83 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.4 t -111.95 130.45 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.293 -0.563 . . . . 1.0 112.306 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.95 128.59 18.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.88 166.28 3.23 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.389 2.059 . . . . 1.0 113.733 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.59 115.35 24.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.605 -1.257 . . . . 1.0 107.605 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.8 ptm -142.3 151.61 42.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.44 0.638 . . . . 1.0 112.684 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.402 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 48.9 t-80 -128.31 124.56 36.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.913 -1.039 . . . . 1.0 108.899 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.546 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 62.2 t60 61.79 -123.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.107 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.546 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 99.0 mm-40 -97.63 3.55 50.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.519 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -107.0 144.83 33.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.683 0.994 . . . . 1.0 113.683 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.5 tp -98.78 125.7 44.21 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.519 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 73.9 m95 -105.21 -36.83 7.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.44 -173.25 23.91 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.694 -1.241 . . . . 1.0 112.39 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -139.57 120.19 14.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.441 -0.379 . . . . 1.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.8 tp -94.73 149.8 20.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.42 134.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.097 -0.641 . . . . 1.0 111.863 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -114.45 137.86 51.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.223 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 30.5 m-70 -111.96 124.69 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 1.0 112.663 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.416 ' NE2' ' OG1' ' A' ' 48' ' ' THR . 71.5 m80 -116.42 121.33 41.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.51 13.38 6.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.785 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.579 -179.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.637 0.256 . . . . 1.0 111.299 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.08 -33.41 73.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.96 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.19 -49.51 75.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.62 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.0 -52.61 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.652 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.8 t -44.98 -39.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 187' ' ' LEU . 83.7 t -73.32 -49.82 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -45.99 -32.02 2.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 tp -68.18 -48.15 66.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.119 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 184' ' ' VAL . 92.7 mt -52.1 -46.3 65.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.94 93.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.423 -0.955 . . . . 1.0 108.423 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.77 -38.89 92.79 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -66.19 -31.16 71.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.74 -46.62 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 42.5 p -51.24 -32.04 22.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.68 -34.59 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.132 -0.94 . . . . 1.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.51 -43.66 80.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.895 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 196' ' ' ALA . 21.0 pt -62.7 -29.57 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -74.92 -52.37 11.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.69 -42.67 97.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.82 72.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.36 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.02 -43.13 81.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.442 ' H ' ' CD1' ' A' ' 200' ' ' LEU . 8.4 mp -52.44 -33.51 44.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.995 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -54.56 -58.61 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.398 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.838 0.351 . . . . 1.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -48.0 -35.49 11.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -75.14 -49.88 18.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.802 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 34' ' ' ILE . 24.4 mm -56.12 -48.54 78.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.141 0.496 . . . . 1.0 110.959 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.519 ' O ' ' OG1' ' A' ' 38' ' ' THR . 32.5 mt -57.42 -29.25 63.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.955 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -66.43 -39.82 89.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.447 -0.501 . . . . 1.0 109.739 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.77 -30.04 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.767 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 75.1 p -68.48 -36.02 78.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.283 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -72.72 -25.48 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.16 0.429 . . . . 1.0 112.16 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.32 -42.67 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.267 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.95 -48.29 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.804 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -56.44 -49.22 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.352 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' GLY . 70.8 ttp85 -51.01 -43.5 60.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 1.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.8 -40.79 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.33 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.59 -35.81 79.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.758 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -96.75 -15.76 21.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 1.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.57 25.23 34.54 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.532 ' OG1' ' NE2' ' A' ' 170' ' ' HIS . 69.9 m -78.63 145.89 34.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -53.37 -44.46 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -148.28 132.44 17.35 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 119.563 -0.855 . . . . 1.0 112.798 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.4 t -136.49 130.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 114.937 -1.029 . . . . 1.0 108.777 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -136.56 148.32 47.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.604 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -98.57 140.72 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.923 -0.769 . . . . 1.0 108.923 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.5 t80 -128.92 133.04 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.464 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -106.62 141.96 37.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.979 0.419 . . . . 1.0 111.234 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.452 ' CE2' ' NH1' ' A' ' 92' ' ' ARG . 64.6 t80 -97.99 124.55 42.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.696 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' HIS . 7.6 t70 -95.22 138.72 21.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -40.76 -29.68 0.46 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.931 2.421 . . . . 1.0 114.564 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -84.44 -4.56 58.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.8 -17.53 45.38 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.929 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 57' ' ' ASP . 75.6 m80 -80.25 149.27 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.376 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.1 162.98 26.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -134.14 156.15 48.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 1.0 111.504 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.4 t -88.39 108.56 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.54 -4.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.42 124.14 7.25 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.301 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 71.2 tt0 -150.69 138.5 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.195 0.521 . . . . 1.0 111.69 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.08 128.02 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.738 -0.838 . . . . 1.0 108.738 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -102.68 137.41 40.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.991 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.733 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.489 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.814 0.34 . . . . 1.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.571 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -108.11 12.95 26.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.991 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.9 tp -64.08 132.04 49.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.28 -4.3 84.01 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.42 -0.809 . . . . 1.0 112.873 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.84 151.45 23.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.357 0.579 . . . . 1.0 110.383 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.9 m -108.04 134.81 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.635 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -108.52 150.9 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.249 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.37 140.6 15.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.73 -33.86 76.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 1.0 110.463 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.2 -16.67 0.17 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' ALA . 11.8 p-10 -55.65 -11.98 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.671 0.272 . . . . 1.0 111.037 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -151.75 146.45 18.76 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.536 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 93.4 Cg_endo -75.7 -92.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.556 2.17 . . . . 1.0 111.675 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' OE2' ' NH2' ' A' ' 92' ' ' ARG . 46.7 tp10 -167.58 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.2 pt-20 -55.23 -41.74 72.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -72.07 -37.64 69.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.76 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.539 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 54.0 ttp180 -62.58 -33.06 74.2 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.776 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -64.05 -37.42 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.915 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.63 -35.87 77.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.589 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.3 -36.94 77.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -75.43 -30.87 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.255 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.54 -38.86 10.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.804 1.039 . . . . 1.0 113.804 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.92 -13.08 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.262 1.208 . . . . 1.0 114.262 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.471 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 9.0 mp0 47.87 56.92 6.55 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.689 -0.804 . . . . 1.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.3 m -159.41 113.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.913 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -165.99 135.77 3.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.896 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.3 p -148.21 156.44 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 1.0 109.705 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.429 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 28.2 mt -109.78 128.5 65.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.84 165.8 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.999 0.74 . . . . 1.0 112.999 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -51.46 118.63 3.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.43 -25.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.656 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -77.18 -38.91 50.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.1 43.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.129 0.49 . . . . 1.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 57.73 60.26 2.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t -94.39 124.82 38.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -119.69 143.85 47.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.65 ' HG ' ' H ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -112.51 152.64 28.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.756 -1.111 . . . . 1.0 108.627 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 120.492 -0.483 . . . . 1.0 111.448 -178.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.492 1.439 0 CA-C-O 120.811 0.255 . . . . 1.0 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -118.17 129.83 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.65 ' H ' ' HG ' ' A' ' 112' ' ' SER . 6.9 t0 -45.99 138.53 5.77 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.729 0.3 . . . . 1.0 111.33 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -39.08 -35.79 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.068 2.512 . . . . 1.0 113.62 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 t -43.53 -63.71 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.261 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.78 -22.49 62.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.678 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.67 -55.2 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.562 0.578 . . . . 1.0 112.562 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.48 -40.14 96.3 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.378 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.79 -35.57 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.64 -42.79 60.96 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -58.68 -43.73 90.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.1 m -62.42 -19.37 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.653 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.6 mmm -99.97 0.87 41.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.088 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.06 18.55 78.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.8 144.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.661 0.267 . . . . 1.0 110.351 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.43 -38.57 2.99 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.087 0.403 . . . . 1.0 112.087 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.1 p -138.4 121.26 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.721 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -130.92 141.46 50.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 1.0 111.332 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.66 131.62 55.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.1 m -116.18 140.04 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.264 -0.575 . . . . 1.0 112.239 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.9 t -131.91 132.66 23.33 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -89.92 159.87 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.326 2.018 . . . . 1.0 113.666 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 34.3 mt -114.89 117.02 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.2 ptm -140.33 148.07 40.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 81.5 t60 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.826 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 22.1 m-70 58.38 -125.44 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.148 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -100.67 6.11 43.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.761 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 11.5 pt-20 -111.98 156.32 22.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.728 1.01 . . . . 1.0 113.728 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.6 tp -102.04 128.1 48.63 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.515 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 29.7 m95 -104.58 -34.74 8.09 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.15 31.06 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.712 -1.232 . . . . 1.0 112.383 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -137.41 123.11 19.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.446 -0.377 . . . . 1.0 111.643 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.65 149.24 21.44 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.69 131.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.1 -0.64 . . . . 1.0 111.899 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.6 t -114.91 135.18 54.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.258 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 11.7 m-70 -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.532 ' NE2' ' OG1' ' A' ' 48' ' ' THR . 72.3 m80 -117.45 119.88 36.42 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.11 24.58 1.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.822 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 1.3 pm0 . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.956 -0.298 . . . . 1.0 110.627 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.585 0.231 . . . . 1.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -64.56 -31.86 73.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 1.0 110.953 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.13 -38.52 91.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.614 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.67 -51.87 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.869 -0.332 . . . . 1.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -42.23 -42.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.689 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.47 -45.94 44.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -50.53 -32.87 19.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.063 -1.088 . . . . 1.0 108.063 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 16.8 tp -73.0 -52.65 13.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.089 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.17 -46.01 65.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.19 80.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -61.23 -38.44 86.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 44.5 tt0 -64.9 -33.11 75.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.4 -45.74 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.376 -0.972 . . . . 1.0 108.376 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -52.46 -36.03 53.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -68.61 -37.0 77.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.272 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.61 -41.01 80.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.405 HD11 HG23 ' A' ' 195' ' ' ILE . 48.0 mt -55.52 -48.43 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.363 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.44 -46.54 88.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.264 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.41 -33.08 74.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 1.0 111.398 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -55.97 -41.13 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 26.0 tp -53.18 -37.29 61.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.8 m -48.94 -57.75 5.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.67 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.7 mp . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.453 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.805 0.336 . . . . 1.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.22 -32.4 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.742 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.8 -48.73 20.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.792 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.6 mm -55.1 -53.3 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 1.0 110.945 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.6 mt -56.44 -30.21 62.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.99 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -64.49 -39.94 94.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.384 -0.526 . . . . 1.0 109.817 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.12 67.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.774 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.5 p -67.49 -36.46 81.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.314 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -73.65 -25.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 71.5 mm-40 -79.6 -43.8 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.773 -0.371 . . . . 1.0 111.318 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.88 -44.6 80.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.807 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -59.42 -46.56 92.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.323 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 47' ' ' GLY . 6.2 ttm180 -50.76 -45.03 58.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 1.0 110.692 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.78 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.254 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.95 -37.86 82.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.852 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.37 -18.69 18.96 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.674 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.76 25.49 56.0 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 50.0 m -78.07 143.23 37.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.38 -39.97 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.409 ' NH2' ' CB ' ' A' ' 69' ' ' ARG . 13.3 mtt85 -148.48 124.19 10.5 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.822 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.5 t -132.63 128.48 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.748 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.416 ' NZ ' ' CD1' ' A' ' 77' ' ' LEU . 34.9 mttt -136.64 148.78 47.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.616 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.39 140.96 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.57 ' HH ' ' CA ' ' A' ' 62' ' ' GLY . 20.1 t80 -130.6 132.3 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.433 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.412 HH12 ' CG2' ' A' ' 195' ' ' ILE . 60.4 ttt85 -110.84 149.84 30.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.035 0.445 . . . . 1.0 111.195 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.14 133.95 46.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.691 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 61' ' ' HIS . 11.6 m-20 -99.26 153.51 37.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -38.68 -51.08 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 122.96 2.44 . . . . 1.0 114.53 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -70.96 -6.43 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.84 -8.23 39.27 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.684 -0.77 . . . . 1.0 111.922 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ASP . 70.0 m80 -78.23 151.03 33.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.424 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' CA ' ' HH ' ' A' ' 54' ' ' TYR . . . -138.59 163.61 25.78 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -135.87 157.72 46.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.999 0.428 . . . . 1.0 111.528 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.6 107.75 17.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.77 -5.19 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.71 123.2 7.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.274 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 55.1 tt0 -148.45 136.99 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.152 0.501 . . . . 1.0 111.734 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.62 129.03 48.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' CB ' ' NH2' ' A' ' 50' ' ' ARG . 30.8 ptt-85 -107.01 137.98 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.292 -0.563 . . . . 1.0 112.052 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 178.518 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.796 0.332 . . . . 1.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.594 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 42.7 mt -110.81 19.43 18.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.0 tp -66.47 130.47 43.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.35 87.2 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.41 -0.814 . . . . 1.0 112.858 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.3 149.23 25.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.32 0.56 . . . . 1.0 110.429 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.1 m -106.89 134.62 49.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.589 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -108.78 148.9 38.75 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.215 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.73 136.17 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.572 2.182 . . . . 1.0 111.502 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -58.28 -30.58 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.817 0.341 . . . . 1.0 110.413 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.61 -16.63 0.06 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.227 -0.749 . . . . 1.0 111.227 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 84' ' ' ALA . 51.4 t0 -62.07 -21.84 65.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.701 0.286 . . . . 1.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.0 mt -143.35 104.71 5.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.529 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -40.38 -84.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.56 2.173 . . . . 1.0 111.629 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' OE2' ' NH2' ' A' ' 92' ' ' ARG . 46.2 tp10 -172.41 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.53 -43.31 93.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.626 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.64 -36.78 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.521 -0.308 . . . . 1.0 111.702 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 65.4 ttp85 -64.6 -32.75 74.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.774 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -64.42 -37.19 86.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.857 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.11 -36.7 80.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.532 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -67.39 -33.98 76.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -74.14 -33.22 63.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.263 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.465 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.2 mt -94.82 -38.11 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.82 -13.56 9.07 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 114.228 1.196 . . . . 1.0 114.228 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.575 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.4 mp0 47.06 49.7 14.72 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.665 -0.814 . . . . 1.0 109.864 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.4 109.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 120.314 -0.554 . . . . 1.0 111.878 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.02 134.88 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.865 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.4 p -151.05 156.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.724 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.446 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 27.8 mt -109.96 128.77 65.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.263 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.69 169.34 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.972 0.73 . . . . 1.0 112.972 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -49.52 113.73 0.89 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.289 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 52.9 t -51.37 -18.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.696 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 109' ' ' GLN . 44.2 tp10 -77.95 -38.81 44.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.795 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -61.75 -7.19 3.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.131 0.491 . . . . 1.0 110.384 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 18.2 pt20 45.67 62.77 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.494 -0.776 . . . . 1.0 112.881 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 m -93.91 127.83 39.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -119.79 144.73 47.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.708 1.003 . . . . 1.0 113.708 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -108.84 150.43 27.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.715 -1.129 . . . . 1.0 108.619 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.3 pt . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.457 -179.572 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.513 ' O ' ' OG ' ' A' ' 112' ' ' SER . 56.1 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.83 0.263 . . . . 1.0 112.356 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.494 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 89.4 t -112.11 123.87 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.533 ' N ' ' OG ' ' A' ' 112' ' ' SER . 5.6 t70 -44.83 139.23 3.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.293 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.67 -25.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.091 2.527 . . . . 1.0 113.632 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.8 t -49.58 -61.97 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.206 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -72.94 -23.21 60.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.68 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.55 -60.96 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -63.31 -39.46 94.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.364 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 83.1 t80 -48.21 -40.01 22.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.27 -44.8 64.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -56.2 -41.77 76.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -62.65 -22.07 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.622 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.588 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 46.1 mtp -97.25 -1.48 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 20.27 73.8 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.17 143.49 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.277 . . . . 1.0 110.344 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.38 -28.2 4.69 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -151.44 120.2 6.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.811 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 72.9 m -128.65 142.46 51.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 1.0 111.46 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tp -100.07 132.43 45.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.91 130.39 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.305 -0.558 . . . . 1.0 112.242 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 19.8 t -135.71 131.35 19.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.247 -1.02 . . . . 1.0 108.247 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.29 163.01 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.389 2.06 . . . . 1.0 113.69 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.2 mt -115.77 113.93 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.4 ptm -142.0 152.31 43.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.751 0.649 . . . . 1.0 112.751 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -128.04 123.74 35.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 1.0 108.88 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.503 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 17.6 t-80 61.98 -123.64 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.1 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.503 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 15.3 mm100 -97.39 3.3 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.843 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.4 tt0 -106.56 144.96 32.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.75 1.018 . . . . 1.0 113.75 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 48.2 tp -100.18 125.05 46.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.9 m95 -103.76 -33.45 8.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.58 0.956 . . . . 1.0 113.58 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.64 -175.99 32.25 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.668 -1.253 . . . . 1.0 112.371 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 mt -135.06 123.12 22.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.447 -0.377 . . . . 1.0 111.617 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 5.2 tp -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.45 132.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.825 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.5 p -114.2 133.69 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.174 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.472 ' O ' ' CG2' ' A' ' 48' ' ' THR . 46.4 m80 -106.05 122.7 46.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 4.7 t-80 -118.08 121.52 40.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.1 -17.36 62.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.537 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.618 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.726 0.298 . . . . 1.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -73.18 -37.24 66.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 1.0 110.941 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.6 -43.97 93.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.625 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 186' ' ' LEU . 63.2 tt0 -64.45 -51.55 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 1.0 111.721 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.8 t -44.25 -42.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.669 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.09 -50.5 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -49.46 -33.44 14.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 190' ' ' GLN . 6.5 tt -74.55 -48.15 28.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.032 -0.985 . . . . 1.0 109.069 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -53.43 -46.52 69.86 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.3 80.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -60.58 -38.37 84.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 186' ' ' LEU . 57.4 tp60 -65.85 -33.4 75.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.3 -47.13 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.1 p -52.64 -35.01 54.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.13 -35.47 71.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.326 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.2 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.412 ' CG2' HH12 ' A' ' 55' ' ' ARG . 64.3 mt -56.49 -45.5 82.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.6 -49.7 67.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.54 -46.3 88.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.24 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -32.2 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 1.0 111.394 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.82 -43.03 80.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 37.6 tp -53.64 -37.64 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.935 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 32.0 t -54.5 -61.84 2.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.657 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.499 179.728 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.781 0.325 . . . . 1.0 110.496 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -48.67 -35.1 13.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.753 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -74.74 -50.57 16.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.798 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.0 mt -56.78 -46.49 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.124 0.488 . . . . 1.0 110.945 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.503 ' O ' ' OG1' ' A' ' 38' ' ' THR . 22.3 mt -58.71 -27.38 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.968 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -69.92 -37.73 76.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.42 -0.512 . . . . 1.0 109.807 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.1 66.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.751 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 57.2 p -67.98 -37.14 81.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 1.0 112.324 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.3 p -72.08 -24.91 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.83 -43.09 23.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.28 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -70.28 -48.34 57.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.78 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 14.4 p -57.67 -47.66 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.366 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLY . 66.2 ttt-85 -51.79 -44.09 63.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 1.0 110.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.39 -40.81 65.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.12 -36.45 83.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.838 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.44 -14.67 21.03 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.722 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 26.06 30.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' ' CE1' ' A' ' 170' ' ' HIS . 49.6 m -76.99 143.66 39.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.8 p30 -53.84 -41.57 67.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.602 0.593 . . . . 1.0 112.602 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 22.2 ttt-85 -151.31 131.85 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 119.612 -0.835 . . . . 1.0 112.826 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 9.0 t -138.66 132.94 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.759 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.715 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 24.3 pttm -137.13 149.27 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.628 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.0 t -96.41 139.18 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.3 t80 -128.36 132.16 48.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.43 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -107.86 143.25 36.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 1.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.8 t80 -99.56 125.19 45.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.687 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 2.5 m-20 -92.07 152.04 42.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.58 -21.43 38.51 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.038 2.492 . . . . 1.0 114.474 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.43 -0.93 57.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.8 -16.58 54.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.716 -0.754 . . . . 1.0 111.901 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 74.5 m80 -80.4 148.91 30.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.41 160.04 24.98 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p -133.19 154.2 50.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.99 0.424 . . . . 1.0 111.503 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 t -91.78 113.29 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.13 -2.95 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.96 128.33 9.91 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.324 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -156.14 138.82 15.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.162 0.506 . . . . 1.0 111.722 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.94 140.54 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.809 -0.812 . . . . 1.0 108.809 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.485 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 23.5 mtt85 -116.77 137.5 52.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.352 -0.539 . . . . 1.0 112.104 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.485 ' CB ' ' HE ' ' A' ' 69' ' ' ARG . 4.9 p . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.825 0.345 . . . . 1.0 111.336 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' CD1' ' NH2' ' A' ' 50' ' ' ARG . 24.0 mt -109.53 9.19 25.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.007 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.4 mt -56.11 129.04 38.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.21 -6.53 81.41 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.468 -0.787 . . . . 1.0 112.861 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.92 147.24 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.348 0.574 . . . . 1.0 110.482 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.5 m -108.8 137.46 46.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.58 149.58 39.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.213 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.8 136.23 11.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.583 2.189 . . . . 1.0 111.449 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -61.23 -32.06 71.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.818 0.342 . . . . 1.0 110.429 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.08 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.5 m-20 -61.11 -24.96 66.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.72 0.295 . . . . 1.0 111.035 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 pt -137.32 143.96 43.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.52 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.544 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 96.4 Cg_endo -76.39 -89.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.581 2.187 . . . . 1.0 111.608 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.544 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 83.3 tt0 -170.01 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.957 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 19.6 pt-20 -59.26 -40.47 86.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.586 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -73.39 -38.28 65.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.703 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.663 HH12 ' NH2' ' A' ' 96' ' ' ARG . 66.9 ttp85 -61.89 -32.89 73.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 1.0 110.808 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -64.61 -36.77 85.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.938 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.91 -36.36 79.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.493 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.55 -38.45 77.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.663 ' NH2' HH12 ' A' ' 92' ' ' ARG . 28.1 ttm180 -74.03 -33.15 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.159 -0.928 . . . . 1.0 111.197 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.514 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.0 mt -94.58 -37.73 11.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.789 1.033 . . . . 1.0 113.789 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.12 -12.65 9.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.274 1.213 . . . . 1.0 114.274 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.548 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.3 mp0 46.99 47.63 15.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.958 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.51 109.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.413 -0.515 . . . . 1.0 111.946 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.58 130.72 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.798 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.14 159.05 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.37 128.45 66.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.004 0.431 . . . . 1.0 110.257 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.96 171.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.021 0.749 . . . . 1.0 113.021 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -50.32 115.0 1.25 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.999 -1.0 . . . . 1.0 112.192 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 p -52.55 -27.15 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.69 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.08 -40.27 62.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.85 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.15 -15.05 3.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 1.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.685 ' NE2' HH21 ' A' ' 111' ' ' ARG . 6.9 tp60 56.81 60.81 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.491 -0.777 . . . . 1.0 112.847 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 m -95.62 125.29 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.685 HH21 ' NE2' ' A' ' 109' ' ' GLN . 87.9 mtt-85 -118.08 144.92 45.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -109.46 145.46 36.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.767 -1.106 . . . . 1.0 108.646 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.441 -178.444 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 N--CA 1.491 1.368 0 CA-C-O 120.855 0.273 . . . . 1.0 112.38 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.3 t -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.1 OUTLIER -45.03 157.27 0.34 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.401 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.94 -9.92 15.91 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.135 2.557 . . . . 1.0 113.711 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -66.56 -63.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.258 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.486 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 41.5 t60 -71.64 -25.41 62.13 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.656 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.2 -58.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.86 -37.9 89.09 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.419 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.455 ' O ' ' OG ' ' A' ' 145' ' ' SER . 80.5 t80 -48.8 -35.28 14.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.8 mt -73.45 -43.25 60.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -58.73 -44.31 90.41 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 96.9 p -62.51 -18.11 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.716 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.8 mmm -100.89 0.57 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.93 19.05 78.13 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.13 143.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.697 0.284 . . . . 1.0 110.292 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.78 -32.15 5.23 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.975 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.8 m -143.79 122.45 12.57 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.746 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 p -126.86 131.7 51.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 1.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -97.0 131.43 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.95 131.13 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.32 -0.552 . . . . 1.0 112.304 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.7 t -135.93 131.36 18.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.199 -1.038 . . . . 1.0 108.199 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -93.78 162.41 2.26 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.424 2.083 . . . . 1.0 113.706 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.5 mt -115.55 113.86 24.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.3 ptm -140.92 150.19 42.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 71.9 t60 -122.09 123.22 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.933 -1.03 . . . . 1.0 108.878 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 45.8 m-70 57.4 -118.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.12 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -98.12 1.87 48.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 143.75 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.7 tp -99.51 124.43 44.68 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.508 -1.293 . . . . 1.0 107.508 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 65.5 m95 -103.24 -32.18 9.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.575 0.954 . . . . 1.0 113.575 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.81 -173.06 32.05 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 119.701 -1.238 . . . . 1.0 112.39 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.6 mt -136.22 122.81 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.443 -0.379 . . . . 1.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.9 tp -95.33 149.35 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.15 134.52 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.867 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.1 m -115.73 139.02 50.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.22 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.715 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 18.9 m-70 -110.64 123.97 51.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.542 ' CE1' ' OG1' ' A' ' 48' ' ' THR . 84.8 m-70 -117.97 113.86 22.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.92 -22.71 59.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.777 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.553 -179.439 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.626 0.25 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.52 -32.61 68.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 1.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.96 -35.8 81.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.667 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.69 -53.17 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.718 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 76.2 t -41.82 -42.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.589 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.1 m -74.67 -45.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -52.91 -31.5 40.21 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 190' ' ' GLN . 39.3 tp -75.84 -56.56 4.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.097 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.0 mt -51.04 -45.42 61.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.43 76.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.361 -0.978 . . . . 1.0 108.361 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -61.11 -39.02 88.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 186' ' ' LEU . 46.8 tp60 -64.44 -33.37 75.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.593 -0.892 . . . . 1.0 108.593 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.75 -46.78 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.0 p -53.14 -33.79 53.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 mt -70.41 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.114 -0.948 . . . . 1.0 110.174 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.48 82.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.871 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 195' ' ' ILE . 48.5 mt -55.74 -48.26 78.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.14 66.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.403 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.82 -46.54 87.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.294 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -33.14 75.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.6 tp -53.07 -38.89 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.5 t -47.67 -58.41 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.638 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.955 -1.022 . . . . 1.0 110.426 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 1.0 110.52 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 2.3 p30 -67.12 -31.09 71.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 79.9 mt-30 -74.53 -49.06 23.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.754 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 34' ' ' ILE . 96.1 mt -55.28 -48.01 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 1.0 110.954 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' ' OG1' ' A' ' 38' ' ' THR . 62.7 mt -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.984 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -65.32 -39.88 93.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.378 -0.529 . . . . 1.0 109.835 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.47 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.768 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.0 p -67.56 -35.97 80.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 1.0 112.303 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -74.69 -24.69 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -178.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.71 -47.25 60.78 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.298 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.31 -32.37 64.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.828 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.99 -55.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.298 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.6 tmm_? -54.22 -43.77 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 1.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -40.68 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.314 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -67.82 -36.08 79.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.826 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.5 mt -96.88 -18.65 19.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.756 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.94 25.19 56.05 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -79.86 147.26 31.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -52.43 -41.48 63.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.697 HH22 ' NE ' ' A' ' 69' ' ' ARG . 84.1 mtt-85 -151.15 128.83 11.52 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.55 -0.86 . . . . 1.0 112.818 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 6.2 t -134.35 128.24 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.771 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.629 ' HZ2' ' HE2' ' A' ' 169' ' ' HIS . 20.9 pttm -138.65 153.54 48.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.662 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.36 139.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -127.14 130.23 49.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -110.68 149.64 30.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.007 0.432 . . . . 1.0 111.156 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.87 138.97 38.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -104.12 153.35 38.98 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 109.392 -0.596 . . . . 1.0 109.392 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -39.18 -51.61 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 123.015 2.477 . . . . 1.0 114.473 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.54 -4.76 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.61 -8.5 43.68 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.693 -0.765 . . . . 1.0 111.944 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' A' ' 57' ' ' ASP . 75.3 m80 -76.97 149.2 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.378 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.19 161.78 25.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -135.9 157.47 46.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 1.0 111.524 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 p -96.87 114.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.39 3.13 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.102 0.408 . . . . 1.0 112.102 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.61 127.16 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.274 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.524 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 79.8 tt0 -156.69 138.87 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.194 0.521 . . . . 1.0 111.683 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.57 134.78 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.697 ' NE ' HH22 ' A' ' 50' ' ' ARG . 10.5 mtp180 -104.08 134.57 47.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.05 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 178.226 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.792 0.329 . . . . 1.0 111.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 25.5 mt -113.6 17.37 18.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.954 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 28.0 tp -66.79 130.72 44.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.56 -1.39 88.29 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.478 -0.783 . . . . 1.0 112.807 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.09 149.9 24.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.407 0.604 . . . . 1.0 110.451 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -104.86 131.15 52.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.629 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -106.09 106.35 56.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.303 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -43.34 139.17 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.562 2.175 . . . . 1.0 111.511 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.44 -32.09 69.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.942 0.401 . . . . 1.0 110.503 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.48 -18.01 0.1 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.25 -0.74 . . . . 1.0 111.25 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 60.1 t0 -64.28 -19.2 65.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.624 0.25 . . . . 1.0 111.075 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mt -138.06 133.26 17.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.515 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.71 -94.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.525 2.15 . . . . 1.0 111.643 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.17 -38.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.994 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.48 -42.73 71.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.576 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.9 71.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.75 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -62.81 -33.43 75.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.747 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -64.15 -38.74 92.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.16 -37.32 79.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 1.0 111.536 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -67.99 -34.65 76.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.77 -28.9 50.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.12 -0.946 . . . . 1.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -94.69 -39.59 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.06 -10.16 8.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.419 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 3.7 mp0 45.74 58.93 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.621 -0.832 . . . . 1.0 109.942 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 10.9 p -163.83 114.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -168.38 136.87 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.824 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.3 p -152.08 157.21 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.677 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.472 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 71.3 mt -109.77 130.07 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.262 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.443 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 9.6 p -85.96 168.56 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.443 ' H ' ' CG2' ' A' ' 104' ' ' VAL . 60.0 m-20 -48.12 114.73 0.99 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.204 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.4 t -51.86 -21.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.697 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -78.18 -37.91 44.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.34 -16.49 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.17 0.509 . . . . 1.0 110.365 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 56.43 63.03 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 1.0 112.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.402 ' OG ' ' CG1' ' A' ' 104' ' ' VAL . 80.0 p -96.31 124.3 40.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -117.17 145.05 44.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 t -108.06 144.15 35.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.713 -1.13 . . . . 1.0 108.618 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--N 1.325 -0.47 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.467 -179.006 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 N--CA 1.491 1.38 0 CA-C-O 120.792 0.247 . . . . 1.0 112.452 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.97 126.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 138' ' ' CYS . 1.7 p30 -45.68 143.5 3.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.401 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -37.36 -25.92 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.118 2.545 . . . . 1.0 113.649 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.427 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.1 t -53.9 -61.23 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.257 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -69.39 -24.9 63.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.664 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.51 -60.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -61.81 -40.25 94.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 1.0 110.353 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -46.75 -39.11 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.06 -45.17 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -57.17 -43.1 82.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 t -63.5 -20.13 65.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 1.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.3 mmm -99.72 -3.45 32.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.093 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.06 78.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.15 141.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 1.0 110.254 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.94 -36.12 3.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.998 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 6.7 m -142.01 119.43 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.705 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 168' ' ' SER . 44.4 t -126.79 136.39 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.981 0.419 . . . . 1.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.77 132.36 41.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 t -113.5 129.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.31 -0.556 . . . . 1.0 112.298 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 166' ' ' LEU . 22.7 t -136.97 136.39 21.09 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.255 -1.017 . . . . 1.0 108.255 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.82 166.25 1.02 Allowed 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.423 2.082 . . . . 1.0 113.699 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 mt -118.43 114.73 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.419 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 22.0 ptm -142.03 153.91 44.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.457 0.646 . . . . 1.0 112.683 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.428 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 43.7 t-80 -129.68 124.19 33.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.903 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.7 t-80 61.84 -123.73 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.144 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.467 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 95.5 mt-30 -97.56 3.61 50.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.813 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.8 144.75 33.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.736 1.013 . . . . 1.0 113.736 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 39.7 tp -100.69 125.26 47.11 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 87.5 m95 -102.92 -32.95 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.09 -173.31 30.61 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.393 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.2 123.19 21.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.433 -0.383 . . . . 1.0 111.634 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 154' ' ' VAL . 4.7 tp -95.29 149.9 20.83 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.01 134.5 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.844 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 151' ' ' SER . 42.2 m -114.94 136.66 52.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.729 -0.669 . . . . 1.0 109.282 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.629 ' HE2' ' HZ2' ' A' ' 52' ' ' LYS . 32.3 m-70 -112.35 129.6 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -120.03 128.62 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.18 23.91 1.7 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.871 -0.331 . . . . 1.0 110.558 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.72 0.295 . . . . 1.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 1.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.6 tp -56.24 -45.29 80.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.9 -53.66 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.66 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 90.8 t -44.58 -40.1 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.07 -49.03 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -48.68 -33.52 10.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 190' ' ' GLN . 47.2 tp -75.17 -46.19 35.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.039 -0.982 . . . . 1.0 109.064 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.8 tp -54.64 -47.74 73.13 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.41 92.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.443 ' O ' ' OG ' ' A' ' 192' ' ' SER . 57.2 t0 -62.28 -39.41 92.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.0 tp60 -64.54 -30.92 71.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 194' ' ' ALA . 51.6 t -77.23 -45.35 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 31.1 p -49.2 -31.64 8.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -73.57 -35.39 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.296 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -66.69 -44.01 82.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.922 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 196' ' ' ALA . 25.2 pt -64.97 -27.01 41.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.6 -54.36 6.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.301 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.3 pt20 -66.06 -37.53 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.289 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.355 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -58.15 -43.72 87.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.204 0.446 . . . . 1.0 112.204 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 47.7 mt -51.94 -30.39 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.502 ' HG ' ' H ' ' A' ' 202' ' ' LEU . 95.8 p -44.87 -55.75 5.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.636 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.502 ' H ' ' HG ' ' A' ' 201' ' ' SER . 10.5 mp . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.459 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 66.9 t0 -48.15 -37.1 14.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.694 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -74.7 -51.19 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.838 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.67 -47.45 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 1.0 110.964 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 38' ' ' THR . 24.5 mt -56.9 -30.17 63.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.943 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -65.25 -38.48 90.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.73 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.739 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -69.59 -34.95 74.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.35 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.7 p -74.12 -25.22 19.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.22 -47.28 18.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.266 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -49.93 67.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.768 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 12.9 p -52.48 -47.08 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.315 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 47' ' ' GLY . 53.5 ttp180 -49.98 -43.93 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 1.0 110.596 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.52 -40.47 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.36 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.45 -37.29 82.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.804 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -96.64 -17.72 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.695 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 25.26 27.57 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 p -79.6 149.54 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.64 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 28.0 p30 -49.94 -41.94 47.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.64 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 29.7 ptt180 -159.41 146.54 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.584 -0.847 . . . . 1.0 112.788 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 13.4 p -144.02 135.65 22.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.956 -1.02 . . . . 1.0 108.733 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -137.54 149.75 46.97 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.239 -0.584 . . . . 1.0 111.573 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -98.09 140.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.401 ' CZ ' ' C ' ' A' ' 62' ' ' GLY . 17.8 t80 -129.48 131.3 46.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.482 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -109.89 148.19 32.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 1.0 111.257 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.47 133.91 45.38 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.755 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 61' ' ' HIS . 23.0 m-20 -98.44 152.95 38.17 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -39.43 -50.37 2.97 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.02 2.48 . . . . 1.0 114.516 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -70.11 -6.18 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.35 41.45 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.871 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' ASP . 31.1 m80 -79.69 152.29 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.369 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' C ' ' CZ ' ' A' ' 54' ' ' TYR . . . -139.21 164.65 25.85 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -135.87 157.67 46.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.0 111.525 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 t -92.03 109.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 ' CG1' ' OD1' ' A' ' 32' ' ' ASP . 21.6 t -111.32 -1.86 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.54 128.43 9.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.274 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -160.09 140.95 12.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.151 0.501 . . . . 1.0 111.762 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.27 136.53 52.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.499 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 15.1 mtt180 -104.33 134.94 46.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.062 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.636 -0.986 . . . . 1.0 110.636 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.794 0.331 . . . . 1.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -109.5 10.05 25.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.929 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.5 mt -53.68 127.9 27.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.4 84.56 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.817 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.36 148.03 28.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.438 0.619 . . . . 1.0 110.448 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 t -106.64 132.72 52.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.614 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.57 107.74 59.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.297 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -43.38 140.35 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.525 2.15 . . . . 1.0 111.464 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -67.16 -26.34 66.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.392 . . . . 1.0 110.471 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.08 -17.57 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ALA . 26.2 p-10 -69.12 -17.2 63.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 1.0 111.035 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.37 133.53 24.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.45 -97.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.616 2.21 . . . . 1.0 111.631 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -163.89 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.932 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -56.39 -41.48 76.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.651 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.81 59.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.695 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 39.9 ttm180 -60.25 -34.45 73.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.797 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -63.44 -33.82 76.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.94 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.81 -34.08 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.513 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.437 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 89.0 m-85 -69.38 -38.94 78.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 14.9 mtm180 -72.35 -33.38 67.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.26 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.11 -36.1 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.45 -16.49 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' GLN . 15.1 mp0 48.72 58.68 5.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.972 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 4.9 m -159.61 112.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.92 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -165.02 135.57 3.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.898 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -150.41 157.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.693 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 3.3 mt -109.43 130.0 63.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.246 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.7 165.16 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -50.0 116.97 2.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.18 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 p -49.92 -21.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.701 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -80.3 -37.4 32.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.837 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.1 -21.66 66.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.119 0.485 . . . . 1.0 110.412 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 57.79 61.43 2.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.523 -0.762 . . . . 1.0 112.9 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.9 m -93.31 125.88 38.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -121.6 146.43 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -113.86 152.01 31.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.782 -1.099 . . . . 1.0 108.668 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 120.416 -0.514 . . . . 1.0 111.446 -178.091 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 120.803 0.251 . . . . 1.0 112.37 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.4 129.5 75.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.455 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.5 m-20 -44.53 140.9 2.97 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.708 0.29 . . . . 1.0 111.365 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -38.32 -23.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.064 2.51 . . . . 1.0 113.685 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -53.78 -62.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.23 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.439 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 71.7 t60 -71.29 -23.48 61.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.676 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.41 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.623 0.601 . . . . 1.0 112.623 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.14 -39.76 95.61 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.37 -37.61 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 61.8 mt -72.99 -42.13 63.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.192 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.81 -42.94 90.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.8 m -62.11 -19.45 63.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.623 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.0 mmm -99.54 0.98 43.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.102 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.76 19.63 75.28 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 93.4 t -110.48 144.47 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.734 0.302 . . . . 1.0 110.245 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.63 -24.61 5.71 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -152.41 119.57 5.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.76 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.2 p -127.85 139.32 52.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 1.0 111.405 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -99.38 134.47 42.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 t -114.91 128.25 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.294 -0.563 . . . . 1.0 112.337 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.5 t -134.3 133.16 21.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.05 161.22 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.415 2.076 . . . . 1.0 113.692 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.4 mt -115.2 116.81 28.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.9 ptm -141.2 156.2 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -133.26 127.46 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.062 -0.972 . . . . 1.0 108.798 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 2.0 t60 62.89 -125.4 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.16 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.529 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 19.5 pt20 -99.38 2.06 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.839 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.471 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 10.0 pt-20 -108.91 154.33 22.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.68 126.87 52.19 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.471 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 43.5 m95 -101.79 -28.21 12.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.1 -170.26 31.75 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.598 -1.287 . . . . 1.0 112.318 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 90.0 mt -136.31 123.94 22.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.454 -0.373 . . . . 1.0 111.631 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.59 149.65 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.0 p -156.3 133.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.139 -0.625 . . . . 1.0 111.912 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.0 p -117.31 133.08 56.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.249 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.512 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 59.8 m80 -101.65 126.19 48.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 -178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 170' ' ' HIS . 1.9 m80 -116.25 117.75 30.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.09 25.06 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.75 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 . . . . . 0 C--N 1.327 -0.409 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.572 -179.741 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.599 0.237 . . . . 1.0 111.214 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.77 -33.7 71.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 1.0 111.015 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.59 -33.29 72.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.644 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.44 -54.82 5.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.915 -0.314 . . . . 1.0 111.609 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.8 m -46.51 -40.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.597 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 187' ' ' LEU . 30.1 m -71.88 -50.62 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -46.46 -32.16 3.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 190' ' ' GLN . 1.7 tt -66.86 -48.04 70.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.027 -0.988 . . . . 1.0 109.1 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 184' ' ' VAL . 91.2 mt -52.69 -45.21 66.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -58.82 -45.38 90.11 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.71 -38.01 89.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.5 tp60 -64.88 -32.52 74.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.4 t -77.1 -44.7 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 1.6 m -52.9 -36.5 59.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -67.57 -36.31 75.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.111 -0.95 . . . . 1.0 110.219 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.45 84.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.948 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.07 -29.73 47.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.55 -55.02 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.398 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.4 pt20 -65.38 -40.03 92.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.222 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.39 -32.91 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 1.0 111.434 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.44 -42.87 83.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.27 -36.4 63.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.945 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.7 t -49.57 -58.21 5.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.631 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.432 179.864 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.338 . . . . 1.0 110.519 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -65.39 -31.11 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -76.07 -48.99 18.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.853 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.54 -49.99 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.072 0.463 . . . . 1.0 110.997 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.49 ' O ' ' OG1' ' A' ' 38' ' ' THR . 55.1 mt -57.45 -31.52 66.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.914 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -63.01 -40.62 98.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.735 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.48 70.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.795 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -65.28 -35.99 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.314 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -75.17 -24.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 1.0 112.201 -177.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.65 -49.99 41.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.247 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.25 -37.25 85.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.779 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.4 t -56.06 -54.1 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.345 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 47' ' ' GLY . 53.7 ttt-85 -51.02 -44.39 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 1.0 110.623 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.77 70.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.323 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.732 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.92 -14.96 21.41 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.664 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.92 26.05 25.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.8 p -81.55 152.38 27.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -48.3 -43.9 33.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.623 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 50.9 ptt85 -158.8 147.28 18.37 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.542 -0.863 . . . . 1.0 112.779 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -139.23 133.88 40.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.002 -0.999 . . . . 1.0 108.736 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.419 ' CE ' HH12 ' A' ' 50' ' ' ARG . 46.1 pttt -137.31 146.25 44.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.379 -0.528 . . . . 1.0 111.66 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.06 142.68 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.412 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.0 t80 -130.74 132.6 45.42 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.407 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -111.54 150.64 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 1.0 111.159 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -101.81 133.84 45.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.594 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -99.18 153.35 37.83 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -38.36 -51.61 2.09 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.994 2.463 . . . . 1.0 114.492 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.44 -5.56 29.41 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.173 0.435 . . . . 1.0 112.173 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -7.75 43.15 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.964 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 57' ' ' ASP . 6.0 m-70 -78.98 151.94 31.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.365 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.99 164.3 25.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.5 p -135.88 157.99 45.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 111.487 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 t -88.08 107.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.83 -3.96 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.083 0.401 . . . . 1.0 112.083 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.19 128.29 8.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.342 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.5 tt0 -158.09 139.31 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 1.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -117.37 137.92 52.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.572 . . . . 1.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.757 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.819 0.342 . . . . 1.0 111.401 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.52 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 25.2 mt -99.85 12.17 37.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.967 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.8 tp -66.57 133.33 50.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.916 0.709 . . . . 1.0 112.916 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.92 86.51 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.402 -0.817 . . . . 1.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -87.67 153.14 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.347 0.574 . . . . 1.0 110.53 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.8 m -106.86 132.21 53.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.58 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -106.0 147.21 34.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 134.78 12.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.603 2.202 . . . . 1.0 111.473 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.62 -32.9 72.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 1.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 -16.11 0.11 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.7 m-20 -59.07 -10.49 2.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.66 0.267 . . . . 1.0 110.997 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.15 145.93 40.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.559 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.59 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.502 2.135 . . . . 1.0 111.709 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 93' ' ' ARG . 79.2 tt0 -163.47 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.963 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -71.7 -39.64 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.662 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.644 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 18.3 ttm180 -61.94 -36.79 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 1.0 110.81 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 18.2 mmt85 -61.51 -35.37 77.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.943 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.08 -33.31 75.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.522 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.29 -34.97 77.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 12.0 mtm180 -75.8 -31.1 59.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.251 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.485 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.8 mt -93.78 -38.08 11.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.792 1.034 . . . . 1.0 113.792 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -120.43 -10.54 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.246 1.202 . . . . 1.0 114.246 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.485 HE22 ' C ' ' A' ' 97' ' ' LEU . 5.0 mp0 44.46 63.31 1.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.641 -0.824 . . . . 1.0 109.859 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 13.2 p -169.33 117.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.315 -0.554 . . . . 1.0 111.882 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.572 HH22 ' CA ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -173.77 131.14 0.42 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.859 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.54 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 2.5 m -142.42 159.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.657 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.8 mt -111.02 128.29 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.252 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.89 171.45 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.43 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 56.3 m-20 -52.26 113.2 0.96 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.277 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.1 p -47.71 -17.74 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 1.0 110.688 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' N ' ' C ' ' A' ' 105' ' ' ASP . 84.7 tt0 -81.81 -36.68 28.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.806 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.58 -20.21 44.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.105 0.479 . . . . 1.0 110.451 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 56.46 58.94 3.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.819 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -96.71 126.83 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -122.39 143.33 49.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.632 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -111.81 156.73 21.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.746 -1.116 . . . . 1.0 108.63 177.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 C--N 1.326 -0.426 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.462 -178.806 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.51 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 63.7 Cg_endo . . . . . 0 N--CA 1.492 1.413 0 CA-C-O 120.824 0.26 . . . . 1.0 112.413 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.572 ' CA ' HH22 ' A' ' 101' ' ' ARG . 1.9 p -117.17 129.26 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.632 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -44.97 141.18 3.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 1.0 111.294 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -40.54 -32.96 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.08 2.52 . . . . 1.0 113.706 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.52 -63.13 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.746 -0.382 . . . . 1.0 111.215 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -71.54 -22.53 61.75 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.589 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.69 -55.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -64.68 -38.83 92.34 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.4 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.459 ' O ' ' OG ' ' A' ' 145' ' ' SER . 88.3 t80 -48.72 -34.74 12.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 58.9 mt -73.53 -42.78 61.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.12 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -58.21 -44.53 88.21 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 87.2 p -62.81 -18.03 62.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.659 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.0 mmm -101.53 -0.71 34.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.137 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.07 18.55 78.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 88.1 t -107.32 142.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 1.0 110.27 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.27 -25.31 6.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.43 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 15.0 m -153.96 120.73 5.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.804 -0.359 . . . . 1.0 110.802 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 168' ' ' SER . 45.7 t -127.66 136.42 51.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.983 0.421 . . . . 1.0 111.38 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -97.97 132.33 43.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.0 t -114.86 132.4 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.268 -0.573 . . . . 1.0 112.212 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.52 133.37 20.28 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.7 161.59 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.361 2.041 . . . . 1.0 113.695 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.8 mt -115.26 116.44 28.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' OG ' ' A' ' 192' ' ' SER . 24.9 ptm -141.19 142.8 33.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -125.23 122.43 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.989 -1.005 . . . . 1.0 108.874 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.454 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 26.0 t-80 71.67 -128.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.223 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 37.4 tt0 -100.47 4.89 44.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.796 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.49 ' CD ' ' CZ2' ' A' ' 163' ' ' TRP . 5.2 pt-20 -111.28 158.31 19.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.726 1.01 . . . . 1.0 113.726 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.3 tp -101.73 128.96 47.82 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.49 ' CZ2' ' CD ' ' A' ' 161' ' ' GLU . 52.1 m95 -105.44 -37.01 6.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.512 0.93 . . . . 1.0 113.512 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.28 -172.82 24.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.731 -1.223 . . . . 1.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.2 tp -141.25 120.92 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.439 -0.38 . . . . 1.0 111.633 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.77 149.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.5 p -155.95 133.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.034 -0.666 . . . . 1.0 111.836 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 151' ' ' SER . 82.1 p -115.62 136.67 52.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 1.0 109.209 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.623 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 65.7 m-70 -115.44 131.15 57.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -123.11 126.19 46.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.51 -16.61 61.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.774 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--N 1.327 -0.399 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.607 179.712 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.601 0.239 . . . . 1.0 111.269 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.79 -30.73 71.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 1.0 110.95 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.65 -36.23 78.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.611 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.16 -55.97 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.699 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.8 m -43.72 -41.02 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.66 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.8 m -75.26 -48.88 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -49.24 -34.4 14.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 190' ' ' GLN . 97.5 mt -76.03 -48.0 22.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.982 -1.008 . . . . 1.0 109.079 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.74 -47.73 67.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.4 89.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.472 -0.936 . . . . 1.0 108.472 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.28 -38.6 91.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 186' ' ' LEU . 78.3 mm-40 -66.72 -31.64 72.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.46 -47.25 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.277 -1.009 . . . . 1.0 108.277 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 157' ' ' MET . 14.4 t -49.17 -32.66 10.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -74.72 -33.4 31.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.205 -0.907 . . . . 1.0 110.28 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.44 77.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.6 pt -62.23 -29.62 47.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.444 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -75.85 -51.83 11.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.02 -43.31 96.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.212 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.457 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -65.57 -31.93 73.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 1.0 111.395 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.43 -43.67 84.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.479 ' H ' ' CD1' ' A' ' 200' ' ' LEU . 8.1 mp -51.19 -28.46 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.973 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 98.8 p -49.75 -56.01 11.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.675 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.471 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 63.5 t0 -48.14 -36.24 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.684 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.52 -50.65 15.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.826 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.93 -48.71 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.021 0.438 . . . . 1.0 110.913 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.504 ' O ' ' OG1' ' A' ' 38' ' ' THR . 31.0 mt -57.38 -28.8 63.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.961 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -67.14 -39.14 86.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.778 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.07 -30.82 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.739 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.6 p -67.0 -36.79 82.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.301 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.62 -25.39 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.35 -36.02 40.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.239 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.58 -48.52 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.833 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 8.2 p -57.59 -52.1 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.31 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.0 ptm180 -51.81 -43.41 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 1.0 110.641 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 43' ' ' ARG . . . -51.95 -39.25 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.296 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -69.49 -32.78 71.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.833 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -97.11 -17.15 20.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.704 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.18 26.15 55.51 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.548 ' OG1' ' NE2' ' A' ' 170' ' ' HIS . 48.0 m -77.79 143.75 37.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -55.57 -40.71 72.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.605 0.594 . . . . 1.0 112.605 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.642 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -149.97 130.77 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.525 -0.87 . . . . 1.0 112.763 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.19 132.72 38.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.911 -1.04 . . . . 1.0 108.727 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.21 150.0 46.33 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.654 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.57 141.25 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.525 ' OH ' ' CD1' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -131.34 136.24 47.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.442 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -110.43 148.89 31.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 1.0 111.251 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -99.82 126.66 45.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.71 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 61' ' ' HIS . 21.5 m-20 -92.0 153.25 43.38 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.19 -50.91 2.69 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.94 2.427 . . . . 1.0 114.523 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -70.12 -7.5 42.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.184 0.438 . . . . 1.0 112.184 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.06 -6.65 40.25 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.753 -0.737 . . . . 1.0 112.014 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' ASP . 76.5 m80 -77.19 149.9 35.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.348 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.57 158.82 23.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.811 -0.915 . . . . 1.0 110.811 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 p -131.86 155.63 47.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.467 . . . . 1.0 111.426 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 77' ' ' LEU . 3.7 p -91.02 109.35 20.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.476 ' CG1' ' OD1' ' A' ' 32' ' ' ASP . 23.7 t -114.72 -4.32 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.116 0.413 . . . . 1.0 112.116 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.15 127.64 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.291 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 12.3 tm-20 -162.36 142.39 9.76 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.703 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' CB ' ' NE ' ' A' ' 43' ' ' ARG . . . -127.95 135.14 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -103.14 135.1 45.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.362 -0.535 . . . . 1.0 112.035 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.797 0 N-CA-C 110.556 -1.017 . . . . 1.0 110.556 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.839 0.352 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.642 ' H ' ' NH2' ' A' ' 50' ' ' ARG . 40.2 mt -117.74 22.09 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.932 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 64.1 mt -67.29 129.77 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.919 0.711 . . . . 1.0 112.919 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.53 -1.88 88.45 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.782 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.5 mt -87.43 149.74 24.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.418 0.609 . . . . 1.0 110.46 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -106.14 133.76 50.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.602 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 54' ' ' TYR . 8.2 m-85 -103.39 144.03 27.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.65 138.05 14.89 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.552 2.168 . . . . 1.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.425 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -61.02 -33.14 72.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.913 0.387 . . . . 1.0 110.449 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.5 -18.77 0.22 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 84' ' ' ALA . 95.1 m-20 -65.4 -20.79 66.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 1.0 110.975 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.25 133.87 25.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.57 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.47 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.589 2.193 . . . . 1.0 111.615 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -163.71 -53.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.927 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -43.84 -43.77 6.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.615 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.64 -34.87 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.701 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 56' ' ' PHE . 48.8 mtp85 -65.04 -35.03 79.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.779 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.71 -37.03 82.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.945 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.39 -35.0 76.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.556 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -68.46 -33.77 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.739 HH21 ' H ' ' A' ' 162' ' ' LEU . 22.1 mtp180 -77.01 -28.63 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.154 -0.93 . . . . 1.0 111.337 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.446 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.5 mt -96.76 -39.28 9.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.84 -13.01 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.266 1.21 . . . . 1.0 114.266 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.465 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 7.2 mp0 48.58 58.22 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.674 -0.811 . . . . 1.0 109.899 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.465 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.0 m -159.42 112.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.374 -0.53 . . . . 1.0 112.012 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -165.21 134.07 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.833 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.9 p -151.31 156.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.715 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.451 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 97.9 mt -110.92 130.84 63.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.204 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.09 170.03 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.609 0.718 . . . . 1.0 112.892 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -50.14 116.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.248 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.45 -19.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.691 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -80.08 -37.24 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.81 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.5 -18.77 42.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 56.77 62.88 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.848 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 t -95.66 124.38 39.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -118.53 145.82 45.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.1 t -109.18 145.92 35.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.811 -1.086 . . . . 1.0 108.641 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.475 -178.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 CA-C-O 120.796 0.248 . . . . 1.0 112.378 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.6 m -120.24 129.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 138' ' ' CYS . 9.7 p30 -45.81 142.08 3.86 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 1.0 111.34 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -37.34 -19.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.113 2.542 . . . . 1.0 113.675 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 t -60.73 -61.57 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -69.71 -25.75 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.627 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.44 -60.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -60.53 -37.46 81.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.372 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -46.42 -37.94 8.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.61 -43.53 63.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -58.99 -42.98 91.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.9 t -63.63 -20.27 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.669 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.5 0.28 42.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.09 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.77 18.37 78.97 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 89.5 t -108.01 143.82 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.681 0.277 . . . . 1.0 110.273 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -24.19 6.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.018 0.377 . . . . 1.0 112.018 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.9 m -154.34 122.38 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.771 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.9 p -128.08 137.16 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 1.0 111.418 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.39 133.08 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.53 129.19 68.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.298 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.85 127.6 20.37 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -90.41 161.72 4.5 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.425 2.083 . . . . 1.0 113.65 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.85 114.35 24.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.4 ptm -141.29 150.7 42.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -125.05 124.14 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.929 -1.032 . . . . 1.0 108.836 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.559 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 53.6 t-80 59.05 -120.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.109 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.559 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.3 pp0? -98.79 0.41 44.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.807 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.408 ' CD ' ' NH2' ' A' ' 96' ' ' ARG . 47.2 tp10 -105.31 145.87 30.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.739 ' H ' HH21 ' A' ' 96' ' ' ARG . 35.9 tp -101.26 124.7 47.37 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.498 -1.297 . . . . 1.0 107.498 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -103.73 -31.67 9.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.563 0.949 . . . . 1.0 113.563 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.57 -168.32 22.32 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.697 -1.239 . . . . 1.0 112.401 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.17 124.07 14.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.418 -0.391 . . . . 1.0 111.658 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.1 tp -97.18 150.52 20.79 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.63 133.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.11 -0.636 . . . . 1.0 111.88 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 t -115.53 134.31 55.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 25.5 m-70 -108.38 124.89 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.548 ' NE2' ' OG1' ' A' ' 48' ' ' THR . 79.9 m80 -117.88 119.39 34.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.6 -18.06 61.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.775 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 C--N 1.327 -0.411 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.558 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.653 0.263 . . . . 1.0 111.254 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.56 -34.87 79.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 1.0 110.932 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 181' ' ' LEU . 3.1 tt -55.36 -59.68 4.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.574 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -59.31 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.713 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.7 t -45.43 -39.63 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.664 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.59 -50.51 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -49.31 -34.55 15.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.55 -48.12 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.033 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.67 -45.51 63.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.86 91.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.07 -39.3 91.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -66.6 -31.93 72.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.91 -48.09 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.6 p -52.03 -35.25 46.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.6 mt -66.95 -35.24 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.251 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.82 -39.68 79.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.986 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.63 -47.78 78.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.99 76.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.39 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.32 -46.27 87.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.269 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.43 75.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.397 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -56.65 -41.3 76.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.6 mt -55.15 -32.84 62.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.966 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.6 m -51.37 -57.09 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.656 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.8 mp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.467 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.805 0.336 . . . . 1.0 110.503 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.5 p-10 -48.74 -33.78 10.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 51.3 tt0 -76.01 -48.82 19.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 34' ' ' ILE . 23.1 mm -56.84 -46.04 83.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 1.0 111.025 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.471 ' O ' ' OG1' ' A' ' 38' ' ' THR . 40.2 mt -57.95 -29.41 65.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 1.0 112.008 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.48 -40.74 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.785 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.14 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 50.6 p -67.97 -37.56 81.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.329 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.62 -22.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.45 -36.5 38.76 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.267 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -71.0 -44.42 65.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.764 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 43' ' ' ARG . 16.6 m -59.53 -47.23 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.336 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 47' ' ' GLY . 50.4 ttp180 -50.4 -46.08 55.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 1.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.18 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.316 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -63.38 -40.55 97.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.807 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.96 -13.58 22.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.713 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.11 26.43 20.17 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.537 ' OG1' ' NE2' ' A' ' 170' ' ' HIS . 59.7 m -77.13 144.3 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.51 -41.02 72.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.522 0.564 . . . . 1.0 112.522 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -150.51 132.26 14.99 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.65 -0.82 . . . . 1.0 112.842 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.95 134.52 28.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.97 -1.013 . . . . 1.0 108.725 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -137.95 151.14 47.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.249 -0.581 . . . . 1.0 111.614 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -97.39 140.88 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.7 t80 -130.57 130.5 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.388 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.6 ttm105 -106.39 145.01 32.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 1.0 111.275 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 57' ' ' ASP . 64.4 t80 -99.56 127.55 45.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.877 -0.602 . . . . 1.0 111.703 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.575 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -98.24 154.41 37.67 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -50.86 -36.25 51.89 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.03 2.487 . . . . 1.0 114.469 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.43 -4.28 55.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.184 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.79 -16.51 47.14 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.859 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.575 ' NE2' ' CB ' ' A' ' 57' ' ' ASP . 36.6 p-80 -78.12 148.74 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.65 160.78 24.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.1 p -133.62 154.79 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 1.0 111.567 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.71 113.02 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.72 -1.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 1.0 112.041 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.52 129.05 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.279 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 18.1 pt-20 -162.71 142.13 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.472 -0.491 . . . . 1.0 111.678 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.7 146.82 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -134.32 146.52 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.969 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 179.617 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.808 0.337 . . . . 1.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.5 mt -94.35 10.26 34.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.952 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.4 tp -57.12 129.24 40.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.85 -4.86 85.32 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.863 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.0 mt -82.21 147.47 28.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.308 0.554 . . . . 1.0 110.392 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.7 m -108.34 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.622 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -105.82 148.12 35.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.208 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.89 137.4 12.48 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.548 2.166 . . . . 1.0 111.428 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.8 -34.75 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.854 0.359 . . . . 1.0 110.439 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.11 -17.77 0.12 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.9 m-20 -58.17 -14.16 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.668 0.271 . . . . 1.0 111.018 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.0 145.62 19.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.513 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.527 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 79.2 Cg_endo -74.52 -88.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.502 2.135 . . . . 1.0 111.691 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 85.1 tt0 -170.15 -36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.16 -39.93 63.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.574 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.51 63.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.515 -0.312 . . . . 1.0 111.733 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.681 HH12 ' NH2' ' A' ' 96' ' ' ARG . 76.6 ttt-85 -61.81 -35.86 79.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.778 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -63.88 -36.89 85.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.937 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.55 -37.02 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.524 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -65.88 -34.51 78.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.681 ' NH2' HH12 ' A' ' 92' ' ' ARG . 40.3 ttm180 -76.3 -30.3 57.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.097 -0.956 . . . . 1.0 111.252 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.467 ' C ' HE22 ' A' ' 99' ' ' GLN . 83.6 mt -93.86 -39.93 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.41 -10.7 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.198 1.184 . . . . 1.0 114.198 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.7 mp0 46.72 49.17 14.27 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.688 -0.805 . . . . 1.0 109.904 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.1 t -152.85 111.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.954 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -165.86 130.23 2.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.875 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.04 158.01 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.726 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 82.2 mt -111.44 128.82 67.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.228 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.7 170.2 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.976 0.732 . . . . 1.0 112.976 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -48.58 115.01 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.221 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.9 t -52.65 -23.07 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.697 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -76.6 -39.01 53.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.781 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.5 -15.51 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.12 0.486 . . . . 1.0 110.436 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.68 HE21 ' NH2' ' A' ' 111' ' ' ARG . 47.6 tt0 56.37 61.85 2.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.465 -0.789 . . . . 1.0 112.885 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 m -96.97 125.23 41.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.808 -1.552 . . . . 1.0 106.808 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.68 ' NH2' HE21 ' A' ' 109' ' ' GLN . 97.2 mtt180 -118.36 146.41 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.2 OUTLIER -109.43 148.51 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.6 178.155 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--N 1.326 -0.446 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.457 -179.86 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.493 ' O ' ' OG ' ' A' ' 112' ' ' SER . 67.7 Cg_exo . . . . . 0 N--CA 1.491 1.335 0 CA-C-O 120.788 0.245 . . . . 1.0 112.391 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.44 122.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 138' ' ' CYS . 17.9 t70 -44.82 138.69 4.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.761 0.315 . . . . 1.0 111.356 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -35.93 -20.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.125 2.55 . . . . 1.0 113.603 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.8 t -62.63 -62.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 58.7 t-80 -69.53 -25.48 64.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.69 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.76 -59.05 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 14.1 p80 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.346 -0.541 . . . . 1.0 110.341 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.636 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 73.8 t80 -46.99 -38.79 11.3 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.53 -43.61 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -58.06 -43.08 86.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.6 m -62.97 -19.96 64.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.645 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.76 -1.28 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.097 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.57 18.14 78.04 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.49 142.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 1.0 110.277 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -22.45 7.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.981 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 p -155.17 123.16 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.769 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.0 m -129.08 137.41 51.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.416 . . . . 1.0 111.449 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.05 133.07 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.17 130.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.327 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.07 133.1 18.39 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -95.32 166.82 1.51 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.412 2.075 . . . . 1.0 113.759 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.44 116.7 27.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.4 ptm -142.45 152.97 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 -176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.43 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 39.7 t-80 -131.68 124.15 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.075 -0.966 . . . . 1.0 108.891 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.458 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.0 t-80 64.63 -126.56 0.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.122 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.458 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 98.0 mm-40 -97.05 4.96 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.784 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.528 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -107.53 145.99 32.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.723 1.009 . . . . 1.0 113.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.2 tp -99.54 125.64 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.528 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 72.1 m95 -103.33 -34.25 8.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.31 33.03 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.651 -1.262 . . . . 1.0 112.403 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 78.1 mt -135.66 121.47 19.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.469 -0.365 . . . . 1.0 111.664 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.6 tp -94.53 150.51 20.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.84 133.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.803 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.1 p -114.13 139.77 49.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.26 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 12.4 m80 -111.21 123.81 50.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.537 ' NE2' ' OG1' ' A' ' 48' ' ' THR . 73.4 m80 -117.87 119.37 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.04 -18.36 62.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.744 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.616 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.646 0.26 . . . . 1.0 111.277 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -67.66 -34.23 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 1.0 110.975 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -40.09 90.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.592 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -77.95 -52.15 9.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.66 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.8 t -44.58 -44.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.678 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 185' ' ' GLN . 7.2 p -74.29 -50.58 26.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.437 ' N ' ' CG1' ' A' ' 184' ' ' VAL . 61.5 tt0 -49.82 -36.05 25.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 190' ' ' GLN . 28.2 tp -71.23 -47.61 56.19 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.016 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.1 tp -54.04 -45.76 71.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.61 91.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -59.63 -36.6 76.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 186' ' ' LEU . 1.0 OUTLIER -67.32 -31.26 71.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.3 t -77.07 -46.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.8 p -50.93 -32.69 21.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.42 -33.06 32.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.232 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.82 80.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.959 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.86 -26.46 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.44 -54.4 6.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 8.0 pt20 -67.39 -37.87 83.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.12 -33.19 74.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.378 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.04 -43.44 86.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.177 0.436 . . . . 1.0 112.177 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.9 mt -53.28 -35.86 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.99 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.8 t -47.22 -56.12 7.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.611 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.407 179.701 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.786 0.326 . . . . 1.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -49.43 -32.84 12.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.735 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -75.91 -48.29 21.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.778 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.3 mt -55.18 -51.47 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.034 0.445 . . . . 1.0 110.993 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' O ' ' OG1' ' A' ' 38' ' ' THR . 88.0 mt -55.69 -31.46 62.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.914 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.62 -38.77 90.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.392 -0.523 . . . . 1.0 109.743 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.24 -32.22 68.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.783 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.3 p -66.9 -36.93 83.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.274 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 p -72.46 -24.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.269 0.47 . . . . 1.0 112.269 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -70.66 -44.99 65.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.276 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -69.93 -35.0 74.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.754 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.64 -54.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.296 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.5 ttt-85 -51.52 -44.55 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 1.0 110.746 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.21 -46.35 79.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.295 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.548 ' CE2' ' OE2' ' A' ' 180' ' ' GLU . 63.6 t80 -62.41 -41.45 98.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.815 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.0 mt -96.33 -12.85 23.84 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.706 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 51.68 25.08 13.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.464 ' HG1' ' CD2' ' A' ' 170' ' ' HIS . 15.2 t -78.45 148.06 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -51.94 -42.25 62.7 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 77' ' ' LEU . 77.9 ttt180 -152.95 137.17 16.51 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.647 -0.821 . . . . 1.0 112.808 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -142.75 133.15 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.668 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.637 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 24.8 pttm -138.33 151.85 47.94 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.679 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.42 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.8 t80 -130.01 132.86 46.41 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.854 -0.338 . . . . 1.0 110.434 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.82 150.9 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.424 . . . . 1.0 111.215 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -102.38 132.71 48.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.698 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 61' ' ' HIS . 26.6 m-20 -97.71 154.52 37.85 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -40.14 -50.81 3.4 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.001 2.467 . . . . 1.0 114.479 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.74 -6.77 39.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.3 -7.41 37.23 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.697 -0.764 . . . . 1.0 111.905 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' ASP . 21.5 m80 -79.72 151.91 30.17 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.371 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.423 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.71 163.52 25.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -135.07 156.92 48.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.024 0.44 . . . . 1.0 111.483 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.26 109.63 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.33 -4.79 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.28 128.12 9.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.251 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG3' HH21 ' A' ' 50' ' ' ARG . 0.6 OUTLIER -159.41 141.28 13.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.655 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.82 137.29 52.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.577 ' CZ ' ' HG ' ' A' ' 76' ' ' SER . 83.4 mtm-85 -111.5 138.39 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.075 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.483 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.849 0 N-CA-C 110.624 -0.99 . . . . 1.0 110.624 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 69' ' ' ARG . 12.9 m . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.851 0.358 . . . . 1.0 111.338 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CG ' HH22 ' A' ' 50' ' ' ARG . 43.3 mt -95.93 11.82 32.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 1.0 109.938 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.1 mt -58.9 131.51 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.85 -3.77 86.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.905 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.29 149.16 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.286 0.543 . . . . 1.0 110.454 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.9 t -105.46 131.14 53.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.643 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -105.5 106.1 54.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -42.26 134.07 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.508 2.139 . . . . 1.0 111.528 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -57.94 -30.6 66.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.861 0.363 . . . . 1.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.85 -17.69 0.1 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.4 t0 -67.49 -28.93 68.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 1.0 111.036 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 87' ' ' ILE . 27.3 mm -112.01 133.05 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.503 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 97.1 Cg_endo -76.28 -111.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.642 2.228 . . . . 1.0 111.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 90.6 mt-10 -151.57 -51.23 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.905 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.2 -40.59 67.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.633 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.32 -37.89 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.749 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 65.3 ttt180 -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.8 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -64.07 -35.53 81.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.911 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.26 -34.93 77.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.504 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -69.78 -37.64 76.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -77.31 -30.65 54.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.47 -40.39 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -117.04 -11.35 10.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 98' ' ' ALA . 5.3 mp0 44.55 62.98 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.663 -0.815 . . . . 1.0 109.898 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 10.8 p -168.54 114.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 120.31 -0.556 . . . . 1.0 111.854 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.442 ' CA ' ' HE ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -167.5 137.22 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.911 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.437 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.3 p -149.5 156.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.676 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.479 ' CD1' ' HE2' ' A' ' 139' ' ' HIS . 3.2 mt -109.57 128.34 65.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.257 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 t -84.65 165.88 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.013 0.745 . . . . 1.0 113.013 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -50.32 116.25 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.216 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.2 p -49.77 -21.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.74 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.28 -38.02 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.797 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.06 -21.19 63.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 1.0 110.399 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.467 HE21 ' CZ ' ' A' ' 111' ' ' ARG . 46.4 tt0 57.97 60.61 2.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.53 -0.759 . . . . 1.0 112.854 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -94.23 125.59 38.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.768 -1.568 . . . . 1.0 106.768 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.467 ' CZ ' HE21 ' A' ' 109' ' ' GLN . 87.0 mtt180 -120.38 144.76 47.73 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -117.03 157.15 26.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.801 -1.09 . . . . 1.0 108.634 177.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.9 pt . . . . . 0 C--N 1.326 -0.455 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.407 -178.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.492 1.401 0 CA-C-O 120.812 0.255 . . . . 1.0 112.396 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.48 131.22 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -40.9 156.57 0.2 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.669 0.271 . . . . 1.0 111.388 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.33 -26.12 80.76 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.13 2.553 . . . . 1.0 113.584 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -58.47 -56.63 19.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.0 111.21 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.526 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 2.0 t60 -68.46 -27.16 65.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.602 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.26 -53.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.37 -40.88 94.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.397 -0.521 . . . . 1.0 110.362 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -47.63 -35.3 9.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.9 mt -73.8 -41.61 62.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.193 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -60.25 -43.59 95.98 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.3 t -61.69 -18.18 58.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.632 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.8 mmm -100.95 2.66 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.166 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.79 19.0 78.34 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 144.77 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.752 0.311 . . . . 1.0 110.211 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.58 -25.1 6.54 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.974 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -154.35 122.24 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.749 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -131.2 141.71 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.006 0.432 . . . . 1.0 111.398 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.74 130.45 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.5 m -117.0 141.3 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.267 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.83 132.41 20.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -86.87 159.67 8.9 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.35 2.034 . . . . 1.0 113.71 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.4 mt -113.51 116.29 29.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.6 ptm -140.85 149.5 42.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -130.42 122.57 28.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.03 -0.986 . . . . 1.0 108.812 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.473 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 51.5 t60 69.73 -126.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.144 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.473 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 93.9 mt-30 -100.91 5.85 43.44 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.781 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.531 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 5.7 pt-20 -111.31 156.72 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 34.4 tp -103.38 127.66 50.69 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.518 -1.29 . . . . 1.0 107.518 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.531 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 32.2 m95 -103.86 -34.98 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.44 -174.52 29.28 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.628 -1.273 . . . . 1.0 112.346 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.3 mt -137.11 122.35 19.27 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.422 -0.389 . . . . 1.0 111.677 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.8 tp -94.31 148.35 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.48 132.01 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.067 -0.653 . . . . 1.0 111.862 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.7 t -115.02 136.8 52.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.709 -0.678 . . . . 1.0 109.227 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.637 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 12.2 m80 -110.55 124.68 52.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.464 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 72.0 m80 -119.15 121.84 40.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.42 -17.36 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.807 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.591 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.741 0.305 . . . . 1.0 111.263 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.548 ' OE2' ' CE2' ' A' ' 45' ' ' PHE . 38.5 tp10 -63.44 -35.94 82.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 1.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -65.82 -37.03 85.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.626 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -78.59 -52.16 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.709 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.1 t -44.28 -43.1 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.621 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 185' ' ' GLN . 6.9 p -75.39 -49.75 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.4 ' N ' ' CG1' ' A' ' 184' ' ' VAL . 58.1 tt0 -49.78 -34.36 19.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tp -72.7 -48.24 40.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.067 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.95 -45.87 64.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.93 95.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -63.11 -38.67 92.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.83 -31.32 71.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 49.1 t -76.05 -47.41 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.5 p -53.42 -34.33 57.4 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.41 -35.77 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.205 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.92 83.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.932 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.9 mt -56.92 -44.57 82.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.84 -50.51 64.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.386 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -61.85 -44.82 96.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.22 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.88 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.376 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -57.85 -44.06 86.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.1 tp -52.63 -38.39 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.5 t -51.71 -59.3 4.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.445 179.705 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.872 0.367 . . . . 1.0 110.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 29.9 p-10 -51.84 -32.82 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.724 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.9 tt0 -76.59 -50.0 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.787 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.18 -51.8 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.041 0.448 . . . . 1.0 110.899 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.496 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.8 mt -56.13 -30.25 61.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.935 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -64.44 -40.25 95.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.407 -0.517 . . . . 1.0 109.661 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.93 -33.45 70.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.721 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.3 p -64.51 -37.35 87.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.346 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -24.59 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.208 0.448 . . . . 1.0 112.208 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -72.04 -40.81 68.11 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.48 -31.33 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.777 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.84 -56.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.339 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -53.55 -43.11 68.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 1.0 110.703 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.39 -43.17 71.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.288 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -65.64 -36.34 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -96.38 -15.02 22.07 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.706 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.77 26.05 53.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.0 p -80.01 147.29 31.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.9 p30 -54.11 -39.35 66.32 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.625 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -153.12 134.69 14.43 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.574 -0.85 . . . . 1.0 112.813 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -139.8 131.83 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.701 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 25.2 pttm -138.73 152.86 48.33 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.294 -0.563 . . . . 1.0 111.614 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.15 140.91 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -130.8 131.18 44.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.45 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -112.64 153.27 27.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.007 0.432 . . . . 1.0 111.217 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.4 136.87 41.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.677 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 61' ' ' HIS . 34.3 m-20 -97.21 150.58 36.97 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -41.94 -21.71 0.17 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.044 2.496 . . . . 1.0 114.528 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -103.04 3.44 36.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.6 -14.03 57.89 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.686 -0.769 . . . . 1.0 111.922 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 57' ' ' ASP . 66.2 m80 -78.86 150.05 32.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.43 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.57 162.11 25.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -134.34 155.78 49.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.034 0.445 . . . . 1.0 111.491 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 t -88.74 109.57 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 t -110.46 -5.15 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.49 126.25 8.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.3 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 1.1 tm-20 -158.71 139.67 12.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 1.0 111.695 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.34 136.35 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -107.5 136.41 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.094 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.801 0.334 . . . . 1.0 111.372 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.625 ' H ' ' NH2' ' A' ' 50' ' ' ARG . 79.2 mt -102.92 15.19 30.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.946 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.6 mt -66.48 131.47 46.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.03 -5.21 72.3 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.818 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.3 154.52 21.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.333 0.566 . . . . 1.0 110.468 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 p -106.23 128.05 53.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.603 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -103.73 150.08 37.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.263 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.24 134.65 9.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.481 2.121 . . . . 1.0 111.46 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -62.56 -30.4 71.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.796 0.332 . . . . 1.0 110.368 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.4 -16.28 0.06 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.196 -0.762 . . . . 1.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' ALA . 55.6 t0 -58.3 -15.97 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.654 0.264 . . . . 1.0 110.99 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.12 143.44 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.468 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 90.5 Cg_endo -76.59 -96.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.548 2.165 . . . . 1.0 111.699 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 2.7 pp20? -162.72 -28.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.92 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 22.5 pt-20 -70.55 -39.72 73.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.585 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.524 ' CB ' HH12 ' A' ' 101' ' ' ARG . . . -74.0 -40.34 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.649 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 61.0 ttp180 -63.14 -36.27 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.349 . . . . 1.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -60.82 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.926 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.92 -34.17 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 1.0 111.538 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 28.0 mtp180 -73.72 -31.55 63.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.295 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.511 ' C ' HE22 ' A' ' 99' ' ' GLN . 90.2 mt -96.8 -37.26 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.17 -16.84 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.616 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.8 OUTLIER 45.73 52.84 9.24 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.619 -0.832 . . . . 1.0 109.964 -178.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.429 ' O ' ' CG ' ' A' ' 101' ' ' ARG . 24.8 t -157.33 101.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 120.293 -0.563 . . . . 1.0 111.862 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.524 HH12 ' CB ' ' A' ' 91' ' ' ALA . 5.4 mtt180 -158.46 137.92 11.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.876 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -145.97 158.35 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.71 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.47 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 2.9 mp -108.04 128.23 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.249 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.9 164.63 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -50.6 118.89 3.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.966 -1.016 . . . . 1.0 112.237 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -51.28 -22.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.709 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -78.88 -37.82 39.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.797 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.35 63.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.192 0.52 . . . . 1.0 110.432 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 57.55 62.59 2.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.904 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -94.02 124.39 38.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.19 145.23 46.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -110.68 149.67 30.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.803 -1.09 . . . . 1.0 108.6 177.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.412 -179.281 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.493 1.464 0 CA-C-O 120.841 0.267 . . . . 1.0 112.375 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.7 m -120.27 131.13 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 112' ' ' SER . 19.7 t70 -43.61 137.57 3.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 1.0 111.378 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -36.22 -25.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.047 2.498 . . . . 1.0 113.696 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 136' ' ' ASP . 25.6 t -53.61 -59.72 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.771 -0.372 . . . . 1.0 111.239 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -69.62 -23.89 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.634 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.11 -61.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -62.04 -40.93 97.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.428 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -45.94 -38.92 8.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.92 -42.81 63.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -57.83 -43.51 85.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.6 t -62.55 -19.9 64.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.336 -0.847 . . . . 1.0 109.636 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.4 mmm -99.0 -0.55 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.09 18.93 75.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 99.0 t -109.32 142.97 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.728 0.299 . . . . 1.0 110.25 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -122.22 -26.01 4.76 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 111.997 0.369 . . . . 1.0 111.997 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p -152.5 118.65 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.727 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 p -129.76 142.21 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.004 0.43 . . . . 1.0 111.359 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tp -98.97 135.19 40.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.06 130.12 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.305 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.0 131.43 18.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -93.92 163.19 2.18 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.363 2.042 . . . . 1.0 113.656 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.3 mt -115.8 113.39 23.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.659 -1.237 . . . . 1.0 107.659 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.8 ptm -140.57 149.28 42.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.477 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.3 t60 -120.75 123.62 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.958 -1.019 . . . . 1.0 108.892 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.477 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 42.8 m-70 55.86 -118.08 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.122 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -97.44 0.55 47.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.802 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.516 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.01 142.74 34.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.784 1.031 . . . . 1.0 113.784 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 49.4 tp -99.59 123.57 43.98 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.535 -1.283 . . . . 1.0 107.535 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.516 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.4 m95 -103.33 -33.77 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.576 0.954 . . . . 1.0 113.576 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.14 31.95 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.351 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 54.4 mt -134.54 121.39 20.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.706 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.61 149.77 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.408 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 10.8 p -157.19 134.13 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.013 -0.675 . . . . 1.0 111.821 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.5 t -114.23 137.47 51.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.485 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 17.0 m80 -110.19 127.46 54.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 4.1 t60 -118.58 120.38 37.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.24 12.77 7.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.83 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.481 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 42.2 mm-40 . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.615 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.639 0.257 . . . . 1.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.42 -27.5 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.974 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -55.02 -49.78 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.665 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.504 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 5.0 pt20 -78.08 -52.14 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.655 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.504 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 80.1 t -44.28 -42.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.649 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.47 -49.3 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -50.42 -33.09 19.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 190' ' ' GLN . 20.6 tp -74.51 -49.4 22.25 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.065 -0.971 . . . . 1.0 109.112 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.35 -46.11 65.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.57 86.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -61.13 -38.33 86.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 186' ' ' LEU . 62.1 tt0 -66.53 -32.34 73.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.29 -47.27 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.8 p -51.96 -35.69 46.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.7 mt -66.32 -35.66 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.212 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.71 78.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.983 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.6 -46.1 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.02 -50.29 64.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.374 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.04 -45.8 91.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.269 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -66.44 -31.99 73.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.393 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.39 -41.8 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 tp -51.54 -35.72 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.962 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 86.8 p -57.29 -60.97 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.621 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 10.3 mp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.005 -0.998 . . . . 1.0 110.446 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -49.63 -32.16 12.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.96 -48.28 25.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.791 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 34' ' ' ILE . 26.6 mm -55.02 -49.95 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.046 0.45 . . . . 1.0 110.939 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.489 ' O ' ' OG1' ' A' ' 38' ' ' THR . 83.2 mt -55.16 -32.95 62.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.935 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -61.93 -42.34 98.98 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.744 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.9 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.787 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.2 p -66.61 -36.66 83.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 1.0 112.242 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.1 p -71.25 -24.51 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.174 0.435 . . . . 1.0 112.174 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -78.74 -37.19 41.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.311 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -72.52 -43.41 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.78 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 43' ' ' ARG . 33.9 m -60.14 -49.69 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.304 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 47' ' ' GLY . 71.2 ttp85 -53.33 -45.79 69.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.683 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.53 68.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.255 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -65.7 -36.68 84.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.758 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.4 mt -96.68 -14.29 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.704 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.84 25.96 38.9 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.5 p -79.29 149.24 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.9 m-20 -49.1 -42.6 39.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.617 HH12 ' CG2' ' A' ' 148' ' ' VAL . 14.9 ptt-85 -158.28 145.44 17.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.576 -0.85 . . . . 1.0 112.791 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.7 t -137.75 135.13 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.943 -1.026 . . . . 1.0 108.684 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.526 ' NZ ' ' OE2' ' A' ' 67' ' ' GLU . 34.6 mttt -136.01 147.07 47.81 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.265 -0.574 . . . . 1.0 111.651 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.81 140.18 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -129.67 130.48 45.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.441 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -111.8 151.76 28.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 1.0 111.215 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.7 OUTLIER -101.91 139.05 38.07 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.631 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.8 m-20 -103.54 154.33 37.94 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -39.98 -51.95 2.93 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.045 2.496 . . . . 1.0 114.51 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.93 -5.03 23.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.11 -8.16 44.96 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.763 -0.732 . . . . 1.0 111.939 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ASP . 57.7 m80 -76.42 148.98 36.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.445 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.77 159.05 23.78 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -132.99 156.09 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.015 0.436 . . . . 1.0 111.449 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 79' ' ' GLY . 7.5 p -94.0 112.05 26.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -115.33 0.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.48 126.08 8.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.341 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 81.9 tt0 -153.75 138.47 17.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 1.0 111.697 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.91 133.39 51.89 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -112.02 138.54 48.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.35 -0.54 . . . . 1.0 112.055 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.775 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.853 0.359 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.457 ' CD1' ' HZ1' ' A' ' 52' ' ' LYS . 32.0 mt -114.66 10.62 16.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.8 mt -55.52 130.1 41.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.99 -2.53 87.11 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.858 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.7 mt -85.7 144.86 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.31 0.555 . . . . 1.0 110.483 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 p -102.56 131.26 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.59 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -104.39 105.31 49.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.214 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.26 136.31 5.64 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.555 2.17 . . . . 1.0 111.484 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.854 0.359 . . . . 1.0 110.391 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.06 -17.92 0.12 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.9 m-20 -64.74 -18.36 64.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.606 0.241 . . . . 1.0 111.028 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.79 133.54 18.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.539 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.57 -96.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.556 2.171 . . . . 1.0 111.672 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.7 pt-20 -164.19 -42.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.947 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 86.1 tt0 -52.95 -43.31 66.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.596 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.35 70.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.526 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 60.8 ttt180 -65.56 -31.61 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.757 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -64.84 -37.93 89.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 mt -59.19 -37.76 78.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.531 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -68.52 -33.88 74.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -77.46 -30.32 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.291 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.514 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.6 mt -94.77 -39.53 10.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.0 -11.81 9.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.514 HE22 ' C ' ' A' ' 97' ' ' LEU . 2.9 mp0 46.64 50.53 12.97 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.958 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 t -152.57 111.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.882 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -164.32 130.13 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.876 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -143.97 156.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.66 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.434 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 54.7 mt -111.99 127.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.209 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.59 169.65 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 27.5 m-20 -50.87 115.86 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.305 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.6 p -50.51 -19.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.661 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -76.28 -40.44 51.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.548 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -62.29 -8.18 5.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.132 0.491 . . . . 1.0 110.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.548 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 9.7 pt20 45.52 62.5 2.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.751 . . . . 1.0 112.868 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -92.5 127.02 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -118.75 145.17 45.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.535 ' OG ' ' C ' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -111.04 151.25 28.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.757 -1.11 . . . . 1.0 108.589 178.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.426 -179.673 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.535 ' C ' ' OG ' ' A' ' 112' ' ' SER . 50.9 Cg_endo . . . . . 0 N--CA 1.492 1.401 0 CA-C-O 120.809 0.254 . . . . 1.0 112.402 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -119.78 128.71 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 138' ' ' CYS . 5.0 t70 -44.86 140.37 3.42 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.802 0.334 . . . . 1.0 111.335 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -36.32 -26.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.198 2.599 . . . . 1.0 113.629 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 136' ' ' ASP . 38.4 t -54.22 -61.45 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.768 -0.373 . . . . 1.0 111.2 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -70.27 -24.92 63.13 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.61 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.51 -58.59 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -62.1 -38.88 90.58 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.363 -0.535 . . . . 1.0 110.402 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -47.29 -36.8 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.33 -43.4 60.86 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -58.15 -43.52 87.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.4 t -62.34 -19.28 63.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.687 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.9 mmm -100.15 0.93 41.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.158 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.7 19.46 77.8 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.617 ' CG2' HH12 ' A' ' 50' ' ' ARG . 99.0 t -108.72 144.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.624 0.249 . . . . 1.0 110.369 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.95 -27.44 5.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.441 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 51.1 m -149.71 121.43 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 87.9 p -130.45 141.8 50.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 1.0 111.418 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -103.21 133.74 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.9 t -112.64 129.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.247 -0.581 . . . . 1.0 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.69 132.83 21.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.27 164.52 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.362 2.042 . . . . 1.0 113.738 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 mt -117.05 114.31 23.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.64 -1.245 . . . . 1.0 107.64 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.5 ptm -141.47 153.02 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.556 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 58.9 t60 -126.97 126.42 43.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.9 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.556 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 38.8 m80 57.0 -120.87 1.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.157 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -97.8 2.32 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.791 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.58 145.3 31.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.76 124.25 46.13 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 75.3 m95 -102.94 -33.22 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.88 -172.33 30.23 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.598 -1.286 . . . . 1.0 112.3 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.62 122.67 19.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.426 -0.387 . . . . 1.0 111.682 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.2 tp -95.99 149.35 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.7 p -154.68 133.81 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.981 -0.687 . . . . 1.0 111.836 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 96.4 p -116.17 133.74 55.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.234 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -108.43 128.35 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.4 123.29 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.269 -1.012 . . . . 1.0 108.269 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.76 -18.94 62.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.774 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.585 0.231 . . . . 1.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -68.68 -26.83 65.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 1.0 110.983 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.25 -38.27 88.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.646 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -54.86 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.704 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -44.22 -41.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.652 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 185' ' ' GLN . 23.4 m -74.13 -47.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.451 ' N ' ' CG2' ' A' ' 184' ' ' VAL . 58.1 tt0 -50.68 -33.08 21.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.84 -50.03 26.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.074 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.4 -44.61 65.46 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.42 92.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -58.42 -37.37 75.23 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -67.77 -31.3 71.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.61 -47.78 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.515 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 44.1 p -50.32 -32.2 16.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.515 ' N ' ' HG ' ' A' ' 192' ' ' SER . 37.3 mt -74.98 -33.95 30.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.094 -0.957 . . . . 1.0 110.236 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.9 79.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.98 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 196' ' ' ALA . 22.4 pt -63.14 -28.91 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.05 -52.3 10.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.356 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.23 -41.81 96.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.302 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.61 72.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.409 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.03 -43.89 87.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.57 -35.77 54.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.707 -0.397 . . . . 1.0 111.003 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -51.08 -57.49 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.627 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.413 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.915 0.388 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 30.9 p-10 -50.66 -32.67 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.677 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 52.7 tt0 -75.67 -49.99 16.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.863 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.77 -50.58 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 1.0 110.936 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.479 ' O ' ' OG1' ' A' ' 38' ' ' THR . 65.8 mt -55.82 -31.04 62.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.001 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -67.13 -38.32 85.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.412 -0.515 . . . . 1.0 109.757 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.53 -31.99 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.754 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 77.7 p -67.13 -37.77 84.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.553 . . . . 1.0 112.329 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.5 p -73.57 -22.79 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -73.09 -40.2 65.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.337 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.92 -33.61 59.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.746 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.8 t -62.27 -56.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.349 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -52.91 -42.91 65.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 1.0 110.656 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.78 -45.5 74.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.327 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.29 -36.79 85.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.87 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.74 -16.12 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.715 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.51 24.84 48.25 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 p -79.21 146.94 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -51.62 -42.23 61.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.64 HH22 ' CG ' ' A' ' 77' ' ' LEU . 67.7 ttt180 -153.31 136.45 15.61 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.635 -0.826 . . . . 1.0 112.819 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 8.8 t -139.22 130.67 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.88 -1.055 . . . . 1.0 108.751 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -137.26 150.61 47.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.349 -0.541 . . . . 1.0 111.69 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.86 140.42 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -129.28 131.99 47.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.488 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -110.9 148.91 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 1.0 111.22 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.8 130.53 48.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.692 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 61' ' ' HIS . 9.9 m-20 -90.53 152.31 45.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -49.5 -18.68 2.56 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.055 2.504 . . . . 1.0 114.466 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.1 4.96 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.137 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.79 -15.56 59.48 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.698 -0.763 . . . . 1.0 111.875 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 74.1 m80 -79.86 151.09 30.41 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.88 163.75 25.85 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -135.39 157.55 46.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.973 0.416 . . . . 1.0 111.5 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -90.91 110.6 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.53 -3.44 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.23 125.89 8.92 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.313 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' OE2' ' CZ ' ' A' ' 50' ' ' ARG . 79.9 tt0 -155.18 138.5 15.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.119 0.485 . . . . 1.0 111.746 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.78 139.89 52.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -131.17 146.03 52.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.031 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.763 0 N-CA-C 110.564 -1.014 . . . . 1.0 110.564 179.663 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.775 0.321 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.64 ' CG ' HH22 ' A' ' 50' ' ' ARG . 26.8 mt -94.08 11.57 29.43 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.9 mt -56.48 130.43 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -3.5 87.0 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.369 -0.832 . . . . 1.0 112.854 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.95 146.83 27.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.336 0.568 . . . . 1.0 110.463 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -107.8 138.39 44.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.633 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -110.71 149.76 40.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.193 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.49 133.98 10.9 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.569 2.179 . . . . 1.0 111.44 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -57.22 -31.17 65.22 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.433 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.78 -16.88 0.23 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 30.4 p-10 -66.77 -17.3 64.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.661 0.267 . . . . 1.0 111.029 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.0 mt -137.02 98.41 10.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.506 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.496 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 43.7 Cg_exo -39.5 -95.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.507 2.138 . . . . 1.0 111.727 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 82.9 tt0 -163.67 -42.51 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.885 0.374 . . . . 1.0 110.991 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -54.64 -39.68 68.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.571 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.77 -42.01 51.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.741 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.525 HH12 HH11 ' A' ' 96' ' ' ARG . 73.6 ttp85 -61.68 -37.51 84.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.827 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.471 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 91.5 mtt-85 -61.95 -34.86 76.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.001 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.08 -33.69 76.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.5 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -68.39 -33.45 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.525 HH11 HH12 ' A' ' 92' ' ' ARG . 12.7 mtm180 -77.01 -30.74 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.236 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.526 ' C ' HE22 ' A' ' 99' ' ' GLN . 97.0 mt -96.03 -38.55 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.71 -14.11 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.188 1.181 . . . . 1.0 114.188 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.599 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.4 mp0 47.82 55.94 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.878 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.487 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 5.7 m -158.95 112.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.949 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.487 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 4.2 tpp180 -168.04 133.96 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.797 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.453 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.0 p -144.56 157.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.709 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.453 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 8.2 mt -110.51 129.1 66.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.322 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 16.7 t -84.06 165.97 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.421 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 57.1 t0 -47.9 119.53 2.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.947 -1.024 . . . . 1.0 112.282 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.22 -23.51 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.685 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -82.01 -37.09 27.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.777 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.9 -16.13 6.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.162 0.506 . . . . 1.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 57.35 60.16 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 1.0 112.844 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.5 p -95.12 125.98 40.15 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -120.98 138.63 54.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.667 0.988 . . . . 1.0 113.667 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -111.74 156.26 22.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.742 -1.117 . . . . 1.0 108.642 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 C--N 1.325 -0.495 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.475 -178.675 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.834 0.264 . . . . 1.0 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.1 p -115.27 130.16 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' N ' ' OG ' ' A' ' 112' ' ' SER . 7.9 t0 -44.96 131.99 5.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 1.0 111.393 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.86 -31.02 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.092 2.528 . . . . 1.0 113.662 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.3 t -47.24 -61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.231 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -70.88 -23.14 62.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.698 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.49 -58.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.87 -41.23 97.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.331 -0.547 . . . . 1.0 110.398 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.54 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 66.7 t80 -47.41 -38.32 13.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.05 -43.68 64.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.04 -42.75 77.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -35.09 75.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.61 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 63.2 mtp -83.39 -1.54 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.071 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.39 75.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.03 143.48 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.272 . . . . 1.0 110.341 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.16 -43.46 2.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.025 0.38 . . . . 1.0 112.025 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.7 m -134.1 119.84 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.763 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.0 m -132.93 144.11 49.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.931 0.396 . . . . 1.0 111.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 14.2 mt -99.02 136.83 38.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.59 105.88 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.337 -0.545 . . . . 1.0 112.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.83 128.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.212 -1.032 . . . . 1.0 108.212 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -93.36 162.54 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.369 2.046 . . . . 1.0 113.782 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.49 116.72 28.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.605 -1.258 . . . . 1.0 107.605 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.545 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.7 ptm -141.1 148.23 39.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.9 t60 -126.78 132.46 51.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.016 -0.993 . . . . 1.0 108.832 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 23.3 m-70 56.62 -126.52 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -98.31 3.33 48.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.776 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 12.4 pt-20 -109.78 153.25 24.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.703 1.001 . . . . 1.0 113.703 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.7 tp -103.88 127.39 51.4 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.542 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 43.6 m95 -103.88 -32.41 9.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.543 0.942 . . . . 1.0 113.543 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 -174.13 31.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.403 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -135.58 125.12 25.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.388 . . . . 1.0 111.701 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.5 tp -96.9 149.92 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 p -156.5 133.43 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.046 -0.661 . . . . 1.0 111.784 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 t -114.77 135.49 54.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.259 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -110.92 128.61 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -120.75 130.54 54.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.91 26.56 2.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.775 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.945 -0.302 . . . . 1.0 110.63 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.648 0.261 . . . . 1.0 111.205 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -70.72 -30.67 67.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.521 -0.308 . . . . 1.0 110.947 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.08 -33.68 74.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.584 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -77.84 -54.58 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.922 -0.311 . . . . 1.0 111.704 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.4 t -42.92 -41.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.42 -47.08 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -51.8 -32.88 33.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 190' ' ' GLN . 43.2 tp -75.7 -51.69 12.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.66 -46.4 67.15 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.59 98.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.494 ' O ' HD12 ' A' ' 193' ' ' ILE . 61.7 t0 -63.79 -37.01 85.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 186' ' ' LEU . 51.6 tt0 -68.05 -29.24 68.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -76.36 -46.01 33.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 157' ' ' MET . 8.2 t -50.87 -37.52 43.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 189' ' ' ASP . 1.1 mp -64.1 -36.83 78.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.261 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.73 82.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.612 . . . . 1.0 110.903 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.33 -47.52 81.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.41 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.712 -0.676 . . . . 1.0 110.342 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.43 -45.63 92.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.175 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.94 71.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.375 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.2 -43.11 82.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.29 -35.64 62.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -55.02 -60.69 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.5 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.407 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 1.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 28.8 p-10 -70.91 -32.36 69.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.723 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 53.3 tt0 -77.45 -48.26 17.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.807 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 34' ' ' ILE . 96.6 mt -56.02 -50.34 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.055 0.455 . . . . 1.0 110.964 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.481 ' O ' ' OG1' ' A' ' 38' ' ' THR . 78.2 mt -57.56 -30.73 65.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.942 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -66.73 -38.81 87.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.391 -0.524 . . . . 1.0 109.781 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -30.13 65.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.787 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 69.0 p -69.69 -36.42 75.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 1.0 112.314 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -71.63 -25.44 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.52 -31.86 32.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 1.0 111.296 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -76.8 -38.34 54.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.709 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 43' ' ' ARG . 30.4 m -66.53 -52.83 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.304 -177.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -51.87 -43.3 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 1.0 110.669 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.2 -44.12 71.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.317 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -64.66 -35.79 82.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.842 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.29 -13.01 23.68 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.703 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.03 25.83 47.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 p -80.03 148.82 30.94 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.991 -0.374 . . . . 1.0 109.991 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' GLY . 87.8 m-20 -50.25 -42.66 52.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.643 0.608 . . . . 1.0 112.643 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.54 HH21 ' CG2' ' A' ' 148' ' ' VAL . 18.7 ptt-85 -158.4 149.78 21.0 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.633 -0.827 . . . . 1.0 112.805 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -141.33 136.14 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.962 -1.017 . . . . 1.0 108.743 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' NZ ' ' CE1' ' A' ' 169' ' ' HIS . 29.8 mttp -137.07 145.58 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.624 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -100.91 142.1 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 20.7 t80 -130.44 133.27 46.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 1.0 110.426 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.426 HH12 ' CG2' ' A' ' 195' ' ' ILE . 78.1 mtp85 -114.44 154.1 28.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.019 0.438 . . . . 1.0 111.14 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.23 138.19 40.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.711 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -97.42 153.64 38.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -45.39 -21.1 0.65 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.012 2.474 . . . . 1.0 114.463 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -102.83 2.97 36.14 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.206 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.32 -13.68 56.96 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.661 -0.781 . . . . 1.0 111.957 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 57' ' ' ASP . 59.1 m80 -78.72 150.13 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.416 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.29 161.6 25.27 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -133.74 155.92 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.473 . . . . 1.0 111.473 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.22 108.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.0 t -109.0 -4.99 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.12 0.415 . . . . 1.0 112.12 -178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.04 125.96 8.41 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -154.89 139.14 16.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.18 0.514 . . . . 1.0 111.739 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.36 131.82 51.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.6 mtm-85 -103.15 135.08 45.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.071 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.755 0.312 . . . . 1.0 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.37 9.96 38.02 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.978 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.75 131.54 50.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.13 73.08 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.877 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.05 152.5 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.345 0.572 . . . . 1.0 110.464 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.0 t -107.43 131.23 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.602 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.07 148.79 36.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.273 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.8 129.18 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.489 2.126 . . . . 1.0 111.459 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -56.97 -31.13 64.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.866 0.365 . . . . 1.0 110.463 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.92 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.7 m-20 -63.72 -26.39 68.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.562 0.22 . . . . 1.0 111.02 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.5 mt -122.59 132.99 24.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.555 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.6 -103.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.608 2.205 . . . . 1.0 111.633 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 22.3 pt-20 -159.66 -40.77 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.032 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 87.2 tt0 -60.27 -41.28 92.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.623 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.82 -39.86 63.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.631 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -63.14 -37.5 87.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 1.0 110.808 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.72 -34.66 74.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.941 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.84 -32.23 73.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.614 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.41 -35.84 78.24 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -73.55 -33.63 64.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.215 -0.902 . . . . 1.0 111.262 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.544 ' C ' HE22 ' A' ' 99' ' ' GLN . 86.4 mt -95.54 -37.67 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.782 1.03 . . . . 1.0 113.782 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.16 -15.05 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -175.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 47.48 57.45 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.658 -0.817 . . . . 1.0 109.969 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.4 m -159.57 114.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.88 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.451 ' HE ' ' CA ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -168.44 132.46 1.57 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.878 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.64 157.78 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.688 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.3 mt -109.75 126.98 66.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.266 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.69 169.56 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -49.84 115.21 1.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.952 -1.022 . . . . 1.0 112.292 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.6 t -51.57 -17.68 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.72 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -81.97 -36.69 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.789 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -60.71 -8.91 3.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.172 0.511 . . . . 1.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.588 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 16.2 pt20 46.8 60.21 3.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.844 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 p -94.43 129.19 41.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -119.69 142.36 48.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.681 0.993 . . . . 1.0 113.681 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.2 p -109.29 149.53 29.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.753 -1.112 . . . . 1.0 108.661 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.451 -178.375 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 120.786 0.244 . . . . 1.0 112.374 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.26 130.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 138' ' ' CYS . 16.9 t70 -45.2 135.9 5.22 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.385 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -36.97 -21.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.07 2.513 . . . . 1.0 113.677 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 136' ' ' ASP . 54.1 t -56.21 -60.17 3.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.758 -0.377 . . . . 1.0 111.237 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -71.26 -25.01 62.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.64 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.3 t -60.14 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.668 0.618 . . . . 1.0 112.668 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 144' ' ' LYS . 86.1 t60 -63.18 -39.48 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.368 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.45 ' O ' ' OG ' ' A' ' 145' ' ' SER . 77.6 t80 -45.77 -36.07 4.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.69 -42.48 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.68 -42.45 92.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 97.4 p -64.16 -20.01 65.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.618 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 25.7 mmm -99.98 1.58 42.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.06 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.89 19.45 77.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.54 ' CG2' HH21 ' A' ' 50' ' ' ARG . 86.4 t -109.38 144.22 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.719 0.295 . . . . 1.0 110.275 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.34 -27.47 6.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.974 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 p -152.0 121.9 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.685 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 168' ' ' SER . 13.7 t -131.04 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.82 132.64 53.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.86 139.49 44.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.336 -0.546 . . . . 1.0 112.323 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.6 t -134.09 134.27 22.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -89.49 159.64 5.41 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.381 2.054 . . . . 1.0 113.718 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.1 mt -114.63 113.59 24.55 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.0 ptm -142.09 153.36 44.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.778 0.658 . . . . 1.0 112.778 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -127.85 122.92 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.872 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 17.2 t60 59.65 -118.1 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.133 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.493 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 13.5 pt20 -99.65 1.15 43.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -106.02 143.73 33.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.84 126.42 45.94 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -105.47 -35.37 7.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.3 -173.75 27.12 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.654 -1.26 . . . . 1.0 112.353 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.8 tp -138.07 122.5 18.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.449 -0.375 . . . . 1.0 111.657 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 11.3 tp -93.76 144.77 25.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.4 p -151.86 132.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.856 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 151' ' ' SER . 50.9 m -118.36 128.97 55.15 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.435 ' CE1' ' NZ ' ' A' ' 52' ' ' LYS . 48.6 m80 -100.22 126.14 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.647 0.61 . . . . 1.0 112.647 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.8 t60 -119.54 109.98 16.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.37 49.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 32.9 mm-40 . . . . . 0 C--N 1.326 -0.433 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.614 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.628 0.252 . . . . 1.0 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.77 -33.53 72.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.24 -42.7 91.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.626 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -67.28 -52.5 39.89 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.664 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.3 t -42.08 -43.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.63 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.05 -46.19 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -52.13 -32.78 37.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.058 -1.089 . . . . 1.0 108.058 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 190' ' ' GLN . 22.8 tp -74.66 -55.97 5.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.088 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -52.03 -45.86 64.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.98 74.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.53 -37.93 82.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 186' ' ' LEU . 49.1 tp60 -64.96 -33.07 75.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.99 -46.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.2 p -51.99 -35.15 45.63 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 mt -68.94 -35.03 67.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.265 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.57 -41.69 75.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.914 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.426 ' CG2' HH12 ' A' ' 55' ' ' ARG . 65.7 mt -56.71 -45.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.38 58.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.367 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -61.73 -44.31 97.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.266 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.74 70.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 1.0 111.419 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.22 -43.43 82.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.181 0.438 . . . . 1.0 112.181 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.424 ' H ' ' CD1' ' A' ' 200' ' ' LEU . 8.7 mp -52.53 -33.26 44.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.984 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.1 -58.76 5.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.691 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.413 ' C ' ' CD2' ' A' ' 202' ' ' LEU . 2.7 tt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.459 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.808 0.337 . . . . 1.0 110.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.3 t0 -70.11 -33.2 71.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.55 -48.49 19.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.834 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.0 mt -54.93 -53.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 1.0 110.924 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.537 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.7 mt -55.72 -31.41 62.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.96 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -62.84 -39.54 94.67 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.383 -0.527 . . . . 1.0 109.822 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.08 -32.74 69.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.762 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 74.9 p -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.272 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' N ' ' HG1' ' A' ' 38' ' ' THR . 2.3 p -73.75 -25.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.211 0.448 . . . . 1.0 112.211 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.44 -44.72 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.287 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.91 -37.85 72.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.751 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.11 -54.25 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.596 -0.274 . . . . 1.0 111.394 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 47' ' ' GLY . 69.9 ttt-85 -52.3 -45.56 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 1.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.45 -44.63 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.257 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -65.4 -39.01 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.795 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.92 -14.69 21.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.68 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.71 25.68 22.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.596 -1.001 . . . . 1.0 110.596 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.466 ' OG1' ' CD2' ' A' ' 170' ' ' HIS . 14.2 t -78.87 147.44 33.14 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -52.91 -41.61 64.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.583 ' HE ' ' CD ' ' A' ' 67' ' ' GLU . 65.0 ttt-85 -152.67 133.44 13.95 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.759 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -141.45 132.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.912 -1.04 . . . . 1.0 108.648 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -137.82 153.59 49.61 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.682 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.4 t -98.33 141.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 11.5 t80 -131.77 133.56 44.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.483 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -113.81 152.56 30.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 1.0 111.166 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.42 134.92 45.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.769 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 61' ' ' HIS . 19.7 m-20 -99.25 154.24 37.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -38.35 -52.19 1.98 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 122.952 2.435 . . . . 1.0 114.549 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' OE2' ' CD2' ' A' ' 61' ' ' HIS . 22.2 pt-20 -70.69 -6.56 38.15 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.71 -6.76 38.31 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.656 -0.783 . . . . 1.0 111.862 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-70 -77.21 149.14 35.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.42 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -135.52 159.54 24.17 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -133.42 155.15 50.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 1.0 111.527 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.19 110.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.425 ' CG1' ' OD1' ' A' ' 32' ' ' ASP . 14.4 t -111.95 -3.99 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.127 0.417 . . . . 1.0 112.127 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.59 124.74 8.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 65.3 tt0 -153.29 138.46 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.176 0.512 . . . . 1.0 111.689 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.53 138.13 52.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -133.46 147.34 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.989 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.578 -1.009 . . . . 1.0 110.578 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.864 0.364 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.79 9.05 29.06 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.01 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.46 131.5 48.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -3.97 86.6 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.88 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.49 147.12 27.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.342 -0.543 . . . . 1.0 110.466 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -104.16 129.83 51.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.54 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -106.17 105.64 54.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.269 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.3 139.35 4.27 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.485 2.123 . . . . 1.0 111.524 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -63.18 -28.21 69.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.817 0.342 . . . . 1.0 110.413 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.91 -17.52 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 24.4 p-10 -68.16 -14.43 62.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.61 0.243 . . . . 1.0 110.996 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.02 133.68 25.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.481 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.16 -102.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.551 2.167 . . . . 1.0 111.639 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -157.84 -43.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.003 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -57.91 -40.34 80.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.636 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -40.65 57.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.679 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 69.3 ttt180 -62.32 -38.35 89.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -62.56 -34.13 76.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.965 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -63.99 -33.37 75.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.593 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -68.92 -33.72 74.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.8 mtm180 -78.07 -30.03 49.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.122 -0.945 . . . . 1.0 111.249 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.409 ' C ' HE22 ' A' ' 99' ' ' GLN . 37.5 mt -95.69 -38.93 10.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.67 -12.6 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.508 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.2 mp0 46.57 49.02 13.97 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 t -152.22 110.86 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -165.41 138.34 4.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.933 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.45 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.4 p -154.11 157.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.709 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.45 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 2.9 mp -111.94 129.85 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.203 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.33 170.84 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.924 0.712 . . . . 1.0 112.924 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -49.21 114.57 1.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.234 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.2 t -51.19 -19.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.686 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -81.18 -37.31 28.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -17.48 19.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 1.0 110.414 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.411 HE21 ' NH2' ' A' ' 111' ' ' ARG . 49.5 tt0 56.56 61.16 2.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.829 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 m -95.2 125.75 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.411 ' NH2' HE21 ' A' ' 109' ' ' GLN . 92.4 mtt180 -118.95 143.98 46.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.65 0.981 . . . . 1.0 113.65 -176.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.3 p -110.54 149.4 30.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.641 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.437 -178.362 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.769 0.237 . . . . 1.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.26 127.43 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.546 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -45.27 144.98 2.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.74 0.305 . . . . 1.0 111.347 -178.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -38.28 -18.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.123 2.549 . . . . 1.0 113.658 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 136' ' ' ASP . 34.6 t -56.98 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.259 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.71 -26.01 62.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.659 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.3 t -56.43 -63.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 142' ' ' TYR . 12.8 p-80 -66.84 -40.88 88.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.386 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.627 ' N ' ' CD2' ' A' ' 141' ' ' HIS . 71.1 t80 -44.3 -39.46 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.6 -41.69 62.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.185 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.25 -43.38 92.42 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -63.34 -21.35 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.618 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.4 mmm -99.14 0.35 43.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.149 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.22 17.46 79.98 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.599 -1.001 . . . . 1.0 110.599 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.73 145.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 1.0 110.289 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.14 -20.75 7.89 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.055 0.391 . . . . 1.0 112.055 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 120.07 4.76 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.778 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -124.96 132.49 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.915 0.388 . . . . 1.0 111.412 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -98.73 127.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.0 108.49 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.279 -0.568 . . . . 1.0 112.266 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.63 135.18 20.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -92.28 166.05 2.98 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.408 2.072 . . . . 1.0 113.737 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.39 116.48 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 24.0 ptm -141.58 151.83 43.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.621 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 32.7 t-80 -124.1 123.59 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.948 -1.024 . . . . 1.0 108.824 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.621 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 45.0 m-70 56.72 -118.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.12 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -98.06 0.58 46.45 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.848 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.467 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.23 143.25 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -176.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.4 tp -99.23 125.71 44.89 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.542 -1.281 . . . . 1.0 107.542 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.467 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 61.7 m95 -104.96 -35.25 7.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.538 0.94 . . . . 1.0 113.538 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.58 -173.58 25.26 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.401 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.7 tp -139.51 120.96 15.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.473 -0.363 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -93.63 150.48 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.4 p -155.73 133.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.028 -0.669 . . . . 1.0 111.869 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -115.03 136.03 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 9.7 m80 -108.73 123.44 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.466 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 54.2 m80 -117.06 125.22 50.98 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.19 -16.63 57.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.817 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--N 1.326 -0.429 0 C-N-CA 120.911 -0.316 . . . . 1.0 110.608 179.889 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.713 0.292 . . . . 1.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.41 -28.99 64.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.998 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.61 -46.91 86.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.614 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 13.1 pt20 -80.18 -47.07 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.667 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.436 ' N ' ' CG ' ' A' ' 182' ' ' GLN . 43.1 t -42.86 -45.58 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.644 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 185' ' ' GLN . 34.1 m -74.41 -47.34 40.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.403 ' N ' ' CG2' ' A' ' 184' ' ' VAL . 40.5 tp60 -49.54 -32.06 11.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.123 -1.066 . . . . 1.0 108.123 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 190' ' ' GLN . 13.8 tp -73.89 -52.11 14.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.034 -0.984 . . . . 1.0 109.098 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.86 -47.51 67.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.62 83.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.429 -0.952 . . . . 1.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.415 ' O ' ' OG ' ' A' ' 192' ' ' SER . 65.0 t0 -62.41 -41.73 98.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 186' ' ' LEU . 59.1 tp60 -61.66 -31.3 71.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.84 -44.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 24.2 p -51.67 -35.8 43.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.51 -37.19 79.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.161 -0.927 . . . . 1.0 110.276 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.22 -41.78 80.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.2 mt -56.83 -46.3 83.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -65.94 -49.55 67.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.394 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.46 -45.36 93.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.216 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.19 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.362 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -58.26 -44.13 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.219 0.451 . . . . 1.0 112.219 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.93 -32.85 54.99 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.996 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 m -51.87 -57.03 10.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.614 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.096 -0.954 . . . . 1.0 110.441 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.713 0.292 . . . . 1.0 110.484 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -48.93 -35.72 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 26.4 mp0 -74.49 -50.7 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.783 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.28 -50.56 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 1.0 110.94 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.485 ' O ' ' OG1' ' A' ' 38' ' ' THR . 30.5 mt -54.78 -29.7 54.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.95 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -64.37 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 109.754 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.57 -32.86 68.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.835 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 70.5 p -66.46 -36.97 84.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.333 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -73.65 -24.48 20.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -45.99 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.308 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -68.55 -38.62 80.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.739 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.9 t -54.78 -55.14 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.296 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -50.11 -43.87 51.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.693 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.54 77.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.269 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.52 -40.72 97.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.753 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -96.92 -14.8 21.52 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.65 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.62 25.8 22.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 p -79.65 149.43 31.27 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 3.0 p30 -53.6 -38.98 64.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 ttt180 -154.51 135.29 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.609 -0.836 . . . . 1.0 112.891 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.0 p -141.81 132.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.01 -0.995 . . . . 1.0 108.783 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -138.25 153.03 49.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.615 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.5 t -98.58 139.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -128.21 131.0 48.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 1.0 110.391 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -109.68 149.13 30.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.41 . . . . 1.0 111.22 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.88 135.76 42.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 61' ' ' HIS . 24.2 m-20 -101.03 153.55 37.67 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -38.85 -51.02 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.06 2.507 . . . . 1.0 114.514 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.41 -5.74 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.199 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.77 -8.84 43.51 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.661 -0.78 . . . . 1.0 111.946 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.567 ' O ' ' N ' ' A' ' 57' ' ' ASP . 73.6 m80 -78.83 151.64 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.34 165.09 25.83 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.1 p -136.95 159.61 41.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 1.0 111.455 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 t -87.8 105.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.68 -6.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.86 122.6 6.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.278 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 81.7 tt0 -150.47 138.06 19.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.122 0.487 . . . . 1.0 111.686 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.61 132.07 51.35 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 44.6 ptt85 -114.17 142.88 45.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.042 -177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 178.786 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 111.345 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.523 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 21.9 mt -111.23 20.37 17.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.021 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.9 tp -64.8 130.67 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.17 88.11 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.861 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.55 149.57 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.325 0.563 . . . . 1.0 110.484 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.5 m -108.46 136.63 47.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.655 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.78 148.67 39.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.256 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.25 138.49 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.494 2.129 . . . . 1.0 111.474 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.915 0.388 . . . . 1.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.87 -16.27 0.2 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 84' ' ' ALA . 93.0 m-20 -70.35 -20.56 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.596 0.236 . . . . 1.0 111.004 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 88' ' ' PRO . 2.2 mt -125.01 95.65 41.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.516 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.0 Cg_exo -44.77 -114.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.521 2.147 . . . . 1.0 111.694 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 56.5 mp0 -147.11 -58.88 0.27 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.936 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -45.72 -42.71 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.681 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.97 -40.09 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.683 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 70.1 ttp85 -62.24 -34.46 76.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.808 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -62.81 -34.58 77.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.914 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.646 ' CD1' HH22 ' A' ' 101' ' ' ARG . 93.3 mt -63.66 -33.6 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.524 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 76.4 m-85 -67.97 -34.06 75.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 36.1 mtp180 -75.33 -31.8 60.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.262 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.465 ' C ' HE22 ' A' ' 99' ' ' GLN . 91.8 mt -97.79 -36.8 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.753 1.02 . . . . 1.0 113.753 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.31 -17.49 8.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.258 1.207 . . . . 1.0 114.258 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.631 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.7 OUTLIER 48.38 55.72 8.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.98 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.7 t -153.3 109.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.891 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.646 HH22 ' CD1' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -161.88 131.87 4.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.921 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 103' ' ' ILE . 54.0 t -146.53 155.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.665 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.406 ' N ' ' CG1' ' A' ' 102' ' ' VAL . 57.6 mt -112.47 128.53 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.268 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.09 170.53 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.052 0.76 . . . . 1.0 113.052 -176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -51.2 115.05 1.38 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.246 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.07 -19.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.716 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -81.07 -36.41 30.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.79 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.5 -18.34 28.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.137 0.494 . . . . 1.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 57.44 61.49 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.532 -0.758 . . . . 1.0 112.819 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -94.62 125.7 39.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.762 -1.569 . . . . 1.0 106.762 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -118.75 142.93 47.23 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.679 0.992 . . . . 1.0 113.679 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -111.87 150.91 29.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.73 -1.123 . . . . 1.0 108.616 178.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.411 -179.589 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 120.838 0.266 . . . . 1.0 112.378 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.24 133.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.485 ' HB3' ' SG ' ' A' ' 138' ' ' CYS . 0.3 OUTLIER -42.08 157.6 0.21 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.356 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.13 -24.57 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.124 2.549 . . . . 1.0 113.614 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -58.02 -58.46 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.246 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.15 -26.76 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.68 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.1 -56.18 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -62.26 -38.95 91.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.303 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -47.53 -36.22 10.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.03 -42.93 62.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -58.31 -43.68 88.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -62.21 -19.3 63.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.683 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.5 mmm -99.34 0.02 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.133 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 18.26 77.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 84.3 t -108.75 143.59 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.738 0.304 . . . . 1.0 110.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.94 -25.39 4.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -152.49 118.68 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.756 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 96.3 p -129.23 144.2 51.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.994 0.426 . . . . 1.0 111.398 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.2 mp -102.69 137.33 41.06 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.76 129.1 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 1.0 112.263 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.3 133.29 20.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.49 162.54 3.58 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.368 2.045 . . . . 1.0 113.736 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.6 mt -117.12 115.03 24.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.0 ptm -141.99 154.74 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 55.9 t60 -128.34 124.78 37.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.021 -0.991 . . . . 1.0 108.871 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 46.2 m-70 59.72 -121.21 1.03 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.117 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -97.94 0.57 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.823 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.535 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -105.46 143.56 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.6 tp -99.71 124.54 45.06 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.535 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.3 m95 -102.92 -31.02 10.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.31 -169.82 26.21 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.448 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.7 mp -140.03 121.74 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 1.0 111.637 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.1 tp -94.67 149.66 21.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 p -157.56 134.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.075 -0.65 . . . . 1.0 111.861 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -114.52 135.76 53.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.267 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -107.82 126.99 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -117.46 122.81 44.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.33 16.69 5.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.797 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.636 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.675 0.274 . . . . 1.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.39 -28.96 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 1.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.65 -39.53 73.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.636 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 11.7 pt20 -80.45 -52.87 7.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.92 -0.312 . . . . 1.0 111.682 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' A' ' 182' ' ' GLN . 9.9 p -44.13 -41.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.645 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.432 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 7.6 p -75.1 -49.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.406 ' N ' ' CG1' ' A' ' 184' ' ' VAL . 56.8 tt0 -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.6 tp -71.74 -48.61 45.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.053 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.42 -44.58 62.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.71 91.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -64.09 -39.32 93.8 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -64.53 -31.41 72.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 53.7 t -77.49 -44.58 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.2 m -51.77 -33.6 35.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.78 -34.61 34.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.56 78.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.98 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.1 pt -62.24 -29.82 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.5 -53.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.639 -0.71 . . . . 1.0 110.37 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.54 -42.63 98.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.321 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.8 74.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.352 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.86 -43.11 80.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 tp -51.35 -38.12 51.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.959 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.4 t -47.85 -57.54 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.631 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.496 179.894 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 1.0 110.517 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -48.07 -36.61 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.764 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -74.09 -50.6 18.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.874 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.47 -45.53 81.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.145 0.498 . . . . 1.0 110.982 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 38' ' ' THR . 29.5 mt -58.07 -28.89 64.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.903 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -68.53 -39.5 81.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.81 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.42 -31.71 69.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.9 p -67.68 -36.93 81.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.371 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.59 -23.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.46 -48.36 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.323 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.34 -35.9 80.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.71 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.6 t -58.1 -53.87 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.613 -0.267 . . . . 1.0 111.313 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 47' ' ' GLY . 65.5 ttt-85 -50.21 -43.73 52.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.942 0.401 . . . . 1.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.03 -43.33 70.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.295 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.65 -37.65 87.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.786 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.84 -14.6 21.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.725 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.47 25.68 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.2 p -81.25 152.52 27.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.3 m-20 -48.83 -43.57 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.599 0.592 . . . . 1.0 112.599 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -159.17 146.93 17.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.625 -0.83 . . . . 1.0 112.765 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.13 133.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.703 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HZ1' ' CD1' ' A' ' 77' ' ' LEU . 61.3 mttt -135.77 142.83 44.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.665 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.02 140.94 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.453 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 19.1 m-85 -131.55 136.59 47.96 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.531 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -112.86 153.28 28.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.036 0.446 . . . . 1.0 111.188 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CD1' ' NH2' ' A' ' 92' ' ' ARG . 43.5 m-85 -100.0 141.84 32.28 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -114.2 166.67 11.0 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -41.75 -55.82 2.17 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.055 2.503 . . . . 1.0 114.497 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -67.88 -12.56 60.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.79 0.28 48.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.752 -0.737 . . . . 1.0 111.904 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.509 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 2.4 p80 -74.6 148.79 40.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.466 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.54 144.34 16.98 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -125.12 149.69 47.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.948 0.404 . . . . 1.0 111.57 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -90.19 108.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 t -112.34 -4.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.32 128.17 9.54 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.271 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 24.0 tt0 -160.75 141.92 11.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 1.0 111.662 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.75 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -110.73 138.59 46.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.038 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 110.611 -0.995 . . . . 1.0 110.611 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.807 0.337 . . . . 1.0 111.346 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' CD1' ' HZ1' ' A' ' 52' ' ' LYS . 41.1 mt -116.19 15.99 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.946 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.15 129.18 40.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.8 -2.35 87.17 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.814 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.1 mt -86.0 147.39 26.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.358 0.579 . . . . 1.0 110.458 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -106.02 133.35 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -105.54 148.39 36.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.217 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.98 140.12 12.43 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.487 2.125 . . . . 1.0 111.493 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -62.97 -31.37 72.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.799 0.333 . . . . 1.0 110.434 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.12 -17.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.8 m-20 -63.23 -24.91 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.624 0.249 . . . . 1.0 111.023 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.66 132.55 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.507 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.58 -99.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.535 2.157 . . . . 1.0 111.672 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -159.25 -47.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.956 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -52.0 -40.99 61.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.621 ' CB ' HH22 ' A' ' 101' ' ' ARG . . . -74.89 -38.32 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.712 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.451 ' NH2' ' CD1' ' A' ' 56' ' ' PHE . 72.4 ttt180 -61.08 -32.36 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.798 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.07 -36.43 83.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.933 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.78 -36.27 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.532 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -67.96 -37.1 81.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -75.54 -30.23 59.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.162 -0.927 . . . . 1.0 111.26 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.52 ' C ' HE22 ' A' ' 99' ' ' GLN . 95.9 mt -96.98 -38.63 9.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.94 -14.47 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.564 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.0 mp0 48.8 51.37 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.902 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.8 t -153.17 109.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.911 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.621 HH22 ' CB ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -164.02 135.91 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.873 178.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -151.58 156.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.684 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 87.7 mt -110.56 130.69 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.265 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 m -85.94 169.66 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.921 0.711 . . . . 1.0 112.921 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.457 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 64.6 m-20 -48.19 116.01 1.4 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.902 -1.044 . . . . 1.0 112.236 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.5 -18.85 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.666 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 109' ' ' GLN . 43.4 tp10 -78.7 -38.83 38.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.821 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.569 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -61.33 -5.91 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.501 . . . . 1.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.569 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 11.6 pt20 46.23 63.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 1.0 112.83 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.5 m -91.24 126.96 36.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.77 -1.567 . . . . 1.0 106.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -118.34 144.48 45.84 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -111.71 149.87 31.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.695 -1.139 . . . . 1.0 108.654 178.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 120.435 -0.506 . . . . 1.0 111.418 -179.263 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo . . . . . 0 N--CA 1.491 1.363 0 CA-C-O 120.864 0.277 . . . . 1.0 112.36 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.69 128.92 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 112' ' ' SER . 21.3 t70 -44.2 135.87 4.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.307 . . . . 1.0 111.345 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -37.41 -23.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.132 2.555 . . . . 1.0 113.645 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 136' ' ' ASP . 36.3 t -55.66 -61.3 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.263 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.94 -24.04 61.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.658 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.6 t -57.97 -61.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.551 0.574 . . . . 1.0 112.551 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.592 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 23.2 p80 -60.79 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.391 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.592 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 83.1 t80 -47.44 -39.75 16.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.4 mt -72.06 -43.44 64.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.64 -43.03 79.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.5 m -61.7 -20.12 63.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.709 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.8 mmm -98.48 -1.16 41.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.074 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.53 19.32 76.38 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 65.7 t -107.56 142.49 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.297 . . . . 1.0 110.242 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.64 -35.17 3.6 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.457 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 22.8 m -143.2 121.17 12.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.766 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 m -129.81 142.11 50.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 1.0 111.378 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -102.76 136.24 42.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.14 128.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.331 -0.548 . . . . 1.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.22 128.97 19.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.255 -1.016 . . . . 1.0 108.255 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -92.6 164.21 2.85 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.4 2.067 . . . . 1.0 113.704 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.9 113.68 22.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.567 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.6 ptm -140.7 152.47 45.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.107 -0.637 . . . . 1.0 112.718 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 53.6 t60 -126.19 123.99 39.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.829 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 56.8 m-70 58.54 -120.73 1.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.182 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -97.42 1.51 49.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.787 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.01 143.44 34.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.403 HD21 ' HE ' ' A' ' 92' ' ' ARG . 39.4 tp -99.31 124.94 44.82 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 66.3 m95 -103.91 -35.31 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -156.87 -174.59 26.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 119.684 -1.246 . . . . 1.0 112.375 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.7 tp -138.42 121.2 16.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.3 tp -93.69 142.57 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -149.41 131.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.815 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.8 t -116.46 130.66 56.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.197 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -106.21 129.33 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 19.1 t-80 -120.77 117.4 27.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.77 -15.65 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.742 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.419 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 51.1 mm-40 . . . . . 0 C--N 1.326 -0.455 0 C-N-CA 120.894 -0.323 . . . . 1.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.675 0.274 . . . . 1.0 111.318 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -72.1 -36.09 69.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.57 -40.54 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.551 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -67.15 -55.8 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.759 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.3 t -45.73 -40.6 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.626 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.48 -50.76 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -48.43 -36.54 15.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 190' ' ' GLN . 87.1 mt -71.64 -46.52 58.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.075 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 tp -52.13 -46.33 65.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.939 -0.764 . . . . 1.0 108.939 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.95 91.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.377 -0.971 . . . . 1.0 108.377 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.82 -38.11 89.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 186' ' ' LEU . 27.2 mt-30 -66.89 -30.6 70.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.72 -45.89 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -52.25 -37.39 55.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.8 mt -65.47 -34.97 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.162 -0.926 . . . . 1.0 110.291 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.05 78.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.928 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mt -55.24 -50.25 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.96 -50.42 66.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.417 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -61.87 -46.96 87.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.325 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.83 -32.74 74.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.41 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -56.4 -41.63 76.61 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.234 0.457 . . . . 1.0 112.234 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.2 mt -53.77 -34.67 59.78 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.987 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.6 t -44.92 -56.73 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.621 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.418 179.583 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 63.0 t0 -48.82 -34.17 11.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.441 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 22.6 mp0 -76.38 -48.44 19.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.826 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.7 mm -56.56 -50.38 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.065 0.459 . . . . 1.0 110.885 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 38' ' ' THR . 47.9 mt -57.38 -30.24 64.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 1.0 111.934 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -65.78 -39.7 91.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.762 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.42 68.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 76.3 p -65.07 -37.85 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.948 -0.569 . . . . 1.0 112.368 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.3 p -71.94 -25.57 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.165 0.432 . . . . 1.0 112.165 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -80.78 -35.12 33.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.298 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -77.15 -42.63 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.76 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 8.7 p -63.65 -52.4 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.356 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -52.22 -42.21 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 1.0 110.697 -179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -53.86 -41.28 67.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.317 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.16 -34.68 78.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.764 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -95.86 -14.83 22.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.8 0.333 . . . . 1.0 111.683 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.92 25.31 45.0 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 p -78.17 145.19 35.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.84 -40.27 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.506 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 44.9 ttt180 -150.47 132.46 15.21 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.511 -0.876 . . . . 1.0 112.762 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 7.1 t -138.69 131.54 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.007 -0.997 . . . . 1.0 108.671 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.669 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 24.9 pttm -137.17 149.97 47.61 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.722 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.99 141.35 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 16.0 t80 -131.05 132.31 44.84 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.42 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -113.04 153.56 27.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.012 0.434 . . . . 1.0 111.253 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.79 135.59 44.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.1 m-20 -95.09 150.73 38.12 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -41.45 -21.87 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.012 2.474 . . . . 1.0 114.485 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -103.22 4.6 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.565 -0.454 . . . . 1.0 112.155 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.21 -14.35 59.77 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.671 -0.776 . . . . 1.0 111.897 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 57' ' ' ASP . 39.9 m80 -78.13 150.44 33.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.56 164.0 25.73 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -136.35 158.07 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.034 0.445 . . . . 1.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.2 106.54 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.92 -5.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.126 0.417 . . . . 1.0 112.126 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.19 123.51 7.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.348 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.506 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 87.1 tt0 -150.87 136.6 18.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 1.0 111.719 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.56 135.85 51.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -119.26 140.06 50.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 1.0 112.044 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.481 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.823 0.344 . . . . 1.0 111.348 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.69 16.03 11.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.946 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.2 132.68 52.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 -2.94 86.98 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.43 -0.805 . . . . 1.0 112.812 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.5 mt -85.55 150.81 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.372 0.586 . . . . 1.0 110.415 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -109.16 137.63 46.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.622 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -108.99 148.72 38.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.274 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.51 137.02 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.574 2.183 . . . . 1.0 111.442 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.9 -34.75 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.865 0.364 . . . . 1.0 110.445 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.14 -16.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 84' ' ' ALA . 97.5 m-20 -66.39 -22.08 66.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.647 0.261 . . . . 1.0 111.03 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.92 133.36 24.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.529 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.64 -98.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.537 2.158 . . . . 1.0 111.685 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -161.96 -50.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.953 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -46.52 -42.84 16.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.593 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.32 -38.48 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.743 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.57 -32.21 72.29 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.791 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -64.01 -35.31 80.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.915 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.41 -36.04 79.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.534 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 45.3 m-85 -68.25 -35.36 77.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -81.11 -27.77 35.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.166 -0.925 . . . . 1.0 111.269 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.95 -42.04 8.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 -15.0 8.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.243 1.201 . . . . 1.0 114.243 -174.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.65 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.6 OUTLIER 45.57 54.9 7.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.7 -0.8 . . . . 1.0 109.866 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.9 m -159.68 111.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.857 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.78 ' NE ' ' N ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -170.81 139.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.852 177.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.5 p -146.01 158.36 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.73 -0.668 . . . . 1.0 109.641 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 49.8 mt -110.62 126.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.217 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.449 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 10.0 p -86.53 168.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.449 ' H ' ' CG2' ' A' ' 104' ' ' VAL . 48.7 m-20 -49.0 115.88 1.45 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.283 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 p -51.03 -21.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.675 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -77.94 -38.08 46.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.835 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.58 -16.13 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.185 0.517 . . . . 1.0 110.404 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 56.24 60.93 2.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.482 -0.781 . . . . 1.0 112.824 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.6 m -96.86 126.19 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -117.87 143.92 45.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.436 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -114.45 153.91 29.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.731 -1.122 . . . . 1.0 108.636 177.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.0 pt . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.473 -178.791 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 120.807 0.253 . . . . 1.0 112.407 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -114.95 128.0 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 112' ' ' SER . 45.9 p-10 -46.53 138.88 6.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.307 . . . . 1.0 111.315 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -39.21 -28.24 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.145 2.563 . . . . 1.0 113.663 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 t -48.94 -64.42 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -71.37 -21.83 61.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.595 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.34 -58.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -63.1 -40.11 96.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.424 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.517 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 71.2 t80 -47.59 -38.42 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.82 -43.7 65.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.104 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -56.41 -41.98 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.0 m -62.66 -21.36 65.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.692 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.517 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 50.6 mtp -98.31 -0.74 43.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.488 -0.778 . . . . 1.0 111.06 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.05 19.71 76.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.2 t -107.78 143.44 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.679 0.276 . . . . 1.0 110.367 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.56 -26.86 6.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.968 0.359 . . . . 1.0 111.968 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 32.4 m -150.77 120.29 6.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.766 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p -129.76 141.85 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 1.0 111.402 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.37 130.7 52.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.617 ' O ' ' NE ' ' A' ' 101' ' ' ARG . 10.9 t -113.83 106.36 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.308 -0.557 . . . . 1.0 112.311 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 42.6 t -110.17 135.77 20.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -94.93 167.3 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.299 1.999 . . . . 1.0 113.723 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.1 mt -119.24 116.33 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.7 ptm -141.02 154.78 46.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -127.99 123.39 34.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.942 -1.026 . . . . 1.0 108.865 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.601 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 82.2 t60 60.23 -120.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.363 . . . . 1.0 110.09 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.601 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 28.0 tp60 -98.26 2.03 47.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.816 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.529 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 144.98 31.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.12 123.99 46.13 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.529 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m95 -102.24 -31.65 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.37 -173.73 31.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.453 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.1 mt -135.12 121.44 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 1.0 111.614 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 4.5 tp -94.69 150.82 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 p -157.33 134.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.859 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.9 t -115.6 132.8 56.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.669 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 21.4 m80 -101.61 122.66 44.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.6 t60 -117.75 108.7 15.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.42 66.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.751 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.495 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 21.2 mt-10 . . . . . 0 C--N 1.327 -0.406 0 C-N-CA 120.942 -0.303 . . . . 1.0 110.569 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.645 0.26 . . . . 1.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 1.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.83 -35.77 75.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.619 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -81.11 -55.4 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.618 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.3 p -44.16 -41.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.419 . . . . 1.0 110.659 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 187' ' ' LEU . 7.4 p -73.96 -48.39 38.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.405 ' N ' ' CG1' ' A' ' 184' ' ' VAL . 62.3 tt0 -46.62 -32.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.106 -1.072 . . . . 1.0 108.106 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 190' ' ' GLN . 7.9 tp -68.84 -47.37 66.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.108 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 184' ' ' VAL . 95.5 mt -53.97 -46.43 71.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.88 86.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 192' ' ' SER . 71.9 m-20 -63.27 -42.35 99.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 186' ' ' LEU . 61.3 tt0 -60.66 -31.3 70.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.43 -44.13 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 26.5 p -52.42 -36.55 54.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.815 -0.809 . . . . 1.0 108.815 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.06 -37.78 80.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.197 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.81 83.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.0 mt -55.15 -50.41 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.93 -50.35 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.411 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.6 -47.07 87.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.282 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.459 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -67.21 -32.67 73.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.39 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -56.14 -40.57 74.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 tp -52.5 -35.44 52.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.528 ' HG ' ' H ' ' A' ' 202' ' ' LEU . 96.8 p -53.11 -58.71 6.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.615 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 201' ' ' SER . 20.6 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.058 -0.973 . . . . 1.0 110.397 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.82 0.343 . . . . 1.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.51 -33.03 68.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -77.51 -48.17 17.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.788 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.0 mt -56.16 -51.2 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.056 0.455 . . . . 1.0 110.957 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.517 ' O ' ' OG1' ' A' ' 38' ' ' THR . 71.0 mt -58.34 -30.88 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.986 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -67.73 -39.36 84.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.408 -0.517 . . . . 1.0 109.732 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' O ' ' OE1' ' A' ' 41' ' ' GLU . . . -70.39 -33.24 71.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.769 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 53.4 p -63.65 -37.15 86.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.305 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -23.34 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.4 -51.71 33.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.341 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 18.1 mp0 -69.7 -34.94 74.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.745 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.74 -55.35 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.337 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.3 tmm_? -53.9 -43.65 69.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 1.0 110.669 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.63 -43.41 72.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.321 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -65.41 -37.28 86.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.8 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 mt -96.65 -15.06 21.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.763 0.316 . . . . 1.0 111.697 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.85 25.04 35.84 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.505 -1.038 . . . . 1.0 110.505 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 87.6 m -78.36 146.07 34.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.8 m-20 -52.17 -41.98 63.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.543 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 49.4 ttt180 -152.45 132.29 13.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.549 -0.86 . . . . 1.0 112.802 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 t -136.76 131.64 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 1.0 108.702 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.758 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 16.0 pttp -137.88 151.74 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.628 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.85 140.36 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 13.7 t80 -129.13 132.57 47.38 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.431 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.993 0.425 . . . . 1.0 111.206 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.9 t80 -100.47 128.49 46.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.696 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' OD2' ' CD2' ' A' ' 61' ' ' HIS . 40.9 m-20 -97.75 151.97 37.88 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.93 -22.45 30.43 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.029 2.486 . . . . 1.0 114.488 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HB2' ' ND1' ' A' ' 61' ' ' HIS . 96.2 mt-10 -91.16 -3.51 56.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.07 -19.59 37.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.67 -0.776 . . . . 1.0 111.901 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 57.2 p-80 -80.49 151.45 29.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.404 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.45 162.85 26.14 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -134.57 154.99 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.015 0.436 . . . . 1.0 111.504 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 t -90.9 113.42 26.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.338 -0.986 . . . . 1.0 108.338 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.28 -3.33 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.92 125.92 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.31 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.543 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 79.1 tt0 -155.34 138.69 15.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 1.0 111.676 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.28 138.95 53.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 74' ' ' LEU . 58.1 mtp180 -113.28 136.48 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.019 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.96 77.62 2.09 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 38.07 29.51 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 53.6 17.91 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 1.0 110.405 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -57.66 -47.52 82.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.078 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.542 ' O ' ' NE ' ' A' ' 69' ' ' ARG . 8.3 mp -101.87 153.06 38.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.79 157.13 35.29 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.514 2.143 . . . . 1.0 112.208 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t -84.97 116.59 23.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.35 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.93 10.86 37.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.978 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.93 129.16 38.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -4.04 86.54 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.847 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.79 147.36 27.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.3 0.55 . . . . 1.0 110.422 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.3 m -107.52 135.81 48.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.611 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.45 112.92 62.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.248 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.08 137.95 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.561 2.174 . . . . 1.0 111.464 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -60.52 -37.6 81.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 1.0 110.432 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.06 -16.33 0.47 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 84' ' ' ALA . 86.9 m-20 -71.76 -23.22 61.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.687 0.28 . . . . 1.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' PRO . 44.7 mt -116.83 101.57 53.44 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.542 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 87' ' ' ILE . 76.9 Cg_exo -45.63 -115.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.575 2.183 . . . . 1.0 111.653 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 80.3 tt0 -157.0 -51.68 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.93 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -49.53 -39.97 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.608 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.85 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.669 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -63.8 -33.9 76.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.819 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.69 -37.15 86.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.947 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.44 -36.65 83.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.484 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.45 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 83.7 m-85 -66.85 -35.0 79.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -77.24 -31.15 54.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.284 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.51 ' C ' HE22 ' A' ' 99' ' ' GLN . 79.1 mt -94.55 -38.99 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.58 -13.12 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.595 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.4 mp0 47.71 56.7 6.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.669 -0.813 . . . . 1.0 109.926 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.5 m -159.09 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.875 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.403 ' NH2' ' O2D' ' A' ' 203' ' ' CYC . 2.9 tpp180 -165.57 133.88 3.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.888 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 78.2 t -145.68 156.3 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.703 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.546 ' CD1' ' HE2' ' A' ' 139' ' ' HIS . 62.4 mt -112.5 127.73 69.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.265 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.1 m -86.96 170.62 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -49.53 114.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.906 -1.043 . . . . 1.0 112.249 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.25 -21.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.512 -0.767 . . . . 1.0 110.674 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -80.36 -37.86 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.2 -14.55 2.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.18 0.514 . . . . 1.0 110.453 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 57.32 59.96 3.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.849 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 t -94.97 124.94 39.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -119.72 143.73 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.5 153.74 28.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.764 -1.107 . . . . 1.0 108.668 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 pt -149.55 153.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.468 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.43 ' C ' ' NE2' ' A' ' 115' ' ' GLN . 70.2 m -91.12 172.69 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 117' ' ' GLU . 2.1 mp0 -134.63 156.85 78.36 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -36.79 -25.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.601 2.201 . . . . 1.0 112.275 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' GLN . 95.5 mt-10 -110.34 160.76 16.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.606 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -111.74 145.34 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.521 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.43 148.14 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.683 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -145.7 -96.69 0.2 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 121' ' ' LEU . 8.7 mp -61.6 -14.98 34.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 1.0 110.635 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.3 t -51.76 -24.52 6.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.72 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 125' ' ' VAL . . . -57.55 -17.4 13.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.743 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -45.92 -14.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.7 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 123' ' ' ALA . 27.9 m -84.95 139.26 37.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 127' ' ' LEU . 84.0 Cg_endo -80.1 117.72 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.338 2.025 . . . . 1.0 111.559 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 126' ' ' PRO . 65.8 mt 39.27 -110.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.398 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.12 50.92 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.129 -0.789 . . . . 1.0 111.129 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 130' ' ' PRO . 49.1 mm-40 -133.29 154.81 81.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.523 0.201 . . . . 1.0 110.624 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 132' ' ' GLN . 65.5 Cg_exo -41.65 168.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.423 2.082 . . . . 1.0 112.012 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.407 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 51.7 mt -63.07 11.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 1.0 112.063 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.546 ' H ' ' C ' ' A' ' 130' ' ' PRO . 9.9 mm100 -137.6 155.48 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.445 . . . . 1.0 111.484 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -125.59 117.41 24.71 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.554 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.4 142.7 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.658 2.239 . . . . 1.0 112.348 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.81 132.89 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -41.68 160.86 0.15 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.401 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.11 -23.67 45.66 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.159 2.573 . . . . 1.0 113.666 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.54 ' H ' ' CG ' ' A' ' 136' ' ' ASP . 7.3 t -58.89 -58.76 7.22 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 1.0 111.298 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.712 ' HE2' HMA3 ' A' ' 203' ' ' CYC . 2.1 t60 -68.38 -27.23 66.06 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.616 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -62.25 -56.95 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.608 0.595 . . . . 1.0 112.608 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -62.23 -38.78 90.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.376 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.463 ' O ' ' OG ' ' A' ' 145' ' ' SER . 74.8 t80 -47.9 -36.58 12.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.9 mt -73.64 -42.73 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -58.24 -44.84 88.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 83.7 p -61.9 -17.73 57.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.687 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.3 mmm -100.48 -0.02 38.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 1.0 111.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.38 18.9 77.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.538 -1.025 . . . . 1.0 110.538 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.29 142.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.696 0.284 . . . . 1.0 110.298 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.2 -26.73 5.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 p -153.78 121.35 5.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.701 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 m -126.77 138.66 53.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 1.0 111.385 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.99 134.27 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.1 t -113.96 127.76 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.332 -0.547 . . . . 1.0 112.291 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.65 126.18 17.91 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -90.51 161.42 4.41 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.351 2.034 . . . . 1.0 113.704 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 24.6 mt -114.34 114.78 26.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.435 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 23.4 ptm -141.9 150.56 41.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.489 ' CE1' ' NE2' ' A' ' 159' ' ' HIS . 9.1 t-80 -125.7 126.29 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.809 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.489 ' NE2' ' CE1' ' A' ' 158' ' ' HIS . 84.0 m-70 58.34 -122.47 1.35 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.105 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.56 2.72 50.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.811 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.527 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.2 tt0 -106.22 145.97 30.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.755 1.02 . . . . 1.0 113.755 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 44.9 tp -101.26 123.8 45.94 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.527 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.7 m95 -101.87 -32.08 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -176.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.88 -167.75 22.77 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.719 -1.229 . . . . 1.0 112.398 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -143.7 122.94 12.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.417 -0.392 . . . . 1.0 111.664 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.4 tp -94.76 150.5 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.31 133.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.822 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.578 ' HG ' ' HE2' ' A' ' 170' ' ' HIS . 87.9 p -113.24 139.73 48.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.249 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.471 ' O ' ' CG2' ' A' ' 48' ' ' THR . 18.1 m80 -111.92 124.38 52.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.578 ' HE2' ' HG ' ' A' ' 168' ' ' SER . 29.0 m-70 -117.44 116.88 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.09 -15.33 62.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.747 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -133.22 151.05 76.98 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.611 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -40.44 132.38 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.631 2.221 . . . . 1.0 111.858 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -164.4 80.98 1.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.532 -0.304 . . . . 1.0 110.684 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 156.06 12.18 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.574 2.183 . . . . 1.0 111.459 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -104.69 148.62 26.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 1.0 110.817 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.2 m -89.84 147.24 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.16 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.35 -29.37 69.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.171 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -77.82 -53.1 7.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.241 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.7 -33.57 74.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.937 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.27 -45.57 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.633 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.33 -55.31 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.724 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.1 t -45.37 -39.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.638 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -74.56 -49.37 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -48.54 -36.59 15.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 190' ' ' GLN . 21.6 tp -70.69 -46.39 63.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.082 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.05 -46.83 75.38 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.43 -48.23 81.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.22 -36.66 75.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 186' ' ' LEU . 7.0 tt0 -68.61 -32.41 72.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.47 -48.54 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.342 -0.985 . . . . 1.0 108.342 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.4 p -50.12 -31.6 13.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mt -74.65 -34.9 35.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.27 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -43.71 79.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.95 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 196' ' ' ALA . 31.7 pt -63.17 -30.77 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.406 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -72.79 -50.12 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.411 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.8 -40.79 95.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.275 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.472 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -67.51 -31.39 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.385 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -57.78 -43.39 85.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.93 -36.17 48.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.965 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 83.1 p -52.17 -57.49 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.647 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.486 179.414 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.758 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.835 0.35 . . . . 1.0 110.546 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 66.6 t0 -48.06 -36.05 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -74.4 -49.95 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.808 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.7 -44.98 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.022 0.439 . . . . 1.0 110.92 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.495 ' O ' ' OG1' ' A' ' 38' ' ' THR . 45.2 mt -58.4 -30.7 67.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.98 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -66.81 -38.35 86.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.78 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.76 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 76.9 p -68.67 -36.65 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.273 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -74.34 -23.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -72.76 -48.48 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.305 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.76 -34.96 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.742 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.7 t -59.98 -54.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.609 -0.269 . . . . 1.0 111.287 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.6 ttp180 -51.45 -43.43 62.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 1.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.17 -42.49 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.254 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.4 -37.19 86.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.793 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.2 mt -97.13 -13.93 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.864 -0.335 . . . . 1.0 111.701 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.65 25.59 22.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.6 p -81.29 152.21 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -48.71 -42.93 36.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.516 HH21 ' CG2' ' A' ' 148' ' ' VAL . 36.1 ptt180 -160.17 146.25 15.52 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.568 -0.853 . . . . 1.0 112.782 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 20.2 t -137.44 133.92 46.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.957 -1.019 . . . . 1.0 108.675 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.595 ' HZ1' ' CD1' ' A' ' 77' ' ' LEU . 17.7 mttt -135.91 144.62 45.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.604 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.43 141.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 18.1 t80 -129.78 130.62 45.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.509 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -111.86 154.11 25.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 1.0 111.239 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.66 136.89 40.73 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.661 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -97.17 150.94 37.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -41.54 -22.03 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.962 2.441 . . . . 1.0 114.468 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -103.85 9.0 37.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.185 0.439 . . . . 1.0 112.185 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.03 -15.81 62.29 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.598 -0.81 . . . . 1.0 111.966 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.585 ' O ' ' N ' ' A' ' 57' ' ' ASP . 35.6 m80 -77.52 151.27 34.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.78 163.56 25.54 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 p -135.63 158.85 43.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 1.0 111.495 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 104.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.78 -4.75 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.0 125.68 7.63 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.33 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 75.1 tt0 -154.45 138.99 16.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.158 0.504 . . . . 1.0 111.684 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.7 131.41 51.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.562 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 34.8 ptt180 -109.03 140.2 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.02 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.72 66.71 3.55 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 81.77 163.68 32.17 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -59.94 6.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 1.0 110.343 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.63 ' H ' ' C ' ' A' ' 71' ' ' GLY . 62.4 ttt180 -62.34 -40.63 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.992 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.2 144.08 40.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.14 166.17 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.47 2.113 . . . . 1.0 112.264 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.2 p -100.95 139.02 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.291 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.617 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 35.0 mt -103.98 18.09 22.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.968 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 24.5 tp -65.21 131.03 45.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.6 88.77 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.843 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.78 151.01 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.352 0.576 . . . . 1.0 110.461 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.4 t -104.41 128.99 52.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.603 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -106.69 107.3 60.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.286 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -43.37 138.89 4.66 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.592 2.195 . . . . 1.0 111.522 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.427 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -61.55 -29.29 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.21 -17.71 0.24 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' N ' ' C ' ' A' ' 84' ' ' ALA . 89.2 m-20 -67.52 -16.55 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.665 0.269 . . . . 1.0 111.032 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' PRO . 16.1 mt -134.55 99.47 12.97 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.53 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' ILE . 40.9 Cg_exo -39.6 -97.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.521 2.147 . . . . 1.0 111.704 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 22.8 pt-20 -165.71 -39.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.003 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -56.97 -43.35 81.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.625 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.12 -35.66 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.686 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -65.01 -32.23 73.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.806 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -64.6 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.541 ' CB ' ' NH2' ' A' ' 101' ' ' ARG . 10.0 mt -60.18 -38.31 82.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.546 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.425 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 83.1 m-85 -66.56 -32.5 73.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.168 -0.679 . . . . 1.0 109.168 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -79.74 -27.53 40.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.172 -0.922 . . . . 1.0 111.305 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.85 -40.43 8.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -119.08 -11.57 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.422 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 4.0 mp0 44.77 64.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.669 -0.812 . . . . 1.0 109.91 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.542 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 11.1 p -168.8 107.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.905 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.542 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -159.15 134.4 8.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.895 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 103' ' ' ILE . 53.7 t -149.01 155.76 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.707 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.408 ' N ' ' CG1' ' A' ' 102' ' ' VAL . 66.2 mt -111.9 129.14 67.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.238 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -87.28 169.58 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.16 115.79 1.58 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.975 -1.011 . . . . 1.0 112.274 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.4 p -51.24 -22.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.644 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -76.38 -38.83 55.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.822 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.87 19.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.234 0.54 . . . . 1.0 110.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 56.33 62.79 2.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.838 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 m -95.43 125.59 40.15 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.777 -1.564 . . . . 1.0 106.777 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -117.62 145.36 44.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.661 0.985 . . . . 1.0 113.661 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -111.97 148.8 33.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.77 -1.105 . . . . 1.0 108.62 177.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -145.6 149.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.438 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.3 m -87.2 171.88 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.09 157.9 37.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.887 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 167.08 28.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.635 2.224 . . . . 1.0 112.24 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 56.88 102.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.65 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.8 m -151.39 165.17 34.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -152.83 -19.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.717 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 122' ' ' SER . . . 85.34 -169.39 43.5 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 tp 56.9 3.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 1.0 110.644 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 120' ' ' GLY . 66.3 p -68.56 -24.06 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.705 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.652 ' C ' ' H ' ' A' ' 125' ' ' VAL . . . -66.35 -3.34 5.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.793 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -49.33 -3.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 1.0 110.682 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.652 ' H ' ' C ' ' A' ' 123' ' ' ALA . 16.9 m -108.7 148.56 38.02 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.8 142.97 32.73 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.417 2.078 . . . . 1.0 111.558 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.432 ' O ' ' OE2' ' A' ' 129' ' ' GLU . 51.8 mt 50.11 -117.88 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.617 -0.265 . . . . 1.0 110.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.66 5.61 58.72 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 3.6 pm0 -154.73 153.21 27.29 Favored Pre-proline 0 C--N 1.329 -0.288 0 O-C-N 122.836 -0.214 . . . . 1.0 110.619 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 132' ' ' GLN . 72.0 Cg_exo -42.97 173.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.481 2.12 . . . . 1.0 111.982 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.17 14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.078 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.56 ' H ' ' C ' ' A' ' 130' ' ' PRO . 48.4 mm-40 -137.98 159.5 41.85 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.596 -0.442 . . . . 1.0 111.523 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.507 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -127.45 79.09 73.87 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.541 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.56 142.76 6.66 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.644 2.229 . . . . 1.0 112.422 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.63 125.44 71.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 178.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.556 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 3.5 p30 -45.67 142.55 3.47 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.752 0.31 . . . . 1.0 111.317 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.8 -20.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.15 2.567 . . . . 1.0 113.634 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.5 t -61.59 -62.78 1.57 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.209 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.466 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 74.0 t60 -70.26 -24.61 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.631 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 135' ' ' VAL . 61.4 t -60.6 -60.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.61 0.596 . . . . 1.0 112.61 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -61.12 -38.4 86.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -47.23 -36.64 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.9 mt -73.33 -43.65 60.39 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.22 -44.63 88.28 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.644 -0.873 . . . . 1.0 108.644 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -62.63 -19.0 63.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.691 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 23.2 mmm -101.27 -0.98 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 1.0 111.052 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.6 17.62 79.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.516 ' CG2' HH21 ' A' ' 50' ' ' ARG . 73.0 t -107.29 143.65 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.655 0.264 . . . . 1.0 110.335 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.7 -42.74 2.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.944 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.7 t -136.87 118.16 14.59 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.77 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.3 m -129.12 143.39 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.998 0.428 . . . . 1.0 111.405 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.45 132.54 45.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.74 107.17 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.304 -0.558 . . . . 1.0 112.258 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.53 132.68 21.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -91.63 163.39 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.386 2.057 . . . . 1.0 113.701 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.5 mt -116.9 113.86 23.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.569 ' N ' ' OG ' ' A' ' 192' ' ' SER . 25.3 ptm -142.69 150.3 39.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -125.66 124.49 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.897 -1.047 . . . . 1.0 108.842 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.615 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 79.5 t60 60.17 -122.04 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.165 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.615 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 41.3 tt0 -97.85 1.71 48.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.808 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.8 tt0 -106.43 144.24 33.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 tp -99.31 125.74 45.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 75.7 m95 -104.37 -34.84 8.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.5 -175.05 31.08 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.717 -1.23 . . . . 1.0 112.417 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -137.44 122.02 18.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.471 -0.365 . . . . 1.0 111.644 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 47.1 tp -94.95 150.02 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.5 p -156.62 134.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.004 -0.678 . . . . 1.0 111.843 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 90.5 p -116.03 132.74 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -104.96 126.83 52.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.56 ' HE2' ' NH1' ' A' ' 174' ' ' ARG . 5.7 t-80 -118.8 115.35 24.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.79 63.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.799 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 21.6 mp0 -134.93 150.7 73.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.535 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -41.83 145.62 0.7 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.637 2.225 . . . . 1.0 111.802 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.56 ' NH1' ' HE2' ' A' ' 170' ' ' HIS . 11.8 tpp85 -172.91 81.62 0.42 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.686 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.16 152.53 24.45 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.538 2.158 . . . . 1.0 111.5 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -105.46 150.45 25.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 110.739 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -94.58 152.94 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.213 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -52.7 -38.05 60.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.159 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -73.99 -44.86 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.246 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -66.37 -28.88 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 1.0 110.902 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.98 -39.25 76.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.651 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -78.92 -54.19 6.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.618 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 184' ' ' VAL . 9.9 p -43.67 -42.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.669 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.443 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 34.0 m -75.09 -48.36 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -48.26 -36.49 14.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 190' ' ' GLN . 24.1 tp -70.85 -45.72 63.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.023 -0.989 . . . . 1.0 109.088 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.08 -47.67 77.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.8 93.54 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -62.78 -37.12 85.42 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 186' ' ' LEU . 7.0 tt0 -66.89 -31.7 72.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.647 -0.871 . . . . 1.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.62 -46.79 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -50.8 -32.84 21.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.2 mt -74.73 -34.32 33.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.198 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.94 -43.53 78.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.984 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 196' ' ' ALA . 24.2 pt -63.06 -30.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.72 -53.47 7.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.392 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.84 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.224 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.452 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -66.05 -34.05 77.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.467 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.7 -40.92 73.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.211 0.449 . . . . 1.0 112.211 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.0 tp -51.45 -34.65 36.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.928 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 94.2 p -48.3 -56.41 8.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.696 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.986 . . . . 1.0 110.482 179.507 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.556 ' HHD' ' OD2' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.362 . . . . 1.0 110.563 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.2 t0 -51.69 -33.24 33.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.728 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -75.98 -49.44 17.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.779 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -55.38 -52.69 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 1.0 110.976 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.7 mt -56.36 -30.94 63.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.988 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -64.6 -38.93 92.7 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.754 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.09 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.844 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 67.2 p -65.8 -37.4 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 1.0 112.311 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -74.58 -25.45 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.58 -43.17 23.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.283 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -72.24 -43.99 63.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.785 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 7.2 p -61.69 -47.63 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.306 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLY . 70.7 ttp85 -54.97 -44.21 74.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 1.0 110.689 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.82 60.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.351 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -70.18 -33.59 71.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.813 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -97.52 -18.96 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.759 0.314 . . . . 1.0 111.695 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.8 25.21 51.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 91.7 m -77.36 144.01 38.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.981 -0.377 . . . . 1.0 109.981 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -52.83 -42.45 65.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.635 0.605 . . . . 1.0 112.635 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.533 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 2.9 mtt-85 -149.48 128.35 12.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.507 -0.877 . . . . 1.0 112.797 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 10.9 t -136.7 129.89 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.968 -1.015 . . . . 1.0 108.739 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -137.95 152.39 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.658 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.3 t -99.12 141.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.445 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.6 t80 -131.85 133.24 44.44 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.468 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -113.66 154.06 27.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 1.0 111.205 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -103.87 137.64 41.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.68 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.3 m-20 -101.75 154.95 36.97 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.54 -52.3 2.04 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.001 2.468 . . . . 1.0 114.481 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.12 -6.31 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.561 -0.456 . . . . 1.0 112.141 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.07 37.42 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.689 -0.767 . . . . 1.0 111.887 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 57' ' ' ASP . 72.8 m80 -77.56 149.29 34.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.445 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.47 161.06 24.95 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 155.48 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 1.0 111.559 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.44 108.68 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.89 -4.27 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.41 123.44 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.25 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.7 tt0 -151.84 136.62 17.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.155 0.502 . . . . 1.0 111.705 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.82 134.36 50.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.061 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.04 66.91 3.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 84.31 36.48 12.52 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 57.41 0.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 1.0 110.34 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.579 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.0 mtp180 -46.35 -49.11 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.056 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.524 ' CB ' ' HE ' ' A' ' 50' ' ' ARG . 15.1 mt -102.61 150.57 37.79 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.327 -0.619 . . . . 1.0 109.327 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.0 150.03 59.97 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.489 2.126 . . . . 1.0 112.217 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.5 t -81.66 120.34 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.284 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 32.6 mt -98.23 14.69 26.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.484 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.7 tp -64.53 131.79 48.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.61 88.15 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.781 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.81 150.21 24.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.344 0.572 . . . . 1.0 110.479 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 p -108.63 137.17 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.566 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE2' HAB1 ' A' ' 203' ' ' CYC . 46.0 m-85 -108.55 149.57 39.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 78.5 Cg_endo -80.12 136.66 11.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.493 2.129 . . . . 1.0 111.507 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.67 -35.05 75.28 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.81 -14.7 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . 47.7 p-10 -68.71 -19.61 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.624 0.249 . . . . 1.0 111.016 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.97 97.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.538 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 41.3 Cg_exo -39.18 -95.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.565 2.177 . . . . 1.0 111.683 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.482 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 41.8 tp10 -162.91 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.969 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -51.03 -40.9 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.646 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.48 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.726 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -64.7 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 1.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -65.21 -38.8 91.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.05 -36.95 75.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.549 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CE2' ' O1A' ' A' ' 203' ' ' CYC . 88.0 m-85 -68.7 -35.37 77.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -76.98 -32.08 56.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.24 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.522 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.7 mt -95.84 -39.24 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.41 -12.94 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.2 1.185 . . . . 1.0 114.2 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.574 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.8 mp0 47.17 48.12 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.0 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.6 t -149.87 108.45 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.912 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.63 ' HE ' ' CZ ' ' A' ' 133' ' ' ARG . 1.1 tpt180 -160.91 130.9 5.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.2 p -150.06 155.96 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.683 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.431 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 95.2 mt -114.32 131.18 67.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.245 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -87.99 171.13 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.028 0.751 . . . . 1.0 113.028 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 42.9 m-20 -50.74 115.4 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.932 -1.031 . . . . 1.0 112.231 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.0 p -49.66 -19.74 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.642 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -76.76 -38.79 53.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.821 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.577 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -61.78 -8.94 5.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.167 0.508 . . . . 1.0 110.43 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 15.8 pt20 46.17 62.03 2.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.435 -0.802 . . . . 1.0 112.891 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -93.35 126.94 38.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.752 -1.573 . . . . 1.0 106.752 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -119.4 147.01 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.666 0.987 . . . . 1.0 113.666 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.529 ' OG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -111.44 149.32 31.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.789 -1.096 . . . . 1.0 108.636 178.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.5 mt -145.82 149.82 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.445 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -84.01 164.07 19.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -151.69 159.72 32.79 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.909 -178.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.78 156.87 62.18 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.67 2.247 . . . . 1.0 112.187 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 59.61 84.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.619 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.1 m -69.77 161.9 28.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.502 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -90.0 -169.17 2.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -128.8 -129.94 3.23 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.0 tp -71.66 35.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.744 0.307 . . . . 1.0 110.569 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 120' ' ' GLY . 65.0 m -60.75 -23.9 65.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.79 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' VAL . . . -49.62 -30.89 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.764 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.79 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 1.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.0 t -92.95 131.27 33.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.717 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 128' ' ' GLY . 84.7 Cg_endo -76.38 135.03 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.395 2.064 . . . . 1.0 111.537 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.3 mt 59.22 -80.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.381 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 65.18 9.04 39.65 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' PRO . 18.5 pt-20 -153.39 152.98 28.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 O-C-N 122.828 -0.219 . . . . 1.0 110.619 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.639 ' C ' ' H ' ' A' ' 132' ' ' GLN . 55.2 Cg_exo -40.97 167.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.385 2.057 . . . . 1.0 111.995 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -57.84 9.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 1.0 112.039 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.639 ' H ' ' C ' ' A' ' 130' ' ' PRO . 47.8 mm-40 -137.37 166.06 24.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.465 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.63 ' CZ ' ' HE ' ' A' ' 101' ' ' ARG . 15.7 ttt-85 -139.76 123.7 10.86 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.509 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.529 ' C ' ' OG ' ' A' ' 112' ' ' SER . 49.6 Cg_endo -84.74 145.39 10.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.647 2.232 . . . . 1.0 112.401 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.509 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -117.61 128.17 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.614 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 4.5 p30 -45.03 140.77 3.41 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 1.0 111.376 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -37.91 -17.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 123.053 2.502 . . . . 1.0 113.748 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 136' ' ' ASP . 42.6 t -63.28 -62.21 1.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.267 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.407 ' CE1' ' CD1' ' A' ' 103' ' ' ILE . 51.7 t-80 -71.1 -25.06 62.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.667 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.36 -60.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -61.41 -37.45 83.52 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.394 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 61.1 t80 -46.17 -37.93 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.16 -43.4 64.68 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.36 -41.49 89.39 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.631 -0.878 . . . . 1.0 108.631 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -64.16 -22.18 66.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.441 -0.799 . . . . 1.0 109.642 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.598 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 70.9 mtp -97.97 2.09 48.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.101 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.97 19.44 78.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.6 -1.0 . . . . 1.0 110.6 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 78.9 t -110.19 145.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.679 0.276 . . . . 1.0 110.276 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.3 -23.9 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.027 0.38 . . . . 1.0 112.027 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 20.2 m -152.36 120.21 6.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.747 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 p -128.17 137.58 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 1.0 111.419 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.0 131.83 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.4 t -111.95 130.45 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.293 -0.563 . . . . 1.0 112.306 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.95 128.59 18.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.88 166.28 3.23 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.389 2.059 . . . . 1.0 113.733 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.59 115.35 24.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.605 -1.257 . . . . 1.0 107.605 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.8 ptm -142.3 151.61 42.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.44 0.638 . . . . 1.0 112.684 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.402 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 48.9 t-80 -128.31 124.56 36.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.913 -1.039 . . . . 1.0 108.899 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.546 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 62.2 t60 61.79 -123.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.107 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.546 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 99.0 mm-40 -97.63 3.55 50.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.519 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -107.0 144.83 33.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.683 0.994 . . . . 1.0 113.683 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.5 tp -98.78 125.7 44.21 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.519 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 73.9 m95 -105.21 -36.83 7.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.44 -173.25 23.91 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.694 -1.241 . . . . 1.0 112.39 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -139.57 120.19 14.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.441 -0.379 . . . . 1.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.8 tp -94.73 149.8 20.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.42 134.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.097 -0.641 . . . . 1.0 111.863 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -114.45 137.86 51.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.223 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 30.5 m-70 -111.96 124.69 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 1.0 112.663 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.598 ' CE1' ' HH ' ' A' ' 176' ' ' TYR . 71.5 m80 -116.42 121.33 41.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.51 13.38 6.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.785 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -156.3 152.02 22.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.579 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -44.52 122.6 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.689 2.259 . . . . 1.0 111.823 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -156.55 106.43 2.0 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.684 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.68 157.73 21.59 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.478 2.119 . . . . 1.0 111.46 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.598 ' HH ' ' CE1' ' A' ' 170' ' ' HIS . 81.9 m-85 -108.85 146.58 33.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.859 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.6 p -88.29 157.81 18.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -58.57 -33.65 70.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.189 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -77.16 -54.16 6.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.299 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.08 -33.41 73.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.96 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.19 -49.51 75.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.62 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.0 -52.61 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.652 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.8 t -44.98 -39.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 187' ' ' LEU . 83.7 t -73.32 -49.82 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -45.99 -32.02 2.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 tp -68.18 -48.15 66.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.119 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 184' ' ' VAL . 92.7 mt -52.1 -46.3 65.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.94 93.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.423 -0.955 . . . . 1.0 108.423 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.77 -38.89 92.79 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -66.19 -31.16 71.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.74 -46.62 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 42.5 p -51.24 -32.04 22.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.68 -34.59 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.132 -0.94 . . . . 1.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.51 -43.66 80.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.895 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 196' ' ' ALA . 21.0 pt -62.7 -29.57 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -74.92 -52.37 11.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.69 -42.67 97.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.82 72.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.36 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.02 -43.13 81.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.442 ' H ' ' CD1' ' A' ' 200' ' ' LEU . 8.4 mp -52.44 -33.51 44.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.995 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -54.56 -58.61 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.398 179.833 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.614 ' HHD' ' OD2' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.838 0.351 . . . . 1.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -48.0 -35.49 11.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -75.14 -49.88 18.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.802 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 34' ' ' ILE . 24.4 mm -56.12 -48.54 78.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.141 0.496 . . . . 1.0 110.959 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.519 ' O ' ' OG1' ' A' ' 38' ' ' THR . 32.5 mt -57.42 -29.25 63.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.955 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -66.43 -39.82 89.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.447 -0.501 . . . . 1.0 109.739 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.77 -30.04 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.767 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 75.1 p -68.48 -36.02 78.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.283 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -72.72 -25.48 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.16 0.429 . . . . 1.0 112.16 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.32 -42.67 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.267 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.95 -48.29 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.804 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -56.44 -49.22 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.352 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' GLY . 70.8 ttp85 -51.01 -43.5 60.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 1.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.8 -40.79 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.33 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.59 -35.81 79.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.758 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -96.75 -15.76 21.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 1.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.57 25.23 34.54 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.532 ' OG1' ' NE2' ' A' ' 170' ' ' HIS . 69.9 m -78.63 145.89 34.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -53.37 -44.46 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.406 HH21 ' HB2' ' A' ' 73' ' ' ARG . 11.0 mtt85 -148.28 132.44 17.35 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 119.563 -0.855 . . . . 1.0 112.798 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.4 t -136.49 130.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 114.937 -1.029 . . . . 1.0 108.777 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -136.56 148.32 47.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.604 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -98.57 140.72 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.923 -0.769 . . . . 1.0 108.923 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.5 t80 -128.92 133.04 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.464 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -106.62 141.96 37.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.979 0.419 . . . . 1.0 111.234 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.452 ' CE2' ' NH1' ' A' ' 92' ' ' ARG . 64.6 t80 -97.99 124.55 42.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.696 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' HIS . 7.6 t70 -95.22 138.72 21.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -40.76 -29.68 0.46 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.931 2.421 . . . . 1.0 114.564 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -84.44 -4.56 58.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.8 -17.53 45.38 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.929 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 57' ' ' ASP . 75.6 m80 -80.25 149.27 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.376 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.1 162.98 26.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -134.14 156.15 48.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 1.0 111.504 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.4 t -88.39 108.56 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.54 -4.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.42 124.14 7.25 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.301 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 71.2 tt0 -150.69 138.5 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.195 0.521 . . . . 1.0 111.69 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.08 128.02 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.738 -0.838 . . . . 1.0 108.738 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -102.68 137.41 40.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.991 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -79.07 -143.18 2.48 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -62.58 61.73 0.03 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 70' ' ' GLY . 3.2 pm0 26.34 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.835 0.35 . . . . 1.0 110.392 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 71' ' ' GLY . 81.6 mtt180 -84.38 -36.0 22.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.0 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.6 tp -124.74 123.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.365 -0.605 . . . . 1.0 109.365 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.7 149.63 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.52 2.147 . . . . 1.0 112.211 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 p -66.66 138.04 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.332 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.571 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -108.11 12.95 26.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.991 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.9 tp -64.08 132.04 49.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.28 -4.3 84.01 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.42 -0.809 . . . . 1.0 112.873 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.84 151.45 23.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.357 0.579 . . . . 1.0 110.383 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.9 m -108.04 134.81 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.635 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -108.52 150.9 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.249 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.37 140.6 15.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.73 -33.86 76.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 1.0 110.463 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.2 -16.67 0.17 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' ALA . 11.8 p-10 -55.65 -11.98 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.671 0.272 . . . . 1.0 111.037 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -151.75 146.45 18.76 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.536 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 93.4 Cg_endo -75.7 -92.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.556 2.17 . . . . 1.0 111.675 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' OE2' ' NH2' ' A' ' 92' ' ' ARG . 46.7 tp10 -167.58 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.2 pt-20 -55.23 -41.74 72.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -72.07 -37.64 69.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.76 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 54.0 ttp180 -62.58 -33.06 74.2 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.776 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -64.05 -37.42 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.915 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.63 -35.87 77.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.589 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.3 -36.94 77.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -75.43 -30.87 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.255 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.54 -38.86 10.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.804 1.039 . . . . 1.0 113.804 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.92 -13.08 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.262 1.208 . . . . 1.0 114.262 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.471 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 9.0 mp0 47.87 56.92 6.55 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.689 -0.804 . . . . 1.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.3 m -159.41 113.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.913 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -165.99 135.77 3.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.896 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.3 p -148.21 156.44 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 1.0 109.705 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.451 HD12 HMA3 ' A' ' 203' ' ' CYC . 28.2 mt -109.78 128.5 65.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.84 165.8 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.999 0.74 . . . . 1.0 112.999 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -51.46 118.63 3.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 p -51.43 -25.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.656 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -77.18 -38.91 50.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.1 43.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.129 0.49 . . . . 1.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 57.73 60.26 2.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t -94.39 124.82 38.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -119.69 143.85 47.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.65 ' HG ' ' H ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -112.51 152.64 28.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.756 -1.111 . . . . 1.0 108.627 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.0 pt -152.72 157.29 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.492 -0.483 . . . . 1.0 111.448 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.5 t -88.8 166.73 13.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 117' ' ' GLU . 6.5 tp-100 -151.2 118.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.401 . . . . 1.0 110.859 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 117' ' ' GLU . 34.4 Cg_exo -37.74 87.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.577 2.185 . . . . 1.0 112.299 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 115' ' ' GLN . 85.0 tt0 44.57 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.653 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 t -157.31 0.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -93.32 144.47 25.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.97 -177.34 51.77 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 40.1 tp -89.27 125.15 34.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.741 0.305 . . . . 1.0 110.645 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.5 m -60.09 -36.1 76.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.0 -27.2 30.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.774 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -56.15 -59.38 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.694 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.61 133.4 12.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.623 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.78 167.81 25.55 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.343 2.028 . . . . 1.0 111.529 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mp 44.68 -107.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.447 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 57.42 37.68 83.08 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.033 -0.827 . . . . 1.0 111.033 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -132.89 151.86 78.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.547 0.213 . . . . 1.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 132' ' ' GLN . 55.2 Cg_endo -66.46 158.13 56.96 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.428 2.085 . . . . 1.0 112.026 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 70.4 mt -47.69 -12.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.064 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 130' ' ' PRO . 17.3 mm-40 -133.51 135.26 44.32 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.477 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -111.85 131.09 22.59 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.525 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.05 139.11 10.58 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.597 2.198 . . . . 1.0 112.409 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -118.17 129.83 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.65 ' H ' ' HG ' ' A' ' 112' ' ' SER . 6.9 t0 -45.99 138.53 5.77 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.729 0.3 . . . . 1.0 111.33 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -39.08 -35.79 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.068 2.512 . . . . 1.0 113.62 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 t -43.53 -63.71 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.261 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.78 -22.49 62.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.678 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.67 -55.2 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.562 0.578 . . . . 1.0 112.562 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.48 -40.14 96.3 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.378 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.79 -35.57 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.64 -42.79 60.96 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -58.68 -43.73 90.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.1 m -62.42 -19.37 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.653 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.6 mmm -99.97 0.87 41.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.088 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.06 18.55 78.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.8 144.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.661 0.267 . . . . 1.0 110.351 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.43 -38.57 2.99 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.087 0.403 . . . . 1.0 112.087 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.1 p -138.4 121.26 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.721 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -130.92 141.46 50.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 1.0 111.332 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.66 131.62 55.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.1 m -116.18 140.04 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.264 -0.575 . . . . 1.0 112.239 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.9 t -131.91 132.66 23.33 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -89.92 159.87 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.326 2.018 . . . . 1.0 113.666 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 34.3 mt -114.89 117.02 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.2 ptm -140.33 148.07 40.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 81.5 t60 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.826 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 22.1 m-70 58.38 -125.44 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.148 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -100.67 6.11 43.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.761 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 11.5 pt-20 -111.98 156.32 22.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.728 1.01 . . . . 1.0 113.728 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.6 tp -102.04 128.1 48.63 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.515 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 29.7 m95 -104.58 -34.74 8.09 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.15 31.06 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.712 -1.232 . . . . 1.0 112.383 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -137.41 123.11 19.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.446 -0.377 . . . . 1.0 111.643 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.65 149.24 21.44 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.69 131.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.1 -0.64 . . . . 1.0 111.899 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.6 t -114.91 135.18 54.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.258 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 11.7 m-70 -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.532 ' NE2' ' OG1' ' A' ' 48' ' ' THR . 72.3 m80 -117.45 119.88 36.42 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.11 24.58 1.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.822 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 1.3 pm0 -160.68 152.98 17.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.956 -0.298 . . . . 1.0 110.627 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.13 124.87 13.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.659 2.24 . . . . 1.0 111.792 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -158.2 93.81 2.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.91 153.76 11.26 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.57 2.18 . . . . 1.0 111.451 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -107.43 152.07 24.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.811 0.339 . . . . 1.0 110.839 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.5 p -94.85 153.99 17.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.48 -34.69 72.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.151 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -71.83 -49.13 41.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.176 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -64.56 -31.86 73.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 1.0 110.953 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.13 -38.52 91.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.614 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.67 -51.87 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.869 -0.332 . . . . 1.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -42.23 -42.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.689 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.47 -45.94 44.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -50.53 -32.87 19.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.063 -1.088 . . . . 1.0 108.063 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 16.8 tp -73.0 -52.65 13.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.089 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.17 -46.01 65.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.19 80.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -61.23 -38.44 86.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 44.5 tt0 -64.9 -33.11 75.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.4 -45.74 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.376 -0.972 . . . . 1.0 108.376 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -52.46 -36.03 53.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -68.61 -37.0 77.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.272 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.61 -41.01 80.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.405 HD11 HG23 ' A' ' 195' ' ' ILE . 48.0 mt -55.52 -48.43 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.363 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.44 -46.54 88.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.264 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.41 -33.08 74.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 1.0 111.398 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -55.97 -41.13 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 26.0 tp -53.18 -37.29 61.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.8 m -48.94 -57.75 5.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.67 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.7 mp . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.453 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.451 HMA3 HD12 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.805 0.336 . . . . 1.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.22 -32.4 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.742 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.8 -48.73 20.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.792 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.6 mm -55.1 -53.3 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 1.0 110.945 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.6 mt -56.44 -30.21 62.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.99 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -64.49 -39.94 94.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.384 -0.526 . . . . 1.0 109.817 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.12 67.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.774 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.5 p -67.49 -36.46 81.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.314 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -73.65 -25.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 71.5 mm-40 -79.6 -43.8 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.773 -0.371 . . . . 1.0 111.318 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.88 -44.6 80.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.807 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -59.42 -46.56 92.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.323 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 47' ' ' GLY . 6.2 ttm180 -50.76 -45.03 58.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 1.0 110.692 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.78 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.254 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.95 -37.86 82.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.852 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.37 -18.69 18.96 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.674 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.76 25.49 56.0 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 50.0 m -78.07 143.23 37.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.38 -39.97 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 13.3 mtt85 -148.48 124.19 10.5 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.822 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.5 t -132.63 128.48 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.748 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' NZ ' ' CD1' ' A' ' 77' ' ' LEU . 34.9 mttt -136.64 148.78 47.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.616 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.39 140.96 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.57 ' HH ' ' CA ' ' A' ' 62' ' ' GLY . 20.1 t80 -130.6 132.3 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.433 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.412 HH12 ' CG2' ' A' ' 195' ' ' ILE . 60.4 ttt85 -110.84 149.84 30.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.035 0.445 . . . . 1.0 111.195 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.14 133.95 46.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.691 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 61' ' ' HIS . 11.6 m-20 -99.26 153.51 37.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -38.68 -51.08 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 122.96 2.44 . . . . 1.0 114.53 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -70.96 -6.43 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.84 -8.23 39.27 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.684 -0.77 . . . . 1.0 111.922 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ASP . 70.0 m80 -78.23 151.03 33.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.424 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' CA ' ' HH ' ' A' ' 54' ' ' TYR . . . -138.59 163.61 25.78 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -135.87 157.72 46.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.999 0.428 . . . . 1.0 111.528 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.6 107.75 17.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.77 -5.19 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.71 123.2 7.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.274 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 55.1 tt0 -148.45 136.99 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.152 0.501 . . . . 1.0 111.734 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.62 129.03 48.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' CB ' ' NH2' ' A' ' 50' ' ' ARG . 30.8 ptt-85 -107.01 137.98 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.292 -0.563 . . . . 1.0 112.052 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.13 65.19 4.14 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 82.52 162.53 31.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.059 -0.816 . . . . 1.0 111.059 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -61.67 11.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 1.0 110.364 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.673 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.6 mtp180 -62.89 -48.94 76.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.045 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 11.9 mt -116.71 148.31 41.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.47 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 86.5 Cg_endo -76.67 166.37 27.27 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.504 2.136 . . . . 1.0 112.237 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.6 p -101.22 148.13 25.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.342 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.594 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 42.7 mt -110.81 19.43 18.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.0 tp -66.47 130.47 43.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.35 87.2 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.41 -0.814 . . . . 1.0 112.858 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.3 149.23 25.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.32 0.56 . . . . 1.0 110.429 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.1 m -106.89 134.62 49.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.589 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CD1' HBB2 ' A' ' 203' ' ' CYC . 61.5 m-85 -108.78 148.9 38.75 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.215 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.73 136.17 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.572 2.182 . . . . 1.0 111.502 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -58.28 -30.58 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.817 0.341 . . . . 1.0 110.413 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.61 -16.63 0.06 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.227 -0.749 . . . . 1.0 111.227 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.671 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 51.4 t0 -62.07 -21.84 65.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.701 0.286 . . . . 1.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.0 mt -143.35 104.71 5.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.529 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -40.38 -84.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.56 2.173 . . . . 1.0 111.629 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' OE2' ' NH2' ' A' ' 92' ' ' ARG . 46.2 tp10 -172.41 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.53 -43.31 93.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.626 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.64 -36.78 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.521 -0.308 . . . . 1.0 111.702 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 65.4 ttp85 -64.6 -32.75 74.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.774 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' NH1' ' CH2' ' A' ' 119' ' ' TRP . 62.6 ttt180 -64.42 -37.19 86.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.857 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.11 -36.7 80.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.532 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -67.39 -33.98 76.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -74.14 -33.22 63.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.263 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.465 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.2 mt -94.82 -38.11 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.82 -13.56 9.07 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 114.228 1.196 . . . . 1.0 114.228 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.575 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.4 mp0 47.06 49.7 14.72 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.665 -0.814 . . . . 1.0 109.864 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.4 109.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 120.314 -0.554 . . . . 1.0 111.878 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.02 134.88 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.865 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.4 p -151.05 156.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.724 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.446 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 27.8 mt -109.96 128.77 65.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.263 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.69 169.34 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.972 0.73 . . . . 1.0 112.972 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -49.52 113.73 0.89 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.289 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 52.9 t -51.37 -18.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.696 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 109' ' ' GLN . 44.2 tp10 -77.95 -38.81 44.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.795 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -61.75 -7.19 3.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.131 0.491 . . . . 1.0 110.384 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 18.2 pt20 45.67 62.77 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.494 -0.776 . . . . 1.0 112.881 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 m -93.91 127.83 39.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -119.79 144.73 47.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.708 1.003 . . . . 1.0 113.708 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -108.84 150.43 27.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.715 -1.129 . . . . 1.0 108.619 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.3 pt -150.61 154.79 8.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.1 t -85.18 163.82 18.49 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 117' ' ' GLU . 62.4 mt-30 -148.17 153.39 41.25 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.866 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -35.81 -27.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.593 2.195 . . . . 1.0 112.272 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 115' ' ' GLN . 94.6 mt-10 -144.58 -128.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.633 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.8 t 60.9 82.43 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.483 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.609 ' CH2' ' NH1' ' A' ' 93' ' ' ARG . 83.6 t90 -156.56 137.07 13.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.761 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.3 31.39 51.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 121' ' ' LEU . 8.6 mp -64.62 -37.32 87.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 1.0 110.608 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 m -59.88 -36.34 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.06 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -57.61 -61.01 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.69 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.52 156.28 45.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.627 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 128' ' ' GLY . 50.0 Cg_endo -65.16 126.06 15.73 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.356 2.038 . . . . 1.0 111.551 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 129' ' ' GLU . 24.8 mt 56.32 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.549 -0.296 . . . . 1.0 110.4 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 56.29 9.98 3.65 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.086 -0.806 . . . . 1.0 111.086 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 127' ' ' LEU . 45.6 mt-10 -154.52 152.03 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.57 0.224 . . . . 1.0 110.576 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.563 ' C ' ' H ' ' A' ' 132' ' ' GLN . 66.3 Cg_exo -41.66 141.37 1.55 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.438 2.092 . . . . 1.0 111.995 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.48 12.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.986 -0.552 . . . . 1.0 112.032 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.563 ' H ' ' C ' ' A' ' 130' ' ' PRO . 27.4 mt-30 -127.34 134.99 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.457 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -132.57 152.56 80.19 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.553 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.513 ' O ' ' OG ' ' A' ' 112' ' ' SER . 56.1 Cg_endo -84.82 148.32 10.87 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.64 2.226 . . . . 1.0 112.356 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.494 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 89.4 t -112.11 123.87 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.533 ' N ' ' OG ' ' A' ' 112' ' ' SER . 5.6 t70 -44.83 139.23 3.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.293 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.67 -25.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.091 2.527 . . . . 1.0 113.632 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.8 t -49.58 -61.97 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.206 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -72.94 -23.21 60.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.68 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.55 -60.96 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -63.31 -39.46 94.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.364 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 83.1 t80 -48.21 -40.01 22.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.27 -44.8 64.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -56.2 -41.77 76.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -62.65 -22.07 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.622 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.588 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 46.1 mtp -97.25 -1.48 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 20.27 73.8 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.17 143.49 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.277 . . . . 1.0 110.344 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.38 -28.2 4.69 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -151.44 120.2 6.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.811 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 72.9 m -128.65 142.46 51.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 1.0 111.46 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tp -100.07 132.43 45.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.91 130.39 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.305 -0.558 . . . . 1.0 112.242 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 19.8 t -135.71 131.35 19.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.247 -1.02 . . . . 1.0 108.247 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.29 163.01 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.389 2.06 . . . . 1.0 113.69 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.2 mt -115.77 113.93 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.4 ptm -142.0 152.31 43.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.751 0.649 . . . . 1.0 112.751 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -128.04 123.74 35.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 1.0 108.88 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.503 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 17.6 t-80 61.98 -123.64 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.1 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.503 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 15.3 mm100 -97.39 3.3 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.843 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.4 tt0 -106.56 144.96 32.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.75 1.018 . . . . 1.0 113.75 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 48.2 tp -100.18 125.05 46.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.9 m95 -103.76 -33.45 8.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.58 0.956 . . . . 1.0 113.58 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.64 -175.99 32.25 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.668 -1.253 . . . . 1.0 112.371 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 mt -135.06 123.12 22.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.447 -0.377 . . . . 1.0 111.617 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 5.2 tp -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.45 132.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.825 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.5 p -114.2 133.69 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.174 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.472 ' O ' ' CG2' ' A' ' 48' ' ' THR . 46.4 m80 -106.05 122.7 46.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.593 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 t-80 -118.08 121.52 40.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.1 -17.36 62.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.537 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 0.1 OUTLIER -126.26 163.66 38.68 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.618 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.51 141.04 34.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.606 2.204 . . . . 1.0 111.867 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.593 ' NE ' ' CG ' ' A' ' 170' ' ' HIS . 10.9 ptt180 -162.87 94.61 1.16 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.585 -0.279 . . . . 1.0 110.683 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.18 152.63 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.574 2.182 . . . . 1.0 111.473 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -110.17 154.16 23.73 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.809 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.489 ' HG ' ' H ' ' A' ' 180' ' ' GLU . 95.4 p -110.05 150.11 29.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.187 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.66 -37.41 70.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.77 -51.86 62.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.219 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.489 ' H ' ' HG ' ' A' ' 177' ' ' SER . 85.7 tt0 -73.18 -37.24 66.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 1.0 110.941 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.6 -43.97 93.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.625 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 186' ' ' LEU . 63.2 tt0 -64.45 -51.55 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 1.0 111.721 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.8 t -44.25 -42.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.669 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.09 -50.5 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -49.46 -33.44 14.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 190' ' ' GLN . 6.5 tt -74.55 -48.15 28.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.032 -0.985 . . . . 1.0 109.069 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -53.43 -46.52 69.86 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.3 80.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -60.58 -38.37 84.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 186' ' ' LEU . 57.4 tp60 -65.85 -33.4 75.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.3 -47.13 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.1 p -52.64 -35.01 54.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.13 -35.47 71.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.326 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.2 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.412 ' CG2' HH12 ' A' ' 55' ' ' ARG . 64.3 mt -56.49 -45.5 82.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.6 -49.7 67.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.54 -46.3 88.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.24 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -32.2 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 1.0 111.394 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.82 -43.03 80.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 37.6 tp -53.64 -37.64 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.935 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 32.0 t -54.5 -61.84 2.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.657 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.499 179.728 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.671 ' HHB' ' OD2' ' A' ' 86' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.781 0.325 . . . . 1.0 110.496 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -48.67 -35.1 13.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.753 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -74.74 -50.57 16.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.798 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.0 mt -56.78 -46.49 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.124 0.488 . . . . 1.0 110.945 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.503 ' O ' ' OG1' ' A' ' 38' ' ' THR . 22.3 mt -58.71 -27.38 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.968 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -69.92 -37.73 76.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.42 -0.512 . . . . 1.0 109.807 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.1 66.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.751 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 57.2 p -67.98 -37.14 81.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 1.0 112.324 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.3 p -72.08 -24.91 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.83 -43.09 23.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.28 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -70.28 -48.34 57.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.78 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 14.4 p -57.67 -47.66 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.366 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLY . 66.2 ttt-85 -51.79 -44.09 63.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 1.0 110.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.39 -40.81 65.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.12 -36.45 83.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.838 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.44 -14.67 21.03 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.722 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 26.06 30.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' ' CE1' ' A' ' 170' ' ' HIS . 49.6 m -76.99 143.66 39.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.8 p30 -53.84 -41.57 67.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.602 0.593 . . . . 1.0 112.602 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 22.2 ttt-85 -151.31 131.85 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 119.612 -0.835 . . . . 1.0 112.826 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 9.0 t -138.66 132.94 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.759 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.715 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 24.3 pttm -137.13 149.27 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.628 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 56.0 t -96.41 139.18 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.3 t80 -128.36 132.16 48.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.43 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -107.86 143.25 36.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 1.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.8 t80 -99.56 125.19 45.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.687 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 2.5 m-20 -92.07 152.04 42.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.58 -21.43 38.51 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.038 2.492 . . . . 1.0 114.474 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.43 -0.93 57.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.8 -16.58 54.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.716 -0.754 . . . . 1.0 111.901 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 74.5 m80 -80.4 148.91 30.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.41 160.04 24.98 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p -133.19 154.2 50.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.99 0.424 . . . . 1.0 111.503 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 t -91.78 113.29 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.13 -2.95 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.96 128.33 9.91 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.324 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -156.14 138.82 15.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.162 0.506 . . . . 1.0 111.722 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.94 140.54 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.809 -0.812 . . . . 1.0 108.809 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.485 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 23.5 mtt85 -116.77 137.5 52.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.352 -0.539 . . . . 1.0 112.104 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.5 82.62 1.63 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 74.64 41.04 36.47 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 49.65 15.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 1.0 110.408 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 71' ' ' GLY . 52.7 ttt85 -55.75 -47.43 76.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.998 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.98 149.01 36.45 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.95 160.13 40.68 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.47 2.113 . . . . 1.0 112.191 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.485 ' CB ' ' HE ' ' A' ' 69' ' ' ARG . 4.9 p -85.51 130.81 34.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.336 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' CD1' ' NH2' ' A' ' 50' ' ' ARG . 24.0 mt -109.53 9.19 25.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.007 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.4 mt -56.11 129.04 38.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.21 -6.53 81.41 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.468 -0.787 . . . . 1.0 112.861 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.92 147.24 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.348 0.574 . . . . 1.0 110.482 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.5 m -108.8 137.46 46.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.58 149.58 39.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.213 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.8 136.23 11.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.583 2.189 . . . . 1.0 111.449 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -61.23 -32.06 71.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.818 0.342 . . . . 1.0 110.429 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.08 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.5 m-20 -61.11 -24.96 66.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.72 0.295 . . . . 1.0 111.035 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 pt -137.32 143.96 43.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.52 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.544 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 96.4 Cg_endo -76.39 -89.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.581 2.187 . . . . 1.0 111.608 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.544 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 83.3 tt0 -170.01 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.957 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 19.6 pt-20 -59.26 -40.47 86.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.586 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -73.39 -38.28 65.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.703 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.663 HH12 ' NH2' ' A' ' 96' ' ' ARG . 66.9 ttp85 -61.89 -32.89 73.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 1.0 110.808 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -64.61 -36.77 85.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.938 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.91 -36.36 79.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.493 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' CE2' ' O1A' ' A' ' 203' ' ' CYC . 87.2 m-85 -69.55 -38.45 77.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.663 ' NH2' HH12 ' A' ' 92' ' ' ARG . 28.1 ttm180 -74.03 -33.15 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.159 -0.928 . . . . 1.0 111.197 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.514 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.0 mt -94.58 -37.73 11.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.789 1.033 . . . . 1.0 113.789 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.12 -12.65 9.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.274 1.213 . . . . 1.0 114.274 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.548 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.3 mp0 46.99 47.63 15.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.958 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.51 109.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.413 -0.515 . . . . 1.0 111.946 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.58 130.72 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.798 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.14 159.05 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.37 128.45 66.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.004 0.431 . . . . 1.0 110.257 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.96 171.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.021 0.749 . . . . 1.0 113.021 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -50.32 115.0 1.25 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.999 -1.0 . . . . 1.0 112.192 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 p -52.55 -27.15 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.69 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.08 -40.27 62.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.85 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.15 -15.05 3.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 1.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.685 ' NE2' HH21 ' A' ' 111' ' ' ARG . 6.9 tp60 56.81 60.81 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.491 -0.777 . . . . 1.0 112.847 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.3 m -95.62 125.29 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.685 HH21 ' NE2' ' A' ' 109' ' ' GLN . 87.9 mtt-85 -118.08 144.92 45.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -109.46 145.46 36.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.767 -1.106 . . . . 1.0 108.646 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.2 mt -146.8 151.78 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.441 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -88.53 160.89 17.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.292 -0.633 . . . . 1.0 109.292 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -152.76 132.08 6.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.929 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 117' ' ' GLU . 32.3 Cg_exo -36.64 129.61 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.699 2.266 . . . . 1.0 112.24 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 116' ' ' PRO . 43.0 tp10 58.06 120.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.606 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.3 p -67.58 154.68 40.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.519 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.26 -36.36 79.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.731 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.34 -171.35 44.2 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.35 138.52 34.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 1.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -53.78 -27.13 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.787 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.33 -34.28 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.751 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -64.92 -139.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.658 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.12 133.55 95.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 145.11 37.27 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.398 2.065 . . . . 1.0 111.537 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.11 -108.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.98 48.1 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -135.78 153.28 77.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 121.207 -0.197 . . . . 1.0 110.615 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 132' ' ' GLN . 68.6 Cg_exo -41.52 167.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.402 2.068 . . . . 1.0 112.04 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.405 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 46.9 mt -59.27 9.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.059 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.595 ' H ' ' C ' ' A' ' 130' ' ' PRO . 46.2 mm-40 -137.28 154.31 50.13 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.471 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -126.88 83.06 66.56 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.65 141.19 27.6 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.657 2.238 . . . . 1.0 112.38 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.456 HG11 HAD2 ' A' ' 203' ' ' CYC . 96.3 t -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.1 OUTLIER -45.03 157.27 0.34 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.401 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.94 -9.92 15.91 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.135 2.557 . . . . 1.0 113.711 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -66.56 -63.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.258 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.492 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 41.5 t60 -71.64 -25.41 62.13 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.656 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.2 -58.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.86 -37.9 89.09 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.419 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.455 ' O ' ' OG ' ' A' ' 145' ' ' SER . 80.5 t80 -48.8 -35.28 14.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.8 mt -73.45 -43.25 60.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -58.73 -44.31 90.41 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 96.9 p -62.51 -18.11 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.716 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.8 mmm -100.89 0.57 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.93 19.05 78.13 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.13 143.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.697 0.284 . . . . 1.0 110.292 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.78 -32.15 5.23 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.975 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.8 m -143.79 122.45 12.57 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.746 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 p -126.86 131.7 51.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 1.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -97.0 131.43 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.95 131.13 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.32 -0.552 . . . . 1.0 112.304 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.7 t -135.93 131.36 18.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.199 -1.038 . . . . 1.0 108.199 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -93.78 162.41 2.26 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.424 2.083 . . . . 1.0 113.706 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.5 mt -115.55 113.86 24.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.3 ptm -140.92 150.19 42.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 71.9 t60 -122.09 123.22 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.933 -1.03 . . . . 1.0 108.878 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 45.8 m-70 57.4 -118.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.12 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -98.12 1.87 48.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 143.75 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.7 tp -99.51 124.43 44.68 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.508 -1.293 . . . . 1.0 107.508 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 65.5 m95 -103.24 -32.18 9.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.575 0.954 . . . . 1.0 113.575 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.81 -173.06 32.05 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 119.701 -1.238 . . . . 1.0 112.39 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.6 mt -136.22 122.81 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.443 -0.379 . . . . 1.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.9 tp -95.33 149.35 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.15 134.52 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.867 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.1 m -115.73 139.02 50.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.22 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.715 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 18.9 m-70 -110.64 123.97 51.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.542 ' CE1' ' OG1' ' A' ' 48' ' ' THR . 84.8 m-70 -117.97 113.86 22.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.92 -22.71 59.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.777 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.17 115.03 61.78 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -42.9 136.12 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.675 2.25 . . . . 1.0 111.806 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -169.1 138.55 1.74 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.588 -0.278 . . . . 1.0 110.685 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 156.01 31.02 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.545 2.164 . . . . 1.0 111.431 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.99 153.64 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.1 m -105.57 150.65 25.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.743 ' H ' ' NE2' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -55.76 -37.7 68.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.19 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.7 -47.04 85.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.305 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.52 -32.61 68.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 1.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.96 -35.8 81.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.667 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.69 -53.17 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.718 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 76.2 t -41.82 -42.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.589 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.1 m -74.67 -45.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -52.91 -31.5 40.21 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 190' ' ' GLN . 39.3 tp -75.84 -56.56 4.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.097 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.0 mt -51.04 -45.42 61.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.43 76.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.361 -0.978 . . . . 1.0 108.361 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -61.11 -39.02 88.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 186' ' ' LEU . 46.8 tp60 -64.44 -33.37 75.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.593 -0.892 . . . . 1.0 108.593 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.75 -46.78 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.0 p -53.14 -33.79 53.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 mt -70.41 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.114 -0.948 . . . . 1.0 110.174 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.48 82.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.871 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 195' ' ' ILE . 48.5 mt -55.74 -48.26 78.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.14 66.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.403 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.82 -46.54 87.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.294 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -33.14 75.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.6 tp -53.07 -38.89 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.5 t -47.67 -58.41 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.638 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.955 -1.022 . . . . 1.0 110.426 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.492 HMA2 ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 1.0 110.52 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 2.3 p30 -67.12 -31.09 71.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 79.9 mt-30 -74.53 -49.06 23.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.754 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 34' ' ' ILE . 96.1 mt -55.28 -48.01 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 1.0 110.954 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' ' OG1' ' A' ' 38' ' ' THR . 62.7 mt -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.984 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -65.32 -39.88 93.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.378 -0.529 . . . . 1.0 109.835 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.47 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.768 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.0 p -67.56 -35.97 80.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 1.0 112.303 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -74.69 -24.69 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -178.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.71 -47.25 60.78 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.298 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.31 -32.37 64.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.828 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.99 -55.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.298 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.6 tmm_? -54.22 -43.77 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 1.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -40.68 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.314 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -67.82 -36.08 79.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.826 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.5 mt -96.88 -18.65 19.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.756 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.94 25.19 56.05 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -79.86 147.26 31.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -52.43 -41.48 63.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.697 HH22 ' NE ' ' A' ' 69' ' ' ARG . 84.1 mtt-85 -151.15 128.83 11.52 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.55 -0.86 . . . . 1.0 112.818 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 6.2 t -134.35 128.24 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.771 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.629 ' HZ2' ' HE2' ' A' ' 169' ' ' HIS . 20.9 pttm -138.65 153.54 48.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.662 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.36 139.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -127.14 130.23 49.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -110.68 149.64 30.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.007 0.432 . . . . 1.0 111.156 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.87 138.97 38.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -104.12 153.35 38.98 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 109.392 -0.596 . . . . 1.0 109.392 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -39.18 -51.61 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 123.015 2.477 . . . . 1.0 114.473 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.54 -4.76 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.61 -8.5 43.68 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.693 -0.765 . . . . 1.0 111.944 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' A' ' 57' ' ' ASP . 75.3 m80 -76.97 149.2 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.378 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.19 161.78 25.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -135.9 157.47 46.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 1.0 111.524 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 p -96.87 114.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.39 3.13 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.102 0.408 . . . . 1.0 112.102 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.61 127.16 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.274 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.524 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 79.8 tt0 -156.69 138.87 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.194 0.521 . . . . 1.0 111.683 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.57 134.78 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.697 ' NE ' HH22 ' A' ' 50' ' ' ARG . 10.5 mtp180 -104.08 134.57 47.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.05 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.13 -142.51 1.21 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -65.98 53.34 0.17 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 70' ' ' GLY . 97.2 mt-10 37.73 33.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.355 . . . . 1.0 110.409 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' GLY . 14.6 tpp85 -81.62 -40.27 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.005 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.419 ' C ' ' HE ' ' A' ' 50' ' ' ARG . 90.7 mt -109.83 148.95 39.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 50' ' ' ARG . 97.5 Cg_endo -74.34 159.4 43.59 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.545 2.164 . . . . 1.0 112.264 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -83.36 133.78 34.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.35 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 25.5 mt -113.6 17.37 18.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.954 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 28.0 tp -66.79 130.72 44.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.56 -1.39 88.29 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.478 -0.783 . . . . 1.0 112.807 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.09 149.9 24.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.407 0.604 . . . . 1.0 110.451 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -104.86 131.15 52.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.629 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.567 ' CD1' HBB1 ' A' ' 203' ' ' CYC . 79.9 m-85 -106.09 106.35 56.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.303 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -43.34 139.17 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.562 2.175 . . . . 1.0 111.511 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.44 -32.09 69.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.942 0.401 . . . . 1.0 110.503 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.48 -18.01 0.1 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.25 -0.74 . . . . 1.0 111.25 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 60.1 t0 -64.28 -19.2 65.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.624 0.25 . . . . 1.0 111.075 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mt -138.06 133.26 17.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.515 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.71 -94.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.525 2.15 . . . . 1.0 111.643 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.17 -38.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.994 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.48 -42.73 71.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.576 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.528 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -71.28 -37.9 71.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.75 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -62.81 -33.43 75.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.747 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -64.15 -38.74 92.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.16 -37.32 79.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 1.0 111.536 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -67.99 -34.65 76.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.77 -28.9 50.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.12 -0.946 . . . . 1.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -94.69 -39.59 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.06 -10.16 8.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.419 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 3.7 mp0 45.74 58.93 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.621 -0.832 . . . . 1.0 109.942 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 10.9 p -163.83 114.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.682 HH22 HH21 ' A' ' 133' ' ' ARG . 7.6 tpt180 -168.38 136.87 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.824 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.3 p -152.08 157.21 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.677 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.472 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 71.3 mt -109.77 130.07 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.262 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.443 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 9.6 p -85.96 168.56 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.443 ' H ' ' CG2' ' A' ' 104' ' ' VAL . 60.0 m-20 -48.12 114.73 0.99 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.204 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.4 t -51.86 -21.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.697 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -78.18 -37.91 44.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.34 -16.49 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.17 0.509 . . . . 1.0 110.365 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 56.43 63.03 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 1.0 112.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.402 ' OG ' ' CG1' ' A' ' 104' ' ' VAL . 80.0 p -96.31 124.3 40.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -117.17 145.05 44.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 t -108.06 144.15 35.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.713 -1.13 . . . . 1.0 108.618 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.71 149.57 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.467 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 t -89.93 164.49 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 117' ' ' GLU . 9.7 pt20 -150.31 148.76 25.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.861 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -37.17 -26.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.696 2.264 . . . . 1.0 112.229 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLN . 89.8 mt-10 -98.18 159.7 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.622 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.4 p -143.13 157.29 44.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.499 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -148.07 160.61 42.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.718 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.11 134.26 3.7 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt -90.41 38.56 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 1.0 110.615 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -48.32 -25.13 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.699 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -69.66 -2.79 12.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.787 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 123' ' ' ALA . 36.3 ttm180 51.08 102.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 1.0 110.677 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.11 135.02 19.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -40.58 158.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.366 2.044 . . . . 1.0 111.587 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 10.0 mp 46.59 -102.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.396 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.46 -14.26 9.5 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -146.95 152.11 43.18 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.538 0.208 . . . . 1.0 110.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.04 173.28 14.7 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.387 2.058 . . . . 1.0 112.042 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.7 -28.3 65.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 1.0 112.094 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.38 134.79 45.58 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.511 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.682 HH21 HH22 ' A' ' 101' ' ' ARG . 9.5 mmm180 -119.71 147.79 44.7 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.5 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -87.39 143.23 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.65 2.234 . . . . 1.0 112.452 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.97 126.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.607 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 1.7 p30 -45.68 143.5 3.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.401 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -37.36 -25.92 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.118 2.545 . . . . 1.0 113.649 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.427 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.1 t -53.9 -61.23 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.257 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.621 ' NE2' HMA1 ' A' ' 203' ' ' CYC . 18.3 t60 -69.39 -24.9 63.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.664 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.51 -60.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -61.81 -40.25 94.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 1.0 110.353 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -46.75 -39.11 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.06 -45.17 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -57.17 -43.1 82.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 t -63.5 -20.13 65.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 1.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.3 mmm -99.72 -3.45 32.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.093 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.06 78.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.15 141.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 1.0 110.254 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.94 -36.12 3.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.998 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 6.7 m -142.01 119.43 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.705 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 168' ' ' SER . 44.4 t -126.79 136.39 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.981 0.419 . . . . 1.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.77 132.36 41.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 t -113.5 129.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.31 -0.556 . . . . 1.0 112.298 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 166' ' ' LEU . 22.7 t -136.97 136.39 21.09 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.255 -1.017 . . . . 1.0 108.255 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.82 166.25 1.02 Allowed 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.423 2.082 . . . . 1.0 113.699 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 mt -118.43 114.73 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.419 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 22.0 ptm -142.03 153.91 44.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.457 0.646 . . . . 1.0 112.683 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.428 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 43.7 t-80 -129.68 124.19 33.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.903 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.7 t-80 61.84 -123.73 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.144 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.467 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 95.5 mt-30 -97.56 3.61 50.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.813 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.8 144.75 33.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.736 1.013 . . . . 1.0 113.736 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 39.7 tp -100.69 125.26 47.11 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 87.5 m95 -102.92 -32.95 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.09 -173.31 30.61 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.393 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.2 123.19 21.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.433 -0.383 . . . . 1.0 111.634 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 154' ' ' VAL . 4.7 tp -95.29 149.9 20.83 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.01 134.5 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.844 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 151' ' ' SER . 42.2 m -114.94 136.66 52.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.729 -0.669 . . . . 1.0 109.282 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.629 ' HE2' ' HZ2' ' A' ' 52' ' ' LYS . 32.3 m-70 -112.35 129.6 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -120.03 128.62 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.18 23.91 1.7 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -151.5 147.73 20.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.871 -0.331 . . . . 1.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.72 112.84 3.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.659 2.239 . . . . 1.0 111.75 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -152.42 139.89 12.93 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.685 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.97 152.88 28.61 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.57 2.18 . . . . 1.0 111.451 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -100.21 157.65 16.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.838 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.9 m -92.64 146.45 23.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.221 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -65.63 -25.35 67.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.142 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.87 -54.82 7.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.231 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 1.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.6 tp -56.24 -45.29 80.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.9 -53.66 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.66 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 90.8 t -44.58 -40.1 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.07 -49.03 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -48.68 -33.52 10.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 190' ' ' GLN . 47.2 tp -75.17 -46.19 35.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.039 -0.982 . . . . 1.0 109.064 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.8 tp -54.64 -47.74 73.13 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.41 92.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.443 ' O ' ' OG ' ' A' ' 192' ' ' SER . 57.2 t0 -62.28 -39.41 92.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.0 tp60 -64.54 -30.92 71.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 194' ' ' ALA . 51.6 t -77.23 -45.35 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 31.1 p -49.2 -31.64 8.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -73.57 -35.39 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.296 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -66.69 -44.01 82.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.922 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 196' ' ' ALA . 25.2 pt -64.97 -27.01 41.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.6 -54.36 6.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.301 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.3 pt20 -66.06 -37.53 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.289 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.355 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -58.15 -43.72 87.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.204 0.446 . . . . 1.0 112.204 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 47.7 mt -51.94 -30.39 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.502 ' HG ' ' H ' ' A' ' 202' ' ' LEU . 95.8 p -44.87 -55.75 5.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.636 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.502 ' H ' ' HG ' ' A' ' 201' ' ' SER . 10.5 mp . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.459 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.621 HMA1 ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 66.9 t0 -48.15 -37.1 14.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.694 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -74.7 -51.19 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.838 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.67 -47.45 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 1.0 110.964 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 38' ' ' THR . 24.5 mt -56.9 -30.17 63.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.943 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -65.25 -38.48 90.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.73 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.739 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -69.59 -34.95 74.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.35 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.7 p -74.12 -25.22 19.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.22 -47.28 18.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.266 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -49.93 67.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.768 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 12.9 p -52.48 -47.08 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.315 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 47' ' ' GLY . 53.5 ttp180 -49.98 -43.93 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 1.0 110.596 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.52 -40.47 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.36 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.45 -37.29 82.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.804 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -96.64 -17.72 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.695 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 25.26 27.57 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 p -79.6 149.54 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.64 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 28.0 p30 -49.94 -41.94 47.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.64 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 29.7 ptt180 -159.41 146.54 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.584 -0.847 . . . . 1.0 112.788 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 13.4 p -144.02 135.65 22.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.956 -1.02 . . . . 1.0 108.733 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.612 ' HZ1' HBB3 ' A' ' 203' ' ' CYC . 48.7 pttt -137.54 149.75 46.97 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.239 -0.584 . . . . 1.0 111.573 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -98.09 140.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.401 ' CZ ' ' C ' ' A' ' 62' ' ' GLY . 17.8 t80 -129.48 131.3 46.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.482 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -109.89 148.19 32.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 1.0 111.257 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.47 133.91 45.38 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.755 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 61' ' ' HIS . 23.0 m-20 -98.44 152.95 38.17 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -39.43 -50.37 2.97 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.02 2.48 . . . . 1.0 114.516 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -70.11 -6.18 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.35 41.45 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.871 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' A' ' 57' ' ' ASP . 31.1 m80 -79.69 152.29 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.369 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' C ' ' CZ ' ' A' ' 54' ' ' TYR . . . -139.21 164.65 25.85 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -135.87 157.67 46.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.0 111.525 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 t -92.03 109.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' CG1' ' OD1' ' A' ' 32' ' ' ASP . 21.6 t -111.32 -1.86 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.54 128.43 9.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.274 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -160.09 140.95 12.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.151 0.501 . . . . 1.0 111.762 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.27 136.53 52.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.499 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 15.1 mtt180 -104.33 134.94 46.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.062 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.44 72.07 2.72 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.636 -0.986 . . . . 1.0 110.636 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 78.63 46.93 8.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 46.66 16.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 1.0 110.336 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' GLY . 41.9 ttm180 -57.21 -46.72 82.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.069 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.07 127.51 26.46 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.59 170.67 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.459 2.106 . . . . 1.0 112.252 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.3 p -95.32 145.82 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.26 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -109.5 10.05 25.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.929 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.5 mt -53.68 127.9 27.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.4 84.56 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.817 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.36 148.03 28.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.438 0.619 . . . . 1.0 110.448 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 t -106.64 132.72 52.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.614 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.413 ' CG ' HAB1 ' A' ' 203' ' ' CYC . 46.2 m-85 -109.57 107.74 59.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -43.38 140.35 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.525 2.15 . . . . 1.0 111.464 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -67.16 -26.34 66.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.392 . . . . 1.0 110.471 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.08 -17.57 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ALA . 26.2 p-10 -69.12 -17.2 63.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 1.0 111.035 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.37 133.53 24.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.45 -97.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.616 2.21 . . . . 1.0 111.631 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -163.89 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.932 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -56.39 -41.48 76.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.651 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.81 59.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.695 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 39.9 ttm180 -60.25 -34.45 73.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.797 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -63.44 -33.82 76.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.94 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.81 -34.08 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.513 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.437 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 89.0 m-85 -69.38 -38.94 78.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 14.9 mtm180 -72.35 -33.38 67.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.26 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.11 -36.1 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.45 -16.49 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' GLN . 15.1 mp0 48.72 58.68 5.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.972 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 4.9 m -159.61 112.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.92 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -165.02 135.57 3.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.898 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -150.41 157.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.693 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 3.3 mt -109.43 130.0 63.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.246 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.7 165.16 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -50.0 116.97 2.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.18 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 p -49.92 -21.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.701 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -80.3 -37.4 32.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.837 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.1 -21.66 66.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.119 0.485 . . . . 1.0 110.412 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 57.79 61.43 2.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.523 -0.762 . . . . 1.0 112.9 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.9 m -93.31 125.88 38.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -121.6 146.43 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -113.86 152.01 31.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.782 -1.099 . . . . 1.0 108.668 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.8 mt -148.3 154.24 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.416 -0.514 . . . . 1.0 111.446 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 p -83.3 164.01 20.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -153.21 163.97 21.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.88 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -40.37 -13.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.61 2.207 . . . . 1.0 112.335 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 115' ' ' GLN . 85.6 tt0 60.49 -95.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.571 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.3 p 44.21 23.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.471 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.424 ' N ' ' C ' ' A' ' 117' ' ' GLU . 59.2 t-105 -89.78 154.22 20.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.684 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.3 -161.28 5.39 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 121' ' ' LEU . 7.9 mp -80.08 143.53 33.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 1.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 t -59.75 -34.33 72.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.725 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.3 -52.12 17.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.721 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -51.64 -59.15 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.687 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 t -109.99 103.67 53.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.659 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.64 146.55 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.397 2.064 . . . . 1.0 111.547 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.46 -117.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.57 -0.286 . . . . 1.0 110.457 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.65 38.42 37.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -142.29 157.03 63.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 122.906 -0.173 . . . . 1.0 110.695 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.604 ' C ' ' H ' ' A' ' 132' ' ' GLN . 40.4 Cg_endo -63.2 168.51 10.82 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.425 2.083 . . . . 1.0 111.988 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 51.1 mt -58.36 9.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.094 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.604 ' H ' ' C ' ' A' ' 130' ' ' PRO . 51.1 mm-40 -137.99 154.13 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.481 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -121.73 80.46 40.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.567 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -48.07 142.55 15.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.649 2.233 . . . . 1.0 112.37 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.4 129.5 75.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.455 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.5 m-20 -44.53 140.9 2.97 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.708 0.29 . . . . 1.0 111.365 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -38.32 -23.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.064 2.51 . . . . 1.0 113.685 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.454 ' SG ' ' HHD' ' A' ' 203' ' ' CYC . 0.0 OUTLIER -53.78 -62.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.23 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.439 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 71.7 t60 -71.29 -23.48 61.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.676 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.41 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.623 0.601 . . . . 1.0 112.623 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.14 -39.76 95.61 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.37 -37.61 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 61.8 mt -72.99 -42.13 63.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.192 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.81 -42.94 90.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.8 m -62.11 -19.45 63.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.623 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.0 mmm -99.54 0.98 43.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.102 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.76 19.63 75.28 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 93.4 t -110.48 144.47 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.734 0.302 . . . . 1.0 110.245 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.63 -24.61 5.71 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -152.41 119.57 5.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.76 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.2 p -127.85 139.32 52.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 1.0 111.405 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -99.38 134.47 42.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 t -114.91 128.25 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.294 -0.563 . . . . 1.0 112.337 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.5 t -134.3 133.16 21.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.05 161.22 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.415 2.076 . . . . 1.0 113.692 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.4 mt -115.2 116.81 28.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.9 ptm -141.2 156.2 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -133.26 127.46 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.062 -0.972 . . . . 1.0 108.798 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 2.0 t60 62.89 -125.4 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.16 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.529 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 19.5 pt20 -99.38 2.06 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.839 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.471 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 10.0 pt-20 -108.91 154.33 22.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.68 126.87 52.19 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.471 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 43.5 m95 -101.79 -28.21 12.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.1 -170.26 31.75 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.598 -1.287 . . . . 1.0 112.318 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 90.0 mt -136.31 123.94 22.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.454 -0.373 . . . . 1.0 111.631 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.59 149.65 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.0 p -156.3 133.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.139 -0.625 . . . . 1.0 111.912 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.0 p -117.31 133.08 56.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.249 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.512 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 59.8 m80 -101.65 126.19 48.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 -178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 170' ' ' HIS . 1.9 m80 -116.25 117.75 30.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.09 25.06 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.75 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.91 150.04 29.19 Favored Pre-proline 0 C--N 1.327 -0.409 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.94 119.06 5.24 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.592 2.195 . . . . 1.0 111.882 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -155.55 136.29 8.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.39 157.01 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.531 2.154 . . . . 1.0 111.466 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -110.1 153.84 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.829 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.8 m -111.3 148.28 33.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.2 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -56.32 -36.83 69.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.122 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -67.13 -54.6 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.429 -0.351 . . . . 1.0 111.214 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.77 -33.7 71.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 1.0 111.015 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.59 -33.29 72.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.644 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.44 -54.82 5.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.915 -0.314 . . . . 1.0 111.609 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.8 m -46.51 -40.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.597 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 187' ' ' LEU . 30.1 m -71.88 -50.62 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -46.46 -32.16 3.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 190' ' ' GLN . 1.7 tt -66.86 -48.04 70.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.027 -0.988 . . . . 1.0 109.1 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 184' ' ' VAL . 91.2 mt -52.69 -45.21 66.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -58.82 -45.38 90.11 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.71 -38.01 89.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.5 tp60 -64.88 -32.52 74.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.4 t -77.1 -44.7 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 1.6 m -52.9 -36.5 59.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -67.57 -36.31 75.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.111 -0.95 . . . . 1.0 110.219 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.45 84.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.948 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.07 -29.73 47.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.55 -55.02 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.398 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.4 pt20 -65.38 -40.03 92.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.222 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.39 -32.91 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 1.0 111.434 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.44 -42.87 83.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.27 -36.4 63.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.945 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.7 t -49.57 -58.21 5.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.631 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.432 179.864 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.612 HBB3 ' HZ1' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.338 . . . . 1.0 110.519 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -65.39 -31.11 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -76.07 -48.99 18.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.853 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.54 -49.99 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.072 0.463 . . . . 1.0 110.997 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.49 ' O ' ' OG1' ' A' ' 38' ' ' THR . 55.1 mt -57.45 -31.52 66.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.914 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -63.01 -40.62 98.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.735 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.48 70.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.795 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -65.28 -35.99 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.314 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -75.17 -24.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 1.0 112.201 -177.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.65 -49.99 41.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.247 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.25 -37.25 85.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.779 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.4 t -56.06 -54.1 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.345 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 47' ' ' GLY . 53.7 ttt-85 -51.02 -44.39 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 1.0 110.623 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.77 70.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.323 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.732 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.92 -14.96 21.41 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.664 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.92 26.05 25.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.8 p -81.55 152.38 27.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -48.3 -43.9 33.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.623 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 50.9 ptt85 -158.8 147.28 18.37 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.542 -0.863 . . . . 1.0 112.779 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -139.23 133.88 40.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.002 -0.999 . . . . 1.0 108.736 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' NZ ' ' OB ' ' A' ' 203' ' ' CYC . 46.1 pttt -137.31 146.25 44.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.379 -0.528 . . . . 1.0 111.66 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.06 142.68 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.412 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.0 t80 -130.74 132.6 45.42 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.407 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -111.54 150.64 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 1.0 111.159 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -101.81 133.84 45.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.594 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -99.18 153.35 37.83 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -38.36 -51.61 2.09 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.994 2.463 . . . . 1.0 114.492 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.44 -5.56 29.41 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.173 0.435 . . . . 1.0 112.173 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -7.75 43.15 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.964 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 57' ' ' ASP . 6.0 m-70 -78.98 151.94 31.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.365 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.99 164.3 25.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.5 p -135.88 157.99 45.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 111.487 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 t -88.08 107.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.83 -3.96 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.083 0.401 . . . . 1.0 112.083 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.19 128.29 8.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.342 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.5 tt0 -158.09 139.31 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 1.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -117.37 137.92 52.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.572 . . . . 1.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.45 87.3 1.56 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 68.09 37.43 87.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 52.8 12.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 1.0 110.397 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 71' ' ' GLY . 28.7 ttm180 -49.62 -47.7 49.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.412 HD21 ' HE ' ' A' ' 50' ' ' ARG . 6.5 mp -108.31 156.01 39.27 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 158.47 50.75 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.55 2.167 . . . . 1.0 112.182 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.3 122.71 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.52 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 25.2 mt -99.85 12.17 37.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.967 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.8 tp -66.57 133.33 50.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.916 0.709 . . . . 1.0 112.916 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.92 86.51 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.402 -0.817 . . . . 1.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -87.67 153.14 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.347 0.574 . . . . 1.0 110.53 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.8 m -106.86 132.21 53.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.58 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -106.0 147.21 34.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 134.78 12.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.603 2.202 . . . . 1.0 111.473 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.62 -32.9 72.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 1.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 -16.11 0.11 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.7 m-20 -59.07 -10.49 2.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.66 0.267 . . . . 1.0 110.997 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pt -141.15 145.93 40.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.559 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.59 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.502 2.135 . . . . 1.0 111.709 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 93' ' ' ARG . 79.2 tt0 -163.47 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.963 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -71.7 -39.64 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.662 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.644 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 18.3 ttm180 -61.94 -36.79 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 1.0 110.81 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 18.2 mmt85 -61.51 -35.37 77.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.943 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.08 -33.31 75.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.522 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.29 -34.97 77.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 12.0 mtm180 -75.8 -31.1 59.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.251 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.485 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.8 mt -93.78 -38.08 11.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.792 1.034 . . . . 1.0 113.792 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -120.43 -10.54 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.246 1.202 . . . . 1.0 114.246 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.485 HE22 ' C ' ' A' ' 97' ' ' LEU . 5.0 mp0 44.46 63.31 1.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.641 -0.824 . . . . 1.0 109.859 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 13.2 p -169.33 117.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.315 -0.554 . . . . 1.0 111.882 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.572 HH22 ' CA ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -173.77 131.14 0.42 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.859 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.54 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 2.5 m -142.42 159.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.657 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 23.8 mt -111.02 128.29 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.252 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 m -87.89 171.45 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.43 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 56.3 m-20 -52.26 113.2 0.96 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.277 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.1 p -47.71 -17.74 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 1.0 110.688 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' N ' ' C ' ' A' ' 105' ' ' ASP . 84.7 tt0 -81.81 -36.68 28.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.806 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.58 -20.21 44.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.105 0.479 . . . . 1.0 110.451 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 56.46 58.94 3.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.819 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -96.71 126.83 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -122.39 143.33 49.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.632 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -111.81 156.73 21.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.746 -1.116 . . . . 1.0 108.63 177.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.6 pt -152.8 156.61 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.462 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.7 p -89.77 172.73 8.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -139.35 152.37 69.14 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.893 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 -14.15 16.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.648 2.232 . . . . 1.0 112.312 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -57.26 136.54 56.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.634 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.5 t -87.81 -10.01 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.486 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -98.75 145.54 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.669 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 86.89 0.07 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.18 110.9 21.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.71 0.29 . . . . 1.0 110.604 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.2 t -65.58 -27.82 68.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -65.84 -5.22 8.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.748 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 125' ' ' VAL . 32.4 ptt180 -58.32 -151.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.74 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.421 ' N ' ' HG3' ' A' ' 124' ' ' ARG . 3.5 m -57.89 151.27 44.65 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.9 143.16 49.31 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.377 2.052 . . . . 1.0 111.529 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.6 mt 59.6 -112.83 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.405 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 24.95 37.08 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.081 -0.807 . . . . 1.0 111.081 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' A' ' 133' ' ' ARG . 54.7 mt-10 -143.03 154.42 61.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.215 -0.194 . . . . 1.0 110.633 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.559 ' C ' ' H ' ' A' ' 132' ' ' GLN . 66.2 Cg_exo -41.65 168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.416 2.077 . . . . 1.0 112.029 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.404 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 53.0 mt -62.72 12.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.521 . . . . 1.0 112.074 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.559 ' H ' ' C ' ' A' ' 130' ' ' PRO . 50.9 mm-40 -137.17 157.09 47.45 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.507 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 129' ' ' GLU . 17.8 mmm180 -124.22 115.91 27.25 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.567 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.51 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 63.7 Cg_endo -83.51 138.59 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.17 . . . . 1.0 112.413 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.572 ' CA ' HH22 ' A' ' 101' ' ' ARG . 1.9 p -117.17 129.26 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.632 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -44.97 141.18 3.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 1.0 111.294 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -40.54 -32.96 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.08 2.52 . . . . 1.0 113.706 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.52 -63.13 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.746 -0.382 . . . . 1.0 111.215 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.519 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 65.5 t60 -71.54 -22.53 61.75 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.589 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.69 -55.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -64.68 -38.83 92.34 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.4 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.459 ' O ' ' OG ' ' A' ' 145' ' ' SER . 88.3 t80 -48.72 -34.74 12.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 58.9 mt -73.53 -42.78 61.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.12 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -58.21 -44.53 88.21 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 87.2 p -62.81 -18.03 62.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.659 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.0 mmm -101.53 -0.71 34.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.137 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.07 18.55 78.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 88.1 t -107.32 142.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 1.0 110.27 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.27 -25.31 6.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.43 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 15.0 m -153.96 120.73 5.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.804 -0.359 . . . . 1.0 110.802 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 168' ' ' SER . 45.7 t -127.66 136.42 51.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.983 0.421 . . . . 1.0 111.38 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -97.97 132.33 43.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.0 t -114.86 132.4 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.268 -0.573 . . . . 1.0 112.212 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.52 133.37 20.28 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.7 161.59 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.361 2.041 . . . . 1.0 113.695 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.8 mt -115.26 116.44 28.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' OG ' ' A' ' 192' ' ' SER . 24.9 ptm -141.19 142.8 33.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -125.23 122.43 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.989 -1.005 . . . . 1.0 108.874 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.454 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 26.0 t-80 71.67 -128.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.223 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 37.4 tt0 -100.47 4.89 44.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.796 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.49 ' CD ' ' CZ2' ' A' ' 163' ' ' TRP . 5.2 pt-20 -111.28 158.31 19.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.726 1.01 . . . . 1.0 113.726 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.3 tp -101.73 128.96 47.82 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.49 ' CZ2' ' CD ' ' A' ' 161' ' ' GLU . 52.1 m95 -105.44 -37.01 6.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.512 0.93 . . . . 1.0 113.512 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.28 -172.82 24.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.731 -1.223 . . . . 1.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.2 tp -141.25 120.92 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.439 -0.38 . . . . 1.0 111.633 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.77 149.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.5 p -155.95 133.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.034 -0.666 . . . . 1.0 111.836 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 151' ' ' SER . 82.1 p -115.62 136.67 52.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 1.0 109.209 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.623 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 65.7 m-70 -115.44 131.15 57.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -123.11 126.19 46.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.51 -16.61 61.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.774 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.9 155.51 75.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.607 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.73 133.97 38.72 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.692 2.261 . . . . 1.0 111.796 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -158.18 93.27 2.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.653 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -52.09 152.54 14.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.543 2.162 . . . . 1.0 111.399 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -107.33 152.44 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.799 0.333 . . . . 1.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.2 m -94.82 154.96 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.221 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -54.18 -35.82 62.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -72.33 -44.68 62.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.269 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.79 -30.73 71.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 1.0 110.95 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.65 -36.23 78.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.611 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.16 -55.97 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.699 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.8 m -43.72 -41.02 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.66 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.8 m -75.26 -48.88 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -49.24 -34.4 14.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 190' ' ' GLN . 97.5 mt -76.03 -48.0 22.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.982 -1.008 . . . . 1.0 109.079 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.74 -47.73 67.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.4 89.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.472 -0.936 . . . . 1.0 108.472 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.28 -38.6 91.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 186' ' ' LEU . 78.3 mm-40 -66.72 -31.64 72.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.46 -47.25 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.277 -1.009 . . . . 1.0 108.277 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 157' ' ' MET . 14.4 t -49.17 -32.66 10.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -74.72 -33.4 31.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.205 -0.907 . . . . 1.0 110.28 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.44 77.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.6 pt -62.23 -29.62 47.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.444 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -75.85 -51.83 11.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.02 -43.31 96.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.212 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.457 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -65.57 -31.93 73.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 1.0 111.395 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.43 -43.67 84.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.479 ' H ' ' CD1' ' A' ' 200' ' ' LEU . 8.1 mp -51.19 -28.46 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.973 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 98.8 p -49.75 -56.01 11.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.675 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.471 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.772 HBC1 ' HD ' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 63.5 t0 -48.14 -36.24 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.684 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.52 -50.65 15.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.826 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.93 -48.71 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.021 0.438 . . . . 1.0 110.913 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.504 ' O ' ' OG1' ' A' ' 38' ' ' THR . 31.0 mt -57.38 -28.8 63.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.961 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -67.14 -39.14 86.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.778 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.07 -30.82 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.739 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.6 p -67.0 -36.79 82.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.301 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.62 -25.39 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.35 -36.02 40.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.239 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.58 -48.52 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.833 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 8.2 p -57.59 -52.1 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.31 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.549 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.0 ptm180 -51.81 -43.41 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 1.0 110.641 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 43' ' ' ARG . . . -51.95 -39.25 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.296 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -69.49 -32.78 71.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.833 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -97.11 -17.15 20.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.704 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.18 26.15 55.51 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.548 ' OG1' ' NE2' ' A' ' 170' ' ' HIS . 48.0 m -77.79 143.75 37.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -55.57 -40.71 72.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.605 0.594 . . . . 1.0 112.605 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.642 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -149.97 130.77 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.525 -0.87 . . . . 1.0 112.763 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.4 t -139.19 132.72 38.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.911 -1.04 . . . . 1.0 108.727 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.734 ' HZ2' HAB2 ' A' ' 203' ' ' CYC . 49.8 pttt -138.21 150.0 46.33 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.654 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.57 141.25 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.525 ' OH ' ' CD1' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -131.34 136.24 47.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.442 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -110.43 148.89 31.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 1.0 111.251 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -99.82 126.66 45.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.71 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 61' ' ' HIS . 21.5 m-20 -92.0 153.25 43.38 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.19 -50.91 2.69 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.94 2.427 . . . . 1.0 114.523 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -70.12 -7.5 42.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.184 0.438 . . . . 1.0 112.184 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.06 -6.65 40.25 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.753 -0.737 . . . . 1.0 112.014 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' ASP . 76.5 m80 -77.19 149.9 35.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.348 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.57 158.82 23.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.811 -0.915 . . . . 1.0 110.811 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 p -131.86 155.63 47.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.467 . . . . 1.0 111.426 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 77' ' ' LEU . 3.7 p -91.02 109.35 20.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.476 ' CG1' ' OD1' ' A' ' 32' ' ' ASP . 23.7 t -114.72 -4.32 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.116 0.413 . . . . 1.0 112.116 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.15 127.64 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.291 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 12.3 tm-20 -162.36 142.39 9.76 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.703 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' CB ' ' NE ' ' A' ' 43' ' ' ARG . . . -127.95 135.14 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -103.14 135.1 45.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.362 -0.535 . . . . 1.0 112.035 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -77.17 -140.13 1.18 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.556 -1.017 . . . . 1.0 110.556 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -64.91 53.62 0.1 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' GLY . 96.3 mt-10 37.27 35.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -83.09 -36.19 25.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.3 mt -111.67 146.29 34.4 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 91.7 Cg_endo -75.44 157.95 40.7 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.462 2.108 . . . . 1.0 112.307 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m -82.01 137.54 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.331 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.642 ' H ' ' NH2' ' A' ' 50' ' ' ARG . 40.2 mt -117.74 22.09 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.932 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 64.1 mt -67.29 129.77 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.919 0.711 . . . . 1.0 112.919 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.53 -1.88 88.45 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.782 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.5 mt -87.43 149.74 24.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.418 0.609 . . . . 1.0 110.46 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -106.14 133.76 50.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.602 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 54' ' ' TYR . 8.2 m-85 -103.39 144.03 27.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.65 138.05 14.89 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.552 2.168 . . . . 1.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.425 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -61.02 -33.14 72.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.913 0.387 . . . . 1.0 110.449 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.5 -18.77 0.22 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 84' ' ' ALA . 95.1 m-20 -65.4 -20.79 66.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 1.0 110.975 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.25 133.87 25.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.57 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.47 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.589 2.193 . . . . 1.0 111.615 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -163.71 -53.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.927 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' OE2' ' CE3' ' A' ' 119' ' ' TRP . 26.6 tp10 -43.84 -43.77 6.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.615 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.64 -34.87 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.701 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 56' ' ' PHE . 48.8 mtp85 -65.04 -35.03 79.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.779 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.71 -37.03 82.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.945 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.39 -35.0 76.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.556 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.405 ' CE1' ' O2A' ' A' ' 203' ' ' CYC . 88.3 m-85 -68.46 -33.77 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.739 HH21 ' H ' ' A' ' 162' ' ' LEU . 22.1 mtp180 -77.01 -28.63 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.154 -0.93 . . . . 1.0 111.337 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.446 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.5 mt -96.76 -39.28 9.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.84 -13.01 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.266 1.21 . . . . 1.0 114.266 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.465 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 7.2 mp0 48.58 58.22 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.674 -0.811 . . . . 1.0 109.899 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.465 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.0 m -159.42 112.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.374 -0.53 . . . . 1.0 112.012 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -165.21 134.07 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.833 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.9 p -151.31 156.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.715 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.451 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 97.9 mt -110.92 130.84 63.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.204 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.09 170.03 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.609 0.718 . . . . 1.0 112.892 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -50.14 116.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.248 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.45 -19.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.691 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -80.08 -37.24 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.81 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.5 -18.77 42.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 56.77 62.88 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.848 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 t -95.66 124.38 39.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -118.53 145.82 45.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.1 t -109.18 145.92 35.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.811 -1.086 . . . . 1.0 108.641 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.6 mt -145.88 150.53 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.475 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.6 p -86.07 162.51 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -143.57 153.53 58.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.89 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.97 -3.62 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.598 2.199 . . . . 1.0 112.217 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.77 -85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.667 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.456 ' HG ' ' N ' ' A' ' 119' ' ' TRP . 22.8 t -158.14 173.45 16.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.514 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.542 ' CE3' ' O ' ' A' ' 120' ' ' GLY . 12.7 p-90 -87.74 -174.14 4.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.667 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.542 ' O ' ' CE3' ' A' ' 119' ' ' TRP . . . -49.38 161.65 0.75 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.2 mt -116.82 48.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 1.0 110.574 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 m -58.64 -42.72 88.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.72 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.69 74.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -65.39 -59.2 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.717 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -149.8 120.54 3.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.646 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -43.42 144.17 2.08 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.364 2.043 . . . . 1.0 111.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.4 tp 59.03 -105.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.425 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.81 35.28 36.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.111 -0.796 . . . . 1.0 111.111 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 130' ' ' PRO . 57.4 mt-10 -146.46 153.84 48.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.545 0.212 . . . . 1.0 110.641 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.602 ' C ' ' H ' ' A' ' 132' ' ' GLN . 61.9 Cg_exo -41.28 166.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.476 2.117 . . . . 1.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 3.3 tp -59.71 10.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.973 -0.558 . . . . 1.0 112.038 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.602 ' H ' ' C ' ' A' ' 130' ' ' PRO . 46.6 mm-40 -138.4 158.88 43.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.476 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -125.56 115.77 25.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.529 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.67 141.86 10.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.683 2.256 . . . . 1.0 112.378 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.466 HG12 HAD2 ' A' ' 203' ' ' CYC . 2.6 m -120.24 129.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 138' ' ' CYS . 9.7 p30 -45.81 142.08 3.86 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 1.0 111.34 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -37.34 -19.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.113 2.542 . . . . 1.0 113.675 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 t -60.73 -61.57 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -69.71 -25.75 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.627 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.44 -60.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -60.53 -37.46 81.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.372 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -46.42 -37.94 8.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.61 -43.53 63.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -58.99 -42.98 91.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.9 t -63.63 -20.27 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.669 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.5 0.28 42.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.09 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.77 18.37 78.97 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 89.5 t -108.01 143.82 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.681 0.277 . . . . 1.0 110.273 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -24.19 6.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.018 0.377 . . . . 1.0 112.018 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.9 m -154.34 122.38 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.771 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.9 p -128.08 137.16 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 1.0 111.418 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.39 133.08 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.53 129.19 68.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.298 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.85 127.6 20.37 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -90.41 161.72 4.5 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.425 2.083 . . . . 1.0 113.65 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.85 114.35 24.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.4 ptm -141.29 150.7 42.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -125.05 124.14 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.929 -1.032 . . . . 1.0 108.836 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.559 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 53.6 t-80 59.05 -120.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.109 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.559 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.3 pp0? -98.79 0.41 44.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.807 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.408 ' CD ' ' NH2' ' A' ' 96' ' ' ARG . 47.2 tp10 -105.31 145.87 30.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.739 ' H ' HH21 ' A' ' 96' ' ' ARG . 35.9 tp -101.26 124.7 47.37 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.498 -1.297 . . . . 1.0 107.498 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -103.73 -31.67 9.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.563 0.949 . . . . 1.0 113.563 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.57 -168.32 22.32 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.697 -1.239 . . . . 1.0 112.401 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.577 ' CD1' HBA2 ' A' ' 203' ' ' CYC . 8.1 tt -143.17 124.07 14.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.418 -0.391 . . . . 1.0 111.658 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.1 tp -97.18 150.52 20.79 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.63 133.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.11 -0.636 . . . . 1.0 111.88 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 t -115.53 134.31 55.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 25.5 m-70 -108.38 124.89 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.548 ' NE2' ' OG1' ' A' ' 48' ' ' THR . 79.9 m80 -117.88 119.39 34.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.6 -18.06 61.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.775 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.42 150.32 60.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.558 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.36 128.15 17.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.662 2.242 . . . . 1.0 111.875 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -154.58 98.53 2.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.632 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.75 151.35 11.05 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.534 2.156 . . . . 1.0 111.449 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -103.45 153.73 20.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 1.0 110.846 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -90.26 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -54.47 -29.59 50.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.189 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -76.82 -52.23 9.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.254 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.56 -34.87 79.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 1.0 110.932 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 181' ' ' LEU . 3.1 tt -55.36 -59.68 4.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.574 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -59.31 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.713 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.7 t -45.43 -39.63 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.664 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.59 -50.51 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -49.31 -34.55 15.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.55 -48.12 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.033 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.67 -45.51 63.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.86 91.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.07 -39.3 91.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -66.6 -31.93 72.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.91 -48.09 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.6 p -52.03 -35.25 46.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.6 mt -66.95 -35.24 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.251 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.82 -39.68 79.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.986 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.63 -47.78 78.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.99 76.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.39 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.32 -46.27 87.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.269 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.43 75.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.397 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -56.65 -41.3 76.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.6 mt -55.15 -32.84 62.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.966 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.6 m -51.37 -57.09 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.656 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.8 mp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.467 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.734 HAB2 ' HZ2' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.805 0.336 . . . . 1.0 110.503 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.5 p-10 -48.74 -33.78 10.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 51.3 tt0 -76.01 -48.82 19.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 34' ' ' ILE . 23.1 mm -56.84 -46.04 83.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 1.0 111.025 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.471 ' O ' ' OG1' ' A' ' 38' ' ' THR . 40.2 mt -57.95 -29.41 65.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 1.0 112.008 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.48 -40.74 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.785 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.14 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 50.6 p -67.97 -37.56 81.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.329 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.62 -22.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.45 -36.5 38.76 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.267 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -71.0 -44.42 65.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.764 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 43' ' ' ARG . 16.6 m -59.53 -47.23 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.336 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 47' ' ' GLY . 50.4 ttp180 -50.4 -46.08 55.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 1.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.18 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.316 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -63.38 -40.55 97.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.807 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.96 -13.58 22.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.713 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.11 26.43 20.17 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.537 ' OG1' ' NE2' ' A' ' 170' ' ' HIS . 59.7 m -77.13 144.3 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.484 ' CG ' ' NH2' ' A' ' 73' ' ' ARG . 89.3 m-20 -55.51 -41.02 72.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.522 0.564 . . . . 1.0 112.522 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -150.51 132.26 14.99 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.65 -0.82 . . . . 1.0 112.842 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.95 134.52 28.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.97 -1.013 . . . . 1.0 108.725 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' NZ ' ' OB ' ' A' ' 203' ' ' CYC . 56.5 pttt -137.95 151.14 47.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.249 -0.581 . . . . 1.0 111.614 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -97.39 140.88 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.7 t80 -130.57 130.5 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.388 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.6 ttm105 -106.39 145.01 32.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 1.0 111.275 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 57' ' ' ASP . 64.4 t80 -99.56 127.55 45.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.877 -0.602 . . . . 1.0 111.703 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.575 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -98.24 154.41 37.67 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -50.86 -36.25 51.89 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.03 2.487 . . . . 1.0 114.469 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.43 -4.28 55.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.184 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.79 -16.51 47.14 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.859 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' NE2' ' CB ' ' A' ' 57' ' ' ASP . 36.6 p-80 -78.12 148.74 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.65 160.78 24.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.1 p -133.62 154.79 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 1.0 111.567 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.71 113.02 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.72 -1.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 1.0 112.041 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.52 129.05 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.279 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 18.1 pt-20 -162.71 142.13 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.472 -0.491 . . . . 1.0 111.678 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.7 146.82 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -134.32 146.52 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.969 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -102.11 141.43 15.27 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 37.77 31.35 0.08 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 70' ' ' GLY . 40.8 tt0 47.74 13.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 1.0 110.36 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 71' ' ' GLY . 19.1 ttp180 -49.9 -38.21 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.959 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.8 mt -110.86 145.08 31.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.91 157.09 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.432 2.088 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 m -80.74 115.94 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.359 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.5 mt -94.35 10.26 34.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.952 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.4 tp -57.12 129.24 40.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.85 -4.86 85.32 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.863 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.0 mt -82.21 147.47 28.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.308 0.554 . . . . 1.0 110.392 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.7 m -108.34 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.622 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -105.82 148.12 35.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.208 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.89 137.4 12.48 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.548 2.166 . . . . 1.0 111.428 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.8 -34.75 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.854 0.359 . . . . 1.0 110.439 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.11 -17.77 0.12 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.9 m-20 -58.17 -14.16 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.668 0.271 . . . . 1.0 111.018 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.0 145.62 19.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.513 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.527 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 79.2 Cg_endo -74.52 -88.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.502 2.135 . . . . 1.0 111.691 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 85.1 tt0 -170.15 -36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.16 -39.93 63.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.574 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.51 63.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.515 -0.312 . . . . 1.0 111.733 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.681 HH12 ' NH2' ' A' ' 96' ' ' ARG . 76.6 ttt-85 -61.81 -35.86 79.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.778 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -63.88 -36.89 85.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.937 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.55 -37.02 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.524 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 84.1 m-85 -65.88 -34.51 78.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.681 ' NH2' HH12 ' A' ' 92' ' ' ARG . 40.3 ttm180 -76.3 -30.3 57.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.097 -0.956 . . . . 1.0 111.252 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.467 ' C ' HE22 ' A' ' 99' ' ' GLN . 83.6 mt -93.86 -39.93 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.41 -10.7 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.198 1.184 . . . . 1.0 114.198 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.7 mp0 46.72 49.17 14.27 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.688 -0.805 . . . . 1.0 109.904 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.1 t -152.85 111.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.954 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.687 ' NH2' ' HE ' ' A' ' 133' ' ' ARG . 5.0 tpt180 -165.86 130.23 2.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.875 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.04 158.01 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.726 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 82.2 mt -111.44 128.82 67.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.228 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.7 170.2 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.976 0.732 . . . . 1.0 112.976 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -48.58 115.01 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.221 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.9 t -52.65 -23.07 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.697 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -76.6 -39.01 53.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.781 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.5 -15.51 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.12 0.486 . . . . 1.0 110.436 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.68 HE21 ' NH2' ' A' ' 111' ' ' ARG . 47.6 tt0 56.37 61.85 2.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.465 -0.789 . . . . 1.0 112.885 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 m -96.97 125.23 41.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.808 -1.552 . . . . 1.0 106.808 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.68 ' NH2' HE21 ' A' ' 109' ' ' GLN . 97.2 mtt180 -118.36 146.41 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.2 OUTLIER -109.43 148.51 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.6 178.155 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.0 pt -148.99 152.59 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.457 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.0 p -87.27 165.25 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -144.22 152.89 55.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -37.39 -46.34 1.67 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.719 2.279 . . . . 1.0 112.257 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 118' ' ' SER . 96.0 mt-10 -117.19 -165.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.599 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.9 p 79.72 115.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -170.04 97.05 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.659 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.5 53.83 5.33 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.53 -4.13 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.666 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 m -57.51 -33.7 68.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.763 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.53 29.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.768 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -61.75 -60.24 3.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.633 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.14 154.44 42.68 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 128' ' ' GLY . 62.8 Cg_endo -69.98 134.65 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.359 2.039 . . . . 1.0 111.468 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 129' ' ' GLU . 15.4 mt 59.0 -77.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.366 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 58.91 0.61 0.68 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.138 -0.785 . . . . 1.0 111.138 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 127' ' ' LEU . 52.2 mm-40 -145.65 155.5 52.73 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.584 0.231 . . . . 1.0 110.592 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.602 ' C ' ' H ' ' A' ' 132' ' ' GLN . 58.7 Cg_exo -40.69 144.98 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.444 2.096 . . . . 1.0 111.987 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.4 mt -61.06 13.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.098 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.602 ' H ' ' C ' ' A' ' 130' ' ' PRO . 35.4 mt-30 -128.11 136.23 50.89 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.512 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.687 ' HE ' ' NH2' ' A' ' 101' ' ' ARG . 12.8 mmm180 -126.72 101.96 26.17 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.529 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.493 ' O ' ' OG ' ' A' ' 112' ' ' SER . 67.7 Cg_exo -45.08 147.87 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.693 2.262 . . . . 1.0 112.391 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.44 122.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 138' ' ' CYS . 17.9 t70 -44.82 138.69 4.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.761 0.315 . . . . 1.0 111.356 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -35.93 -20.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.125 2.55 . . . . 1.0 113.603 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.8 t -62.63 -62.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 58.7 t-80 -69.53 -25.48 64.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.69 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.76 -59.05 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 14.1 p80 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.346 -0.541 . . . . 1.0 110.341 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.636 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 73.8 t80 -46.99 -38.79 11.3 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.53 -43.61 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -58.06 -43.08 86.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.6 m -62.97 -19.96 64.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.645 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.76 -1.28 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.097 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.57 18.14 78.04 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.49 142.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 1.0 110.277 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -22.45 7.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.981 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 p -155.17 123.16 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.769 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.0 m -129.08 137.41 51.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.416 . . . . 1.0 111.449 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.05 133.07 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.17 130.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.327 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.07 133.1 18.39 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -95.32 166.82 1.51 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.412 2.075 . . . . 1.0 113.759 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.44 116.7 27.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.4 ptm -142.45 152.97 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 -176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.43 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 39.7 t-80 -131.68 124.15 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.075 -0.966 . . . . 1.0 108.891 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.458 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.0 t-80 64.63 -126.56 0.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.122 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.458 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 98.0 mm-40 -97.05 4.96 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.784 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.528 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -107.53 145.99 32.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.723 1.009 . . . . 1.0 113.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.2 tp -99.54 125.64 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.528 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 72.1 m95 -103.33 -34.25 8.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.31 33.03 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.651 -1.262 . . . . 1.0 112.403 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 78.1 mt -135.66 121.47 19.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.469 -0.365 . . . . 1.0 111.664 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.6 tp -94.53 150.51 20.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.84 133.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.803 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.1 p -114.13 139.77 49.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.26 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 12.4 m80 -111.21 123.81 50.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.537 ' NE2' ' OG1' ' A' ' 48' ' ' THR . 73.4 m80 -117.87 119.37 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.04 -18.36 62.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.744 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -132.07 151.45 78.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -41.77 141.8 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.649 2.233 . . . . 1.0 111.867 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -165.48 78.32 1.26 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.929 -0.309 . . . . 1.0 110.655 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.22 153.31 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.571 2.181 . . . . 1.0 111.489 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -106.63 148.09 28.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.823 0.344 . . . . 1.0 110.803 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.8 m -94.42 157.12 16.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 178' ' ' GLN . 8.7 mp0 -53.03 -37.62 61.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.123 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -77.01 -42.85 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.277 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -67.66 -34.23 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 1.0 110.975 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -40.09 90.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.592 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -77.95 -52.15 9.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.66 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.8 t -44.58 -44.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.678 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 185' ' ' GLN . 7.2 p -74.29 -50.58 26.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.437 ' N ' ' CG1' ' A' ' 184' ' ' VAL . 61.5 tt0 -49.82 -36.05 25.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 190' ' ' GLN . 28.2 tp -71.23 -47.61 56.19 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.016 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.1 tp -54.04 -45.76 71.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.61 91.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -59.63 -36.6 76.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 186' ' ' LEU . 1.0 OUTLIER -67.32 -31.26 71.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.3 t -77.07 -46.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.8 p -50.93 -32.69 21.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.42 -33.06 32.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.232 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.82 80.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.959 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.86 -26.46 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.44 -54.4 6.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 8.0 pt20 -67.39 -37.87 83.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.12 -33.19 74.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.378 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.04 -43.44 86.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.177 0.436 . . . . 1.0 112.177 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.9 mt -53.28 -35.86 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.99 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.8 t -47.22 -56.12 7.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.611 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.407 179.701 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.452 ' O2A' ' CE2' ' A' ' 95' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.786 0.326 . . . . 1.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -49.43 -32.84 12.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.735 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -75.91 -48.29 21.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.778 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.3 mt -55.18 -51.47 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.034 0.445 . . . . 1.0 110.993 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' O ' ' OG1' ' A' ' 38' ' ' THR . 88.0 mt -55.69 -31.46 62.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.914 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.62 -38.77 90.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.392 -0.523 . . . . 1.0 109.743 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.24 -32.22 68.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.783 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.3 p -66.9 -36.93 83.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.274 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 p -72.46 -24.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.269 0.47 . . . . 1.0 112.269 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -70.66 -44.99 65.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.276 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -69.93 -35.0 74.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.754 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.64 -54.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.296 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.5 ttt-85 -51.52 -44.55 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 1.0 110.746 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.21 -46.35 79.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.295 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.548 ' CE2' ' OE2' ' A' ' 180' ' ' GLU . 63.6 t80 -62.41 -41.45 98.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.815 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.0 mt -96.33 -12.85 23.84 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.706 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 51.68 25.08 13.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.464 ' HG1' ' CD2' ' A' ' 170' ' ' HIS . 15.2 t -78.45 148.06 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 73' ' ' ARG . 94.7 m-20 -51.94 -42.25 62.7 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.554 ' NH1' ' O ' ' A' ' 75' ' ' PRO . 77.9 ttt180 -152.95 137.17 16.51 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.647 -0.821 . . . . 1.0 112.808 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -142.75 133.15 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.668 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.637 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 24.8 pttm -138.33 151.85 47.94 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.679 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.42 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.8 t80 -130.01 132.86 46.41 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.854 -0.338 . . . . 1.0 110.434 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.82 150.9 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.424 . . . . 1.0 111.215 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -102.38 132.71 48.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.698 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 61' ' ' HIS . 26.6 m-20 -97.71 154.52 37.85 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -40.14 -50.81 3.4 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.001 2.467 . . . . 1.0 114.479 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.74 -6.77 39.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.3 -7.41 37.23 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.697 -0.764 . . . . 1.0 111.905 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' ASP . 21.5 m80 -79.72 151.91 30.17 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.371 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.423 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.71 163.52 25.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -135.07 156.92 48.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.024 0.44 . . . . 1.0 111.483 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.26 109.63 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.33 -4.79 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.28 128.12 9.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.251 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG3' HH21 ' A' ' 50' ' ' ARG . 0.6 OUTLIER -159.41 141.28 13.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.655 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.82 137.29 52.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.577 ' CZ ' ' HG ' ' A' ' 76' ' ' SER . 83.4 mtm-85 -111.5 138.39 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.075 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.483 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -86.81 76.11 2.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.624 -0.99 . . . . 1.0 110.624 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.07 30.44 42.37 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 61.71 16.03 7.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 1.0 110.354 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 35.3 ttm180 -56.5 -44.69 80.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.067 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mt -107.21 121.76 43.58 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.554 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 90.5 Cg_exo -49.56 157.39 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.505 2.136 . . . . 1.0 112.268 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 69' ' ' ARG . 12.9 m -83.15 117.38 22.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.338 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CG ' HH22 ' A' ' 50' ' ' ARG . 43.3 mt -95.93 11.82 32.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 1.0 109.938 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.1 mt -58.9 131.51 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.85 -3.77 86.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.905 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.29 149.16 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.286 0.543 . . . . 1.0 110.454 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.9 t -105.46 131.14 53.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.643 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -105.5 106.1 54.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -42.26 134.07 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.508 2.139 . . . . 1.0 111.528 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -57.94 -30.6 66.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.861 0.363 . . . . 1.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.85 -17.69 0.1 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.4 t0 -67.49 -28.93 68.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 1.0 111.036 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 87' ' ' ILE . 27.3 mm -112.01 133.05 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.503 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 97.1 Cg_endo -76.28 -111.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.642 2.228 . . . . 1.0 111.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 90.6 mt-10 -151.57 -51.23 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.905 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.2 -40.59 67.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.633 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.32 -37.89 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.749 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 65.3 ttt180 -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.8 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -64.07 -35.53 81.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.911 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.26 -34.93 77.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.504 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CE1' ' O2A' ' A' ' 203' ' ' CYC . 80.1 m-85 -69.78 -37.64 76.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -77.31 -30.65 54.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.47 -40.39 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -117.04 -11.35 10.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 98' ' ' ALA . 5.3 mp0 44.55 62.98 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.663 -0.815 . . . . 1.0 109.898 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 10.8 p -168.54 114.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 120.31 -0.556 . . . . 1.0 111.854 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.464 ' HG2' HBD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -167.5 137.22 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.911 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.437 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.3 p -149.5 156.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.676 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.479 ' CD1' ' HE2' ' A' ' 139' ' ' HIS . 3.2 mt -109.57 128.34 65.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.257 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.0 t -84.65 165.88 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.013 0.745 . . . . 1.0 113.013 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -50.32 116.25 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.216 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.2 p -49.77 -21.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.74 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.28 -38.02 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.797 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.06 -21.19 63.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 1.0 110.399 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.467 HE21 ' CZ ' ' A' ' 111' ' ' ARG . 46.4 tt0 57.97 60.61 2.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.53 -0.759 . . . . 1.0 112.854 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -94.23 125.59 38.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.768 -1.568 . . . . 1.0 106.768 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.467 ' CZ ' HE21 ' A' ' 109' ' ' GLN . 87.0 mtt180 -120.38 144.76 47.73 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -117.03 157.15 26.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.801 -1.09 . . . . 1.0 108.634 177.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.9 pt -154.7 158.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.407 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.1 m -86.29 167.22 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' PRO . 54.6 mt-30 -151.02 152.61 31.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.912 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 117' ' ' GLU . 31.4 Cg_exo -34.41 -62.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.584 2.189 . . . . 1.0 112.281 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' PRO . 84.5 tt0 58.78 141.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.629 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 t -86.06 -85.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.516 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.573 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 73.5 t-105 -157.74 174.65 15.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.698 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.573 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 88.28 111.51 1.1 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.0 mt -136.11 -45.73 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 1.0 110.625 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -55.28 -31.01 61.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' ARG . . . -67.19 -38.31 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.74 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 123' ' ' ALA . 56.2 mmt-85 -35.74 119.02 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.656 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.0 158.95 51.14 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.592 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 62.7 Cg_endo -70.12 111.09 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.352 2.034 . . . . 1.0 111.567 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 126' ' ' PRO . 45.2 tp 167.58 131.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.419 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.92 39.27 13.66 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.106 -0.797 . . . . 1.0 111.106 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -121.54 147.28 47.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.559 0.219 . . . . 1.0 110.629 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.19 173.66 14.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.395 2.064 . . . . 1.0 111.955 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.7 tp -72.08 -9.17 58.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.974 -0.557 . . . . 1.0 112.085 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -134.56 138.34 44.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.529 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -113.98 90.98 20.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.49 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -46.92 141.54 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.583 2.188 . . . . 1.0 112.396 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG12 HAD2 ' A' ' 203' ' ' CYC . 3.6 m -118.48 131.22 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -40.9 156.57 0.2 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.669 0.271 . . . . 1.0 111.388 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.33 -26.12 80.76 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.13 2.553 . . . . 1.0 113.584 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -58.47 -56.63 19.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.0 111.21 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.673 ' HE2' HMA2 ' A' ' 203' ' ' CYC . 2.0 t60 -68.46 -27.16 65.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.602 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.26 -53.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.37 -40.88 94.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.397 -0.521 . . . . 1.0 110.362 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -47.63 -35.3 9.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.9 mt -73.8 -41.61 62.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.193 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -60.25 -43.59 95.98 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.3 t -61.69 -18.18 58.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.632 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.8 mmm -100.95 2.66 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.166 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.79 19.0 78.34 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 144.77 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.752 0.311 . . . . 1.0 110.211 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.58 -25.1 6.54 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.974 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -154.35 122.24 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.749 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -131.2 141.71 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.006 0.432 . . . . 1.0 111.398 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.74 130.45 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 28.5 m -117.0 141.3 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.267 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.83 132.41 20.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -86.87 159.67 8.9 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.35 2.034 . . . . 1.0 113.71 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.4 mt -113.51 116.29 29.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.6 ptm -140.85 149.5 42.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -130.42 122.57 28.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.03 -0.986 . . . . 1.0 108.812 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.473 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 51.5 t60 69.73 -126.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.144 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.473 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 93.9 mt-30 -100.91 5.85 43.44 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.781 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.531 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 5.7 pt-20 -111.31 156.72 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 34.4 tp -103.38 127.66 50.69 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.518 -1.29 . . . . 1.0 107.518 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.531 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 32.2 m95 -103.86 -34.98 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.44 -174.52 29.28 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.628 -1.273 . . . . 1.0 112.346 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.3 mt -137.11 122.35 19.27 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.422 -0.389 . . . . 1.0 111.677 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.8 tp -94.31 148.35 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.48 132.01 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.067 -0.653 . . . . 1.0 111.862 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.7 t -115.02 136.8 52.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.709 -0.678 . . . . 1.0 109.227 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.637 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 12.2 m80 -110.55 124.68 52.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.464 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 72.0 m80 -119.15 121.84 40.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.42 -17.36 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.807 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -133.32 152.59 79.64 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.591 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.32 142.46 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.602 2.201 . . . . 1.0 111.882 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.83 78.2 1.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.555 -0.293 . . . . 1.0 110.693 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -54.68 153.65 23.32 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.481 2.12 . . . . 1.0 111.457 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -108.35 147.74 31.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 1.0 110.819 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 66.9 m -95.29 158.11 15.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.212 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -53.86 -39.24 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.151 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.44 -47.75 22.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.263 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.548 ' OE2' ' CE2' ' A' ' 45' ' ' PHE . 38.5 tp10 -63.44 -35.94 82.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 1.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -65.82 -37.03 85.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.626 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -78.59 -52.16 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.709 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.1 t -44.28 -43.1 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.621 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 185' ' ' GLN . 6.9 p -75.39 -49.75 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.4 ' N ' ' CG1' ' A' ' 184' ' ' VAL . 58.1 tt0 -49.78 -34.36 19.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tp -72.7 -48.24 40.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.067 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.95 -45.87 64.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.93 95.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -63.11 -38.67 92.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.83 -31.32 71.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 49.1 t -76.05 -47.41 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.5 p -53.42 -34.33 57.4 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.41 -35.77 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.205 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.92 83.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.932 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.9 mt -56.92 -44.57 82.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.84 -50.51 64.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.386 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -61.85 -44.82 96.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.22 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.88 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.376 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -57.85 -44.06 86.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.1 tp -52.63 -38.39 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.5 t -51.71 -59.3 4.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.445 179.705 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.673 HMA2 ' HE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.872 0.367 . . . . 1.0 110.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 29.9 p-10 -51.84 -32.82 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.724 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.9 tt0 -76.59 -50.0 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.787 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.18 -51.8 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.041 0.448 . . . . 1.0 110.899 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.496 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.8 mt -56.13 -30.25 61.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.935 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -64.44 -40.25 95.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.407 -0.517 . . . . 1.0 109.661 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.93 -33.45 70.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.721 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.3 p -64.51 -37.35 87.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.346 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -24.59 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.208 0.448 . . . . 1.0 112.208 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -72.04 -40.81 68.11 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.48 -31.33 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.777 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.84 -56.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.339 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -53.55 -43.11 68.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 1.0 110.703 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.39 -43.17 71.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.288 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -65.64 -36.34 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -96.38 -15.02 22.07 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.706 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.77 26.05 53.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.0 p -80.01 147.29 31.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.9 p30 -54.11 -39.35 66.32 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.625 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -153.12 134.69 14.43 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.574 -0.85 . . . . 1.0 112.813 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -139.8 131.83 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.701 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 25.2 pttm -138.73 152.86 48.33 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.294 -0.563 . . . . 1.0 111.614 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.15 140.91 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -130.8 131.18 44.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.45 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -112.64 153.27 27.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.007 0.432 . . . . 1.0 111.217 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.4 136.87 41.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.677 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 61' ' ' HIS . 34.3 m-20 -97.21 150.58 36.97 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -41.94 -21.71 0.17 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.044 2.496 . . . . 1.0 114.528 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -103.04 3.44 36.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.6 -14.03 57.89 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.686 -0.769 . . . . 1.0 111.922 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 57' ' ' ASP . 66.2 m80 -78.86 150.05 32.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.43 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.57 162.11 25.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -134.34 155.78 49.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.034 0.445 . . . . 1.0 111.491 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 t -88.74 109.57 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 t -110.46 -5.15 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.49 126.25 8.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.3 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 1.1 tm-20 -158.71 139.67 12.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 1.0 111.695 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.34 136.35 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -107.5 136.41 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.094 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.26 68.16 3.61 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.04 42.5 7.56 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 50.44 20.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 1.0 110.337 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -61.62 -46.92 87.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.971 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mp -109.11 129.62 23.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.527 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 80.5 Cg_exo -51.06 165.86 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.48 2.12 . . . . 1.0 112.226 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 t -93.59 129.31 39.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.372 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.625 ' H ' ' NH2' ' A' ' 50' ' ' ARG . 79.2 mt -102.92 15.19 30.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.946 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.6 mt -66.48 131.47 46.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.03 -5.21 72.3 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.818 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.3 154.52 21.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.333 0.566 . . . . 1.0 110.468 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 p -106.23 128.05 53.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.603 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -103.73 150.08 37.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.263 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.24 134.65 9.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.481 2.121 . . . . 1.0 111.46 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -62.56 -30.4 71.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.796 0.332 . . . . 1.0 110.368 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.4 -16.28 0.06 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.196 -0.762 . . . . 1.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' ALA . 55.6 t0 -58.3 -15.97 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.654 0.264 . . . . 1.0 110.99 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.12 143.44 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.468 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 90.5 Cg_endo -76.59 -96.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.548 2.165 . . . . 1.0 111.699 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 2.7 pp20? -162.72 -28.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.92 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 22.5 pt-20 -70.55 -39.72 73.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.585 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.524 ' CB ' HH12 ' A' ' 101' ' ' ARG . . . -74.0 -40.34 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.649 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 61.0 ttp180 -63.14 -36.27 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.349 . . . . 1.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -60.82 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.926 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.92 -34.17 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 1.0 111.538 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE1' ' O2A' ' A' ' 203' ' ' CYC . 68.6 m-85 -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 28.0 mtp180 -73.72 -31.55 63.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.295 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.511 ' C ' HE22 ' A' ' 99' ' ' GLN . 90.2 mt -96.8 -37.26 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.17 -16.84 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.616 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.8 OUTLIER 45.73 52.84 9.24 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.619 -0.832 . . . . 1.0 109.964 -178.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.429 ' O ' ' CG ' ' A' ' 101' ' ' ARG . 24.8 t -157.33 101.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 120.293 -0.563 . . . . 1.0 111.862 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.524 HH12 ' CB ' ' A' ' 91' ' ' ALA . 5.4 mtt180 -158.46 137.92 11.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.876 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -145.97 158.35 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.71 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.47 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 2.9 mp -108.04 128.23 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.249 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.9 164.63 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -50.6 118.89 3.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.966 -1.016 . . . . 1.0 112.237 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -51.28 -22.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.709 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -78.88 -37.82 39.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.797 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.35 63.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.192 0.52 . . . . 1.0 110.432 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 57.55 62.59 2.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.904 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -94.02 124.39 38.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.19 145.23 46.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -110.68 149.67 30.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.803 -1.09 . . . . 1.0 108.6 177.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 pt -149.91 154.03 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.412 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.0 t -88.89 165.98 14.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 117' ' ' GLU . 41.1 tt0 -152.87 123.44 3.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.964 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -36.87 88.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.67 2.247 . . . . 1.0 112.221 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 115' ' ' GLN . 84.8 tt0 -161.59 -82.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.1 m 42.34 47.41 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.494 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 73.6 t-105 -136.56 158.12 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 91.28 164.86 39.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -99.95 132.85 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 1.0 110.634 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -63.72 -32.83 74.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.59 -45.92 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -39.18 -72.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.683 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.41 107.73 46.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.631 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -84.48 144.6 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.377 2.051 . . . . 1.0 111.494 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 tp 60.83 -116.16 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.355 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.08 39.51 96.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.467 ' CD ' ' NH2' ' A' ' 133' ' ' ARG . 74.3 mt-10 -135.14 152.04 76.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.551 0.215 . . . . 1.0 110.576 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.589 ' C ' ' H ' ' A' ' 132' ' ' GLN . 59.0 Cg_endo -67.68 167.21 21.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.403 2.069 . . . . 1.0 112.052 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.99 6.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 1.0 112.03 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.589 ' H ' ' C ' ' A' ' 130' ' ' PRO . 26.0 mt-30 -140.81 161.28 38.18 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.444 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' NH2' ' CD ' ' A' ' 129' ' ' GLU . 9.1 tpp180 -129.03 103.76 18.49 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.595 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.47 143.11 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.59 2.193 . . . . 1.0 112.375 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.468 ' CG1' HAD2 ' A' ' 203' ' ' CYC . 25.7 m -120.27 131.13 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 112' ' ' SER . 19.7 t70 -43.61 137.57 3.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 1.0 111.378 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -36.22 -25.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.047 2.498 . . . . 1.0 113.696 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 136' ' ' ASP . 25.6 t -53.61 -59.72 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.771 -0.372 . . . . 1.0 111.239 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.456 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 73.8 t60 -69.62 -23.89 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.634 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.2 t -59.11 -61.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -62.04 -40.93 97.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.428 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -45.94 -38.92 8.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.92 -42.81 63.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -57.83 -43.51 85.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.6 t -62.55 -19.9 64.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.336 -0.847 . . . . 1.0 109.636 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.4 mmm -99.0 -0.55 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.09 18.93 75.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 99.0 t -109.32 142.97 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.728 0.299 . . . . 1.0 110.25 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -122.22 -26.01 4.76 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 111.997 0.369 . . . . 1.0 111.997 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p -152.5 118.65 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.727 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 p -129.76 142.21 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.004 0.43 . . . . 1.0 111.359 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tp -98.97 135.19 40.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.06 130.12 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.305 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.0 131.43 18.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -93.92 163.19 2.18 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.363 2.042 . . . . 1.0 113.656 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.3 mt -115.8 113.39 23.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.659 -1.237 . . . . 1.0 107.659 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.8 ptm -140.57 149.28 42.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.477 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.3 t60 -120.75 123.62 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.958 -1.019 . . . . 1.0 108.892 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.477 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 42.8 m-70 55.86 -118.08 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.122 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -97.44 0.55 47.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.802 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.516 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.01 142.74 34.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.784 1.031 . . . . 1.0 113.784 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 49.4 tp -99.59 123.57 43.98 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.535 -1.283 . . . . 1.0 107.535 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.516 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.4 m95 -103.33 -33.77 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.576 0.954 . . . . 1.0 113.576 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.14 31.95 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.351 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 54.4 mt -134.54 121.39 20.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.706 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.2 tp -94.61 149.77 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.408 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 10.8 p -157.19 134.13 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.013 -0.675 . . . . 1.0 111.821 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.5 t -114.23 137.47 51.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.485 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 17.0 m80 -110.19 127.46 54.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 4.1 t60 -118.58 120.38 37.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.24 12.77 7.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.83 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.481 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 42.2 mm-40 -143.26 152.02 56.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.615 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.65 132.19 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.676 2.25 . . . . 1.0 111.826 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -172.93 127.38 0.51 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.08 153.69 32.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.517 2.145 . . . . 1.0 111.451 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -103.67 155.58 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.768 0.318 . . . . 1.0 110.846 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 51.1 m -92.21 151.39 20.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.206 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.15 -27.38 68.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.158 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.39 -50.91 57.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.236 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.42 -27.5 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.974 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -55.02 -49.78 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.665 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.504 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 5.0 pt20 -78.08 -52.14 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.655 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.504 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 80.1 t -44.28 -42.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.649 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.47 -49.3 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -50.42 -33.09 19.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 190' ' ' GLN . 20.6 tp -74.51 -49.4 22.25 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.065 -0.971 . . . . 1.0 109.112 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.35 -46.11 65.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.57 86.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -61.13 -38.33 86.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 186' ' ' LEU . 62.1 tt0 -66.53 -32.34 73.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.29 -47.27 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.8 p -51.96 -35.69 46.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.7 mt -66.32 -35.66 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.212 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.71 78.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.983 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.6 -46.1 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.02 -50.29 64.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.374 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.04 -45.8 91.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.269 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -66.44 -31.99 73.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.393 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.39 -41.8 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 tp -51.54 -35.72 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.962 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 86.8 p -57.29 -60.97 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.621 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 10.3 mp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.005 -0.998 . . . . 1.0 110.446 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.473 ' HHB' ' OD2' ' A' ' 86' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -49.63 -32.16 12.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.96 -48.28 25.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.791 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 34' ' ' ILE . 26.6 mm -55.02 -49.95 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.046 0.45 . . . . 1.0 110.939 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.489 ' O ' ' OG1' ' A' ' 38' ' ' THR . 83.2 mt -55.16 -32.95 62.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.935 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -61.93 -42.34 98.98 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.744 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.9 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.787 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 82.2 p -66.61 -36.66 83.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 1.0 112.242 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.1 p -71.25 -24.51 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.174 0.435 . . . . 1.0 112.174 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -78.74 -37.19 41.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.311 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -72.52 -43.41 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.78 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 43' ' ' ARG . 33.9 m -60.14 -49.69 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.304 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 47' ' ' GLY . 71.2 ttp85 -53.33 -45.79 69.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.683 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.53 68.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.255 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -65.7 -36.68 84.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.758 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.4 mt -96.68 -14.29 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.704 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.84 25.96 38.9 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.5 p -79.29 149.24 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.9 m-20 -49.1 -42.6 39.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.617 HH12 ' CG2' ' A' ' 148' ' ' VAL . 14.9 ptt-85 -158.28 145.44 17.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.576 -0.85 . . . . 1.0 112.791 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.7 t -137.75 135.13 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.943 -1.026 . . . . 1.0 108.684 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.526 ' NZ ' ' OE2' ' A' ' 67' ' ' GLU . 34.6 mttt -136.01 147.07 47.81 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.265 -0.574 . . . . 1.0 111.651 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.81 140.18 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -129.67 130.48 45.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.441 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -111.8 151.76 28.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 1.0 111.215 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.7 OUTLIER -101.91 139.05 38.07 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.631 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.8 m-20 -103.54 154.33 37.94 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -39.98 -51.95 2.93 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.045 2.496 . . . . 1.0 114.51 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.93 -5.03 23.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.11 -8.16 44.96 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.763 -0.732 . . . . 1.0 111.939 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ASP . 57.7 m80 -76.42 148.98 36.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.445 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.77 159.05 23.78 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -132.99 156.09 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.015 0.436 . . . . 1.0 111.449 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 79' ' ' GLY . 7.5 p -94.0 112.05 26.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -115.33 0.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.48 126.08 8.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.341 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 81.9 tt0 -153.75 138.47 17.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 1.0 111.697 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.91 133.39 51.89 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -112.02 138.54 48.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.35 -0.54 . . . . 1.0 112.055 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.34 67.04 3.7 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.658 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 84.98 163.91 37.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.69 11.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 1.0 110.327 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.658 ' H ' ' C ' ' A' ' 71' ' ' GLY . 40.6 ttm180 -66.11 -40.11 90.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.014 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.1 mt -116.71 142.22 29.35 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.19 168.08 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.484 2.122 . . . . 1.0 112.255 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m -95.78 144.61 26.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.34 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.457 ' CD1' ' HZ1' ' A' ' 52' ' ' LYS . 32.0 mt -114.66 10.62 16.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.8 mt -55.52 130.1 41.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.99 -2.53 87.11 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.858 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.7 mt -85.7 144.86 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.31 0.555 . . . . 1.0 110.483 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 p -102.56 131.26 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.59 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -104.39 105.31 49.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.214 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.26 136.31 5.64 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.555 2.17 . . . . 1.0 111.484 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.854 0.359 . . . . 1.0 110.391 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.06 -17.92 0.12 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.9 m-20 -64.74 -18.36 64.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.606 0.241 . . . . 1.0 111.028 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.79 133.54 18.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.539 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.57 -96.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.556 2.171 . . . . 1.0 111.672 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.7 pt-20 -164.19 -42.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.947 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 86.1 tt0 -52.95 -43.31 66.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.596 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.35 70.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.526 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 60.8 ttt180 -65.56 -31.61 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.757 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -64.84 -37.93 89.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 mt -59.19 -37.76 78.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.531 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.433 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 86.9 m-85 -68.52 -33.88 74.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -77.46 -30.32 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.291 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.514 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.6 mt -94.77 -39.53 10.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.0 -11.81 9.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.514 HE22 ' C ' ' A' ' 97' ' ' LEU . 2.9 mp0 46.64 50.53 12.97 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.958 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 t -152.57 111.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.882 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.454 ' NE ' ' O2D' ' A' ' 203' ' ' CYC . 3.8 tpt180 -164.32 130.13 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.876 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -143.97 156.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.66 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.434 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 54.7 mt -111.99 127.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.209 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.59 169.65 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 27.5 m-20 -50.87 115.86 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.305 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.6 p -50.51 -19.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.661 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -76.28 -40.44 51.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.548 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -62.29 -8.18 5.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.132 0.491 . . . . 1.0 110.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.548 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 9.7 pt20 45.52 62.5 2.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.751 . . . . 1.0 112.868 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -92.5 127.02 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -118.75 145.17 45.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.535 ' OG ' ' C ' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -111.04 151.25 28.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.757 -1.11 . . . . 1.0 108.589 178.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 pt -148.02 151.71 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.426 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.602 ' HG ' ' H ' ' A' ' 115' ' ' GLN . 25.7 t -85.82 168.55 14.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.602 ' H ' ' HG ' ' A' ' 114' ' ' SER . 67.1 mt-30 -148.38 155.48 42.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.884 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 115' ' ' GLN . 37.4 Cg_exo -35.23 156.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.704 2.269 . . . . 1.0 112.232 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 119' ' ' TRP . 82.9 tt0 -45.29 -42.14 9.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.566 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.9 m 41.16 20.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.545 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' GLU . 93.6 m95 42.31 50.56 4.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.82 148.61 51.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.9 mt -95.12 136.13 35.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 1.0 110.627 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.414 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 60.4 m -61.45 -37.02 82.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.05 -28.7 65.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.81 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 61.02 -143.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.682 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.21 154.54 61.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.619 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.43 118.5 5.71 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.331 2.021 . . . . 1.0 111.524 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.483 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 5.2 tp 53.75 -132.87 1.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.483 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . 69.53 39.11 79.5 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 133' ' ' ARG . 43.0 mt-10 -130.93 151.3 78.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.53 0.205 . . . . 1.0 110.583 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.6 169.02 23.48 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.485 2.123 . . . . 1.0 112.04 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.4 mt -63.52 -3.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.096 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -134.6 168.28 19.27 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.488 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.497 ' NH2' ' OE1' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -141.16 124.89 10.14 Favored Pre-proline 0 N--CA 1.462 0.168 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.501 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.535 ' C ' ' OG ' ' A' ' 112' ' ' SER . 50.9 Cg_endo -84.32 143.97 10.23 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.679 2.252 . . . . 1.0 112.402 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -119.78 128.71 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 138' ' ' CYS . 5.0 t70 -44.86 140.37 3.42 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.802 0.334 . . . . 1.0 111.335 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -36.32 -26.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.198 2.599 . . . . 1.0 113.629 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 136' ' ' ASP . 38.4 t -54.22 -61.45 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.768 -0.373 . . . . 1.0 111.2 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.569 ' NE2' HMA3 ' A' ' 203' ' ' CYC . 38.9 t60 -70.27 -24.92 63.13 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.61 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.51 -58.59 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -62.1 -38.88 90.58 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.363 -0.535 . . . . 1.0 110.402 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -47.29 -36.8 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.33 -43.4 60.86 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -58.15 -43.52 87.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.4 t -62.34 -19.28 63.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.687 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.9 mmm -100.15 0.93 41.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.158 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.7 19.46 77.8 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.617 ' CG2' HH12 ' A' ' 50' ' ' ARG . 99.0 t -108.72 144.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.624 0.249 . . . . 1.0 110.369 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.95 -27.44 5.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.441 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 51.1 m -149.71 121.43 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 87.9 p -130.45 141.8 50.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 1.0 111.418 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -103.21 133.74 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.9 t -112.64 129.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.247 -0.581 . . . . 1.0 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.69 132.83 21.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.27 164.52 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.362 2.042 . . . . 1.0 113.738 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 mt -117.05 114.31 23.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.64 -1.245 . . . . 1.0 107.64 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.5 ptm -141.47 153.02 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.556 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 58.9 t60 -126.97 126.42 43.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.9 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.556 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 38.8 m80 57.0 -120.87 1.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.157 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -97.8 2.32 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.791 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.58 145.3 31.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.76 124.25 46.13 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 75.3 m95 -102.94 -33.22 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.88 -172.33 30.23 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.598 -1.286 . . . . 1.0 112.3 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.62 122.67 19.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.426 -0.387 . . . . 1.0 111.682 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.2 tp -95.99 149.35 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.7 p -154.68 133.81 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.981 -0.687 . . . . 1.0 111.836 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 96.4 p -116.17 133.74 55.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.234 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -108.43 128.35 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.4 123.29 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.269 -1.012 . . . . 1.0 108.269 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.76 -18.94 62.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.774 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -119.01 160.52 40.55 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.555 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.62 -80.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.599 2.199 . . . . 1.0 111.866 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 46.97 90.86 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.662 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.78 159.65 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.514 2.143 . . . . 1.0 111.466 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.68 106.49 14.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.787 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -47.42 146.52 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.266 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.2 -25.77 65.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.12 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -68.89 -47.6 65.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.25 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -68.68 -26.83 65.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 1.0 110.983 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.25 -38.27 88.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.646 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -54.86 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.704 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -44.22 -41.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.652 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 185' ' ' GLN . 23.4 m -74.13 -47.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.451 ' N ' ' CG2' ' A' ' 184' ' ' VAL . 58.1 tt0 -50.68 -33.08 21.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.84 -50.03 26.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.074 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.4 -44.61 65.46 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.42 92.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -58.42 -37.37 75.23 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -67.77 -31.3 71.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.61 -47.78 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.515 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 44.1 p -50.32 -32.2 16.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.515 ' N ' ' HG ' ' A' ' 192' ' ' SER . 37.3 mt -74.98 -33.95 30.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.094 -0.957 . . . . 1.0 110.236 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.9 79.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.98 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 196' ' ' ALA . 22.4 pt -63.14 -28.91 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.05 -52.3 10.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.356 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.23 -41.81 96.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.302 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.61 72.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.409 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.03 -43.89 87.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.57 -35.77 54.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.707 -0.397 . . . . 1.0 111.003 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -51.08 -57.49 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.627 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.413 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.569 HMA3 ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.915 0.388 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 30.9 p-10 -50.66 -32.67 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.677 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 52.7 tt0 -75.67 -49.99 16.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.863 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.77 -50.58 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 1.0 110.936 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.479 ' O ' ' OG1' ' A' ' 38' ' ' THR . 65.8 mt -55.82 -31.04 62.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.001 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -67.13 -38.32 85.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.412 -0.515 . . . . 1.0 109.757 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.53 -31.99 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.754 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 77.7 p -67.13 -37.77 84.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.553 . . . . 1.0 112.329 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.5 p -73.57 -22.79 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -73.09 -40.2 65.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.337 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.92 -33.61 59.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.746 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.8 t -62.27 -56.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.349 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -52.91 -42.91 65.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 1.0 110.656 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.78 -45.5 74.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.327 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.29 -36.79 85.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.87 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.74 -16.12 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.715 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.51 24.84 48.25 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 p -79.21 146.94 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -51.62 -42.23 61.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.64 HH22 ' CG ' ' A' ' 77' ' ' LEU . 67.7 ttt180 -153.31 136.45 15.61 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.635 -0.826 . . . . 1.0 112.819 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 8.8 t -139.22 130.67 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.88 -1.055 . . . . 1.0 108.751 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.551 ' HZ2' HBB1 ' A' ' 203' ' ' CYC . 58.0 pttt -137.26 150.61 47.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.349 -0.541 . . . . 1.0 111.69 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.86 140.42 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -129.28 131.99 47.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.488 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -110.9 148.91 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 1.0 111.22 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.8 130.53 48.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.692 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 61' ' ' HIS . 9.9 m-20 -90.53 152.31 45.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -49.5 -18.68 2.56 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.055 2.504 . . . . 1.0 114.466 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.1 4.96 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.137 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.79 -15.56 59.48 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.698 -0.763 . . . . 1.0 111.875 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 74.1 m80 -79.86 151.09 30.41 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.88 163.75 25.85 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -135.39 157.55 46.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.973 0.416 . . . . 1.0 111.5 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -90.91 110.6 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.53 -3.44 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.23 125.89 8.92 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.313 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' OE2' ' CZ ' ' A' ' 50' ' ' ARG . 79.9 tt0 -155.18 138.5 15.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.119 0.485 . . . . 1.0 111.746 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.78 139.89 52.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -131.17 146.03 52.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.031 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.59 134.58 11.86 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.564 -1.014 . . . . 1.0 110.564 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 40.63 38.35 1.5 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 42.58 20.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 1.0 110.415 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 71' ' ' GLY . 43.9 ttm180 -54.75 -42.21 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.061 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.4 mt -108.25 146.45 33.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.67 161.94 33.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.411 2.074 . . . . 1.0 112.24 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p -89.16 115.76 26.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.64 ' CG ' HH22 ' A' ' 50' ' ' ARG . 26.8 mt -94.08 11.57 29.43 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.9 mt -56.48 130.43 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -3.5 87.0 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.369 -0.832 . . . . 1.0 112.854 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.95 146.83 27.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.336 0.568 . . . . 1.0 110.463 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -107.8 138.39 44.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.633 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -110.71 149.76 40.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.193 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.49 133.98 10.9 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.569 2.179 . . . . 1.0 111.44 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -57.22 -31.17 65.22 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.433 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.78 -16.88 0.23 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 30.4 p-10 -66.77 -17.3 64.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.661 0.267 . . . . 1.0 111.029 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.0 mt -137.02 98.41 10.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.506 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.496 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 43.7 Cg_exo -39.5 -95.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.507 2.138 . . . . 1.0 111.727 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 82.9 tt0 -163.67 -42.51 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.885 0.374 . . . . 1.0 110.991 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -54.64 -39.68 68.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.571 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.77 -42.01 51.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.741 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.525 HH12 HH11 ' A' ' 96' ' ' ARG . 73.6 ttp85 -61.68 -37.51 84.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.827 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.471 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 91.5 mtt-85 -61.95 -34.86 76.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.001 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.08 -33.69 76.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.5 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -68.39 -33.45 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.525 HH11 HH12 ' A' ' 92' ' ' ARG . 12.7 mtm180 -77.01 -30.74 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.236 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.526 ' C ' HE22 ' A' ' 99' ' ' GLN . 97.0 mt -96.03 -38.55 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.71 -14.11 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.188 1.181 . . . . 1.0 114.188 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.599 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.4 mp0 47.82 55.94 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.878 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.487 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 5.7 m -158.95 112.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.949 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.591 ' NH1' ' NH1' ' A' ' 133' ' ' ARG . 4.2 tpp180 -168.04 133.96 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.797 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.453 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.0 p -144.56 157.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.709 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.453 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 8.2 mt -110.51 129.1 66.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.322 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 16.7 t -84.06 165.97 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.421 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 57.1 t0 -47.9 119.53 2.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.947 -1.024 . . . . 1.0 112.282 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.22 -23.51 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.685 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -82.01 -37.09 27.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.777 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.9 -16.13 6.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.162 0.506 . . . . 1.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 57.35 60.16 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 1.0 112.844 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.5 p -95.12 125.98 40.15 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -120.98 138.63 54.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.667 0.988 . . . . 1.0 113.667 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -111.74 156.26 22.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.742 -1.117 . . . . 1.0 108.642 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.7 pt -154.06 158.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.475 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.6 p -87.55 170.36 11.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -143.14 153.94 60.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.865 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.49 -26.39 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.642 2.228 . . . . 1.0 112.302 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.97 139.96 57.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.1 m -69.06 151.26 46.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -146.43 148.14 31.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.624 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.59 -168.91 41.78 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 mt 57.57 46.03 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.0 110.654 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.9 m -60.46 -32.1 71.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.719 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' A' ' 125' ' ' VAL . . . -55.32 -44.46 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -68.69 4.33 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.694 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 123' ' ' ALA . 13.4 t -146.6 99.03 4.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.685 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.02 130.34 2.54 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.443 2.095 . . . . 1.0 111.502 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 9.8 mp 54.72 -109.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.449 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.53 36.82 62.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.111 -0.796 . . . . 1.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -142.48 153.94 62.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 121.228 -0.189 . . . . 1.0 110.642 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' A' ' 132' ' ' GLN . 43.7 Cg_endo -63.9 163.03 26.59 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.401 2.067 . . . . 1.0 111.998 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 69.5 mt -49.35 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.006 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.58 ' H ' ' C ' ' A' ' 130' ' ' PRO . 31.5 mm-40 -134.29 138.82 45.27 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.477 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.591 ' NH1' ' NH1' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -116.82 128.1 26.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.458 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.58 140.32 11.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.701 2.267 . . . . 1.0 112.338 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.1 p -115.27 130.16 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' N ' ' OG ' ' A' ' 112' ' ' SER . 7.9 t0 -44.96 131.99 5.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 1.0 111.393 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.86 -31.02 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.092 2.528 . . . . 1.0 113.662 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.3 t -47.24 -61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.231 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -70.88 -23.14 62.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.698 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.49 -58.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.87 -41.23 97.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.331 -0.547 . . . . 1.0 110.398 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.54 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 66.7 t80 -47.41 -38.32 13.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.05 -43.68 64.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.04 -42.75 77.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -35.09 75.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.61 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 63.2 mtp -83.39 -1.54 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.071 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.39 75.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.03 143.48 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.272 . . . . 1.0 110.341 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.16 -43.46 2.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.025 0.38 . . . . 1.0 112.025 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.7 m -134.1 119.84 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.763 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.0 m -132.93 144.11 49.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.931 0.396 . . . . 1.0 111.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 14.2 mt -99.02 136.83 38.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.59 105.88 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.337 -0.545 . . . . 1.0 112.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.83 128.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.212 -1.032 . . . . 1.0 108.212 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -93.36 162.54 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.369 2.046 . . . . 1.0 113.782 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.49 116.72 28.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.605 -1.258 . . . . 1.0 107.605 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.545 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.7 ptm -141.1 148.23 39.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.9 t60 -126.78 132.46 51.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.016 -0.993 . . . . 1.0 108.832 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 23.3 m-70 56.62 -126.52 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -98.31 3.33 48.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.776 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 12.4 pt-20 -109.78 153.25 24.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.703 1.001 . . . . 1.0 113.703 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.7 tp -103.88 127.39 51.4 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.542 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 43.6 m95 -103.88 -32.41 9.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.543 0.942 . . . . 1.0 113.543 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 -174.13 31.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.403 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -135.58 125.12 25.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.388 . . . . 1.0 111.701 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.5 tp -96.9 149.92 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 p -156.5 133.43 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.046 -0.661 . . . . 1.0 111.784 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 t -114.77 135.49 54.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.259 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -110.92 128.61 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.606 ' HE2' ' NH1' ' A' ' 174' ' ' ARG . 14.0 t60 -120.75 130.54 54.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.91 26.56 2.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.775 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -148.65 146.12 21.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.945 -0.302 . . . . 1.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.77 137.97 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.63 2.22 . . . . 1.0 111.85 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.606 ' NH1' ' HE2' ' A' ' 170' ' ' HIS . 1.6 ptp85 -178.76 149.41 0.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 1.0 110.647 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.13 150.02 25.8 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.579 2.186 . . . . 1.0 111.478 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -106.12 162.19 13.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.35 . . . . 1.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.9 m -114.29 143.09 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.182 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -58.39 -34.22 70.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.106 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -56.39 -55.4 34.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.205 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -70.72 -30.67 67.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.521 -0.308 . . . . 1.0 110.947 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.08 -33.68 74.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.584 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -77.84 -54.58 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.922 -0.311 . . . . 1.0 111.704 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.4 t -42.92 -41.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.42 -47.08 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -51.8 -32.88 33.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 190' ' ' GLN . 43.2 tp -75.7 -51.69 12.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.66 -46.4 67.15 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.59 98.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.494 ' O ' HD12 ' A' ' 193' ' ' ILE . 61.7 t0 -63.79 -37.01 85.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 186' ' ' LEU . 51.6 tt0 -68.05 -29.24 68.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -76.36 -46.01 33.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 157' ' ' MET . 8.2 t -50.87 -37.52 43.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.494 HD12 ' O ' ' A' ' 189' ' ' ASP . 1.1 mp -64.1 -36.83 78.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.261 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.73 82.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.612 . . . . 1.0 110.903 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.33 -47.52 81.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.41 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.712 -0.676 . . . . 1.0 110.342 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.43 -45.63 92.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.175 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.94 71.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.375 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.2 -43.11 82.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.29 -35.64 62.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -55.02 -60.69 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.5 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.407 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.551 HBB1 ' HZ2' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 1.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 28.8 p-10 -70.91 -32.36 69.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.723 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 53.3 tt0 -77.45 -48.26 17.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.807 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 34' ' ' ILE . 96.6 mt -56.02 -50.34 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.055 0.455 . . . . 1.0 110.964 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.481 ' O ' ' OG1' ' A' ' 38' ' ' THR . 78.2 mt -57.56 -30.73 65.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.942 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -66.73 -38.81 87.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.391 -0.524 . . . . 1.0 109.781 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -30.13 65.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.787 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 69.0 p -69.69 -36.42 75.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 1.0 112.314 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.4 p -71.63 -25.44 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.52 -31.86 32.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 1.0 111.296 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -76.8 -38.34 54.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.709 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 43' ' ' ARG . 30.4 m -66.53 -52.83 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.304 -177.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -51.87 -43.3 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 1.0 110.669 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.2 -44.12 71.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.317 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -64.66 -35.79 82.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.842 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.29 -13.01 23.68 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.703 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.03 25.83 47.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 p -80.03 148.82 30.94 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.991 -0.374 . . . . 1.0 109.991 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' GLY . 87.8 m-20 -50.25 -42.66 52.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.643 0.608 . . . . 1.0 112.643 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.54 HH21 ' CG2' ' A' ' 148' ' ' VAL . 18.7 ptt-85 -158.4 149.78 21.0 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.633 -0.827 . . . . 1.0 112.805 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -141.33 136.14 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.962 -1.017 . . . . 1.0 108.743 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' NZ ' ' CE1' ' A' ' 169' ' ' HIS . 29.8 mttp -137.07 145.58 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.624 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -100.91 142.1 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 20.7 t80 -130.44 133.27 46.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 1.0 110.426 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.426 HH12 ' CG2' ' A' ' 195' ' ' ILE . 78.1 mtp85 -114.44 154.1 28.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.019 0.438 . . . . 1.0 111.14 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.23 138.19 40.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.711 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -97.42 153.64 38.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -45.39 -21.1 0.65 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.012 2.474 . . . . 1.0 114.463 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -102.83 2.97 36.14 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.206 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.32 -13.68 56.96 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.661 -0.781 . . . . 1.0 111.957 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 57' ' ' ASP . 59.1 m80 -78.72 150.13 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.416 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.29 161.6 25.27 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -133.74 155.92 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.473 . . . . 1.0 111.473 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.22 108.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.0 t -109.0 -4.99 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.12 0.415 . . . . 1.0 112.12 -178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.04 125.96 8.41 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -154.89 139.14 16.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.18 0.514 . . . . 1.0 111.739 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.36 131.82 51.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.6 mtm-85 -103.15 135.08 45.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.071 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -79.1 74.65 2.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.85 38.75 30.31 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 54.55 21.73 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.791 0.329 . . . . 1.0 110.3 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -57.58 -43.19 84.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.972 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.51 159.91 35.11 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.56 147.61 19.97 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.514 2.142 . . . . 1.0 112.223 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -67.33 124.24 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.355 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.37 9.96 38.02 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.978 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.75 131.54 50.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.13 73.08 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.877 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.05 152.5 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.345 0.572 . . . . 1.0 110.464 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.0 t -107.43 131.23 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.602 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.07 148.79 36.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.273 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.8 129.18 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.489 2.126 . . . . 1.0 111.459 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -56.97 -31.13 64.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.866 0.365 . . . . 1.0 110.463 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.92 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.7 m-20 -63.72 -26.39 68.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.562 0.22 . . . . 1.0 111.02 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.5 mt -122.59 132.99 24.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.555 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.6 -103.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.608 2.205 . . . . 1.0 111.633 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 22.3 pt-20 -159.66 -40.77 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.032 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 87.2 tt0 -60.27 -41.28 92.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.623 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.82 -39.86 63.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.631 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -63.14 -37.5 87.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 1.0 110.808 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.72 -34.66 74.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.941 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.84 -32.23 73.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.614 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.41 -35.84 78.24 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -73.55 -33.63 64.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.215 -0.902 . . . . 1.0 111.262 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.544 ' C ' HE22 ' A' ' 99' ' ' GLN . 86.4 mt -95.54 -37.67 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.782 1.03 . . . . 1.0 113.782 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.16 -15.05 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -175.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 47.48 57.45 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.658 -0.817 . . . . 1.0 109.969 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.4 m -159.57 114.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.88 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.567 ' NH1' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -168.44 132.46 1.57 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.878 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.64 157.78 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.688 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.3 mt -109.75 126.98 66.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.266 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.69 169.56 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -49.84 115.21 1.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.952 -1.022 . . . . 1.0 112.292 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.6 t -51.57 -17.68 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.72 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -81.97 -36.69 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.789 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -60.71 -8.91 3.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.172 0.511 . . . . 1.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.588 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 16.2 pt20 46.8 60.21 3.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.844 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 p -94.43 129.19 41.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -119.69 142.36 48.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.681 0.993 . . . . 1.0 113.681 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.2 p -109.29 149.53 29.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.753 -1.112 . . . . 1.0 108.661 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.2 mt -147.15 152.56 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.451 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 m -85.31 169.13 14.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -151.81 132.54 7.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.74 14.87 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.259 . . . . 1.0 112.223 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.56 143.09 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.648 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -55.29 96.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -61.07 -31.45 71.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.667 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.27 -173.63 34.5 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 121' ' ' LEU . 8.3 mp -92.58 125.18 37.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 1.0 110.622 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.427 ' OG ' ' CD1' ' A' ' 97' ' ' LEU . 85.3 p -67.16 -27.16 67.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.72 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.99 -11.09 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.84 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -50.56 -60.01 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.7 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.24 133.86 16.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.567 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 165.66 31.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.376 2.05 . . . . 1.0 111.605 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.6 mt 44.79 -118.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.362 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 56.34 38.63 79.75 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -119.06 150.49 48.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.513 0.197 . . . . 1.0 110.592 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.44 154.44 40.47 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.41 2.073 . . . . 1.0 111.991 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.5 mt -54.39 -27.16 34.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.572 . . . . 1.0 112.068 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -132.43 135.14 45.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.567 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.567 ' HE ' ' NH1' ' A' ' 101' ' ' ARG . 12.3 mmm180 -123.94 147.95 55.51 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.578 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -85.77 144.04 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.631 2.221 . . . . 1.0 112.374 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.423 HG11 HAD2 ' A' ' 203' ' ' CYC . 4.6 t -118.26 130.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 138' ' ' CYS . 16.9 t70 -45.2 135.9 5.22 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.385 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -36.97 -21.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.07 2.513 . . . . 1.0 113.677 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 136' ' ' ASP . 54.1 t -56.21 -60.17 3.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.758 -0.377 . . . . 1.0 111.237 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -71.26 -25.01 62.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.64 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.3 t -60.14 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.668 0.618 . . . . 1.0 112.668 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 144' ' ' LYS . 86.1 t60 -63.18 -39.48 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.368 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.45 ' O ' ' OG ' ' A' ' 145' ' ' SER . 77.6 t80 -45.77 -36.07 4.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.69 -42.48 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.68 -42.45 92.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 97.4 p -64.16 -20.01 65.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.618 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 25.7 mmm -99.98 1.58 42.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.06 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.89 19.45 77.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.54 ' CG2' HH21 ' A' ' 50' ' ' ARG . 86.4 t -109.38 144.22 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.719 0.295 . . . . 1.0 110.275 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.34 -27.47 6.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.974 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 p -152.0 121.9 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.685 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 168' ' ' SER . 13.7 t -131.04 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.82 132.64 53.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.86 139.49 44.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.336 -0.546 . . . . 1.0 112.323 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.6 t -134.09 134.27 22.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -89.49 159.64 5.41 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.381 2.054 . . . . 1.0 113.718 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.1 mt -114.63 113.59 24.55 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.0 ptm -142.09 153.36 44.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.778 0.658 . . . . 1.0 112.778 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -127.85 122.92 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.872 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 17.2 t60 59.65 -118.1 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.133 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 13.5 pt20 -99.65 1.15 43.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -106.02 143.73 33.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.84 126.42 45.94 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -105.47 -35.37 7.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.3 -173.75 27.12 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.654 -1.26 . . . . 1.0 112.353 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.8 tp -138.07 122.5 18.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.449 -0.375 . . . . 1.0 111.657 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 11.3 tp -93.76 144.77 25.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.4 p -151.86 132.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.856 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 151' ' ' SER . 50.9 m -118.36 128.97 55.15 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.435 ' CE1' ' NZ ' ' A' ' 52' ' ' LYS . 48.6 m80 -100.22 126.14 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.647 0.61 . . . . 1.0 112.647 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.8 t60 -119.54 109.98 16.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.37 49.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 32.9 mm-40 -108.84 155.66 40.35 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' ARG . 35.9 Cg_endo -61.44 -92.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.657 2.238 . . . . 1.0 111.8 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 173' ' ' PRO . 11.2 tpp180 58.76 124.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.57 -0.286 . . . . 1.0 110.684 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.58 163.98 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.512 2.141 . . . . 1.0 111.436 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -108.54 152.71 24.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 1.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.1 m -112.45 147.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.18 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -55.15 -37.04 66.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.164 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.28 -54.28 48.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.26 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.77 -33.53 72.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.24 -42.7 91.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.626 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -67.28 -52.5 39.89 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.664 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.3 t -42.08 -43.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.63 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.05 -46.19 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -52.13 -32.78 37.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.058 -1.089 . . . . 1.0 108.058 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 190' ' ' GLN . 22.8 tp -74.66 -55.97 5.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.088 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -52.03 -45.86 64.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.98 74.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.53 -37.93 82.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 186' ' ' LEU . 49.1 tp60 -64.96 -33.07 75.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.99 -46.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.2 p -51.99 -35.15 45.63 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 mt -68.94 -35.03 67.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.265 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.57 -41.69 75.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.914 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.426 ' CG2' HH12 ' A' ' 55' ' ' ARG . 65.7 mt -56.71 -45.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.38 58.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.367 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -61.73 -44.31 97.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.266 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.74 70.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 1.0 111.419 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.22 -43.43 82.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.181 0.438 . . . . 1.0 112.181 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.424 ' H ' ' CD1' ' A' ' 200' ' ' LEU . 8.7 mp -52.53 -33.26 44.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.984 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.1 -58.76 5.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.691 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.413 ' C ' ' CD2' ' A' ' 202' ' ' LEU . 2.7 tt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.459 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.423 HAD2 HG11 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.808 0.337 . . . . 1.0 110.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.3 t0 -70.11 -33.2 71.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.55 -48.49 19.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.834 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.0 mt -54.93 -53.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 1.0 110.924 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.537 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.7 mt -55.72 -31.41 62.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.96 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -62.84 -39.54 94.67 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.383 -0.527 . . . . 1.0 109.822 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.08 -32.74 69.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.762 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 74.9 p -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.272 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' N ' ' HG1' ' A' ' 38' ' ' THR . 2.3 p -73.75 -25.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.211 0.448 . . . . 1.0 112.211 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.44 -44.72 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.287 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.91 -37.85 72.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.751 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.2 t -57.11 -54.25 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.596 -0.274 . . . . 1.0 111.394 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 47' ' ' GLY . 69.9 ttt-85 -52.3 -45.56 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 1.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.45 -44.63 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.257 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -65.4 -39.01 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.795 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.92 -14.69 21.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.68 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.71 25.68 22.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.596 -1.001 . . . . 1.0 110.596 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.466 ' OG1' ' CD2' ' A' ' 170' ' ' HIS . 14.2 t -78.87 147.44 33.14 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -52.91 -41.61 64.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.583 ' HE ' ' CD ' ' A' ' 67' ' ' GLU . 65.0 ttt-85 -152.67 133.44 13.95 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.759 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -141.45 132.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.912 -1.04 . . . . 1.0 108.648 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.65 ' NZ ' HBB3 ' A' ' 203' ' ' CYC . 41.5 pttt -137.82 153.59 49.61 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.682 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.4 t -98.33 141.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 11.5 t80 -131.77 133.56 44.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.483 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -113.81 152.56 30.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 1.0 111.166 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.42 134.92 45.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.769 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 61' ' ' HIS . 19.7 m-20 -99.25 154.24 37.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -38.35 -52.19 1.98 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 122.952 2.435 . . . . 1.0 114.549 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' OE2' ' CD2' ' A' ' 61' ' ' HIS . 22.2 pt-20 -70.69 -6.56 38.15 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.71 -6.76 38.31 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.656 -0.783 . . . . 1.0 111.862 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-70 -77.21 149.14 35.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.42 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -135.52 159.54 24.17 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -133.42 155.15 50.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 1.0 111.527 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.19 110.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.425 ' CG1' ' OD1' ' A' ' 32' ' ' ASP . 14.4 t -111.95 -3.99 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.127 0.417 . . . . 1.0 112.127 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.59 124.74 8.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.287 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 65.3 tt0 -153.29 138.46 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.176 0.512 . . . . 1.0 111.689 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.53 138.13 52.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -133.46 147.34 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.989 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -105.98 140.83 15.29 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.578 -1.009 . . . . 1.0 110.578 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 36.08 36.84 0.15 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 42.64 19.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 1.0 110.353 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' GLY . 31.9 ttm180 -55.36 -40.13 70.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.036 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.71 113.71 55.26 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -49.38 161.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.518 2.146 . . . . 1.0 112.148 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p -84.69 129.53 34.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.331 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.79 9.05 29.06 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.01 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.46 131.5 48.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -3.97 86.6 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.88 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.49 147.12 27.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.342 -0.543 . . . . 1.0 110.466 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -104.16 129.83 51.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.54 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.721 ' CD1' HAB1 ' A' ' 203' ' ' CYC . 30.5 m-85 -106.17 105.64 54.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.269 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.3 139.35 4.27 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.485 2.123 . . . . 1.0 111.524 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -63.18 -28.21 69.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.817 0.342 . . . . 1.0 110.413 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.91 -17.52 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 24.4 p-10 -68.16 -14.43 62.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.61 0.243 . . . . 1.0 110.996 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.429 HG12 ' HNE' ' A' ' 203' ' ' CYC . 31.8 mt -129.02 133.68 25.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.481 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD3' ' HD ' ' A' ' 203' ' ' CYC . 94.8 Cg_endo -74.16 -102.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.551 2.167 . . . . 1.0 111.639 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -157.84 -43.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.003 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -57.91 -40.34 80.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.636 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -40.65 57.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.679 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 69.3 ttt180 -62.32 -38.35 89.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -62.56 -34.13 76.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.965 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -63.99 -33.37 75.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.593 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -68.92 -33.72 74.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.8 mtm180 -78.07 -30.03 49.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.122 -0.945 . . . . 1.0 111.249 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.409 ' C ' HE22 ' A' ' 99' ' ' GLN . 37.5 mt -95.69 -38.93 10.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.67 -12.6 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.508 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.2 mp0 46.57 49.02 13.97 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 t -152.22 110.86 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -165.41 138.34 4.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.933 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.45 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.4 p -154.11 157.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.709 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.45 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 2.9 mp -111.94 129.85 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.203 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.33 170.84 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.924 0.712 . . . . 1.0 112.924 -176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -49.21 114.57 1.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.234 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.2 t -51.19 -19.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.686 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -81.18 -37.31 28.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -17.48 19.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 1.0 110.414 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.411 HE21 ' NH2' ' A' ' 111' ' ' ARG . 49.5 tt0 56.56 61.16 2.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.829 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 m -95.2 125.75 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.411 ' NH2' HE21 ' A' ' 109' ' ' GLN . 92.4 mtt180 -118.95 143.98 46.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.65 0.981 . . . . 1.0 113.65 -176.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.3 p -110.54 149.4 30.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.641 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.4 mt -146.9 150.88 14.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.437 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.1 m -89.86 171.9 9.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -119.32 147.64 43.6 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.889 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -35.87 -54.97 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.657 2.238 . . . . 1.0 112.237 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.11 146.98 32.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.62 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.4 t -134.83 142.36 46.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.501 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.442 ' CD1' ' N ' ' A' ' 120' ' ' GLY . 2.2 t90 -155.34 -139.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.706 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -161.47 -171.87 28.08 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 121' ' ' LEU . 10.0 mp 54.93 4.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 1.0 110.608 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 120' ' ' GLY . 19.6 t -66.75 -27.52 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.748 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' A' ' 125' ' ' VAL . . . -68.63 -21.49 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.75 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -46.75 -19.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.714 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.421 ' N ' ' C ' ' A' ' 123' ' ' ALA . 8.0 p -62.69 131.14 94.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.612 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.26 120.07 3.99 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.469 2.113 . . . . 1.0 111.563 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.425 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 6.3 tp 43.57 -123.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.015 -0.274 . . . . 1.0 110.391 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . 73.85 36.78 52.05 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -143.46 157.24 59.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.504 0.193 . . . . 1.0 110.608 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 132' ' ' GLN . 60.9 Cg_endo -69.27 170.14 16.66 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.443 2.095 . . . . 1.0 112.019 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.89 3.06 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 1.0 112.014 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 130' ' ' PRO . 41.2 mm-40 -136.78 164.97 27.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.508 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -136.38 122.44 13.67 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.7 139.24 8.69 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.635 2.223 . . . . 1.0 112.365 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.587 ' CG1' HAD2 ' A' ' 203' ' ' CYC . 2.9 t -116.26 127.43 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.63 ' OD2' HMD1 ' A' ' 203' ' ' CYC . 0.8 OUTLIER -45.27 144.98 2.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.74 0.305 . . . . 1.0 111.347 -178.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -38.28 -18.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.123 2.549 . . . . 1.0 113.658 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 136' ' ' ASP . 34.6 t -56.98 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.259 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' NE2' HMA1 ' A' ' 203' ' ' CYC . 0.8 OUTLIER -71.71 -26.01 62.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.659 179.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.3 t -56.43 -63.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 142' ' ' TYR . 12.8 p-80 -66.84 -40.88 88.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.386 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.627 ' N ' ' CD2' ' A' ' 141' ' ' HIS . 71.1 t80 -44.3 -39.46 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.6 -41.69 62.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.185 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.25 -43.38 92.42 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -63.34 -21.35 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.618 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.4 mmm -99.14 0.35 43.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.149 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.22 17.46 79.98 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.599 -1.001 . . . . 1.0 110.599 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.73 145.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 1.0 110.289 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.14 -20.75 7.89 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.055 0.391 . . . . 1.0 112.055 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 120.07 4.76 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.778 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -124.96 132.49 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.915 0.388 . . . . 1.0 111.412 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -98.73 127.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.0 108.49 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.279 -0.568 . . . . 1.0 112.266 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.63 135.18 20.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -92.28 166.05 2.98 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.408 2.072 . . . . 1.0 113.737 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.39 116.48 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 24.0 ptm -141.58 151.83 43.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.621 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 32.7 t-80 -124.1 123.59 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.948 -1.024 . . . . 1.0 108.824 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.621 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 45.0 m-70 56.72 -118.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.12 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -98.06 0.58 46.45 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.848 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.467 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.23 143.25 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -176.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.4 tp -99.23 125.71 44.89 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.542 -1.281 . . . . 1.0 107.542 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.467 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 61.7 m95 -104.96 -35.25 7.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.538 0.94 . . . . 1.0 113.538 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.58 -173.58 25.26 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.401 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.7 tp -139.51 120.96 15.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.473 -0.363 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -93.63 150.48 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.4 p -155.73 133.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.028 -0.669 . . . . 1.0 111.869 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -115.03 136.03 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 9.7 m80 -108.73 123.44 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.466 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 54.2 m80 -117.06 125.22 50.98 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.19 -16.63 57.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.817 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -134.54 152.37 77.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.911 -0.316 . . . . 1.0 110.608 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -42.79 127.51 4.74 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.646 2.231 . . . . 1.0 111.88 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -149.81 77.52 8.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.932 -0.307 . . . . 1.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.97 151.65 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.495 2.13 . . . . 1.0 111.416 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -105.57 148.14 27.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.869 -0.333 . . . . 1.0 110.803 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.493 ' HG ' ' N ' ' A' ' 178' ' ' GLN . 34.1 t -92.97 157.72 16.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.151 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.493 ' N ' ' HG ' ' A' ' 177' ' ' SER . 99.2 mm-40 -53.61 -37.36 62.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.14 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -73.43 -43.12 61.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.288 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.41 -28.99 64.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.998 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.61 -46.91 86.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.614 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 13.1 pt20 -80.18 -47.07 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.667 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.436 ' N ' ' CG ' ' A' ' 182' ' ' GLN . 43.1 t -42.86 -45.58 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.644 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 185' ' ' GLN . 34.1 m -74.41 -47.34 40.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.403 ' N ' ' CG2' ' A' ' 184' ' ' VAL . 40.5 tp60 -49.54 -32.06 11.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.123 -1.066 . . . . 1.0 108.123 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 190' ' ' GLN . 13.8 tp -73.89 -52.11 14.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.034 -0.984 . . . . 1.0 109.098 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.86 -47.51 67.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.62 83.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.429 -0.952 . . . . 1.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.415 ' O ' ' OG ' ' A' ' 192' ' ' SER . 65.0 t0 -62.41 -41.73 98.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 186' ' ' LEU . 59.1 tp60 -61.66 -31.3 71.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.84 -44.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 24.2 p -51.67 -35.8 43.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.51 -37.19 79.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.161 -0.927 . . . . 1.0 110.276 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.22 -41.78 80.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.2 mt -56.83 -46.3 83.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -65.94 -49.55 67.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.394 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.46 -45.36 93.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.216 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.19 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.362 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -58.26 -44.13 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.219 0.451 . . . . 1.0 112.219 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.93 -32.85 54.99 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.996 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 m -51.87 -57.03 10.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.614 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.096 -0.954 . . . . 1.0 110.441 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.721 HAB1 ' CD1' ' A' ' 82' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.713 0.292 . . . . 1.0 110.484 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -48.93 -35.72 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 26.4 mp0 -74.49 -50.7 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.783 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.28 -50.56 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 1.0 110.94 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.485 ' O ' ' OG1' ' A' ' 38' ' ' THR . 30.5 mt -54.78 -29.7 54.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.95 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -64.37 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 109.754 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.57 -32.86 68.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.835 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 70.5 p -66.46 -36.97 84.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.333 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -73.65 -24.48 20.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -45.99 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.308 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -68.55 -38.62 80.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.739 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.9 t -54.78 -55.14 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.296 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -50.11 -43.87 51.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.693 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.54 77.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.269 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.52 -40.72 97.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.753 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -96.92 -14.8 21.52 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.65 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.62 25.8 22.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 p -79.65 149.43 31.27 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 3.0 p30 -53.6 -38.98 64.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 ttt180 -154.51 135.29 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.609 -0.836 . . . . 1.0 112.891 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.0 p -141.81 132.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.01 -0.995 . . . . 1.0 108.783 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CE ' HAB2 ' A' ' 203' ' ' CYC . 13.5 pttp -138.25 153.03 49.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.615 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.5 t -98.58 139.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -128.21 131.0 48.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 1.0 110.391 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -109.68 149.13 30.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.41 . . . . 1.0 111.22 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.88 135.76 42.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 61' ' ' HIS . 24.2 m-20 -101.03 153.55 37.67 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -38.85 -51.02 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.06 2.507 . . . . 1.0 114.514 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.41 -5.74 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.199 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.77 -8.84 43.51 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.661 -0.78 . . . . 1.0 111.946 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.567 ' O ' ' N ' ' A' ' 57' ' ' ASP . 73.6 m80 -78.83 151.64 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.34 165.09 25.83 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.1 p -136.95 159.61 41.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 1.0 111.455 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 t -87.8 105.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.68 -6.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.86 122.6 6.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.278 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 81.7 tt0 -150.47 138.06 19.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.122 0.487 . . . . 1.0 111.686 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.61 132.07 51.35 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 44.6 ptt85 -114.17 142.88 45.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.042 -177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.06 67.13 2.09 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 83.77 161.11 31.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.033 -0.827 . . . . 1.0 111.033 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.86 4.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.87 0.367 . . . . 1.0 110.323 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.654 ' H ' ' C ' ' A' ' 71' ' ' GLY . 8.6 tpm_? -62.0 -42.07 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.52 108.86 33.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.66 167.34 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.132 . . . . 1.0 112.24 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 m -105.1 149.58 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.345 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.523 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 21.9 mt -111.23 20.37 17.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.021 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.9 tp -64.8 130.67 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.17 88.11 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.861 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.55 149.57 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.325 0.563 . . . . 1.0 110.484 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.5 m -108.46 136.63 47.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.655 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.78 148.67 39.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.256 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.25 138.49 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.494 2.129 . . . . 1.0 111.474 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.915 0.388 . . . . 1.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.87 -16.27 0.2 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 84' ' ' ALA . 93.0 m-20 -70.35 -20.56 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.596 0.236 . . . . 1.0 111.004 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 88' ' ' PRO . 2.2 mt -125.01 95.65 41.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.516 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.0 Cg_exo -44.77 -114.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.521 2.147 . . . . 1.0 111.694 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 56.5 mp0 -147.11 -58.88 0.27 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.936 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -45.72 -42.71 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.681 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.97 -40.09 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.683 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 70.1 ttp85 -62.24 -34.46 76.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.808 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -62.81 -34.58 77.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.914 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.646 ' CD1' HH22 ' A' ' 101' ' ' ARG . 93.3 mt -63.66 -33.6 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.524 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 76.4 m-85 -67.97 -34.06 75.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 36.1 mtp180 -75.33 -31.8 60.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.262 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.465 ' C ' HE22 ' A' ' 99' ' ' GLN . 91.8 mt -97.79 -36.8 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.753 1.02 . . . . 1.0 113.753 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.31 -17.49 8.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.258 1.207 . . . . 1.0 114.258 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.631 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.7 OUTLIER 48.38 55.72 8.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.98 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.7 t -153.3 109.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.891 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.646 HH22 ' CD1' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -161.88 131.87 4.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.921 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 103' ' ' ILE . 54.0 t -146.53 155.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.665 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.406 ' N ' ' CG1' ' A' ' 102' ' ' VAL . 57.6 mt -112.47 128.53 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.268 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.09 170.53 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.052 0.76 . . . . 1.0 113.052 -176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -51.2 115.05 1.38 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.246 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.07 -19.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.716 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -81.07 -36.41 30.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.79 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.5 -18.34 28.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.137 0.494 . . . . 1.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 57.44 61.49 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.532 -0.758 . . . . 1.0 112.819 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -94.62 125.7 39.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.762 -1.569 . . . . 1.0 106.762 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -118.75 142.93 47.23 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.679 0.992 . . . . 1.0 113.679 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -111.87 150.91 29.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.73 -1.123 . . . . 1.0 108.616 178.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.4 pt -150.83 155.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.411 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.0 p -84.76 163.63 19.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -150.88 158.52 35.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.896 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.22 -13.52 20.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.687 2.258 . . . . 1.0 112.286 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' A' ' 118' ' ' SER . 83.5 tt0 -63.23 -34.54 77.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.616 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 117' ' ' GLU . 8.2 p 62.98 125.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.514 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -98.27 145.63 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.675 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -168.73 -175.11 37.95 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.8 mt 46.72 50.4 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 1.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.2 m -60.06 -31.41 69.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.71 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.22 58.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.4 mmm-85 -49.93 -56.19 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.759 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.2 109.5 10.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.684 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' GLY . 63.8 Cg_endo -83.04 164.94 15.23 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 122.356 2.037 . . . . 1.0 111.505 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.2 mp 44.75 -92.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.458 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 57.36 35.54 72.13 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -139.42 154.06 71.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 1.0 110.639 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.619 ' C ' ' H ' ' A' ' 132' ' ' GLN . 65.6 Cg_exo -41.54 165.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.398 2.066 . . . . 1.0 112.048 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.423 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 3.6 tp -59.92 12.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.036 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.619 ' H ' ' C ' ' A' ' 130' ' ' PRO . 50.7 mm-40 -138.11 156.18 48.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.511 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.565 HH21 ' CZ ' ' A' ' 101' ' ' ARG . 21.0 mmm180 -122.42 113.81 30.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.587 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -84.65 142.92 9.43 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.641 2.227 . . . . 1.0 112.378 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.24 133.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.485 ' HB3' ' SG ' ' A' ' 138' ' ' CYS . 0.3 OUTLIER -42.08 157.6 0.21 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.356 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.13 -24.57 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.124 2.549 . . . . 1.0 113.614 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.541 ' SG ' ' HHD' ' A' ' 203' ' ' CYC . 0.8 OUTLIER -58.02 -58.46 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.246 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.876 ' CG ' ' HD ' ' A' ' 203' ' ' CYC . 0.4 OUTLIER -71.15 -26.76 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.68 -178.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.1 -56.18 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -62.26 -38.95 91.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.303 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -47.53 -36.22 10.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.03 -42.93 62.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -58.31 -43.68 88.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -62.21 -19.3 63.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.683 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.5 mmm -99.34 0.02 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.133 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 18.26 77.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 84.3 t -108.75 143.59 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.738 0.304 . . . . 1.0 110.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.94 -25.39 4.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -152.49 118.68 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.756 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 96.3 p -129.23 144.2 51.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.994 0.426 . . . . 1.0 111.398 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.2 mp -102.69 137.33 41.06 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.76 129.1 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 1.0 112.263 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.3 133.29 20.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.49 162.54 3.58 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.368 2.045 . . . . 1.0 113.736 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.6 mt -117.12 115.03 24.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.0 ptm -141.99 154.74 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 55.9 t60 -128.34 124.78 37.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.021 -0.991 . . . . 1.0 108.871 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 46.2 m-70 59.72 -121.21 1.03 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.117 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -97.94 0.57 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.823 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.535 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -105.46 143.56 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.6 tp -99.71 124.54 45.06 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.535 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.3 m95 -102.92 -31.02 10.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.31 -169.82 26.21 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.448 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.7 mp -140.03 121.74 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 1.0 111.637 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.1 tp -94.67 149.66 21.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 p -157.56 134.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.075 -0.65 . . . . 1.0 111.861 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -114.52 135.76 53.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.267 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -107.82 126.99 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -117.46 122.81 44.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.33 16.69 5.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.797 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -159.21 143.79 11.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.636 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -42.77 139.13 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.668 2.245 . . . . 1.0 111.816 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -173.19 114.16 0.36 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.653 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.05 153.33 21.98 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.56 2.173 . . . . 1.0 111.45 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -108.01 151.32 25.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.812 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 91.4 p -104.12 156.69 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.237 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -54.25 -40.72 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.159 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.35 -43.7 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.249 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.39 -28.96 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 1.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.65 -39.53 73.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.636 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 11.7 pt20 -80.45 -52.87 7.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.92 -0.312 . . . . 1.0 111.682 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' A' ' 182' ' ' GLN . 9.9 p -44.13 -41.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.645 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.432 ' N ' ' CG1' ' A' ' 183' ' ' VAL . 7.6 p -75.1 -49.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.406 ' N ' ' CG1' ' A' ' 184' ' ' VAL . 56.8 tt0 -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.6 tp -71.74 -48.61 45.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.053 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.42 -44.58 62.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.71 91.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -64.09 -39.32 93.8 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -64.53 -31.41 72.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 53.7 t -77.49 -44.58 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.2 m -51.77 -33.6 35.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.78 -34.61 34.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.56 78.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.98 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.1 pt -62.24 -29.82 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.5 -53.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.639 -0.71 . . . . 1.0 110.37 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.54 -42.63 98.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.321 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.8 74.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.352 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.86 -43.11 80.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 tp -51.35 -38.12 51.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.959 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.4 t -47.85 -57.54 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.631 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.496 179.894 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.876 ' HD ' ' CG ' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 1.0 110.517 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -48.07 -36.61 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.764 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -74.09 -50.6 18.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.874 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.47 -45.53 81.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.145 0.498 . . . . 1.0 110.982 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 38' ' ' THR . 29.5 mt -58.07 -28.89 64.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.903 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -68.53 -39.5 81.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.81 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.42 -31.71 69.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.9 p -67.68 -36.93 81.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.371 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.59 -23.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.46 -48.36 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.323 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.34 -35.9 80.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.71 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 70.6 t -58.1 -53.87 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.613 -0.267 . . . . 1.0 111.313 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 47' ' ' GLY . 65.5 ttt-85 -50.21 -43.73 52.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.942 0.401 . . . . 1.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.03 -43.33 70.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.295 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.65 -37.65 87.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.786 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.84 -14.6 21.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.725 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.47 25.68 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.2 p -81.25 152.52 27.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.3 m-20 -48.83 -43.57 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.599 0.592 . . . . 1.0 112.599 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -159.17 146.93 17.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.625 -0.83 . . . . 1.0 112.765 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.13 133.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.703 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HZ1' ' CD1' ' A' ' 77' ' ' LEU . 61.3 mttt -135.77 142.83 44.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.665 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.02 140.94 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.453 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 19.1 m-85 -131.55 136.59 47.96 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.531 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -112.86 153.28 28.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.036 0.446 . . . . 1.0 111.188 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CD1' ' NH2' ' A' ' 92' ' ' ARG . 43.5 m-85 -100.0 141.84 32.28 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -114.2 166.67 11.0 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -41.75 -55.82 2.17 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.055 2.503 . . . . 1.0 114.497 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -67.88 -12.56 60.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.79 0.28 48.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.752 -0.737 . . . . 1.0 111.904 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.509 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 2.4 p80 -74.6 148.79 40.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.466 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.54 144.34 16.98 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -125.12 149.69 47.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.948 0.404 . . . . 1.0 111.57 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -90.19 108.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 t -112.34 -4.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.32 128.17 9.54 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.271 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 24.0 tt0 -160.75 141.92 11.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 1.0 111.662 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.75 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -110.73 138.59 46.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.038 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.02 67.33 3.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.611 -0.995 . . . . 1.0 110.611 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 82.82 162.42 32.02 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.43 3.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.33 . . . . 1.0 110.328 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.611 ' H ' ' C ' ' A' ' 71' ' ' GLY . 8.9 tpm_? -59.14 -42.59 91.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.971 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -117.63 143.08 31.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.63 167.9 23.41 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.475 2.117 . . . . 1.0 112.28 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p -98.42 149.7 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.346 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' CD1' ' HZ1' ' A' ' 52' ' ' LYS . 41.1 mt -116.19 15.99 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.946 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.15 129.18 40.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.8 -2.35 87.17 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.814 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.1 mt -86.0 147.39 26.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.358 0.579 . . . . 1.0 110.458 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -106.02 133.35 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -105.54 148.39 36.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.217 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.98 140.12 12.43 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.487 2.125 . . . . 1.0 111.493 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -62.97 -31.37 72.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.799 0.333 . . . . 1.0 110.434 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.12 -17.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.8 m-20 -63.23 -24.91 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.624 0.249 . . . . 1.0 111.023 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.66 132.55 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.507 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.58 -99.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.535 2.157 . . . . 1.0 111.672 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -159.25 -47.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.956 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -52.0 -40.99 61.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.621 ' CB ' HH22 ' A' ' 101' ' ' ARG . . . -74.89 -38.32 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.712 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.451 ' NH2' ' CD1' ' A' ' 56' ' ' PHE . 72.4 ttt180 -61.08 -32.36 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.798 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.07 -36.43 83.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.933 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.78 -36.27 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.532 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -67.96 -37.1 81.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -75.54 -30.23 59.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.162 -0.927 . . . . 1.0 111.26 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.52 ' C ' HE22 ' A' ' 99' ' ' GLN . 95.9 mt -96.98 -38.63 9.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.94 -14.47 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.564 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.0 mp0 48.8 51.37 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.902 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.8 t -153.17 109.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.911 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.621 HH22 ' CB ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -164.02 135.91 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.873 178.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -151.58 156.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.684 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.511 HD11 HMA1 ' A' ' 203' ' ' CYC . 87.7 mt -110.56 130.69 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.265 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 m -85.94 169.66 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.921 0.711 . . . . 1.0 112.921 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.457 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 64.6 m-20 -48.19 116.01 1.4 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.902 -1.044 . . . . 1.0 112.236 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.5 -18.85 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.666 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 109' ' ' GLN . 43.4 tp10 -78.7 -38.83 38.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.821 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.569 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -61.33 -5.91 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.501 . . . . 1.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.569 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 11.6 pt20 46.23 63.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 1.0 112.83 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.5 m -91.24 126.96 36.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.77 -1.567 . . . . 1.0 106.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -118.34 144.48 45.84 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -111.71 149.87 31.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.695 -1.139 . . . . 1.0 108.654 178.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -150.52 154.61 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.435 -0.506 . . . . 1.0 111.418 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -87.16 167.21 14.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -147.52 153.26 43.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.968 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.12 -5.04 15.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.69 2.26 . . . . 1.0 112.208 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.1 160.82 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.633 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.8 p -51.7 166.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.562 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -58.42 146.06 36.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.685 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.91 -27.07 49.72 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.5 tp 57.93 71.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 1.0 110.653 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.5 m -59.75 -29.85 68.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.73 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.1 -33.25 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.779 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' CG ' ' H ' ' A' ' 125' ' ' VAL . 18.0 ttp180 -64.67 -143.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.68 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.438 ' H ' ' CG ' ' A' ' 124' ' ' ARG . 22.0 t -60.05 133.84 90.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.82 141.76 37.92 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.359 2.039 . . . . 1.0 111.569 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.7 -112.71 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.419 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.52 30.0 57.15 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.144 -0.783 . . . . 1.0 111.144 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -131.31 150.61 76.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 122.828 -0.219 . . . . 1.0 110.639 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.619 ' C ' ' H ' ' A' ' 132' ' ' GLN . 71.0 Cg_exo -42.62 162.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.421 2.081 . . . . 1.0 111.985 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.41 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 55.9 mt -54.59 3.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 1.0 112.086 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.619 ' H ' ' C ' ' A' ' 130' ' ' PRO . 38.9 mm-40 -137.49 143.36 41.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.467 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -117.83 82.77 17.21 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.538 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.81 142.64 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.704 2.269 . . . . 1.0 112.36 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.69 128.92 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 112' ' ' SER . 21.3 t70 -44.2 135.87 4.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.307 . . . . 1.0 111.345 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -37.41 -23.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.132 2.555 . . . . 1.0 113.645 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 136' ' ' ASP . 36.3 t -55.66 -61.3 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.263 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.775 ' CE1' HBC2 ' A' ' 203' ' ' CYC . 0.4 OUTLIER -71.94 -24.04 61.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.658 -178.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.6 t -57.97 -61.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.551 0.574 . . . . 1.0 112.551 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.592 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 23.2 p80 -60.79 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.391 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.592 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 83.1 t80 -47.44 -39.75 16.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.4 mt -72.06 -43.44 64.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.64 -43.03 79.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.5 m -61.7 -20.12 63.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.709 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.8 mmm -98.48 -1.16 41.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.074 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.53 19.32 76.38 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 65.7 t -107.56 142.49 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.297 . . . . 1.0 110.242 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.64 -35.17 3.6 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.457 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 22.8 m -143.2 121.17 12.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.766 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 m -129.81 142.11 50.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 1.0 111.378 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -102.76 136.24 42.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.14 128.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.331 -0.548 . . . . 1.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.22 128.97 19.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.255 -1.016 . . . . 1.0 108.255 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -92.6 164.21 2.85 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.4 2.067 . . . . 1.0 113.704 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.9 113.68 22.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.567 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.6 ptm -140.7 152.47 45.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.107 -0.637 . . . . 1.0 112.718 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 53.6 t60 -126.19 123.99 39.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.829 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 56.8 m-70 58.54 -120.73 1.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.182 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -97.42 1.51 49.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.787 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.01 143.44 34.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.403 HD21 ' HE ' ' A' ' 92' ' ' ARG . 39.4 tp -99.31 124.94 44.82 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 66.3 m95 -103.91 -35.31 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -156.87 -174.59 26.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 119.684 -1.246 . . . . 1.0 112.375 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.7 tp -138.42 121.2 16.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.3 tp -93.69 142.57 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.1 p -149.41 131.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.815 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.8 t -116.46 130.66 56.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.197 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -106.21 129.33 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 19.1 t-80 -120.77 117.4 27.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.77 -15.65 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.742 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.419 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 51.1 mm-40 -131.27 141.64 42.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.894 -0.323 . . . . 1.0 110.553 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -41.74 150.07 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.67 2.247 . . . . 1.0 111.896 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -173.38 88.33 0.38 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.712 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.81 153.71 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.497 2.132 . . . . 1.0 111.433 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -110.98 151.55 27.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.3 t -110.29 146.95 34.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.239 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -53.61 -39.28 64.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.124 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.38 -55.83 27.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.318 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -72.1 -36.09 69.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.57 -40.54 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.551 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -67.15 -55.8 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.759 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.3 t -45.73 -40.6 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.626 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.48 -50.76 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -48.43 -36.54 15.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 190' ' ' GLN . 87.1 mt -71.64 -46.52 58.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.075 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 tp -52.13 -46.33 65.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.939 -0.764 . . . . 1.0 108.939 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.95 91.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.377 -0.971 . . . . 1.0 108.377 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.82 -38.11 89.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 186' ' ' LEU . 27.2 mt-30 -66.89 -30.6 70.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.72 -45.89 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -52.25 -37.39 55.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.8 mt -65.47 -34.97 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.162 -0.926 . . . . 1.0 110.291 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.05 78.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.928 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mt -55.24 -50.25 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.96 -50.42 66.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.417 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -61.87 -46.96 87.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.325 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.83 -32.74 74.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.41 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -56.4 -41.63 76.61 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.234 0.457 . . . . 1.0 112.234 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.2 mt -53.77 -34.67 59.78 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.987 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.6 t -44.92 -56.73 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.621 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.418 179.583 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.775 HBC2 ' CE1' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 63.0 t0 -48.82 -34.17 11.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 22.6 mp0 -76.38 -48.44 19.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.826 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.7 mm -56.56 -50.38 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.065 0.459 . . . . 1.0 110.885 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 38' ' ' THR . 47.9 mt -57.38 -30.24 64.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 1.0 111.934 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -65.78 -39.7 91.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.762 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.42 68.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 76.3 p -65.07 -37.85 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.948 -0.569 . . . . 1.0 112.368 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 1.3 p -71.94 -25.57 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.165 0.432 . . . . 1.0 112.165 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -80.78 -35.12 33.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.298 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -77.15 -42.63 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.76 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 8.7 p -63.65 -52.4 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.356 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -52.22 -42.21 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 1.0 110.697 -179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -53.86 -41.28 67.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.317 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.16 -34.68 78.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.764 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -95.86 -14.83 22.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.8 0.333 . . . . 1.0 111.683 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.92 25.31 45.0 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 p -78.17 145.19 35.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.84 -40.27 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.506 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 44.9 ttt180 -150.47 132.46 15.21 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.511 -0.876 . . . . 1.0 112.762 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 7.1 t -138.69 131.54 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.007 -0.997 . . . . 1.0 108.671 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.669 ' NZ ' ' HE2' ' A' ' 169' ' ' HIS . 24.9 pttm -137.17 149.97 47.61 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.722 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.99 141.35 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 16.0 t80 -131.05 132.31 44.84 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.42 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -113.04 153.56 27.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.012 0.434 . . . . 1.0 111.253 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.79 135.59 44.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.1 m-20 -95.09 150.73 38.12 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -41.45 -21.87 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.012 2.474 . . . . 1.0 114.485 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -103.22 4.6 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.565 -0.454 . . . . 1.0 112.155 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.21 -14.35 59.77 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.671 -0.776 . . . . 1.0 111.897 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 57' ' ' ASP . 39.9 m80 -78.13 150.44 33.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.56 164.0 25.73 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -136.35 158.07 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.034 0.445 . . . . 1.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.2 106.54 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -107.92 -5.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.126 0.417 . . . . 1.0 112.126 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.19 123.51 7.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.348 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.506 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 87.1 tt0 -150.87 136.6 18.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 1.0 111.719 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.56 135.85 51.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -119.26 140.06 50.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 1.0 112.044 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.85 4.55 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.413 ' C ' ' N ' ' A' ' 73' ' ' ARG . . . 49.52 36.06 23.39 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.049 -0.821 . . . . 1.0 111.049 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 50.32 16.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.825 0.345 . . . . 1.0 110.385 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' C ' ' A' ' 71' ' ' GLY . 14.5 tpp85 -55.91 -46.4 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.009 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.03 150.19 37.23 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.32 151.18 42.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.454 2.102 . . . . 1.0 112.267 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.9 m -84.35 110.88 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.348 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.69 16.03 11.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.946 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.2 132.68 52.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 -2.94 86.98 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.43 -0.805 . . . . 1.0 112.812 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.5 mt -85.55 150.81 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.372 0.586 . . . . 1.0 110.415 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -109.16 137.63 46.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.622 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -108.99 148.72 38.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.274 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.51 137.02 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.574 2.183 . . . . 1.0 111.442 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.9 -34.75 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.865 0.364 . . . . 1.0 110.445 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.14 -16.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 84' ' ' ALA . 97.5 m-20 -66.39 -22.08 66.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.647 0.261 . . . . 1.0 111.03 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.92 133.36 24.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.529 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.64 -98.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.537 2.158 . . . . 1.0 111.685 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -161.96 -50.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.953 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -46.52 -42.84 16.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.593 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.32 -38.48 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.743 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.57 -32.21 72.29 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.791 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -64.01 -35.31 80.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.915 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.41 -36.04 79.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.534 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 45.3 m-85 -68.25 -35.36 77.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -81.11 -27.77 35.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.166 -0.925 . . . . 1.0 111.269 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.95 -42.04 8.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 -15.0 8.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.243 1.201 . . . . 1.0 114.243 -174.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.65 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.6 OUTLIER 45.57 54.9 7.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.7 -0.8 . . . . 1.0 109.866 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 99' ' ' GLN . 5.9 m -159.68 111.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.857 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.78 ' NE ' ' N ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -170.81 139.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.852 177.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.5 p -146.01 158.36 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.73 -0.668 . . . . 1.0 109.641 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 49.8 mt -110.62 126.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.217 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.449 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 10.0 p -86.53 168.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.449 ' H ' ' CG2' ' A' ' 104' ' ' VAL . 48.7 m-20 -49.0 115.88 1.45 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.283 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 p -51.03 -21.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.675 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -77.94 -38.08 46.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.835 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.58 -16.13 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.185 0.517 . . . . 1.0 110.404 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 56.24 60.93 2.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.482 -0.781 . . . . 1.0 112.824 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.6 m -96.86 126.19 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -117.87 143.92 45.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.436 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -114.45 153.91 29.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.731 -1.122 . . . . 1.0 108.636 177.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 29.0 pt -154.23 158.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.473 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -94.08 173.26 7.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -149.7 151.36 32.71 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.921 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.0 -22.36 10.12 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.603 2.202 . . . . 1.0 112.262 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.31 154.64 19.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 m -58.04 156.39 9.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.502 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -139.65 164.71 29.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.648 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.65 115.41 6.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.2 mt -89.03 148.82 23.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 1.0 110.553 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.8 p -59.56 -27.7 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.687 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.02 -35.31 73.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.742 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -55.46 -60.54 3.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.785 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.94 153.31 60.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.629 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.44 145.78 43.37 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.324 2.016 . . . . 1.0 111.533 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 10.3 mp 51.26 -107.01 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.447 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.23 36.02 92.7 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -134.32 153.86 79.59 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.541 0.21 . . . . 1.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 132' ' ' GLN . 56.0 Cg_endo -66.26 159.89 47.75 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.403 2.069 . . . . 1.0 111.965 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 176' ' ' TYR . 70.3 mt -47.45 -8.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.577 . . . . 1.0 112.092 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' H ' ' C ' ' A' ' 130' ' ' PRO . 5.9 mm100 -131.2 167.38 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.524 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -143.98 91.3 6.59 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.514 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.91 137.84 21.67 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.619 2.213 . . . . 1.0 112.407 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -114.95 128.0 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.58 ' OD1' HMD3 ' A' ' 203' ' ' CYC . 45.9 p-10 -46.53 138.88 6.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.307 . . . . 1.0 111.315 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -39.21 -28.24 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.145 2.563 . . . . 1.0 113.663 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 t -48.94 -64.42 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.587 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 29.6 t60 -71.37 -21.83 61.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.34 -58.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -63.1 -40.11 96.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.424 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.517 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 71.2 t80 -47.59 -38.42 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.82 -43.7 65.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.104 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -56.41 -41.98 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.0 m -62.66 -21.36 65.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.692 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.517 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 50.6 mtp -98.31 -0.74 43.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.488 -0.778 . . . . 1.0 111.06 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.05 19.71 76.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.2 t -107.78 143.44 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.679 0.276 . . . . 1.0 110.367 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.56 -26.86 6.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.968 0.359 . . . . 1.0 111.968 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 32.4 m -150.77 120.29 6.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.766 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p -129.76 141.85 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 1.0 111.402 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.37 130.7 52.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.617 ' O ' ' NE ' ' A' ' 101' ' ' ARG . 10.9 t -113.83 106.36 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.308 -0.557 . . . . 1.0 112.311 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 42.6 t -110.17 135.77 20.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -94.93 167.3 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.299 1.999 . . . . 1.0 113.723 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.1 mt -119.24 116.33 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.7 ptm -141.02 154.78 46.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -127.99 123.39 34.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.942 -1.026 . . . . 1.0 108.865 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.601 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 82.2 t60 60.23 -120.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.363 . . . . 1.0 110.09 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.601 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 28.0 tp60 -98.26 2.03 47.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.816 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.529 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 144.98 31.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.12 123.99 46.13 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.529 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m95 -102.24 -31.65 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.37 -173.73 31.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.453 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.1 mt -135.12 121.44 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 1.0 111.614 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 4.5 tp -94.69 150.82 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 p -157.33 134.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.859 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.9 t -115.6 132.8 56.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.669 ' HE2' ' NZ ' ' A' ' 52' ' ' LYS . 21.4 m80 -101.61 122.66 44.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.6 t60 -117.75 108.7 15.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.42 66.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.751 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.495 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 21.2 mt-10 -104.77 157.82 33.35 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.942 -0.303 . . . . 1.0 110.569 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.48 ' O ' ' O ' ' A' ' 174' ' ' ARG . 59.1 Cg_endo -69.08 -97.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.695 2.264 . . . . 1.0 111.845 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 173' ' ' PRO . 59.9 ttp85 58.71 131.38 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.572 -0.286 . . . . 1.0 110.609 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.47 160.59 28.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.514 2.143 . . . . 1.0 111.416 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.457 ' OH ' ' O ' ' A' ' 131' ' ' LEU . 37.2 p90 -109.3 157.77 18.54 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.401 ' HG ' ' H ' ' A' ' 180' ' ' GLU . 96.0 p -110.27 147.4 33.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.16 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.19 -34.69 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.122 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.89 -47.76 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.209 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.401 ' H ' ' HG ' ' A' ' 177' ' ' SER . 97.1 mt-10 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 1.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.83 -35.77 75.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.619 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -81.11 -55.4 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.618 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.3 p -44.16 -41.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.419 . . . . 1.0 110.659 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 187' ' ' LEU . 7.4 p -73.96 -48.39 38.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.405 ' N ' ' CG1' ' A' ' 184' ' ' VAL . 62.3 tt0 -46.62 -32.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.106 -1.072 . . . . 1.0 108.106 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 190' ' ' GLN . 7.9 tp -68.84 -47.37 66.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.108 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 184' ' ' VAL . 95.5 mt -53.97 -46.43 71.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.88 86.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 192' ' ' SER . 71.9 m-20 -63.27 -42.35 99.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 186' ' ' LEU . 61.3 tt0 -60.66 -31.3 70.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.43 -44.13 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 26.5 p -52.42 -36.55 54.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.815 -0.809 . . . . 1.0 108.815 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.06 -37.78 80.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.197 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.81 83.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.0 mt -55.15 -50.41 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.93 -50.35 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.411 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.6 -47.07 87.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.282 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.459 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -67.21 -32.67 73.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.39 -178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -56.14 -40.57 74.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 tp -52.5 -35.44 52.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.528 ' HG ' ' H ' ' A' ' 202' ' ' LEU . 96.8 p -53.11 -58.71 6.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.615 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 201' ' ' SER . 20.6 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.058 -0.973 . . . . 1.0 110.397 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.587 HMA2 ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.82 0.343 . . . . 1.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.51 -33.03 68.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -77.51 -48.17 17.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.788 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -56.16 -51.2 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.056 0.455 . . . . 1.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.492 ' O ' ' OG1' ' A' ' 38' ' ' THR . 71.0 mt -58.34 -30.88 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.986 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 39' ' ' VAL . 41.2 mtp180 -67.73 -39.36 84.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.408 -0.517 . . . . 1.0 109.732 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.469 ' O ' ' OE1' ' A' ' 41' ' ' GLU . . . -70.39 -33.24 71.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.769 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 42' ' ' VAL . 53.4 p -63.65 -37.15 86.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.305 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.545 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -74.27 -23.34 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.4 -51.71 33.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.341 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 18.1 mp0 -69.7 -34.94 74.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.745 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' THR . 53.5 t -58.74 -55.35 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.337 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.3 tmm_? -53.9 -43.65 69.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 1.0 110.669 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.63 -43.41 72.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.321 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -65.41 -37.28 86.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.8 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 mt -96.65 -15.06 21.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.763 0.316 . . . . 1.0 111.697 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.85 25.04 35.84 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.505 -1.038 . . . . 1.0 110.505 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 87.6 m -78.36 146.07 34.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.8 m-20 -52.17 -41.98 63.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 67' ' ' GLU . 49.4 ttt180 -152.45 132.29 13.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.549 -0.86 . . . . 1.0 112.802 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 t -136.76 131.64 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 1.0 108.702 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.88 151.74 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.628 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.6 t -98.85 140.36 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 13.7 t80 -129.13 132.57 47.38 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.431 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.993 0.425 . . . . 1.0 111.206 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.9 t80 -100.47 128.49 46.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.696 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' OD2' ' CD2' ' A' ' 61' ' ' HIS . 40.9 m-20 -97.75 151.97 37.88 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.93 -22.45 30.43 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.029 2.486 . . . . 1.0 114.488 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HB2' ' ND1' ' A' ' 61' ' ' HIS . 96.2 mt-10 -91.16 -3.51 56.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 84' ' ' ALA . . . 106.07 -19.59 37.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.67 -0.776 . . . . 1.0 111.901 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 57.2 p-80 -80.49 151.45 29.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.404 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.45 162.85 26.14 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -134.57 154.99 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.015 0.436 . . . . 1.0 111.504 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 t -90.9 113.42 26.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.338 -0.986 . . . . 1.0 108.338 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 65' ' ' VAL . 11.3 t -112.28 -3.33 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -151.92 125.92 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.31 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 50' ' ' ARG . 79.1 tt0 -155.34 138.69 15.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 1.0 111.676 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.28 138.95 53.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -113.28 136.48 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.019 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.781 0.324 . . . . 1.0 111.35 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.492 HD12 HH22 ' A' ' 50' ' ' ARG . 17.6 mt -96.93 10.86 37.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.978 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.424 HD21 ' CB ' ' A' ' 67' ' ' GLU . 88.0 mt -55.93 129.16 38.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -4.04 86.54 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.847 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.79 147.36 27.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.3 0.55 . . . . 1.0 110.422 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.3 m -107.52 135.81 48.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.611 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.45 112.92 62.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.248 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.08 137.95 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.561 2.174 . . . . 1.0 111.464 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' A' ' 60' ' ' GLY . . . -60.52 -37.6 81.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 1.0 110.432 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.06 -16.33 0.47 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 84' ' ' ALA . 86.9 m-20 -71.76 -23.22 61.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.687 0.28 . . . . 1.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' PRO . 44.7 mt -116.83 101.57 53.44 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.542 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 87' ' ' ILE . 76.9 Cg_exo -45.63 -115.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.575 2.183 . . . . 1.0 111.653 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -157.0 -51.68 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.93 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -49.53 -39.97 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.608 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.85 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.669 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -63.8 -33.9 76.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.819 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.69 -37.15 86.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.947 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.44 -36.65 83.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.484 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -66.85 -35.0 79.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -77.24 -31.15 54.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.284 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.55 -38.99 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.58 -13.12 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.651 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER 47.71 56.7 6.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.669 -0.813 . . . . 1.0 109.926 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.5 m -159.09 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.875 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -165.57 133.88 3.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.888 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 103' ' ' ILE . 78.2 t -145.68 156.3 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.703 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.513 ' CD1' ' NE2' ' A' ' 139' ' ' HIS . 62.4 mt -112.5 127.73 69.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.265 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.1 m -86.96 170.62 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -49.53 114.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.906 -1.043 . . . . 1.0 112.249 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG22 HG13 ' A' ' 140' ' ' VAL . 52.9 t -53.25 -21.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.512 -0.767 . . . . 1.0 110.674 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -80.36 -37.86 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.2 -14.55 2.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.18 0.514 . . . . 1.0 110.453 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 57.32 59.96 3.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.849 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 t -94.97 124.94 39.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -119.72 143.73 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.5 153.74 28.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.764 -1.107 . . . . 1.0 108.668 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.325 -0.484 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.468 -178.909 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.491 1.375 0 CA-C-O 120.835 0.264 . . . . 1.0 112.348 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.477 HG11 HG12 ' A' ' 103' ' ' ILE . 2.4 m -119.81 132.89 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -41.68 160.86 0.15 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.401 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.11 -23.67 45.66 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.159 2.573 . . . . 1.0 113.666 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.576 ' H ' ' CG ' ' A' ' 136' ' ' ASP . 7.3 t -58.89 -58.76 7.22 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 1.0 111.298 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.53 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 2.1 t60 -68.38 -27.23 66.06 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.616 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 136' ' ' ASP . 43.7 t -62.25 -56.95 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.608 0.595 . . . . 1.0 112.608 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -62.23 -38.78 90.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.376 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.428 ' O ' ' OG ' ' A' ' 145' ' ' SER . 74.8 t80 -47.9 -36.58 12.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 139' ' ' HIS . 49.9 mt -73.64 -42.73 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -58.24 -44.84 88.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 83.7 p -61.9 -17.73 57.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.687 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.3 mmm -100.48 -0.02 38.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 1.0 111.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.38 18.9 77.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.538 -1.025 . . . . 1.0 110.538 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.29 142.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.696 0.284 . . . . 1.0 110.298 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.2 -26.73 5.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 p -153.78 121.35 5.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.701 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 m -126.77 138.66 53.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 1.0 111.385 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.99 134.27 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.1 t -113.96 127.76 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.332 -0.547 . . . . 1.0 112.291 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.65 126.18 17.91 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -90.51 161.42 4.41 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.351 2.034 . . . . 1.0 113.704 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.506 HD23 ' HB1' ' A' ' 188' ' ' ALA . 24.6 mt -114.34 114.78 26.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.435 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 23.4 ptm -141.9 150.56 41.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.489 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 40.7 t60 -125.7 126.29 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.809 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.489 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 38.4 m80 58.34 -122.47 1.35 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.105 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.56 2.72 50.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.811 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.527 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.2 tt0 -106.22 145.97 30.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.755 1.02 . . . . 1.0 113.755 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 44.9 tp -101.26 123.8 45.94 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.527 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.7 m95 -101.87 -32.08 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -176.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.88 -167.75 22.77 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.719 -1.229 . . . . 1.0 112.398 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -143.7 122.94 12.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.417 -0.392 . . . . 1.0 111.664 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.487 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.4 tp -94.76 150.5 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.3 p -156.31 133.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.822 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 87.9 p -113.24 139.73 48.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.249 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.471 ' O ' ' CG2' ' A' ' 48' ' ' THR . 18.1 m80 -111.92 124.38 52.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -117.44 116.88 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.09 -15.33 62.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.747 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 . . . . . 0 C--N 1.326 -0.417 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.611 179.817 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.65 0.262 . . . . 1.0 111.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.7 -33.57 74.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.937 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.27 -45.57 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.633 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.33 -55.31 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.724 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.1 t -45.37 -39.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.638 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -74.56 -49.37 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -48.54 -36.59 15.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 190' ' ' GLN . 21.6 tp -70.69 -46.39 63.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.082 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.05 -46.83 75.38 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.506 ' HB1' HD23 ' A' ' 156' ' ' LEU . . . -58.43 -48.23 81.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.22 -36.66 75.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 186' ' ' LEU . 56.6 tt0 -68.61 -32.41 72.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.47 -48.54 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.342 -0.985 . . . . 1.0 108.342 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.4 p -50.12 -31.6 13.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mt -74.65 -34.9 35.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.27 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -43.71 79.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.95 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 196' ' ' ALA . 31.7 pt -63.17 -30.77 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -72.79 -50.12 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.411 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.8 -40.79 95.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.275 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -67.51 -31.39 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.385 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -57.78 -43.39 85.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.93 -36.17 48.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.965 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 83.1 p -52.17 -57.49 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.647 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.486 179.414 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.835 0.35 . . . . 1.0 110.546 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 66.6 t0 -48.06 -36.05 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -74.4 -49.95 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.808 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' THR . 96.3 mt -56.7 -44.98 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.022 0.439 . . . . 1.0 110.92 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.48 ' O ' ' OG1' ' A' ' 38' ' ' THR . 45.2 mt -58.4 -30.7 67.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.98 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 39' ' ' VAL . 54.3 mtp180 -66.81 -38.35 86.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.78 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.76 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 42' ' ' VAL . 76.9 p -68.67 -36.65 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.273 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -74.34 -23.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -72.76 -48.48 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.305 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.76 -34.96 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.742 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 38' ' ' THR . 77.7 t -59.98 -54.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.609 -0.269 . . . . 1.0 111.287 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.6 ttp180 -51.45 -43.43 62.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 1.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.17 -42.49 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.254 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.4 -37.19 86.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.793 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.2 mt -97.13 -13.93 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.864 -0.335 . . . . 1.0 111.701 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.65 25.59 22.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.6 p -81.29 152.21 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -48.71 -42.93 36.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.534 HH21 ' CG2' ' A' ' 148' ' ' VAL . 36.1 ptt180 -160.17 146.25 15.52 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.568 -0.853 . . . . 1.0 112.782 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 20.2 t -137.44 133.92 46.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.957 -1.019 . . . . 1.0 108.675 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HZ2' HD12 ' A' ' 77' ' ' LEU . 17.7 mttt -135.91 144.62 45.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.604 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 166' ' ' LEU . 48.9 t -99.43 141.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 18.1 t80 -129.78 130.62 45.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.509 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -111.86 154.11 25.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 1.0 111.239 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.66 136.89 40.73 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.661 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -97.17 150.94 37.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -41.54 -22.03 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.962 2.441 . . . . 1.0 114.468 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -103.85 9.0 37.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.185 0.439 . . . . 1.0 112.185 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 96.03 -15.81 62.29 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.598 -0.81 . . . . 1.0 111.966 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.585 ' O ' ' N ' ' A' ' 57' ' ' ASP . 35.6 m80 -77.52 151.27 34.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.78 163.56 25.54 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 p -135.63 158.85 43.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 1.0 111.495 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 104.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.78 -4.75 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -154.0 125.68 7.63 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.652 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 75.1 tt0 -154.45 138.99 16.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.158 0.504 . . . . 1.0 111.684 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.7 131.41 51.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.562 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 34.8 ptt180 -109.03 140.2 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.02 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 178.97 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.77 0.319 . . . . 1.0 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 35.0 mt -103.98 18.09 22.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.968 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 24.5 tp -65.21 131.03 45.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.6 88.77 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.843 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.78 151.01 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.352 0.576 . . . . 1.0 110.461 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 81' ' ' THR . 14.4 t -104.41 128.99 52.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -106.69 107.3 60.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.286 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -43.37 138.89 4.66 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.592 2.195 . . . . 1.0 111.522 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -61.55 -29.29 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.21 -17.71 0.24 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' N ' ' C ' ' A' ' 84' ' ' ALA . 89.2 m-20 -67.52 -16.55 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.665 0.269 . . . . 1.0 111.032 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' PRO . 16.1 mt -134.55 99.47 12.97 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.53 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 40.9 Cg_exo -39.6 -97.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.521 2.147 . . . . 1.0 111.704 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 22.8 pt-20 -165.71 -39.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.003 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -56.97 -43.35 81.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.625 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.12 -35.66 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.686 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -65.01 -32.23 73.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.806 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -64.6 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.541 ' CB ' ' NH2' ' A' ' 101' ' ' ARG . 10.0 mt -60.18 -38.31 82.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.546 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -66.56 -32.5 73.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.168 -0.679 . . . . 1.0 109.168 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -79.74 -27.53 40.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.172 -0.922 . . . . 1.0 111.305 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.85 -40.43 8.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -119.08 -11.57 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.422 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 1.9 mp0 44.77 64.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.669 -0.812 . . . . 1.0 109.91 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.1 p -168.8 107.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.905 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.542 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -159.15 134.4 8.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.895 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 103' ' ' ILE . 53.7 t -149.01 155.76 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.707 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.438 HG23 HG21 ' A' ' 135' ' ' VAL . 66.2 mt -111.9 129.14 67.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.238 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -87.28 169.58 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.16 115.79 1.58 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.975 -1.011 . . . . 1.0 112.274 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG23 ' CG1' ' A' ' 140' ' ' VAL . 13.4 p -51.24 -22.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.644 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -76.38 -38.83 55.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.822 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.87 19.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.234 0.54 . . . . 1.0 110.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 56.33 62.79 2.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.838 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 m -95.43 125.59 40.15 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.777 -1.564 . . . . 1.0 106.777 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -117.62 145.36 44.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.661 0.985 . . . . 1.0 113.661 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -111.97 148.8 33.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.77 -1.105 . . . . 1.0 108.62 177.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.438 -179.074 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 120.784 0.243 . . . . 1.0 112.422 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.63 125.44 71.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 178.128 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 138' ' ' CYS . 3.5 p30 -45.67 142.55 3.47 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.752 0.31 . . . . 1.0 111.317 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.8 -20.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.15 2.567 . . . . 1.0 113.634 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.5 t -61.59 -62.78 1.57 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.209 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -70.26 -24.61 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.631 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG1' HG23 ' A' ' 106' ' ' VAL . 61.4 t -60.6 -60.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.61 0.596 . . . . 1.0 112.61 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -61.12 -38.4 86.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -47.23 -36.64 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.9 mt -73.33 -43.65 60.39 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.22 -44.63 88.28 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.644 -0.873 . . . . 1.0 108.644 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -62.63 -19.0 63.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.691 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 23.2 mmm -101.27 -0.98 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 1.0 111.052 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.6 17.62 79.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.534 ' CG2' HH21 ' A' ' 50' ' ' ARG . 73.0 t -107.29 143.65 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.655 0.264 . . . . 1.0 110.335 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.7 -42.74 2.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.944 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.7 t -136.87 118.16 14.59 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.77 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.3 m -129.12 143.39 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.998 0.428 . . . . 1.0 111.405 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.0 mp -100.45 132.54 45.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.74 107.17 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.304 -0.558 . . . . 1.0 112.258 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.53 132.68 21.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -91.63 163.39 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.386 2.057 . . . . 1.0 113.701 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.5 mt -116.9 113.86 23.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.569 ' N ' ' OG ' ' A' ' 192' ' ' SER . 25.3 ptm -142.69 150.3 39.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 58.1 t-80 -125.66 124.49 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.897 -1.047 . . . . 1.0 108.842 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 38.1 t-80 60.17 -122.04 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.165 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.533 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 41.3 tt0 -97.85 1.71 48.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.808 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.8 tt0 -106.43 144.24 33.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 tp -99.31 125.74 45.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 75.7 m95 -104.37 -34.84 8.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.5 -175.05 31.08 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.717 -1.23 . . . . 1.0 112.417 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -137.44 122.02 18.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.471 -0.365 . . . . 1.0 111.644 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 53' ' ' VAL . 47.1 tp -94.95 150.02 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.5 p -156.62 134.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.004 -0.678 . . . . 1.0 111.843 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 90.5 p -116.03 132.74 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -104.96 126.83 52.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 5.7 t-80 -118.8 115.35 24.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.79 63.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.799 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 21.6 mp0 . . . . . 0 C--N 1.326 -0.42 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.535 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.647 0.26 . . . . 1.0 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 184' ' ' VAL . 77.3 mm-40 -66.37 -28.88 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 1.0 110.902 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -69.98 -39.25 76.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.651 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -78.92 -54.19 6.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.618 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 184' ' ' VAL . 9.9 p -43.67 -42.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.669 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 185' ' ' GLN . 34.0 m -75.09 -48.36 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.578 ' N ' HG23 ' A' ' 184' ' ' VAL . 60.9 tt0 -48.26 -36.49 14.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 190' ' ' GLN . 24.1 tp -70.85 -45.72 63.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.023 -0.989 . . . . 1.0 109.088 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.08 -47.67 77.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.8 93.54 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -62.78 -37.12 85.42 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 186' ' ' LEU . 55.5 tt0 -66.89 -31.7 72.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.647 -0.871 . . . . 1.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.62 -46.79 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -50.8 -32.84 21.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.2 mt -74.73 -34.32 33.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.198 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.94 -43.53 78.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.984 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 196' ' ' ALA . 24.2 pt -63.06 -30.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.72 -53.47 7.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.392 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.84 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.224 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.05 77.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.7 -40.92 73.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.211 0.449 . . . . 1.0 112.211 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.0 tp -51.45 -34.65 36.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.928 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.2 p -48.3 -56.41 8.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.696 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.986 . . . . 1.0 110.482 179.507 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' A' ' 35' ' ' LEU . 6.7 tp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.362 . . . . 1.0 110.563 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.2 t0 -51.69 -33.24 33.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.728 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -75.98 -49.44 17.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.779 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 38' ' ' THR . 97.0 mt -55.38 -52.69 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 1.0 110.976 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.7 mt -56.36 -30.94 63.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.988 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.447 ' O ' HG12 ' A' ' 39' ' ' VAL . 67.9 ttp85 -64.6 -38.93 92.7 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.754 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.09 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.844 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 67.2 p -65.8 -37.4 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 1.0 112.311 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -74.58 -25.45 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.58 -43.17 23.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.283 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -72.24 -43.99 63.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.785 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 43' ' ' ARG . 7.2 p -61.69 -47.63 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.306 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG13 ' A' ' 42' ' ' VAL . 70.7 ttp85 -54.97 -44.21 74.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 1.0 110.689 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.82 60.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.351 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -70.18 -33.59 71.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.813 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -97.52 -18.96 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.759 0.314 . . . . 1.0 111.695 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.8 25.21 51.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 170' ' ' HIS . 91.7 m -77.36 144.01 38.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.981 -0.377 . . . . 1.0 109.981 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -52.83 -42.45 65.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.635 0.605 . . . . 1.0 112.635 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 2.9 mtt-85 -149.48 128.35 12.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.507 -0.877 . . . . 1.0 112.797 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 10.9 t -136.7 129.89 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.968 -1.015 . . . . 1.0 108.739 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -137.95 152.39 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.658 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 46.3 t -99.12 141.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.6 t80 -131.85 133.24 44.44 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.468 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -113.66 154.06 27.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 1.0 111.205 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -103.87 137.64 41.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.68 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.3 m-20 -101.75 154.95 36.97 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.54 -52.3 2.04 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.001 2.468 . . . . 1.0 114.481 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.12 -6.31 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.561 -0.456 . . . . 1.0 112.141 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.07 37.42 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.689 -0.767 . . . . 1.0 111.887 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 57' ' ' ASP . 72.8 m80 -77.56 149.29 34.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.444 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.47 161.06 24.95 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 155.48 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 1.0 111.559 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.44 108.68 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.5 t -108.89 -4.27 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.41 123.44 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.25 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.7 tt0 -151.84 136.62 17.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.155 0.502 . . . . 1.0 111.705 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.82 134.36 50.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.061 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -179.714 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.864 0.364 . . . . 1.0 111.284 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 32.6 mt -98.23 14.69 26.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.484 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.7 tp -64.53 131.79 48.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.61 88.15 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.781 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.81 150.21 24.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.344 0.572 . . . . 1.0 110.479 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 p -108.63 137.17 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.566 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.55 149.57 39.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.235 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 78.5 Cg_endo -80.12 136.66 11.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.493 2.129 . . . . 1.0 111.507 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.67 -35.05 75.28 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.81 -14.7 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . 47.7 p-10 -68.71 -19.61 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.624 0.249 . . . . 1.0 111.016 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.97 97.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.538 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 41.3 Cg_exo -39.18 -95.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.565 2.177 . . . . 1.0 111.683 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 41.8 tp10 -162.91 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.969 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -51.03 -40.9 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.646 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.48 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.726 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -64.7 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 1.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -65.21 -38.8 91.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.05 -36.95 75.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.549 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -68.7 -35.37 77.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -76.98 -32.08 56.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.24 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.7 mt -95.84 -39.24 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.41 -12.94 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.2 1.185 . . . . 1.0 114.2 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.426 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 1.3 mp0 47.17 48.12 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.0 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.6 t -149.87 108.45 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.912 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -160.91 130.9 5.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.84 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.2 p -150.06 155.96 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.683 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 135' ' ' VAL . 95.2 mt -114.32 131.18 67.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.245 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -87.99 171.13 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.028 0.751 . . . . 1.0 113.028 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -50.74 115.4 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.932 -1.031 . . . . 1.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.474 HG23 ' CG1' ' A' ' 140' ' ' VAL . 13.0 p -49.66 -19.74 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.642 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -76.76 -38.79 53.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.821 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.78 -8.94 5.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.167 0.508 . . . . 1.0 110.43 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 15.8 pt20 46.17 62.03 2.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.435 -0.802 . . . . 1.0 112.891 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -93.35 126.94 38.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.752 -1.573 . . . . 1.0 106.752 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -119.4 147.01 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.666 0.987 . . . . 1.0 113.666 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.634 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -111.44 149.32 31.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.789 -1.096 . . . . 1.0 108.636 178.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 113' ' ' ILE . 7.5 mt . . . . . 0 C--N 1.326 -0.438 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.445 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.634 ' C ' ' HG ' ' A' ' 112' ' ' SER . 49.6 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 CA-C-O 120.83 0.262 . . . . 1.0 112.401 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -117.61 128.17 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 138' ' ' CYS . 4.5 p30 -45.03 140.77 3.41 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 1.0 111.376 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -37.91 -17.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 123.053 2.502 . . . . 1.0 113.748 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 136' ' ' ASP . 42.6 t -63.28 -62.21 1.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.267 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.407 ' CE1' ' CD1' ' A' ' 103' ' ' ILE . 51.7 t-80 -71.1 -25.06 62.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.667 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.474 ' CG1' HG23 ' A' ' 106' ' ' VAL . 65.2 t -58.36 -60.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -61.41 -37.45 83.52 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.394 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 61.1 t80 -46.17 -37.93 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.16 -43.4 64.68 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.36 -41.49 89.39 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.631 -0.878 . . . . 1.0 108.631 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -64.16 -22.18 66.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.441 -0.799 . . . . 1.0 109.642 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.598 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 70.9 mtp -97.97 2.09 48.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.101 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.97 19.44 78.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.6 -1.0 . . . . 1.0 110.6 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 78.9 t -110.19 145.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.679 0.276 . . . . 1.0 110.276 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.3 -23.9 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.027 0.38 . . . . 1.0 112.027 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -152.36 120.21 6.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.747 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 p -128.17 137.58 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 1.0 111.419 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.0 131.83 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.4 t -111.95 130.45 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.293 -0.563 . . . . 1.0 112.306 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.95 128.59 18.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.88 166.28 3.23 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.389 2.059 . . . . 1.0 113.733 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.59 115.35 24.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.605 -1.257 . . . . 1.0 107.605 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.448 ' H ' ' HB2' ' A' ' 192' ' ' SER . 23.8 ptm -142.3 151.61 42.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.44 0.638 . . . . 1.0 112.684 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.469 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 51.9 t60 -128.31 124.56 36.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.913 -1.039 . . . . 1.0 108.899 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.498 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 14.9 t-80 61.79 -123.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.107 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.498 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 99.0 mm-40 -97.63 3.55 50.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.519 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -107.0 144.83 33.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.683 0.994 . . . . 1.0 113.683 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.5 tp -98.78 125.7 44.21 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.519 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 73.9 m95 -105.21 -36.83 7.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.44 -173.25 23.91 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.694 -1.241 . . . . 1.0 112.39 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -139.57 120.19 14.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.441 -0.379 . . . . 1.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.455 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.8 tp -94.73 149.8 20.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.5 p -156.42 134.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.097 -0.641 . . . . 1.0 111.863 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -114.45 137.86 51.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.223 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 30.5 m-70 -111.96 124.69 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 1.0 112.663 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.506 ' CD2' HG23 ' A' ' 48' ' ' THR . 71.5 m80 -116.42 121.33 41.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.51 13.38 6.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.785 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.579 -179.718 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.637 0.256 . . . . 1.0 111.299 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 184' ' ' VAL . 50.8 tp10 -61.08 -33.41 73.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.96 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.19 -49.51 75.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.62 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.0 -52.61 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.652 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.8 t -44.98 -39.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 187' ' ' LEU . 83.7 t -73.32 -49.82 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -45.99 -32.02 2.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 tp -68.18 -48.15 66.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.119 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 184' ' ' VAL . 92.7 mt -52.1 -46.3 65.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.94 93.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.423 -0.955 . . . . 1.0 108.423 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.77 -38.89 92.79 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -66.19 -31.16 71.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.74 -46.62 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 157' ' ' MET . 42.5 p -51.24 -32.04 22.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.68 -34.59 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.132 -0.94 . . . . 1.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.51 -43.66 80.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.895 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 196' ' ' ALA . 21.0 pt -62.7 -29.57 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.437 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -74.92 -52.37 11.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.69 -42.67 97.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.82 72.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.36 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.02 -43.13 81.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.4 mp -52.44 -33.51 44.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.995 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -54.56 -58.61 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.398 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.838 0.351 . . . . 1.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -48.0 -35.49 11.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -75.14 -49.88 18.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.802 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 38' ' ' THR . 24.4 mm -56.12 -48.54 78.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.141 0.496 . . . . 1.0 110.959 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' OG1' ' A' ' 38' ' ' THR . 32.5 mt -57.42 -29.25 63.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.955 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' HG12 ' A' ' 39' ' ' VAL . 36.4 ttm180 -66.43 -39.82 89.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.447 -0.501 . . . . 1.0 109.739 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.77 -30.04 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.767 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 42' ' ' VAL . 75.1 p -68.48 -36.02 78.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.283 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -72.72 -25.48 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.16 0.429 . . . . 1.0 112.16 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.32 -42.67 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.267 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.95 -48.29 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.804 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 43' ' ' ARG . 34.4 m -56.44 -49.22 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.352 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG23 ' A' ' 42' ' ' VAL . 70.8 ttp85 -51.01 -43.5 60.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 1.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.8 -40.79 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.33 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.59 -35.81 79.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.758 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -96.75 -15.76 21.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 1.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.57 25.23 34.54 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 170' ' ' HIS . 69.9 m -78.63 145.89 34.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -53.37 -44.46 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -148.28 132.44 17.35 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 119.563 -0.855 . . . . 1.0 112.798 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.4 t -136.49 130.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 114.937 -1.029 . . . . 1.0 108.777 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -136.56 148.32 47.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.604 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 47.6 t -98.57 140.72 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.923 -0.769 . . . . 1.0 108.923 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.5 t80 -128.92 133.04 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.464 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -106.62 141.96 37.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.979 0.419 . . . . 1.0 111.234 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.452 ' CE2' ' NH1' ' A' ' 92' ' ' ARG . 64.6 t80 -97.99 124.55 42.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.696 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' HIS . 7.6 t70 -95.22 138.72 21.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -40.76 -29.68 0.46 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.931 2.421 . . . . 1.0 114.564 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -84.44 -4.56 58.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 104.8 -17.53 45.38 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.929 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 57' ' ' ASP . 75.6 m80 -80.25 149.27 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.376 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.1 162.98 26.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -134.14 156.15 48.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 1.0 111.504 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.4 t -88.39 108.56 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.54 -4.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.42 124.14 7.25 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.301 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 71.2 tt0 -150.69 138.5 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.195 0.521 . . . . 1.0 111.69 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.08 128.02 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.738 -0.838 . . . . 1.0 108.738 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -102.68 137.41 40.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.991 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.733 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.489 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.814 0.34 . . . . 1.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.602 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -108.11 12.95 26.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.991 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.9 tp -64.08 132.04 49.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.28 -4.3 84.01 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.42 -0.809 . . . . 1.0 112.873 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.84 151.45 23.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.357 0.579 . . . . 1.0 110.383 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.9 m -108.04 134.81 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.635 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -108.52 150.9 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.249 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.37 140.6 15.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -63.73 -33.86 76.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 1.0 110.463 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.2 -16.67 0.17 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' ALA . 11.8 p-10 -55.65 -11.98 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.671 0.272 . . . . 1.0 111.037 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -151.75 146.45 18.76 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.536 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 93.4 Cg_endo -75.7 -92.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.556 2.17 . . . . 1.0 111.675 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' OE2' ' NH2' ' A' ' 92' ' ' ARG . 46.7 tp10 -167.58 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.2 pt-20 -55.23 -41.74 72.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -72.07 -37.64 69.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.76 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.539 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 54.0 ttp180 -62.58 -33.06 74.2 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.776 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -64.05 -37.42 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.915 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.63 -35.87 77.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.589 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.3 -36.94 77.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -75.43 -30.87 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.255 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.54 -38.86 10.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.804 1.039 . . . . 1.0 113.804 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.92 -13.08 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.262 1.208 . . . . 1.0 114.262 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.659 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.0 mp0 47.87 56.92 6.55 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.689 -0.804 . . . . 1.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.3 m -159.41 113.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.913 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -165.99 135.77 3.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.896 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.3 p -148.21 156.44 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 1.0 109.705 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.594 HG23 HG11 ' A' ' 135' ' ' VAL . 28.2 mt -109.78 128.5 65.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.4 t -83.84 165.8 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.999 0.74 . . . . 1.0 112.999 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.507 ' H ' HG12 ' A' ' 104' ' ' VAL . 63.1 t0 -51.46 118.63 3.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.291 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.446 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.3 p -51.43 -25.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.656 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -77.18 -38.91 50.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.1 43.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.129 0.49 . . . . 1.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 57.73 60.26 2.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t -94.39 124.82 38.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -119.69 143.85 47.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -112.51 152.64 28.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.756 -1.111 . . . . 1.0 108.627 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 120.492 -0.483 . . . . 1.0 111.448 -178.993 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.492 1.439 0 CA-C-O 120.811 0.255 . . . . 1.0 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.594 HG11 HG23 ' A' ' 103' ' ' ILE . 1.4 p -118.17 129.83 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.505 ' N ' ' OG ' ' A' ' 112' ' ' SER . 6.9 t0 -45.99 138.53 5.77 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.729 0.3 . . . . 1.0 111.33 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -39.08 -35.79 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.068 2.512 . . . . 1.0 113.62 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 t -43.53 -63.71 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.261 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.78 -22.49 62.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.678 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' A' ' 106' ' ' VAL . 92.9 t -61.67 -55.2 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.562 0.578 . . . . 1.0 112.562 -177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.48 -40.14 96.3 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.378 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.79 -35.57 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.64 -42.79 60.96 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -58.68 -43.73 90.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.1 m -62.42 -19.37 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.653 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.6 mmm -99.97 0.87 41.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.088 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.06 18.55 78.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.8 144.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.661 0.267 . . . . 1.0 110.351 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.43 -38.57 2.99 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.087 0.403 . . . . 1.0 112.087 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.1 p -138.4 121.26 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.721 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -130.92 141.46 50.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 1.0 111.332 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.66 131.62 55.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.52 HG12 HG23 ' A' ' 167' ' ' VAL . 20.1 m -116.18 140.04 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.264 -0.575 . . . . 1.0 112.239 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.9 t -131.91 132.66 23.33 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -89.92 159.87 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.326 2.018 . . . . 1.0 113.666 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 34.3 mt -114.89 117.02 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.2 ptm -140.33 148.07 40.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 81.5 t60 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.826 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 22.1 m-70 58.38 -125.44 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.148 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -100.67 6.11 43.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.761 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 11.5 pt-20 -111.98 156.32 22.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.728 1.01 . . . . 1.0 113.728 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.6 tp -102.04 128.1 48.63 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.515 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 29.7 m95 -104.58 -34.74 8.09 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.15 31.06 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.712 -1.232 . . . . 1.0 112.383 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -137.41 123.11 19.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.446 -0.377 . . . . 1.0 111.643 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.65 149.24 21.44 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.52 HG23 HG12 ' A' ' 153' ' ' VAL . 12.1 p -152.69 131.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.1 -0.64 . . . . 1.0 111.899 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 48' ' ' THR . 7.6 t -114.91 135.18 54.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.258 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 11.7 m-70 -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.63 ' CD2' HG23 ' A' ' 48' ' ' THR . 72.3 m80 -117.45 119.88 36.42 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.11 24.58 1.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.822 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 1.3 pm0 . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.956 -0.298 . . . . 1.0 110.627 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.585 0.231 . . . . 1.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 184' ' ' VAL . 76.6 mm-40 -64.56 -31.86 73.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 1.0 110.953 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.13 -38.52 91.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.614 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -79.67 -51.87 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.869 -0.332 . . . . 1.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -42.23 -42.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.689 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 185' ' ' GLN . 26.9 m -74.47 -45.94 44.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.523 ' N ' HG23 ' A' ' 184' ' ' VAL . 56.0 tt0 -50.53 -32.87 19.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.063 -1.088 . . . . 1.0 108.063 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 16.8 tp -73.0 -52.65 13.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.089 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.17 -46.01 65.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.19 80.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -61.23 -38.44 86.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 44.5 tt0 -64.9 -33.11 75.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.4 -45.74 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.376 -0.972 . . . . 1.0 108.376 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -52.46 -36.03 53.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -68.61 -37.0 77.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.272 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.61 -41.01 80.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -55.52 -48.43 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.363 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.44 -46.54 88.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.264 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.41 -33.08 74.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 1.0 111.398 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -55.97 -41.13 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 26.0 tp -53.18 -37.29 61.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.8 m -48.94 -57.75 5.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.67 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.7 mp . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.453 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.805 0.336 . . . . 1.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.22 -32.4 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.742 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.8 -48.73 20.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.792 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 38' ' ' THR . 25.6 mm -55.1 -53.3 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 1.0 110.945 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.6 mt -56.44 -30.21 62.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.99 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 39' ' ' VAL . 59.9 ttp180 -64.49 -39.94 94.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.384 -0.526 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.12 67.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.774 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.5 p -67.49 -36.46 81.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.314 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.603 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -73.65 -25.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 71.5 mm-40 -79.6 -43.8 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.773 -0.371 . . . . 1.0 111.318 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.88 -44.6 80.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.807 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 43' ' ' ARG . 36.0 m -59.42 -46.56 92.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.323 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 47' ' ' GLY . 6.2 ttm180 -50.76 -45.03 58.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 1.0 110.692 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.78 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.254 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.95 -37.86 82.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.852 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.37 -18.69 18.96 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.674 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.76 25.49 56.0 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 50.0 m -78.07 143.23 37.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.38 -39.97 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.409 ' NH2' ' CB ' ' A' ' 69' ' ' ARG . 13.3 mtt85 -148.48 124.19 10.5 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.822 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.5 t -132.63 128.48 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.748 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HZ2' HD12 ' A' ' 77' ' ' LEU . 34.9 mttt -136.64 148.78 47.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.616 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.587 HG22 ' CD1' ' A' ' 166' ' ' LEU . 59.9 t -98.39 140.96 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.405 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 20.1 t80 -130.6 132.3 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.433 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.431 HH12 ' CG2' ' A' ' 195' ' ' ILE . 60.4 ttt85 -110.84 149.84 30.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.035 0.445 . . . . 1.0 111.195 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.14 133.95 46.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.691 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 61' ' ' HIS . 11.6 m-20 -99.26 153.51 37.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -38.68 -51.08 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 122.96 2.44 . . . . 1.0 114.53 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -70.96 -6.43 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 106.84 -8.23 39.27 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.684 -0.77 . . . . 1.0 111.922 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ASP . 70.0 m80 -78.23 151.03 33.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.424 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.59 163.61 25.78 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -135.87 157.72 46.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.999 0.428 . . . . 1.0 111.528 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.6 107.75 17.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 65' ' ' VAL . 21.6 t -107.77 -5.19 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.71 123.2 7.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.274 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 55.1 tt0 -148.45 136.99 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.152 0.501 . . . . 1.0 111.734 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.62 129.03 48.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' CB ' ' NH2' ' A' ' 50' ' ' ARG . 30.8 ptt-85 -107.01 137.98 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.292 -0.563 . . . . 1.0 112.052 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 178.518 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.796 0.332 . . . . 1.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.61 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 42.7 mt -110.81 19.43 18.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.0 tp -66.47 130.47 43.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.35 87.2 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.41 -0.814 . . . . 1.0 112.858 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.3 149.23 25.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.32 0.56 . . . . 1.0 110.429 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.1 m -106.89 134.62 49.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.589 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -108.78 148.9 38.75 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.215 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.73 136.17 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.572 2.182 . . . . 1.0 111.502 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -58.28 -30.58 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.817 0.341 . . . . 1.0 110.413 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.61 -16.63 0.06 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.227 -0.749 . . . . 1.0 111.227 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 84' ' ' ALA . 51.4 t0 -62.07 -21.84 65.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.701 0.286 . . . . 1.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.0 mt -143.35 104.71 5.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.529 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 47.9 Cg_exo -40.38 -84.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.56 2.173 . . . . 1.0 111.629 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.486 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 46.2 tp10 -172.41 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.53 -43.31 93.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.626 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.64 -36.78 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.521 -0.308 . . . . 1.0 111.702 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 65.4 ttp85 -64.6 -32.75 74.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.774 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -64.42 -37.19 86.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.857 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.11 -36.7 80.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.532 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -67.39 -33.98 76.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -74.14 -33.22 63.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.263 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.2 mt -94.82 -38.11 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.82 -13.56 9.07 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 114.228 1.196 . . . . 1.0 114.228 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.425 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 47.06 49.7 14.72 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.665 -0.814 . . . . 1.0 109.864 -178.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.4 109.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 120.314 -0.554 . . . . 1.0 111.878 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.02 134.88 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.865 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.4 p -151.05 156.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.724 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.544 HG12 HG21 ' A' ' 135' ' ' VAL . 27.8 mt -109.96 128.77 65.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.263 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.69 169.34 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.972 0.73 . . . . 1.0 112.972 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -49.52 113.73 0.89 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.289 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.482 HG13 ' CG1' ' A' ' 140' ' ' VAL . 52.9 t -51.37 -18.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -77.95 -38.81 44.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.795 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.75 -7.19 3.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.131 0.491 . . . . 1.0 110.384 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 18.2 pt20 45.67 62.77 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.494 -0.776 . . . . 1.0 112.881 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 m -93.91 127.83 39.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -119.79 144.73 47.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.708 1.003 . . . . 1.0 113.708 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.655 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -108.84 150.43 27.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.715 -1.129 . . . . 1.0 108.619 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.3 pt . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.457 -179.572 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.655 ' C ' ' HG ' ' A' ' 112' ' ' SER . 56.1 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.83 0.263 . . . . 1.0 112.356 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.544 HG21 HG12 ' A' ' 103' ' ' ILE . 89.4 t -112.11 123.87 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.533 ' N ' ' OG ' ' A' ' 112' ' ' SER . 5.6 t70 -44.83 139.23 3.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.293 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.67 -25.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.091 2.527 . . . . 1.0 113.632 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.8 t -49.58 -61.97 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.206 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -72.94 -23.21 60.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.68 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.482 ' CG1' HG13 ' A' ' 106' ' ' VAL . 72.5 t -55.55 -60.96 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -63.31 -39.46 94.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.364 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 83.1 t80 -48.21 -40.01 22.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.27 -44.8 64.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -56.2 -41.77 76.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -62.65 -22.07 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.622 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.588 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 46.1 mtp -97.25 -1.48 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 20.27 73.8 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.17 143.49 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.277 . . . . 1.0 110.344 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.38 -28.2 4.69 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -151.44 120.2 6.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.811 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 72.9 m -128.65 142.46 51.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 1.0 111.46 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tp -100.07 132.43 45.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.91 130.39 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.305 -0.558 . . . . 1.0 112.242 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 19.8 t -135.71 131.35 19.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.247 -1.02 . . . . 1.0 108.247 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.29 163.01 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.389 2.06 . . . . 1.0 113.69 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.2 mt -115.77 113.93 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.4 ptm -142.0 152.31 43.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.751 0.649 . . . . 1.0 112.751 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -128.04 123.74 35.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 1.0 108.88 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.451 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 17.6 t-80 61.98 -123.64 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.1 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.451 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 15.3 mm100 -97.39 3.3 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.843 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.4 tt0 -106.56 144.96 32.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.75 1.018 . . . . 1.0 113.75 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 48.2 tp -100.18 125.05 46.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.9 m95 -103.76 -33.45 8.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.58 0.956 . . . . 1.0 113.58 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.64 -175.99 32.25 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.668 -1.253 . . . . 1.0 112.371 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 mt -135.06 123.12 22.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.447 -0.377 . . . . 1.0 111.617 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.587 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.4 p -155.45 132.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.825 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.5 p -114.2 133.69 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.174 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.472 ' O ' ' CG2' ' A' ' 48' ' ' THR . 46.4 m80 -106.05 122.7 46.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 4.7 t-80 -118.08 121.52 40.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.1 -17.36 62.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.618 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.726 0.298 . . . . 1.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -73.18 -37.24 66.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 1.0 110.941 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.6 -43.97 93.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.625 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -64.45 -51.55 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 1.0 111.721 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.8 t -44.25 -42.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.669 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.09 -50.5 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -49.46 -33.44 14.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 190' ' ' GLN . 6.5 tt -74.55 -48.15 28.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.032 -0.985 . . . . 1.0 109.069 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -53.43 -46.52 69.86 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.3 80.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -60.58 -38.37 84.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 186' ' ' LEU . 57.4 tp60 -65.85 -33.4 75.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.3 -47.13 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.1 p -52.64 -35.01 54.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.13 -35.47 71.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.326 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.2 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.431 ' CG2' HH12 ' A' ' 55' ' ' ARG . 64.3 mt -56.49 -45.5 82.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.6 -49.7 67.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.54 -46.3 88.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.24 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -32.2 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 1.0 111.394 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.82 -43.03 80.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 37.6 tp -53.64 -37.64 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.935 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 32.0 t -54.5 -61.84 2.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.657 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.499 179.728 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.781 0.325 . . . . 1.0 110.496 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -48.67 -35.1 13.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.753 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -74.74 -50.57 16.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.798 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -56.78 -46.49 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.124 0.488 . . . . 1.0 110.945 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' O ' ' OG1' ' A' ' 38' ' ' THR . 22.3 mt -58.71 -27.38 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.968 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 39' ' ' VAL . 70.9 mtp85 -69.92 -37.73 76.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.42 -0.512 . . . . 1.0 109.807 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.1 66.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.751 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 57.2 p -67.98 -37.14 81.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 1.0 112.324 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p -72.08 -24.91 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.83 -43.09 23.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.28 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -70.28 -48.34 57.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.78 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 43' ' ' ARG . 14.4 p -57.67 -47.66 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.366 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG13 ' A' ' 42' ' ' VAL . 66.2 ttt-85 -51.79 -44.09 63.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 1.0 110.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.39 -40.81 65.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.12 -36.45 83.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.838 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.44 -14.67 21.03 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.722 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 26.06 30.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' ' CE1' ' A' ' 170' ' ' HIS . 49.6 m -76.99 143.66 39.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.8 p30 -53.84 -41.57 67.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.602 0.593 . . . . 1.0 112.602 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 22.2 ttt-85 -151.31 131.85 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 119.612 -0.835 . . . . 1.0 112.826 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 9.0 t -138.66 132.94 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.759 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.3 pttm -137.13 149.27 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.628 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 56.0 t -96.41 139.18 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.3 t80 -128.36 132.16 48.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.43 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -107.86 143.25 36.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 1.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.8 t80 -99.56 125.19 45.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.687 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 2.5 m-20 -92.07 152.04 42.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.58 -21.43 38.51 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.038 2.492 . . . . 1.0 114.474 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.43 -0.93 57.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.8 -16.58 54.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.716 -0.754 . . . . 1.0 111.901 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 74.5 m80 -80.4 148.91 30.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.41 160.04 24.98 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p -133.19 154.2 50.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.99 0.424 . . . . 1.0 111.503 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 t -91.78 113.29 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.13 -2.95 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.96 128.33 9.91 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.324 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CB ' HD21 ' A' ' 78' ' ' LEU . 88.7 tt0 -156.14 138.82 15.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.162 0.506 . . . . 1.0 111.722 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.94 140.54 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.809 -0.812 . . . . 1.0 108.809 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 23.5 mtt85 -116.77 137.5 52.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.352 -0.539 . . . . 1.0 112.104 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.516 ' CB ' ' HE ' ' A' ' 69' ' ' ARG . 4.9 p . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.825 0.345 . . . . 1.0 111.336 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.549 HD12 ' NH2' ' A' ' 50' ' ' ARG . 24.0 mt -109.53 9.19 25.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.007 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD21 ' CB ' ' A' ' 67' ' ' GLU . 89.4 mt -56.11 129.04 38.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.21 -6.53 81.41 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.468 -0.787 . . . . 1.0 112.861 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.92 147.24 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.348 0.574 . . . . 1.0 110.482 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.5 m -108.8 137.46 46.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.58 149.58 39.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.213 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.8 136.23 11.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.583 2.189 . . . . 1.0 111.449 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -61.23 -32.06 71.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.818 0.342 . . . . 1.0 110.429 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.08 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.5 m-20 -61.11 -24.96 66.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.72 0.295 . . . . 1.0 111.035 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 pt -137.32 143.96 43.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.52 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 96.4 Cg_endo -76.39 -89.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.581 2.187 . . . . 1.0 111.608 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.512 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 83.3 tt0 -170.01 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.957 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 19.6 pt-20 -59.26 -40.47 86.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.586 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -73.39 -38.28 65.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.703 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.675 HH12 ' NH2' ' A' ' 96' ' ' ARG . 66.9 ttp85 -61.89 -32.89 73.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 1.0 110.808 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -64.61 -36.77 85.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.938 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.91 -36.36 79.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.493 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.55 -38.45 77.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.675 ' NH2' HH12 ' A' ' 92' ' ' ARG . 28.1 ttm180 -74.03 -33.15 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.159 -0.928 . . . . 1.0 111.197 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.58 -37.73 11.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.789 1.033 . . . . 1.0 113.789 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.12 -12.65 9.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.274 1.213 . . . . 1.0 114.274 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 46.99 47.63 15.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.958 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.51 109.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.413 -0.515 . . . . 1.0 111.946 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.58 130.72 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.798 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.14 159.05 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.719 HG12 HG21 ' A' ' 135' ' ' VAL . 4.7 mt -110.37 128.45 66.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.004 0.431 . . . . 1.0 110.257 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.47 HG21 ' OG ' ' A' ' 110' ' ' SER . 5.2 m -86.96 171.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.021 0.749 . . . . 1.0 113.021 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -50.32 115.0 1.25 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.999 -1.0 . . . . 1.0 112.192 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.491 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.3 p -52.55 -27.15 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.69 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.08 -40.27 62.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.85 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.15 -15.05 3.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 1.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.425 ' OE1' ' NH2' ' A' ' 111' ' ' ARG . 0.3 OUTLIER 56.81 60.81 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.491 -0.777 . . . . 1.0 112.847 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.47 ' OG ' HG21 ' A' ' 104' ' ' VAL . 2.3 m -95.62 125.29 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.425 ' NH2' ' OE1' ' A' ' 109' ' ' GLN . 87.9 mtt-85 -118.08 144.92 45.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -109.46 145.46 36.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.767 -1.106 . . . . 1.0 108.646 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.441 -178.444 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 N--CA 1.491 1.368 0 CA-C-O 120.855 0.273 . . . . 1.0 112.38 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.719 HG21 HG12 ' A' ' 103' ' ' ILE . 96.3 t -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -45.03 157.27 0.34 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.401 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.94 -9.92 15.91 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.135 2.557 . . . . 1.0 113.711 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -66.56 -63.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.258 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.486 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 41.5 t60 -71.64 -25.41 62.13 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.656 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 136' ' ' ASP . 92.4 t -61.2 -58.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.86 -37.9 89.09 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.419 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.438 ' O ' ' OG ' ' A' ' 145' ' ' SER . 80.5 t80 -48.8 -35.28 14.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.445 HD11 ' NE2' ' A' ' 139' ' ' HIS . 49.8 mt -73.45 -43.25 60.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -58.73 -44.31 90.41 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 96.9 p -62.51 -18.11 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.716 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.8 mmm -100.89 0.57 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.93 19.05 78.13 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.605 HG21 ' HD1' ' A' ' 169' ' ' HIS . 97.8 t -108.13 143.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.697 0.284 . . . . 1.0 110.292 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.78 -32.15 5.23 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.975 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.8 m -143.79 122.45 12.57 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.746 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 p -126.86 131.7 51.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 1.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -97.0 131.43 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.95 131.13 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.32 -0.552 . . . . 1.0 112.304 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.7 t -135.93 131.36 18.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.199 -1.038 . . . . 1.0 108.199 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -93.78 162.41 2.26 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.424 2.083 . . . . 1.0 113.706 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.5 mt -115.55 113.86 24.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.3 ptm -140.92 150.19 42.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 71.9 t60 -122.09 123.22 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.933 -1.03 . . . . 1.0 108.878 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 45.8 m-70 57.4 -118.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.12 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -98.12 1.87 48.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 143.75 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.7 tp -99.51 124.43 44.68 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.508 -1.293 . . . . 1.0 107.508 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 65.5 m95 -103.24 -32.18 9.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.575 0.954 . . . . 1.0 113.575 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.81 -173.06 32.05 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 119.701 -1.238 . . . . 1.0 112.39 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.6 mt -136.22 122.81 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.443 -0.379 . . . . 1.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 53' ' ' VAL . 17.9 tp -95.33 149.35 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.464 HG11 ' NZ ' ' A' ' 52' ' ' LYS . 11.0 p -155.15 134.52 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.867 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.1 m -115.73 139.02 50.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.22 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.605 ' HD1' HG21 ' A' ' 148' ' ' VAL . 18.9 m-70 -110.64 123.97 51.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.542 ' CE1' ' OG1' ' A' ' 48' ' ' THR . 84.8 m-70 -117.97 113.86 22.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.92 -22.71 59.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.777 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.553 -179.439 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.626 0.25 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.52 -32.61 68.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 1.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.96 -35.8 81.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.667 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.69 -53.17 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.718 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 76.2 t -41.82 -42.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.589 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 185' ' ' GLN . 29.1 m -74.67 -45.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.511 ' N ' HG23 ' A' ' 184' ' ' VAL . 53.4 tt0 -52.91 -31.5 40.21 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 190' ' ' GLN . 39.3 tp -75.84 -56.56 4.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.097 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.0 mt -51.04 -45.42 61.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.43 76.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.361 -0.978 . . . . 1.0 108.361 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -61.11 -39.02 88.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 186' ' ' LEU . 46.8 tp60 -64.44 -33.37 75.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.593 -0.892 . . . . 1.0 108.593 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.75 -46.78 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.0 p -53.14 -33.79 53.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 mt -70.41 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.114 -0.948 . . . . 1.0 110.174 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.48 82.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.871 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.5 mt -55.74 -48.26 78.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.14 66.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.403 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.82 -46.54 87.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.294 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -33.14 75.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.6 tp -53.07 -38.89 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.5 t -47.67 -58.41 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.638 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.955 -1.022 . . . . 1.0 110.426 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.553 ' CD2' HD11 ' A' ' 35' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 1.0 110.52 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 2.3 p30 -67.12 -31.09 71.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 79.9 mt-30 -74.53 -49.06 23.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.754 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.28 -48.01 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 1.0 110.954 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 31' ' ' LEU . 62.7 mt -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.984 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 39' ' ' VAL . 78.2 mtm180 -65.32 -39.88 93.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.378 -0.529 . . . . 1.0 109.835 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.47 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.768 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.722 ' O ' HG23 ' A' ' 42' ' ' VAL . 73.0 p -67.56 -35.97 80.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 1.0 112.303 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -74.69 -24.69 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -178.252 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.71 -47.25 60.78 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.298 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.31 -32.37 64.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.828 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 38' ' ' THR . 62.0 t -62.99 -55.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.298 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.6 tmm_? -54.22 -43.77 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 1.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -40.68 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.314 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -67.82 -36.08 79.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.826 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.5 mt -96.88 -18.65 19.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.756 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.94 25.19 56.05 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -79.86 147.26 31.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -52.43 -41.48 63.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.708 HH22 ' NE ' ' A' ' 69' ' ' ARG . 84.1 mtt-85 -151.15 128.83 11.52 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.55 -0.86 . . . . 1.0 112.818 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 6.2 t -134.35 128.24 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.771 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.556 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 20.9 pttm -138.65 153.54 48.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.662 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG22 ' CD1' ' A' ' 166' ' ' LEU . 48.2 t -98.36 139.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -127.14 130.23 49.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.609 HH12 HD12 ' A' ' 195' ' ' ILE . 16.6 mmm180 -110.68 149.64 30.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.007 0.432 . . . . 1.0 111.156 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.87 138.97 38.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -104.12 153.35 38.98 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 109.392 -0.596 . . . . 1.0 109.392 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -39.18 -51.61 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 123.015 2.477 . . . . 1.0 114.473 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.54 -4.76 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 105.61 -8.5 43.68 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.693 -0.765 . . . . 1.0 111.944 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' A' ' 57' ' ' ASP . 75.3 m80 -76.97 149.2 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.378 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.19 161.78 25.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -135.9 157.47 46.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 1.0 111.524 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 80' ' ' LEU . 4.3 p -96.87 114.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.39 3.13 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.102 0.408 . . . . 1.0 112.102 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.61 127.16 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.274 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.524 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 79.8 tt0 -156.69 138.87 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.194 0.521 . . . . 1.0 111.683 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.57 134.78 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.708 ' NE ' HH22 ' A' ' 50' ' ' ARG . 10.5 mtp180 -104.08 134.57 47.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.05 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 178.226 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.792 0.329 . . . . 1.0 111.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.745 ' O ' HG11 ' A' ' 64' ' ' VAL . 25.5 mt -113.6 17.37 18.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.954 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 28.0 tp -66.79 130.72 44.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.585 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 85.56 -1.39 88.29 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.478 -0.783 . . . . 1.0 112.807 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.817 ' O ' HG12 ' A' ' 64' ' ' VAL . 86.0 mt -87.09 149.9 24.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.407 0.604 . . . . 1.0 110.451 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 81' ' ' THR . 13.7 t -104.86 131.15 52.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.629 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -106.09 106.35 56.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.303 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -43.34 139.17 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.562 2.175 . . . . 1.0 111.511 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.44 -32.09 69.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.942 0.401 . . . . 1.0 110.503 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.48 -18.01 0.1 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.25 -0.74 . . . . 1.0 111.25 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 60.1 t0 -64.28 -19.2 65.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.624 0.25 . . . . 1.0 111.075 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mt -138.06 133.26 17.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.515 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.71 -94.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.525 2.15 . . . . 1.0 111.643 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.17 -38.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.994 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.48 -42.73 71.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.576 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.9 71.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.75 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -62.81 -33.43 75.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.747 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -64.15 -38.74 92.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.16 -37.32 79.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 1.0 111.536 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -67.99 -34.65 76.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.77 -28.9 50.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.12 -0.946 . . . . 1.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -94.69 -39.59 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.06 -10.16 8.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.419 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 1.9 mp0 45.74 58.93 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.621 -0.832 . . . . 1.0 109.942 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.9 p -163.83 114.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -168.38 136.87 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.824 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.3 p -152.08 157.21 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.677 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.472 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 71.3 mt -109.77 130.07 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.262 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.601 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.6 p -85.96 168.56 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.601 ' N ' HG22 ' A' ' 104' ' ' VAL . 60.0 m-20 -48.12 114.73 0.99 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.204 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.492 HG13 ' CG1' ' A' ' 140' ' ' VAL . 41.4 t -51.86 -21.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.697 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -78.18 -37.91 44.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.34 -16.49 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.17 0.509 . . . . 1.0 110.365 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 56.43 63.03 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 1.0 112.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.402 ' OG ' ' CG1' ' A' ' 104' ' ' VAL . 80.0 p -96.31 124.3 40.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -117.17 145.05 44.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 1.5 t -108.06 144.15 35.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.713 -1.13 . . . . 1.0 108.618 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--N 1.325 -0.47 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.467 -179.006 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 N--CA 1.491 1.38 0 CA-C-O 120.792 0.247 . . . . 1.0 112.452 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.97 126.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.451 ' HA ' ' H ' ' A' ' 112' ' ' SER . 1.7 p30 -45.68 143.5 3.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.401 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -37.36 -25.92 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.118 2.545 . . . . 1.0 113.649 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.427 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.1 t -53.9 -61.23 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.257 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -69.39 -24.9 63.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.664 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.492 ' CG1' HG13 ' A' ' 106' ' ' VAL . 47.3 t -59.51 -60.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -61.81 -40.25 94.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 1.0 110.353 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -46.75 -39.11 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.06 -45.17 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -57.17 -43.1 82.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 t -63.5 -20.13 65.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 1.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.3 mmm -99.72 -3.45 32.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.093 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.06 78.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.15 141.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 1.0 110.254 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.94 -36.12 3.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.998 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 m -142.01 119.43 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.705 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 168' ' ' SER . 44.4 t -126.79 136.39 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.981 0.419 . . . . 1.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.77 132.36 41.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 t -113.5 129.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.31 -0.556 . . . . 1.0 112.298 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.7 t -136.97 136.39 21.09 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.255 -1.017 . . . . 1.0 108.255 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.82 166.25 1.02 Allowed 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.423 2.082 . . . . 1.0 113.699 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 mt -118.43 114.73 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.419 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 22.0 ptm -142.03 153.91 44.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.457 0.646 . . . . 1.0 112.683 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 40.4 t60 -129.68 124.19 33.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.903 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.41 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.7 t-80 61.84 -123.73 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.144 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.41 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 95.5 mt-30 -97.56 3.61 50.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.813 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.8 144.75 33.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.736 1.013 . . . . 1.0 113.736 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 39.7 tp -100.69 125.26 47.11 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 87.5 m95 -102.92 -32.95 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.09 -173.31 30.61 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.393 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.2 123.19 21.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.433 -0.383 . . . . 1.0 111.634 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.7 tp -95.29 149.9 20.83 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.1 p -158.01 134.5 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.844 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 151' ' ' SER . 42.2 m -114.94 136.66 52.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.729 -0.669 . . . . 1.0 109.282 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.556 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 32.3 m-70 -112.35 129.6 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -120.03 128.62 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.18 23.91 1.7 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.871 -0.331 . . . . 1.0 110.558 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.72 0.295 . . . . 1.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 1.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.6 tp -56.24 -45.29 80.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.9 -53.66 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.66 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 90.8 t -44.58 -40.1 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.07 -49.03 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -48.68 -33.52 10.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 190' ' ' GLN . 47.2 tp -75.17 -46.19 35.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.039 -0.982 . . . . 1.0 109.064 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.8 tp -54.64 -47.74 73.13 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.41 92.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.595 ' O ' HD13 ' A' ' 193' ' ' ILE . 57.2 t0 -62.28 -39.41 92.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.0 tp60 -64.54 -30.92 71.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 194' ' ' ALA . 51.6 t -77.23 -45.35 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 31.1 p -49.2 -31.64 8.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -73.57 -35.39 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.296 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -66.69 -44.01 82.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.922 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.609 HD12 HH12 ' A' ' 55' ' ' ARG . 25.2 pt -64.97 -27.01 41.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.414 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.6 -54.36 6.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.301 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.3 pt20 -66.06 -37.53 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.289 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.415 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.355 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -58.15 -43.72 87.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.204 0.446 . . . . 1.0 112.204 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 47.7 mt -51.94 -30.39 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 95.8 p -44.87 -55.75 5.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.636 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.459 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 66.9 t0 -48.15 -37.1 14.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.694 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -74.7 -51.19 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.838 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 38' ' ' THR . 95.3 mt -55.67 -47.45 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 1.0 110.964 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.489 ' O ' ' OG1' ' A' ' 38' ' ' THR . 24.5 mt -56.9 -30.17 63.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.943 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.507 ' O ' HG12 ' A' ' 39' ' ' VAL . 28.3 ttm180 -65.25 -38.48 90.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.73 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.739 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -69.59 -34.95 74.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.35 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.512 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.7 p -74.12 -25.22 19.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.22 -47.28 18.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.266 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -49.93 67.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.768 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.9 p -52.48 -47.08 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.315 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.593 ' N ' HG13 ' A' ' 42' ' ' VAL . 53.5 ttp180 -49.98 -43.93 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 1.0 110.596 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.52 -40.47 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.36 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.45 -37.29 82.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.804 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -96.64 -17.72 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.695 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 25.26 27.57 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 p -79.6 149.54 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.64 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 28.0 p30 -49.94 -41.94 47.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.64 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 29.7 ptt180 -159.41 146.54 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.584 -0.847 . . . . 1.0 112.788 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 13.4 p -144.02 135.65 22.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.956 -1.02 . . . . 1.0 108.733 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -137.54 149.75 46.97 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.239 -0.584 . . . . 1.0 111.573 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 166' ' ' LEU . 54.7 t -98.09 140.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.501 ' HH ' ' C ' ' A' ' 62' ' ' GLY . 17.8 t80 -129.48 131.3 46.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.482 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -109.89 148.19 32.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 1.0 111.257 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.47 133.91 45.38 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.755 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 61' ' ' HIS . 23.0 m-20 -98.44 152.95 38.17 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -39.43 -50.37 2.97 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.02 2.48 . . . . 1.0 114.516 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -70.11 -6.18 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.35 41.45 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.871 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 57' ' ' ASP . 31.1 m80 -79.69 152.29 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.369 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.501 ' C ' ' HH ' ' A' ' 54' ' ' TYR . . . -139.21 164.65 25.85 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -135.87 157.67 46.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.0 111.525 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 t -92.03 109.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 65' ' ' VAL . 21.6 t -111.32 -1.86 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.54 128.43 9.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' N ' HD21 ' A' ' 78' ' ' LEU . 84.8 tt0 -160.09 140.95 12.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.151 0.501 . . . . 1.0 111.762 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.27 136.53 52.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.499 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 15.1 mtt180 -104.33 134.94 46.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.062 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.636 -0.986 . . . . 1.0 110.636 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.794 0.331 . . . . 1.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -109.5 10.05 25.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.929 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 67' ' ' GLU . 53.5 mt -53.68 127.9 27.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.4 84.56 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.817 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 80' ' ' LEU . 90.2 mt -82.36 148.03 28.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.438 0.619 . . . . 1.0 110.448 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 81' ' ' THR . 14.2 t -106.64 132.72 52.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.614 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.57 107.74 59.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.297 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -43.38 140.35 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.525 2.15 . . . . 1.0 111.464 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -67.16 -26.34 66.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.392 . . . . 1.0 110.471 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.08 -17.57 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ALA . 26.2 p-10 -69.12 -17.2 63.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 1.0 111.035 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.37 133.53 24.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.45 -97.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.616 2.21 . . . . 1.0 111.631 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -163.89 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.932 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -56.39 -41.48 76.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.651 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.81 59.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.695 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 39.9 ttm180 -60.25 -34.45 73.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.797 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -63.44 -33.82 76.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.94 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.81 -34.08 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.513 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -69.38 -38.94 78.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 14.9 mtm180 -72.35 -33.38 67.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.26 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.11 -36.1 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.45 -16.49 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.664 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.5 mp0 48.72 58.68 5.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.972 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 99' ' ' GLN . 4.9 m -159.61 112.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.92 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -165.02 135.57 3.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.898 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -150.41 157.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.693 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.694 HG12 HG21 ' A' ' 135' ' ' VAL . 3.3 mt -109.43 130.0 63.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.246 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.4 t -83.7 165.16 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' H ' HG12 ' A' ' 104' ' ' VAL . 61.2 m-20 -50.0 116.97 2.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.18 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.8 p -49.92 -21.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.701 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -80.3 -37.4 32.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.837 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.1 -21.66 66.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.119 0.485 . . . . 1.0 110.412 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 57.79 61.43 2.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.523 -0.762 . . . . 1.0 112.9 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.9 m -93.31 125.88 38.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -121.6 146.43 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.431 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -113.86 152.01 31.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.782 -1.099 . . . . 1.0 108.668 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 120.416 -0.514 . . . . 1.0 111.446 -178.091 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 120.803 0.251 . . . . 1.0 112.37 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 103' ' ' ILE . 3.0 t -120.4 129.5 75.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.431 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.5 m-20 -44.53 140.9 2.97 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.708 0.29 . . . . 1.0 111.365 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -38.32 -23.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.064 2.51 . . . . 1.0 113.685 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -53.78 -62.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.23 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.442 ' CD2' HD11 ' A' ' 143' ' ' LEU . 71.7 t60 -71.29 -23.48 61.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.676 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.443 ' CG1' HG23 ' A' ' 106' ' ' VAL . 80.4 t -59.41 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.623 0.601 . . . . 1.0 112.623 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.14 -39.76 95.61 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.37 -37.61 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.442 HD11 ' CD2' ' A' ' 139' ' ' HIS . 61.8 mt -72.99 -42.13 63.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.192 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.81 -42.94 90.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.8 m -62.11 -19.45 63.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.623 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.0 mmm -99.54 0.98 43.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.102 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.76 19.63 75.28 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.473 HG21 HH21 ' A' ' 50' ' ' ARG . 93.4 t -110.48 144.47 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.734 0.302 . . . . 1.0 110.245 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.63 -24.61 5.71 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -152.41 119.57 5.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.76 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.2 p -127.85 139.32 52.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 1.0 111.405 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -99.38 134.47 42.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 t -114.91 128.25 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.294 -0.563 . . . . 1.0 112.337 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 26.5 t -134.3 133.16 21.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.05 161.22 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.415 2.076 . . . . 1.0 113.692 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.4 mt -115.2 116.81 28.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.9 ptm -141.2 156.2 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -133.26 127.46 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.062 -0.972 . . . . 1.0 108.798 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.497 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 2.0 t60 62.89 -125.4 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.16 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.497 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 19.5 pt20 -99.38 2.06 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.839 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.471 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 10.0 pt-20 -108.91 154.33 22.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.68 126.87 52.19 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.471 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 43.5 m95 -101.79 -28.21 12.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.1 -170.26 31.75 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.598 -1.287 . . . . 1.0 112.318 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 90.0 mt -136.31 123.94 22.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.454 -0.373 . . . . 1.0 111.631 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.483 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.0 tp -96.59 149.65 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.0 p -156.3 133.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.139 -0.625 . . . . 1.0 111.912 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.0 p -117.31 133.08 56.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.249 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.512 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 59.8 m80 -101.65 126.19 48.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 -178.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 170' ' ' HIS . 1.9 m80 -116.25 117.75 30.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.09 25.06 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.75 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 . . . . . 0 C--N 1.327 -0.409 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.572 -179.741 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 183' ' ' VAL . 78.6 mm-40 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.599 0.237 . . . . 1.0 111.214 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.8 mt-10 -70.77 -33.7 71.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 1.0 111.015 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.59 -33.29 72.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.644 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.44 -54.82 5.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.915 -0.314 . . . . 1.0 111.609 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 184' ' ' VAL . 31.8 m -46.51 -40.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.597 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 185' ' ' GLN . 30.1 m -71.88 -50.62 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.58 ' N ' HG23 ' A' ' 184' ' ' VAL . 60.8 tt0 -46.46 -32.16 3.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.7 tt -66.86 -48.04 70.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.027 -0.988 . . . . 1.0 109.1 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 184' ' ' VAL . 91.2 mt -52.69 -45.21 66.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.38 90.11 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.71 -38.01 89.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.5 tp60 -64.88 -32.52 74.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.4 t -77.1 -44.7 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.6 m -52.9 -36.5 59.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -67.57 -36.31 75.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.111 -0.95 . . . . 1.0 110.219 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.45 84.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.948 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.07 -29.73 47.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.55 -55.02 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.398 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.4 pt20 -65.38 -40.03 92.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.222 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.39 -32.91 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 1.0 111.434 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.44 -42.87 83.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.6 mp -54.27 -36.4 63.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.945 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.7 t -49.57 -58.21 5.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.631 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.432 179.864 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.338 . . . . 1.0 110.519 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -65.39 -31.11 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -76.07 -48.99 18.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.853 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.54 -49.99 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.072 0.463 . . . . 1.0 110.997 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.562 HD11 ' CD2' ' A' ' 31' ' ' LEU . 55.1 mt -57.45 -31.52 66.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.914 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.421 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.0 ttt180 -63.01 -40.62 98.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.735 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.48 70.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.795 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.747 ' O ' HG23 ' A' ' 42' ' ' VAL . 73.6 p -65.28 -35.99 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.314 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -75.17 -24.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 1.0 112.201 -177.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.65 -49.99 41.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.247 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.25 -37.25 85.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.779 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 38' ' ' THR . 77.4 t -56.06 -54.1 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.345 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 47' ' ' GLY . 53.7 ttt-85 -51.02 -44.39 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 1.0 110.623 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.77 70.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.323 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.732 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.92 -14.96 21.41 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.664 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.92 26.05 25.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.8 p -81.55 152.38 27.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -48.3 -43.9 33.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.623 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 50.9 ptt85 -158.8 147.28 18.37 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.542 -0.863 . . . . 1.0 112.779 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -139.23 133.88 40.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.002 -0.999 . . . . 1.0 108.736 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.439 ' CE ' HH12 ' A' ' 50' ' ' ARG . 46.1 pttt -137.31 146.25 44.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.379 -0.528 . . . . 1.0 111.66 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.9 t -98.06 142.68 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.0 t80 -130.74 132.6 45.42 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.407 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -111.54 150.64 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 1.0 111.159 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -101.81 133.84 45.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.594 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -99.18 153.35 37.83 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -38.36 -51.61 2.09 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.994 2.463 . . . . 1.0 114.492 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.44 -5.56 29.41 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.173 0.435 . . . . 1.0 112.173 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -7.75 43.15 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.964 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 57' ' ' ASP . 6.0 m-70 -78.98 151.94 31.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.365 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.411 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.99 164.3 25.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.5 p -135.88 157.99 45.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 111.487 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 t -88.08 107.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.83 -3.96 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.083 0.401 . . . . 1.0 112.083 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -154.19 128.29 8.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.342 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.5 tt0 -158.09 139.31 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 1.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -117.37 137.92 52.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.572 . . . . 1.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.757 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.819 0.342 . . . . 1.0 111.401 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.569 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 25.2 mt -99.85 12.17 37.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.967 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.8 tp -66.57 133.33 50.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.916 0.709 . . . . 1.0 112.916 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.92 86.51 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.402 -0.817 . . . . 1.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -87.67 153.14 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.347 0.574 . . . . 1.0 110.53 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.8 m -106.86 132.21 53.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.58 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -106.0 147.21 34.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 134.78 12.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.603 2.202 . . . . 1.0 111.473 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.62 -32.9 72.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 1.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 -16.11 0.11 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.7 m-20 -59.07 -10.49 2.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.66 0.267 . . . . 1.0 110.997 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' HE ' ' A' ' 92' ' ' ARG . 1.8 pt -141.15 145.93 40.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.559 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.59 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.502 2.135 . . . . 1.0 111.709 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 93' ' ' ARG . 79.2 tt0 -163.47 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.963 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -71.7 -39.64 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.662 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.644 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.493 ' HE ' HD12 ' A' ' 87' ' ' ILE . 18.3 ttm180 -61.94 -36.79 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 1.0 110.81 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 18.2 mmt85 -61.51 -35.37 77.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.943 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.08 -33.31 75.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.522 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.29 -34.97 77.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 12.0 mtm180 -75.8 -31.1 59.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.251 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.8 mt -93.78 -38.08 11.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.792 1.034 . . . . 1.0 113.792 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -120.43 -10.54 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.246 1.202 . . . . 1.0 114.246 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.417 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 2.1 mp0 44.46 63.31 1.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.641 -0.824 . . . . 1.0 109.859 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 100' ' ' VAL . 13.2 p -169.33 117.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.315 -0.554 . . . . 1.0 111.882 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.587 HH22 ' CA ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -173.77 131.14 0.42 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.859 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.54 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 2.5 m -142.42 159.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.657 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.498 HG23 HG11 ' A' ' 135' ' ' VAL . 23.8 mt -111.02 128.29 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.252 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 104' ' ' VAL . 19.2 m -87.89 171.45 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.419 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 56.3 m-20 -52.26 113.2 0.96 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.277 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.736 HG23 ' CG1' ' A' ' 140' ' ' VAL . 10.1 p -47.71 -17.74 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 1.0 110.688 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' N ' ' C ' ' A' ' 105' ' ' ASP . 84.7 tt0 -81.81 -36.68 28.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.806 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.58 -20.21 44.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.105 0.479 . . . . 1.0 110.451 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 56.46 58.94 3.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.819 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -96.71 126.83 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -122.39 143.33 49.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.757 ' HG ' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -111.81 156.73 21.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.746 -1.116 . . . . 1.0 108.63 177.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 C--N 1.326 -0.426 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.462 -178.806 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.51 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 63.7 Cg_endo . . . . . 0 N--CA 1.492 1.413 0 CA-C-O 120.824 0.26 . . . . 1.0 112.413 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.587 ' CA ' HH22 ' A' ' 101' ' ' ARG . 1.9 p -117.17 129.26 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.757 ' N ' ' HG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -44.97 141.18 3.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 1.0 111.294 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -40.54 -32.96 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.08 2.52 . . . . 1.0 113.706 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.52 -63.13 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.746 -0.382 . . . . 1.0 111.215 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -71.54 -22.53 61.75 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.589 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.736 ' CG1' HG23 ' A' ' 106' ' ' VAL . 82.3 t -61.69 -55.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -64.68 -38.83 92.34 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.4 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.443 ' O ' ' OG ' ' A' ' 145' ' ' SER . 88.3 t80 -48.72 -34.74 12.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 58.9 mt -73.53 -42.78 61.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.12 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -58.21 -44.53 88.21 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 87.2 p -62.81 -18.03 62.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.659 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.0 mmm -101.53 -0.71 34.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.137 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.07 18.55 78.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 88.1 t -107.32 142.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 1.0 110.27 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.27 -25.31 6.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.419 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 15.0 m -153.96 120.73 5.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.804 -0.359 . . . . 1.0 110.802 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.7 t -127.66 136.42 51.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.983 0.421 . . . . 1.0 111.38 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -97.97 132.33 43.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.0 t -114.86 132.4 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.268 -0.573 . . . . 1.0 112.212 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.52 133.37 20.28 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.7 161.59 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.361 2.041 . . . . 1.0 113.695 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.8 mt -115.26 116.44 28.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' OG ' ' A' ' 192' ' ' SER . 24.9 ptm -141.19 142.8 33.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -125.23 122.43 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.989 -1.005 . . . . 1.0 108.874 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.412 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 26.0 t-80 71.67 -128.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.223 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.412 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 37.4 tt0 -100.47 4.89 44.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.796 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.49 ' CD ' ' CZ2' ' A' ' 163' ' ' TRP . 5.2 pt-20 -111.28 158.31 19.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.726 1.01 . . . . 1.0 113.726 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.3 tp -101.73 128.96 47.82 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.49 ' CZ2' ' CD ' ' A' ' 161' ' ' GLU . 52.1 m95 -105.44 -37.01 6.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.512 0.93 . . . . 1.0 113.512 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.28 -172.82 24.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.731 -1.223 . . . . 1.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.2 tp -141.25 120.92 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.439 -0.38 . . . . 1.0 111.633 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.77 149.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 167' ' ' VAL . 13.5 p -155.95 133.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.034 -0.666 . . . . 1.0 111.836 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 82.1 p -115.62 136.67 52.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 1.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.623 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 65.7 m-70 -115.44 131.15 57.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -123.11 126.19 46.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.51 -16.61 61.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.774 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--N 1.327 -0.399 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.607 179.712 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.408 ' OE1' ' N ' ' A' ' 179' ' ' GLU . 48.7 mp0 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.601 0.239 . . . . 1.0 111.269 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.545 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.7 mt-10 -65.79 -30.73 71.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 1.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.65 -36.23 78.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.611 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.16 -55.97 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.699 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 184' ' ' VAL . 31.8 m -43.72 -41.02 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.66 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.576 HG23 ' N ' ' A' ' 185' ' ' GLN . 27.8 m -75.26 -48.88 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.576 ' N ' HG23 ' A' ' 184' ' ' VAL . 62.0 tt0 -49.24 -34.4 14.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 190' ' ' GLN . 97.5 mt -76.03 -48.0 22.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.982 -1.008 . . . . 1.0 109.079 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.74 -47.73 67.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.4 89.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.472 -0.936 . . . . 1.0 108.472 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.28 -38.6 91.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 186' ' ' LEU . 78.3 mm-40 -66.72 -31.64 72.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.46 -47.25 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.277 -1.009 . . . . 1.0 108.277 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 157' ' ' MET . 14.4 t -49.17 -32.66 10.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -74.72 -33.4 31.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.205 -0.907 . . . . 1.0 110.28 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.44 77.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.6 pt -62.23 -29.62 47.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -75.85 -51.83 11.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.02 -43.31 96.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.212 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.57 -31.93 73.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 1.0 111.395 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.43 -43.67 84.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.1 mp -51.19 -28.46 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.973 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 98.8 p -49.75 -56.01 11.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.471 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 63.5 t0 -48.14 -36.24 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.684 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.52 -50.65 15.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.826 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.93 -48.71 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.021 0.438 . . . . 1.0 110.913 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.48 ' O ' ' OG1' ' A' ' 38' ' ' THR . 31.0 mt -57.38 -28.8 63.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.961 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.2 ttp180 -67.14 -39.14 86.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.778 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.07 -30.82 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.739 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.6 p -67.0 -36.79 82.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.301 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 36' ' ' ARG . 1.1 p -71.62 -25.39 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.35 -36.02 40.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.239 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.58 -48.52 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.833 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.2 p -57.59 -52.1 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.31 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.646 ' N ' HG13 ' A' ' 42' ' ' VAL . 9.0 ptm180 -51.81 -43.41 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 1.0 110.641 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 43' ' ' ARG . . . -51.95 -39.25 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.296 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -69.49 -32.78 71.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.833 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -97.11 -17.15 20.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.704 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.18 26.15 55.51 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 170' ' ' HIS . 48.0 m -77.79 143.75 37.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -55.57 -40.71 72.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.605 0.594 . . . . 1.0 112.605 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.677 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -149.97 130.77 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.525 -0.87 . . . . 1.0 112.763 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.411 HG22 ' OG ' ' A' ' 168' ' ' SER . 6.4 t -139.19 132.72 38.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.911 -1.04 . . . . 1.0 108.727 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.21 150.0 46.33 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.654 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 166' ' ' LEU . 45.3 t -99.57 141.25 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.525 ' OH ' ' CD1' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -131.34 136.24 47.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.442 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -110.43 148.89 31.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 1.0 111.251 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -99.82 126.66 45.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.71 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -92.0 153.25 43.38 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.19 -50.91 2.69 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.94 2.427 . . . . 1.0 114.523 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -70.12 -7.5 42.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.184 0.438 . . . . 1.0 112.184 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.06 -6.65 40.25 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.753 -0.737 . . . . 1.0 112.014 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -77.19 149.9 35.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.348 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.57 158.82 23.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.811 -0.915 . . . . 1.0 110.811 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 p -131.86 155.63 47.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.467 . . . . 1.0 111.426 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.903 HG11 ' O ' ' A' ' 77' ' ' LEU . 3.7 p -91.02 109.35 20.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' VAL . 23.7 t -114.72 -4.32 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.116 0.413 . . . . 1.0 112.116 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . . . -152.15 127.64 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.291 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 12.3 tm-20 -162.36 142.39 9.76 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.703 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' CB ' ' NE ' ' A' ' 43' ' ' ARG . . . -127.95 135.14 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -103.14 135.1 45.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.362 -0.535 . . . . 1.0 112.035 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.797 0 N-CA-C 110.556 -1.017 . . . . 1.0 110.556 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.839 0.352 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.903 ' O ' HG11 ' A' ' 64' ' ' VAL . 40.2 mt -117.74 22.09 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.932 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 67' ' ' GLU . 64.1 mt -67.29 129.77 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.919 0.711 . . . . 1.0 112.919 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.509 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 84.53 -1.88 88.45 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.782 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.783 ' O ' HG12 ' A' ' 64' ' ' VAL . 84.5 mt -87.43 149.74 24.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.418 0.609 . . . . 1.0 110.46 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 81' ' ' THR . 8.8 t -106.14 133.76 50.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.602 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 54' ' ' TYR . 8.2 m-85 -103.39 144.03 27.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.65 138.05 14.89 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.552 2.168 . . . . 1.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.425 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -61.02 -33.14 72.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.913 0.387 . . . . 1.0 110.449 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.5 -18.77 0.22 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 84' ' ' ALA . 95.1 m-20 -65.4 -20.79 66.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 1.0 110.975 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.25 133.87 25.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.57 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.47 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.589 2.193 . . . . 1.0 111.615 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -163.71 -53.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.927 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -43.84 -43.77 6.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.615 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.64 -34.87 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.701 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.581 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 48.8 mtp85 -65.04 -35.03 79.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.779 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.71 -37.03 82.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.945 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.39 -35.0 76.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.556 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -68.46 -33.77 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.73 HH21 ' H ' ' A' ' 162' ' ' LEU . 22.1 mtp180 -77.01 -28.63 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.154 -0.93 . . . . 1.0 111.337 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.76 -39.28 9.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.84 -13.01 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.266 1.21 . . . . 1.0 114.266 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.649 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.8 mp0 48.58 58.22 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.674 -0.811 . . . . 1.0 109.899 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.0 m -159.42 112.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.374 -0.53 . . . . 1.0 112.012 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -165.21 134.07 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.833 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.9 p -151.31 156.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.715 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.451 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 97.9 mt -110.92 130.84 63.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.204 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.09 170.03 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.609 0.718 . . . . 1.0 112.892 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -50.14 116.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.248 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.562 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.5 p -50.45 -19.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.691 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -80.08 -37.24 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.81 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.5 -18.77 42.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 56.77 62.88 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.848 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 t -95.66 124.38 39.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -118.53 145.82 45.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.1 t -109.18 145.92 35.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.811 -1.086 . . . . 1.0 108.641 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.475 -178.873 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 CA-C-O 120.796 0.248 . . . . 1.0 112.378 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.6 m -120.24 129.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 138' ' ' CYS . 9.7 p30 -45.81 142.08 3.86 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 1.0 111.34 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -37.34 -19.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.113 2.542 . . . . 1.0 113.675 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 t -60.73 -61.57 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -69.71 -25.75 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.627 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.562 ' CG1' HG23 ' A' ' 106' ' ' VAL . 88.0 t -59.44 -60.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -60.53 -37.46 81.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.372 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -46.42 -37.94 8.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.61 -43.53 63.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -58.99 -42.98 91.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.9 t -63.63 -20.27 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.669 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.5 0.28 42.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.09 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.77 18.37 78.97 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 89.5 t -108.01 143.82 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.681 0.277 . . . . 1.0 110.273 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -24.19 6.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.018 0.377 . . . . 1.0 112.018 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.9 m -154.34 122.38 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.771 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.9 p -128.08 137.16 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 1.0 111.418 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.39 133.08 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.53 129.19 68.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.298 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.85 127.6 20.37 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -90.41 161.72 4.5 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.425 2.083 . . . . 1.0 113.65 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.85 114.35 24.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.4 ptm -141.29 150.7 42.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 84.5 t60 -125.05 124.14 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.929 -1.032 . . . . 1.0 108.836 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.559 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 53.6 t-80 59.05 -120.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.109 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.559 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.3 pp0? -98.79 0.41 44.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.807 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.429 ' HA ' HH21 ' A' ' 96' ' ' ARG . 47.2 tp10 -105.31 145.87 30.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.73 ' H ' HH21 ' A' ' 96' ' ' ARG . 35.9 tp -101.26 124.7 47.37 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.498 -1.297 . . . . 1.0 107.498 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.435 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 71.6 m95 -103.73 -31.67 9.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.563 0.949 . . . . 1.0 113.563 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.57 -168.32 22.32 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.697 -1.239 . . . . 1.0 112.401 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.17 124.07 14.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.418 -0.391 . . . . 1.0 111.658 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.641 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.1 tp -97.18 150.52 20.79 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.0 p -155.63 133.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.11 -0.636 . . . . 1.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.431 ' OG ' HG21 ' A' ' 48' ' ' THR . 4.1 t -115.53 134.31 55.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 25.5 m-70 -108.38 124.89 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 48' ' ' THR . 79.9 m80 -117.88 119.39 34.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.6 -18.06 61.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.775 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 C--N 1.327 -0.411 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.558 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 183' ' ' VAL . 97.3 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.653 0.263 . . . . 1.0 111.254 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.56 -34.87 79.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 1.0 110.932 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 181' ' ' LEU . 3.1 tt -55.36 -59.68 4.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.574 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -59.31 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.713 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 179' ' ' GLU . 92.7 t -45.43 -39.63 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.664 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.59 -50.51 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -49.31 -34.55 15.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 186' ' ' LEU . 36.1 tp -72.55 -48.12 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.033 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.67 -45.51 63.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.86 91.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.07 -39.3 91.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.474 ' HA ' HD12 ' A' ' 193' ' ' ILE . 79.8 mm-40 -66.6 -31.93 72.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.91 -48.09 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.6 p -52.03 -35.25 46.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 190' ' ' GLN . 25.6 mt -66.95 -35.24 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.82 -39.68 79.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.986 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.63 -47.78 78.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -62.91 -48.99 76.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.39 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.32 -46.27 87.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.269 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.43 75.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.397 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -56.65 -41.3 76.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.6 mt -55.15 -32.84 62.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.966 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.6 m -51.37 -57.09 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.656 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.8 mp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.467 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 195' ' ' ILE . 1.4 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.805 0.336 . . . . 1.0 110.503 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.5 p-10 -48.74 -33.78 10.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 51.3 tt0 -76.01 -48.82 19.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 38' ' ' THR . 23.1 mm -56.84 -46.04 83.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 1.0 111.025 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 38' ' ' THR . 40.2 mt -57.95 -29.41 65.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 1.0 112.008 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 39' ' ' VAL . 96.9 mtt180 -69.48 -40.74 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.785 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.14 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.533 ' O ' HG13 ' A' ' 42' ' ' VAL . 50.6 p -67.97 -37.56 81.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.329 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -69.62 -22.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.45 -36.5 38.76 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.267 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -71.0 -44.42 65.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.764 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 43' ' ' ARG . 16.6 m -59.53 -47.23 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.336 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 47' ' ' GLY . 50.4 ttp180 -50.4 -46.08 55.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 1.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.18 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.316 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -63.38 -40.55 97.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.807 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.96 -13.58 22.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.713 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.11 26.43 20.17 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.618 ' HG1' ' CE1' ' A' ' 170' ' ' HIS . 59.7 m -77.13 144.3 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.51 -41.02 72.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.522 0.564 . . . . 1.0 112.522 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' NH2' HD12 ' A' ' 77' ' ' LEU . 71.1 ttt-85 -150.51 132.26 14.99 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.65 -0.82 . . . . 1.0 112.842 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 42' ' ' VAL . 14.6 p -141.95 134.52 28.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.97 -1.013 . . . . 1.0 108.725 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -137.95 151.14 47.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.249 -0.581 . . . . 1.0 111.614 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 48.0 t -97.39 140.88 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.7 t80 -130.57 130.5 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.388 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.432 HH22 HG21 ' A' ' 65' ' ' VAL . 24.6 ttm105 -106.39 145.01 32.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 1.0 111.275 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 57' ' ' ASP . 64.4 t80 -99.56 127.55 45.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.877 -0.602 . . . . 1.0 111.703 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.575 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -98.24 154.41 37.67 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -50.86 -36.25 51.89 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.03 2.487 . . . . 1.0 114.469 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.43 -4.28 55.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.184 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.79 -16.51 47.14 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.859 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.575 ' NE2' ' CB ' ' A' ' 57' ' ' ASP . 36.6 p-80 -78.12 148.74 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.65 160.78 24.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.1 p -133.62 154.79 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 1.0 111.567 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.797 HG11 ' O ' ' A' ' 77' ' ' LEU . 7.1 p -92.71 113.02 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.432 HG21 HH22 ' A' ' 55' ' ' ARG . 2.5 t -114.72 -1.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 1.0 112.041 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.52 129.05 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.279 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 18.1 pt-20 -162.71 142.13 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.472 -0.491 . . . . 1.0 111.678 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.7 146.82 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -134.32 146.52 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.969 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 179.617 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.808 0.337 . . . . 1.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.797 ' O ' HG11 ' A' ' 64' ' ' VAL . 20.5 mt -94.35 10.26 34.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.952 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.4 tp -57.12 129.24 40.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.54 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 85.85 -4.86 85.32 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.863 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.774 ' O ' HG12 ' A' ' 64' ' ' VAL . 88.0 mt -82.21 147.47 28.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.308 0.554 . . . . 1.0 110.392 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.7 m -108.34 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.622 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -105.82 148.12 35.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.208 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.89 137.4 12.48 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.548 2.166 . . . . 1.0 111.428 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.8 -34.75 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.854 0.359 . . . . 1.0 110.439 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.11 -17.77 0.12 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.9 m-20 -58.17 -14.16 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.668 0.271 . . . . 1.0 111.018 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.0 145.62 19.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.513 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.496 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 79.2 Cg_endo -74.52 -88.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.502 2.135 . . . . 1.0 111.691 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 85.1 tt0 -170.15 -36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.16 -39.93 63.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.574 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.51 63.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.515 -0.312 . . . . 1.0 111.733 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.695 HH12 ' NH2' ' A' ' 96' ' ' ARG . 76.6 ttt-85 -61.81 -35.86 79.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.778 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -63.88 -36.89 85.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.937 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD13 ' NH1' ' A' ' 101' ' ' ARG . 7.3 mt -61.55 -37.02 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.524 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -65.88 -34.51 78.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.695 ' NH2' HH12 ' A' ' 92' ' ' ARG . 40.3 ttm180 -76.3 -30.3 57.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.097 -0.956 . . . . 1.0 111.252 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.6 mt -93.86 -39.93 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.41 -10.7 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.198 1.184 . . . . 1.0 114.198 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 100' ' ' VAL . 1.6 mp0 46.72 49.17 14.27 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.688 -0.805 . . . . 1.0 109.904 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 99' ' ' GLN . 17.1 t -152.85 111.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.954 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.499 ' NH1' HD13 ' A' ' 94' ' ' LEU . 5.0 tpt180 -165.86 130.23 2.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.875 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.04 158.01 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.726 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 135' ' ' VAL . 82.2 mt -111.44 128.82 67.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.228 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 104' ' ' VAL . 3.0 m -86.7 170.2 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.976 0.732 . . . . 1.0 112.976 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -48.58 115.01 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.221 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.546 HG13 ' CG1' ' A' ' 140' ' ' VAL . 54.9 t -52.65 -23.07 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.697 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -76.6 -39.01 53.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.781 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.5 -15.51 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.12 0.486 . . . . 1.0 110.436 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.406 ' OE1' ' NH2' ' A' ' 111' ' ' ARG . 6.4 tt0 56.37 61.85 2.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.465 -0.789 . . . . 1.0 112.885 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 m -96.97 125.23 41.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.808 -1.552 . . . . 1.0 106.808 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.406 ' NH2' ' OE1' ' A' ' 109' ' ' GLN . 97.2 mtt180 -118.36 146.41 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -109.43 148.51 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.6 178.155 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 113' ' ' ILE . 22.0 pt . . . . . 0 C--N 1.326 -0.446 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.457 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo . . . . . 0 N--CA 1.491 1.335 0 CA-C-O 120.788 0.245 . . . . 1.0 112.391 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.439 HG21 HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -111.44 122.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 138' ' ' CYS . 17.9 t70 -44.82 138.69 4.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.761 0.315 . . . . 1.0 111.356 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -35.93 -20.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.125 2.55 . . . . 1.0 113.603 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.8 t -62.63 -62.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 58.7 t-80 -69.53 -25.48 64.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.69 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.546 ' CG1' HG13 ' A' ' 106' ' ' VAL . 96.7 t -58.76 -59.05 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 14.1 p80 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.346 -0.541 . . . . 1.0 110.341 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.636 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 73.8 t80 -46.99 -38.79 11.3 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.53 -43.61 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -58.06 -43.08 86.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.6 m -62.97 -19.96 64.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.645 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.76 -1.28 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.097 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.57 18.14 78.04 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.49 142.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 1.0 110.277 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -22.45 7.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.981 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 p -155.17 123.16 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.769 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.0 m -129.08 137.41 51.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.416 . . . . 1.0 111.449 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.05 133.07 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.17 130.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.327 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.07 133.1 18.39 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.563 ' HB2' HD11 ' A' ' 162' ' ' LEU . 5.9 Cg_endo -95.32 166.82 1.51 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.412 2.075 . . . . 1.0 113.759 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.44 116.7 27.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.564 ' HB3' HD12 ' A' ' 162' ' ' LEU . 24.4 ptm -142.45 152.97 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 -176.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 58.7 t60 -131.68 124.15 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.075 -0.966 . . . . 1.0 108.891 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.415 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.0 t-80 64.63 -126.56 0.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.122 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.415 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 98.0 mm-40 -97.05 4.96 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.784 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.528 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -107.53 145.99 32.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.723 1.009 . . . . 1.0 113.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 157' ' ' MET . 20.2 tp -99.54 125.64 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.528 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 72.1 m95 -103.33 -34.25 8.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.31 33.03 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.651 -1.262 . . . . 1.0 112.403 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 78.1 mt -135.66 121.47 19.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.469 -0.365 . . . . 1.0 111.664 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.474 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.6 tp -94.53 150.51 20.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.5 p -156.84 133.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.803 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.1 p -114.13 139.77 49.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.26 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 12.4 m80 -111.21 123.81 50.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.618 ' CE1' ' HG1' ' A' ' 48' ' ' THR . 73.4 m80 -117.87 119.37 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.04 -18.36 62.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.744 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.616 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.646 0.26 . . . . 1.0 111.277 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 184' ' ' VAL . 77.8 mm-40 -67.66 -34.23 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 1.0 110.975 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -65.96 -40.09 90.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.592 -179.175 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -77.95 -52.15 9.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.66 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.8 t -44.58 -44.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.678 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.629 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.2 p -74.29 -50.58 26.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.629 ' N ' HG13 ' A' ' 184' ' ' VAL . 61.5 tt0 -49.82 -36.05 25.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 190' ' ' GLN . 28.2 tp -71.23 -47.61 56.19 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.016 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 187' ' ' LEU . 53.1 tp -54.04 -45.76 71.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.61 91.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -59.63 -36.6 76.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 186' ' ' LEU . 1.0 OUTLIER -67.32 -31.26 71.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.3 t -77.07 -46.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 157' ' ' MET . 37.8 p -50.93 -32.69 21.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.42 -33.06 32.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.232 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.82 80.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.959 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.409 ' HA ' HD21 ' A' ' 31' ' ' LEU . 25.1 pt -65.86 -26.46 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.44 -54.4 6.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.362 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 8.0 pt20 -67.39 -37.87 83.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.12 -33.19 74.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.378 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.04 -43.44 86.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.177 0.436 . . . . 1.0 112.177 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.9 mt -53.28 -35.86 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.99 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.8 t -47.22 -56.12 7.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.611 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.407 179.701 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.786 0.326 . . . . 1.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -49.43 -32.84 12.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.735 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -75.91 -48.29 21.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.778 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 38' ' ' THR . 98.3 mt -55.18 -51.47 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.034 0.445 . . . . 1.0 110.993 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.491 ' O ' ' OG1' ' A' ' 38' ' ' THR . 88.0 mt -55.69 -31.46 62.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.914 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 39' ' ' VAL . 91.0 mtt180 -65.62 -38.77 90.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.392 -0.523 . . . . 1.0 109.743 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.24 -32.22 68.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.783 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 p -66.9 -36.93 83.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.274 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.584 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.9 p -72.46 -24.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.269 0.47 . . . . 1.0 112.269 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -70.66 -44.99 65.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.276 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -69.93 -35.0 74.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.754 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 38' ' ' THR . 77.5 t -59.64 -54.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.296 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.5 ttt-85 -51.52 -44.55 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 1.0 110.746 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.21 -46.35 79.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.295 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.548 ' CE2' ' OE2' ' A' ' 180' ' ' GLU . 63.6 t80 -62.41 -41.45 98.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.815 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.0 mt -96.33 -12.85 23.84 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.706 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 51.68 25.08 13.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.542 ' HB ' ' CE1' ' A' ' 170' ' ' HIS . 15.2 t -78.45 148.06 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -51.94 -42.25 62.7 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.538 HH22 ' CG ' ' A' ' 77' ' ' LEU . 77.9 ttt180 -152.95 137.17 16.51 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.647 -0.821 . . . . 1.0 112.808 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 51' ' ' VAL . 11.7 p -142.75 133.15 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.668 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.8 pttm -138.33 151.85 47.94 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.679 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.2 t -97.42 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.8 t80 -130.01 132.86 46.41 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.854 -0.338 . . . . 1.0 110.434 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.82 150.9 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.424 . . . . 1.0 111.215 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -102.38 132.71 48.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.698 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 61' ' ' HIS . 26.6 m-20 -97.71 154.52 37.85 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -40.14 -50.81 3.4 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.001 2.467 . . . . 1.0 114.479 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.74 -6.77 39.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.3 -7.41 37.23 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.697 -0.764 . . . . 1.0 111.905 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' ASP . 21.5 m80 -79.72 151.91 30.17 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.371 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.71 163.52 25.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -135.07 156.92 48.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.024 0.44 . . . . 1.0 111.483 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.26 109.63 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.33 -4.79 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.28 128.12 9.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.251 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HG3' HH21 ' A' ' 50' ' ' ARG . 0.6 OUTLIER -159.41 141.28 13.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.655 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.82 137.29 52.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 76' ' ' SER . 83.4 mtm-85 -111.5 138.39 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.075 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.501 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.849 0 N-CA-C 110.624 -0.99 . . . . 1.0 110.624 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 12.9 m . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.851 0.358 . . . . 1.0 111.338 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' CG ' HH22 ' A' ' 50' ' ' ARG . 43.3 mt -95.93 11.82 32.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 1.0 109.938 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.1 mt -58.9 131.51 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.85 -3.77 86.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.905 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.29 149.16 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.286 0.543 . . . . 1.0 110.454 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 81' ' ' THR . 12.9 t -105.46 131.14 53.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -105.5 106.1 54.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -42.26 134.07 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.508 2.139 . . . . 1.0 111.528 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -57.94 -30.6 66.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.861 0.363 . . . . 1.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.85 -17.69 0.1 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.4 t0 -67.49 -28.93 68.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 1.0 111.036 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mm -112.01 133.05 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.503 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 97.1 Cg_endo -76.28 -111.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.642 2.228 . . . . 1.0 111.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 90.6 mt-10 -151.57 -51.23 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.905 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.2 -40.59 67.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.633 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.32 -37.89 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.749 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 65.3 ttt180 -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.8 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -64.07 -35.53 81.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.911 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.26 -34.93 77.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.504 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -69.78 -37.64 76.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -77.31 -30.65 54.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.47 -40.39 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -117.04 -11.35 10.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 98' ' ' ALA . 2.4 mp0 44.55 62.98 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.663 -0.815 . . . . 1.0 109.898 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.8 p -168.54 114.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 120.31 -0.556 . . . . 1.0 111.854 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.466 ' HE ' ' CA ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -167.5 137.22 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.911 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.3 p -149.5 156.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.676 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.576 HG23 HG21 ' A' ' 135' ' ' VAL . 3.2 mt -109.57 128.34 65.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.257 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 105' ' ' ASP . 4.0 t -84.65 165.88 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.013 0.745 . . . . 1.0 113.013 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.538 ' N ' HG12 ' A' ' 104' ' ' VAL . 75.8 m-20 -50.32 116.25 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.216 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.428 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.2 p -49.77 -21.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.74 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.28 -38.02 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.797 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.06 -21.19 63.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 1.0 110.399 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 57.97 60.61 2.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.53 -0.759 . . . . 1.0 112.854 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -94.23 125.59 38.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.768 -1.568 . . . . 1.0 106.768 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -120.38 144.76 47.73 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -117.03 157.15 26.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.801 -1.09 . . . . 1.0 108.634 177.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.41 HG23 ' C ' ' A' ' 112' ' ' SER . 27.9 pt . . . . . 0 C--N 1.326 -0.455 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.407 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.492 1.401 0 CA-C-O 120.812 0.255 . . . . 1.0 112.396 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 103' ' ' ILE . 3.6 m -118.48 131.22 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -40.9 156.57 0.2 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.669 0.271 . . . . 1.0 111.388 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.33 -26.12 80.76 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.13 2.553 . . . . 1.0 113.584 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -58.47 -56.63 19.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.0 111.21 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.526 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 2.0 t60 -68.46 -27.16 65.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.602 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.448 ' CG2' HG23 ' A' ' 135' ' ' VAL . 78.1 t -65.26 -53.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.37 -40.88 94.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.397 -0.521 . . . . 1.0 110.362 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -47.63 -35.3 9.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.491 HD11 ' CE1' ' A' ' 139' ' ' HIS . 50.9 mt -73.8 -41.61 62.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.193 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -60.25 -43.59 95.98 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.3 t -61.69 -18.18 58.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.632 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.8 mmm -100.95 2.66 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.166 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.79 19.0 78.34 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 144.77 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.752 0.311 . . . . 1.0 110.211 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.58 -25.1 6.54 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.974 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -154.35 122.24 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.749 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -131.2 141.71 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.006 0.432 . . . . 1.0 111.398 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.74 130.45 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 167' ' ' VAL . 28.5 m -117.0 141.3 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.267 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.83 132.41 20.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -86.87 159.67 8.9 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.35 2.034 . . . . 1.0 113.71 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.4 mt -113.51 116.29 29.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.6 ptm -140.85 149.5 42.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.511 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 86.6 t60 -130.42 122.57 28.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.03 -0.986 . . . . 1.0 108.812 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.441 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 12.1 t-80 69.73 -126.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.144 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.441 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 93.9 mt-30 -100.91 5.85 43.44 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.781 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.531 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 5.7 pt-20 -111.31 156.72 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 34.4 tp -103.38 127.66 50.69 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.518 -1.29 . . . . 1.0 107.518 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.531 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 32.2 m95 -103.86 -34.98 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.44 -174.52 29.28 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.628 -1.273 . . . . 1.0 112.346 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.3 mt -137.11 122.35 19.27 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.422 -0.389 . . . . 1.0 111.677 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.463 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.8 tp -94.31 148.35 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.505 HG23 HG12 ' A' ' 153' ' ' VAL . 11.0 p -152.48 132.01 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.067 -0.653 . . . . 1.0 111.862 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.7 t -115.02 136.8 52.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.709 -0.678 . . . . 1.0 109.227 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.509 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 12.2 m80 -110.55 124.68 52.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.542 ' CE1' ' HB ' ' A' ' 48' ' ' THR . 84.3 m-70 -119.15 121.84 40.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.42 -17.36 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.807 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.591 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.741 0.305 . . . . 1.0 111.263 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.548 ' OE2' ' CE2' ' A' ' 45' ' ' PHE . 38.5 tp10 -63.44 -35.94 82.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 1.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -65.82 -37.03 85.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.626 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -78.59 -52.16 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.709 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.1 t -44.28 -43.1 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.621 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 185' ' ' GLN . 6.9 p -75.39 -49.75 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.595 ' N ' HG13 ' A' ' 184' ' ' VAL . 58.1 tt0 -49.78 -34.36 19.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tp -72.7 -48.24 40.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.067 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.95 -45.87 64.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.93 95.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -63.11 -38.67 92.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.83 -31.32 71.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 49.1 t -76.05 -47.41 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.5 p -53.42 -34.33 57.4 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.41 -35.77 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.205 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.92 83.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.932 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.9 mt -56.92 -44.57 82.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.84 -50.51 64.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.386 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -61.85 -44.82 96.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.22 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.88 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.376 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -57.85 -44.06 86.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.1 tp -52.63 -38.39 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.5 t -51.71 -59.3 4.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.445 179.705 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 35' ' ' LEU . 5.5 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.872 0.367 . . . . 1.0 110.49 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 29.9 p-10 -51.84 -32.82 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.724 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.9 tt0 -76.59 -50.0 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.787 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 38' ' ' THR . 96.6 mt -55.18 -51.8 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.041 0.448 . . . . 1.0 110.899 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.488 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.8 mt -56.13 -30.25 61.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.935 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 39' ' ' VAL . 75.9 ttt180 -64.44 -40.25 95.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.407 -0.517 . . . . 1.0 109.661 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.93 -33.45 70.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.721 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 p -64.51 -37.35 87.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.346 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -73.35 -24.59 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.208 0.448 . . . . 1.0 112.208 -178.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -72.04 -40.81 68.11 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.48 -31.33 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.777 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 38' ' ' THR . 66.6 t -64.84 -56.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.339 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -53.55 -43.11 68.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 1.0 110.703 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.39 -43.17 71.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.288 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -65.64 -36.34 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -96.38 -15.02 22.07 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.706 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.77 26.05 53.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.0 p -80.01 147.29 31.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.9 p30 -54.11 -39.35 66.32 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.644 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -153.12 134.69 14.43 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.574 -0.85 . . . . 1.0 112.813 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -139.8 131.83 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.701 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' NZ ' ' CE1' ' A' ' 169' ' ' HIS . 25.2 pttm -138.73 152.86 48.33 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.294 -0.563 . . . . 1.0 111.614 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -98.15 140.91 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -130.8 131.18 44.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.45 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HE ' HG21 ' A' ' 65' ' ' VAL . 71.8 mtm180 -112.64 153.27 27.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.007 0.432 . . . . 1.0 111.217 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.4 136.87 41.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.677 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 61' ' ' HIS . 34.3 m-20 -97.21 150.58 36.97 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -41.94 -21.71 0.17 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.044 2.496 . . . . 1.0 114.528 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -103.04 3.44 36.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.6 -14.03 57.89 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.686 -0.769 . . . . 1.0 111.922 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 57' ' ' ASP . 66.2 m80 -78.86 150.05 32.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.43 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.57 162.11 25.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -134.34 155.78 49.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.034 0.445 . . . . 1.0 111.491 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 t -88.74 109.57 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.403 HG21 ' HE ' ' A' ' 55' ' ' ARG . 9.1 t -110.46 -5.15 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . . . -152.49 126.25 8.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.3 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.619 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 1.1 tm-20 -158.71 139.67 12.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 1.0 111.695 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.34 136.35 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -107.5 136.41 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.094 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.801 0.334 . . . . 1.0 111.372 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' H ' ' NH2' ' A' ' 50' ' ' ARG . 79.2 mt -102.92 15.19 30.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.946 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.6 mt -66.48 131.47 46.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.03 -5.21 72.3 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.818 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.3 154.52 21.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.333 0.566 . . . . 1.0 110.468 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 p -106.23 128.05 53.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.603 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -103.73 150.08 37.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.263 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.24 134.65 9.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.481 2.121 . . . . 1.0 111.46 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -62.56 -30.4 71.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.796 0.332 . . . . 1.0 110.368 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.4 -16.28 0.06 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.196 -0.762 . . . . 1.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' ALA . 55.6 t0 -58.3 -15.97 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.654 0.264 . . . . 1.0 110.99 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.12 143.44 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.468 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.59 -96.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.548 2.165 . . . . 1.0 111.699 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 2.7 pp20? -162.72 -28.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.92 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 22.5 pt-20 -70.55 -39.72 73.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.585 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.791 ' HB1' HH12 ' A' ' 101' ' ' ARG . . . -74.0 -40.34 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.649 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 61.0 ttp180 -63.14 -36.27 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.349 . . . . 1.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -60.82 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.926 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 94' ' ' LEU . 94.5 mt -63.92 -34.17 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 1.0 111.538 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 28.0 mtp180 -73.72 -31.55 63.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.295 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.8 -37.26 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.17 -16.84 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.571 ' O ' HG23 ' A' ' 100' ' ' VAL . 0.9 OUTLIER 45.73 52.84 9.24 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.619 -0.832 . . . . 1.0 109.964 -178.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 99' ' ' GLN . 24.8 t -157.33 101.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 120.293 -0.563 . . . . 1.0 111.862 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.791 HH12 ' HB1' ' A' ' 91' ' ' ALA . 5.4 mtt180 -158.46 137.92 11.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.876 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -145.97 158.35 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.71 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.47 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 2.9 mp -108.04 128.23 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.249 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.7 t -82.9 164.63 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.476 ' H ' HG12 ' A' ' 104' ' ' VAL . 64.5 t0 -50.6 118.89 3.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.966 -1.016 . . . . 1.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 140' ' ' VAL . 12.1 p -51.28 -22.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.709 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -78.88 -37.82 39.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.797 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.35 63.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.192 0.52 . . . . 1.0 110.432 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 57.55 62.59 2.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.904 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -94.02 124.39 38.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.19 145.23 46.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -110.68 149.67 30.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.803 -1.09 . . . . 1.0 108.6 177.577 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.412 -179.281 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.493 1.464 0 CA-C-O 120.841 0.267 . . . . 1.0 112.375 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.7 m -120.27 131.13 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 112' ' ' SER . 19.7 t70 -43.61 137.57 3.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 1.0 111.378 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -36.22 -25.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.047 2.498 . . . . 1.0 113.696 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 136' ' ' ASP . 25.6 t -53.61 -59.72 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.771 -0.372 . . . . 1.0 111.239 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.5 ' CD2' HD11 ' A' ' 143' ' ' LEU . 73.8 t60 -69.62 -23.89 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.634 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 106' ' ' VAL . 61.2 t -59.11 -61.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -62.04 -40.93 97.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.428 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -45.94 -38.92 8.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.5 HD11 ' CD2' ' A' ' 139' ' ' HIS . 69.4 mt -72.92 -42.81 63.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -57.83 -43.51 85.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.6 t -62.55 -19.9 64.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.336 -0.847 . . . . 1.0 109.636 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.4 mmm -99.0 -0.55 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.09 18.93 75.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 99.0 t -109.32 142.97 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.728 0.299 . . . . 1.0 110.25 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -122.22 -26.01 4.76 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 111.997 0.369 . . . . 1.0 111.997 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p -152.5 118.65 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.727 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 p -129.76 142.21 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.004 0.43 . . . . 1.0 111.359 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tp -98.97 135.19 40.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.06 130.12 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.305 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.0 131.43 18.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -93.92 163.19 2.18 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.363 2.042 . . . . 1.0 113.656 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.3 mt -115.8 113.39 23.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.659 -1.237 . . . . 1.0 107.659 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.8 ptm -140.57 149.28 42.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.466 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 80.3 t60 -120.75 123.62 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.958 -1.019 . . . . 1.0 108.892 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.43 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 31.5 m170 55.86 -118.08 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.122 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -97.44 0.55 47.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.802 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.516 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.01 142.74 34.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.784 1.031 . . . . 1.0 113.784 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 49.4 tp -99.59 123.57 43.98 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.535 -1.283 . . . . 1.0 107.535 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.516 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.4 m95 -103.33 -33.77 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.576 0.954 . . . . 1.0 113.576 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.14 31.95 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.351 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 54.4 mt -134.54 121.39 20.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.706 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.61 149.77 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.444 ' CG1' ' HZ3' ' A' ' 52' ' ' LYS . 10.8 p -157.19 134.13 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.013 -0.675 . . . . 1.0 111.821 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.5 t -114.23 137.47 51.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.464 ' CE1' ' NZ ' ' A' ' 52' ' ' LYS . 17.0 m80 -110.19 127.46 54.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -118.58 120.38 37.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.24 12.77 7.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.83 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.615 -179.373 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.639 0.257 . . . . 1.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.42 -27.5 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.974 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -55.02 -49.78 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.665 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.494 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 5.0 pt20 -78.08 -52.14 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.655 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.494 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 80.1 t -44.28 -42.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.649 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.47 -49.3 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -50.42 -33.09 19.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 190' ' ' GLN . 20.6 tp -74.51 -49.4 22.25 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.065 -0.971 . . . . 1.0 109.112 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 187' ' ' LEU . 1.1 tt -52.35 -46.11 65.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.57 86.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -61.13 -38.33 86.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 186' ' ' LEU . 62.1 tt0 -66.53 -32.34 73.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.29 -47.27 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.8 p -51.96 -35.69 46.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 190' ' ' GLN . 27.7 mt -66.32 -35.66 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.212 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.71 78.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.983 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.6 -46.1 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -66.02 -50.29 64.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.374 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.04 -45.8 91.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.269 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.99 73.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.393 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.39 -41.8 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 tp -51.54 -35.72 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.962 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.8 p -57.29 -60.97 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.621 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.3 mp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.005 -0.998 . . . . 1.0 110.446 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD22 HD11 ' A' ' 35' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.576 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -49.63 -32.16 12.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.96 -48.28 25.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.791 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 38' ' ' THR . 26.6 mm -55.02 -49.95 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.046 0.45 . . . . 1.0 110.939 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 HD22 ' A' ' 31' ' ' LEU . 83.2 mt -55.16 -32.95 62.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.935 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 39' ' ' VAL . 33.9 ttm180 -61.93 -42.34 98.98 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.9 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.787 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 34' ' ' ILE . 82.2 p -66.61 -36.66 83.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 1.0 112.242 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.633 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p -71.25 -24.51 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.174 0.435 . . . . 1.0 112.174 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -78.74 -37.19 41.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.311 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -72.52 -43.41 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.78 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 43' ' ' ARG . 33.9 m -60.14 -49.69 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.304 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.602 ' N ' HG23 ' A' ' 42' ' ' VAL . 71.2 ttp85 -53.33 -45.79 69.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.683 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.53 68.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.255 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -65.7 -36.68 84.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.758 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CB ' HG23 ' A' ' 48' ' ' THR . 14.4 mt -96.68 -14.29 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.704 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.84 25.96 38.9 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.616 HG22 ' CE1' ' A' ' 170' ' ' HIS . 69.5 p -79.29 149.24 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.9 m-20 -49.1 -42.6 39.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.635 HH12 ' CG2' ' A' ' 148' ' ' VAL . 14.9 ptt-85 -158.28 145.44 17.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.576 -0.85 . . . . 1.0 112.791 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.7 t -137.75 135.13 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.943 -1.026 . . . . 1.0 108.684 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 67' ' ' GLU . 34.6 mttt -136.01 147.07 47.81 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.265 -0.574 . . . . 1.0 111.651 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 166' ' ' LEU . 46.9 t -98.81 140.18 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.407 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 16.6 t80 -129.67 130.48 45.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.441 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -111.8 151.76 28.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 1.0 111.215 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.7 OUTLIER -101.91 139.05 38.07 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.631 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.8 m-20 -103.54 154.33 37.94 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -39.98 -51.95 2.93 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.045 2.496 . . . . 1.0 114.51 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.93 -5.03 23.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.11 -8.16 44.96 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.763 -0.732 . . . . 1.0 111.939 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ASP . 57.7 m80 -76.42 148.98 36.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.445 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.77 159.05 23.78 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -132.99 156.09 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.015 0.436 . . . . 1.0 111.449 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 80' ' ' LEU . 7.5 p -94.0 112.05 26.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -115.33 0.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.633 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.48 126.08 8.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.341 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 81.9 tt0 -153.75 138.47 17.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 1.0 111.697 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.91 133.39 51.89 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -112.02 138.54 48.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.35 -0.54 . . . . 1.0 112.055 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.775 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.853 0.359 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' O ' HG11 ' A' ' 64' ' ' VAL . 32.0 mt -114.66 10.62 16.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 67' ' ' GLU . 77.8 mt -55.52 130.1 41.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.517 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.99 -2.53 87.11 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.858 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 64' ' ' VAL . 88.7 mt -85.7 144.86 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.31 0.555 . . . . 1.0 110.483 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 p -102.56 131.26 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.59 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -104.39 105.31 49.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.214 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.26 136.31 5.64 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.555 2.17 . . . . 1.0 111.484 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.854 0.359 . . . . 1.0 110.391 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.06 -17.92 0.12 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.9 m-20 -64.74 -18.36 64.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.606 0.241 . . . . 1.0 111.028 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.79 133.54 18.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.539 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.57 -96.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.556 2.171 . . . . 1.0 111.672 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.7 pt-20 -164.19 -42.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.947 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 86.1 tt0 -52.95 -43.31 66.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.596 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.35 70.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.572 ' HE ' HD23 ' A' ' 162' ' ' LEU . 60.8 ttt180 -65.56 -31.61 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.757 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -64.84 -37.93 89.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 101' ' ' ARG . 8.7 mt -59.19 -37.76 78.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.531 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -68.52 -33.88 74.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -77.46 -30.32 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.291 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.77 -39.53 10.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.0 -11.81 9.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 100' ' ' VAL . 1.5 mp0 46.64 50.53 12.97 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.958 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 99' ' ' GLN . 16.1 t -152.57 111.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.457 HH12 HD13 ' A' ' 94' ' ' LEU . 3.8 tpt180 -164.32 130.13 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.876 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -143.97 156.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.66 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.489 HD12 ' OG ' ' A' ' 151' ' ' SER . 54.7 mt -111.99 127.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.209 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.59 169.65 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.423 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 27.5 m-20 -50.87 115.86 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.305 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.618 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.6 p -50.51 -19.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.661 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -76.28 -40.44 51.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -62.29 -8.18 5.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.132 0.491 . . . . 1.0 110.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 9.7 pt20 45.52 62.5 2.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.751 . . . . 1.0 112.868 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -92.5 127.02 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -118.75 145.17 45.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.623 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -111.04 151.25 28.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.757 -1.11 . . . . 1.0 108.589 178.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.426 -179.673 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.623 ' C ' ' HG ' ' A' ' 112' ' ' SER . 50.9 Cg_endo . . . . . 0 N--CA 1.492 1.401 0 CA-C-O 120.809 0.254 . . . . 1.0 112.402 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -119.78 128.71 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.501 ' HA ' ' H ' ' A' ' 112' ' ' SER . 5.0 t70 -44.86 140.37 3.42 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.802 0.334 . . . . 1.0 111.335 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -36.32 -26.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.198 2.599 . . . . 1.0 113.629 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 136' ' ' ASP . 38.4 t -54.22 -61.45 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.768 -0.373 . . . . 1.0 111.2 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -70.27 -24.92 63.13 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.61 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.618 ' CG1' HG23 ' A' ' 106' ' ' VAL . 59.2 t -60.51 -58.59 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -62.1 -38.88 90.58 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.363 -0.535 . . . . 1.0 110.402 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -47.29 -36.8 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.33 -43.4 60.86 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -58.15 -43.52 87.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.4 t -62.34 -19.28 63.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.687 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.9 mmm -100.15 0.93 41.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.158 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.7 19.46 77.8 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.635 ' CG2' HH12 ' A' ' 50' ' ' ARG . 99.0 t -108.72 144.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.624 0.249 . . . . 1.0 110.369 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.95 -27.44 5.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.423 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 51.1 m -149.71 121.43 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.489 ' OG ' HD12 ' A' ' 103' ' ' ILE . 87.9 p -130.45 141.8 50.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 1.0 111.418 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -103.21 133.74 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.9 t -112.64 129.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.247 -0.581 . . . . 1.0 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.69 132.83 21.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.27 164.52 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.362 2.042 . . . . 1.0 113.738 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 mt -117.05 114.31 23.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.64 -1.245 . . . . 1.0 107.64 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.432 ' H ' ' HB2' ' A' ' 192' ' ' SER . 23.5 ptm -141.47 153.02 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.556 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 58.9 t60 -126.97 126.42 43.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.9 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.556 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 38.8 m80 57.0 -120.87 1.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.157 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -97.8 2.32 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.791 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.58 145.3 31.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.572 HD23 ' HE ' ' A' ' 92' ' ' ARG . 51.7 tp -100.76 124.25 46.13 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 75.3 m95 -102.94 -33.22 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 54' ' ' TYR . . . -162.88 -172.33 30.23 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.598 -1.286 . . . . 1.0 112.3 -177.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.62 122.67 19.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.426 -0.387 . . . . 1.0 111.682 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -95.99 149.35 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.7 p -154.68 133.81 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.981 -0.687 . . . . 1.0 111.836 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 96.4 p -116.17 133.74 55.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.234 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -108.43 128.35 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.616 ' CE1' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.4 123.29 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.269 -1.012 . . . . 1.0 108.269 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.76 -18.94 62.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.774 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.585 0.231 . . . . 1.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.8 mt-10 -68.68 -26.83 65.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 1.0 110.983 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.25 -38.27 88.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.646 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -54.86 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.704 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -44.22 -41.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.652 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 185' ' ' GLN . 23.4 m -74.13 -47.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.586 ' N ' HG23 ' A' ' 184' ' ' VAL . 58.1 tt0 -50.68 -33.08 21.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.3 tt -72.84 -50.03 26.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.074 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.4 -44.61 65.46 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.42 92.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -58.42 -37.37 75.23 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -67.77 -31.3 71.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.61 -47.78 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.432 ' HB2' ' H ' ' A' ' 157' ' ' MET . 44.1 p -50.32 -32.2 16.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -74.98 -33.95 30.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.094 -0.957 . . . . 1.0 110.236 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.9 79.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.98 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 196' ' ' ALA . 22.4 pt -63.14 -28.91 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.05 -52.3 10.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.356 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.23 -41.81 96.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.302 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.61 72.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.409 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.03 -43.89 87.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.57 -35.77 54.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.707 -0.397 . . . . 1.0 111.003 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -51.08 -57.49 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.627 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.413 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.915 0.388 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 30.9 p-10 -50.66 -32.67 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.677 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 52.7 tt0 -75.67 -49.99 16.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.863 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.77 -50.58 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 1.0 110.936 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.468 ' O ' ' OG1' ' A' ' 38' ' ' THR . 65.8 mt -55.82 -31.04 62.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.001 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 39' ' ' VAL . 87.5 mtt180 -67.13 -38.32 85.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.412 -0.515 . . . . 1.0 109.757 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.53 -31.99 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.754 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 42' ' ' VAL . 77.7 p -67.13 -37.77 84.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.553 . . . . 1.0 112.329 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.515 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.5 p -73.57 -22.79 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -73.09 -40.2 65.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.337 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.92 -33.61 59.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.746 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' THR . 79.8 t -62.27 -56.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.349 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -52.91 -42.91 65.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 1.0 110.656 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.78 -45.5 74.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.327 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.29 -36.79 85.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.87 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.74 -16.12 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.715 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.51 24.84 48.25 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 p -79.21 146.94 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -51.62 -42.23 61.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.657 HH22 ' CG ' ' A' ' 77' ' ' LEU . 67.7 ttt180 -153.31 136.45 15.61 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.635 -0.826 . . . . 1.0 112.819 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 8.8 t -139.22 130.67 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.88 -1.055 . . . . 1.0 108.751 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -137.26 150.61 47.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.349 -0.541 . . . . 1.0 111.69 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 166' ' ' LEU . 48.2 t -98.86 140.42 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -129.28 131.99 47.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.488 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -110.9 148.91 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 1.0 111.22 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.8 130.53 48.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.692 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 61' ' ' HIS . 9.9 m-20 -90.53 152.31 45.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -49.5 -18.68 2.56 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.055 2.504 . . . . 1.0 114.466 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.1 4.96 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.137 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 99.79 -15.56 59.48 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.698 -0.763 . . . . 1.0 111.875 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 74.1 m80 -79.86 151.09 30.41 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.88 163.75 25.85 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -135.39 157.55 46.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.973 0.416 . . . . 1.0 111.5 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -90.91 110.6 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 65' ' ' VAL . 15.8 t -111.53 -3.44 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.23 125.89 8.92 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.313 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' OE2' ' CZ ' ' A' ' 50' ' ' ARG . 79.9 tt0 -155.18 138.5 15.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.119 0.485 . . . . 1.0 111.746 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.78 139.89 52.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -131.17 146.03 52.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.031 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.763 0 N-CA-C 110.564 -1.014 . . . . 1.0 110.564 179.663 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.775 0.321 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.657 ' CG ' HH22 ' A' ' 50' ' ' ARG . 26.8 mt -94.08 11.57 29.43 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.421 HD21 ' CB ' ' A' ' 67' ' ' GLU . 86.9 mt -56.48 130.43 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -3.5 87.0 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.369 -0.832 . . . . 1.0 112.854 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.95 146.83 27.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.336 0.568 . . . . 1.0 110.463 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -107.8 138.39 44.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.633 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -110.71 149.76 40.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.193 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.49 133.98 10.9 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.569 2.179 . . . . 1.0 111.44 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -57.22 -31.17 65.22 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.433 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.78 -16.88 0.23 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 30.4 p-10 -66.77 -17.3 64.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.661 0.267 . . . . 1.0 111.029 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.0 mt -137.02 98.41 10.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.506 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 43.7 Cg_exo -39.5 -95.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.507 2.138 . . . . 1.0 111.727 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 82.9 tt0 -163.67 -42.51 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.885 0.374 . . . . 1.0 110.991 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -54.64 -39.68 68.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.571 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.77 -42.01 51.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.741 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.546 HH12 HH11 ' A' ' 96' ' ' ARG . 73.6 ttp85 -61.68 -37.51 84.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.827 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.471 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 91.5 mtt-85 -61.95 -34.86 76.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.001 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.08 -33.69 76.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.5 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -68.39 -33.45 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.546 HH11 HH12 ' A' ' 92' ' ' ARG . 12.7 mtm180 -77.01 -30.74 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.236 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.03 -38.55 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.71 -14.11 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.188 1.181 . . . . 1.0 114.188 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.644 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.1 mp0 47.82 55.94 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.878 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.7 m -158.95 112.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.949 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.487 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 4.2 tpp180 -168.04 133.96 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.797 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.502 HG23 HD23 ' A' ' 152' ' ' LEU . 2.0 p -144.56 157.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.709 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.64 HG23 HG11 ' A' ' 135' ' ' VAL . 8.2 mt -110.51 129.1 66.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.322 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 105' ' ' ASP . 16.7 t -84.06 165.97 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.615 ' N ' HG12 ' A' ' 104' ' ' VAL . 57.1 t0 -47.9 119.53 2.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.947 -1.024 . . . . 1.0 112.282 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.22 -23.51 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.685 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -82.01 -37.09 27.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.777 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.9 -16.13 6.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.162 0.506 . . . . 1.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 57.35 60.16 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 1.0 112.844 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.5 p -95.12 125.98 40.15 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -120.98 138.63 54.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.667 0.988 . . . . 1.0 113.667 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -111.74 156.26 22.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.742 -1.117 . . . . 1.0 108.642 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.403 HG23 ' C ' ' A' ' 112' ' ' SER . 30.7 pt . . . . . 0 C--N 1.325 -0.495 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.475 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.834 0.264 . . . . 1.0 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.64 HG11 HG23 ' A' ' 103' ' ' ILE . 1.1 p -115.27 130.16 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' N ' ' OG ' ' A' ' 112' ' ' SER . 7.9 t0 -44.96 131.99 5.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 1.0 111.393 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.86 -31.02 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.092 2.528 . . . . 1.0 113.662 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.3 t -47.24 -61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.231 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.582 ' CD2' HD11 ' A' ' 143' ' ' LEU . 43.7 t60 -70.88 -23.14 62.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.698 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.49 -58.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.87 -41.23 97.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.331 -0.547 . . . . 1.0 110.398 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.54 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 66.7 t80 -47.41 -38.32 13.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 139' ' ' HIS . 32.9 mt -72.05 -43.68 64.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.04 -42.75 77.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -35.09 75.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.61 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 63.2 mtp -83.39 -1.54 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.071 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.39 75.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.03 143.48 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.272 . . . . 1.0 110.341 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.16 -43.46 2.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.025 0.38 . . . . 1.0 112.025 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.7 m -134.1 119.84 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.763 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.0 m -132.93 144.11 49.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.931 0.396 . . . . 1.0 111.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 102' ' ' VAL . 14.2 mt -99.02 136.83 38.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.59 105.88 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.337 -0.545 . . . . 1.0 112.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 57.5 t -112.83 128.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.212 -1.032 . . . . 1.0 108.212 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -93.36 162.54 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.369 2.046 . . . . 1.0 113.782 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.49 116.72 28.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.605 -1.258 . . . . 1.0 107.605 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.545 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.7 ptm -141.1 148.23 39.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.9 t60 -126.78 132.46 51.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.016 -0.993 . . . . 1.0 108.832 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 23.3 m-70 56.62 -126.52 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -98.31 3.33 48.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.776 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 12.4 pt-20 -109.78 153.25 24.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.703 1.001 . . . . 1.0 113.703 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.7 tp -103.88 127.39 51.4 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.542 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 43.6 m95 -103.88 -32.41 9.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.543 0.942 . . . . 1.0 113.543 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 -174.13 31.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.403 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -135.58 125.12 25.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.388 . . . . 1.0 111.701 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.569 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.5 tp -96.9 149.92 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.7 p -156.5 133.43 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.046 -0.661 . . . . 1.0 111.784 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 t -114.77 135.49 54.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.259 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -110.92 128.61 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -120.75 130.54 54.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.91 26.56 2.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.775 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.945 -0.302 . . . . 1.0 110.63 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.648 0.261 . . . . 1.0 111.205 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -70.72 -30.67 67.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.521 -0.308 . . . . 1.0 110.947 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.08 -33.68 74.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.584 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -77.84 -54.58 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.922 -0.311 . . . . 1.0 111.704 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.4 t -42.92 -41.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 185' ' ' GLN . 28.8 m -75.42 -47.08 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.538 ' N ' HG23 ' A' ' 184' ' ' VAL . 56.2 tt0 -51.8 -32.88 33.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 190' ' ' GLN . 43.2 tp -75.7 -51.69 12.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.66 -46.4 67.15 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.59 98.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.62 ' O ' HD13 ' A' ' 193' ' ' ILE . 61.7 t0 -63.79 -37.01 85.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 186' ' ' LEU . 51.6 tt0 -68.05 -29.24 68.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -76.36 -46.01 33.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 157' ' ' MET . 8.2 t -50.87 -37.52 43.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.1 mp -64.1 -36.83 78.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.261 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.73 82.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.612 . . . . 1.0 110.903 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.33 -47.52 81.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.457 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -64.82 -49.41 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.712 -0.676 . . . . 1.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.43 -45.63 92.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.175 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.94 71.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.375 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.2 -43.11 82.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.29 -35.64 62.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -55.02 -60.69 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.5 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.407 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 1.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 28.8 p-10 -70.91 -32.36 69.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.723 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 53.3 tt0 -77.45 -48.26 17.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.807 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' THR . 96.6 mt -56.02 -50.34 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.055 0.455 . . . . 1.0 110.964 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.471 ' O ' ' OG1' ' A' ' 38' ' ' THR . 78.2 mt -57.56 -30.73 65.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.942 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 39' ' ' VAL . 90.0 mtt180 -66.73 -38.81 87.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.391 -0.524 . . . . 1.0 109.781 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -30.13 65.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.787 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 34' ' ' ILE . 69.0 p -69.69 -36.42 75.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 1.0 112.314 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -71.63 -25.44 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.52 -31.86 32.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 1.0 111.296 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -76.8 -38.34 54.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.709 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.629 HG23 ' N ' ' A' ' 43' ' ' ARG . 30.4 m -66.53 -52.83 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.304 -177.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.629 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -51.87 -43.3 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 1.0 110.669 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.2 -44.12 71.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.317 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -64.66 -35.79 82.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.842 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.29 -13.01 23.68 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.703 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.03 25.83 47.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 p -80.03 148.82 30.94 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.991 -0.374 . . . . 1.0 109.991 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' GLY . 87.8 m-20 -50.25 -42.66 52.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.643 0.608 . . . . 1.0 112.643 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.556 HH21 ' CG2' ' A' ' 148' ' ' VAL . 18.7 ptt-85 -158.4 149.78 21.0 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.633 -0.827 . . . . 1.0 112.805 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -141.33 136.14 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.962 -1.017 . . . . 1.0 108.743 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -137.07 145.58 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.624 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.5 t -100.91 142.1 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 20.7 t80 -130.44 133.27 46.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 1.0 110.426 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.444 HH12 ' CG2' ' A' ' 195' ' ' ILE . 78.1 mtp85 -114.44 154.1 28.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.019 0.438 . . . . 1.0 111.14 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.23 138.19 40.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.711 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -97.42 153.64 38.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -45.39 -21.1 0.65 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.012 2.474 . . . . 1.0 114.463 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -102.83 2.97 36.14 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.206 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.32 -13.68 56.96 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.661 -0.781 . . . . 1.0 111.957 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 57' ' ' ASP . 59.1 m80 -78.72 150.13 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.416 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.29 161.6 25.27 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -133.74 155.92 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.473 . . . . 1.0 111.473 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.22 108.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 65' ' ' VAL . 13.0 t -109.0 -4.99 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.12 0.415 . . . . 1.0 112.12 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.04 125.96 8.41 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.329 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB3' HD21 ' A' ' 78' ' ' LEU . 55.0 tt0 -154.89 139.14 16.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.18 0.514 . . . . 1.0 111.739 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.36 131.82 51.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.6 mtm-85 -103.15 135.08 45.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.071 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.755 0.312 . . . . 1.0 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.37 9.96 38.02 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.978 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 67' ' ' GLU . 95.1 mt -61.75 131.54 50.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.13 73.08 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.877 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.05 152.5 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.345 0.572 . . . . 1.0 110.464 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 81' ' ' THR . 9.0 t -107.43 131.23 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.602 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.07 148.79 36.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.273 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.8 129.18 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.489 2.126 . . . . 1.0 111.459 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -56.97 -31.13 64.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.866 0.365 . . . . 1.0 110.463 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.92 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.7 m-20 -63.72 -26.39 68.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.562 0.22 . . . . 1.0 111.02 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.5 mt -122.59 132.99 24.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.555 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.6 -103.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.608 2.205 . . . . 1.0 111.633 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 22.3 pt-20 -159.66 -40.77 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.032 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 87.2 tt0 -60.27 -41.28 92.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.623 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.82 -39.86 63.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.631 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 60.9 ttp180 -63.14 -37.5 87.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 1.0 110.808 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.72 -34.66 74.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.941 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.84 -32.23 73.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.614 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.41 -35.84 78.24 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.3 mtm180 -73.55 -33.63 64.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.215 -0.902 . . . . 1.0 111.262 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.4 mt -95.54 -37.67 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.782 1.03 . . . . 1.0 113.782 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.16 -15.05 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -175.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.662 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER 47.48 57.45 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.658 -0.817 . . . . 1.0 109.969 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.4 m -159.57 114.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.88 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.475 ' HE ' ' CA ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -168.44 132.46 1.57 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.878 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.64 157.78 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.688 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 135' ' ' VAL . 6.3 mt -109.75 126.98 66.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.266 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.69 169.56 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -49.84 115.21 1.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.952 -1.022 . . . . 1.0 112.292 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 140' ' ' VAL . 55.6 t -51.57 -17.68 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.72 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -81.97 -36.69 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.789 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -60.71 -8.91 3.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.172 0.511 . . . . 1.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.588 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 16.2 pt20 46.8 60.21 3.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.844 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 p -94.43 129.19 41.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -119.69 142.36 48.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.681 0.993 . . . . 1.0 113.681 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.2 p -109.29 149.53 29.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.753 -1.112 . . . . 1.0 108.661 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 113' ' ' ILE . 6.2 mt . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.451 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 120.786 0.244 . . . . 1.0 112.374 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.733 HG21 HG12 ' A' ' 103' ' ' ILE . 4.6 t -118.26 130.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 138' ' ' CYS . 16.9 t70 -45.2 135.9 5.22 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.385 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -36.97 -21.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.07 2.513 . . . . 1.0 113.677 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 136' ' ' ASP . 54.1 t -56.21 -60.17 3.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.758 -0.377 . . . . 1.0 111.237 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -71.26 -25.01 62.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.64 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 106' ' ' VAL . 19.3 t -60.14 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.668 0.618 . . . . 1.0 112.668 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 144' ' ' LYS . 86.1 t60 -63.18 -39.48 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.368 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' O ' ' OG ' ' A' ' 145' ' ' SER . 77.6 t80 -45.77 -36.07 4.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.69 -42.48 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.68 -42.45 92.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 97.4 p -64.16 -20.01 65.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.618 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 25.7 mmm -99.98 1.58 42.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.06 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.89 19.45 77.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.556 ' CG2' HH21 ' A' ' 50' ' ' ARG . 86.4 t -109.38 144.22 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.719 0.295 . . . . 1.0 110.275 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.34 -27.47 6.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.974 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 p -152.0 121.9 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.685 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.7 t -131.04 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 111.474 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.82 132.64 53.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.525 HG12 HG23 ' A' ' 167' ' ' VAL . 31.9 m -117.86 139.49 44.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.336 -0.546 . . . . 1.0 112.323 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.6 t -134.09 134.27 22.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -89.49 159.64 5.41 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.381 2.054 . . . . 1.0 113.718 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.1 mt -114.63 113.59 24.55 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.0 ptm -142.09 153.36 44.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.778 0.658 . . . . 1.0 112.778 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -127.85 122.92 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.872 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 160' ' ' GLN . 17.2 t60 59.65 -118.1 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.133 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.477 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 13.5 pt20 -99.65 1.15 43.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -106.02 143.73 33.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.84 126.42 45.94 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -105.47 -35.37 7.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.3 -173.75 27.12 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.654 -1.26 . . . . 1.0 112.353 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.8 tp -138.07 122.5 18.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.449 -0.375 . . . . 1.0 111.657 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.408 HD12 HG22 ' A' ' 53' ' ' VAL . 11.3 tp -93.76 144.77 25.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 153' ' ' VAL . 8.4 p -151.86 132.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.856 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.9 m -118.36 128.97 55.15 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.555 ' CD2' ' HG3' ' A' ' 50' ' ' ARG . 66.5 m-70 -100.22 126.14 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.647 0.61 . . . . 1.0 112.647 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.8 t60 -119.54 109.98 16.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.37 49.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 32.9 mm-40 . . . . . 0 C--N 1.326 -0.433 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.614 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.628 0.252 . . . . 1.0 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.77 -33.53 72.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.24 -42.7 91.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.626 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -67.28 -52.5 39.89 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.664 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.3 t -42.08 -43.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.63 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.05 -46.19 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -52.13 -32.78 37.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.058 -1.089 . . . . 1.0 108.058 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 190' ' ' GLN . 22.8 tp -74.66 -55.97 5.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.088 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -52.03 -45.86 64.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.98 74.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.53 -37.93 82.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 186' ' ' LEU . 49.1 tp60 -64.96 -33.07 75.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.99 -46.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.2 p -51.99 -35.15 45.63 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 mt -68.94 -35.03 67.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.265 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.57 -41.69 75.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.914 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.444 ' CG2' HH12 ' A' ' 55' ' ' ARG . 65.7 mt -56.71 -45.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.38 58.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.367 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -61.73 -44.31 97.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.266 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.74 70.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 1.0 111.419 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.22 -43.43 82.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.181 0.438 . . . . 1.0 112.181 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.7 mp -52.53 -33.26 44.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.984 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.1 -58.76 5.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.691 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.548 HD23 ' C ' ' A' ' 202' ' ' LEU . 2.7 tt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.459 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.808 0.337 . . . . 1.0 110.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.3 t0 -70.11 -33.2 71.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.55 -48.49 19.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.834 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -54.93 -53.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 1.0 110.924 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.487 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.7 mt -55.72 -31.41 62.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.96 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' O ' HG12 ' A' ' 39' ' ' VAL . 67.0 ttt180 -62.84 -39.54 94.67 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.383 -0.527 . . . . 1.0 109.822 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.08 -32.74 69.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.762 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 42' ' ' VAL . 74.9 p -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.272 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 2.3 p -73.75 -25.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.211 0.448 . . . . 1.0 112.211 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.44 -44.72 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.287 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.91 -37.85 72.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.751 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' THR . 68.2 t -57.11 -54.25 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.596 -0.274 . . . . 1.0 111.394 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 47' ' ' GLY . 69.9 ttt-85 -52.3 -45.56 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 1.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.45 -44.63 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.257 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -65.4 -39.01 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.795 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.92 -14.69 21.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.68 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.71 25.68 22.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.596 -1.001 . . . . 1.0 110.596 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.495 ' HB ' ' CE1' ' A' ' 170' ' ' HIS . 14.2 t -78.87 147.44 33.14 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -52.91 -41.61 64.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.613 ' HE ' ' CD ' ' A' ' 67' ' ' GLU . 65.0 ttt-85 -152.67 133.44 13.95 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.759 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 51' ' ' VAL . 11.2 p -141.45 132.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.912 -1.04 . . . . 1.0 108.648 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -137.82 153.59 49.61 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.682 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 54.4 t -98.33 141.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 11.5 t80 -131.77 133.56 44.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.483 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -113.81 152.56 30.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 1.0 111.166 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.42 134.92 45.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.769 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 61' ' ' HIS . 19.7 m-20 -99.25 154.24 37.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -38.35 -52.19 1.98 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 122.952 2.435 . . . . 1.0 114.549 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' OE2' ' CD2' ' A' ' 61' ' ' HIS . 22.2 pt-20 -70.69 -6.56 38.15 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.71 -6.76 38.31 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.656 -0.783 . . . . 1.0 111.862 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-70 -77.21 149.14 35.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.42 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -135.52 159.54 24.17 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -133.42 155.15 50.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 1.0 111.527 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.19 110.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 65' ' ' VAL . 14.4 t -111.95 -3.99 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.127 0.417 . . . . 1.0 112.127 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.59 124.74 8.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.287 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.613 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 65.3 tt0 -153.29 138.46 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.176 0.512 . . . . 1.0 111.689 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.53 138.13 52.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -133.46 147.34 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.989 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.578 -1.009 . . . . 1.0 110.578 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.864 0.364 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 HH22 ' A' ' 50' ' ' ARG . 21.3 mt -107.79 9.05 29.06 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.408 HD21 ' CB ' ' A' ' 67' ' ' GLU . 76.8 mt -56.46 131.5 48.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -3.97 86.6 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.88 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.49 147.12 27.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.342 -0.543 . . . . 1.0 110.466 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -104.16 129.83 51.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.54 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -106.17 105.64 54.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.269 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.3 139.35 4.27 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.485 2.123 . . . . 1.0 111.524 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -63.18 -28.21 69.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.817 0.342 . . . . 1.0 110.413 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.91 -17.52 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 24.4 p-10 -68.16 -14.43 62.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.61 0.243 . . . . 1.0 110.996 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.02 133.68 25.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.481 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.16 -102.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.551 2.167 . . . . 1.0 111.639 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -157.84 -43.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.003 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -57.91 -40.34 80.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.636 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -40.65 57.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.679 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 69.3 ttt180 -62.32 -38.35 89.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -62.56 -34.13 76.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.965 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD13 ' NH1' ' A' ' 101' ' ' ARG . 7.9 mt -63.99 -33.37 75.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.593 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -68.92 -33.72 74.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.8 mtm180 -78.07 -30.03 49.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.122 -0.945 . . . . 1.0 111.249 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.5 mt -95.69 -38.93 10.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.67 -12.6 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.455 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 1.5 mp0 46.57 49.02 13.97 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 t -152.22 110.86 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 101' ' ' ARG . 0.4 OUTLIER -165.41 138.34 4.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.933 178.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.4 p -154.11 157.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.709 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.569 HG12 HG21 ' A' ' 135' ' ' VAL . 2.9 mp -111.94 129.85 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.203 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 104' ' ' VAL . 1.2 m -87.33 170.84 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.924 0.712 . . . . 1.0 112.924 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -49.21 114.57 1.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.234 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.414 HG13 ' CG1' ' A' ' 140' ' ' VAL . 39.2 t -51.19 -19.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.686 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -81.18 -37.31 28.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -17.48 19.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 1.0 110.414 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 56.56 61.16 2.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.829 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 m -95.2 125.75 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -118.95 143.98 46.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.65 0.981 . . . . 1.0 113.65 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.3 p -110.54 149.4 30.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.641 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 113' ' ' ILE . 6.4 mt . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.437 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.769 0.237 . . . . 1.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.569 HG21 HG12 ' A' ' 103' ' ' ILE . 2.9 t -116.26 127.43 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.546 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -45.27 144.98 2.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.74 0.305 . . . . 1.0 111.347 -178.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -38.28 -18.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.123 2.549 . . . . 1.0 113.658 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 136' ' ' ASP . 34.6 t -56.98 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.259 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.71 -26.01 62.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.659 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG1' HG13 ' A' ' 106' ' ' VAL . 45.3 t -56.43 -63.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.47 ' CG ' ' N ' ' A' ' 142' ' ' TYR . 23.0 p80 -66.84 -40.88 88.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.386 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.47 ' N ' ' CG ' ' A' ' 141' ' ' HIS . 71.1 t80 -44.3 -39.46 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.6 -41.69 62.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.185 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.25 -43.38 92.42 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -63.34 -21.35 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.618 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.4 mmm -99.14 0.35 43.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.149 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.22 17.46 79.98 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.599 -1.001 . . . . 1.0 110.599 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.73 145.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 1.0 110.289 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.14 -20.75 7.89 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.055 0.391 . . . . 1.0 112.055 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 120.07 4.76 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.778 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -124.96 132.49 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.915 0.388 . . . . 1.0 111.412 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -98.73 127.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.0 108.49 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.279 -0.568 . . . . 1.0 112.266 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.63 135.18 20.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -92.28 166.05 2.98 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.408 2.072 . . . . 1.0 113.737 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.39 116.48 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 24.0 ptm -141.58 151.83 43.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.441 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 63.3 t60 -124.1 123.59 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.948 -1.024 . . . . 1.0 108.824 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.2 m170 56.72 -118.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.12 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -98.06 0.58 46.45 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.848 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.467 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.23 143.25 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -176.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.4 tp -99.23 125.71 44.89 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.542 -1.281 . . . . 1.0 107.542 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.467 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 61.7 m95 -104.96 -35.25 7.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.538 0.94 . . . . 1.0 113.538 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.58 -173.58 25.26 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.401 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.7 tp -139.51 120.96 15.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.473 -0.363 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.7 tp -93.63 150.48 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.4 p -155.73 133.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.028 -0.669 . . . . 1.0 111.869 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -115.03 136.03 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 9.7 m80 -108.73 123.44 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.495 ' CE1' ' HB ' ' A' ' 48' ' ' THR . 97.7 m-70 -117.06 125.22 50.98 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.19 -16.63 57.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.817 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--N 1.326 -0.429 0 C-N-CA 120.911 -0.316 . . . . 1.0 110.608 179.889 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 183' ' ' VAL . 78.3 mm-40 . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.713 0.292 . . . . 1.0 111.288 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 184' ' ' VAL . 77.8 mm-40 -71.41 -28.99 64.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.998 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.61 -46.91 86.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.614 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 13.1 pt20 -80.18 -47.07 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.667 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 179' ' ' GLU . 43.1 t -42.86 -45.58 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.644 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 185' ' ' GLN . 34.1 m -74.41 -47.34 40.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.557 ' N ' HG23 ' A' ' 184' ' ' VAL . 40.5 tp60 -49.54 -32.06 11.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.123 -1.066 . . . . 1.0 108.123 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 190' ' ' GLN . 13.8 tp -73.89 -52.11 14.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.034 -0.984 . . . . 1.0 109.098 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.86 -47.51 67.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.62 83.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.429 -0.952 . . . . 1.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.56 ' O ' HD13 ' A' ' 193' ' ' ILE . 65.0 t0 -62.41 -41.73 98.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 186' ' ' LEU . 59.1 tp60 -61.66 -31.3 71.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.84 -44.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.2 p -51.67 -35.8 43.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -66.51 -37.19 79.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.161 -0.927 . . . . 1.0 110.276 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.22 -41.78 80.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.2 mt -56.83 -46.3 83.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.441 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.94 -49.55 67.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.394 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.46 -45.36 93.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.216 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.19 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.362 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -58.26 -44.13 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.219 0.451 . . . . 1.0 112.219 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.93 -32.85 54.99 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.996 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 m -51.87 -57.03 10.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.614 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.096 -0.954 . . . . 1.0 110.441 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 35' ' ' LEU . 1.2 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.713 0.292 . . . . 1.0 110.484 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -48.93 -35.72 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 26.4 mp0 -74.49 -50.7 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.783 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.28 -50.56 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 1.0 110.94 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 38' ' ' THR . 30.5 mt -54.78 -29.7 54.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.95 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.515 ' O ' HG12 ' A' ' 39' ' ' VAL . 76.6 ttt180 -64.37 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 109.754 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.57 -32.86 68.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.835 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.62 ' O ' HG23 ' A' ' 42' ' ' VAL . 70.5 p -66.46 -36.97 84.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.333 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 2.4 p -73.65 -24.48 20.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -45.99 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.308 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -68.55 -38.62 80.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.739 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 38' ' ' THR . 76.9 t -54.78 -55.14 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.296 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -50.11 -43.87 51.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.693 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.54 77.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.269 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.52 -40.72 97.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.753 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -96.92 -14.8 21.52 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.65 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.62 25.8 22.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 p -79.65 149.43 31.27 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 3.0 p30 -53.6 -38.98 64.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 ttt180 -154.51 135.29 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.609 -0.836 . . . . 1.0 112.891 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.0 p -141.81 132.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.01 -0.995 . . . . 1.0 108.783 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -138.25 153.03 49.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.615 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 43.5 t -98.58 139.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HH ' ' C ' ' A' ' 62' ' ' GLY . 23.7 t80 -128.21 131.0 48.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 1.0 110.391 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -109.68 149.13 30.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.41 . . . . 1.0 111.22 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.88 135.76 42.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 61' ' ' HIS . 24.2 m-20 -101.03 153.55 37.67 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -38.85 -51.02 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.06 2.507 . . . . 1.0 114.514 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.41 -5.74 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.199 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.77 -8.84 43.51 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.661 -0.78 . . . . 1.0 111.946 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.567 ' O ' ' N ' ' A' ' 57' ' ' ASP . 73.6 m80 -78.83 151.64 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' HH ' ' A' ' 54' ' ' TYR . . . -139.34 165.09 25.83 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.1 p -136.95 159.61 41.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 1.0 111.455 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 t -87.8 105.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 65' ' ' VAL . 25.8 t -105.68 -6.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.86 122.6 6.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.278 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 81.7 tt0 -150.47 138.06 19.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.122 0.487 . . . . 1.0 111.686 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.61 132.07 51.35 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 44.6 ptt85 -114.17 142.88 45.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.042 -177.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 178.786 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 111.345 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 21.9 mt -111.23 20.37 17.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.021 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.9 tp -64.8 130.67 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.17 88.11 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.861 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.55 149.57 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.325 0.563 . . . . 1.0 110.484 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.5 m -108.46 136.63 47.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.655 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.78 148.67 39.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.256 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.25 138.49 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.494 2.129 . . . . 1.0 111.474 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.915 0.388 . . . . 1.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.87 -16.27 0.2 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 84' ' ' ALA . 93.0 m-20 -70.35 -20.56 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.596 0.236 . . . . 1.0 111.004 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 88' ' ' PRO . 2.2 mt -125.01 95.65 41.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.516 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.0 Cg_exo -44.77 -114.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.521 2.147 . . . . 1.0 111.694 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 56.5 mp0 -147.11 -58.88 0.27 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.936 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -45.72 -42.71 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.681 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.97 -40.09 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.683 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 70.1 ttp85 -62.24 -34.46 76.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.808 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -62.81 -34.58 77.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.914 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.662 ' CD1' HH22 ' A' ' 101' ' ' ARG . 93.3 mt -63.66 -33.6 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.524 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -67.97 -34.06 75.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 36.1 mtp180 -75.33 -31.8 60.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.262 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.79 -36.8 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.753 1.02 . . . . 1.0 113.753 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.31 -17.49 8.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.258 1.207 . . . . 1.0 114.258 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.481 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 0.9 OUTLIER 48.38 55.72 8.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.98 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 99' ' ' GLN . 20.7 t -153.3 109.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.891 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.662 HH22 ' CD1' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -161.88 131.87 4.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.921 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 103' ' ' ILE . 54.0 t -146.53 155.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.665 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.564 HG12 HG21 ' A' ' 135' ' ' VAL . 57.6 mt -112.47 128.53 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.268 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.09 170.53 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.052 0.76 . . . . 1.0 113.052 -176.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -51.2 115.05 1.38 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.246 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.482 HG23 ' CG1' ' A' ' 140' ' ' VAL . 12.0 p -50.07 -19.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.716 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -81.07 -36.41 30.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.79 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.5 -18.34 28.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.137 0.494 . . . . 1.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 57.44 61.49 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.532 -0.758 . . . . 1.0 112.819 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -94.62 125.7 39.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.762 -1.569 . . . . 1.0 106.762 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -118.75 142.93 47.23 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.679 0.992 . . . . 1.0 113.679 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -111.87 150.91 29.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.73 -1.123 . . . . 1.0 108.616 178.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 113' ' ' ILE . 31.4 pt . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.411 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 120.838 0.266 . . . . 1.0 112.378 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.564 HG21 HG12 ' A' ' 103' ' ' ILE . 22.3 t -122.24 133.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -42.08 157.6 0.21 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.356 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.13 -24.57 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.124 2.549 . . . . 1.0 113.614 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -58.02 -58.46 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.246 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.15 -26.76 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.68 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 136' ' ' ASP . 76.3 t -61.1 -56.18 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -62.26 -38.95 91.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.303 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -47.53 -36.22 10.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.03 -42.93 62.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -58.31 -43.68 88.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -62.21 -19.3 63.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.683 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.5 mmm -99.34 0.02 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.133 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 18.26 77.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 84.3 t -108.75 143.59 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.738 0.304 . . . . 1.0 110.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.94 -25.39 4.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -152.49 118.68 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.756 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 96.3 p -129.23 144.2 51.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.994 0.426 . . . . 1.0 111.398 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 152' ' ' LEU . 8.2 mp -102.69 137.33 41.06 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.76 129.1 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 1.0 112.263 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.3 133.29 20.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.49 162.54 3.58 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.368 2.045 . . . . 1.0 113.736 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.6 mt -117.12 115.03 24.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.414 ' H ' ' HB3' ' A' ' 192' ' ' SER . 22.0 ptm -141.99 154.74 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 55.9 t60 -128.34 124.78 37.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.021 -0.991 . . . . 1.0 108.871 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 46.2 m-70 59.72 -121.21 1.03 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.117 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -97.94 0.57 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.823 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.535 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -105.46 143.56 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.6 tp -99.71 124.54 45.06 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.535 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.3 m95 -102.92 -31.02 10.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.31 -169.82 26.21 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.448 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.7 mp -140.03 121.74 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 1.0 111.637 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.1 tp -94.67 149.66 21.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.7 p -157.56 134.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.075 -0.65 . . . . 1.0 111.861 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -114.52 135.76 53.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.267 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -107.82 126.99 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -117.46 122.81 44.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.33 16.69 5.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.797 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.636 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.675 0.274 . . . . 1.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 184' ' ' VAL . 96.1 mt-10 -78.39 -28.96 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 1.0 110.971 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.65 -39.53 73.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.636 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 11.7 pt20 -80.45 -52.87 7.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.92 -0.312 . . . . 1.0 111.682 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' A' ' 182' ' ' GLN . 9.9 p -44.13 -41.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.645 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.6 p -75.1 -49.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.597 ' N ' HG13 ' A' ' 184' ' ' VAL . 56.8 tt0 -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.6 tp -71.74 -48.61 45.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.053 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 187' ' ' LEU . 62.9 tp -51.42 -44.58 62.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.71 91.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -64.09 -39.32 93.8 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -64.53 -31.41 72.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 53.7 t -77.49 -44.58 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 157' ' ' MET . 2.2 m -51.77 -33.6 35.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.78 -34.61 34.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.56 78.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.98 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.1 pt -62.24 -29.82 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.42 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.5 -53.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.639 -0.71 . . . . 1.0 110.37 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.54 -42.63 98.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.321 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.8 74.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.352 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.86 -43.11 80.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 tp -51.35 -38.12 51.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.959 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.4 t -47.85 -57.54 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.631 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.496 179.894 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 31' ' ' LEU . 11.0 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 1.0 110.517 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -48.07 -36.61 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.764 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -74.09 -50.6 18.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.874 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 38' ' ' THR . 95.7 mt -56.47 -45.53 81.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.145 0.498 . . . . 1.0 110.982 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.44 ' O ' ' OG1' ' A' ' 38' ' ' THR . 29.5 mt -58.07 -28.89 64.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.903 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.502 HH12 HD22 ' A' ' 78' ' ' LEU . 87.4 mtt-85 -68.53 -39.5 81.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.81 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.42 -31.71 69.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.9 p -67.68 -36.93 81.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.371 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -74.59 -23.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.209 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.46 -48.36 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.323 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.34 -35.9 80.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.71 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' THR . 70.6 t -58.1 -53.87 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.613 -0.267 . . . . 1.0 111.313 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 47' ' ' GLY . 65.5 ttt-85 -50.21 -43.73 52.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.942 0.401 . . . . 1.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.03 -43.33 70.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.295 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.65 -37.65 87.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.786 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.84 -14.6 21.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.725 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.47 25.68 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.2 p -81.25 152.52 27.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.3 m-20 -48.83 -43.57 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.599 0.592 . . . . 1.0 112.599 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.432 HH21 HG21 ' A' ' 148' ' ' VAL . 30.1 ptt180 -159.17 146.93 17.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.625 -0.83 . . . . 1.0 112.765 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.13 133.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.703 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 61.3 mttt -135.77 142.83 44.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.665 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 166' ' ' LEU . 59.8 t -102.02 140.94 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.453 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 19.1 m-85 -131.55 136.59 47.96 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.531 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -112.86 153.28 28.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.036 0.446 . . . . 1.0 111.188 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CD1' ' NH2' ' A' ' 92' ' ' ARG . 43.5 m-85 -100.0 141.84 32.28 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -114.2 166.67 11.0 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -41.75 -55.82 2.17 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.055 2.503 . . . . 1.0 114.497 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -67.88 -12.56 60.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.79 0.28 48.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.752 -0.737 . . . . 1.0 111.904 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.509 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 2.4 p80 -74.6 148.79 40.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.466 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.54 144.34 16.98 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -125.12 149.69 47.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.948 0.404 . . . . 1.0 111.57 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 77' ' ' LEU . 4.2 p -90.19 108.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 65' ' ' VAL . 12.1 t -112.34 -4.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.32 128.17 9.54 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.271 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 24.0 tt0 -160.75 141.92 11.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 1.0 111.662 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.75 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -110.73 138.59 46.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.038 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 110.611 -0.995 . . . . 1.0 110.611 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.807 0.337 . . . . 1.0 111.346 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.877 ' O ' HG11 ' A' ' 64' ' ' VAL . 41.1 mt -116.19 15.99 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.946 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.502 HD22 HH12 ' A' ' 36' ' ' ARG . 52.3 mt -60.15 129.18 40.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.564 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.8 -2.35 87.17 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.814 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.813 ' O ' HG12 ' A' ' 64' ' ' VAL . 84.1 mt -86.0 147.39 26.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.358 0.579 . . . . 1.0 110.458 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -106.02 133.35 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -105.54 148.39 36.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.217 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.98 140.12 12.43 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.487 2.125 . . . . 1.0 111.493 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -62.97 -31.37 72.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.799 0.333 . . . . 1.0 110.434 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.12 -17.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.8 m-20 -63.23 -24.91 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.624 0.249 . . . . 1.0 111.023 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.66 132.55 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.507 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.58 -99.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.535 2.157 . . . . 1.0 111.672 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -159.25 -47.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.956 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -52.0 -40.99 61.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.636 ' CB ' HH22 ' A' ' 101' ' ' ARG . . . -74.89 -38.32 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.712 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.46 ' HE ' HD23 ' A' ' 162' ' ' LEU . 72.4 ttt180 -61.08 -32.36 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.798 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.07 -36.43 83.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.933 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.78 -36.27 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.532 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -67.96 -37.1 81.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -75.54 -30.23 59.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.162 -0.927 . . . . 1.0 111.26 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -96.98 -38.63 9.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -177.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.94 -14.47 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 100' ' ' VAL . 1.4 mp0 48.8 51.37 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.902 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 99' ' ' GLN . 22.8 t -153.17 109.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.911 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.636 HH22 ' CB ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -164.02 135.91 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.873 178.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -151.58 156.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.684 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 87.7 mt -110.56 130.69 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.265 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 104' ' ' VAL . 1.4 m -85.94 169.66 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.921 0.711 . . . . 1.0 112.921 -177.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.457 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 64.6 m-20 -48.19 116.01 1.4 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.902 -1.044 . . . . 1.0 112.236 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.5 -18.85 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.666 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 109' ' ' GLN . 43.4 tp10 -78.7 -38.83 38.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.821 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.33 -5.91 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.501 . . . . 1.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 11.6 pt20 46.23 63.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 1.0 112.83 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.5 m -91.24 126.96 36.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.77 -1.567 . . . . 1.0 106.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -118.34 144.48 45.84 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -111.71 149.87 31.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.695 -1.139 . . . . 1.0 108.654 178.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 120.435 -0.506 . . . . 1.0 111.418 -179.263 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo . . . . . 0 N--CA 1.491 1.363 0 CA-C-O 120.864 0.277 . . . . 1.0 112.36 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.69 128.92 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 112' ' ' SER . 21.3 t70 -44.2 135.87 4.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.307 . . . . 1.0 111.345 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -37.41 -23.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.132 2.555 . . . . 1.0 113.645 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 136' ' ' ASP . 36.3 t -55.66 -61.3 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.263 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.94 -24.04 61.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.658 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.6 t -57.97 -61.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.551 0.574 . . . . 1.0 112.551 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.592 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 23.2 p80 -60.79 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.391 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.592 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 83.1 t80 -47.44 -39.75 16.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.4 mt -72.06 -43.44 64.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.64 -43.03 79.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.5 m -61.7 -20.12 63.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.709 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.8 mmm -98.48 -1.16 41.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.074 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.53 19.32 76.38 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.432 HG21 HH21 ' A' ' 50' ' ' ARG . 65.7 t -107.56 142.49 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.297 . . . . 1.0 110.242 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.64 -35.17 3.6 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.457 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 22.8 m -143.2 121.17 12.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.766 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 m -129.81 142.11 50.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 1.0 111.378 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -102.76 136.24 42.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.14 128.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.331 -0.548 . . . . 1.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.22 128.97 19.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.255 -1.016 . . . . 1.0 108.255 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -92.6 164.21 2.85 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.4 2.067 . . . . 1.0 113.704 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.9 113.68 22.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.567 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.6 ptm -140.7 152.47 45.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.107 -0.637 . . . . 1.0 112.718 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 53.6 t60 -126.19 123.99 39.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.829 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 56.8 m-70 58.54 -120.73 1.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.182 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -97.42 1.51 49.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.787 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.01 143.44 34.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.46 HD23 ' HE ' ' A' ' 92' ' ' ARG . 39.4 tp -99.31 124.94 44.82 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 66.3 m95 -103.91 -35.31 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -156.87 -174.59 26.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 119.684 -1.246 . . . . 1.0 112.375 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.7 tp -138.42 121.2 16.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.457 HD12 HG22 ' A' ' 53' ' ' VAL . 10.3 tp -93.69 142.57 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.1 p -149.41 131.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.815 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.8 t -116.46 130.66 56.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.197 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -106.21 129.33 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 19.1 t-80 -120.77 117.4 27.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.77 -15.65 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.742 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.419 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 51.1 mm-40 . . . . . 0 C--N 1.326 -0.455 0 C-N-CA 120.894 -0.323 . . . . 1.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.675 0.274 . . . . 1.0 111.318 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -72.1 -36.09 69.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.57 -40.54 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.551 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -67.15 -55.8 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.759 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.3 t -45.73 -40.6 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.626 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.48 -50.76 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -48.43 -36.54 15.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 87.1 mt -71.64 -46.52 58.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.075 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 tp -52.13 -46.33 65.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.939 -0.764 . . . . 1.0 108.939 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.95 91.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.377 -0.971 . . . . 1.0 108.377 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.82 -38.11 89.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 86.0 mt-30 -66.89 -30.6 70.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.72 -45.89 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -52.25 -37.39 55.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 190' ' ' GLN . 31.8 mt -65.47 -34.97 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.162 -0.926 . . . . 1.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.05 78.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.928 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mt -55.24 -50.25 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.96 -50.42 66.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.417 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -61.87 -46.96 87.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.325 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.83 -32.74 74.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.41 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -56.4 -41.63 76.61 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.234 0.457 . . . . 1.0 112.234 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.2 mt -53.77 -34.67 59.78 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.987 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.6 t -44.92 -56.73 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.621 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.418 179.583 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 63.0 t0 -48.82 -34.17 11.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.485 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 22.6 mp0 -76.38 -48.44 19.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.826 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 38' ' ' THR . 25.7 mm -56.56 -50.38 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.065 0.459 . . . . 1.0 110.885 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 38' ' ' THR . 47.9 mt -57.38 -30.24 64.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 1.0 111.934 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.4 ttp85 -65.78 -39.7 91.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.762 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.42 68.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 76.3 p -65.07 -37.85 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.948 -0.569 . . . . 1.0 112.368 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p -71.94 -25.57 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.165 0.432 . . . . 1.0 112.165 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -80.78 -35.12 33.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.298 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -77.15 -42.63 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.76 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.7 p -63.65 -52.4 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.356 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.651 ' N ' HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.22 -42.21 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 1.0 110.697 -179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -53.86 -41.28 67.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.317 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.16 -34.68 78.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.764 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -95.86 -14.83 22.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.8 0.333 . . . . 1.0 111.683 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.92 25.31 45.0 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 p -78.17 145.19 35.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.84 -40.27 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' A' ' 67' ' ' GLU . 44.9 ttt180 -150.47 132.46 15.21 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.511 -0.876 . . . . 1.0 112.762 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 7.1 t -138.69 131.54 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.007 -0.997 . . . . 1.0 108.671 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.598 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.9 pttm -137.17 149.97 47.61 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.722 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 166' ' ' LEU . 61.4 t -98.99 141.35 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 16.0 t80 -131.05 132.31 44.84 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.42 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -113.04 153.56 27.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.012 0.434 . . . . 1.0 111.253 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.79 135.59 44.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.1 m-20 -95.09 150.73 38.12 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -41.45 -21.87 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.012 2.474 . . . . 1.0 114.485 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -103.22 4.6 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.565 -0.454 . . . . 1.0 112.155 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.21 -14.35 59.77 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.671 -0.776 . . . . 1.0 111.897 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 57' ' ' ASP . 39.9 m80 -78.13 150.44 33.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.56 164.0 25.73 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -136.35 158.07 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.034 0.445 . . . . 1.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.2 106.54 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 65' ' ' VAL . 54.7 t -107.92 -5.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.126 0.417 . . . . 1.0 112.126 -177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.19 123.51 7.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.348 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' CD ' HH21 ' A' ' 50' ' ' ARG . 87.1 tt0 -150.87 136.6 18.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 1.0 111.719 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.56 135.85 51.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -119.26 140.06 50.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 1.0 112.044 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.481 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.823 0.344 . . . . 1.0 111.348 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.485 HD12 HH22 ' A' ' 50' ' ' ARG . 15.9 mt -91.69 16.03 11.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.946 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.2 132.68 52.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 -2.94 86.98 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.43 -0.805 . . . . 1.0 112.812 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.5 mt -85.55 150.81 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.372 0.586 . . . . 1.0 110.415 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -109.16 137.63 46.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.622 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -108.99 148.72 38.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.274 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.51 137.02 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.574 2.183 . . . . 1.0 111.442 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.9 -34.75 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.865 0.364 . . . . 1.0 110.445 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.14 -16.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 84' ' ' ALA . 97.5 m-20 -66.39 -22.08 66.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.647 0.261 . . . . 1.0 111.03 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.92 133.36 24.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.529 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.64 -98.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.537 2.158 . . . . 1.0 111.685 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -161.96 -50.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.953 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -46.52 -42.84 16.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.593 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.32 -38.48 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.743 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.57 -32.21 72.29 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.791 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -64.01 -35.31 80.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.915 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.41 -36.04 79.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.534 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.434 ' CE2' ' HG3' ' A' ' 101' ' ' ARG . 45.3 m-85 -68.25 -35.36 77.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -81.11 -27.77 35.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.166 -0.925 . . . . 1.0 111.269 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.95 -42.04 8.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 100' ' ' VAL . . . -119.8 -15.0 8.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.243 1.201 . . . . 1.0 114.243 -174.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.674 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.9 OUTLIER 45.57 54.9 7.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.7 -0.8 . . . . 1.0 109.866 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.9 m -159.68 111.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.857 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.78 ' NE ' ' N ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -170.81 139.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.852 177.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.5 p -146.01 158.36 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.73 -0.668 . . . . 1.0 109.641 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.524 HG23 HG11 ' A' ' 135' ' ' VAL . 49.8 mt -110.62 126.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.217 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 105' ' ' ASP . 10.0 p -86.53 168.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.613 ' N ' HG22 ' A' ' 104' ' ' VAL . 48.7 m-20 -49.0 115.88 1.45 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.283 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.77 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.8 p -51.03 -21.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.675 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -77.94 -38.08 46.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.835 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.58 -16.13 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.185 0.517 . . . . 1.0 110.404 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 56.24 60.93 2.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.482 -0.781 . . . . 1.0 112.824 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.6 m -96.86 126.19 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -117.87 143.92 45.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.519 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -114.45 153.91 29.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.731 -1.122 . . . . 1.0 108.636 177.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 112' ' ' SER . 29.0 pt . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.473 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 120.807 0.253 . . . . 1.0 112.407 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 103' ' ' ILE . 1.4 p -114.95 128.0 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.519 ' HA ' ' H ' ' A' ' 112' ' ' SER . 45.9 p-10 -46.53 138.88 6.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.307 . . . . 1.0 111.315 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -39.21 -28.24 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.145 2.563 . . . . 1.0 113.663 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 t -48.94 -64.42 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.475 ' NE2' HD11 ' A' ' 143' ' ' LEU . 29.6 t60 -71.37 -21.83 61.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.77 ' CG1' HG23 ' A' ' 106' ' ' VAL . 88.5 t -59.34 -58.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -63.1 -40.11 96.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.424 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.517 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 71.2 t80 -47.59 -38.42 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.475 HD11 ' NE2' ' A' ' 139' ' ' HIS . 84.5 mt -71.82 -43.7 65.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.104 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -56.41 -41.98 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.0 m -62.66 -21.36 65.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.692 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.517 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 50.6 mtp -98.31 -0.74 43.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.488 -0.778 . . . . 1.0 111.06 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.05 19.71 76.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.2 t -107.78 143.44 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.679 0.276 . . . . 1.0 110.367 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.56 -26.86 6.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.968 0.359 . . . . 1.0 111.968 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 32.4 m -150.77 120.29 6.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.766 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p -129.76 141.85 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 1.0 111.402 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.3 mp -104.37 130.7 52.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.617 ' O ' ' NE ' ' A' ' 101' ' ' ARG . 10.9 t -113.83 106.36 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.308 -0.557 . . . . 1.0 112.311 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 42.6 t -110.17 135.77 20.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -94.93 167.3 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.299 1.999 . . . . 1.0 113.723 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.1 mt -119.24 116.33 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.7 ptm -141.02 154.78 46.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.408 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 74.8 t60 -127.99 123.39 34.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.942 -1.026 . . . . 1.0 108.865 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.531 ' CG ' ' N ' ' A' ' 160' ' ' GLN . 37.7 t-80 60.23 -120.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.363 . . . . 1.0 110.09 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.531 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 28.0 tp60 -98.26 2.03 47.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.816 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.529 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 144.98 31.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.12 123.99 46.13 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.529 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m95 -102.24 -31.65 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.37 -173.73 31.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.453 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.1 mt -135.12 121.44 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 1.0 111.614 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.649 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.5 tp -94.69 150.82 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.431 HG11 ' NZ ' ' A' ' 52' ' ' LYS . 13.0 p -157.33 134.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.859 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.9 t -115.6 132.8 56.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.598 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 21.4 m80 -101.61 122.66 44.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -117.75 108.7 15.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.42 66.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.751 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 . . . . . 0 C--N 1.327 -0.406 0 C-N-CA 120.942 -0.303 . . . . 1.0 110.569 179.822 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.645 0.26 . . . . 1.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 184' ' ' VAL . 97.1 mt-10 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 1.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.83 -35.77 75.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.619 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -81.11 -55.4 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.618 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 184' ' ' VAL . 9.3 p -44.16 -41.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.419 . . . . 1.0 110.659 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.4 p -73.96 -48.39 38.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.591 ' N ' HG13 ' A' ' 184' ' ' VAL . 62.3 tt0 -46.62 -32.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.106 -1.072 . . . . 1.0 108.106 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 190' ' ' GLN . 7.9 tp -68.84 -47.37 66.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.108 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 184' ' ' VAL . 95.5 mt -53.97 -46.43 71.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.88 86.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.541 ' O ' HD13 ' A' ' 193' ' ' ILE . 71.9 m-20 -63.27 -42.35 99.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 186' ' ' LEU . 61.3 tt0 -60.66 -31.3 70.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.43 -44.13 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.5 p -52.42 -36.55 54.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.815 -0.809 . . . . 1.0 108.815 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.4 mp -66.06 -37.78 80.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.197 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.81 83.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.0 mt -55.15 -50.41 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.93 -50.35 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.411 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.6 -47.07 87.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.282 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.21 -32.67 73.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.39 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -56.14 -40.57 74.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 tp -52.5 -35.44 52.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 96.8 p -53.11 -58.71 6.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.615 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.058 -0.973 . . . . 1.0 110.397 179.647 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.82 0.343 . . . . 1.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.51 -33.03 68.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -77.51 -48.17 17.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.788 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -56.16 -51.2 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.056 0.455 . . . . 1.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.492 ' O ' ' OG1' ' A' ' 38' ' ' THR . 71.0 mt -58.34 -30.88 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.986 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 39' ' ' VAL . 41.2 mtp180 -67.73 -39.36 84.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.408 -0.517 . . . . 1.0 109.732 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' O ' ' OE1' ' A' ' 41' ' ' GLU . . . -70.39 -33.24 71.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.769 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 42' ' ' VAL . 53.4 p -63.65 -37.15 86.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.305 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.545 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -74.27 -23.34 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.4 -51.71 33.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.341 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 18.1 mp0 -69.7 -34.94 74.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.745 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' THR . 53.5 t -58.74 -55.35 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.337 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.3 tmm_? -53.9 -43.65 69.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 1.0 110.669 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.63 -43.41 72.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.321 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -65.41 -37.28 86.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.8 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 mt -96.65 -15.06 21.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.763 0.316 . . . . 1.0 111.697 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.85 25.04 35.84 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.505 -1.038 . . . . 1.0 110.505 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 87.6 m -78.36 146.07 34.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.8 m-20 -52.17 -41.98 63.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 67' ' ' GLU . 49.4 ttt180 -152.45 132.29 13.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.549 -0.86 . . . . 1.0 112.802 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 t -136.76 131.64 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 1.0 108.702 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.477 ' HE2' HBB2 ' A' ' 203' ' ' CYC . 16.0 pttp -137.88 151.74 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.628 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.6 t -98.85 140.36 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 13.7 t80 -129.13 132.57 47.38 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.431 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.993 0.425 . . . . 1.0 111.206 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.9 t80 -100.47 128.49 46.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.696 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' OD2' ' CD2' ' A' ' 61' ' ' HIS . 40.9 m-20 -97.75 151.97 37.88 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.93 -22.45 30.43 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.029 2.486 . . . . 1.0 114.488 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HB2' ' ND1' ' A' ' 61' ' ' HIS . 96.2 mt-10 -91.16 -3.51 56.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 84' ' ' ALA . . . 106.07 -19.59 37.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.67 -0.776 . . . . 1.0 111.901 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 57.2 p-80 -80.49 151.45 29.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.404 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.45 162.85 26.14 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -134.57 154.99 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.015 0.436 . . . . 1.0 111.504 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 t -90.9 113.42 26.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.338 -0.986 . . . . 1.0 108.338 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 65' ' ' VAL . 11.3 t -112.28 -3.33 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -151.92 125.92 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.31 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 50' ' ' ARG . 79.1 tt0 -155.34 138.69 15.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 1.0 111.676 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.28 138.95 53.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 74' ' ' LEU . 58.1 mtp180 -113.28 136.48 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.019 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.96 77.62 2.09 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 38.07 29.51 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 53.6 17.91 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 1.0 110.405 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -57.66 -47.52 82.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.078 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.542 ' O ' ' NE ' ' A' ' 69' ' ' ARG . 8.3 mp -101.87 153.06 38.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.79 157.13 35.29 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.514 2.143 . . . . 1.0 112.208 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t -84.97 116.59 23.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.35 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.492 HD12 HH22 ' A' ' 50' ' ' ARG . 17.6 mt -96.93 10.86 37.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.978 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.424 HD21 ' CB ' ' A' ' 67' ' ' GLU . 88.0 mt -55.93 129.16 38.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -4.04 86.54 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.847 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.79 147.36 27.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.3 0.55 . . . . 1.0 110.422 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.3 m -107.52 135.81 48.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.611 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.45 112.92 62.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.248 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.08 137.95 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.561 2.174 . . . . 1.0 111.464 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' A' ' 60' ' ' GLY . . . -60.52 -37.6 81.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 1.0 110.432 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.06 -16.33 0.47 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 84' ' ' ALA . 86.9 m-20 -71.76 -23.22 61.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.687 0.28 . . . . 1.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' PRO . 44.7 mt -116.83 101.57 53.44 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.542 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 87' ' ' ILE . 76.9 Cg_exo -45.63 -115.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.575 2.183 . . . . 1.0 111.653 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -157.0 -51.68 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.93 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -49.53 -39.97 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.608 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.85 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.669 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -63.8 -33.9 76.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.819 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.69 -37.15 86.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.947 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.44 -36.65 83.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.484 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.405 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 83.7 m-85 -66.85 -35.0 79.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -77.24 -31.15 54.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.284 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 123' ' ' ALA . 79.1 mt -94.55 -38.99 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.58 -13.12 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.651 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER 47.71 56.7 6.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.669 -0.813 . . . . 1.0 109.926 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.5 m -159.09 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.875 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.403 ' NH2' ' O2D' ' A' ' 203' ' ' CYC . 2.9 tpp180 -165.57 133.88 3.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.888 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 103' ' ' ILE . 78.2 t -145.68 156.3 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.703 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.513 ' CD1' ' NE2' ' A' ' 139' ' ' HIS . 62.4 mt -112.5 127.73 69.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.265 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.1 m -86.96 170.62 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -49.53 114.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.906 -1.043 . . . . 1.0 112.249 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG22 HG13 ' A' ' 140' ' ' VAL . 52.9 t -53.25 -21.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.512 -0.767 . . . . 1.0 110.674 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -80.36 -37.86 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.2 -14.55 2.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.18 0.514 . . . . 1.0 110.453 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 57.32 59.96 3.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.849 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 t -94.97 124.94 39.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -119.72 143.73 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.5 153.74 28.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.764 -1.107 . . . . 1.0 108.668 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 pt -149.55 153.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.468 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.43 ' C ' ' NE2' ' A' ' 115' ' ' GLN . 70.2 m -91.12 172.69 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 117' ' ' GLU . 2.1 mp0 -134.63 156.85 78.36 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -36.79 -25.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.601 2.201 . . . . 1.0 112.275 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' GLN . 95.5 mt-10 -110.34 160.76 16.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.606 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -111.74 145.34 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.521 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.43 148.14 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.683 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -145.7 -96.69 0.2 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 121' ' ' LEU . 8.7 mp -61.6 -14.98 34.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 1.0 110.635 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.3 t -51.76 -24.52 6.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.72 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 97' ' ' LEU . . . -57.55 -17.4 13.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.743 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -45.92 -14.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.7 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 123' ' ' ALA . 27.9 m -84.95 139.26 37.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 127' ' ' LEU . 84.0 Cg_endo -80.1 117.72 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.338 2.025 . . . . 1.0 111.559 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 100' ' ' VAL . 65.8 mt 39.27 -110.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.398 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.12 50.92 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.129 -0.789 . . . . 1.0 111.129 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 130' ' ' PRO . 49.1 mm-40 -133.29 154.81 81.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.523 0.201 . . . . 1.0 110.624 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 132' ' ' GLN . 65.5 Cg_exo -41.65 168.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.423 2.082 . . . . 1.0 112.012 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.407 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 51.7 mt -63.07 11.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 1.0 112.063 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 130' ' ' PRO . 9.9 mm100 -137.6 155.48 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.445 . . . . 1.0 111.484 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -125.59 117.41 24.71 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.554 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.4 142.7 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.658 2.239 . . . . 1.0 112.348 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.477 HG11 HG12 ' A' ' 103' ' ' ILE . 2.4 m -119.81 132.89 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -41.68 160.86 0.15 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.401 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.11 -23.67 45.66 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.159 2.573 . . . . 1.0 113.666 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.576 ' H ' ' CG ' ' A' ' 136' ' ' ASP . 7.3 t -58.89 -58.76 7.22 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 1.0 111.298 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.543 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 2.1 t60 -68.38 -27.23 66.06 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.616 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 136' ' ' ASP . 43.7 t -62.25 -56.95 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.608 0.595 . . . . 1.0 112.608 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -62.23 -38.78 90.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.376 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.428 ' O ' ' OG ' ' A' ' 145' ' ' SER . 74.8 t80 -47.9 -36.58 12.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 139' ' ' HIS . 49.9 mt -73.64 -42.73 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -58.24 -44.84 88.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 83.7 p -61.9 -17.73 57.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.687 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.3 mmm -100.48 -0.02 38.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 1.0 111.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.38 18.9 77.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.538 -1.025 . . . . 1.0 110.538 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.29 142.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.696 0.284 . . . . 1.0 110.298 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.2 -26.73 5.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 p -153.78 121.35 5.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.701 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 m -126.77 138.66 53.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 1.0 111.385 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.99 134.27 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.1 t -113.96 127.76 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.332 -0.547 . . . . 1.0 112.291 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.65 126.18 17.91 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -90.51 161.42 4.41 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.351 2.034 . . . . 1.0 113.704 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.506 HD23 ' HB1' ' A' ' 188' ' ' ALA . 24.6 mt -114.34 114.78 26.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.435 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 23.4 ptm -141.9 150.56 41.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.489 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 40.7 t60 -125.7 126.29 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.809 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.489 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 38.4 m80 58.34 -122.47 1.35 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.105 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.56 2.72 50.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.811 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.527 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.2 tt0 -106.22 145.97 30.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.755 1.02 . . . . 1.0 113.755 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 44.9 tp -101.26 123.8 45.94 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.527 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.7 m95 -101.87 -32.08 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -176.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.88 -167.75 22.77 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.719 -1.229 . . . . 1.0 112.398 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -143.7 122.94 12.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.417 -0.392 . . . . 1.0 111.664 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.487 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.4 tp -94.76 150.5 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.3 p -156.31 133.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.822 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 87.9 p -113.24 139.73 48.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.249 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.471 ' O ' ' CG2' ' A' ' 48' ' ' THR . 18.1 m80 -111.92 124.38 52.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.541 ' HD2' ' HD2' ' A' ' 174' ' ' ARG . 32.2 m80 -117.44 116.88 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.09 -15.33 62.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.747 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -133.22 151.05 76.98 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.611 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -40.44 132.38 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.631 2.221 . . . . 1.0 111.858 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.541 ' HD2' ' HD2' ' A' ' 170' ' ' HIS . 28.0 ttm180 -164.4 80.98 1.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.532 -0.304 . . . . 1.0 110.684 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 156.06 12.18 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.574 2.183 . . . . 1.0 111.459 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -104.69 148.62 26.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 1.0 110.817 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.2 m -89.84 147.24 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.16 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.35 -29.37 69.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.171 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -77.82 -53.1 7.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.241 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.7 -33.57 74.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.937 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.27 -45.57 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.633 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.33 -55.31 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.724 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.1 t -45.37 -39.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.638 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -74.56 -49.37 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -48.54 -36.59 15.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 190' ' ' GLN . 21.6 tp -70.69 -46.39 63.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.082 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.05 -46.83 75.38 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.506 ' HB1' HD23 ' A' ' 156' ' ' LEU . . . -58.43 -48.23 81.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.22 -36.66 75.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 186' ' ' LEU . 56.6 tt0 -68.61 -32.41 72.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.47 -48.54 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.342 -0.985 . . . . 1.0 108.342 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.4 p -50.12 -31.6 13.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mt -74.65 -34.9 35.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.27 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -43.71 79.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.95 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 196' ' ' ALA . 31.7 pt -63.17 -30.77 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -72.79 -50.12 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.411 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.8 -40.79 95.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.275 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -67.51 -31.39 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.385 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -57.78 -43.39 85.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.93 -36.17 48.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.965 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 83.1 p -52.17 -57.49 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.647 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.486 179.414 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.543 HMA2 ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.835 0.35 . . . . 1.0 110.546 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 66.6 t0 -48.06 -36.05 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -74.4 -49.95 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.808 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' THR . 96.3 mt -56.7 -44.98 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.022 0.439 . . . . 1.0 110.92 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.48 ' O ' ' OG1' ' A' ' 38' ' ' THR . 45.2 mt -58.4 -30.7 67.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.98 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 39' ' ' VAL . 54.3 mtp180 -66.81 -38.35 86.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.78 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.76 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 42' ' ' VAL . 76.9 p -68.67 -36.65 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.273 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -74.34 -23.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -72.76 -48.48 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.305 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.76 -34.96 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.742 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 38' ' ' THR . 77.7 t -59.98 -54.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.609 -0.269 . . . . 1.0 111.287 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.6 ttp180 -51.45 -43.43 62.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 1.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.17 -42.49 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.254 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.4 -37.19 86.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.793 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.2 mt -97.13 -13.93 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.864 -0.335 . . . . 1.0 111.701 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.65 25.59 22.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.6 p -81.29 152.21 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -48.71 -42.93 36.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.534 HH21 ' CG2' ' A' ' 148' ' ' VAL . 36.1 ptt180 -160.17 146.25 15.52 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.568 -0.853 . . . . 1.0 112.782 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 20.2 t -137.44 133.92 46.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.957 -1.019 . . . . 1.0 108.675 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HZ2' HD12 ' A' ' 77' ' ' LEU . 17.7 mttt -135.91 144.62 45.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.604 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 166' ' ' LEU . 48.9 t -99.43 141.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 18.1 t80 -129.78 130.62 45.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.509 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -111.86 154.11 25.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 1.0 111.239 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.66 136.89 40.73 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.661 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -97.17 150.94 37.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -41.54 -22.03 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.962 2.441 . . . . 1.0 114.468 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -103.85 9.0 37.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.185 0.439 . . . . 1.0 112.185 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 96.03 -15.81 62.29 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.598 -0.81 . . . . 1.0 111.966 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.585 ' O ' ' N ' ' A' ' 57' ' ' ASP . 35.6 m80 -77.52 151.27 34.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.78 163.56 25.54 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 p -135.63 158.85 43.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 1.0 111.495 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 104.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.78 -4.75 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -154.0 125.68 7.63 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.652 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 75.1 tt0 -154.45 138.99 16.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.158 0.504 . . . . 1.0 111.684 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.7 131.41 51.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.562 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 34.8 ptt180 -109.03 140.2 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.02 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.72 66.71 3.55 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 81.77 163.68 32.17 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -59.94 6.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 1.0 110.343 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.614 ' H ' ' C ' ' A' ' 71' ' ' GLY . 62.4 ttt180 -62.34 -40.63 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.992 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.2 144.08 40.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.14 166.17 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.47 2.113 . . . . 1.0 112.264 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.2 p -100.95 139.02 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.291 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 35.0 mt -103.98 18.09 22.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.968 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 24.5 tp -65.21 131.03 45.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.6 88.77 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.843 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.78 151.01 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.352 0.576 . . . . 1.0 110.461 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 81' ' ' THR . 14.4 t -104.41 128.99 52.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 5.1 m-85 -106.69 107.3 60.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -43.37 138.89 4.66 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.592 2.195 . . . . 1.0 111.522 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -61.55 -29.29 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.21 -17.71 0.24 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' N ' ' C ' ' A' ' 84' ' ' ALA . 89.2 m-20 -67.52 -16.55 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.665 0.269 . . . . 1.0 111.032 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' PRO . 16.1 mt -134.55 99.47 12.97 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.53 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 40.9 Cg_exo -39.6 -97.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.521 2.147 . . . . 1.0 111.704 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 22.8 pt-20 -165.71 -39.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.003 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -56.97 -43.35 81.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.625 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.12 -35.66 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.686 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -65.01 -32.23 73.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.806 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -64.6 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.541 ' CB ' ' NH2' ' A' ' 101' ' ' ARG . 10.0 mt -60.18 -38.31 82.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.546 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -66.56 -32.5 73.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.168 -0.679 . . . . 1.0 109.168 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -79.74 -27.53 40.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.172 -0.922 . . . . 1.0 111.305 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.85 -40.43 8.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -119.08 -11.57 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.422 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 1.9 mp0 44.77 64.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.669 -0.812 . . . . 1.0 109.91 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.1 p -168.8 107.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.905 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.542 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -159.15 134.4 8.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.895 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 103' ' ' ILE . 53.7 t -149.01 155.76 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.707 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.552 HD11 HMA2 ' A' ' 203' ' ' CYC . 66.2 mt -111.9 129.14 67.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.238 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -87.28 169.58 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.16 115.79 1.58 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.975 -1.011 . . . . 1.0 112.274 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG23 ' CG1' ' A' ' 140' ' ' VAL . 13.4 p -51.24 -22.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.644 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -76.38 -38.83 55.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.822 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.87 19.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.234 0.54 . . . . 1.0 110.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 56.33 62.79 2.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.838 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 m -95.43 125.59 40.15 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.777 -1.564 . . . . 1.0 106.777 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -117.62 145.36 44.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.661 0.985 . . . . 1.0 113.661 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -111.97 148.8 33.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.77 -1.105 . . . . 1.0 108.62 177.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -145.6 149.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.438 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.3 m -87.2 171.88 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.09 157.9 37.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.887 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 167.08 28.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.635 2.224 . . . . 1.0 112.24 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 56.88 102.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.65 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.8 m -151.39 165.17 34.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -152.83 -19.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.717 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' SER . . . 85.34 -169.39 43.5 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 tp 56.9 3.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 1.0 110.644 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' GLY . 66.3 p -68.56 -24.06 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.705 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.632 ' C ' ' H ' ' A' ' 125' ' ' VAL . . . -66.35 -3.34 5.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.793 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -49.33 -3.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 1.0 110.682 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.632 ' H ' ' C ' ' A' ' 123' ' ' ALA . 16.9 m -108.7 148.56 38.02 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.8 142.97 32.73 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.417 2.078 . . . . 1.0 111.558 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.432 ' O ' ' OE2' ' A' ' 129' ' ' GLU . 51.8 mt 50.11 -117.88 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.617 -0.265 . . . . 1.0 110.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.66 5.61 58.72 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 3.6 pm0 -154.73 153.21 27.29 Favored Pre-proline 0 C--N 1.329 -0.288 0 O-C-N 122.836 -0.214 . . . . 1.0 110.619 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 132' ' ' GLN . 72.0 Cg_exo -42.97 173.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.481 2.12 . . . . 1.0 111.982 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.17 14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.078 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' H ' ' C ' ' A' ' 130' ' ' PRO . 48.4 mm-40 -137.98 159.5 41.85 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.596 -0.442 . . . . 1.0 111.523 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.533 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -127.45 79.09 73.87 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.541 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.56 142.76 6.66 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.644 2.229 . . . . 1.0 112.422 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.63 125.44 71.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 178.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.644 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 3.5 p30 -45.67 142.55 3.47 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.752 0.31 . . . . 1.0 111.317 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.8 -20.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.15 2.567 . . . . 1.0 113.634 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.5 t -61.59 -62.78 1.57 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.209 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -70.26 -24.61 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.631 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG1' HG23 ' A' ' 106' ' ' VAL . 61.4 t -60.6 -60.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.61 0.596 . . . . 1.0 112.61 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -61.12 -38.4 86.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -47.23 -36.64 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.9 mt -73.33 -43.65 60.39 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.22 -44.63 88.28 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.644 -0.873 . . . . 1.0 108.644 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -62.63 -19.0 63.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.691 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 23.2 mmm -101.27 -0.98 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 1.0 111.052 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.6 17.62 79.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.534 ' CG2' HH21 ' A' ' 50' ' ' ARG . 73.0 t -107.29 143.65 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.655 0.264 . . . . 1.0 110.335 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.7 -42.74 2.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.944 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.7 t -136.87 118.16 14.59 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.77 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.3 m -129.12 143.39 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.998 0.428 . . . . 1.0 111.405 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.0 mp -100.45 132.54 45.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.74 107.17 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.304 -0.558 . . . . 1.0 112.258 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.53 132.68 21.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -91.63 163.39 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.386 2.057 . . . . 1.0 113.701 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.5 mt -116.9 113.86 23.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.569 ' N ' ' OG ' ' A' ' 192' ' ' SER . 25.3 ptm -142.69 150.3 39.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 58.1 t-80 -125.66 124.49 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.897 -1.047 . . . . 1.0 108.842 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 38.1 t-80 60.17 -122.04 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.165 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.533 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 41.3 tt0 -97.85 1.71 48.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.808 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.8 tt0 -106.43 144.24 33.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 tp -99.31 125.74 45.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 75.7 m95 -104.37 -34.84 8.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.5 -175.05 31.08 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.717 -1.23 . . . . 1.0 112.417 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -137.44 122.02 18.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.471 -0.365 . . . . 1.0 111.644 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 53' ' ' VAL . 47.1 tp -94.95 150.02 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.5 p -156.62 134.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.004 -0.678 . . . . 1.0 111.843 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 90.5 p -116.03 132.74 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -104.96 126.83 52.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.598 ' HE2' ' NH1' ' A' ' 174' ' ' ARG . 5.7 t-80 -118.8 115.35 24.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.79 63.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.799 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 21.6 mp0 -134.93 150.7 73.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.535 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -41.83 145.62 0.7 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.637 2.225 . . . . 1.0 111.802 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.598 ' NH1' ' HE2' ' A' ' 170' ' ' HIS . 11.8 tpp85 -172.91 81.62 0.42 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.686 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.16 152.53 24.45 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.538 2.158 . . . . 1.0 111.5 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CE1' HD12 ' A' ' 181' ' ' LEU . 20.5 p90 -105.46 150.45 25.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 110.739 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -94.58 152.94 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.213 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -52.7 -38.05 60.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.159 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -73.99 -44.86 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.246 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 184' ' ' VAL . 77.3 mm-40 -66.37 -28.88 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 1.0 110.902 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -69.98 -39.25 76.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.651 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -78.92 -54.19 6.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.618 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 184' ' ' VAL . 9.9 p -43.67 -42.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.669 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 185' ' ' GLN . 34.0 m -75.09 -48.36 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.578 ' N ' HG23 ' A' ' 184' ' ' VAL . 60.9 tt0 -48.26 -36.49 14.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 190' ' ' GLN . 24.1 tp -70.85 -45.72 63.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.023 -0.989 . . . . 1.0 109.088 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.08 -47.67 77.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.8 93.54 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -62.78 -37.12 85.42 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 186' ' ' LEU . 55.5 tt0 -66.89 -31.7 72.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.647 -0.871 . . . . 1.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.62 -46.79 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -50.8 -32.84 21.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.2 mt -74.73 -34.32 33.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.198 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.94 -43.53 78.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.984 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 196' ' ' ALA . 24.2 pt -63.06 -30.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.72 -53.47 7.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.392 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.84 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.224 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.05 77.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.7 -40.92 73.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.211 0.449 . . . . 1.0 112.211 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.0 tp -51.45 -34.65 36.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.928 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.2 p -48.3 -56.41 8.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.696 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.986 . . . . 1.0 110.482 179.507 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.644 ' HHD' ' OD2' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' A' ' 35' ' ' LEU . 6.7 tp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.362 . . . . 1.0 110.563 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.2 t0 -51.69 -33.24 33.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.728 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -75.98 -49.44 17.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.779 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 38' ' ' THR . 97.0 mt -55.38 -52.69 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 1.0 110.976 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.7 mt -56.36 -30.94 63.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.988 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.447 ' O ' HG12 ' A' ' 39' ' ' VAL . 67.9 ttp85 -64.6 -38.93 92.7 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.754 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.09 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.844 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 67.2 p -65.8 -37.4 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 1.0 112.311 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -74.58 -25.45 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.58 -43.17 23.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.283 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -72.24 -43.99 63.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.785 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 43' ' ' ARG . 7.2 p -61.69 -47.63 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.306 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG13 ' A' ' 42' ' ' VAL . 70.7 ttp85 -54.97 -44.21 74.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 1.0 110.689 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.82 60.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.351 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -70.18 -33.59 71.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.813 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -97.52 -18.96 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.759 0.314 . . . . 1.0 111.695 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.8 25.21 51.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 170' ' ' HIS . 91.7 m -77.36 144.01 38.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.981 -0.377 . . . . 1.0 109.981 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -52.83 -42.45 65.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.635 0.605 . . . . 1.0 112.635 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' HE ' ' CB ' ' A' ' 74' ' ' LEU . 2.9 mtt-85 -149.48 128.35 12.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.507 -0.877 . . . . 1.0 112.797 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 10.9 t -136.7 129.89 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.968 -1.015 . . . . 1.0 108.739 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.875 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 49.8 pttt -137.95 152.39 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.658 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 46.3 t -99.12 141.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.6 t80 -131.85 133.24 44.44 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.468 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -113.66 154.06 27.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 1.0 111.205 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -103.87 137.64 41.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.68 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.3 m-20 -101.75 154.95 36.97 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.54 -52.3 2.04 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.001 2.468 . . . . 1.0 114.481 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.12 -6.31 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.561 -0.456 . . . . 1.0 112.141 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.07 37.42 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.689 -0.767 . . . . 1.0 111.887 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 57' ' ' ASP . 72.8 m80 -77.56 149.29 34.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.444 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.47 161.06 24.95 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 155.48 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 1.0 111.559 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.44 108.68 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.5 t -108.89 -4.27 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.41 123.44 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.25 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.7 tt0 -151.84 136.62 17.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.155 0.502 . . . . 1.0 111.705 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.82 134.36 50.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.061 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.04 66.91 3.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 84.31 36.48 12.52 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 57.41 0.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 1.0 110.34 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.56 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.0 mtp180 -46.35 -49.11 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.056 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.55 ' CB ' ' HE ' ' A' ' 50' ' ' ARG . 15.1 mt -102.61 150.57 37.79 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.327 -0.619 . . . . 1.0 109.327 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.0 150.03 59.97 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.489 2.126 . . . . 1.0 112.217 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.5 t -81.66 120.34 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.284 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 32.6 mt -98.23 14.69 26.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.484 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.7 tp -64.53 131.79 48.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.61 88.15 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.781 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.81 150.21 24.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.344 0.572 . . . . 1.0 110.479 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 p -108.63 137.17 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.566 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 46.0 m-85 -108.55 149.57 39.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 78.5 Cg_endo -80.12 136.66 11.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.493 2.129 . . . . 1.0 111.507 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.67 -35.05 75.28 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.81 -14.7 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . 47.7 p-10 -68.71 -19.61 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.624 0.249 . . . . 1.0 111.016 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.97 97.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.538 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 41.3 Cg_exo -39.18 -95.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.565 2.177 . . . . 1.0 111.683 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 41.8 tp10 -162.91 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.969 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -51.03 -40.9 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.646 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.48 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.726 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -64.7 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 1.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -65.21 -38.8 91.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.05 -36.95 75.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.549 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CE2' ' O1A' ' A' ' 203' ' ' CYC . 88.0 m-85 -68.7 -35.37 77.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -76.98 -32.08 56.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.24 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 123' ' ' ALA . 94.7 mt -95.84 -39.24 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.41 -12.94 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.2 1.185 . . . . 1.0 114.2 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.426 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 1.3 mp0 47.17 48.12 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.0 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.6 t -149.87 108.45 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.912 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.656 ' HE ' ' CZ ' ' A' ' 133' ' ' ARG . 1.1 tpt180 -160.91 130.9 5.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.2 p -150.06 155.96 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.683 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 135' ' ' VAL . 95.2 mt -114.32 131.18 67.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.245 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -87.99 171.13 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.028 0.751 . . . . 1.0 113.028 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -50.74 115.4 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.932 -1.031 . . . . 1.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.474 HG23 ' CG1' ' A' ' 140' ' ' VAL . 13.0 p -49.66 -19.74 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.642 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -76.76 -38.79 53.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.821 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.78 -8.94 5.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.167 0.508 . . . . 1.0 110.43 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 15.8 pt20 46.17 62.03 2.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.435 -0.802 . . . . 1.0 112.891 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -93.35 126.94 38.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.752 -1.573 . . . . 1.0 106.752 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -119.4 147.01 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.666 0.987 . . . . 1.0 113.666 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.634 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -111.44 149.32 31.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.789 -1.096 . . . . 1.0 108.636 178.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 113' ' ' ILE . 7.5 mt -145.82 149.82 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.445 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -84.01 164.07 19.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -151.69 159.72 32.79 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.909 -178.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.78 156.87 62.18 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.67 2.247 . . . . 1.0 112.187 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 59.61 84.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.619 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.1 m -69.77 161.9 28.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.502 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -90.0 -169.17 2.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -128.8 -129.94 3.23 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.0 tp -71.66 35.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.744 0.307 . . . . 1.0 110.569 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 120' ' ' GLY . 65.0 m -60.75 -23.9 65.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.79 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' VAL . . . -49.62 -30.89 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.764 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.79 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 1.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.0 t -92.95 131.27 33.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.717 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 128' ' ' GLY . 84.7 Cg_endo -76.38 135.03 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.395 2.064 . . . . 1.0 111.537 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.3 mt 59.22 -80.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.381 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 65.18 9.04 39.65 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' PRO . 18.5 pt-20 -153.39 152.98 28.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 O-C-N 122.828 -0.219 . . . . 1.0 110.619 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.612 ' C ' ' H ' ' A' ' 132' ' ' GLN . 55.2 Cg_exo -40.97 167.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.385 2.057 . . . . 1.0 111.995 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -57.84 9.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 1.0 112.039 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.612 ' H ' ' C ' ' A' ' 130' ' ' PRO . 47.8 mm-40 -137.37 166.06 24.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.465 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.656 ' CZ ' ' HE ' ' A' ' 101' ' ' ARG . 15.7 ttt-85 -139.76 123.7 10.86 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.509 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.634 ' C ' ' HG ' ' A' ' 112' ' ' SER . 49.6 Cg_endo -84.74 145.39 10.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.647 2.232 . . . . 1.0 112.401 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -117.61 128.17 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.699 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 4.5 p30 -45.03 140.77 3.41 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 1.0 111.376 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -37.91 -17.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 123.053 2.502 . . . . 1.0 113.748 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 136' ' ' ASP . 42.6 t -63.28 -62.21 1.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.267 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.407 ' CE1' ' CD1' ' A' ' 103' ' ' ILE . 51.7 t-80 -71.1 -25.06 62.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.667 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.474 ' CG1' HG23 ' A' ' 106' ' ' VAL . 65.2 t -58.36 -60.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -61.41 -37.45 83.52 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.394 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 61.1 t80 -46.17 -37.93 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.16 -43.4 64.68 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.36 -41.49 89.39 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.631 -0.878 . . . . 1.0 108.631 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -64.16 -22.18 66.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.441 -0.799 . . . . 1.0 109.642 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.598 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 70.9 mtp -97.97 2.09 48.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.101 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.97 19.44 78.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.6 -1.0 . . . . 1.0 110.6 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 78.9 t -110.19 145.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.679 0.276 . . . . 1.0 110.276 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.3 -23.9 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.027 0.38 . . . . 1.0 112.027 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -152.36 120.21 6.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.747 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 p -128.17 137.58 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 1.0 111.419 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.0 131.83 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.4 t -111.95 130.45 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.293 -0.563 . . . . 1.0 112.306 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.95 128.59 18.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.88 166.28 3.23 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.389 2.059 . . . . 1.0 113.733 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.59 115.35 24.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.605 -1.257 . . . . 1.0 107.605 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.448 ' H ' ' HB2' ' A' ' 192' ' ' SER . 23.8 ptm -142.3 151.61 42.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.44 0.638 . . . . 1.0 112.684 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.469 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 51.9 t60 -128.31 124.56 36.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.913 -1.039 . . . . 1.0 108.899 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.498 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 14.9 t-80 61.79 -123.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.107 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.498 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 99.0 mm-40 -97.63 3.55 50.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.519 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -107.0 144.83 33.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.683 0.994 . . . . 1.0 113.683 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.5 tp -98.78 125.7 44.21 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.519 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 73.9 m95 -105.21 -36.83 7.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.44 -173.25 23.91 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.694 -1.241 . . . . 1.0 112.39 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -139.57 120.19 14.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.441 -0.379 . . . . 1.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.455 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.8 tp -94.73 149.8 20.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.5 p -156.42 134.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.097 -0.641 . . . . 1.0 111.863 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -114.45 137.86 51.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.223 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 30.5 m-70 -111.96 124.69 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 1.0 112.663 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.506 ' CD2' HG23 ' A' ' 48' ' ' THR . 71.5 m80 -116.42 121.33 41.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.51 13.38 6.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.785 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -156.3 152.02 22.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.579 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -44.52 122.6 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.689 2.259 . . . . 1.0 111.823 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -156.55 106.43 2.0 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.684 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.68 157.73 21.59 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.478 2.119 . . . . 1.0 111.46 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.502 ' OH ' ' CE1' ' A' ' 170' ' ' HIS . 81.9 m-85 -108.85 146.58 33.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.859 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.6 p -88.29 157.81 18.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -58.57 -33.65 70.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.189 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -77.16 -54.16 6.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.299 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 184' ' ' VAL . 50.8 tp10 -61.08 -33.41 73.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.96 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.19 -49.51 75.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.62 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.0 -52.61 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.652 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.8 t -44.98 -39.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 187' ' ' LEU . 83.7 t -73.32 -49.82 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -45.99 -32.02 2.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 tp -68.18 -48.15 66.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.119 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 184' ' ' VAL . 92.7 mt -52.1 -46.3 65.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.94 93.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.423 -0.955 . . . . 1.0 108.423 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.77 -38.89 92.79 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -66.19 -31.16 71.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.74 -46.62 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 157' ' ' MET . 42.5 p -51.24 -32.04 22.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.68 -34.59 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.132 -0.94 . . . . 1.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.51 -43.66 80.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.895 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 196' ' ' ALA . 21.0 pt -62.7 -29.57 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.437 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -74.92 -52.37 11.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.69 -42.67 97.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.82 72.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.36 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.02 -43.13 81.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.4 mp -52.44 -33.51 44.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.995 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -54.56 -58.61 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.398 179.833 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.875 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.838 0.351 . . . . 1.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -48.0 -35.49 11.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -75.14 -49.88 18.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.802 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 38' ' ' THR . 24.4 mm -56.12 -48.54 78.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.141 0.496 . . . . 1.0 110.959 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' OG1' ' A' ' 38' ' ' THR . 32.5 mt -57.42 -29.25 63.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.955 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' HG12 ' A' ' 39' ' ' VAL . 36.4 ttm180 -66.43 -39.82 89.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.447 -0.501 . . . . 1.0 109.739 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.77 -30.04 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.767 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 42' ' ' VAL . 75.1 p -68.48 -36.02 78.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.283 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -72.72 -25.48 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.16 0.429 . . . . 1.0 112.16 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.32 -42.67 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.267 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.95 -48.29 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.804 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 43' ' ' ARG . 34.4 m -56.44 -49.22 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.352 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG23 ' A' ' 42' ' ' VAL . 70.8 ttp85 -51.01 -43.5 60.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 1.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.8 -40.79 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.33 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.59 -35.81 79.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.758 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -96.75 -15.76 21.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 1.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.57 25.23 34.54 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 170' ' ' HIS . 69.9 m -78.63 145.89 34.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -53.37 -44.46 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.445 HH21 ' HB2' ' A' ' 73' ' ' ARG . 11.0 mtt85 -148.28 132.44 17.35 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 119.563 -0.855 . . . . 1.0 112.798 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.4 t -136.49 130.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 114.937 -1.029 . . . . 1.0 108.777 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -136.56 148.32 47.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.604 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 47.6 t -98.57 140.72 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.923 -0.769 . . . . 1.0 108.923 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.5 t80 -128.92 133.04 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.464 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -106.62 141.96 37.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.979 0.419 . . . . 1.0 111.234 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.452 ' CE2' ' NH1' ' A' ' 92' ' ' ARG . 64.6 t80 -97.99 124.55 42.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.696 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' HIS . 7.6 t70 -95.22 138.72 21.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -40.76 -29.68 0.46 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.931 2.421 . . . . 1.0 114.564 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -84.44 -4.56 58.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 104.8 -17.53 45.38 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.929 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 57' ' ' ASP . 75.6 m80 -80.25 149.27 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.376 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.1 162.98 26.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -134.14 156.15 48.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 1.0 111.504 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.4 t -88.39 108.56 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.54 -4.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.42 124.14 7.25 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.301 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 71.2 tt0 -150.69 138.5 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.195 0.521 . . . . 1.0 111.69 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.08 128.02 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.738 -0.838 . . . . 1.0 108.738 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -102.68 137.41 40.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.991 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -79.07 -143.18 2.48 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -62.58 61.73 0.03 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 70' ' ' GLY . 3.2 pm0 26.34 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.835 0.35 . . . . 1.0 110.392 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 71' ' ' GLY . 81.6 mtt180 -84.38 -36.0 22.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.0 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 146' ' ' MET . 12.6 tp -124.74 123.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.365 -0.605 . . . . 1.0 109.365 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.7 149.63 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.52 2.147 . . . . 1.0 112.211 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 p -66.66 138.04 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.332 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.602 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -108.11 12.95 26.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.991 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.9 tp -64.08 132.04 49.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.28 -4.3 84.01 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.42 -0.809 . . . . 1.0 112.873 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.84 151.45 23.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.357 0.579 . . . . 1.0 110.383 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.9 m -108.04 134.81 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.635 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -108.52 150.9 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.249 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.37 140.6 15.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -63.73 -33.86 76.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 1.0 110.463 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.2 -16.67 0.17 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' ALA . 11.8 p-10 -55.65 -11.98 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.671 0.272 . . . . 1.0 111.037 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -151.75 146.45 18.76 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.536 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 93.4 Cg_endo -75.7 -92.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.556 2.17 . . . . 1.0 111.675 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' OE2' ' NH2' ' A' ' 92' ' ' ARG . 46.7 tp10 -167.58 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.2 pt-20 -55.23 -41.74 72.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -72.07 -37.64 69.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.76 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 54.0 ttp180 -62.58 -33.06 74.2 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.776 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -64.05 -37.42 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.915 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.63 -35.87 77.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.589 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.3 -36.94 77.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -75.43 -30.87 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.255 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.54 -38.86 10.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.804 1.039 . . . . 1.0 113.804 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.92 -13.08 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.262 1.208 . . . . 1.0 114.262 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.659 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.0 mp0 47.87 56.92 6.55 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.689 -0.804 . . . . 1.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.3 m -159.41 113.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.913 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -165.99 135.77 3.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.896 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.3 p -148.21 156.44 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 1.0 109.705 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.681 HD11 HMA2 ' A' ' 203' ' ' CYC . 28.2 mt -109.78 128.5 65.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.4 t -83.84 165.8 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.999 0.74 . . . . 1.0 112.999 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.507 ' H ' HG12 ' A' ' 104' ' ' VAL . 63.1 t0 -51.46 118.63 3.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.291 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.446 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.3 p -51.43 -25.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.656 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -77.18 -38.91 50.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.1 43.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.129 0.49 . . . . 1.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 57.73 60.26 2.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t -94.39 124.82 38.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -119.69 143.85 47.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -112.51 152.64 28.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.756 -1.111 . . . . 1.0 108.627 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.0 pt -152.72 157.29 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.492 -0.483 . . . . 1.0 111.448 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.5 t -88.8 166.73 13.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 117' ' ' GLU . 6.5 tp-100 -151.2 118.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.401 . . . . 1.0 110.859 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 117' ' ' GLU . 34.4 Cg_exo -37.74 87.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.577 2.185 . . . . 1.0 112.299 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 115' ' ' GLN . 85.0 tt0 44.57 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.653 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 t -157.31 0.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -93.32 144.47 25.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.97 -177.34 51.77 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 123' ' ' ALA . 40.1 tp -89.27 125.15 34.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.741 0.305 . . . . 1.0 110.645 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.5 m -60.09 -36.1 76.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' H ' ' HG ' ' A' ' 121' ' ' LEU . . . -54.0 -27.2 30.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.774 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -56.15 -59.38 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.694 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 125' ' ' VAL . 8.0 p -142.61 133.4 12.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.623 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.78 167.81 25.55 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.343 2.028 . . . . 1.0 111.529 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 127' ' ' LEU . 8.2 mp 44.68 -107.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.447 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 57.42 37.68 83.08 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.033 -0.827 . . . . 1.0 111.033 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -132.89 151.86 78.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.547 0.213 . . . . 1.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 132' ' ' GLN . 55.2 Cg_endo -66.46 158.13 56.96 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.428 2.085 . . . . 1.0 112.026 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 70.4 mt -47.69 -12.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.064 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' PRO . 3.2 mm100 -133.51 135.26 44.32 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.477 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -111.85 131.09 22.59 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.525 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.05 139.11 10.58 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.597 2.198 . . . . 1.0 112.409 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.594 HG11 HG23 ' A' ' 103' ' ' ILE . 1.4 p -118.17 129.83 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.505 ' N ' ' OG ' ' A' ' 112' ' ' SER . 6.9 t0 -45.99 138.53 5.77 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.729 0.3 . . . . 1.0 111.33 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -39.08 -35.79 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.068 2.512 . . . . 1.0 113.62 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 t -43.53 -63.71 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.261 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.78 -22.49 62.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.678 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' A' ' 106' ' ' VAL . 92.9 t -61.67 -55.2 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.562 0.578 . . . . 1.0 112.562 -177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.48 -40.14 96.3 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.378 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.79 -35.57 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.64 -42.79 60.96 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -58.68 -43.73 90.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.1 m -62.42 -19.37 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.653 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.569 ' O ' HD13 ' A' ' 74' ' ' LEU . 24.6 mmm -99.97 0.87 41.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.088 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.06 18.55 78.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.8 144.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.661 0.267 . . . . 1.0 110.351 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.43 -38.57 2.99 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.087 0.403 . . . . 1.0 112.087 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.1 p -138.4 121.26 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.721 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -130.92 141.46 50.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 1.0 111.332 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.66 131.62 55.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.52 HG12 HG23 ' A' ' 167' ' ' VAL . 20.1 m -116.18 140.04 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.264 -0.575 . . . . 1.0 112.239 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.9 t -131.91 132.66 23.33 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -89.92 159.87 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.326 2.018 . . . . 1.0 113.666 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 34.3 mt -114.89 117.02 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.2 ptm -140.33 148.07 40.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 81.5 t60 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.826 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 22.1 m-70 58.38 -125.44 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.148 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -100.67 6.11 43.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.761 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 11.5 pt-20 -111.98 156.32 22.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.728 1.01 . . . . 1.0 113.728 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.6 tp -102.04 128.1 48.63 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.515 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 29.7 m95 -104.58 -34.74 8.09 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.15 31.06 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.712 -1.232 . . . . 1.0 112.383 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -137.41 123.11 19.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.446 -0.377 . . . . 1.0 111.643 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.65 149.24 21.44 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.52 HG23 HG12 ' A' ' 153' ' ' VAL . 12.1 p -152.69 131.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.1 -0.64 . . . . 1.0 111.899 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 48' ' ' THR . 7.6 t -114.91 135.18 54.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.258 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 11.7 m-70 -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.63 ' CD2' HG23 ' A' ' 48' ' ' THR . 72.3 m80 -117.45 119.88 36.42 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.11 24.58 1.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.822 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 1.3 pm0 -160.68 152.98 17.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.956 -0.298 . . . . 1.0 110.627 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.13 124.87 13.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.659 2.24 . . . . 1.0 111.792 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -158.2 93.81 2.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.91 153.76 11.26 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.57 2.18 . . . . 1.0 111.451 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -107.43 152.07 24.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.811 0.339 . . . . 1.0 110.839 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.5 p -94.85 153.99 17.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.48 -34.69 72.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.151 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -71.83 -49.13 41.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.176 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 184' ' ' VAL . 76.6 mm-40 -64.56 -31.86 73.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 1.0 110.953 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.13 -38.52 91.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.614 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -79.67 -51.87 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.869 -0.332 . . . . 1.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -42.23 -42.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.689 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 185' ' ' GLN . 26.9 m -74.47 -45.94 44.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.523 ' N ' HG23 ' A' ' 184' ' ' VAL . 56.0 tt0 -50.53 -32.87 19.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.063 -1.088 . . . . 1.0 108.063 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 16.8 tp -73.0 -52.65 13.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.089 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.17 -46.01 65.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.19 80.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -61.23 -38.44 86.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 44.5 tt0 -64.9 -33.11 75.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.4 -45.74 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.376 -0.972 . . . . 1.0 108.376 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -52.46 -36.03 53.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -68.61 -37.0 77.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.272 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.61 -41.01 80.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -55.52 -48.43 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.363 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.44 -46.54 88.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.264 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.41 -33.08 74.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 1.0 111.398 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -55.97 -41.13 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 26.0 tp -53.18 -37.29 61.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.8 m -48.94 -57.75 5.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.67 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.7 mp . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.453 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.681 HMA2 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.805 0.336 . . . . 1.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.22 -32.4 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.742 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.8 -48.73 20.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.792 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 38' ' ' THR . 25.6 mm -55.1 -53.3 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 1.0 110.945 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.6 mt -56.44 -30.21 62.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.99 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 39' ' ' VAL . 59.9 ttp180 -64.49 -39.94 94.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.384 -0.526 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.12 67.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.774 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.5 p -67.49 -36.46 81.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.314 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.603 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -73.65 -25.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 71.5 mm-40 -79.6 -43.8 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.773 -0.371 . . . . 1.0 111.318 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.88 -44.6 80.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.807 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 43' ' ' ARG . 36.0 m -59.42 -46.56 92.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.323 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 47' ' ' GLY . 6.2 ttm180 -50.76 -45.03 58.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 1.0 110.692 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.78 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.254 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.95 -37.86 82.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.852 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.37 -18.69 18.96 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.674 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.76 25.49 56.0 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 50.0 m -78.07 143.23 37.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.38 -39.97 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 13.3 mtt85 -148.48 124.19 10.5 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.822 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.5 t -132.63 128.48 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.748 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HZ2' HD12 ' A' ' 77' ' ' LEU . 34.9 mttt -136.64 148.78 47.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.616 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.587 HG22 ' CD1' ' A' ' 166' ' ' LEU . 59.9 t -98.39 140.96 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.405 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 20.1 t80 -130.6 132.3 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.433 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.431 HH12 ' CG2' ' A' ' 195' ' ' ILE . 60.4 ttt85 -110.84 149.84 30.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.035 0.445 . . . . 1.0 111.195 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.14 133.95 46.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.691 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 61' ' ' HIS . 11.6 m-20 -99.26 153.51 37.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -38.68 -51.08 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 122.96 2.44 . . . . 1.0 114.53 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -70.96 -6.43 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 106.84 -8.23 39.27 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.684 -0.77 . . . . 1.0 111.922 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ASP . 70.0 m80 -78.23 151.03 33.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.424 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.59 163.61 25.78 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -135.87 157.72 46.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.999 0.428 . . . . 1.0 111.528 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.6 107.75 17.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 65' ' ' VAL . 21.6 t -107.77 -5.19 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.71 123.2 7.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.274 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 55.1 tt0 -148.45 136.99 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.152 0.501 . . . . 1.0 111.734 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.62 129.03 48.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' CB ' ' NH2' ' A' ' 50' ' ' ARG . 30.8 ptt-85 -107.01 137.98 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.292 -0.563 . . . . 1.0 112.052 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.13 65.19 4.14 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 82.52 162.53 31.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.059 -0.816 . . . . 1.0 111.059 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -61.67 11.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 1.0 110.364 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.652 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.6 mtp180 -62.89 -48.94 76.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.045 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 11.9 mt -116.71 148.31 41.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.47 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 86.5 Cg_endo -76.67 166.37 27.27 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.504 2.136 . . . . 1.0 112.237 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.6 p -101.22 148.13 25.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.342 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.61 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 42.7 mt -110.81 19.43 18.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.0 tp -66.47 130.47 43.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.35 87.2 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.41 -0.814 . . . . 1.0 112.858 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.3 149.23 25.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.32 0.56 . . . . 1.0 110.429 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.1 m -106.89 134.62 49.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.589 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' CG ' HBB3 ' A' ' 203' ' ' CYC . 61.5 m-85 -108.78 148.9 38.75 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.215 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.73 136.17 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.572 2.182 . . . . 1.0 111.502 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -58.28 -30.58 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.817 0.341 . . . . 1.0 110.413 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.61 -16.63 0.06 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.227 -0.749 . . . . 1.0 111.227 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.754 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 51.4 t0 -62.07 -21.84 65.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.701 0.286 . . . . 1.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.0 mt -143.35 104.71 5.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.529 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 47.9 Cg_exo -40.38 -84.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.56 2.173 . . . . 1.0 111.629 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.486 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 46.2 tp10 -172.41 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.53 -43.31 93.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.626 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.64 -36.78 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.521 -0.308 . . . . 1.0 111.702 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 65.4 ttp85 -64.6 -32.75 74.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.774 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' NH1' ' CH2' ' A' ' 119' ' ' TRP . 62.6 ttt180 -64.42 -37.19 86.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.857 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.11 -36.7 80.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.532 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' CZ ' HBA1 ' A' ' 203' ' ' CYC . 91.2 m-85 -67.39 -33.98 76.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -74.14 -33.22 63.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.263 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.2 mt -94.82 -38.11 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.82 -13.56 9.07 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 114.228 1.196 . . . . 1.0 114.228 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.425 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 47.06 49.7 14.72 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.665 -0.814 . . . . 1.0 109.864 -178.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.4 109.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 120.314 -0.554 . . . . 1.0 111.878 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.02 134.88 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.865 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.4 p -151.05 156.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.724 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.544 HG12 HG21 ' A' ' 135' ' ' VAL . 27.8 mt -109.96 128.77 65.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.263 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.69 169.34 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.972 0.73 . . . . 1.0 112.972 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -49.52 113.73 0.89 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.289 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.482 HG13 ' CG1' ' A' ' 140' ' ' VAL . 52.9 t -51.37 -18.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -77.95 -38.81 44.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.795 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.75 -7.19 3.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.131 0.491 . . . . 1.0 110.384 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 18.2 pt20 45.67 62.77 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.494 -0.776 . . . . 1.0 112.881 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 m -93.91 127.83 39.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -119.79 144.73 47.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.708 1.003 . . . . 1.0 113.708 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.655 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -108.84 150.43 27.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.715 -1.129 . . . . 1.0 108.619 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.3 pt -150.61 154.79 8.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.1 t -85.18 163.82 18.49 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 117' ' ' GLU . 62.4 mt-30 -148.17 153.39 41.25 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.866 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -35.81 -27.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.593 2.195 . . . . 1.0 112.272 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 115' ' ' GLN . 94.6 mt-10 -144.58 -128.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.633 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.8 t 60.9 82.43 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.483 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.609 ' CH2' ' NH1' ' A' ' 93' ' ' ARG . 83.6 t90 -156.56 137.07 13.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.761 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.3 31.39 51.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 121' ' ' LEU . 8.6 mp -64.62 -37.32 87.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 1.0 110.608 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 m -59.88 -36.34 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.06 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -57.61 -61.01 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.69 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.52 156.28 45.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.627 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 128' ' ' GLY . 50.0 Cg_endo -65.16 126.06 15.73 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.356 2.038 . . . . 1.0 111.551 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.8 mt 56.32 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.549 -0.296 . . . . 1.0 110.4 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 56.29 9.98 3.65 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.086 -0.806 . . . . 1.0 111.086 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -154.52 152.03 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.57 0.224 . . . . 1.0 110.576 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' A' ' 132' ' ' GLN . 66.3 Cg_exo -41.66 141.37 1.55 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.438 2.092 . . . . 1.0 111.995 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.48 12.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.986 -0.552 . . . . 1.0 112.032 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 130' ' ' PRO . 27.4 mt-30 -127.34 134.99 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.457 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -132.57 152.56 80.19 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.553 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.655 ' C ' ' HG ' ' A' ' 112' ' ' SER . 56.1 Cg_endo -84.82 148.32 10.87 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.64 2.226 . . . . 1.0 112.356 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.544 HG21 HG12 ' A' ' 103' ' ' ILE . 89.4 t -112.11 123.87 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.533 ' N ' ' OG ' ' A' ' 112' ' ' SER . 5.6 t70 -44.83 139.23 3.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.293 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.67 -25.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.091 2.527 . . . . 1.0 113.632 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.8 t -49.58 -61.97 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.206 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.416 ' HE2' ' CHB' ' A' ' 203' ' ' CYC . 30.9 t-80 -72.94 -23.21 60.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.68 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.482 ' CG1' HG13 ' A' ' 106' ' ' VAL . 72.5 t -55.55 -60.96 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -63.31 -39.46 94.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.364 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 83.1 t80 -48.21 -40.01 22.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.27 -44.8 64.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -56.2 -41.77 76.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -62.65 -22.07 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.622 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.588 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 46.1 mtp -97.25 -1.48 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 20.27 73.8 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.17 143.49 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.277 . . . . 1.0 110.344 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.38 -28.2 4.69 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -151.44 120.2 6.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.811 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 72.9 m -128.65 142.46 51.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 1.0 111.46 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tp -100.07 132.43 45.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.91 130.39 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.305 -0.558 . . . . 1.0 112.242 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 19.8 t -135.71 131.35 19.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.247 -1.02 . . . . 1.0 108.247 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.29 163.01 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.389 2.06 . . . . 1.0 113.69 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.2 mt -115.77 113.93 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.4 ptm -142.0 152.31 43.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.751 0.649 . . . . 1.0 112.751 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -128.04 123.74 35.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 1.0 108.88 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.451 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 17.6 t-80 61.98 -123.64 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.1 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.451 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 15.3 mm100 -97.39 3.3 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.843 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.4 tt0 -106.56 144.96 32.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.75 1.018 . . . . 1.0 113.75 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 48.2 tp -100.18 125.05 46.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.9 m95 -103.76 -33.45 8.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.58 0.956 . . . . 1.0 113.58 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.64 -175.99 32.25 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.668 -1.253 . . . . 1.0 112.371 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 mt -135.06 123.12 22.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.447 -0.377 . . . . 1.0 111.617 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.587 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.4 p -155.45 132.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.825 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.5 p -114.2 133.69 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.174 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.472 ' O ' ' CG2' ' A' ' 48' ' ' THR . 46.4 m80 -106.05 122.7 46.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.593 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 t-80 -118.08 121.52 40.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.1 -17.36 62.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 0.1 OUTLIER -126.26 163.66 38.68 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.618 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.51 141.04 34.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.606 2.204 . . . . 1.0 111.867 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.593 ' NE ' ' CG ' ' A' ' 170' ' ' HIS . 10.9 ptt180 -162.87 94.61 1.16 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.585 -0.279 . . . . 1.0 110.683 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.18 152.63 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.574 2.182 . . . . 1.0 111.473 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -110.17 154.16 23.73 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.809 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.4 p -110.05 150.11 29.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.187 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.66 -37.41 70.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.77 -51.86 62.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.219 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -73.18 -37.24 66.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 1.0 110.941 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.6 -43.97 93.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.625 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -64.45 -51.55 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 1.0 111.721 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.8 t -44.25 -42.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.669 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.09 -50.5 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -49.46 -33.44 14.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 190' ' ' GLN . 6.5 tt -74.55 -48.15 28.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.032 -0.985 . . . . 1.0 109.069 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -53.43 -46.52 69.86 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.3 80.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -60.58 -38.37 84.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 186' ' ' LEU . 57.4 tp60 -65.85 -33.4 75.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.3 -47.13 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.1 p -52.64 -35.01 54.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.13 -35.47 71.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.326 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.2 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.431 ' CG2' HH12 ' A' ' 55' ' ' ARG . 64.3 mt -56.49 -45.5 82.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.6 -49.7 67.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.54 -46.3 88.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.24 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -32.2 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 1.0 111.394 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.82 -43.03 80.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 37.6 tp -53.64 -37.64 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.935 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 32.0 t -54.5 -61.84 2.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.657 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.499 179.728 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.754 ' HHB' ' OD2' ' A' ' 86' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.781 0.325 . . . . 1.0 110.496 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -48.67 -35.1 13.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.753 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -74.74 -50.57 16.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.798 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -56.78 -46.49 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.124 0.488 . . . . 1.0 110.945 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' O ' ' OG1' ' A' ' 38' ' ' THR . 22.3 mt -58.71 -27.38 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.968 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 39' ' ' VAL . 70.9 mtp85 -69.92 -37.73 76.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.42 -0.512 . . . . 1.0 109.807 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.1 66.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.751 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 57.2 p -67.98 -37.14 81.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 1.0 112.324 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p -72.08 -24.91 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.83 -43.09 23.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.28 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -70.28 -48.34 57.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.78 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 43' ' ' ARG . 14.4 p -57.67 -47.66 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.366 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG13 ' A' ' 42' ' ' VAL . 66.2 ttt-85 -51.79 -44.09 63.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 1.0 110.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.39 -40.81 65.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.12 -36.45 83.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.838 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.44 -14.67 21.03 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.722 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 26.06 30.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' ' CE1' ' A' ' 170' ' ' HIS . 49.6 m -76.99 143.66 39.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.8 p30 -53.84 -41.57 67.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.602 0.593 . . . . 1.0 112.602 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 22.2 ttt-85 -151.31 131.85 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 119.612 -0.835 . . . . 1.0 112.826 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 9.0 t -138.66 132.94 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.759 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HE3' HBB2 ' A' ' 203' ' ' CYC . 24.3 pttm -137.13 149.27 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.628 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 56.0 t -96.41 139.18 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.3 t80 -128.36 132.16 48.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.43 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -107.86 143.25 36.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 1.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.8 t80 -99.56 125.19 45.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.687 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 2.5 m-20 -92.07 152.04 42.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.58 -21.43 38.51 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.038 2.492 . . . . 1.0 114.474 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.43 -0.93 57.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.8 -16.58 54.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.716 -0.754 . . . . 1.0 111.901 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 74.5 m80 -80.4 148.91 30.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.41 160.04 24.98 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p -133.19 154.2 50.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.99 0.424 . . . . 1.0 111.503 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 t -91.78 113.29 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.13 -2.95 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.96 128.33 9.91 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.324 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CB ' HD21 ' A' ' 78' ' ' LEU . 88.7 tt0 -156.14 138.82 15.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.162 0.506 . . . . 1.0 111.722 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.94 140.54 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.809 -0.812 . . . . 1.0 108.809 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 23.5 mtt85 -116.77 137.5 52.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.352 -0.539 . . . . 1.0 112.104 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.5 82.62 1.63 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' C ' ' N ' ' A' ' 73' ' ' ARG . . . 74.64 41.04 36.47 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 49.65 15.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 1.0 110.408 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' N ' ' C ' ' A' ' 71' ' ' GLY . 52.7 ttt85 -55.75 -47.43 76.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.998 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.98 149.01 36.45 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.95 160.13 40.68 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.47 2.113 . . . . 1.0 112.191 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.516 ' CB ' ' HE ' ' A' ' 69' ' ' ARG . 4.9 p -85.51 130.81 34.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.336 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.549 HD12 ' NH2' ' A' ' 50' ' ' ARG . 24.0 mt -109.53 9.19 25.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.007 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD21 ' CB ' ' A' ' 67' ' ' GLU . 89.4 mt -56.11 129.04 38.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.21 -6.53 81.41 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.468 -0.787 . . . . 1.0 112.861 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.92 147.24 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.348 0.574 . . . . 1.0 110.482 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.5 m -108.8 137.46 46.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.58 149.58 39.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.213 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.8 136.23 11.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.583 2.189 . . . . 1.0 111.449 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -61.23 -32.06 71.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.818 0.342 . . . . 1.0 110.429 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.08 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.5 m-20 -61.11 -24.96 66.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.72 0.295 . . . . 1.0 111.035 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.474 HG22 ' HD ' ' A' ' 203' ' ' CYC . 7.7 pt -137.32 143.96 43.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.52 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 96.4 Cg_endo -76.39 -89.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.581 2.187 . . . . 1.0 111.608 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.512 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 83.3 tt0 -170.01 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.957 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 19.6 pt-20 -59.26 -40.47 86.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.586 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -73.39 -38.28 65.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.703 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.675 HH12 ' NH2' ' A' ' 96' ' ' ARG . 66.9 ttp85 -61.89 -32.89 73.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 1.0 110.808 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -64.61 -36.77 85.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.938 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.91 -36.36 79.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.493 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' CE2' ' O1A' ' A' ' 203' ' ' CYC . 87.2 m-85 -69.55 -38.45 77.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.675 ' NH2' HH12 ' A' ' 92' ' ' ARG . 28.1 ttm180 -74.03 -33.15 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.159 -0.928 . . . . 1.0 111.197 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.0 mt -94.58 -37.73 11.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.789 1.033 . . . . 1.0 113.789 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.12 -12.65 9.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.274 1.213 . . . . 1.0 114.274 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 46.99 47.63 15.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.958 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.51 109.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.413 -0.515 . . . . 1.0 111.946 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.466 ' HD2' HBD2 ' A' ' 203' ' ' CYC . 0.1 OUTLIER -166.58 130.72 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.798 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.14 159.05 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.719 HG12 HG21 ' A' ' 135' ' ' VAL . 4.7 mt -110.37 128.45 66.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.004 0.431 . . . . 1.0 110.257 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.47 HG21 ' OG ' ' A' ' 110' ' ' SER . 5.2 m -86.96 171.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.021 0.749 . . . . 1.0 113.021 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -50.32 115.0 1.25 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.999 -1.0 . . . . 1.0 112.192 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.491 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.3 p -52.55 -27.15 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.69 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.08 -40.27 62.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.85 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.15 -15.05 3.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 1.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.425 ' OE1' ' NH2' ' A' ' 111' ' ' ARG . 0.3 OUTLIER 56.81 60.81 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.491 -0.777 . . . . 1.0 112.847 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.47 ' OG ' HG21 ' A' ' 104' ' ' VAL . 2.3 m -95.62 125.29 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' NH2' ' OE1' ' A' ' 109' ' ' GLN . 87.9 mtt-85 -118.08 144.92 45.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -109.46 145.46 36.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.767 -1.106 . . . . 1.0 108.646 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.2 mt -146.8 151.78 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.441 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -88.53 160.89 17.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.292 -0.633 . . . . 1.0 109.292 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -152.76 132.08 6.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.929 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 117' ' ' GLU . 32.3 Cg_exo -36.64 129.61 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.699 2.266 . . . . 1.0 112.24 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 116' ' ' PRO . 43.0 tp10 58.06 120.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.606 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.3 p -67.58 154.68 40.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.519 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.26 -36.36 79.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.731 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.34 -171.35 44.2 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 123' ' ' ALA . 21.4 tp -97.35 138.52 34.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 1.0 110.624 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -53.78 -27.13 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.787 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.449 ' H ' ' HG ' ' A' ' 121' ' ' LEU . . . -48.33 -34.28 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.751 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -64.92 -139.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.658 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.12 133.55 95.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 145.11 37.27 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.398 2.065 . . . . 1.0 111.537 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.11 -108.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.98 48.1 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -135.78 153.28 77.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 121.207 -0.197 . . . . 1.0 110.615 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.576 ' C ' ' H ' ' A' ' 132' ' ' GLN . 68.6 Cg_exo -41.52 167.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.402 2.068 . . . . 1.0 112.04 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.405 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 46.9 mt -59.27 9.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.059 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.576 ' H ' ' C ' ' A' ' 130' ' ' PRO . 46.2 mm-40 -137.28 154.31 50.13 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.471 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -126.88 83.06 66.56 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.65 141.19 27.6 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.657 2.238 . . . . 1.0 112.38 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.779 HG13 HAD2 ' A' ' 203' ' ' CYC . 96.3 t -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -45.03 157.27 0.34 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.401 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.94 -9.92 15.91 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.135 2.557 . . . . 1.0 113.711 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -66.56 -63.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.258 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.486 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 41.5 t60 -71.64 -25.41 62.13 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.656 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 136' ' ' ASP . 92.4 t -61.2 -58.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.86 -37.9 89.09 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.419 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.438 ' O ' ' OG ' ' A' ' 145' ' ' SER . 80.5 t80 -48.8 -35.28 14.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.445 HD11 ' NE2' ' A' ' 139' ' ' HIS . 49.8 mt -73.45 -43.25 60.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -58.73 -44.31 90.41 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 96.9 p -62.51 -18.11 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.716 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.8 mmm -100.89 0.57 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.93 19.05 78.13 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.605 HG21 ' HD1' ' A' ' 169' ' ' HIS . 97.8 t -108.13 143.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.697 0.284 . . . . 1.0 110.292 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.78 -32.15 5.23 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.975 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.8 m -143.79 122.45 12.57 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.746 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 p -126.86 131.7 51.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 1.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -97.0 131.43 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.95 131.13 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.32 -0.552 . . . . 1.0 112.304 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.7 t -135.93 131.36 18.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.199 -1.038 . . . . 1.0 108.199 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -93.78 162.41 2.26 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.424 2.083 . . . . 1.0 113.706 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.5 mt -115.55 113.86 24.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.3 ptm -140.92 150.19 42.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 71.9 t60 -122.09 123.22 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.933 -1.03 . . . . 1.0 108.878 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 45.8 m-70 57.4 -118.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.12 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -98.12 1.87 48.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 143.75 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.7 tp -99.51 124.43 44.68 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.508 -1.293 . . . . 1.0 107.508 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 65.5 m95 -103.24 -32.18 9.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.575 0.954 . . . . 1.0 113.575 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.81 -173.06 32.05 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 119.701 -1.238 . . . . 1.0 112.39 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.6 mt -136.22 122.81 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.443 -0.379 . . . . 1.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 53' ' ' VAL . 17.9 tp -95.33 149.35 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.464 HG11 ' NZ ' ' A' ' 52' ' ' LYS . 11.0 p -155.15 134.52 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.867 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.1 m -115.73 139.02 50.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.22 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.605 ' HD1' HG21 ' A' ' 148' ' ' VAL . 18.9 m-70 -110.64 123.97 51.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.542 ' CE1' ' OG1' ' A' ' 48' ' ' THR . 84.8 m-70 -117.97 113.86 22.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.92 -22.71 59.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.777 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.17 115.03 61.78 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -42.9 136.12 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.675 2.25 . . . . 1.0 111.806 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -169.1 138.55 1.74 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.588 -0.278 . . . . 1.0 110.685 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 156.01 31.02 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.545 2.164 . . . . 1.0 111.431 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.99 153.64 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.1 m -105.57 150.65 25.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -55.76 -37.7 68.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.19 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.7 -47.04 85.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.305 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.52 -32.61 68.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 1.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.96 -35.8 81.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.667 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.69 -53.17 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.718 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 76.2 t -41.82 -42.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.589 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 185' ' ' GLN . 29.1 m -74.67 -45.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.511 ' N ' HG23 ' A' ' 184' ' ' VAL . 53.4 tt0 -52.91 -31.5 40.21 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 190' ' ' GLN . 39.3 tp -75.84 -56.56 4.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.097 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.0 mt -51.04 -45.42 61.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.43 76.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.361 -0.978 . . . . 1.0 108.361 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -61.11 -39.02 88.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 186' ' ' LEU . 46.8 tp60 -64.44 -33.37 75.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.593 -0.892 . . . . 1.0 108.593 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.75 -46.78 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.0 p -53.14 -33.79 53.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 mt -70.41 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.114 -0.948 . . . . 1.0 110.174 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.48 82.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.871 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.5 mt -55.74 -48.26 78.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.14 66.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.403 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.82 -46.54 87.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.294 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -33.14 75.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.6 tp -53.07 -38.89 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.5 t -47.67 -58.41 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.638 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.955 -1.022 . . . . 1.0 110.426 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.779 HAD2 HG13 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.553 ' CD2' HD11 ' A' ' 35' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 1.0 110.52 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 2.3 p30 -67.12 -31.09 71.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 79.9 mt-30 -74.53 -49.06 23.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.754 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.28 -48.01 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 1.0 110.954 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 31' ' ' LEU . 62.7 mt -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.984 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 39' ' ' VAL . 78.2 mtm180 -65.32 -39.88 93.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.378 -0.529 . . . . 1.0 109.835 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.47 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.768 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.722 ' O ' HG23 ' A' ' 42' ' ' VAL . 73.0 p -67.56 -35.97 80.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 1.0 112.303 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -74.69 -24.69 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -178.252 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.71 -47.25 60.78 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.298 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.31 -32.37 64.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.828 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 38' ' ' THR . 62.0 t -62.99 -55.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.298 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.6 tmm_? -54.22 -43.77 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 1.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -40.68 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.314 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -67.82 -36.08 79.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.826 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.5 mt -96.88 -18.65 19.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.756 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.94 25.19 56.05 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -79.86 147.26 31.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -52.43 -41.48 63.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.708 HH22 ' NE ' ' A' ' 69' ' ' ARG . 84.1 mtt-85 -151.15 128.83 11.52 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.55 -0.86 . . . . 1.0 112.818 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 6.2 t -134.35 128.24 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.771 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.556 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 20.9 pttm -138.65 153.54 48.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.662 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG22 ' CD1' ' A' ' 166' ' ' LEU . 48.2 t -98.36 139.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -127.14 130.23 49.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.609 HH12 HD12 ' A' ' 195' ' ' ILE . 16.6 mmm180 -110.68 149.64 30.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.007 0.432 . . . . 1.0 111.156 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.87 138.97 38.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -104.12 153.35 38.98 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 109.392 -0.596 . . . . 1.0 109.392 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -39.18 -51.61 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 123.015 2.477 . . . . 1.0 114.473 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.54 -4.76 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 105.61 -8.5 43.68 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.693 -0.765 . . . . 1.0 111.944 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' A' ' 57' ' ' ASP . 75.3 m80 -76.97 149.2 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.378 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.19 161.78 25.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -135.9 157.47 46.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 1.0 111.524 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 80' ' ' LEU . 4.3 p -96.87 114.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.39 3.13 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.102 0.408 . . . . 1.0 112.102 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.61 127.16 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.274 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.524 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 79.8 tt0 -156.69 138.87 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.194 0.521 . . . . 1.0 111.683 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.57 134.78 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.708 ' NE ' HH22 ' A' ' 50' ' ' ARG . 10.5 mtp180 -104.08 134.57 47.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.05 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.13 -142.51 1.21 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -65.98 53.34 0.17 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 70' ' ' GLY . 97.2 mt-10 37.73 33.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.355 . . . . 1.0 110.409 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' GLY . 14.6 tpp85 -81.62 -40.27 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.005 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.453 ' C ' ' HE ' ' A' ' 50' ' ' ARG . 90.7 mt -109.83 148.95 39.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 50' ' ' ARG . 97.5 Cg_endo -74.34 159.4 43.59 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.545 2.164 . . . . 1.0 112.264 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -83.36 133.78 34.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.35 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.745 ' O ' HG11 ' A' ' 64' ' ' VAL . 25.5 mt -113.6 17.37 18.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.954 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 28.0 tp -66.79 130.72 44.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.585 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 85.56 -1.39 88.29 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.478 -0.783 . . . . 1.0 112.807 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.817 ' O ' HG12 ' A' ' 64' ' ' VAL . 86.0 mt -87.09 149.9 24.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.407 0.604 . . . . 1.0 110.451 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 81' ' ' THR . 13.7 t -104.86 131.15 52.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.629 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CG ' HBB3 ' A' ' 203' ' ' CYC . 79.9 m-85 -106.09 106.35 56.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.303 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -43.34 139.17 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.562 2.175 . . . . 1.0 111.511 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.44 -32.09 69.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.942 0.401 . . . . 1.0 110.503 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.48 -18.01 0.1 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.25 -0.74 . . . . 1.0 111.25 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 60.1 t0 -64.28 -19.2 65.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.624 0.25 . . . . 1.0 111.075 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mt -138.06 133.26 17.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.515 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.71 -94.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.525 2.15 . . . . 1.0 111.643 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.17 -38.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.994 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.48 -42.73 71.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.576 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.926 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -71.28 -37.9 71.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.75 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -62.81 -33.43 75.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.747 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -64.15 -38.74 92.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.16 -37.32 79.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 1.0 111.536 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -67.99 -34.65 76.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.77 -28.9 50.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.12 -0.946 . . . . 1.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -94.69 -39.59 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.06 -10.16 8.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.419 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 1.9 mp0 45.74 58.93 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.621 -0.832 . . . . 1.0 109.942 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.9 p -163.83 114.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.703 HH22 HH21 ' A' ' 133' ' ' ARG . 7.6 tpt180 -168.38 136.87 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.824 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.3 p -152.08 157.21 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.677 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.472 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 71.3 mt -109.77 130.07 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.262 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.601 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.6 p -85.96 168.56 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.601 ' N ' HG22 ' A' ' 104' ' ' VAL . 60.0 m-20 -48.12 114.73 0.99 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.204 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.492 HG13 ' CG1' ' A' ' 140' ' ' VAL . 41.4 t -51.86 -21.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.697 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -78.18 -37.91 44.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.34 -16.49 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.17 0.509 . . . . 1.0 110.365 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 56.43 63.03 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 1.0 112.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.402 ' OG ' ' CG1' ' A' ' 104' ' ' VAL . 80.0 p -96.31 124.3 40.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -117.17 145.05 44.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 1.5 t -108.06 144.15 35.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.713 -1.13 . . . . 1.0 108.618 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.71 149.57 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.467 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 t -89.93 164.49 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 117' ' ' GLU . 9.7 pt20 -150.31 148.76 25.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.861 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -37.17 -26.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.696 2.264 . . . . 1.0 112.229 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLN . 89.8 mt-10 -98.18 159.7 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.622 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.4 p -143.13 157.29 44.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.499 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -148.07 160.61 42.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.718 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.11 134.26 3.7 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt -90.41 38.56 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 1.0 110.615 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -48.32 -25.13 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.699 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -69.66 -2.79 12.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.787 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 123' ' ' ALA . 36.3 ttm180 51.08 102.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 1.0 110.677 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.11 135.02 19.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -40.58 158.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.366 2.044 . . . . 1.0 111.587 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.0 mp 46.59 -102.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.396 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.46 -14.26 9.5 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -146.95 152.11 43.18 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.538 0.208 . . . . 1.0 110.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.04 173.28 14.7 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.387 2.058 . . . . 1.0 112.042 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.7 -28.3 65.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 1.0 112.094 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -132.38 134.79 45.58 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.511 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.703 HH21 HH22 ' A' ' 101' ' ' ARG . 9.5 mmm180 -119.71 147.79 44.7 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.5 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -87.39 143.23 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.65 2.234 . . . . 1.0 112.452 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.97 126.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.678 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 1.7 p30 -45.68 143.5 3.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.401 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -37.36 -25.92 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.118 2.545 . . . . 1.0 113.649 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.427 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.1 t -53.9 -61.23 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.257 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.545 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 18.3 t60 -69.39 -24.9 63.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.664 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.492 ' CG1' HG13 ' A' ' 106' ' ' VAL . 47.3 t -59.51 -60.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -61.81 -40.25 94.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 1.0 110.353 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -46.75 -39.11 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.06 -45.17 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -57.17 -43.1 82.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 t -63.5 -20.13 65.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 1.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.3 mmm -99.72 -3.45 32.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.093 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.06 78.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.15 141.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 1.0 110.254 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.94 -36.12 3.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.998 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 m -142.01 119.43 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.705 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 168' ' ' SER . 44.4 t -126.79 136.39 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.981 0.419 . . . . 1.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.77 132.36 41.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 t -113.5 129.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.31 -0.556 . . . . 1.0 112.298 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.7 t -136.97 136.39 21.09 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.255 -1.017 . . . . 1.0 108.255 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.82 166.25 1.02 Allowed 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.423 2.082 . . . . 1.0 113.699 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 mt -118.43 114.73 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.419 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 22.0 ptm -142.03 153.91 44.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.457 0.646 . . . . 1.0 112.683 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 40.4 t60 -129.68 124.19 33.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.903 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.41 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.7 t-80 61.84 -123.73 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.144 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.41 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 95.5 mt-30 -97.56 3.61 50.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.813 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.8 144.75 33.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.736 1.013 . . . . 1.0 113.736 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 39.7 tp -100.69 125.26 47.11 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 87.5 m95 -102.92 -32.95 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.09 -173.31 30.61 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.393 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.2 123.19 21.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.433 -0.383 . . . . 1.0 111.634 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.7 tp -95.29 149.9 20.83 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.1 p -158.01 134.5 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.844 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 151' ' ' SER . 42.2 m -114.94 136.66 52.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.729 -0.669 . . . . 1.0 109.282 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.556 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 32.3 m-70 -112.35 129.6 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -120.03 128.62 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.18 23.91 1.7 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -151.5 147.73 20.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.871 -0.331 . . . . 1.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.72 112.84 3.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.659 2.239 . . . . 1.0 111.75 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -152.42 139.89 12.93 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.685 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.97 152.88 28.61 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.57 2.18 . . . . 1.0 111.451 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -100.21 157.65 16.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.838 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.9 m -92.64 146.45 23.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.221 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -65.63 -25.35 67.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.142 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.87 -54.82 7.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.231 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 1.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.6 tp -56.24 -45.29 80.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.9 -53.66 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.66 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 90.8 t -44.58 -40.1 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.07 -49.03 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -48.68 -33.52 10.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 190' ' ' GLN . 47.2 tp -75.17 -46.19 35.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.039 -0.982 . . . . 1.0 109.064 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.8 tp -54.64 -47.74 73.13 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.41 92.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.595 ' O ' HD13 ' A' ' 193' ' ' ILE . 57.2 t0 -62.28 -39.41 92.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.0 tp60 -64.54 -30.92 71.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 194' ' ' ALA . 51.6 t -77.23 -45.35 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 31.1 p -49.2 -31.64 8.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -73.57 -35.39 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.296 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -66.69 -44.01 82.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.922 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.609 HD12 HH12 ' A' ' 55' ' ' ARG . 25.2 pt -64.97 -27.01 41.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.414 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.6 -54.36 6.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.301 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.3 pt20 -66.06 -37.53 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.289 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.415 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.355 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -58.15 -43.72 87.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.204 0.446 . . . . 1.0 112.204 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 47.7 mt -51.94 -30.39 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 95.8 p -44.87 -55.75 5.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.636 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.459 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.926 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 66.9 t0 -48.15 -37.1 14.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.694 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -74.7 -51.19 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.838 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 38' ' ' THR . 95.3 mt -55.67 -47.45 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 1.0 110.964 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.489 ' O ' ' OG1' ' A' ' 38' ' ' THR . 24.5 mt -56.9 -30.17 63.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.943 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.507 ' O ' HG12 ' A' ' 39' ' ' VAL . 28.3 ttm180 -65.25 -38.48 90.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.73 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.739 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -69.59 -34.95 74.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.35 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.512 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.7 p -74.12 -25.22 19.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.22 -47.28 18.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.266 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -49.93 67.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.768 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.9 p -52.48 -47.08 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.315 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.593 ' N ' HG13 ' A' ' 42' ' ' VAL . 53.5 ttp180 -49.98 -43.93 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 1.0 110.596 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.52 -40.47 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.36 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.45 -37.29 82.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.804 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -96.64 -17.72 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.695 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 25.26 27.57 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 p -79.6 149.54 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.64 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 28.0 p30 -49.94 -41.94 47.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.64 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 29.7 ptt180 -159.41 146.54 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.584 -0.847 . . . . 1.0 112.788 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 13.4 p -144.02 135.65 22.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.956 -1.02 . . . . 1.0 108.733 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.717 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 48.7 pttt -137.54 149.75 46.97 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.239 -0.584 . . . . 1.0 111.573 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 166' ' ' LEU . 54.7 t -98.09 140.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.501 ' HH ' ' C ' ' A' ' 62' ' ' GLY . 17.8 t80 -129.48 131.3 46.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.482 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -109.89 148.19 32.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 1.0 111.257 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.47 133.91 45.38 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.755 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 61' ' ' HIS . 23.0 m-20 -98.44 152.95 38.17 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -39.43 -50.37 2.97 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.02 2.48 . . . . 1.0 114.516 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -70.11 -6.18 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.35 41.45 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.871 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 57' ' ' ASP . 31.1 m80 -79.69 152.29 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.369 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.501 ' C ' ' HH ' ' A' ' 54' ' ' TYR . . . -139.21 164.65 25.85 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -135.87 157.67 46.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.0 111.525 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 t -92.03 109.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 65' ' ' VAL . 21.6 t -111.32 -1.86 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.54 128.43 9.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' N ' HD21 ' A' ' 78' ' ' LEU . 84.8 tt0 -160.09 140.95 12.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.151 0.501 . . . . 1.0 111.762 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.27 136.53 52.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.499 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 15.1 mtt180 -104.33 134.94 46.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.062 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.44 72.07 2.72 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.636 -0.986 . . . . 1.0 110.636 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 78.63 46.93 8.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 46.66 16.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 1.0 110.336 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' GLY . 41.9 ttm180 -57.21 -46.72 82.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.069 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.07 127.51 26.46 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.59 170.67 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.459 2.106 . . . . 1.0 112.252 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.3 p -95.32 145.82 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.26 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -109.5 10.05 25.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.929 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 67' ' ' GLU . 53.5 mt -53.68 127.9 27.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.4 84.56 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.817 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 80' ' ' LEU . 90.2 mt -82.36 148.03 28.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.438 0.619 . . . . 1.0 110.448 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 81' ' ' THR . 14.2 t -106.64 132.72 52.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.614 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CG ' HAB2 ' A' ' 203' ' ' CYC . 46.2 m-85 -109.57 107.74 59.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -43.38 140.35 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.525 2.15 . . . . 1.0 111.464 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -67.16 -26.34 66.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.392 . . . . 1.0 110.471 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.08 -17.57 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ALA . 26.2 p-10 -69.12 -17.2 63.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 1.0 111.035 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.37 133.53 24.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.45 -97.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.616 2.21 . . . . 1.0 111.631 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -163.89 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.932 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -56.39 -41.48 76.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.651 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.81 59.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.695 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 39.9 ttm180 -60.25 -34.45 73.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.797 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -63.44 -33.82 76.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.94 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.81 -34.08 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.513 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -69.38 -38.94 78.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 14.9 mtm180 -72.35 -33.38 67.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.26 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.11 -36.1 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.45 -16.49 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.664 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.5 mp0 48.72 58.68 5.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.972 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 99' ' ' GLN . 4.9 m -159.61 112.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.92 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -165.02 135.57 3.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.898 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -150.41 157.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.693 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.694 HG12 HG21 ' A' ' 135' ' ' VAL . 3.3 mt -109.43 130.0 63.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.246 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.4 t -83.7 165.16 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' H ' HG12 ' A' ' 104' ' ' VAL . 61.2 m-20 -50.0 116.97 2.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.18 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.8 p -49.92 -21.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.701 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -80.3 -37.4 32.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.837 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.1 -21.66 66.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.119 0.485 . . . . 1.0 110.412 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 57.79 61.43 2.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.523 -0.762 . . . . 1.0 112.9 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.9 m -93.31 125.88 38.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -121.6 146.43 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.431 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -113.86 152.01 31.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.782 -1.099 . . . . 1.0 108.668 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.8 mt -148.3 154.24 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.416 -0.514 . . . . 1.0 111.446 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 p -83.3 164.01 20.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -153.21 163.97 21.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.88 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -40.37 -13.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.61 2.207 . . . . 1.0 112.335 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 115' ' ' GLN . 85.6 tt0 60.49 -95.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.571 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.3 p 44.21 23.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.471 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.424 ' N ' ' C ' ' A' ' 117' ' ' GLU . 59.2 t-105 -89.78 154.22 20.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.684 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.3 -161.28 5.39 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 121' ' ' LEU . 7.9 mp -80.08 143.53 33.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 1.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 t -59.75 -34.33 72.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.725 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.3 -52.12 17.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.721 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -51.64 -59.15 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.687 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 t -109.99 103.67 53.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.659 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.64 146.55 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.397 2.064 . . . . 1.0 111.547 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.46 -117.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.57 -0.286 . . . . 1.0 110.457 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.65 38.42 37.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -142.29 157.03 63.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 122.906 -0.173 . . . . 1.0 110.695 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.593 ' C ' ' H ' ' A' ' 132' ' ' GLN . 40.4 Cg_endo -63.2 168.51 10.82 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.425 2.083 . . . . 1.0 111.988 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 51.1 mt -58.36 9.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.094 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.593 ' H ' ' C ' ' A' ' 130' ' ' PRO . 51.1 mm-40 -137.99 154.13 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.481 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -121.73 80.46 40.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.567 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -48.07 142.55 15.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.649 2.233 . . . . 1.0 112.37 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 103' ' ' ILE . 3.0 t -120.4 129.5 75.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.494 ' H ' HMD2 ' A' ' 203' ' ' CYC . 1.5 m-20 -44.53 140.9 2.97 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.708 0.29 . . . . 1.0 111.365 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -38.32 -23.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.064 2.51 . . . . 1.0 113.685 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.51 ' SG ' ' HHD' ' A' ' 203' ' ' CYC . 0.0 OUTLIER -53.78 -62.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.23 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.442 ' CD2' HD11 ' A' ' 143' ' ' LEU . 71.7 t60 -71.29 -23.48 61.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.676 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.443 ' CG1' HG23 ' A' ' 106' ' ' VAL . 80.4 t -59.41 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.623 0.601 . . . . 1.0 112.623 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.14 -39.76 95.61 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.37 -37.61 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.442 HD11 ' CD2' ' A' ' 139' ' ' HIS . 61.8 mt -72.99 -42.13 63.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.192 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.81 -42.94 90.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.8 m -62.11 -19.45 63.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.623 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.0 mmm -99.54 0.98 43.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.102 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.76 19.63 75.28 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.473 HG21 HH21 ' A' ' 50' ' ' ARG . 93.4 t -110.48 144.47 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.734 0.302 . . . . 1.0 110.245 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.63 -24.61 5.71 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -152.41 119.57 5.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.76 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.2 p -127.85 139.32 52.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 1.0 111.405 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -99.38 134.47 42.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 t -114.91 128.25 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.294 -0.563 . . . . 1.0 112.337 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 26.5 t -134.3 133.16 21.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.05 161.22 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.415 2.076 . . . . 1.0 113.692 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.4 mt -115.2 116.81 28.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.9 ptm -141.2 156.2 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -133.26 127.46 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.062 -0.972 . . . . 1.0 108.798 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.497 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 2.0 t60 62.89 -125.4 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.16 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.497 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 19.5 pt20 -99.38 2.06 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.839 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.471 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 10.0 pt-20 -108.91 154.33 22.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.68 126.87 52.19 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.471 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 43.5 m95 -101.79 -28.21 12.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.1 -170.26 31.75 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.598 -1.287 . . . . 1.0 112.318 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 90.0 mt -136.31 123.94 22.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.454 -0.373 . . . . 1.0 111.631 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.483 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.0 tp -96.59 149.65 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.0 p -156.3 133.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.139 -0.625 . . . . 1.0 111.912 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.0 p -117.31 133.08 56.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.249 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.512 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 59.8 m80 -101.65 126.19 48.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 -178.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 170' ' ' HIS . 1.9 m80 -116.25 117.75 30.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.09 25.06 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.75 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.91 150.04 29.19 Favored Pre-proline 0 C--N 1.327 -0.409 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.94 119.06 5.24 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.592 2.195 . . . . 1.0 111.882 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -155.55 136.29 8.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.39 157.01 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.531 2.154 . . . . 1.0 111.466 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -110.1 153.84 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.829 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.8 m -111.3 148.28 33.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.2 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -56.32 -36.83 69.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.122 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 183' ' ' VAL . 78.6 mm-40 -67.13 -54.6 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.429 -0.351 . . . . 1.0 111.214 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.8 mt-10 -70.77 -33.7 71.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 1.0 111.015 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.59 -33.29 72.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.644 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.44 -54.82 5.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.915 -0.314 . . . . 1.0 111.609 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 184' ' ' VAL . 31.8 m -46.51 -40.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.597 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 185' ' ' GLN . 30.1 m -71.88 -50.62 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.58 ' N ' HG23 ' A' ' 184' ' ' VAL . 60.8 tt0 -46.46 -32.16 3.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.7 tt -66.86 -48.04 70.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.027 -0.988 . . . . 1.0 109.1 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 184' ' ' VAL . 91.2 mt -52.69 -45.21 66.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.38 90.11 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.71 -38.01 89.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.5 tp60 -64.88 -32.52 74.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.4 t -77.1 -44.7 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.6 m -52.9 -36.5 59.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -67.57 -36.31 75.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.111 -0.95 . . . . 1.0 110.219 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.45 84.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.948 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.07 -29.73 47.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.55 -55.02 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.398 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.4 pt20 -65.38 -40.03 92.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.222 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.39 -32.91 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 1.0 111.434 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.44 -42.87 83.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.6 mp -54.27 -36.4 63.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.945 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.7 t -49.57 -58.21 5.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.631 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.432 179.864 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.717 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.338 . . . . 1.0 110.519 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -65.39 -31.11 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -76.07 -48.99 18.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.853 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.54 -49.99 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.072 0.463 . . . . 1.0 110.997 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.562 HD11 ' CD2' ' A' ' 31' ' ' LEU . 55.1 mt -57.45 -31.52 66.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.914 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.0 ttt180 -63.01 -40.62 98.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.735 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.48 70.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.795 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.747 ' O ' HG23 ' A' ' 42' ' ' VAL . 73.6 p -65.28 -35.99 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.314 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -75.17 -24.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 1.0 112.201 -177.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.65 -49.99 41.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.247 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.25 -37.25 85.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.779 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 38' ' ' THR . 77.4 t -56.06 -54.1 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.345 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 47' ' ' GLY . 53.7 ttt-85 -51.02 -44.39 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 1.0 110.623 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.77 70.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.323 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.732 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.92 -14.96 21.41 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.664 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.92 26.05 25.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.8 p -81.55 152.38 27.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -48.3 -43.9 33.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.623 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 50.9 ptt85 -158.8 147.28 18.37 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.542 -0.863 . . . . 1.0 112.779 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -139.23 133.88 40.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.002 -0.999 . . . . 1.0 108.736 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' CE ' HH12 ' A' ' 50' ' ' ARG . 46.1 pttt -137.31 146.25 44.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.379 -0.528 . . . . 1.0 111.66 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.9 t -98.06 142.68 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.0 t80 -130.74 132.6 45.42 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.407 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -111.54 150.64 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 1.0 111.159 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -101.81 133.84 45.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.594 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -99.18 153.35 37.83 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -38.36 -51.61 2.09 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.994 2.463 . . . . 1.0 114.492 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.44 -5.56 29.41 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.173 0.435 . . . . 1.0 112.173 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -7.75 43.15 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.964 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 57' ' ' ASP . 6.0 m-70 -78.98 151.94 31.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.365 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.411 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.99 164.3 25.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.5 p -135.88 157.99 45.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 111.487 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 t -88.08 107.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.83 -3.96 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.083 0.401 . . . . 1.0 112.083 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -154.19 128.29 8.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.342 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.5 tt0 -158.09 139.31 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 1.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -117.37 137.92 52.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.572 . . . . 1.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.45 87.3 1.56 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' C ' ' N ' ' A' ' 73' ' ' ARG . . . 68.09 37.43 87.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 52.8 12.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 1.0 110.397 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.421 ' N ' ' C ' ' A' ' 71' ' ' GLY . 28.7 ttm180 -49.62 -47.7 49.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.421 HD23 ' HE ' ' A' ' 50' ' ' ARG . 6.5 mp -108.31 156.01 39.27 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 158.47 50.75 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.55 2.167 . . . . 1.0 112.182 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.3 122.71 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.569 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 25.2 mt -99.85 12.17 37.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.967 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.8 tp -66.57 133.33 50.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.916 0.709 . . . . 1.0 112.916 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.92 86.51 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.402 -0.817 . . . . 1.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -87.67 153.14 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.347 0.574 . . . . 1.0 110.53 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.8 m -106.86 132.21 53.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.58 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -106.0 147.21 34.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 134.78 12.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.603 2.202 . . . . 1.0 111.473 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.62 -32.9 72.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 1.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 -16.11 0.11 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.7 m-20 -59.07 -10.49 2.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.66 0.267 . . . . 1.0 110.997 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' HE ' ' A' ' 92' ' ' ARG . 1.8 pt -141.15 145.93 40.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.559 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.59 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.502 2.135 . . . . 1.0 111.709 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 93' ' ' ARG . 79.2 tt0 -163.47 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.963 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -71.7 -39.64 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.662 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.644 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.493 ' HE ' HD12 ' A' ' 87' ' ' ILE . 18.3 ttm180 -61.94 -36.79 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 1.0 110.81 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 18.2 mmt85 -61.51 -35.37 77.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.943 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.08 -33.31 75.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.522 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.29 -34.97 77.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 12.0 mtm180 -75.8 -31.1 59.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.251 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.8 mt -93.78 -38.08 11.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.792 1.034 . . . . 1.0 113.792 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -120.43 -10.54 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.246 1.202 . . . . 1.0 114.246 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.417 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 2.1 mp0 44.46 63.31 1.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.641 -0.824 . . . . 1.0 109.859 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 100' ' ' VAL . 13.2 p -169.33 117.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.315 -0.554 . . . . 1.0 111.882 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.587 HH22 ' CA ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -173.77 131.14 0.42 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.859 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.54 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 2.5 m -142.42 159.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.657 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.573 HD11 HMA2 ' A' ' 203' ' ' CYC . 23.8 mt -111.02 128.29 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.252 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 104' ' ' VAL . 19.2 m -87.89 171.45 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.419 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 56.3 m-20 -52.26 113.2 0.96 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.277 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.736 HG23 ' CG1' ' A' ' 140' ' ' VAL . 10.1 p -47.71 -17.74 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 1.0 110.688 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' N ' ' C ' ' A' ' 105' ' ' ASP . 84.7 tt0 -81.81 -36.68 28.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.806 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.58 -20.21 44.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.105 0.479 . . . . 1.0 110.451 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 56.46 58.94 3.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.819 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -96.71 126.83 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -122.39 143.33 49.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.757 ' HG ' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -111.81 156.73 21.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.746 -1.116 . . . . 1.0 108.63 177.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.6 pt -152.8 156.61 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.462 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.7 p -89.77 172.73 8.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -139.35 152.37 69.14 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.893 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 -14.15 16.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.648 2.232 . . . . 1.0 112.312 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -57.26 136.54 56.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.634 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.5 t -87.81 -10.01 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.486 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -98.75 145.54 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.669 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 86.89 0.07 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.18 110.9 21.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.71 0.29 . . . . 1.0 110.604 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.2 t -65.58 -27.82 68.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -65.84 -5.22 8.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.748 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 125' ' ' VAL . 32.4 ptt180 -58.32 -151.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.74 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.424 ' N ' ' HG3' ' A' ' 124' ' ' ARG . 3.5 m -57.89 151.27 44.65 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.9 143.16 49.31 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.377 2.052 . . . . 1.0 111.529 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.6 mt 59.6 -112.83 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.405 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 24.95 37.08 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.081 -0.807 . . . . 1.0 111.081 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' A' ' 133' ' ' ARG . 54.7 mt-10 -143.03 154.42 61.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.215 -0.194 . . . . 1.0 110.633 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 132' ' ' GLN . 66.2 Cg_exo -41.65 168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.416 2.077 . . . . 1.0 112.029 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.404 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 53.0 mt -62.72 12.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.521 . . . . 1.0 112.074 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' H ' ' C ' ' A' ' 130' ' ' PRO . 50.9 mm-40 -137.17 157.09 47.45 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.507 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 129' ' ' GLU . 17.8 mmm180 -124.22 115.91 27.25 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.567 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.51 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 63.7 Cg_endo -83.51 138.59 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.17 . . . . 1.0 112.413 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.587 ' CA ' HH22 ' A' ' 101' ' ' ARG . 1.9 p -117.17 129.26 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.757 ' N ' ' HG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -44.97 141.18 3.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 1.0 111.294 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -40.54 -32.96 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.08 2.52 . . . . 1.0 113.706 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.52 -63.13 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.746 -0.382 . . . . 1.0 111.215 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -71.54 -22.53 61.75 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.589 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.736 ' CG1' HG23 ' A' ' 106' ' ' VAL . 82.3 t -61.69 -55.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -64.68 -38.83 92.34 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.4 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.443 ' O ' ' OG ' ' A' ' 145' ' ' SER . 88.3 t80 -48.72 -34.74 12.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 58.9 mt -73.53 -42.78 61.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.12 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -58.21 -44.53 88.21 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 87.2 p -62.81 -18.03 62.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.659 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.0 mmm -101.53 -0.71 34.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.137 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.07 18.55 78.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 88.1 t -107.32 142.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 1.0 110.27 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.27 -25.31 6.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.419 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 15.0 m -153.96 120.73 5.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.804 -0.359 . . . . 1.0 110.802 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.7 t -127.66 136.42 51.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.983 0.421 . . . . 1.0 111.38 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -97.97 132.33 43.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.0 t -114.86 132.4 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.268 -0.573 . . . . 1.0 112.212 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.52 133.37 20.28 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.7 161.59 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.361 2.041 . . . . 1.0 113.695 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.8 mt -115.26 116.44 28.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' OG ' ' A' ' 192' ' ' SER . 24.9 ptm -141.19 142.8 33.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -125.23 122.43 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.989 -1.005 . . . . 1.0 108.874 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.412 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 26.0 t-80 71.67 -128.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.223 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.412 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 37.4 tt0 -100.47 4.89 44.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.796 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.49 ' CD ' ' CZ2' ' A' ' 163' ' ' TRP . 5.2 pt-20 -111.28 158.31 19.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.726 1.01 . . . . 1.0 113.726 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.3 tp -101.73 128.96 47.82 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.49 ' CZ2' ' CD ' ' A' ' 161' ' ' GLU . 52.1 m95 -105.44 -37.01 6.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.512 0.93 . . . . 1.0 113.512 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.28 -172.82 24.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.731 -1.223 . . . . 1.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.2 tp -141.25 120.92 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.439 -0.38 . . . . 1.0 111.633 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.77 149.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 167' ' ' VAL . 13.5 p -155.95 133.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.034 -0.666 . . . . 1.0 111.836 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 82.1 p -115.62 136.67 52.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 1.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.623 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 65.7 m-70 -115.44 131.15 57.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -123.11 126.19 46.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.51 -16.61 61.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.774 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.9 155.51 75.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.607 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.73 133.97 38.72 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.692 2.261 . . . . 1.0 111.796 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -158.18 93.27 2.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.653 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -52.09 152.54 14.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.543 2.162 . . . . 1.0 111.399 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -107.33 152.44 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.799 0.333 . . . . 1.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.2 m -94.82 154.96 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.221 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -54.18 -35.82 62.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -72.33 -44.68 62.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.269 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.545 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.7 mt-10 -65.79 -30.73 71.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 1.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.65 -36.23 78.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.611 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.16 -55.97 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.699 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 184' ' ' VAL . 31.8 m -43.72 -41.02 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.66 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.576 HG23 ' N ' ' A' ' 185' ' ' GLN . 27.8 m -75.26 -48.88 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.576 ' N ' HG23 ' A' ' 184' ' ' VAL . 62.0 tt0 -49.24 -34.4 14.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 190' ' ' GLN . 97.5 mt -76.03 -48.0 22.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.982 -1.008 . . . . 1.0 109.079 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.74 -47.73 67.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.4 89.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.472 -0.936 . . . . 1.0 108.472 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.28 -38.6 91.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 186' ' ' LEU . 78.3 mm-40 -66.72 -31.64 72.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.46 -47.25 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.277 -1.009 . . . . 1.0 108.277 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 157' ' ' MET . 14.4 t -49.17 -32.66 10.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -74.72 -33.4 31.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.205 -0.907 . . . . 1.0 110.28 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.44 77.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.6 pt -62.23 -29.62 47.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.45 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -75.85 -51.83 11.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.02 -43.31 96.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.212 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.57 -31.93 73.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 1.0 111.395 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.43 -43.67 84.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.1 mp -51.19 -28.46 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.973 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 98.8 p -49.75 -56.01 11.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.471 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.776 HBC2 ' HD ' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 63.5 t0 -48.14 -36.24 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.684 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.52 -50.65 15.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.826 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.93 -48.71 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.021 0.438 . . . . 1.0 110.913 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.48 ' O ' ' OG1' ' A' ' 38' ' ' THR . 31.0 mt -57.38 -28.8 63.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.961 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.2 ttp180 -67.14 -39.14 86.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.778 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.07 -30.82 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.739 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.6 p -67.0 -36.79 82.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.301 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 36' ' ' ARG . 1.1 p -71.62 -25.39 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.35 -36.02 40.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.239 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.58 -48.52 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.833 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.2 p -57.59 -52.1 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.31 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.646 ' N ' HG13 ' A' ' 42' ' ' VAL . 9.0 ptm180 -51.81 -43.41 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 1.0 110.641 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 43' ' ' ARG . . . -51.95 -39.25 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.296 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -69.49 -32.78 71.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.833 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -97.11 -17.15 20.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.704 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.18 26.15 55.51 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 170' ' ' HIS . 48.0 m -77.79 143.75 37.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -55.57 -40.71 72.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.605 0.594 . . . . 1.0 112.605 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.677 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -149.97 130.77 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.525 -0.87 . . . . 1.0 112.763 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.411 HG22 ' OG ' ' A' ' 168' ' ' SER . 6.4 t -139.19 132.72 38.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.911 -1.04 . . . . 1.0 108.727 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 49.8 pttt -138.21 150.0 46.33 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.654 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 166' ' ' LEU . 45.3 t -99.57 141.25 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.886 ' CZ ' HBB1 ' A' ' 203' ' ' CYC . 0.3 OUTLIER -131.34 136.24 47.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.442 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -110.43 148.89 31.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 1.0 111.251 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -99.82 126.66 45.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.71 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -92.0 153.25 43.38 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.19 -50.91 2.69 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.94 2.427 . . . . 1.0 114.523 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -70.12 -7.5 42.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.184 0.438 . . . . 1.0 112.184 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.06 -6.65 40.25 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.753 -0.737 . . . . 1.0 112.014 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -77.19 149.9 35.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.348 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.57 158.82 23.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.811 -0.915 . . . . 1.0 110.811 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 p -131.86 155.63 47.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.467 . . . . 1.0 111.426 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.903 HG11 ' O ' ' A' ' 77' ' ' LEU . 3.7 p -91.02 109.35 20.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' VAL . 23.7 t -114.72 -4.32 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.116 0.413 . . . . 1.0 112.116 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . . . -152.15 127.64 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.291 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 12.3 tm-20 -162.36 142.39 9.76 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.703 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' CB ' ' NE ' ' A' ' 43' ' ' ARG . . . -127.95 135.14 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -103.14 135.1 45.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.362 -0.535 . . . . 1.0 112.035 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -77.17 -140.13 1.18 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.556 -1.017 . . . . 1.0 110.556 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -64.91 53.62 0.1 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' GLY . 96.3 mt-10 37.27 35.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -83.09 -36.19 25.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.3 mt -111.67 146.29 34.4 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 91.7 Cg_endo -75.44 157.95 40.7 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.462 2.108 . . . . 1.0 112.307 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m -82.01 137.54 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.331 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.903 ' O ' HG11 ' A' ' 64' ' ' VAL . 40.2 mt -117.74 22.09 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.932 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 67' ' ' GLU . 64.1 mt -67.29 129.77 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.919 0.711 . . . . 1.0 112.919 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.509 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 84.53 -1.88 88.45 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.782 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.783 ' O ' HG12 ' A' ' 64' ' ' VAL . 84.5 mt -87.43 149.74 24.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.418 0.609 . . . . 1.0 110.46 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 81' ' ' THR . 8.8 t -106.14 133.76 50.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.602 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.665 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 8.2 m-85 -103.39 144.03 27.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.65 138.05 14.89 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.552 2.168 . . . . 1.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.425 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -61.02 -33.14 72.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.913 0.387 . . . . 1.0 110.449 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.5 -18.77 0.22 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 84' ' ' ALA . 95.1 m-20 -65.4 -20.79 66.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 1.0 110.975 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.25 133.87 25.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.57 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.47 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.589 2.193 . . . . 1.0 111.615 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -163.71 -53.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.927 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' OE2' ' CE3' ' A' ' 119' ' ' TRP . 26.6 tp10 -43.84 -43.77 6.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.615 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.64 -34.87 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.701 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.581 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 48.8 mtp85 -65.04 -35.03 79.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.779 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.71 -37.03 82.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.945 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.39 -35.0 76.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.556 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -68.46 -33.77 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.73 HH21 ' H ' ' A' ' 162' ' ' LEU . 22.1 mtp180 -77.01 -28.63 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.154 -0.93 . . . . 1.0 111.337 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.76 -39.28 9.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.84 -13.01 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.266 1.21 . . . . 1.0 114.266 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.649 ' O ' HG13 ' A' ' 100' ' ' VAL . 2.8 mp0 48.58 58.22 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.674 -0.811 . . . . 1.0 109.899 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.0 m -159.42 112.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.374 -0.53 . . . . 1.0 112.012 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -165.21 134.07 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.833 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.9 p -151.31 156.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.715 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.451 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 97.9 mt -110.92 130.84 63.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.204 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.09 170.03 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.609 0.718 . . . . 1.0 112.892 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -50.14 116.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.248 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.562 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.5 p -50.45 -19.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.691 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -80.08 -37.24 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.81 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.5 -18.77 42.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 56.77 62.88 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.848 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 t -95.66 124.38 39.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -118.53 145.82 45.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.1 t -109.18 145.92 35.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.811 -1.086 . . . . 1.0 108.641 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.6 mt -145.88 150.53 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.475 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.6 p -86.07 162.51 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -143.57 153.53 58.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.89 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.97 -3.62 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.598 2.199 . . . . 1.0 112.217 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.77 -85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.667 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 t -158.14 173.45 16.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.542 ' CE3' ' O ' ' A' ' 120' ' ' GLY . 12.7 p-90 -87.74 -174.14 4.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.667 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.542 ' O ' ' CE3' ' A' ' 119' ' ' TRP . . . -49.38 161.65 0.75 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.2 mt -116.82 48.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 1.0 110.574 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 m -58.64 -42.72 88.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.72 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.69 74.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -65.39 -59.2 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.717 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -149.8 120.54 3.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.646 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -43.42 144.17 2.08 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.364 2.043 . . . . 1.0 111.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.4 tp 59.03 -105.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.425 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.81 35.28 36.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.111 -0.796 . . . . 1.0 111.111 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 130' ' ' PRO . 57.4 mt-10 -146.46 153.84 48.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.545 0.212 . . . . 1.0 110.641 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' C ' ' H ' ' A' ' 132' ' ' GLN . 61.9 Cg_exo -41.28 166.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.476 2.117 . . . . 1.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 3.3 tp -59.71 10.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.973 -0.558 . . . . 1.0 112.038 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.587 ' H ' ' C ' ' A' ' 130' ' ' PRO . 8.3 mm100 -138.4 158.88 43.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.476 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -125.56 115.77 25.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.529 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.67 141.86 10.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.683 2.256 . . . . 1.0 112.378 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.679 HG12 HAD2 ' A' ' 203' ' ' CYC . 2.6 m -120.24 129.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 138' ' ' CYS . 9.7 p30 -45.81 142.08 3.86 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 1.0 111.34 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -37.34 -19.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.113 2.542 . . . . 1.0 113.675 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 t -60.73 -61.57 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -69.71 -25.75 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.627 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.562 ' CG1' HG23 ' A' ' 106' ' ' VAL . 88.0 t -59.44 -60.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -60.53 -37.46 81.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.372 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -46.42 -37.94 8.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.61 -43.53 63.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -58.99 -42.98 91.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.9 t -63.63 -20.27 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.669 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.5 0.28 42.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.09 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.77 18.37 78.97 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 89.5 t -108.01 143.82 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.681 0.277 . . . . 1.0 110.273 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -24.19 6.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.018 0.377 . . . . 1.0 112.018 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.9 m -154.34 122.38 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.771 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.9 p -128.08 137.16 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 1.0 111.418 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.39 133.08 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.53 129.19 68.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.298 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.85 127.6 20.37 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -90.41 161.72 4.5 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.425 2.083 . . . . 1.0 113.65 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.85 114.35 24.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.4 ptm -141.29 150.7 42.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 84.5 t60 -125.05 124.14 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.929 -1.032 . . . . 1.0 108.836 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.559 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 53.6 t-80 59.05 -120.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.109 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.559 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.3 pp0? -98.79 0.41 44.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.807 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.429 ' HA ' HH21 ' A' ' 96' ' ' ARG . 47.2 tp10 -105.31 145.87 30.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.73 ' H ' HH21 ' A' ' 96' ' ' ARG . 35.9 tp -101.26 124.7 47.37 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.498 -1.297 . . . . 1.0 107.498 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.435 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 71.6 m95 -103.73 -31.67 9.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.563 0.949 . . . . 1.0 113.563 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.57 -168.32 22.32 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.697 -1.239 . . . . 1.0 112.401 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.666 ' CD1' HBA2 ' A' ' 203' ' ' CYC . 8.1 tt -143.17 124.07 14.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.418 -0.391 . . . . 1.0 111.658 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.641 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.1 tp -97.18 150.52 20.79 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.0 p -155.63 133.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.11 -0.636 . . . . 1.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.431 ' OG ' HG21 ' A' ' 48' ' ' THR . 4.1 t -115.53 134.31 55.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 25.5 m-70 -108.38 124.89 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 48' ' ' THR . 79.9 m80 -117.88 119.39 34.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.6 -18.06 61.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.775 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.42 150.32 60.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.558 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.36 128.15 17.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.662 2.242 . . . . 1.0 111.875 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -154.58 98.53 2.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.632 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.75 151.35 11.05 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.534 2.156 . . . . 1.0 111.449 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -103.45 153.73 20.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 1.0 110.846 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -90.26 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -54.47 -29.59 50.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.189 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 183' ' ' VAL . 97.3 mt-10 -76.82 -52.23 9.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.254 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.56 -34.87 79.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 1.0 110.932 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 181' ' ' LEU . 3.1 tt -55.36 -59.68 4.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.574 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -59.31 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.713 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 179' ' ' GLU . 92.7 t -45.43 -39.63 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.664 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.59 -50.51 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -49.31 -34.55 15.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 186' ' ' LEU . 36.1 tp -72.55 -48.12 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.033 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.67 -45.51 63.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.86 91.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.07 -39.3 91.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.474 ' HA ' HD12 ' A' ' 193' ' ' ILE . 79.8 mm-40 -66.6 -31.93 72.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.91 -48.09 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.6 p -52.03 -35.25 46.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 190' ' ' GLN . 25.6 mt -66.95 -35.24 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.82 -39.68 79.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.986 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.63 -47.78 78.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -62.91 -48.99 76.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.39 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.32 -46.27 87.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.269 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.43 75.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.397 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -56.65 -41.3 76.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.6 mt -55.15 -32.84 62.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.966 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.6 m -51.37 -57.09 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.656 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.8 mp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.467 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.886 HBB1 ' CZ ' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 195' ' ' ILE . 1.4 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.805 0.336 . . . . 1.0 110.503 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.5 p-10 -48.74 -33.78 10.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 51.3 tt0 -76.01 -48.82 19.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 38' ' ' THR . 23.1 mm -56.84 -46.04 83.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 1.0 111.025 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 38' ' ' THR . 40.2 mt -57.95 -29.41 65.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 1.0 112.008 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 39' ' ' VAL . 96.9 mtt180 -69.48 -40.74 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.785 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.14 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.533 ' O ' HG13 ' A' ' 42' ' ' VAL . 50.6 p -67.97 -37.56 81.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.329 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -69.62 -22.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.45 -36.5 38.76 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.267 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -71.0 -44.42 65.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.764 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 43' ' ' ARG . 16.6 m -59.53 -47.23 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.336 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 47' ' ' GLY . 50.4 ttp180 -50.4 -46.08 55.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 1.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.18 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.316 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -63.38 -40.55 97.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.807 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.96 -13.58 22.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.713 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.11 26.43 20.17 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.618 ' HG1' ' CE1' ' A' ' 170' ' ' HIS . 59.7 m -77.13 144.3 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.484 ' CG ' ' NH2' ' A' ' 73' ' ' ARG . 89.3 m-20 -55.51 -41.02 72.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.522 0.564 . . . . 1.0 112.522 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' NH2' HD12 ' A' ' 77' ' ' LEU . 71.1 ttt-85 -150.51 132.26 14.99 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.65 -0.82 . . . . 1.0 112.842 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 42' ' ' VAL . 14.6 p -141.95 134.52 28.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.97 -1.013 . . . . 1.0 108.725 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.624 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 56.5 pttt -137.95 151.14 47.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.249 -0.581 . . . . 1.0 111.614 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 48.0 t -97.39 140.88 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.7 t80 -130.57 130.5 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.388 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.432 HH22 HG21 ' A' ' 65' ' ' VAL . 24.6 ttm105 -106.39 145.01 32.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 1.0 111.275 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 57' ' ' ASP . 64.4 t80 -99.56 127.55 45.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.877 -0.602 . . . . 1.0 111.703 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.575 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -98.24 154.41 37.67 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -50.86 -36.25 51.89 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.03 2.487 . . . . 1.0 114.469 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.43 -4.28 55.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.184 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.79 -16.51 47.14 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.859 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' NE2' ' CB ' ' A' ' 57' ' ' ASP . 36.6 p-80 -78.12 148.74 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.65 160.78 24.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.1 p -133.62 154.79 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 1.0 111.567 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.797 HG11 ' O ' ' A' ' 77' ' ' LEU . 7.1 p -92.71 113.02 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.432 HG21 HH22 ' A' ' 55' ' ' ARG . 2.5 t -114.72 -1.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 1.0 112.041 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.52 129.05 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.279 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 18.1 pt-20 -162.71 142.13 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.472 -0.491 . . . . 1.0 111.678 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.7 146.82 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -134.32 146.52 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.969 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -102.11 141.43 15.27 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 37.77 31.35 0.08 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 70' ' ' GLY . 40.8 tt0 47.74 13.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 1.0 110.36 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.484 ' NH2' ' CG ' ' A' ' 49' ' ' ASP . 19.1 ttp180 -49.9 -38.21 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.959 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.8 mt -110.86 145.08 31.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.91 157.09 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.432 2.088 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 m -80.74 115.94 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.359 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.797 ' O ' HG11 ' A' ' 64' ' ' VAL . 20.5 mt -94.35 10.26 34.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.952 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.4 tp -57.12 129.24 40.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.54 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 85.85 -4.86 85.32 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.863 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.774 ' O ' HG12 ' A' ' 64' ' ' VAL . 88.0 mt -82.21 147.47 28.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.308 0.554 . . . . 1.0 110.392 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.7 m -108.34 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.622 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -105.82 148.12 35.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.208 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.89 137.4 12.48 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.548 2.166 . . . . 1.0 111.428 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.8 -34.75 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.854 0.359 . . . . 1.0 110.439 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.11 -17.77 0.12 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.9 m-20 -58.17 -14.16 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.668 0.271 . . . . 1.0 111.018 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.0 145.62 19.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.513 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.496 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 79.2 Cg_endo -74.52 -88.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.502 2.135 . . . . 1.0 111.691 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 85.1 tt0 -170.15 -36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.16 -39.93 63.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.574 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.459 ' CB ' HAD2 ' A' ' 203' ' ' CYC . . . -73.83 -40.51 63.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.515 -0.312 . . . . 1.0 111.733 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.695 HH12 ' NH2' ' A' ' 96' ' ' ARG . 76.6 ttt-85 -61.81 -35.86 79.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.778 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -63.88 -36.89 85.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.937 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD13 ' NH1' ' A' ' 101' ' ' ARG . 7.3 mt -61.55 -37.02 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.524 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.412 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 84.1 m-85 -65.88 -34.51 78.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.695 ' NH2' HH12 ' A' ' 92' ' ' ARG . 40.3 ttm180 -76.3 -30.3 57.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.097 -0.956 . . . . 1.0 111.252 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.6 mt -93.86 -39.93 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.41 -10.7 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.198 1.184 . . . . 1.0 114.198 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 100' ' ' VAL . 1.6 mp0 46.72 49.17 14.27 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.688 -0.805 . . . . 1.0 109.904 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 99' ' ' GLN . 17.1 t -152.85 111.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.954 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.716 ' NH2' ' HE ' ' A' ' 133' ' ' ARG . 5.0 tpt180 -165.86 130.23 2.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.875 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.04 158.01 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.726 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 135' ' ' VAL . 82.2 mt -111.44 128.82 67.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.228 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 104' ' ' VAL . 3.0 m -86.7 170.2 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.976 0.732 . . . . 1.0 112.976 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -48.58 115.01 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.221 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.546 HG13 ' CG1' ' A' ' 140' ' ' VAL . 54.9 t -52.65 -23.07 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.697 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -76.6 -39.01 53.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.781 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.5 -15.51 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.12 0.486 . . . . 1.0 110.436 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.406 ' OE1' ' NH2' ' A' ' 111' ' ' ARG . 6.4 tt0 56.37 61.85 2.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.465 -0.789 . . . . 1.0 112.885 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 m -96.97 125.23 41.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.808 -1.552 . . . . 1.0 106.808 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.406 ' NH2' ' OE1' ' A' ' 109' ' ' GLN . 97.2 mtt180 -118.36 146.41 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -109.43 148.51 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.6 178.155 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 113' ' ' ILE . 22.0 pt -148.99 152.59 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.457 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.0 p -87.27 165.25 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -144.22 152.89 55.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -37.39 -46.34 1.67 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.719 2.279 . . . . 1.0 112.257 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 118' ' ' SER . 96.0 mt-10 -117.19 -165.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.599 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.9 p 79.72 115.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -170.04 97.05 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.659 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.5 53.83 5.33 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.53 -4.13 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.666 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 m -57.51 -33.7 68.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.763 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.53 29.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.768 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -61.75 -60.24 3.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.633 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.14 154.44 42.68 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 128' ' ' GLY . 62.8 Cg_endo -69.98 134.65 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.359 2.039 . . . . 1.0 111.468 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 129' ' ' GLU . 15.4 mt 59.0 -77.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.366 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 58.91 0.61 0.68 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.138 -0.785 . . . . 1.0 111.138 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 127' ' ' LEU . 52.2 mm-40 -145.65 155.5 52.73 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.584 0.231 . . . . 1.0 110.592 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.565 ' C ' ' H ' ' A' ' 132' ' ' GLN . 58.7 Cg_exo -40.69 144.98 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.444 2.096 . . . . 1.0 111.987 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.4 mt -61.06 13.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.098 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' A' ' 130' ' ' PRO . 35.4 mt-30 -128.11 136.23 50.89 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.512 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.716 ' HE ' ' NH2' ' A' ' 101' ' ' ARG . 12.8 mmm180 -126.72 101.96 26.17 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.529 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -45.08 147.87 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.693 2.262 . . . . 1.0 112.391 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.439 HG21 HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -111.44 122.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 138' ' ' CYS . 17.9 t70 -44.82 138.69 4.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.761 0.315 . . . . 1.0 111.356 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -35.93 -20.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.125 2.55 . . . . 1.0 113.603 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.8 t -62.63 -62.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 58.7 t-80 -69.53 -25.48 64.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.69 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.546 ' CG1' HG13 ' A' ' 106' ' ' VAL . 96.7 t -58.76 -59.05 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 14.1 p80 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.346 -0.541 . . . . 1.0 110.341 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.636 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 73.8 t80 -46.99 -38.79 11.3 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.53 -43.61 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -58.06 -43.08 86.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.6 m -62.97 -19.96 64.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.645 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.76 -1.28 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.097 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.57 18.14 78.04 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.49 142.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 1.0 110.277 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -22.45 7.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.981 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 p -155.17 123.16 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.769 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.0 m -129.08 137.41 51.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.416 . . . . 1.0 111.449 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.05 133.07 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.442 HG11 HBA2 ' A' ' 203' ' ' CYC . 8.1 t -114.17 130.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.327 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.07 133.1 18.39 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.563 ' HB2' HD11 ' A' ' 162' ' ' LEU . 5.9 Cg_endo -95.32 166.82 1.51 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.412 2.075 . . . . 1.0 113.759 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.44 116.7 27.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.564 ' HB3' HD12 ' A' ' 162' ' ' LEU . 24.4 ptm -142.45 152.97 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 -176.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 58.7 t60 -131.68 124.15 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.075 -0.966 . . . . 1.0 108.891 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.415 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.0 t-80 64.63 -126.56 0.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.122 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.415 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 98.0 mm-40 -97.05 4.96 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.784 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.528 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -107.53 145.99 32.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.723 1.009 . . . . 1.0 113.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 157' ' ' MET . 20.2 tp -99.54 125.64 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.528 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 72.1 m95 -103.33 -34.25 8.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.31 33.03 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.651 -1.262 . . . . 1.0 112.403 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 78.1 mt -135.66 121.47 19.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.469 -0.365 . . . . 1.0 111.664 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.6 tp -94.53 150.51 20.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.5 p -156.84 133.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.803 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.1 p -114.13 139.77 49.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.26 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 12.4 m80 -111.21 123.81 50.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.618 ' CE1' ' HG1' ' A' ' 48' ' ' THR . 73.4 m80 -117.87 119.37 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.04 -18.36 62.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.744 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -132.07 151.45 78.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -41.77 141.8 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.649 2.233 . . . . 1.0 111.867 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -165.48 78.32 1.26 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.929 -0.309 . . . . 1.0 110.655 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.22 153.31 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.571 2.181 . . . . 1.0 111.489 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.582 ' CE1' HD12 ' A' ' 181' ' ' LEU . 12.9 p90 -106.63 148.09 28.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.823 0.344 . . . . 1.0 110.803 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.8 m -94.42 157.12 16.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.567 ' CD ' ' H ' ' A' ' 178' ' ' GLN . 3.2 mp0 -53.03 -37.62 61.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.123 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -77.01 -42.85 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.277 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 184' ' ' VAL . 77.8 mm-40 -67.66 -34.23 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 1.0 110.975 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -65.96 -40.09 90.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.592 -179.175 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -77.95 -52.15 9.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.66 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.8 t -44.58 -44.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.678 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.629 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.2 p -74.29 -50.58 26.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.629 ' N ' HG13 ' A' ' 184' ' ' VAL . 61.5 tt0 -49.82 -36.05 25.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 190' ' ' GLN . 28.2 tp -71.23 -47.61 56.19 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.016 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 187' ' ' LEU . 53.1 tp -54.04 -45.76 71.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.61 91.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -59.63 -36.6 76.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 186' ' ' LEU . 1.0 OUTLIER -67.32 -31.26 71.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.3 t -77.07 -46.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 157' ' ' MET . 37.8 p -50.93 -32.69 21.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.42 -33.06 32.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.232 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.82 80.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.959 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.409 ' HA ' HD21 ' A' ' 31' ' ' LEU . 25.1 pt -65.86 -26.46 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.44 -54.4 6.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.362 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 8.0 pt20 -67.39 -37.87 83.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.12 -33.19 74.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.378 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.04 -43.44 86.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.177 0.436 . . . . 1.0 112.177 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.9 mt -53.28 -35.86 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.99 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.8 t -47.22 -56.12 7.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.611 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.407 179.701 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.624 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.786 0.326 . . . . 1.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -49.43 -32.84 12.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.735 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -75.91 -48.29 21.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.778 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 38' ' ' THR . 98.3 mt -55.18 -51.47 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.034 0.445 . . . . 1.0 110.993 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.491 ' O ' ' OG1' ' A' ' 38' ' ' THR . 88.0 mt -55.69 -31.46 62.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.914 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 39' ' ' VAL . 91.0 mtt180 -65.62 -38.77 90.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.392 -0.523 . . . . 1.0 109.743 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.24 -32.22 68.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.783 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 p -66.9 -36.93 83.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.274 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.584 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.9 p -72.46 -24.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.269 0.47 . . . . 1.0 112.269 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -70.66 -44.99 65.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.276 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -69.93 -35.0 74.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.754 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 38' ' ' THR . 77.5 t -59.64 -54.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.296 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.5 ttt-85 -51.52 -44.55 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 1.0 110.746 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.21 -46.35 79.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.295 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.548 ' CE2' ' OE2' ' A' ' 180' ' ' GLU . 63.6 t80 -62.41 -41.45 98.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.815 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.0 mt -96.33 -12.85 23.84 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.706 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 51.68 25.08 13.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.542 ' HB ' ' CE1' ' A' ' 170' ' ' HIS . 15.2 t -78.45 148.06 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 73' ' ' ARG . 94.7 m-20 -51.94 -42.25 62.7 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.554 ' NH1' ' O ' ' A' ' 75' ' ' PRO . 77.9 ttt180 -152.95 137.17 16.51 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.647 -0.821 . . . . 1.0 112.808 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 51' ' ' VAL . 11.7 p -142.75 133.15 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.668 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.8 pttm -138.33 151.85 47.94 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.679 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.2 t -97.42 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.8 t80 -130.01 132.86 46.41 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.854 -0.338 . . . . 1.0 110.434 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.82 150.9 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.424 . . . . 1.0 111.215 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -102.38 132.71 48.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.698 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 61' ' ' HIS . 26.6 m-20 -97.71 154.52 37.85 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -40.14 -50.81 3.4 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.001 2.467 . . . . 1.0 114.479 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.74 -6.77 39.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.3 -7.41 37.23 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.697 -0.764 . . . . 1.0 111.905 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' ASP . 21.5 m80 -79.72 151.91 30.17 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.371 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.71 163.52 25.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -135.07 156.92 48.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.024 0.44 . . . . 1.0 111.483 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.26 109.63 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.33 -4.79 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.28 128.12 9.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.251 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HG3' HH21 ' A' ' 50' ' ' ARG . 0.6 OUTLIER -159.41 141.28 13.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.655 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.82 137.29 52.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 76' ' ' SER . 83.4 mtm-85 -111.5 138.39 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.075 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.501 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -86.81 76.11 2.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.624 -0.99 . . . . 1.0 110.624 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.07 30.44 42.37 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 61.71 16.03 7.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 1.0 110.354 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 35.3 ttm180 -56.5 -44.69 80.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.067 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mt -107.21 121.76 43.58 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.554 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 90.5 Cg_exo -49.56 157.39 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.505 2.136 . . . . 1.0 112.268 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 12.9 m -83.15 117.38 22.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.338 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' CG ' HH22 ' A' ' 50' ' ' ARG . 43.3 mt -95.93 11.82 32.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 1.0 109.938 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.1 mt -58.9 131.51 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.85 -3.77 86.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.905 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.29 149.16 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.286 0.543 . . . . 1.0 110.454 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 81' ' ' THR . 12.9 t -105.46 131.14 53.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -105.5 106.1 54.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -42.26 134.07 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.508 2.139 . . . . 1.0 111.528 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -57.94 -30.6 66.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.861 0.363 . . . . 1.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.85 -17.69 0.1 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.4 t0 -67.49 -28.93 68.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 1.0 111.036 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mm -112.01 133.05 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.503 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 97.1 Cg_endo -76.28 -111.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.642 2.228 . . . . 1.0 111.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 90.6 mt-10 -151.57 -51.23 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.905 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.2 -40.59 67.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.633 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.32 -37.89 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.749 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 65.3 ttt180 -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.8 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -64.07 -35.53 81.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.911 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.26 -34.93 77.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.504 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CE1' ' O2A' ' A' ' 203' ' ' CYC . 80.1 m-85 -69.78 -37.64 76.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -77.31 -30.65 54.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.47 -40.39 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -117.04 -11.35 10.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 98' ' ' ALA . 2.4 mp0 44.55 62.98 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.663 -0.815 . . . . 1.0 109.898 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.8 p -168.54 114.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 120.31 -0.556 . . . . 1.0 111.854 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.549 ' HG2' HBD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -167.5 137.22 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.911 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.3 p -149.5 156.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.676 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.576 HG23 HG21 ' A' ' 135' ' ' VAL . 3.2 mt -109.57 128.34 65.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.257 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 105' ' ' ASP . 4.0 t -84.65 165.88 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.013 0.745 . . . . 1.0 113.013 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.538 ' N ' HG12 ' A' ' 104' ' ' VAL . 75.8 m-20 -50.32 116.25 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.216 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.428 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.2 p -49.77 -21.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.74 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.28 -38.02 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.797 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.06 -21.19 63.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 1.0 110.399 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 57.97 60.61 2.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.53 -0.759 . . . . 1.0 112.854 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -94.23 125.59 38.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.768 -1.568 . . . . 1.0 106.768 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -120.38 144.76 47.73 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -117.03 157.15 26.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.801 -1.09 . . . . 1.0 108.634 177.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.41 HG23 ' C ' ' A' ' 112' ' ' SER . 27.9 pt -154.7 158.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.407 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.1 m -86.29 167.22 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' PRO . 54.6 mt-30 -151.02 152.61 31.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.912 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 117' ' ' GLU . 31.4 Cg_exo -34.41 -62.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.584 2.189 . . . . 1.0 112.281 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' PRO . 84.5 tt0 58.78 141.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.629 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 t -86.06 -85.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.516 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.573 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 73.5 t-105 -157.74 174.65 15.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.698 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.573 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 88.28 111.51 1.1 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.0 mt -136.11 -45.73 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 1.0 110.625 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -55.28 -31.01 61.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' ARG . . . -67.19 -38.31 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.74 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 123' ' ' ALA . 56.2 mmt-85 -35.74 119.02 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.656 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.0 158.95 51.14 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.592 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 62.7 Cg_endo -70.12 111.09 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.352 2.034 . . . . 1.0 111.567 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 126' ' ' PRO . 45.2 tp 167.58 131.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.419 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.92 39.27 13.66 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.106 -0.797 . . . . 1.0 111.106 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -121.54 147.28 47.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.559 0.219 . . . . 1.0 110.629 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.19 173.66 14.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.395 2.064 . . . . 1.0 111.955 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.7 tp -72.08 -9.17 58.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.974 -0.557 . . . . 1.0 112.085 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -134.56 138.34 44.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.529 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -113.98 90.98 20.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.49 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -46.92 141.54 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.583 2.188 . . . . 1.0 112.396 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.783 HG12 HAD2 ' A' ' 203' ' ' CYC . 3.6 m -118.48 131.22 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -40.9 156.57 0.2 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.669 0.271 . . . . 1.0 111.388 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.33 -26.12 80.76 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.13 2.553 . . . . 1.0 113.584 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -58.47 -56.63 19.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.0 111.21 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.549 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 2.0 t60 -68.46 -27.16 65.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.602 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.448 ' CG2' HG23 ' A' ' 135' ' ' VAL . 78.1 t -65.26 -53.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.37 -40.88 94.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.397 -0.521 . . . . 1.0 110.362 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -47.63 -35.3 9.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.491 HD11 ' CE1' ' A' ' 139' ' ' HIS . 50.9 mt -73.8 -41.61 62.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.193 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -60.25 -43.59 95.98 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.3 t -61.69 -18.18 58.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.632 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.8 mmm -100.95 2.66 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.166 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.79 19.0 78.34 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 144.77 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.752 0.311 . . . . 1.0 110.211 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.58 -25.1 6.54 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.974 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -154.35 122.24 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.749 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -131.2 141.71 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.006 0.432 . . . . 1.0 111.398 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.74 130.45 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 167' ' ' VAL . 28.5 m -117.0 141.3 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.267 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.83 132.41 20.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -86.87 159.67 8.9 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.35 2.034 . . . . 1.0 113.71 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.4 mt -113.51 116.29 29.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.6 ptm -140.85 149.5 42.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.511 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 86.6 t60 -130.42 122.57 28.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.03 -0.986 . . . . 1.0 108.812 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.441 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 12.1 t-80 69.73 -126.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.144 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.441 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 93.9 mt-30 -100.91 5.85 43.44 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.781 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.531 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 5.7 pt-20 -111.31 156.72 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 34.4 tp -103.38 127.66 50.69 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.518 -1.29 . . . . 1.0 107.518 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.531 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 32.2 m95 -103.86 -34.98 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.44 -174.52 29.28 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.628 -1.273 . . . . 1.0 112.346 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.3 mt -137.11 122.35 19.27 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.422 -0.389 . . . . 1.0 111.677 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.463 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.8 tp -94.31 148.35 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.505 HG23 HG12 ' A' ' 153' ' ' VAL . 11.0 p -152.48 132.01 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.067 -0.653 . . . . 1.0 111.862 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.7 t -115.02 136.8 52.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.709 -0.678 . . . . 1.0 109.227 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.509 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 12.2 m80 -110.55 124.68 52.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.542 ' CE1' ' HB ' ' A' ' 48' ' ' THR . 84.3 m-70 -119.15 121.84 40.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.42 -17.36 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.807 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -133.32 152.59 79.64 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.591 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.32 142.46 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.602 2.201 . . . . 1.0 111.882 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.83 78.2 1.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.555 -0.293 . . . . 1.0 110.693 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -54.68 153.65 23.32 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.481 2.12 . . . . 1.0 111.457 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -108.35 147.74 31.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 1.0 110.819 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 66.9 m -95.29 158.11 15.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.212 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -53.86 -39.24 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.151 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.44 -47.75 22.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.263 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.548 ' OE2' ' CE2' ' A' ' 45' ' ' PHE . 38.5 tp10 -63.44 -35.94 82.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 1.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -65.82 -37.03 85.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.626 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -78.59 -52.16 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.709 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.1 t -44.28 -43.1 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.621 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 185' ' ' GLN . 6.9 p -75.39 -49.75 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.595 ' N ' HG13 ' A' ' 184' ' ' VAL . 58.1 tt0 -49.78 -34.36 19.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tp -72.7 -48.24 40.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.067 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.95 -45.87 64.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.93 95.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -63.11 -38.67 92.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.83 -31.32 71.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 49.1 t -76.05 -47.41 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.5 p -53.42 -34.33 57.4 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.41 -35.77 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.205 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.92 83.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.932 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.9 mt -56.92 -44.57 82.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.84 -50.51 64.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.386 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -61.85 -44.82 96.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.22 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.88 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.376 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -57.85 -44.06 86.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.1 tp -52.63 -38.39 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.5 t -51.71 -59.3 4.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.445 179.705 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.783 HAD2 HG12 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 35' ' ' LEU . 5.5 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.872 0.367 . . . . 1.0 110.49 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 29.9 p-10 -51.84 -32.82 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.724 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.9 tt0 -76.59 -50.0 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.787 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 38' ' ' THR . 96.6 mt -55.18 -51.8 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.041 0.448 . . . . 1.0 110.899 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.488 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.8 mt -56.13 -30.25 61.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.935 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 39' ' ' VAL . 75.9 ttt180 -64.44 -40.25 95.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.407 -0.517 . . . . 1.0 109.661 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.93 -33.45 70.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.721 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 p -64.51 -37.35 87.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.346 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -73.35 -24.59 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.208 0.448 . . . . 1.0 112.208 -178.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -72.04 -40.81 68.11 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.48 -31.33 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.777 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 38' ' ' THR . 66.6 t -64.84 -56.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.339 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -53.55 -43.11 68.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 1.0 110.703 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.39 -43.17 71.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.288 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -65.64 -36.34 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -96.38 -15.02 22.07 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.706 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.77 26.05 53.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.0 p -80.01 147.29 31.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.9 p30 -54.11 -39.35 66.32 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.644 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -153.12 134.69 14.43 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.574 -0.85 . . . . 1.0 112.813 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -139.8 131.83 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.701 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' NZ ' ' CE1' ' A' ' 169' ' ' HIS . 25.2 pttm -138.73 152.86 48.33 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.294 -0.563 . . . . 1.0 111.614 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -98.15 140.91 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -130.8 131.18 44.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.45 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HE ' HG21 ' A' ' 65' ' ' VAL . 71.8 mtm180 -112.64 153.27 27.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.007 0.432 . . . . 1.0 111.217 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.4 136.87 41.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.677 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 61' ' ' HIS . 34.3 m-20 -97.21 150.58 36.97 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -41.94 -21.71 0.17 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.044 2.496 . . . . 1.0 114.528 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -103.04 3.44 36.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.6 -14.03 57.89 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.686 -0.769 . . . . 1.0 111.922 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 57' ' ' ASP . 66.2 m80 -78.86 150.05 32.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.43 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.57 162.11 25.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -134.34 155.78 49.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.034 0.445 . . . . 1.0 111.491 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 t -88.74 109.57 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.403 HG21 ' HE ' ' A' ' 55' ' ' ARG . 9.1 t -110.46 -5.15 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . . . -152.49 126.25 8.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.3 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.619 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 1.1 tm-20 -158.71 139.67 12.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 1.0 111.695 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.34 136.35 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -107.5 136.41 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.094 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.26 68.16 3.61 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.04 42.5 7.56 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 50.44 20.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 1.0 110.337 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' C ' HD12 ' A' ' 74' ' ' LEU . 74.0 ttt-85 -61.62 -46.92 87.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.971 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 73' ' ' ARG . 8.3 mp -109.11 129.62 23.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.527 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 80.5 Cg_exo -51.06 165.86 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.48 2.12 . . . . 1.0 112.226 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 t -93.59 129.31 39.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.372 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' H ' ' NH2' ' A' ' 50' ' ' ARG . 79.2 mt -102.92 15.19 30.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.946 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.6 mt -66.48 131.47 46.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.03 -5.21 72.3 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.818 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.3 154.52 21.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.333 0.566 . . . . 1.0 110.468 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 p -106.23 128.05 53.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.603 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -103.73 150.08 37.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.263 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.24 134.65 9.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.481 2.121 . . . . 1.0 111.46 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -62.56 -30.4 71.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.796 0.332 . . . . 1.0 110.368 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.4 -16.28 0.06 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.196 -0.762 . . . . 1.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.555 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 55.6 t0 -58.3 -15.97 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.654 0.264 . . . . 1.0 110.99 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.12 143.44 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.468 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.59 -96.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.548 2.165 . . . . 1.0 111.699 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 2.7 pp20? -162.72 -28.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.92 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 22.5 pt-20 -70.55 -39.72 73.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.585 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.791 ' HB1' HH12 ' A' ' 101' ' ' ARG . . . -74.0 -40.34 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.649 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 61.0 ttp180 -63.14 -36.27 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.349 . . . . 1.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -60.82 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.926 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 94' ' ' LEU . 94.5 mt -63.92 -34.17 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 1.0 111.538 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CE1' HBA1 ' A' ' 203' ' ' CYC . 68.6 m-85 -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 28.0 mtp180 -73.72 -31.55 63.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.295 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.8 -37.26 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.17 -16.84 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.571 ' O ' HG23 ' A' ' 100' ' ' VAL . 0.9 OUTLIER 45.73 52.84 9.24 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.619 -0.832 . . . . 1.0 109.964 -178.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 99' ' ' GLN . 24.8 t -157.33 101.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 120.293 -0.563 . . . . 1.0 111.862 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.791 HH12 ' HB1' ' A' ' 91' ' ' ALA . 5.4 mtt180 -158.46 137.92 11.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.876 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.487 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 2.1 p -145.97 158.35 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.71 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.47 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 2.9 mp -108.04 128.23 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.249 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.7 t -82.9 164.63 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.476 ' H ' HG12 ' A' ' 104' ' ' VAL . 64.5 t0 -50.6 118.89 3.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.966 -1.016 . . . . 1.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 140' ' ' VAL . 12.1 p -51.28 -22.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.709 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -78.88 -37.82 39.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.797 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.35 63.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.192 0.52 . . . . 1.0 110.432 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 57.55 62.59 2.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.904 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -94.02 124.39 38.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.19 145.23 46.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -110.68 149.67 30.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.803 -1.09 . . . . 1.0 108.6 177.577 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 pt -149.91 154.03 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.412 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.0 t -88.89 165.98 14.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 117' ' ' GLU . 41.1 tt0 -152.87 123.44 3.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.964 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -36.87 88.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.67 2.247 . . . . 1.0 112.221 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 115' ' ' GLN . 84.8 tt0 -161.59 -82.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.1 m 42.34 47.41 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.494 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 73.6 t-105 -136.56 158.12 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 91.28 164.86 39.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -99.95 132.85 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 1.0 110.634 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -63.72 -32.83 74.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.59 -45.92 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -39.18 -72.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.683 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.41 107.73 46.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.631 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -84.48 144.6 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.377 2.051 . . . . 1.0 111.494 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 tp 60.83 -116.16 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.355 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.08 39.51 96.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.467 ' CD ' ' NH2' ' A' ' 133' ' ' ARG . 74.3 mt-10 -135.14 152.04 76.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.551 0.215 . . . . 1.0 110.576 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.563 ' C ' ' H ' ' A' ' 132' ' ' GLN . 59.0 Cg_endo -67.68 167.21 21.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.403 2.069 . . . . 1.0 112.052 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.99 6.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 1.0 112.03 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.563 ' H ' ' C ' ' A' ' 130' ' ' PRO . 26.0 mt-30 -140.81 161.28 38.18 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.444 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.487 ' HB3' ' H ' ' A' ' 102' ' ' VAL . 9.1 tpp180 -129.03 103.76 18.49 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.595 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 133' ' ' ARG . 72.4 Cg_endo -71.47 143.11 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.59 2.193 . . . . 1.0 112.375 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.54 ' CG1' HAD2 ' A' ' 203' ' ' CYC . 25.7 m -120.27 131.13 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 112' ' ' SER . 19.7 t70 -43.61 137.57 3.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 1.0 111.378 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -36.22 -25.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.047 2.498 . . . . 1.0 113.696 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 136' ' ' ASP . 25.6 t -53.61 -59.72 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.771 -0.372 . . . . 1.0 111.239 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.5 ' CD2' HD11 ' A' ' 143' ' ' LEU . 73.8 t60 -69.62 -23.89 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.634 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 106' ' ' VAL . 61.2 t -59.11 -61.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -62.04 -40.93 97.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.428 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -45.94 -38.92 8.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.5 HD11 ' CD2' ' A' ' 139' ' ' HIS . 69.4 mt -72.92 -42.81 63.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -57.83 -43.51 85.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.6 t -62.55 -19.9 64.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.336 -0.847 . . . . 1.0 109.636 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.4 mmm -99.0 -0.55 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.09 18.93 75.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 99.0 t -109.32 142.97 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.728 0.299 . . . . 1.0 110.25 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -122.22 -26.01 4.76 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 111.997 0.369 . . . . 1.0 111.997 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p -152.5 118.65 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.727 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 p -129.76 142.21 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.004 0.43 . . . . 1.0 111.359 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tp -98.97 135.19 40.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.06 130.12 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.305 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.0 131.43 18.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -93.92 163.19 2.18 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.363 2.042 . . . . 1.0 113.656 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.3 mt -115.8 113.39 23.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.659 -1.237 . . . . 1.0 107.659 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.8 ptm -140.57 149.28 42.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.466 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 80.3 t60 -120.75 123.62 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.958 -1.019 . . . . 1.0 108.892 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.43 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 31.5 m170 55.86 -118.08 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.122 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -97.44 0.55 47.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.802 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.516 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.01 142.74 34.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.784 1.031 . . . . 1.0 113.784 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 49.4 tp -99.59 123.57 43.98 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.535 -1.283 . . . . 1.0 107.535 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.516 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.4 m95 -103.33 -33.77 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.576 0.954 . . . . 1.0 113.576 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.14 31.95 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.351 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 54.4 mt -134.54 121.39 20.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.706 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.61 149.77 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.444 ' CG1' ' HZ3' ' A' ' 52' ' ' LYS . 10.8 p -157.19 134.13 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.013 -0.675 . . . . 1.0 111.821 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.5 t -114.23 137.47 51.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.464 ' CE1' ' NZ ' ' A' ' 52' ' ' LYS . 17.0 m80 -110.19 127.46 54.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -118.58 120.38 37.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.24 12.77 7.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.83 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -143.26 152.02 56.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.615 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.65 132.19 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.676 2.25 . . . . 1.0 111.826 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -172.93 127.38 0.51 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.08 153.69 32.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.517 2.145 . . . . 1.0 111.451 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -103.67 155.58 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.768 0.318 . . . . 1.0 110.846 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 51.1 m -92.21 151.39 20.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.206 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.15 -27.38 68.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.158 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.39 -50.91 57.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.236 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.42 -27.5 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.974 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -55.02 -49.78 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.665 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.494 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 5.0 pt20 -78.08 -52.14 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.655 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.494 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 80.1 t -44.28 -42.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.649 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.47 -49.3 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -50.42 -33.09 19.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 190' ' ' GLN . 20.6 tp -74.51 -49.4 22.25 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.065 -0.971 . . . . 1.0 109.112 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 187' ' ' LEU . 1.1 tt -52.35 -46.11 65.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.57 86.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -61.13 -38.33 86.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 186' ' ' LEU . 62.1 tt0 -66.53 -32.34 73.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.29 -47.27 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.8 p -51.96 -35.69 46.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 190' ' ' GLN . 27.7 mt -66.32 -35.66 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.212 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.71 78.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.983 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.6 -46.1 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -66.02 -50.29 64.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.374 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.04 -45.8 91.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.269 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.99 73.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.393 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.39 -41.8 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 tp -51.54 -35.72 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.962 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.8 p -57.29 -60.97 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.621 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.3 mp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.005 -0.998 . . . . 1.0 110.446 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.555 ' HHB' ' OD2' ' A' ' 86' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD22 HD11 ' A' ' 35' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.576 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -49.63 -32.16 12.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.96 -48.28 25.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.791 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 38' ' ' THR . 26.6 mm -55.02 -49.95 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.046 0.45 . . . . 1.0 110.939 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 HD22 ' A' ' 31' ' ' LEU . 83.2 mt -55.16 -32.95 62.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.935 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 39' ' ' VAL . 33.9 ttm180 -61.93 -42.34 98.98 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.9 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.787 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 34' ' ' ILE . 82.2 p -66.61 -36.66 83.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 1.0 112.242 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.633 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p -71.25 -24.51 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.174 0.435 . . . . 1.0 112.174 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -78.74 -37.19 41.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.311 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -72.52 -43.41 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.78 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 43' ' ' ARG . 33.9 m -60.14 -49.69 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.304 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.602 ' N ' HG23 ' A' ' 42' ' ' VAL . 71.2 ttp85 -53.33 -45.79 69.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.683 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.53 68.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.255 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -65.7 -36.68 84.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.758 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CB ' HG23 ' A' ' 48' ' ' THR . 14.4 mt -96.68 -14.29 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.704 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.84 25.96 38.9 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.616 HG22 ' CE1' ' A' ' 170' ' ' HIS . 69.5 p -79.29 149.24 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.9 m-20 -49.1 -42.6 39.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.635 HH12 ' CG2' ' A' ' 148' ' ' VAL . 14.9 ptt-85 -158.28 145.44 17.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.576 -0.85 . . . . 1.0 112.791 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.7 t -137.75 135.13 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.943 -1.026 . . . . 1.0 108.684 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 67' ' ' GLU . 34.6 mttt -136.01 147.07 47.81 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.265 -0.574 . . . . 1.0 111.651 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 166' ' ' LEU . 46.9 t -98.81 140.18 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.407 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 16.6 t80 -129.67 130.48 45.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.441 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -111.8 151.76 28.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 1.0 111.215 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.7 OUTLIER -101.91 139.05 38.07 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.631 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.8 m-20 -103.54 154.33 37.94 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -39.98 -51.95 2.93 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.045 2.496 . . . . 1.0 114.51 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.93 -5.03 23.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.11 -8.16 44.96 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.763 -0.732 . . . . 1.0 111.939 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ASP . 57.7 m80 -76.42 148.98 36.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.445 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.77 159.05 23.78 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -132.99 156.09 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.015 0.436 . . . . 1.0 111.449 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 80' ' ' LEU . 7.5 p -94.0 112.05 26.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -115.33 0.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.633 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.48 126.08 8.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.341 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 81.9 tt0 -153.75 138.47 17.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 1.0 111.697 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.91 133.39 51.89 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -112.02 138.54 48.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.35 -0.54 . . . . 1.0 112.055 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.34 67.04 3.7 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 84.98 163.91 37.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.69 11.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 1.0 110.327 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.635 ' H ' ' C ' ' A' ' 71' ' ' GLY . 40.6 ttm180 -66.11 -40.11 90.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.014 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.1 mt -116.71 142.22 29.35 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.19 168.08 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.484 2.122 . . . . 1.0 112.255 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m -95.78 144.61 26.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.34 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' O ' HG11 ' A' ' 64' ' ' VAL . 32.0 mt -114.66 10.62 16.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 67' ' ' GLU . 77.8 mt -55.52 130.1 41.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.99 -2.53 87.11 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.858 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 64' ' ' VAL . 88.7 mt -85.7 144.86 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.31 0.555 . . . . 1.0 110.483 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 p -102.56 131.26 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.59 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -104.39 105.31 49.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.214 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.26 136.31 5.64 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.555 2.17 . . . . 1.0 111.484 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.854 0.359 . . . . 1.0 110.391 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.06 -17.92 0.12 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.9 m-20 -64.74 -18.36 64.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.606 0.241 . . . . 1.0 111.028 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.79 133.54 18.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.539 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.57 -96.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.556 2.171 . . . . 1.0 111.672 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.7 pt-20 -164.19 -42.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.947 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 86.1 tt0 -52.95 -43.31 66.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.596 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.35 70.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.572 ' HE ' HD23 ' A' ' 162' ' ' LEU . 60.8 ttt180 -65.56 -31.61 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.757 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -64.84 -37.93 89.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD22 HH11 ' A' ' 124' ' ' ARG . 8.7 mt -59.19 -37.76 78.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.531 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -68.52 -33.88 74.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -77.46 -30.32 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.291 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' CD1' ' O ' ' A' ' 122' ' ' SER . 94.6 mt -94.77 -39.53 10.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.0 -11.81 9.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 100' ' ' VAL . 1.5 mp0 46.64 50.53 12.97 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.958 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 99' ' ' GLN . 16.1 t -152.57 111.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.457 HH12 HD13 ' A' ' 94' ' ' LEU . 3.8 tpt180 -164.32 130.13 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.876 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -143.97 156.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.66 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.571 HD11 HMA2 ' A' ' 203' ' ' CYC . 54.7 mt -111.99 127.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.209 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.59 169.65 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.414 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 27.5 m-20 -50.87 115.86 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.305 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.618 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.6 p -50.51 -19.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.661 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -76.28 -40.44 51.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -62.29 -8.18 5.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.132 0.491 . . . . 1.0 110.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 9.7 pt20 45.52 62.5 2.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.751 . . . . 1.0 112.868 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -92.5 127.02 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -118.75 145.17 45.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.623 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -111.04 151.25 28.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.757 -1.11 . . . . 1.0 108.589 178.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 pt -148.02 151.71 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.426 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.7 t -85.82 168.55 14.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 116' ' ' PRO . 67.1 mt-30 -148.38 155.48 42.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.884 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 115' ' ' GLN . 37.4 Cg_exo -35.23 156.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.704 2.269 . . . . 1.0 112.232 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 119' ' ' TRP . 82.9 tt0 -45.29 -42.14 9.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.566 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.9 m 41.16 20.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.545 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' GLU . 93.6 m95 42.31 50.56 4.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.82 148.61 51.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.9 mt -95.12 136.13 35.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 1.0 110.627 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.414 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 60.4 m -61.45 -37.02 82.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.05 -28.7 65.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.81 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.485 HH11 HD22 ' A' ' 94' ' ' LEU . 45.5 mtp180 61.02 -143.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.682 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.21 154.54 61.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.619 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.43 118.5 5.71 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.331 2.021 . . . . 1.0 111.524 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.453 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 5.2 tp 53.75 -132.87 1.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.453 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . 69.53 39.11 79.5 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 133' ' ' ARG . 43.0 mt-10 -130.93 151.3 78.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.53 0.205 . . . . 1.0 110.583 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.6 169.02 23.48 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.485 2.123 . . . . 1.0 112.04 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.418 ' HB2' HE21 ' A' ' 132' ' ' GLN . 52.4 mt -63.52 -3.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.096 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.418 HE21 ' HB2' ' A' ' 131' ' ' LEU . 20.9 mm-40 -134.6 168.28 19.27 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.488 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.497 ' NH2' ' OE1' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -141.16 124.89 10.14 Favored Pre-proline 0 N--CA 1.462 0.168 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.501 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.623 ' C ' ' HG ' ' A' ' 112' ' ' SER . 50.9 Cg_endo -84.32 143.97 10.23 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.679 2.252 . . . . 1.0 112.402 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -119.78 128.71 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.501 ' HA ' ' H ' ' A' ' 112' ' ' SER . 5.0 t70 -44.86 140.37 3.42 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.802 0.334 . . . . 1.0 111.335 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -36.32 -26.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.198 2.599 . . . . 1.0 113.629 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 136' ' ' ASP . 38.4 t -54.22 -61.45 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.768 -0.373 . . . . 1.0 111.2 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -70.27 -24.92 63.13 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.61 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.618 ' CG1' HG23 ' A' ' 106' ' ' VAL . 59.2 t -60.51 -58.59 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -62.1 -38.88 90.58 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.363 -0.535 . . . . 1.0 110.402 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -47.29 -36.8 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.33 -43.4 60.86 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -58.15 -43.52 87.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.4 t -62.34 -19.28 63.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.687 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.9 mmm -100.15 0.93 41.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.158 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.7 19.46 77.8 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.635 ' CG2' HH12 ' A' ' 50' ' ' ARG . 99.0 t -108.72 144.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.624 0.249 . . . . 1.0 110.369 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.95 -27.44 5.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.414 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 51.1 m -149.71 121.43 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.489 ' OG ' HD12 ' A' ' 103' ' ' ILE . 87.9 p -130.45 141.8 50.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 1.0 111.418 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -103.21 133.74 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.9 t -112.64 129.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.247 -0.581 . . . . 1.0 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.69 132.83 21.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.27 164.52 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.362 2.042 . . . . 1.0 113.738 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 mt -117.05 114.31 23.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.64 -1.245 . . . . 1.0 107.64 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.432 ' H ' ' HB2' ' A' ' 192' ' ' SER . 23.5 ptm -141.47 153.02 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.556 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 58.9 t60 -126.97 126.42 43.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.9 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.556 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 38.8 m80 57.0 -120.87 1.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.157 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -97.8 2.32 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.791 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.58 145.3 31.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.572 HD23 ' HE ' ' A' ' 92' ' ' ARG . 51.7 tp -100.76 124.25 46.13 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 75.3 m95 -102.94 -33.22 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 54' ' ' TYR . . . -162.88 -172.33 30.23 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.598 -1.286 . . . . 1.0 112.3 -177.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.62 122.67 19.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.426 -0.387 . . . . 1.0 111.682 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -95.99 149.35 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.7 p -154.68 133.81 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.981 -0.687 . . . . 1.0 111.836 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 96.4 p -116.17 133.74 55.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.234 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -108.43 128.35 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.616 ' CE1' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.4 123.29 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.269 -1.012 . . . . 1.0 108.269 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.76 -18.94 62.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.774 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -119.01 160.52 40.55 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.555 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.62 -80.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.599 2.199 . . . . 1.0 111.866 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 46.97 90.86 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.662 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.78 159.65 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.514 2.143 . . . . 1.0 111.466 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.68 106.49 14.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.787 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -47.42 146.52 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.266 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.2 -25.77 65.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.12 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -68.89 -47.6 65.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.25 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.8 mt-10 -68.68 -26.83 65.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 1.0 110.983 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.25 -38.27 88.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.646 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -54.86 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.704 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -44.22 -41.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.652 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 185' ' ' GLN . 23.4 m -74.13 -47.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.586 ' N ' HG23 ' A' ' 184' ' ' VAL . 58.1 tt0 -50.68 -33.08 21.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.3 tt -72.84 -50.03 26.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.074 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.4 -44.61 65.46 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.42 92.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -58.42 -37.37 75.23 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -67.77 -31.3 71.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.61 -47.78 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.432 ' HB2' ' H ' ' A' ' 157' ' ' MET . 44.1 p -50.32 -32.2 16.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -74.98 -33.95 30.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.094 -0.957 . . . . 1.0 110.236 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.9 79.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.98 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 196' ' ' ALA . 22.4 pt -63.14 -28.91 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.05 -52.3 10.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.356 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.23 -41.81 96.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.302 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.61 72.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.409 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.03 -43.89 87.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.57 -35.77 54.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.707 -0.397 . . . . 1.0 111.003 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -51.08 -57.49 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.627 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.413 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.571 HMA2 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.915 0.388 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 30.9 p-10 -50.66 -32.67 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.677 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 52.7 tt0 -75.67 -49.99 16.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.863 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.77 -50.58 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 1.0 110.936 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.468 ' O ' ' OG1' ' A' ' 38' ' ' THR . 65.8 mt -55.82 -31.04 62.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.001 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 39' ' ' VAL . 87.5 mtt180 -67.13 -38.32 85.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.412 -0.515 . . . . 1.0 109.757 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.53 -31.99 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.754 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 42' ' ' VAL . 77.7 p -67.13 -37.77 84.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.553 . . . . 1.0 112.329 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.515 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.5 p -73.57 -22.79 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -73.09 -40.2 65.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.337 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.92 -33.61 59.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.746 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' THR . 79.8 t -62.27 -56.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.349 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -52.91 -42.91 65.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 1.0 110.656 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.78 -45.5 74.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.327 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.29 -36.79 85.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.87 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.74 -16.12 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.715 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.51 24.84 48.25 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 p -79.21 146.94 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -51.62 -42.23 61.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.657 HH22 ' CG ' ' A' ' 77' ' ' LEU . 67.7 ttt180 -153.31 136.45 15.61 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.635 -0.826 . . . . 1.0 112.819 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 8.8 t -139.22 130.67 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.88 -1.055 . . . . 1.0 108.751 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.681 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 58.0 pttt -137.26 150.61 47.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.349 -0.541 . . . . 1.0 111.69 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 166' ' ' LEU . 48.2 t -98.86 140.42 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -129.28 131.99 47.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.488 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -110.9 148.91 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 1.0 111.22 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.8 130.53 48.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.692 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 61' ' ' HIS . 9.9 m-20 -90.53 152.31 45.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -49.5 -18.68 2.56 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.055 2.504 . . . . 1.0 114.466 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.1 4.96 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.137 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 99.79 -15.56 59.48 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.698 -0.763 . . . . 1.0 111.875 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 74.1 m80 -79.86 151.09 30.41 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.88 163.75 25.85 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -135.39 157.55 46.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.973 0.416 . . . . 1.0 111.5 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -90.91 110.6 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 65' ' ' VAL . 15.8 t -111.53 -3.44 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.23 125.89 8.92 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.313 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' OE2' ' CZ ' ' A' ' 50' ' ' ARG . 79.9 tt0 -155.18 138.5 15.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.119 0.485 . . . . 1.0 111.746 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.78 139.89 52.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -131.17 146.03 52.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.031 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.59 134.58 11.86 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.564 -1.014 . . . . 1.0 110.564 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 40.63 38.35 1.5 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 42.58 20.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 1.0 110.415 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 71' ' ' GLY . 43.9 ttm180 -54.75 -42.21 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.061 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.4 mt -108.25 146.45 33.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.67 161.94 33.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.411 2.074 . . . . 1.0 112.24 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p -89.16 115.76 26.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.657 ' CG ' HH22 ' A' ' 50' ' ' ARG . 26.8 mt -94.08 11.57 29.43 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.421 HD21 ' CB ' ' A' ' 67' ' ' GLU . 86.9 mt -56.48 130.43 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -3.5 87.0 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.369 -0.832 . . . . 1.0 112.854 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.95 146.83 27.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.336 0.568 . . . . 1.0 110.463 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -107.8 138.39 44.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.633 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -110.71 149.76 40.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.193 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.49 133.98 10.9 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.569 2.179 . . . . 1.0 111.44 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -57.22 -31.17 65.22 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.433 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.78 -16.88 0.23 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 30.4 p-10 -66.77 -17.3 64.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.661 0.267 . . . . 1.0 111.029 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.0 mt -137.02 98.41 10.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.506 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 43.7 Cg_exo -39.5 -95.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.507 2.138 . . . . 1.0 111.727 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 82.9 tt0 -163.67 -42.51 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.885 0.374 . . . . 1.0 110.991 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -54.64 -39.68 68.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.571 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.77 -42.01 51.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.741 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.546 HH12 HH11 ' A' ' 96' ' ' ARG . 73.6 ttp85 -61.68 -37.51 84.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.827 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.471 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 91.5 mtt-85 -61.95 -34.86 76.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.001 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.08 -33.69 76.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.5 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -68.39 -33.45 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.546 HH11 HH12 ' A' ' 92' ' ' ARG . 12.7 mtm180 -77.01 -30.74 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.236 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.03 -38.55 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.71 -14.11 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.188 1.181 . . . . 1.0 114.188 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.644 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.1 mp0 47.82 55.94 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.878 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.7 m -158.95 112.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.949 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.591 ' NH1' ' NH1' ' A' ' 133' ' ' ARG . 4.2 tpp180 -168.04 133.96 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.797 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.502 HG23 HD23 ' A' ' 152' ' ' LEU . 2.0 p -144.56 157.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.709 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.64 HG23 HG11 ' A' ' 135' ' ' VAL . 8.2 mt -110.51 129.1 66.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.322 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 105' ' ' ASP . 16.7 t -84.06 165.97 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.615 ' N ' HG12 ' A' ' 104' ' ' VAL . 57.1 t0 -47.9 119.53 2.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.947 -1.024 . . . . 1.0 112.282 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.22 -23.51 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.685 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -82.01 -37.09 27.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.777 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.9 -16.13 6.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.162 0.506 . . . . 1.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 57.35 60.16 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 1.0 112.844 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.5 p -95.12 125.98 40.15 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -120.98 138.63 54.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.667 0.988 . . . . 1.0 113.667 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -111.74 156.26 22.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.742 -1.117 . . . . 1.0 108.642 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.403 HG23 ' C ' ' A' ' 112' ' ' SER . 30.7 pt -154.06 158.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.475 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.6 p -87.55 170.36 11.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -143.14 153.94 60.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.865 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.49 -26.39 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.642 2.228 . . . . 1.0 112.302 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.97 139.96 57.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.1 m -69.06 151.26 46.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -146.43 148.14 31.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.624 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.59 -168.91 41.78 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 mt 57.57 46.03 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.0 110.654 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.9 m -60.46 -32.1 71.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.719 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 125' ' ' VAL . . . -55.32 -44.46 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -68.69 4.33 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.694 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 123' ' ' ALA . 13.4 t -146.6 99.03 4.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.685 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.02 130.34 2.54 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.443 2.095 . . . . 1.0 111.502 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 127' ' ' LEU . 9.8 mp 54.72 -109.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.449 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.53 36.82 62.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.111 -0.796 . . . . 1.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -142.48 153.94 62.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 121.228 -0.189 . . . . 1.0 110.642 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 132' ' ' GLN . 43.7 Cg_endo -63.9 163.03 26.59 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.401 2.067 . . . . 1.0 111.998 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 69.5 mt -49.35 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.006 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 130' ' ' PRO . 5.8 mm100 -134.29 138.82 45.27 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.477 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.591 ' NH1' ' NH1' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -116.82 128.1 26.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.458 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.58 140.32 11.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.701 2.267 . . . . 1.0 112.338 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.64 HG11 HG23 ' A' ' 103' ' ' ILE . 1.1 p -115.27 130.16 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' N ' ' OG ' ' A' ' 112' ' ' SER . 7.9 t0 -44.96 131.99 5.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 1.0 111.393 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.86 -31.02 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.092 2.528 . . . . 1.0 113.662 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.3 t -47.24 -61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.231 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.582 ' CD2' HD11 ' A' ' 143' ' ' LEU . 43.7 t60 -70.88 -23.14 62.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.698 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.49 -58.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.87 -41.23 97.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.331 -0.547 . . . . 1.0 110.398 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.54 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 66.7 t80 -47.41 -38.32 13.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 139' ' ' HIS . 32.9 mt -72.05 -43.68 64.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.04 -42.75 77.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -35.09 75.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.61 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 63.2 mtp -83.39 -1.54 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.071 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.39 75.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.03 143.48 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.272 . . . . 1.0 110.341 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.16 -43.46 2.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.025 0.38 . . . . 1.0 112.025 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.7 m -134.1 119.84 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.763 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.0 m -132.93 144.11 49.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.931 0.396 . . . . 1.0 111.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 102' ' ' VAL . 14.2 mt -99.02 136.83 38.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.59 105.88 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.337 -0.545 . . . . 1.0 112.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 57.5 t -112.83 128.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.212 -1.032 . . . . 1.0 108.212 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -93.36 162.54 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.369 2.046 . . . . 1.0 113.782 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.49 116.72 28.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.605 -1.258 . . . . 1.0 107.605 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.545 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.7 ptm -141.1 148.23 39.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.9 t60 -126.78 132.46 51.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.016 -0.993 . . . . 1.0 108.832 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 23.3 m-70 56.62 -126.52 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -98.31 3.33 48.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.776 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 12.4 pt-20 -109.78 153.25 24.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.703 1.001 . . . . 1.0 113.703 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.7 tp -103.88 127.39 51.4 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.542 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 43.6 m95 -103.88 -32.41 9.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.543 0.942 . . . . 1.0 113.543 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 -174.13 31.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.403 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.474 HD22 ' O2A' ' A' ' 203' ' ' CYC . 80.8 mt -135.58 125.12 25.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.388 . . . . 1.0 111.701 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.569 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.5 tp -96.9 149.92 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.7 p -156.5 133.43 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.046 -0.661 . . . . 1.0 111.784 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 t -114.77 135.49 54.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.259 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -110.92 128.61 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -120.75 130.54 54.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.91 26.56 2.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.775 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -148.65 146.12 21.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.945 -0.302 . . . . 1.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.77 137.97 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.63 2.22 . . . . 1.0 111.85 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -178.76 149.41 0.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 1.0 110.647 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.13 150.02 25.8 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.579 2.186 . . . . 1.0 111.478 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.485 ' CZ ' HD21 ' A' ' 152' ' ' LEU . 70.5 m-85 -106.12 162.19 13.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.35 . . . . 1.0 110.833 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.9 m -114.29 143.09 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.182 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -58.39 -34.22 70.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.106 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -56.39 -55.4 34.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.205 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -70.72 -30.67 67.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.521 -0.308 . . . . 1.0 110.947 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.08 -33.68 74.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.584 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -77.84 -54.58 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.922 -0.311 . . . . 1.0 111.704 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.4 t -42.92 -41.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 185' ' ' GLN . 28.8 m -75.42 -47.08 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.538 ' N ' HG23 ' A' ' 184' ' ' VAL . 56.2 tt0 -51.8 -32.88 33.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 190' ' ' GLN . 43.2 tp -75.7 -51.69 12.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.66 -46.4 67.15 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.59 98.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.62 ' O ' HD13 ' A' ' 193' ' ' ILE . 61.7 t0 -63.79 -37.01 85.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 186' ' ' LEU . 51.6 tt0 -68.05 -29.24 68.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -76.36 -46.01 33.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 157' ' ' MET . 8.2 t -50.87 -37.52 43.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.1 mp -64.1 -36.83 78.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.261 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.73 82.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.612 . . . . 1.0 110.903 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.33 -47.52 81.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.457 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -64.82 -49.41 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.712 -0.676 . . . . 1.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.43 -45.63 92.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.175 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.94 71.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.375 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.2 -43.11 82.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.29 -35.64 62.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -55.02 -60.69 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.5 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.407 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.681 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 1.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 28.8 p-10 -70.91 -32.36 69.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.723 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 53.3 tt0 -77.45 -48.26 17.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.807 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' THR . 96.6 mt -56.02 -50.34 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.055 0.455 . . . . 1.0 110.964 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.471 ' O ' ' OG1' ' A' ' 38' ' ' THR . 78.2 mt -57.56 -30.73 65.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.942 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 39' ' ' VAL . 90.0 mtt180 -66.73 -38.81 87.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.391 -0.524 . . . . 1.0 109.781 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -30.13 65.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.787 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 34' ' ' ILE . 69.0 p -69.69 -36.42 75.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 1.0 112.314 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -71.63 -25.44 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.52 -31.86 32.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 1.0 111.296 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -76.8 -38.34 54.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.709 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.629 HG23 ' N ' ' A' ' 43' ' ' ARG . 30.4 m -66.53 -52.83 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.304 -177.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.629 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -51.87 -43.3 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 1.0 110.669 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.2 -44.12 71.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.317 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -64.66 -35.79 82.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.842 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.29 -13.01 23.68 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.703 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.03 25.83 47.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 p -80.03 148.82 30.94 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.991 -0.374 . . . . 1.0 109.991 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' GLY . 87.8 m-20 -50.25 -42.66 52.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.643 0.608 . . . . 1.0 112.643 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.556 HH21 ' CG2' ' A' ' 148' ' ' VAL . 18.7 ptt-85 -158.4 149.78 21.0 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.633 -0.827 . . . . 1.0 112.805 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -141.33 136.14 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.962 -1.017 . . . . 1.0 108.743 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -137.07 145.58 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.624 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.5 t -100.91 142.1 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 20.7 t80 -130.44 133.27 46.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 1.0 110.426 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.444 HH12 ' CG2' ' A' ' 195' ' ' ILE . 78.1 mtp85 -114.44 154.1 28.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.019 0.438 . . . . 1.0 111.14 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.23 138.19 40.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.711 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -97.42 153.64 38.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -45.39 -21.1 0.65 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.012 2.474 . . . . 1.0 114.463 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -102.83 2.97 36.14 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.206 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.32 -13.68 56.96 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.661 -0.781 . . . . 1.0 111.957 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 57' ' ' ASP . 59.1 m80 -78.72 150.13 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.416 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.29 161.6 25.27 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -133.74 155.92 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.473 . . . . 1.0 111.473 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.22 108.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 65' ' ' VAL . 13.0 t -109.0 -4.99 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.12 0.415 . . . . 1.0 112.12 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.04 125.96 8.41 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.329 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB3' HD21 ' A' ' 78' ' ' LEU . 55.0 tt0 -154.89 139.14 16.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.18 0.514 . . . . 1.0 111.739 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.36 131.82 51.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.6 mtm-85 -103.15 135.08 45.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.071 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -79.1 74.65 2.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.85 38.75 30.31 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 54.55 21.73 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.791 0.329 . . . . 1.0 110.3 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -57.58 -43.19 84.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.972 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.539 HD22 ' NE ' ' A' ' 50' ' ' ARG . 2.9 mp -114.51 159.91 35.11 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 177.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.56 147.61 19.97 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.514 2.142 . . . . 1.0 112.223 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -67.33 124.24 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.355 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.37 9.96 38.02 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.978 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 67' ' ' GLU . 95.1 mt -61.75 131.54 50.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.13 73.08 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.877 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.05 152.5 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.345 0.572 . . . . 1.0 110.464 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 81' ' ' THR . 9.0 t -107.43 131.23 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.602 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.07 148.79 36.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.273 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.8 129.18 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.489 2.126 . . . . 1.0 111.459 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -56.97 -31.13 64.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.866 0.365 . . . . 1.0 110.463 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.92 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.7 m-20 -63.72 -26.39 68.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.562 0.22 . . . . 1.0 111.02 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.449 HG23 ' HHA' ' A' ' 203' ' ' CYC . 9.5 mt -122.59 132.99 24.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.555 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.6 -103.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.608 2.205 . . . . 1.0 111.633 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 22.3 pt-20 -159.66 -40.77 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.032 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 87.2 tt0 -60.27 -41.28 92.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.623 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.82 -39.86 63.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.631 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 60.9 ttp180 -63.14 -37.5 87.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 1.0 110.808 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.72 -34.66 74.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.941 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.84 -32.23 73.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.614 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.41 -35.84 78.24 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.3 mtm180 -73.55 -33.63 64.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.215 -0.902 . . . . 1.0 111.262 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.427 ' CD1' ' OG ' ' A' ' 122' ' ' SER . 86.4 mt -95.54 -37.67 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.782 1.03 . . . . 1.0 113.782 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.16 -15.05 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -175.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.662 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER 47.48 57.45 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.658 -0.817 . . . . 1.0 109.969 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.4 m -159.57 114.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.88 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.594 ' NH1' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -168.44 132.46 1.57 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.878 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.64 157.78 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.688 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 135' ' ' VAL . 6.3 mt -109.75 126.98 66.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.266 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.69 169.56 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -49.84 115.21 1.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.952 -1.022 . . . . 1.0 112.292 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 140' ' ' VAL . 55.6 t -51.57 -17.68 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.72 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -81.97 -36.69 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.789 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -60.71 -8.91 3.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.172 0.511 . . . . 1.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.588 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 16.2 pt20 46.8 60.21 3.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.844 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 p -94.43 129.19 41.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -119.69 142.36 48.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.681 0.993 . . . . 1.0 113.681 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.2 p -109.29 149.53 29.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.753 -1.112 . . . . 1.0 108.661 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 113' ' ' ILE . 6.2 mt -147.15 152.56 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.451 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 m -85.31 169.13 14.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -151.81 132.54 7.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.74 14.87 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.259 . . . . 1.0 112.223 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.56 143.09 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.648 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -55.29 96.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -61.07 -31.45 71.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.667 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.27 -173.63 34.5 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.681 HD12 ' N ' ' A' ' 121' ' ' LEU . 8.3 mp -92.58 125.18 37.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 1.0 110.622 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.427 ' OG ' ' CD1' ' A' ' 97' ' ' LEU . 85.3 p -67.16 -27.16 67.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.72 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.99 -11.09 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.84 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -50.56 -60.01 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.7 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.24 133.86 16.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.567 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 165.66 31.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.376 2.05 . . . . 1.0 111.605 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.6 mt 44.79 -118.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.362 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 56.34 38.63 79.75 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -119.06 150.49 48.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.513 0.197 . . . . 1.0 110.592 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.44 154.44 40.47 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.41 2.073 . . . . 1.0 111.991 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.5 mt -54.39 -27.16 34.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.572 . . . . 1.0 112.068 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -132.43 135.14 45.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.567 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.594 ' HE ' ' NH1' ' A' ' 101' ' ' ARG . 12.3 mmm180 -123.94 147.95 55.51 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.578 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -85.77 144.04 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.631 2.221 . . . . 1.0 112.374 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.733 HG21 HG12 ' A' ' 103' ' ' ILE . 4.6 t -118.26 130.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 138' ' ' CYS . 16.9 t70 -45.2 135.9 5.22 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.385 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -36.97 -21.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.07 2.513 . . . . 1.0 113.677 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 136' ' ' ASP . 54.1 t -56.21 -60.17 3.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.758 -0.377 . . . . 1.0 111.237 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -71.26 -25.01 62.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.64 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 106' ' ' VAL . 19.3 t -60.14 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.668 0.618 . . . . 1.0 112.668 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 144' ' ' LYS . 86.1 t60 -63.18 -39.48 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.368 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' O ' ' OG ' ' A' ' 145' ' ' SER . 77.6 t80 -45.77 -36.07 4.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.69 -42.48 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.68 -42.45 92.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 97.4 p -64.16 -20.01 65.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.618 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 25.7 mmm -99.98 1.58 42.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.06 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.89 19.45 77.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.556 ' CG2' HH21 ' A' ' 50' ' ' ARG . 86.4 t -109.38 144.22 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.719 0.295 . . . . 1.0 110.275 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.34 -27.47 6.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.974 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 p -152.0 121.9 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.685 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.7 t -131.04 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 111.474 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.82 132.64 53.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.525 HG12 HG23 ' A' ' 167' ' ' VAL . 31.9 m -117.86 139.49 44.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.336 -0.546 . . . . 1.0 112.323 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.6 t -134.09 134.27 22.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -89.49 159.64 5.41 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.381 2.054 . . . . 1.0 113.718 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.1 mt -114.63 113.59 24.55 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.0 ptm -142.09 153.36 44.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.778 0.658 . . . . 1.0 112.778 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -127.85 122.92 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.872 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 160' ' ' GLN . 17.2 t60 59.65 -118.1 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.133 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.477 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 13.5 pt20 -99.65 1.15 43.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -106.02 143.73 33.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.84 126.42 45.94 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -105.47 -35.37 7.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.3 -173.75 27.12 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.654 -1.26 . . . . 1.0 112.353 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.517 HD23 HMB2 ' A' ' 203' ' ' CYC . 4.8 tp -138.07 122.5 18.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.449 -0.375 . . . . 1.0 111.657 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.408 HD12 HG22 ' A' ' 53' ' ' VAL . 11.3 tp -93.76 144.77 25.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 153' ' ' VAL . 8.4 p -151.86 132.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.856 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.9 m -118.36 128.97 55.15 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.555 ' CD2' ' HG3' ' A' ' 50' ' ' ARG . 66.5 m-70 -100.22 126.14 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.647 0.61 . . . . 1.0 112.647 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.8 t60 -119.54 109.98 16.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.37 49.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 32.9 mm-40 -108.84 155.66 40.35 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' ARG . 35.9 Cg_endo -61.44 -92.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.657 2.238 . . . . 1.0 111.8 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 173' ' ' PRO . 11.2 tpp180 58.76 124.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.57 -0.286 . . . . 1.0 110.684 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.58 163.98 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.512 2.141 . . . . 1.0 111.436 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -108.54 152.71 24.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 1.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.1 m -112.45 147.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.18 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -55.15 -37.04 66.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.164 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.28 -54.28 48.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.26 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.77 -33.53 72.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.24 -42.7 91.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.626 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -67.28 -52.5 39.89 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.664 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.3 t -42.08 -43.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.63 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.05 -46.19 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -52.13 -32.78 37.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.058 -1.089 . . . . 1.0 108.058 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 190' ' ' GLN . 22.8 tp -74.66 -55.97 5.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.088 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -52.03 -45.86 64.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.98 74.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.53 -37.93 82.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 186' ' ' LEU . 49.1 tp60 -64.96 -33.07 75.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.99 -46.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.2 p -51.99 -35.15 45.63 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 mt -68.94 -35.03 67.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.265 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.57 -41.69 75.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.914 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.444 ' CG2' HH12 ' A' ' 55' ' ' ARG . 65.7 mt -56.71 -45.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.38 58.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.367 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -61.73 -44.31 97.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.266 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.74 70.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 1.0 111.419 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.22 -43.43 82.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.181 0.438 . . . . 1.0 112.181 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.7 mp -52.53 -33.26 44.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.984 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.1 -58.76 5.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.691 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.548 HD23 ' C ' ' A' ' 202' ' ' LEU . 2.7 tt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.459 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.534 HAD2 HG13 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.808 0.337 . . . . 1.0 110.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.3 t0 -70.11 -33.2 71.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.55 -48.49 19.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.834 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -54.93 -53.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 1.0 110.924 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.487 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.7 mt -55.72 -31.41 62.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.96 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' O ' HG12 ' A' ' 39' ' ' VAL . 67.0 ttt180 -62.84 -39.54 94.67 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.383 -0.527 . . . . 1.0 109.822 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.08 -32.74 69.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.762 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 42' ' ' VAL . 74.9 p -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.272 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 2.3 p -73.75 -25.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.211 0.448 . . . . 1.0 112.211 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.44 -44.72 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.287 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.91 -37.85 72.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.751 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' THR . 68.2 t -57.11 -54.25 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.596 -0.274 . . . . 1.0 111.394 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 47' ' ' GLY . 69.9 ttt-85 -52.3 -45.56 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 1.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.45 -44.63 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.257 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -65.4 -39.01 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.795 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.92 -14.69 21.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.68 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.71 25.68 22.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.596 -1.001 . . . . 1.0 110.596 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.495 ' HB ' ' CE1' ' A' ' 170' ' ' HIS . 14.2 t -78.87 147.44 33.14 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -52.91 -41.61 64.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.613 ' HE ' ' CD ' ' A' ' 67' ' ' GLU . 65.0 ttt-85 -152.67 133.44 13.95 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.759 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 51' ' ' VAL . 11.2 p -141.45 132.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.912 -1.04 . . . . 1.0 108.648 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.88 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 41.5 pttt -137.82 153.59 49.61 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.682 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 54.4 t -98.33 141.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 11.5 t80 -131.77 133.56 44.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.483 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -113.81 152.56 30.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 1.0 111.166 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.42 134.92 45.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.769 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 61' ' ' HIS . 19.7 m-20 -99.25 154.24 37.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -38.35 -52.19 1.98 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 122.952 2.435 . . . . 1.0 114.549 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' OE2' ' CD2' ' A' ' 61' ' ' HIS . 22.2 pt-20 -70.69 -6.56 38.15 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.71 -6.76 38.31 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.656 -0.783 . . . . 1.0 111.862 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-70 -77.21 149.14 35.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.42 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -135.52 159.54 24.17 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -133.42 155.15 50.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 1.0 111.527 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.19 110.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 65' ' ' VAL . 14.4 t -111.95 -3.99 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.127 0.417 . . . . 1.0 112.127 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.59 124.74 8.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.287 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.613 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 65.3 tt0 -153.29 138.46 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.176 0.512 . . . . 1.0 111.689 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.53 138.13 52.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -133.46 147.34 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.989 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -105.98 140.83 15.29 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.578 -1.009 . . . . 1.0 110.578 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 36.08 36.84 0.15 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 42.64 19.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 1.0 110.353 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' GLY . 31.9 ttm180 -55.36 -40.13 70.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.036 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 73' ' ' ARG . 7.7 mp -110.71 113.71 55.26 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -49.38 161.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.518 2.146 . . . . 1.0 112.148 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p -84.69 129.53 34.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.331 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 HH22 ' A' ' 50' ' ' ARG . 21.3 mt -107.79 9.05 29.06 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.408 HD21 ' CB ' ' A' ' 67' ' ' GLU . 76.8 mt -56.46 131.5 48.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -3.97 86.6 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.88 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.49 147.12 27.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.342 -0.543 . . . . 1.0 110.466 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -104.16 129.83 51.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.54 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.803 ' CD1' HAB2 ' A' ' 203' ' ' CYC . 30.5 m-85 -106.17 105.64 54.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.269 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.3 139.35 4.27 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.485 2.123 . . . . 1.0 111.524 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -63.18 -28.21 69.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.817 0.342 . . . . 1.0 110.413 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.91 -17.52 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 24.4 p-10 -68.16 -14.43 62.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.61 0.243 . . . . 1.0 110.996 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.02 133.68 25.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.481 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HD ' ' A' ' 203' ' ' CYC . 94.8 Cg_endo -74.16 -102.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.551 2.167 . . . . 1.0 111.639 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -157.84 -43.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.003 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -57.91 -40.34 80.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.636 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -40.65 57.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.679 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 69.3 ttt180 -62.32 -38.35 89.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -62.56 -34.13 76.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.965 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD13 ' NH1' ' A' ' 101' ' ' ARG . 7.9 mt -63.99 -33.37 75.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.593 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -68.92 -33.72 74.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.8 mtm180 -78.07 -30.03 49.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.122 -0.945 . . . . 1.0 111.249 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 123' ' ' ALA . 37.5 mt -95.69 -38.93 10.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.67 -12.6 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.455 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 1.5 mp0 46.57 49.02 13.97 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 t -152.22 110.86 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 101' ' ' ARG . 0.4 OUTLIER -165.41 138.34 4.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.933 178.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.4 p -154.11 157.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.709 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.569 HG12 HG21 ' A' ' 135' ' ' VAL . 2.9 mp -111.94 129.85 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.203 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 104' ' ' VAL . 1.2 m -87.33 170.84 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.924 0.712 . . . . 1.0 112.924 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -49.21 114.57 1.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.234 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.414 HG13 ' CG1' ' A' ' 140' ' ' VAL . 39.2 t -51.19 -19.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.686 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -81.18 -37.31 28.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -17.48 19.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 1.0 110.414 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 56.56 61.16 2.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.829 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 m -95.2 125.75 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -118.95 143.98 46.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.65 0.981 . . . . 1.0 113.65 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.3 p -110.54 149.4 30.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.641 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 113' ' ' ILE . 6.4 mt -146.9 150.88 14.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.437 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.1 m -89.86 171.9 9.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -119.32 147.64 43.6 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.889 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -35.87 -54.97 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.657 2.238 . . . . 1.0 112.237 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.11 146.98 32.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.62 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.4 t -134.83 142.36 46.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.501 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.442 ' CD1' ' N ' ' A' ' 120' ' ' GLY . 2.2 t90 -155.34 -139.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.706 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -161.47 -171.87 28.08 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 121' ' ' LEU . 10.0 mp 54.93 4.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 1.0 110.608 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 120' ' ' GLY . 19.6 t -66.75 -27.52 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.748 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' A' ' 97' ' ' LEU . . . -68.63 -21.49 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.75 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -46.75 -19.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.714 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 125' ' ' VAL . 8.0 p -62.69 131.14 94.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.612 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.26 120.07 3.99 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.469 2.113 . . . . 1.0 111.563 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 tp 43.57 -123.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.015 -0.274 . . . . 1.0 110.391 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.85 36.78 52.05 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -143.46 157.24 59.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.504 0.193 . . . . 1.0 110.608 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 132' ' ' GLN . 60.9 Cg_endo -69.27 170.14 16.66 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.443 2.095 . . . . 1.0 112.019 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.89 3.06 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 1.0 112.014 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 130' ' ' PRO . 41.2 mm-40 -136.78 164.97 27.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.508 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -136.38 122.44 13.67 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.7 139.24 8.69 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.635 2.223 . . . . 1.0 112.365 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.677 ' CG1' HAD2 ' A' ' 203' ' ' CYC . 2.9 t -116.26 127.43 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.773 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.8 OUTLIER -45.27 144.98 2.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.74 0.305 . . . . 1.0 111.347 -178.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -38.28 -18.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.123 2.549 . . . . 1.0 113.658 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 136' ' ' ASP . 34.6 t -56.98 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.259 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.667 ' CG ' HAA2 ' A' ' 203' ' ' CYC . 0.8 OUTLIER -71.71 -26.01 62.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.659 179.75 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG1' HG13 ' A' ' 106' ' ' VAL . 45.3 t -56.43 -63.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.47 ' CG ' ' N ' ' A' ' 142' ' ' TYR . 23.0 p80 -66.84 -40.88 88.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.386 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.47 ' N ' ' CG ' ' A' ' 141' ' ' HIS . 71.1 t80 -44.3 -39.46 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.6 -41.69 62.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.185 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.25 -43.38 92.42 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -63.34 -21.35 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.618 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.4 mmm -99.14 0.35 43.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.149 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.22 17.46 79.98 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.599 -1.001 . . . . 1.0 110.599 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.73 145.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 1.0 110.289 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.14 -20.75 7.89 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.055 0.391 . . . . 1.0 112.055 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 120.07 4.76 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.778 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -124.96 132.49 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.915 0.388 . . . . 1.0 111.412 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -98.73 127.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.0 108.49 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.279 -0.568 . . . . 1.0 112.266 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.63 135.18 20.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -92.28 166.05 2.98 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.408 2.072 . . . . 1.0 113.737 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.39 116.48 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 24.0 ptm -141.58 151.83 43.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.441 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 63.3 t60 -124.1 123.59 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.948 -1.024 . . . . 1.0 108.824 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.2 m170 56.72 -118.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.12 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -98.06 0.58 46.45 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.848 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.467 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.23 143.25 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -176.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.4 tp -99.23 125.71 44.89 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.542 -1.281 . . . . 1.0 107.542 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.467 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 61.7 m95 -104.96 -35.25 7.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.538 0.94 . . . . 1.0 113.538 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.58 -173.58 25.26 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.401 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.7 tp -139.51 120.96 15.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.473 -0.363 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.7 tp -93.63 150.48 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.4 p -155.73 133.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.028 -0.669 . . . . 1.0 111.869 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -115.03 136.03 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 9.7 m80 -108.73 123.44 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.495 ' CE1' ' HB ' ' A' ' 48' ' ' THR . 97.7 m-70 -117.06 125.22 50.98 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.19 -16.63 57.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.817 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -134.54 152.37 77.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.911 -0.316 . . . . 1.0 110.608 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -42.79 127.51 4.74 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.646 2.231 . . . . 1.0 111.88 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -149.81 77.52 8.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.932 -0.307 . . . . 1.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.97 151.65 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.495 2.13 . . . . 1.0 111.416 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -105.57 148.14 27.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.869 -0.333 . . . . 1.0 110.803 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.1 t -92.97 157.72 16.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.151 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -53.61 -37.36 62.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.14 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 183' ' ' VAL . 78.3 mm-40 -73.43 -43.12 61.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.288 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 184' ' ' VAL . 77.8 mm-40 -71.41 -28.99 64.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.998 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.61 -46.91 86.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.614 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 13.1 pt20 -80.18 -47.07 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.667 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 179' ' ' GLU . 43.1 t -42.86 -45.58 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.644 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 185' ' ' GLN . 34.1 m -74.41 -47.34 40.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.557 ' N ' HG23 ' A' ' 184' ' ' VAL . 40.5 tp60 -49.54 -32.06 11.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.123 -1.066 . . . . 1.0 108.123 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 190' ' ' GLN . 13.8 tp -73.89 -52.11 14.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.034 -0.984 . . . . 1.0 109.098 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.86 -47.51 67.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.62 83.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.429 -0.952 . . . . 1.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.56 ' O ' HD13 ' A' ' 193' ' ' ILE . 65.0 t0 -62.41 -41.73 98.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 186' ' ' LEU . 59.1 tp60 -61.66 -31.3 71.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.84 -44.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.2 p -51.67 -35.8 43.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -66.51 -37.19 79.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.161 -0.927 . . . . 1.0 110.276 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.22 -41.78 80.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.2 mt -56.83 -46.3 83.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.441 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.94 -49.55 67.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.394 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.46 -45.36 93.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.216 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.19 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.362 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -58.26 -44.13 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.219 0.451 . . . . 1.0 112.219 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.93 -32.85 54.99 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.996 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 m -51.87 -57.03 10.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.614 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.096 -0.954 . . . . 1.0 110.441 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.88 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 35' ' ' LEU . 1.2 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.713 0.292 . . . . 1.0 110.484 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -48.93 -35.72 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 26.4 mp0 -74.49 -50.7 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.783 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.28 -50.56 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 1.0 110.94 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 38' ' ' THR . 30.5 mt -54.78 -29.7 54.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.95 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.515 ' O ' HG12 ' A' ' 39' ' ' VAL . 76.6 ttt180 -64.37 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 109.754 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.57 -32.86 68.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.835 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.62 ' O ' HG23 ' A' ' 42' ' ' VAL . 70.5 p -66.46 -36.97 84.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.333 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 2.4 p -73.65 -24.48 20.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -45.99 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.308 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -68.55 -38.62 80.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.739 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 38' ' ' THR . 76.9 t -54.78 -55.14 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.296 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -50.11 -43.87 51.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.693 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.54 77.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.269 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.52 -40.72 97.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.753 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -96.92 -14.8 21.52 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.65 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.62 25.8 22.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 p -79.65 149.43 31.27 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 3.0 p30 -53.6 -38.98 64.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 ttt180 -154.51 135.29 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.609 -0.836 . . . . 1.0 112.891 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.0 p -141.81 132.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.01 -0.995 . . . . 1.0 108.783 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' CE ' HAB1 ' A' ' 203' ' ' CYC . 13.5 pttp -138.25 153.03 49.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.615 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 43.5 t -98.58 139.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HH ' ' C ' ' A' ' 62' ' ' GLY . 23.7 t80 -128.21 131.0 48.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 1.0 110.391 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -109.68 149.13 30.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.41 . . . . 1.0 111.22 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.88 135.76 42.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 61' ' ' HIS . 24.2 m-20 -101.03 153.55 37.67 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -38.85 -51.02 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.06 2.507 . . . . 1.0 114.514 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.41 -5.74 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.199 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.77 -8.84 43.51 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.661 -0.78 . . . . 1.0 111.946 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.567 ' O ' ' N ' ' A' ' 57' ' ' ASP . 73.6 m80 -78.83 151.64 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' HH ' ' A' ' 54' ' ' TYR . . . -139.34 165.09 25.83 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.1 p -136.95 159.61 41.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 1.0 111.455 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 t -87.8 105.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 65' ' ' VAL . 25.8 t -105.68 -6.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.86 122.6 6.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.278 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 81.7 tt0 -150.47 138.06 19.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.122 0.487 . . . . 1.0 111.686 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.61 132.07 51.35 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 44.6 ptt85 -114.17 142.88 45.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.042 -177.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.06 67.13 2.09 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.625 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 83.77 161.11 31.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.033 -0.827 . . . . 1.0 111.033 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.86 4.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.87 0.367 . . . . 1.0 110.323 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 71' ' ' GLY . 8.6 tpm_? -62.0 -42.07 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.52 108.86 33.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.66 167.34 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.132 . . . . 1.0 112.24 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 m -105.1 149.58 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.345 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 21.9 mt -111.23 20.37 17.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.021 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.9 tp -64.8 130.67 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.17 88.11 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.861 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.55 149.57 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.325 0.563 . . . . 1.0 110.484 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.5 m -108.46 136.63 47.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.655 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.78 148.67 39.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.256 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.25 138.49 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.494 2.129 . . . . 1.0 111.474 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.915 0.388 . . . . 1.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.87 -16.27 0.2 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 84' ' ' ALA . 93.0 m-20 -70.35 -20.56 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.596 0.236 . . . . 1.0 111.004 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 88' ' ' PRO . 2.2 mt -125.01 95.65 41.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.516 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.0 Cg_exo -44.77 -114.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.521 2.147 . . . . 1.0 111.694 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 56.5 mp0 -147.11 -58.88 0.27 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.936 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -45.72 -42.71 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.681 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.97 -40.09 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.683 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 70.1 ttp85 -62.24 -34.46 76.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.808 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -62.81 -34.58 77.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.914 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.662 ' CD1' HH22 ' A' ' 101' ' ' ARG . 93.3 mt -63.66 -33.6 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.524 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.496 ' CZ ' HBA2 ' A' ' 203' ' ' CYC . 76.4 m-85 -67.97 -34.06 75.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 36.1 mtp180 -75.33 -31.8 60.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.262 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.79 -36.8 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.753 1.02 . . . . 1.0 113.753 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.31 -17.49 8.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.258 1.207 . . . . 1.0 114.258 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.481 ' N ' ' OE1' ' A' ' 99' ' ' GLN . 0.9 OUTLIER 48.38 55.72 8.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.98 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 99' ' ' GLN . 20.7 t -153.3 109.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.891 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.662 HH22 ' CD1' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -161.88 131.87 4.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.921 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 103' ' ' ILE . 54.0 t -146.53 155.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.665 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.564 HG12 HG21 ' A' ' 135' ' ' VAL . 57.6 mt -112.47 128.53 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.268 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.09 170.53 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.052 0.76 . . . . 1.0 113.052 -176.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -51.2 115.05 1.38 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.246 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.482 HG23 ' CG1' ' A' ' 140' ' ' VAL . 12.0 p -50.07 -19.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.716 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -81.07 -36.41 30.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.79 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.5 -18.34 28.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.137 0.494 . . . . 1.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 57.44 61.49 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.532 -0.758 . . . . 1.0 112.819 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -94.62 125.7 39.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.762 -1.569 . . . . 1.0 106.762 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -118.75 142.93 47.23 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.679 0.992 . . . . 1.0 113.679 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -111.87 150.91 29.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.73 -1.123 . . . . 1.0 108.616 178.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 113' ' ' ILE . 31.4 pt -150.83 155.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.411 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.0 p -84.76 163.63 19.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -150.88 158.52 35.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.896 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.22 -13.52 20.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.687 2.258 . . . . 1.0 112.286 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.23 -34.54 77.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 p 62.98 125.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.514 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -98.27 145.63 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.675 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -168.73 -175.11 37.95 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.8 mt 46.72 50.4 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 1.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.2 m -60.06 -31.41 69.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.71 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.22 58.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.4 mmm-85 -49.93 -56.19 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.759 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.2 109.5 10.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.684 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' GLY . 63.8 Cg_endo -83.04 164.94 15.23 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 122.356 2.037 . . . . 1.0 111.505 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 127' ' ' LEU . 11.2 mp 44.75 -92.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.458 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 57.36 35.54 72.13 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -139.42 154.06 71.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 1.0 110.639 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 132' ' ' GLN . 65.6 Cg_exo -41.54 165.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.398 2.066 . . . . 1.0 112.048 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.423 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 3.6 tp -59.92 12.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.036 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.591 ' H ' ' C ' ' A' ' 130' ' ' PRO . 50.7 mm-40 -138.11 156.18 48.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.511 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.581 HH21 ' CZ ' ' A' ' 101' ' ' ARG . 21.0 mmm180 -122.42 113.81 30.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.587 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -84.65 142.92 9.43 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.641 2.227 . . . . 1.0 112.378 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.564 HG21 HG12 ' A' ' 103' ' ' ILE . 22.3 t -122.24 133.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -42.08 157.6 0.21 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.356 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.13 -24.57 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.124 2.549 . . . . 1.0 113.614 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.589 ' SG ' ' HHD' ' A' ' 203' ' ' CYC . 0.8 OUTLIER -58.02 -58.46 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.246 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.876 ' CG ' ' HD ' ' A' ' 203' ' ' CYC . 0.4 OUTLIER -71.15 -26.76 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.68 -178.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 136' ' ' ASP . 76.3 t -61.1 -56.18 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -62.26 -38.95 91.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.303 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -47.53 -36.22 10.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.03 -42.93 62.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -58.31 -43.68 88.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -62.21 -19.3 63.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.683 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.5 mmm -99.34 0.02 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.133 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 18.26 77.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 84.3 t -108.75 143.59 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.738 0.304 . . . . 1.0 110.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.94 -25.39 4.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -152.49 118.68 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.756 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 96.3 p -129.23 144.2 51.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.994 0.426 . . . . 1.0 111.398 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 152' ' ' LEU . 8.2 mp -102.69 137.33 41.06 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.76 129.1 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 1.0 112.263 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.3 133.29 20.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.49 162.54 3.58 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.368 2.045 . . . . 1.0 113.736 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.6 mt -117.12 115.03 24.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.414 ' H ' ' HB3' ' A' ' 192' ' ' SER . 22.0 ptm -141.99 154.74 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 55.9 t60 -128.34 124.78 37.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.021 -0.991 . . . . 1.0 108.871 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 46.2 m-70 59.72 -121.21 1.03 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.117 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -97.94 0.57 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.823 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.535 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -105.46 143.56 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.6 tp -99.71 124.54 45.06 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.535 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.3 m95 -102.92 -31.02 10.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.31 -169.82 26.21 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.448 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.7 mp -140.03 121.74 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 1.0 111.637 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.1 tp -94.67 149.66 21.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.7 p -157.56 134.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.075 -0.65 . . . . 1.0 111.861 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -114.52 135.76 53.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.267 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -107.82 126.99 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -117.46 122.81 44.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.33 16.69 5.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.797 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -159.21 143.79 11.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.636 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -42.77 139.13 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.668 2.245 . . . . 1.0 111.816 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -173.19 114.16 0.36 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.653 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.05 153.33 21.98 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.56 2.173 . . . . 1.0 111.45 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -108.01 151.32 25.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.812 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 91.4 p -104.12 156.69 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.237 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -54.25 -40.72 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.159 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.35 -43.7 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.249 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 184' ' ' VAL . 96.1 mt-10 -78.39 -28.96 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 1.0 110.971 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.65 -39.53 73.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.636 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 11.7 pt20 -80.45 -52.87 7.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.92 -0.312 . . . . 1.0 111.682 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' A' ' 182' ' ' GLN . 9.9 p -44.13 -41.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.645 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.6 p -75.1 -49.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.597 ' N ' HG13 ' A' ' 184' ' ' VAL . 56.8 tt0 -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.6 tp -71.74 -48.61 45.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.053 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 187' ' ' LEU . 62.9 tp -51.42 -44.58 62.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.71 91.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -64.09 -39.32 93.8 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -64.53 -31.41 72.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 53.7 t -77.49 -44.58 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 157' ' ' MET . 2.2 m -51.77 -33.6 35.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.78 -34.61 34.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.56 78.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.98 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.1 pt -62.24 -29.82 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.42 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.5 -53.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.639 -0.71 . . . . 1.0 110.37 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.54 -42.63 98.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.321 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.8 74.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.352 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.86 -43.11 80.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 tp -51.35 -38.12 51.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.959 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.4 t -47.85 -57.54 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.631 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.496 179.894 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.876 ' HD ' ' CG ' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 31' ' ' LEU . 11.0 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 1.0 110.517 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -48.07 -36.61 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.764 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -74.09 -50.6 18.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.874 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 38' ' ' THR . 95.7 mt -56.47 -45.53 81.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.145 0.498 . . . . 1.0 110.982 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.44 ' O ' ' OG1' ' A' ' 38' ' ' THR . 29.5 mt -58.07 -28.89 64.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.903 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.502 HH12 HD22 ' A' ' 78' ' ' LEU . 87.4 mtt-85 -68.53 -39.5 81.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.81 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.42 -31.71 69.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.9 p -67.68 -36.93 81.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.371 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -74.59 -23.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.209 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.46 -48.36 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.323 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.34 -35.9 80.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.71 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' THR . 70.6 t -58.1 -53.87 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.613 -0.267 . . . . 1.0 111.313 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 47' ' ' GLY . 65.5 ttt-85 -50.21 -43.73 52.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.942 0.401 . . . . 1.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.03 -43.33 70.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.295 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.65 -37.65 87.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.786 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.84 -14.6 21.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.725 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.47 25.68 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.2 p -81.25 152.52 27.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.3 m-20 -48.83 -43.57 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.599 0.592 . . . . 1.0 112.599 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.432 HH21 HG21 ' A' ' 148' ' ' VAL . 30.1 ptt180 -159.17 146.93 17.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.625 -0.83 . . . . 1.0 112.765 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.13 133.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.703 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 61.3 mttt -135.77 142.83 44.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.665 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 166' ' ' LEU . 59.8 t -102.02 140.94 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.748 ' CE2' HBB1 ' A' ' 203' ' ' CYC . 19.1 m-85 -131.55 136.59 47.96 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.531 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -112.86 153.28 28.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.036 0.446 . . . . 1.0 111.188 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CD1' ' NH2' ' A' ' 92' ' ' ARG . 43.5 m-85 -100.0 141.84 32.28 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -114.2 166.67 11.0 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -41.75 -55.82 2.17 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.055 2.503 . . . . 1.0 114.497 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -67.88 -12.56 60.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.79 0.28 48.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.752 -0.737 . . . . 1.0 111.904 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.509 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 2.4 p80 -74.6 148.79 40.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.466 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.54 144.34 16.98 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -125.12 149.69 47.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.948 0.404 . . . . 1.0 111.57 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 77' ' ' LEU . 4.2 p -90.19 108.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 65' ' ' VAL . 12.1 t -112.34 -4.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.32 128.17 9.54 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.271 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 24.0 tt0 -160.75 141.92 11.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 1.0 111.662 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.75 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -110.73 138.59 46.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.038 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.02 67.33 3.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.611 -0.995 . . . . 1.0 110.611 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 82.82 162.42 32.02 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.43 3.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.33 . . . . 1.0 110.328 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.585 ' H ' ' C ' ' A' ' 71' ' ' GLY . 8.9 tpm_? -59.14 -42.59 91.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.971 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -117.63 143.08 31.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.63 167.9 23.41 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.475 2.117 . . . . 1.0 112.28 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p -98.42 149.7 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.346 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.877 ' O ' HG11 ' A' ' 64' ' ' VAL . 41.1 mt -116.19 15.99 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.946 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.502 HD22 HH12 ' A' ' 36' ' ' ARG . 52.3 mt -60.15 129.18 40.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.564 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.8 -2.35 87.17 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.814 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.813 ' O ' HG12 ' A' ' 64' ' ' VAL . 84.1 mt -86.0 147.39 26.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.358 0.579 . . . . 1.0 110.458 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -106.02 133.35 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -105.54 148.39 36.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.217 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.98 140.12 12.43 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.487 2.125 . . . . 1.0 111.493 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -62.97 -31.37 72.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.799 0.333 . . . . 1.0 110.434 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.12 -17.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.8 m-20 -63.23 -24.91 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.624 0.249 . . . . 1.0 111.023 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.66 132.55 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.507 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.58 -99.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.535 2.157 . . . . 1.0 111.672 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -159.25 -47.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.956 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -52.0 -40.99 61.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.636 ' CB ' HH22 ' A' ' 101' ' ' ARG . . . -74.89 -38.32 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.712 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.46 ' HE ' HD23 ' A' ' 162' ' ' LEU . 72.4 ttt180 -61.08 -32.36 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.798 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.07 -36.43 83.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.933 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.78 -36.27 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.532 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -67.96 -37.1 81.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -75.54 -30.23 59.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.162 -0.927 . . . . 1.0 111.26 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -96.98 -38.63 9.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -177.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.94 -14.47 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 100' ' ' VAL . 1.4 mp0 48.8 51.37 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.902 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 99' ' ' GLN . 22.8 t -153.17 109.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.911 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.636 HH22 ' CB ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -164.02 135.91 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.873 178.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -151.58 156.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.684 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.798 HD11 HAA1 ' A' ' 203' ' ' CYC . 87.7 mt -110.56 130.69 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.265 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 104' ' ' VAL . 1.4 m -85.94 169.66 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.921 0.711 . . . . 1.0 112.921 -177.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.457 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 64.6 m-20 -48.19 116.01 1.4 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.902 -1.044 . . . . 1.0 112.236 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.5 -18.85 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.666 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 109' ' ' GLN . 43.4 tp10 -78.7 -38.83 38.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.821 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.33 -5.91 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.501 . . . . 1.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 11.6 pt20 46.23 63.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 1.0 112.83 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.5 m -91.24 126.96 36.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.77 -1.567 . . . . 1.0 106.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -118.34 144.48 45.84 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -111.71 149.87 31.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.695 -1.139 . . . . 1.0 108.654 178.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -150.52 154.61 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.435 -0.506 . . . . 1.0 111.418 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -87.16 167.21 14.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -147.52 153.26 43.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.968 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.12 -5.04 15.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.69 2.26 . . . . 1.0 112.208 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.1 160.82 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.633 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.8 p -51.7 166.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.562 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -58.42 146.06 36.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.685 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.91 -27.07 49.72 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.5 tp 57.93 71.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 1.0 110.653 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.5 m -59.75 -29.85 68.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.73 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.1 -33.25 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.779 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HE ' ' H ' ' A' ' 125' ' ' VAL . 18.0 ttp180 -64.67 -143.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.68 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' H ' ' HE ' ' A' ' 124' ' ' ARG . 22.0 t -60.05 133.84 90.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.82 141.76 37.92 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.359 2.039 . . . . 1.0 111.569 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.7 -112.71 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.419 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.52 30.0 57.15 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.144 -0.783 . . . . 1.0 111.144 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -131.31 150.61 76.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 122.828 -0.219 . . . . 1.0 110.639 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.577 ' C ' ' H ' ' A' ' 132' ' ' GLN . 71.0 Cg_exo -42.62 162.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.421 2.081 . . . . 1.0 111.985 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.41 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 55.9 mt -54.59 3.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 1.0 112.086 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.577 ' H ' ' C ' ' A' ' 130' ' ' PRO . 38.9 mm-40 -137.49 143.36 41.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.467 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -117.83 82.77 17.21 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.538 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.81 142.64 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.704 2.269 . . . . 1.0 112.36 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.69 128.92 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 112' ' ' SER . 21.3 t70 -44.2 135.87 4.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.307 . . . . 1.0 111.345 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -37.41 -23.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.132 2.555 . . . . 1.0 113.645 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 136' ' ' ASP . 36.3 t -55.66 -61.3 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.263 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.758 ' CE1' ' HD ' ' A' ' 203' ' ' CYC . 0.4 OUTLIER -71.94 -24.04 61.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.658 -178.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.6 t -57.97 -61.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.551 0.574 . . . . 1.0 112.551 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.592 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 23.2 p80 -60.79 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.391 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.592 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 83.1 t80 -47.44 -39.75 16.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.4 mt -72.06 -43.44 64.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.64 -43.03 79.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.5 m -61.7 -20.12 63.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.709 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.8 mmm -98.48 -1.16 41.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.074 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.53 19.32 76.38 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.432 HG21 HH21 ' A' ' 50' ' ' ARG . 65.7 t -107.56 142.49 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.297 . . . . 1.0 110.242 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.64 -35.17 3.6 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.457 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 22.8 m -143.2 121.17 12.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.766 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 m -129.81 142.11 50.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 1.0 111.378 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -102.76 136.24 42.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.14 128.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.331 -0.548 . . . . 1.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.22 128.97 19.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.255 -1.016 . . . . 1.0 108.255 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -92.6 164.21 2.85 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.4 2.067 . . . . 1.0 113.704 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.9 113.68 22.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.567 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.6 ptm -140.7 152.47 45.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.107 -0.637 . . . . 1.0 112.718 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 53.6 t60 -126.19 123.99 39.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.829 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 56.8 m-70 58.54 -120.73 1.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.182 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -97.42 1.51 49.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.787 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.01 143.44 34.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.46 HD23 ' HE ' ' A' ' 92' ' ' ARG . 39.4 tp -99.31 124.94 44.82 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 66.3 m95 -103.91 -35.31 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -156.87 -174.59 26.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 119.684 -1.246 . . . . 1.0 112.375 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.7 tp -138.42 121.2 16.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.457 HD12 HG22 ' A' ' 53' ' ' VAL . 10.3 tp -93.69 142.57 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.1 p -149.41 131.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.815 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.8 t -116.46 130.66 56.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.197 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -106.21 129.33 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 19.1 t-80 -120.77 117.4 27.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.77 -15.65 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.742 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.419 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 51.1 mm-40 -131.27 141.64 42.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.894 -0.323 . . . . 1.0 110.553 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -41.74 150.07 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.67 2.247 . . . . 1.0 111.896 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -173.38 88.33 0.38 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.712 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.81 153.71 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.497 2.132 . . . . 1.0 111.433 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -110.98 151.55 27.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.3 t -110.29 146.95 34.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.239 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -53.61 -39.28 64.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.124 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.38 -55.83 27.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.318 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -72.1 -36.09 69.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.57 -40.54 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.551 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -67.15 -55.8 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.759 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.3 t -45.73 -40.6 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.626 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.48 -50.76 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -48.43 -36.54 15.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 87.1 mt -71.64 -46.52 58.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.075 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 tp -52.13 -46.33 65.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.939 -0.764 . . . . 1.0 108.939 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.95 91.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.377 -0.971 . . . . 1.0 108.377 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.82 -38.11 89.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 86.0 mt-30 -66.89 -30.6 70.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.72 -45.89 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -52.25 -37.39 55.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 190' ' ' GLN . 31.8 mt -65.47 -34.97 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.162 -0.926 . . . . 1.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.05 78.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.928 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mt -55.24 -50.25 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.96 -50.42 66.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.417 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -61.87 -46.96 87.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.325 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.83 -32.74 74.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.41 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -56.4 -41.63 76.61 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.234 0.457 . . . . 1.0 112.234 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.2 mt -53.77 -34.67 59.78 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.987 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.6 t -44.92 -56.73 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.621 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.418 179.583 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.798 HAA1 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 63.0 t0 -48.82 -34.17 11.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.485 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 22.6 mp0 -76.38 -48.44 19.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.826 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 38' ' ' THR . 25.7 mm -56.56 -50.38 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.065 0.459 . . . . 1.0 110.885 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 38' ' ' THR . 47.9 mt -57.38 -30.24 64.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 1.0 111.934 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.4 ttp85 -65.78 -39.7 91.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.762 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.42 68.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 76.3 p -65.07 -37.85 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.948 -0.569 . . . . 1.0 112.368 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p -71.94 -25.57 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.165 0.432 . . . . 1.0 112.165 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -80.78 -35.12 33.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.298 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -77.15 -42.63 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.76 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.7 p -63.65 -52.4 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.356 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.651 ' N ' HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.22 -42.21 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 1.0 110.697 -179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -53.86 -41.28 67.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.317 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.16 -34.68 78.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.764 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -95.86 -14.83 22.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.8 0.333 . . . . 1.0 111.683 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.92 25.31 45.0 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 p -78.17 145.19 35.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.84 -40.27 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' A' ' 67' ' ' GLU . 44.9 ttt180 -150.47 132.46 15.21 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.511 -0.876 . . . . 1.0 112.762 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 7.1 t -138.69 131.54 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.007 -0.997 . . . . 1.0 108.671 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.598 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.9 pttm -137.17 149.97 47.61 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.722 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 166' ' ' LEU . 61.4 t -98.99 141.35 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 16.0 t80 -131.05 132.31 44.84 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.42 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -113.04 153.56 27.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.012 0.434 . . . . 1.0 111.253 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.79 135.59 44.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.1 m-20 -95.09 150.73 38.12 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -41.45 -21.87 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.012 2.474 . . . . 1.0 114.485 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -103.22 4.6 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.565 -0.454 . . . . 1.0 112.155 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.21 -14.35 59.77 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.671 -0.776 . . . . 1.0 111.897 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 57' ' ' ASP . 39.9 m80 -78.13 150.44 33.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.56 164.0 25.73 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -136.35 158.07 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.034 0.445 . . . . 1.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.2 106.54 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 65' ' ' VAL . 54.7 t -107.92 -5.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.126 0.417 . . . . 1.0 112.126 -177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.19 123.51 7.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.348 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' CD ' HH21 ' A' ' 50' ' ' ARG . 87.1 tt0 -150.87 136.6 18.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 1.0 111.719 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.56 135.85 51.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -119.26 140.06 50.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 1.0 112.044 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.85 4.55 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.413 ' C ' ' N ' ' A' ' 73' ' ' ARG . . . 49.52 36.06 23.39 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.049 -0.821 . . . . 1.0 111.049 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 50.32 16.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.825 0.345 . . . . 1.0 110.385 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' C ' ' A' ' 71' ' ' GLY . 14.5 tpp85 -55.91 -46.4 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.009 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.03 150.19 37.23 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.32 151.18 42.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.454 2.102 . . . . 1.0 112.267 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.9 m -84.35 110.88 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.348 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.485 HD12 HH22 ' A' ' 50' ' ' ARG . 15.9 mt -91.69 16.03 11.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.946 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.2 132.68 52.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 -2.94 86.98 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.43 -0.805 . . . . 1.0 112.812 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.5 mt -85.55 150.81 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.372 0.586 . . . . 1.0 110.415 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -109.16 137.63 46.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.622 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -108.99 148.72 38.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.274 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.51 137.02 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.574 2.183 . . . . 1.0 111.442 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.9 -34.75 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.865 0.364 . . . . 1.0 110.445 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.14 -16.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 84' ' ' ALA . 97.5 m-20 -66.39 -22.08 66.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.647 0.261 . . . . 1.0 111.03 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.92 133.36 24.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.529 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.64 -98.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.537 2.158 . . . . 1.0 111.685 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -161.96 -50.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.953 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -46.52 -42.84 16.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.593 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.32 -38.48 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.743 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.57 -32.21 72.29 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.791 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -64.01 -35.31 80.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.915 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.41 -36.04 79.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.534 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.434 ' CE2' ' HG3' ' A' ' 101' ' ' ARG . 45.3 m-85 -68.25 -35.36 77.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -81.11 -27.77 35.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.166 -0.925 . . . . 1.0 111.269 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.415 HD13 ' OG ' ' A' ' 122' ' ' SER . 97.0 mt -96.95 -42.04 8.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -176.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 100' ' ' VAL . . . -119.8 -15.0 8.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.243 1.201 . . . . 1.0 114.243 -174.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.674 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.9 OUTLIER 45.57 54.9 7.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.7 -0.8 . . . . 1.0 109.866 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.9 m -159.68 111.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.857 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.78 ' NE ' ' N ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -170.81 139.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.852 177.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.5 p -146.01 158.36 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.73 -0.668 . . . . 1.0 109.641 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.524 HG23 HG11 ' A' ' 135' ' ' VAL . 49.8 mt -110.62 126.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.217 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 105' ' ' ASP . 10.0 p -86.53 168.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.613 ' N ' HG22 ' A' ' 104' ' ' VAL . 48.7 m-20 -49.0 115.88 1.45 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.283 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.77 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.8 p -51.03 -21.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.675 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -77.94 -38.08 46.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.835 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.58 -16.13 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.185 0.517 . . . . 1.0 110.404 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 56.24 60.93 2.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.482 -0.781 . . . . 1.0 112.824 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.6 m -96.86 126.19 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -117.87 143.92 45.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.519 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -114.45 153.91 29.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.731 -1.122 . . . . 1.0 108.636 177.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 112' ' ' SER . 29.0 pt -154.23 158.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.473 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -94.08 173.26 7.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -149.7 151.36 32.71 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.921 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.0 -22.36 10.12 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.603 2.202 . . . . 1.0 112.262 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.31 154.64 19.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 m -58.04 156.39 9.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.502 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -139.65 164.71 29.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.648 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.65 115.41 6.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.2 mt -89.03 148.82 23.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 1.0 110.553 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.415 ' OG ' HD13 ' A' ' 97' ' ' LEU . 88.8 p -59.56 -27.7 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.687 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.02 -35.31 73.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.742 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -55.46 -60.54 3.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.785 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.94 153.31 60.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.629 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.44 145.78 43.37 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.324 2.016 . . . . 1.0 111.533 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.3 mp 51.26 -107.01 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.447 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.23 36.02 92.7 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -134.32 153.86 79.59 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.541 0.21 . . . . 1.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 132' ' ' GLN . 56.0 Cg_endo -66.26 159.89 47.75 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.403 2.069 . . . . 1.0 111.965 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.432 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 70.3 mt -47.45 -8.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.577 . . . . 1.0 112.092 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 130' ' ' PRO . 5.9 mm100 -131.2 167.38 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.524 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -143.98 91.3 6.59 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.514 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.91 137.84 21.67 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.619 2.213 . . . . 1.0 112.407 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 103' ' ' ILE . 1.4 p -114.95 128.0 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.7 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 45.9 p-10 -46.53 138.88 6.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.307 . . . . 1.0 111.315 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -39.21 -28.24 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.145 2.563 . . . . 1.0 113.663 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 t -48.94 -64.42 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.475 ' NE2' HD11 ' A' ' 143' ' ' LEU . 29.6 t60 -71.37 -21.83 61.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.77 ' CG1' HG23 ' A' ' 106' ' ' VAL . 88.5 t -59.34 -58.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -63.1 -40.11 96.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.424 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.517 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 71.2 t80 -47.59 -38.42 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.475 HD11 ' NE2' ' A' ' 139' ' ' HIS . 84.5 mt -71.82 -43.7 65.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.104 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -56.41 -41.98 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.0 m -62.66 -21.36 65.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.692 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.517 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 50.6 mtp -98.31 -0.74 43.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.488 -0.778 . . . . 1.0 111.06 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.05 19.71 76.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.2 t -107.78 143.44 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.679 0.276 . . . . 1.0 110.367 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.56 -26.86 6.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.968 0.359 . . . . 1.0 111.968 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 32.4 m -150.77 120.29 6.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.766 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p -129.76 141.85 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 1.0 111.402 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.3 mp -104.37 130.7 52.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.617 ' O ' ' NE ' ' A' ' 101' ' ' ARG . 10.9 t -113.83 106.36 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.308 -0.557 . . . . 1.0 112.311 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 42.6 t -110.17 135.77 20.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -94.93 167.3 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.299 1.999 . . . . 1.0 113.723 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.1 mt -119.24 116.33 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.7 ptm -141.02 154.78 46.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.408 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 74.8 t60 -127.99 123.39 34.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.942 -1.026 . . . . 1.0 108.865 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.531 ' CG ' ' N ' ' A' ' 160' ' ' GLN . 37.7 t-80 60.23 -120.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.363 . . . . 1.0 110.09 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.531 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 28.0 tp60 -98.26 2.03 47.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.816 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.529 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 144.98 31.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.12 123.99 46.13 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.529 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m95 -102.24 -31.65 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.37 -173.73 31.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.453 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.1 mt -135.12 121.44 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 1.0 111.614 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.649 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.5 tp -94.69 150.82 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.431 HG11 ' NZ ' ' A' ' 52' ' ' LYS . 13.0 p -157.33 134.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.859 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.9 t -115.6 132.8 56.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.598 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 21.4 m80 -101.61 122.66 44.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -117.75 108.7 15.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.42 66.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.751 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -104.77 157.82 33.35 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.942 -0.303 . . . . 1.0 110.569 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.48 ' O ' ' O ' ' A' ' 174' ' ' ARG . 59.1 Cg_endo -69.08 -97.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.695 2.264 . . . . 1.0 111.845 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 173' ' ' PRO . 59.9 ttp85 58.71 131.38 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.572 -0.286 . . . . 1.0 110.609 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.47 160.59 28.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.514 2.143 . . . . 1.0 111.416 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 181' ' ' LEU . 37.2 p90 -109.3 157.77 18.54 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 96.0 p -110.27 147.4 33.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.16 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.19 -34.69 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.122 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.89 -47.76 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.209 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 184' ' ' VAL . 97.1 mt-10 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 1.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 176' ' ' TYR . 42.5 tp -69.83 -35.77 75.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.619 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -81.11 -55.4 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.618 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 184' ' ' VAL . 9.3 p -44.16 -41.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.419 . . . . 1.0 110.659 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.4 p -73.96 -48.39 38.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.591 ' N ' HG13 ' A' ' 184' ' ' VAL . 62.3 tt0 -46.62 -32.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.106 -1.072 . . . . 1.0 108.106 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 190' ' ' GLN . 7.9 tp -68.84 -47.37 66.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.108 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 184' ' ' VAL . 95.5 mt -53.97 -46.43 71.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.88 86.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.541 ' O ' HD13 ' A' ' 193' ' ' ILE . 71.9 m-20 -63.27 -42.35 99.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 186' ' ' LEU . 61.3 tt0 -60.66 -31.3 70.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.43 -44.13 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.5 p -52.42 -36.55 54.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.815 -0.809 . . . . 1.0 108.815 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.4 mp -66.06 -37.78 80.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.197 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.81 83.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.0 mt -55.15 -50.41 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.93 -50.35 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.411 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.6 -47.07 87.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.282 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.21 -32.67 73.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.39 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -56.14 -40.57 74.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 tp -52.5 -35.44 52.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 96.8 p -53.11 -58.71 6.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.615 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.058 -0.973 . . . . 1.0 110.397 179.647 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.831 HBC2 ' HD ' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.82 0.343 . . . . 1.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.51 -33.03 68.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -77.51 -48.17 17.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.788 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -56.16 -51.2 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.056 0.455 . . . . 1.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.492 ' O ' ' OG1' ' A' ' 38' ' ' THR . 71.0 mt -58.34 -30.88 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.986 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 39' ' ' VAL . 41.2 mtp180 -67.73 -39.36 84.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.408 -0.517 . . . . 1.0 109.732 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.469 ' O ' ' OE1' ' A' ' 41' ' ' GLU . . . -70.39 -33.24 71.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.769 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 42' ' ' VAL . 53.4 p -63.65 -37.15 86.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.305 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.545 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -74.27 -23.34 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.4 -51.71 33.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.341 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 18.1 mp0 -69.7 -34.94 74.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.745 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' THR . 53.5 t -58.74 -55.35 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.337 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.3 tmm_? -53.9 -43.65 69.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 1.0 110.669 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.63 -43.41 72.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.321 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -65.41 -37.28 86.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.8 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 mt -96.65 -15.06 21.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.763 0.316 . . . . 1.0 111.697 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.85 25.04 35.84 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.505 -1.038 . . . . 1.0 110.505 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 87.6 m -78.36 146.07 34.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.8 m-20 -52.17 -41.98 63.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 67' ' ' GLU . 49.4 ttt180 -152.45 132.29 13.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.549 -0.86 . . . . 1.0 112.802 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 t -136.76 131.64 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 1.0 108.702 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -137.88 151.74 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.628 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.6 t -98.85 140.36 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 13.7 t80 -129.13 132.57 47.38 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.431 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.993 0.425 . . . . 1.0 111.206 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.9 t80 -100.47 128.49 46.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.696 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' OD2' ' CD2' ' A' ' 61' ' ' HIS . 40.9 m-20 -97.75 151.97 37.88 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.93 -22.45 30.43 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.029 2.486 . . . . 1.0 114.488 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HB2' ' ND1' ' A' ' 61' ' ' HIS . 96.2 mt-10 -91.16 -3.51 56.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 84' ' ' ALA . . . 106.07 -19.59 37.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.67 -0.776 . . . . 1.0 111.901 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 57.2 p-80 -80.49 151.45 29.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.404 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.45 162.85 26.14 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -134.57 154.99 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.015 0.436 . . . . 1.0 111.504 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 t -90.9 113.42 26.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.338 -0.986 . . . . 1.0 108.338 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 65' ' ' VAL . 11.3 t -112.28 -3.33 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -151.92 125.92 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.31 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 50' ' ' ARG . 79.1 tt0 -155.34 138.69 15.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 1.0 111.676 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.28 138.95 53.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -113.28 136.48 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.019 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.781 0.324 . . . . 1.0 111.35 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.492 HD12 HH22 ' A' ' 50' ' ' ARG . 17.6 mt -96.93 10.86 37.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.978 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.424 HD21 ' CB ' ' A' ' 67' ' ' GLU . 88.0 mt -55.93 129.16 38.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -4.04 86.54 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.847 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.79 147.36 27.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.3 0.55 . . . . 1.0 110.422 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.3 m -107.52 135.81 48.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.611 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.45 112.92 62.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.248 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.08 137.95 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.561 2.174 . . . . 1.0 111.464 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' A' ' 60' ' ' GLY . . . -60.52 -37.6 81.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 1.0 110.432 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.06 -16.33 0.47 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 84' ' ' ALA . 86.9 m-20 -71.76 -23.22 61.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.687 0.28 . . . . 1.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' PRO . 44.7 mt -116.83 101.57 53.44 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.542 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 87' ' ' ILE . 76.9 Cg_exo -45.63 -115.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.575 2.183 . . . . 1.0 111.653 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -157.0 -51.68 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.93 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -49.53 -39.97 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.608 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.85 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.669 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -63.8 -33.9 76.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.819 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.69 -37.15 86.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.947 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.44 -36.65 83.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.484 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -66.85 -35.0 79.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -77.24 -31.15 54.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.284 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' C ' HE22 ' A' ' 99' ' ' GLN . 79.1 mt -94.55 -38.99 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.58 -13.12 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.651 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.4 mp0 47.71 56.7 6.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.669 -0.813 . . . . 1.0 109.926 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.5 m -159.09 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.875 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -165.57 133.88 3.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.888 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 103' ' ' ILE . 78.2 t -145.68 156.3 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.703 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.513 ' CD1' ' NE2' ' A' ' 139' ' ' HIS . 62.4 mt -112.5 127.73 69.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.265 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.1 m -86.96 170.62 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -49.53 114.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.906 -1.043 . . . . 1.0 112.249 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG22 HG13 ' A' ' 140' ' ' VAL . 52.9 t -53.25 -21.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.512 -0.767 . . . . 1.0 110.674 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -80.36 -37.86 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.2 -14.55 2.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.18 0.514 . . . . 1.0 110.453 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 57.32 59.96 3.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.849 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 t -94.97 124.94 39.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -119.72 143.73 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.5 153.74 28.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.764 -1.107 . . . . 1.0 108.668 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.325 -0.484 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.468 -178.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.491 1.375 0 CA-C-O 120.835 0.264 . . . . 1.0 112.348 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.477 HG11 HG12 ' A' ' 103' ' ' ILE . 2.4 m -119.81 132.89 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -41.68 160.86 0.15 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.401 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.11 -23.67 45.66 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.159 2.573 . . . . 1.0 113.666 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.576 ' H ' ' CG ' ' A' ' 136' ' ' ASP . 7.3 t -58.89 -58.76 7.22 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 1.0 111.298 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.53 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 2.1 t60 -68.38 -27.23 66.06 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.616 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 136' ' ' ASP . 43.7 t -62.25 -56.95 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.608 0.595 . . . . 1.0 112.608 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -62.23 -38.78 90.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.376 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.428 ' O ' ' OG ' ' A' ' 145' ' ' SER . 74.8 t80 -47.9 -36.58 12.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 139' ' ' HIS . 49.9 mt -73.64 -42.73 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -58.24 -44.84 88.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 83.7 p -61.9 -17.73 57.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.687 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.3 mmm -100.48 -0.02 38.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 1.0 111.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.38 18.9 77.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.538 -1.025 . . . . 1.0 110.538 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.29 142.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.696 0.284 . . . . 1.0 110.298 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.2 -26.73 5.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 p -153.78 121.35 5.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.701 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 m -126.77 138.66 53.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 1.0 111.385 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.99 134.27 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.1 t -113.96 127.76 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.332 -0.547 . . . . 1.0 112.291 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.65 126.18 17.91 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -90.51 161.42 4.41 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.351 2.034 . . . . 1.0 113.704 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.506 HD23 ' HB1' ' A' ' 188' ' ' ALA . 24.6 mt -114.34 114.78 26.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.435 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 23.4 ptm -141.9 150.56 41.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.489 ' CE1' ' NE2' ' A' ' 159' ' ' HIS . 9.1 t-80 -125.7 126.29 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.809 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.489 ' NE2' ' CE1' ' A' ' 158' ' ' HIS . 84.0 m-70 58.34 -122.47 1.35 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.105 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.56 2.72 50.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.811 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.527 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.2 tt0 -106.22 145.97 30.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.755 1.02 . . . . 1.0 113.755 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 44.9 tp -101.26 123.8 45.94 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.527 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.7 m95 -101.87 -32.08 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -176.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.88 -167.75 22.77 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.719 -1.229 . . . . 1.0 112.398 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -143.7 122.94 12.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.417 -0.392 . . . . 1.0 111.664 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.487 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.4 tp -94.76 150.5 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.3 p -156.31 133.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.822 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 87.9 p -113.24 139.73 48.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.249 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.471 ' O ' ' CG2' ' A' ' 48' ' ' THR . 18.1 m80 -111.92 124.38 52.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -117.44 116.88 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.09 -15.33 62.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.747 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 . . . . . 0 C--N 1.326 -0.417 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.611 179.817 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.65 0.262 . . . . 1.0 111.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.7 -33.57 74.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.937 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.27 -45.57 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.633 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.33 -55.31 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.724 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.1 t -45.37 -39.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.638 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -74.56 -49.37 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -48.54 -36.59 15.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 190' ' ' GLN . 21.6 tp -70.69 -46.39 63.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.082 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.05 -46.83 75.38 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.506 ' HB1' HD23 ' A' ' 156' ' ' LEU . . . -58.43 -48.23 81.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.22 -36.66 75.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 186' ' ' LEU . 7.0 tt0 -68.61 -32.41 72.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.47 -48.54 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.342 -0.985 . . . . 1.0 108.342 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.4 p -50.12 -31.6 13.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mt -74.65 -34.9 35.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.27 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -43.71 79.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.95 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 196' ' ' ALA . 31.7 pt -63.17 -30.77 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -72.79 -50.12 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.411 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.8 -40.79 95.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.275 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -67.51 -31.39 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.385 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -57.78 -43.39 85.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.93 -36.17 48.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.965 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 83.1 p -52.17 -57.49 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.647 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.486 179.414 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.835 0.35 . . . . 1.0 110.546 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 66.6 t0 -48.06 -36.05 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -74.4 -49.95 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.808 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' THR . 96.3 mt -56.7 -44.98 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.022 0.439 . . . . 1.0 110.92 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.48 ' O ' ' OG1' ' A' ' 38' ' ' THR . 45.2 mt -58.4 -30.7 67.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.98 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 39' ' ' VAL . 54.3 mtp180 -66.81 -38.35 86.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.78 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.76 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 42' ' ' VAL . 76.9 p -68.67 -36.65 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.273 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -74.34 -23.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -72.76 -48.48 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.305 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.76 -34.96 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.742 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 38' ' ' THR . 77.7 t -59.98 -54.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.609 -0.269 . . . . 1.0 111.287 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.6 ttp180 -51.45 -43.43 62.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 1.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.17 -42.49 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.254 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.4 -37.19 86.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.793 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.2 mt -97.13 -13.93 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.864 -0.335 . . . . 1.0 111.701 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.65 25.59 22.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.6 p -81.29 152.21 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -48.71 -42.93 36.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.534 HH21 ' CG2' ' A' ' 148' ' ' VAL . 36.1 ptt180 -160.17 146.25 15.52 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.568 -0.853 . . . . 1.0 112.782 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 20.2 t -137.44 133.92 46.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.957 -1.019 . . . . 1.0 108.675 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HZ2' HD12 ' A' ' 77' ' ' LEU . 17.7 mttt -135.91 144.62 45.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.604 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 166' ' ' LEU . 48.9 t -99.43 141.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 18.1 t80 -129.78 130.62 45.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.509 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -111.86 154.11 25.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 1.0 111.239 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.66 136.89 40.73 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.661 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -97.17 150.94 37.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -41.54 -22.03 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.962 2.441 . . . . 1.0 114.468 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -103.85 9.0 37.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.185 0.439 . . . . 1.0 112.185 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 96.03 -15.81 62.29 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.598 -0.81 . . . . 1.0 111.966 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.585 ' O ' ' N ' ' A' ' 57' ' ' ASP . 35.6 m80 -77.52 151.27 34.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.78 163.56 25.54 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 p -135.63 158.85 43.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 1.0 111.495 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 104.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.78 -4.75 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -154.0 125.68 7.63 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.652 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 75.1 tt0 -154.45 138.99 16.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.158 0.504 . . . . 1.0 111.684 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.7 131.41 51.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.562 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 34.8 ptt180 -109.03 140.2 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.02 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 178.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.77 0.319 . . . . 1.0 111.291 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 35.0 mt -103.98 18.09 22.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.968 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 24.5 tp -65.21 131.03 45.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.6 88.77 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.843 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.78 151.01 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.352 0.576 . . . . 1.0 110.461 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 81' ' ' THR . 14.4 t -104.41 128.99 52.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -106.69 107.3 60.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.286 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -43.37 138.89 4.66 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.592 2.195 . . . . 1.0 111.522 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -61.55 -29.29 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.21 -17.71 0.24 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' N ' ' C ' ' A' ' 84' ' ' ALA . 89.2 m-20 -67.52 -16.55 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.665 0.269 . . . . 1.0 111.032 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' PRO . 16.1 mt -134.55 99.47 12.97 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.53 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 40.9 Cg_exo -39.6 -97.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.521 2.147 . . . . 1.0 111.704 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 22.8 pt-20 -165.71 -39.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.003 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -56.97 -43.35 81.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.625 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.12 -35.66 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.686 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -65.01 -32.23 73.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.806 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -64.6 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.541 ' CB ' ' NH2' ' A' ' 101' ' ' ARG . 10.0 mt -60.18 -38.31 82.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.546 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -66.56 -32.5 73.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.168 -0.679 . . . . 1.0 109.168 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -79.74 -27.53 40.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.172 -0.922 . . . . 1.0 111.305 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.85 -40.43 8.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -119.08 -11.57 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.422 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 4.0 mp0 44.77 64.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.669 -0.812 . . . . 1.0 109.91 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.1 p -168.8 107.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.905 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.542 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -159.15 134.4 8.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.895 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 103' ' ' ILE . 53.7 t -149.01 155.76 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.707 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.438 HG23 HG21 ' A' ' 135' ' ' VAL . 66.2 mt -111.9 129.14 67.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.238 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -87.28 169.58 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.16 115.79 1.58 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.975 -1.011 . . . . 1.0 112.274 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG23 ' CG1' ' A' ' 140' ' ' VAL . 13.4 p -51.24 -22.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.644 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -76.38 -38.83 55.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.822 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.87 19.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.234 0.54 . . . . 1.0 110.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 56.33 62.79 2.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.838 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 m -95.43 125.59 40.15 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.777 -1.564 . . . . 1.0 106.777 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -117.62 145.36 44.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.661 0.985 . . . . 1.0 113.661 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -111.97 148.8 33.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.77 -1.105 . . . . 1.0 108.62 177.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.438 -179.074 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 120.784 0.243 . . . . 1.0 112.422 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.63 125.44 71.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 178.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 138' ' ' CYS . 3.5 p30 -45.67 142.55 3.47 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.752 0.31 . . . . 1.0 111.317 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.8 -20.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.15 2.567 . . . . 1.0 113.634 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.5 t -61.59 -62.78 1.57 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.209 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -70.26 -24.61 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.631 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG1' HG23 ' A' ' 106' ' ' VAL . 61.4 t -60.6 -60.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.61 0.596 . . . . 1.0 112.61 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -61.12 -38.4 86.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -47.23 -36.64 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.9 mt -73.33 -43.65 60.39 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.22 -44.63 88.28 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.644 -0.873 . . . . 1.0 108.644 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -62.63 -19.0 63.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.691 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 23.2 mmm -101.27 -0.98 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 1.0 111.052 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.6 17.62 79.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.534 ' CG2' HH21 ' A' ' 50' ' ' ARG . 73.0 t -107.29 143.65 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.655 0.264 . . . . 1.0 110.335 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.7 -42.74 2.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.944 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.7 t -136.87 118.16 14.59 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.77 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.3 m -129.12 143.39 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.998 0.428 . . . . 1.0 111.405 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.0 mp -100.45 132.54 45.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.74 107.17 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.304 -0.558 . . . . 1.0 112.258 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.53 132.68 21.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -91.63 163.39 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.386 2.057 . . . . 1.0 113.701 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.5 mt -116.9 113.86 23.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.569 ' N ' ' OG ' ' A' ' 192' ' ' SER . 25.3 ptm -142.69 150.3 39.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 58.1 t-80 -125.66 124.49 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.897 -1.047 . . . . 1.0 108.842 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 79.5 t60 60.17 -122.04 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.165 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.618 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 41.3 tt0 -97.85 1.71 48.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.808 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.8 tt0 -106.43 144.24 33.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 tp -99.31 125.74 45.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 75.7 m95 -104.37 -34.84 8.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.5 -175.05 31.08 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.717 -1.23 . . . . 1.0 112.417 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -137.44 122.02 18.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.471 -0.365 . . . . 1.0 111.644 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 53' ' ' VAL . 47.1 tp -94.95 150.02 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.5 p -156.62 134.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.004 -0.678 . . . . 1.0 111.843 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 90.5 p -116.03 132.74 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -104.96 126.83 52.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 5.7 t-80 -118.8 115.35 24.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.79 63.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.799 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 21.6 mp0 . . . . . 0 C--N 1.326 -0.42 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.535 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.647 0.26 . . . . 1.0 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 184' ' ' VAL . 77.3 mm-40 -66.37 -28.88 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 1.0 110.902 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -69.98 -39.25 76.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.651 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -78.92 -54.19 6.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.618 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 184' ' ' VAL . 9.9 p -43.67 -42.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.669 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 185' ' ' GLN . 34.0 m -75.09 -48.36 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.578 ' N ' HG23 ' A' ' 184' ' ' VAL . 60.9 tt0 -48.26 -36.49 14.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 190' ' ' GLN . 24.1 tp -70.85 -45.72 63.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.023 -0.989 . . . . 1.0 109.088 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.08 -47.67 77.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.8 93.54 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -62.78 -37.12 85.42 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 186' ' ' LEU . 7.0 tt0 -66.89 -31.7 72.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.647 -0.871 . . . . 1.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.62 -46.79 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -50.8 -32.84 21.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.2 mt -74.73 -34.32 33.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.198 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.94 -43.53 78.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.984 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 196' ' ' ALA . 24.2 pt -63.06 -30.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.72 -53.47 7.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.392 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.84 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.224 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.05 77.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.7 -40.92 73.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.211 0.449 . . . . 1.0 112.211 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.0 tp -51.45 -34.65 36.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.928 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.2 p -48.3 -56.41 8.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.696 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.986 . . . . 1.0 110.482 179.507 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' A' ' 35' ' ' LEU . 6.7 tp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.362 . . . . 1.0 110.563 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.2 t0 -51.69 -33.24 33.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.728 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -75.98 -49.44 17.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.779 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 38' ' ' THR . 97.0 mt -55.38 -52.69 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 1.0 110.976 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.7 mt -56.36 -30.94 63.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.988 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.447 ' O ' HG12 ' A' ' 39' ' ' VAL . 67.9 ttp85 -64.6 -38.93 92.7 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.754 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.09 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.844 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 67.2 p -65.8 -37.4 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 1.0 112.311 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -74.58 -25.45 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.58 -43.17 23.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.283 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -72.24 -43.99 63.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.785 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 43' ' ' ARG . 7.2 p -61.69 -47.63 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.306 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG13 ' A' ' 42' ' ' VAL . 70.7 ttp85 -54.97 -44.21 74.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 1.0 110.689 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.82 60.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.351 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -70.18 -33.59 71.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.813 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -97.52 -18.96 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.759 0.314 . . . . 1.0 111.695 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.8 25.21 51.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 170' ' ' HIS . 91.7 m -77.36 144.01 38.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.981 -0.377 . . . . 1.0 109.981 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -52.83 -42.45 65.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.635 0.605 . . . . 1.0 112.635 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' NH1' ' OE2' ' A' ' 67' ' ' GLU . 2.9 mtt-85 -149.48 128.35 12.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.507 -0.877 . . . . 1.0 112.797 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 10.9 t -136.7 129.89 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.968 -1.015 . . . . 1.0 108.739 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -137.95 152.39 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.658 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 46.3 t -99.12 141.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.6 t80 -131.85 133.24 44.44 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.468 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -113.66 154.06 27.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 1.0 111.205 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -103.87 137.64 41.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.68 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.3 m-20 -101.75 154.95 36.97 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.54 -52.3 2.04 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.001 2.468 . . . . 1.0 114.481 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.12 -6.31 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.561 -0.456 . . . . 1.0 112.141 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.07 37.42 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.689 -0.767 . . . . 1.0 111.887 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 57' ' ' ASP . 72.8 m80 -77.56 149.29 34.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.444 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.47 161.06 24.95 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 155.48 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 1.0 111.559 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.44 108.68 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.5 t -108.89 -4.27 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.41 123.44 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.25 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.7 tt0 -151.84 136.62 17.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.155 0.502 . . . . 1.0 111.705 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.82 134.36 50.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.061 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -179.714 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.864 0.364 . . . . 1.0 111.284 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 32.6 mt -98.23 14.69 26.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.484 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.7 tp -64.53 131.79 48.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.61 88.15 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.781 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.81 150.21 24.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.344 0.572 . . . . 1.0 110.479 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 p -108.63 137.17 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.566 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -108.55 149.57 39.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.235 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 78.5 Cg_endo -80.12 136.66 11.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.493 2.129 . . . . 1.0 111.507 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.67 -35.05 75.28 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.81 -14.7 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . 47.7 p-10 -68.71 -19.61 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.624 0.249 . . . . 1.0 111.016 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.97 97.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.538 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 41.3 Cg_exo -39.18 -95.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.565 2.177 . . . . 1.0 111.683 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 41.8 tp10 -162.91 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.969 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -51.03 -40.9 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.646 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.48 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.726 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -64.7 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 1.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -65.21 -38.8 91.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.05 -36.95 75.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.549 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -68.7 -35.37 77.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -76.98 -32.08 56.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.24 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.553 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.7 mt -95.84 -39.24 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.41 -12.94 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.2 1.185 . . . . 1.0 114.2 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.574 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.8 mp0 47.17 48.12 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.0 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.6 t -149.87 108.45 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.912 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -160.91 130.9 5.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.84 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.2 p -150.06 155.96 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.683 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 135' ' ' VAL . 95.2 mt -114.32 131.18 67.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.245 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -87.99 171.13 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.028 0.751 . . . . 1.0 113.028 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -50.74 115.4 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.932 -1.031 . . . . 1.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.474 HG23 ' CG1' ' A' ' 140' ' ' VAL . 13.0 p -49.66 -19.74 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.642 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -76.76 -38.79 53.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.821 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.78 -8.94 5.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.167 0.508 . . . . 1.0 110.43 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 15.8 pt20 46.17 62.03 2.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.435 -0.802 . . . . 1.0 112.891 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -93.35 126.94 38.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.752 -1.573 . . . . 1.0 106.752 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -119.4 147.01 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.666 0.987 . . . . 1.0 113.666 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.634 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -111.44 149.32 31.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.789 -1.096 . . . . 1.0 108.636 178.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 113' ' ' ILE . 7.5 mt . . . . . 0 C--N 1.326 -0.438 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.445 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.634 ' C ' ' HG ' ' A' ' 112' ' ' SER . 49.6 Cg_endo . . . . . 0 N--CA 1.491 1.369 0 CA-C-O 120.83 0.262 . . . . 1.0 112.401 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -117.61 128.17 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 138' ' ' CYS . 4.5 p30 -45.03 140.77 3.41 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 1.0 111.376 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -37.91 -17.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 123.053 2.502 . . . . 1.0 113.748 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 136' ' ' ASP . 42.6 t -63.28 -62.21 1.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.267 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.407 ' CE1' ' CD1' ' A' ' 103' ' ' ILE . 51.7 t-80 -71.1 -25.06 62.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.667 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.474 ' CG1' HG23 ' A' ' 106' ' ' VAL . 65.2 t -58.36 -60.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -61.41 -37.45 83.52 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.394 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 61.1 t80 -46.17 -37.93 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.16 -43.4 64.68 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.36 -41.49 89.39 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.631 -0.878 . . . . 1.0 108.631 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -64.16 -22.18 66.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.441 -0.799 . . . . 1.0 109.642 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.598 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 70.9 mtp -97.97 2.09 48.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.101 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.97 19.44 78.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.6 -1.0 . . . . 1.0 110.6 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 78.9 t -110.19 145.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.679 0.276 . . . . 1.0 110.276 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.3 -23.9 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.027 0.38 . . . . 1.0 112.027 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -152.36 120.21 6.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.747 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 p -128.17 137.58 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 1.0 111.419 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.0 131.83 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.4 t -111.95 130.45 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.293 -0.563 . . . . 1.0 112.306 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.95 128.59 18.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.88 166.28 3.23 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.389 2.059 . . . . 1.0 113.733 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.59 115.35 24.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.605 -1.257 . . . . 1.0 107.605 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.448 ' H ' ' HB2' ' A' ' 192' ' ' SER . 23.8 ptm -142.3 151.61 42.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.44 0.638 . . . . 1.0 112.684 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.469 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 48.9 t-80 -128.31 124.56 36.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.913 -1.039 . . . . 1.0 108.899 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.498 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 62.2 t60 61.79 -123.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.107 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.498 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 99.0 mm-40 -97.63 3.55 50.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.519 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -107.0 144.83 33.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.683 0.994 . . . . 1.0 113.683 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.5 tp -98.78 125.7 44.21 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.519 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 73.9 m95 -105.21 -36.83 7.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.44 -173.25 23.91 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.694 -1.241 . . . . 1.0 112.39 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -139.57 120.19 14.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.441 -0.379 . . . . 1.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.455 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.8 tp -94.73 149.8 20.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.5 p -156.42 134.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.097 -0.641 . . . . 1.0 111.863 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -114.45 137.86 51.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.223 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 30.5 m-70 -111.96 124.69 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 1.0 112.663 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.506 ' CD2' HG23 ' A' ' 48' ' ' THR . 71.5 m80 -116.42 121.33 41.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.51 13.38 6.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.785 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.579 -179.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.637 0.256 . . . . 1.0 111.299 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 184' ' ' VAL . 50.8 tp10 -61.08 -33.41 73.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.96 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.19 -49.51 75.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.62 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.0 -52.61 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.652 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.8 t -44.98 -39.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 187' ' ' LEU . 83.7 t -73.32 -49.82 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -45.99 -32.02 2.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 tp -68.18 -48.15 66.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.119 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 184' ' ' VAL . 92.7 mt -52.1 -46.3 65.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.94 93.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.423 -0.955 . . . . 1.0 108.423 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.77 -38.89 92.79 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -66.19 -31.16 71.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.74 -46.62 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 157' ' ' MET . 42.5 p -51.24 -32.04 22.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.68 -34.59 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.132 -0.94 . . . . 1.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.51 -43.66 80.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.895 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 196' ' ' ALA . 21.0 pt -62.7 -29.57 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.437 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -74.92 -52.37 11.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.69 -42.67 97.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.82 72.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.36 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.02 -43.13 81.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.4 mp -52.44 -33.51 44.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.995 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -54.56 -58.61 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.398 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.838 0.351 . . . . 1.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -48.0 -35.49 11.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -75.14 -49.88 18.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.802 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 38' ' ' THR . 24.4 mm -56.12 -48.54 78.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.141 0.496 . . . . 1.0 110.959 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' OG1' ' A' ' 38' ' ' THR . 32.5 mt -57.42 -29.25 63.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.955 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' HG12 ' A' ' 39' ' ' VAL . 36.4 ttm180 -66.43 -39.82 89.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.447 -0.501 . . . . 1.0 109.739 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.77 -30.04 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.767 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 42' ' ' VAL . 75.1 p -68.48 -36.02 78.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.283 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -72.72 -25.48 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.16 0.429 . . . . 1.0 112.16 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.32 -42.67 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.267 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.95 -48.29 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.804 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 43' ' ' ARG . 34.4 m -56.44 -49.22 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.352 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG23 ' A' ' 42' ' ' VAL . 70.8 ttp85 -51.01 -43.5 60.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 1.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.8 -40.79 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.33 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.59 -35.81 79.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.758 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -96.75 -15.76 21.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 1.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.57 25.23 34.54 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 170' ' ' HIS . 69.9 m -78.63 145.89 34.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -53.37 -44.46 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -148.28 132.44 17.35 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 119.563 -0.855 . . . . 1.0 112.798 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.4 t -136.49 130.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 114.937 -1.029 . . . . 1.0 108.777 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -136.56 148.32 47.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.604 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 47.6 t -98.57 140.72 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.923 -0.769 . . . . 1.0 108.923 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.5 t80 -128.92 133.04 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.464 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -106.62 141.96 37.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.979 0.419 . . . . 1.0 111.234 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.452 ' CE2' ' NH1' ' A' ' 92' ' ' ARG . 64.6 t80 -97.99 124.55 42.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.696 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' HIS . 7.6 t70 -95.22 138.72 21.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -40.76 -29.68 0.46 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.931 2.421 . . . . 1.0 114.564 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -84.44 -4.56 58.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 104.8 -17.53 45.38 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.929 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 57' ' ' ASP . 75.6 m80 -80.25 149.27 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.376 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.1 162.98 26.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -134.14 156.15 48.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 1.0 111.504 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.4 t -88.39 108.56 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.54 -4.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.42 124.14 7.25 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.301 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 71.2 tt0 -150.69 138.5 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.195 0.521 . . . . 1.0 111.69 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.08 128.02 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.738 -0.838 . . . . 1.0 108.738 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -102.68 137.41 40.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.991 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.733 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.489 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.814 0.34 . . . . 1.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.602 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -108.11 12.95 26.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.991 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.9 tp -64.08 132.04 49.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.28 -4.3 84.01 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.42 -0.809 . . . . 1.0 112.873 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.84 151.45 23.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.357 0.579 . . . . 1.0 110.383 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.9 m -108.04 134.81 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.635 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -108.52 150.9 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.249 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.37 140.6 15.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -63.73 -33.86 76.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 1.0 110.463 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.2 -16.67 0.17 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' ALA . 11.8 p-10 -55.65 -11.98 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.671 0.272 . . . . 1.0 111.037 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -151.75 146.45 18.76 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.536 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 93.4 Cg_endo -75.7 -92.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.556 2.17 . . . . 1.0 111.675 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' OE2' ' NH2' ' A' ' 92' ' ' ARG . 46.7 tp10 -167.58 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.2 pt-20 -55.23 -41.74 72.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -72.07 -37.64 69.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.76 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.539 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 54.0 ttp180 -62.58 -33.06 74.2 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.776 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -64.05 -37.42 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.915 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.63 -35.87 77.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.589 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.3 -36.94 77.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -75.43 -30.87 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.255 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.54 -38.86 10.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.804 1.039 . . . . 1.0 113.804 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.92 -13.08 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.262 1.208 . . . . 1.0 114.262 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.659 ' O ' HG13 ' A' ' 100' ' ' VAL . 9.0 mp0 47.87 56.92 6.55 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.689 -0.804 . . . . 1.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.3 m -159.41 113.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.913 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -165.99 135.77 3.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.896 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.3 p -148.21 156.44 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 1.0 109.705 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.594 HG23 HG11 ' A' ' 135' ' ' VAL . 28.2 mt -109.78 128.5 65.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.4 t -83.84 165.8 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.999 0.74 . . . . 1.0 112.999 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.507 ' H ' HG12 ' A' ' 104' ' ' VAL . 63.1 t0 -51.46 118.63 3.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.291 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.446 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.3 p -51.43 -25.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.656 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -77.18 -38.91 50.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.1 43.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.129 0.49 . . . . 1.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 57.73 60.26 2.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t -94.39 124.82 38.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -119.69 143.85 47.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -112.51 152.64 28.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.756 -1.111 . . . . 1.0 108.627 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 120.492 -0.483 . . . . 1.0 111.448 -178.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.492 1.439 0 CA-C-O 120.811 0.255 . . . . 1.0 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.594 HG11 HG23 ' A' ' 103' ' ' ILE . 1.4 p -118.17 129.83 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.505 ' N ' ' OG ' ' A' ' 112' ' ' SER . 6.9 t0 -45.99 138.53 5.77 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.729 0.3 . . . . 1.0 111.33 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -39.08 -35.79 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.068 2.512 . . . . 1.0 113.62 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 t -43.53 -63.71 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.261 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.78 -22.49 62.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.678 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' A' ' 106' ' ' VAL . 92.9 t -61.67 -55.2 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.562 0.578 . . . . 1.0 112.562 -177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.48 -40.14 96.3 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.378 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.79 -35.57 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.64 -42.79 60.96 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -58.68 -43.73 90.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.1 m -62.42 -19.37 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.653 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.6 mmm -99.97 0.87 41.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.088 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.06 18.55 78.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.8 144.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.661 0.267 . . . . 1.0 110.351 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.43 -38.57 2.99 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.087 0.403 . . . . 1.0 112.087 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.1 p -138.4 121.26 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.721 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -130.92 141.46 50.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 1.0 111.332 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.66 131.62 55.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.52 HG12 HG23 ' A' ' 167' ' ' VAL . 20.1 m -116.18 140.04 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.264 -0.575 . . . . 1.0 112.239 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.9 t -131.91 132.66 23.33 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -89.92 159.87 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.326 2.018 . . . . 1.0 113.666 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 34.3 mt -114.89 117.02 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.2 ptm -140.33 148.07 40.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 81.5 t60 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.826 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 22.1 m-70 58.38 -125.44 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.148 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -100.67 6.11 43.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.761 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 11.5 pt-20 -111.98 156.32 22.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.728 1.01 . . . . 1.0 113.728 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.6 tp -102.04 128.1 48.63 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.515 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 29.7 m95 -104.58 -34.74 8.09 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.15 31.06 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.712 -1.232 . . . . 1.0 112.383 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -137.41 123.11 19.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.446 -0.377 . . . . 1.0 111.643 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.65 149.24 21.44 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.52 HG23 HG12 ' A' ' 153' ' ' VAL . 12.1 p -152.69 131.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.1 -0.64 . . . . 1.0 111.899 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 48' ' ' THR . 7.6 t -114.91 135.18 54.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.258 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 11.7 m-70 -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.63 ' CD2' HG23 ' A' ' 48' ' ' THR . 72.3 m80 -117.45 119.88 36.42 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.11 24.58 1.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.822 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 1.3 pm0 . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.956 -0.298 . . . . 1.0 110.627 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.585 0.231 . . . . 1.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 184' ' ' VAL . 76.6 mm-40 -64.56 -31.86 73.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 1.0 110.953 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.13 -38.52 91.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.614 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.67 -51.87 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.869 -0.332 . . . . 1.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -42.23 -42.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.689 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 185' ' ' GLN . 26.9 m -74.47 -45.94 44.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.523 ' N ' HG23 ' A' ' 184' ' ' VAL . 56.0 tt0 -50.53 -32.87 19.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.063 -1.088 . . . . 1.0 108.063 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 16.8 tp -73.0 -52.65 13.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.089 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.17 -46.01 65.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.19 80.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -61.23 -38.44 86.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 44.5 tt0 -64.9 -33.11 75.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.4 -45.74 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.376 -0.972 . . . . 1.0 108.376 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -52.46 -36.03 53.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -68.61 -37.0 77.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.272 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.61 -41.01 80.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -55.52 -48.43 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.363 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.44 -46.54 88.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.264 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.41 -33.08 74.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 1.0 111.398 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -55.97 -41.13 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 26.0 tp -53.18 -37.29 61.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.8 m -48.94 -57.75 5.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.67 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.7 mp . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.453 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.805 0.336 . . . . 1.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.22 -32.4 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.742 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.8 -48.73 20.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.792 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 38' ' ' THR . 25.6 mm -55.1 -53.3 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 1.0 110.945 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.6 mt -56.44 -30.21 62.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.99 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 39' ' ' VAL . 59.9 ttp180 -64.49 -39.94 94.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.384 -0.526 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.12 67.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.774 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.5 p -67.49 -36.46 81.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.314 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.603 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -73.65 -25.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 71.5 mm-40 -79.6 -43.8 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.773 -0.371 . . . . 1.0 111.318 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.88 -44.6 80.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.807 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 43' ' ' ARG . 36.0 m -59.42 -46.56 92.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.323 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 47' ' ' GLY . 6.2 ttm180 -50.76 -45.03 58.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 1.0 110.692 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.78 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.254 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.95 -37.86 82.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.852 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.37 -18.69 18.96 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.674 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.76 25.49 56.0 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 50.0 m -78.07 143.23 37.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.38 -39.97 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.409 ' NH2' ' CB ' ' A' ' 69' ' ' ARG . 13.3 mtt85 -148.48 124.19 10.5 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.822 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.5 t -132.63 128.48 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.748 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HZ2' HD12 ' A' ' 77' ' ' LEU . 34.9 mttt -136.64 148.78 47.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.616 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.587 HG22 ' CD1' ' A' ' 166' ' ' LEU . 59.9 t -98.39 140.96 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.405 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 20.1 t80 -130.6 132.3 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.433 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.431 HH12 ' CG2' ' A' ' 195' ' ' ILE . 60.4 ttt85 -110.84 149.84 30.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.035 0.445 . . . . 1.0 111.195 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.14 133.95 46.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.691 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 61' ' ' HIS . 11.6 m-20 -99.26 153.51 37.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -38.68 -51.08 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 122.96 2.44 . . . . 1.0 114.53 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -70.96 -6.43 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 106.84 -8.23 39.27 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.684 -0.77 . . . . 1.0 111.922 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ASP . 70.0 m80 -78.23 151.03 33.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.424 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.59 163.61 25.78 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -135.87 157.72 46.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.999 0.428 . . . . 1.0 111.528 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.6 107.75 17.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 65' ' ' VAL . 21.6 t -107.77 -5.19 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.71 123.2 7.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.274 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 55.1 tt0 -148.45 136.99 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.152 0.501 . . . . 1.0 111.734 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.62 129.03 48.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' CB ' ' NH2' ' A' ' 50' ' ' ARG . 30.8 ptt-85 -107.01 137.98 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.292 -0.563 . . . . 1.0 112.052 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 178.518 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.796 0.332 . . . . 1.0 111.342 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.61 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 42.7 mt -110.81 19.43 18.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.0 tp -66.47 130.47 43.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.35 87.2 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.41 -0.814 . . . . 1.0 112.858 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.3 149.23 25.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.32 0.56 . . . . 1.0 110.429 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.1 m -106.89 134.62 49.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.589 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -108.78 148.9 38.75 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.215 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.73 136.17 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.572 2.182 . . . . 1.0 111.502 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -58.28 -30.58 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.817 0.341 . . . . 1.0 110.413 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.61 -16.63 0.06 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.227 -0.749 . . . . 1.0 111.227 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 84' ' ' ALA . 51.4 t0 -62.07 -21.84 65.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.701 0.286 . . . . 1.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.0 mt -143.35 104.71 5.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.529 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 47.9 Cg_exo -40.38 -84.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.56 2.173 . . . . 1.0 111.629 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.486 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 46.2 tp10 -172.41 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.53 -43.31 93.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.626 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.64 -36.78 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.521 -0.308 . . . . 1.0 111.702 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 65.4 ttp85 -64.6 -32.75 74.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.774 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -64.42 -37.19 86.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.857 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.11 -36.7 80.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.532 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -67.39 -33.98 76.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -74.14 -33.22 63.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.263 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.492 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.2 mt -94.82 -38.11 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.82 -13.56 9.07 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 114.228 1.196 . . . . 1.0 114.228 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.575 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.4 mp0 47.06 49.7 14.72 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.665 -0.814 . . . . 1.0 109.864 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.4 109.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 120.314 -0.554 . . . . 1.0 111.878 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.02 134.88 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.865 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.4 p -151.05 156.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.724 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.544 HG12 HG21 ' A' ' 135' ' ' VAL . 27.8 mt -109.96 128.77 65.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.263 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.69 169.34 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.972 0.73 . . . . 1.0 112.972 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -49.52 113.73 0.89 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.289 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.482 HG13 ' CG1' ' A' ' 140' ' ' VAL . 52.9 t -51.37 -18.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -77.95 -38.81 44.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.795 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.75 -7.19 3.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.131 0.491 . . . . 1.0 110.384 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 18.2 pt20 45.67 62.77 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.494 -0.776 . . . . 1.0 112.881 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 m -93.91 127.83 39.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -119.79 144.73 47.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.708 1.003 . . . . 1.0 113.708 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.655 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -108.84 150.43 27.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.715 -1.129 . . . . 1.0 108.619 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.3 pt . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.457 -179.572 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.655 ' C ' ' HG ' ' A' ' 112' ' ' SER . 56.1 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.83 0.263 . . . . 1.0 112.356 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.544 HG21 HG12 ' A' ' 103' ' ' ILE . 89.4 t -112.11 123.87 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.533 ' N ' ' OG ' ' A' ' 112' ' ' SER . 5.6 t70 -44.83 139.23 3.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.293 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.67 -25.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.091 2.527 . . . . 1.0 113.632 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.8 t -49.58 -61.97 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.206 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -72.94 -23.21 60.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.68 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.482 ' CG1' HG13 ' A' ' 106' ' ' VAL . 72.5 t -55.55 -60.96 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -63.31 -39.46 94.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.364 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 83.1 t80 -48.21 -40.01 22.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.27 -44.8 64.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -56.2 -41.77 76.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -62.65 -22.07 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.622 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.588 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 46.1 mtp -97.25 -1.48 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 20.27 73.8 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.17 143.49 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.277 . . . . 1.0 110.344 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.38 -28.2 4.69 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -151.44 120.2 6.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.811 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 72.9 m -128.65 142.46 51.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 1.0 111.46 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tp -100.07 132.43 45.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.91 130.39 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.305 -0.558 . . . . 1.0 112.242 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 19.8 t -135.71 131.35 19.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.247 -1.02 . . . . 1.0 108.247 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.29 163.01 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.389 2.06 . . . . 1.0 113.69 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.2 mt -115.77 113.93 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.4 ptm -142.0 152.31 43.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.751 0.649 . . . . 1.0 112.751 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -128.04 123.74 35.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 1.0 108.88 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.451 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 17.6 t-80 61.98 -123.64 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.1 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.451 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 15.3 mm100 -97.39 3.3 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.843 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.4 tt0 -106.56 144.96 32.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.75 1.018 . . . . 1.0 113.75 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 48.2 tp -100.18 125.05 46.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.9 m95 -103.76 -33.45 8.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.58 0.956 . . . . 1.0 113.58 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.64 -175.99 32.25 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.668 -1.253 . . . . 1.0 112.371 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 mt -135.06 123.12 22.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.447 -0.377 . . . . 1.0 111.617 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.587 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.4 p -155.45 132.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.825 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.5 p -114.2 133.69 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.174 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.472 ' O ' ' CG2' ' A' ' 48' ' ' THR . 46.4 m80 -106.05 122.7 46.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 4.7 t-80 -118.08 121.52 40.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.1 -17.36 62.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.618 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.726 0.298 . . . . 1.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -73.18 -37.24 66.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 1.0 110.941 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.6 -43.97 93.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.625 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -64.45 -51.55 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 1.0 111.721 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.8 t -44.25 -42.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.669 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.09 -50.5 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -49.46 -33.44 14.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 190' ' ' GLN . 6.5 tt -74.55 -48.15 28.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.032 -0.985 . . . . 1.0 109.069 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -53.43 -46.52 69.86 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.3 80.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -60.58 -38.37 84.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 186' ' ' LEU . 57.4 tp60 -65.85 -33.4 75.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.3 -47.13 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.1 p -52.64 -35.01 54.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.13 -35.47 71.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.326 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.2 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.431 ' CG2' HH12 ' A' ' 55' ' ' ARG . 64.3 mt -56.49 -45.5 82.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.6 -49.7 67.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.54 -46.3 88.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.24 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -32.2 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 1.0 111.394 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.82 -43.03 80.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 37.6 tp -53.64 -37.64 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.935 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 32.0 t -54.5 -61.84 2.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.657 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.499 179.728 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.781 0.325 . . . . 1.0 110.496 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -48.67 -35.1 13.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.753 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -74.74 -50.57 16.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.798 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -56.78 -46.49 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.124 0.488 . . . . 1.0 110.945 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' O ' ' OG1' ' A' ' 38' ' ' THR . 22.3 mt -58.71 -27.38 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.968 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 39' ' ' VAL . 70.9 mtp85 -69.92 -37.73 76.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.42 -0.512 . . . . 1.0 109.807 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.1 66.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.751 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 57.2 p -67.98 -37.14 81.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 1.0 112.324 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p -72.08 -24.91 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.83 -43.09 23.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.28 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -70.28 -48.34 57.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.78 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 43' ' ' ARG . 14.4 p -57.67 -47.66 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.366 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG13 ' A' ' 42' ' ' VAL . 66.2 ttt-85 -51.79 -44.09 63.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 1.0 110.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.39 -40.81 65.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.12 -36.45 83.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.838 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.44 -14.67 21.03 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.722 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 26.06 30.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' ' CE1' ' A' ' 170' ' ' HIS . 49.6 m -76.99 143.66 39.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.8 p30 -53.84 -41.57 67.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.602 0.593 . . . . 1.0 112.602 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 22.2 ttt-85 -151.31 131.85 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 119.612 -0.835 . . . . 1.0 112.826 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 9.0 t -138.66 132.94 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.759 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.3 pttm -137.13 149.27 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.628 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 56.0 t -96.41 139.18 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.3 t80 -128.36 132.16 48.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.43 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -107.86 143.25 36.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 1.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.8 t80 -99.56 125.19 45.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.687 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 2.5 m-20 -92.07 152.04 42.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.58 -21.43 38.51 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.038 2.492 . . . . 1.0 114.474 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.43 -0.93 57.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.8 -16.58 54.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.716 -0.754 . . . . 1.0 111.901 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 74.5 m80 -80.4 148.91 30.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.41 160.04 24.98 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p -133.19 154.2 50.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.99 0.424 . . . . 1.0 111.503 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 t -91.78 113.29 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.13 -2.95 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.96 128.33 9.91 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.324 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CB ' HD21 ' A' ' 78' ' ' LEU . 88.7 tt0 -156.14 138.82 15.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.162 0.506 . . . . 1.0 111.722 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.94 140.54 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.809 -0.812 . . . . 1.0 108.809 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 23.5 mtt85 -116.77 137.5 52.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.352 -0.539 . . . . 1.0 112.104 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.741 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.516 ' CB ' ' HE ' ' A' ' 69' ' ' ARG . 4.9 p . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.825 0.345 . . . . 1.0 111.336 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.549 HD12 ' NH2' ' A' ' 50' ' ' ARG . 24.0 mt -109.53 9.19 25.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.007 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD21 ' CB ' ' A' ' 67' ' ' GLU . 89.4 mt -56.11 129.04 38.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.21 -6.53 81.41 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.468 -0.787 . . . . 1.0 112.861 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.92 147.24 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.348 0.574 . . . . 1.0 110.482 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.5 m -108.8 137.46 46.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.58 149.58 39.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.213 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.8 136.23 11.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.583 2.189 . . . . 1.0 111.449 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -61.23 -32.06 71.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.818 0.342 . . . . 1.0 110.429 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.08 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.5 m-20 -61.11 -24.96 66.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.72 0.295 . . . . 1.0 111.035 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 pt -137.32 143.96 43.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.52 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 96.4 Cg_endo -76.39 -89.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.581 2.187 . . . . 1.0 111.608 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.512 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 83.3 tt0 -170.01 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.957 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 19.6 pt-20 -59.26 -40.47 86.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.586 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -73.39 -38.28 65.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.703 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.675 HH12 ' NH2' ' A' ' 96' ' ' ARG . 66.9 ttp85 -61.89 -32.89 73.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 1.0 110.808 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -64.61 -36.77 85.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.938 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.91 -36.36 79.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.493 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.55 -38.45 77.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.675 ' NH2' HH12 ' A' ' 92' ' ' ARG . 28.1 ttm180 -74.03 -33.15 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.159 -0.928 . . . . 1.0 111.197 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.541 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.0 mt -94.58 -37.73 11.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.789 1.033 . . . . 1.0 113.789 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.12 -12.65 9.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.274 1.213 . . . . 1.0 114.274 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.548 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.3 mp0 46.99 47.63 15.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.958 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.51 109.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.413 -0.515 . . . . 1.0 111.946 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.58 130.72 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.798 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.14 159.05 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.719 HG12 HG21 ' A' ' 135' ' ' VAL . 4.7 mt -110.37 128.45 66.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.004 0.431 . . . . 1.0 110.257 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.47 HG21 ' OG ' ' A' ' 110' ' ' SER . 5.2 m -86.96 171.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.021 0.749 . . . . 1.0 113.021 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -50.32 115.0 1.25 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.999 -1.0 . . . . 1.0 112.192 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.491 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.3 p -52.55 -27.15 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.69 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.08 -40.27 62.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.85 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.15 -15.05 3.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 1.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.693 ' NE2' HH21 ' A' ' 111' ' ' ARG . 6.9 tp60 56.81 60.81 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.491 -0.777 . . . . 1.0 112.847 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.47 ' OG ' HG21 ' A' ' 104' ' ' VAL . 2.3 m -95.62 125.29 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.693 HH21 ' NE2' ' A' ' 109' ' ' GLN . 87.9 mtt-85 -118.08 144.92 45.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -109.46 145.46 36.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.767 -1.106 . . . . 1.0 108.646 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.441 -178.444 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 N--CA 1.491 1.368 0 CA-C-O 120.855 0.273 . . . . 1.0 112.38 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.719 HG21 HG12 ' A' ' 103' ' ' ILE . 96.3 t -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -45.03 157.27 0.34 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.401 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.94 -9.92 15.91 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.135 2.557 . . . . 1.0 113.711 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -66.56 -63.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.258 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.486 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 41.5 t60 -71.64 -25.41 62.13 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.656 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 136' ' ' ASP . 92.4 t -61.2 -58.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.86 -37.9 89.09 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.419 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.438 ' O ' ' OG ' ' A' ' 145' ' ' SER . 80.5 t80 -48.8 -35.28 14.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.445 HD11 ' NE2' ' A' ' 139' ' ' HIS . 49.8 mt -73.45 -43.25 60.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -58.73 -44.31 90.41 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 96.9 p -62.51 -18.11 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.716 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.8 mmm -100.89 0.57 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.93 19.05 78.13 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.605 HG21 ' HD1' ' A' ' 169' ' ' HIS . 97.8 t -108.13 143.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.697 0.284 . . . . 1.0 110.292 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.78 -32.15 5.23 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.975 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.8 m -143.79 122.45 12.57 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.746 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 p -126.86 131.7 51.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 1.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -97.0 131.43 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.95 131.13 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.32 -0.552 . . . . 1.0 112.304 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.7 t -135.93 131.36 18.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.199 -1.038 . . . . 1.0 108.199 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -93.78 162.41 2.26 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.424 2.083 . . . . 1.0 113.706 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.5 mt -115.55 113.86 24.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.3 ptm -140.92 150.19 42.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 71.9 t60 -122.09 123.22 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.933 -1.03 . . . . 1.0 108.878 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 45.8 m-70 57.4 -118.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.12 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -98.12 1.87 48.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 143.75 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.7 tp -99.51 124.43 44.68 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.508 -1.293 . . . . 1.0 107.508 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 65.5 m95 -103.24 -32.18 9.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.575 0.954 . . . . 1.0 113.575 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.81 -173.06 32.05 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 119.701 -1.238 . . . . 1.0 112.39 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.6 mt -136.22 122.81 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.443 -0.379 . . . . 1.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 53' ' ' VAL . 17.9 tp -95.33 149.35 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.464 HG11 ' NZ ' ' A' ' 52' ' ' LYS . 11.0 p -155.15 134.52 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.867 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.1 m -115.73 139.02 50.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.22 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.605 ' HD1' HG21 ' A' ' 148' ' ' VAL . 18.9 m-70 -110.64 123.97 51.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.542 ' CE1' ' OG1' ' A' ' 48' ' ' THR . 84.8 m-70 -117.97 113.86 22.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.92 -22.71 59.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.777 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.553 -179.439 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.626 0.25 . . . . 1.0 111.305 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.52 -32.61 68.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 1.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.96 -35.8 81.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.667 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.69 -53.17 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.718 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 76.2 t -41.82 -42.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.589 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 185' ' ' GLN . 29.1 m -74.67 -45.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.511 ' N ' HG23 ' A' ' 184' ' ' VAL . 53.4 tt0 -52.91 -31.5 40.21 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 190' ' ' GLN . 39.3 tp -75.84 -56.56 4.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.097 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.0 mt -51.04 -45.42 61.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.43 76.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.361 -0.978 . . . . 1.0 108.361 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -61.11 -39.02 88.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 186' ' ' LEU . 46.8 tp60 -64.44 -33.37 75.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.593 -0.892 . . . . 1.0 108.593 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.75 -46.78 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.0 p -53.14 -33.79 53.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 mt -70.41 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.114 -0.948 . . . . 1.0 110.174 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.48 82.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.871 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.5 mt -55.74 -48.26 78.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.14 66.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.403 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.82 -46.54 87.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.294 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -33.14 75.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.6 tp -53.07 -38.89 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.5 t -47.67 -58.41 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.638 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.955 -1.022 . . . . 1.0 110.426 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.553 ' CD2' HD11 ' A' ' 35' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 1.0 110.52 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 2.3 p30 -67.12 -31.09 71.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 79.9 mt-30 -74.53 -49.06 23.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.754 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.28 -48.01 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 1.0 110.954 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 31' ' ' LEU . 62.7 mt -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.984 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 39' ' ' VAL . 78.2 mtm180 -65.32 -39.88 93.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.378 -0.529 . . . . 1.0 109.835 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.47 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.768 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.722 ' O ' HG23 ' A' ' 42' ' ' VAL . 73.0 p -67.56 -35.97 80.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 1.0 112.303 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -74.69 -24.69 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -178.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.71 -47.25 60.78 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.298 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.31 -32.37 64.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.828 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 38' ' ' THR . 62.0 t -62.99 -55.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.298 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.6 tmm_? -54.22 -43.77 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 1.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -40.68 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.314 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -67.82 -36.08 79.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.826 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.5 mt -96.88 -18.65 19.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.756 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.94 25.19 56.05 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -79.86 147.26 31.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -52.43 -41.48 63.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.708 HH22 ' NE ' ' A' ' 69' ' ' ARG . 84.1 mtt-85 -151.15 128.83 11.52 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.55 -0.86 . . . . 1.0 112.818 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 6.2 t -134.35 128.24 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.771 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.556 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 20.9 pttm -138.65 153.54 48.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.662 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.481 HG22 ' CD1' ' A' ' 166' ' ' LEU . 48.2 t -98.36 139.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -127.14 130.23 49.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.609 HH12 HD12 ' A' ' 195' ' ' ILE . 16.6 mmm180 -110.68 149.64 30.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.007 0.432 . . . . 1.0 111.156 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.87 138.97 38.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -104.12 153.35 38.98 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 109.392 -0.596 . . . . 1.0 109.392 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -39.18 -51.61 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 123.015 2.477 . . . . 1.0 114.473 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.54 -4.76 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 105.61 -8.5 43.68 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.693 -0.765 . . . . 1.0 111.944 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' A' ' 57' ' ' ASP . 75.3 m80 -76.97 149.2 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.378 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.19 161.78 25.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -135.9 157.47 46.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 1.0 111.524 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 80' ' ' LEU . 4.3 p -96.87 114.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.39 3.13 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.102 0.408 . . . . 1.0 112.102 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.61 127.16 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.274 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.524 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 79.8 tt0 -156.69 138.87 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.194 0.521 . . . . 1.0 111.683 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.57 134.78 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.708 ' NE ' HH22 ' A' ' 50' ' ' ARG . 10.5 mtp180 -104.08 134.57 47.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.05 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 178.226 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.792 0.329 . . . . 1.0 111.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.745 ' O ' HG11 ' A' ' 64' ' ' VAL . 25.5 mt -113.6 17.37 18.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.954 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 28.0 tp -66.79 130.72 44.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.585 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 85.56 -1.39 88.29 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.478 -0.783 . . . . 1.0 112.807 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.817 ' O ' HG12 ' A' ' 64' ' ' VAL . 86.0 mt -87.09 149.9 24.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.407 0.604 . . . . 1.0 110.451 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 81' ' ' THR . 13.7 t -104.86 131.15 52.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.629 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -106.09 106.35 56.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.303 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -43.34 139.17 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.562 2.175 . . . . 1.0 111.511 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.44 -32.09 69.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.942 0.401 . . . . 1.0 110.503 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.48 -18.01 0.1 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.25 -0.74 . . . . 1.0 111.25 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 60.1 t0 -64.28 -19.2 65.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.624 0.25 . . . . 1.0 111.075 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mt -138.06 133.26 17.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.515 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.71 -94.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.525 2.15 . . . . 1.0 111.643 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.17 -38.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.994 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.48 -42.73 71.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.576 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.9 71.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.75 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -62.81 -33.43 75.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.747 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -64.15 -38.74 92.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.16 -37.32 79.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 1.0 111.536 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -67.99 -34.65 76.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.77 -28.9 50.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.12 -0.946 . . . . 1.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -94.69 -39.59 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.06 -10.16 8.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.419 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 3.7 mp0 45.74 58.93 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.621 -0.832 . . . . 1.0 109.942 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.9 p -163.83 114.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -168.38 136.87 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.824 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.3 p -152.08 157.21 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.677 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.472 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 71.3 mt -109.77 130.07 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.262 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.601 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.6 p -85.96 168.56 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.601 ' N ' HG22 ' A' ' 104' ' ' VAL . 60.0 m-20 -48.12 114.73 0.99 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.204 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.492 HG13 ' CG1' ' A' ' 140' ' ' VAL . 41.4 t -51.86 -21.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.697 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -78.18 -37.91 44.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.34 -16.49 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.17 0.509 . . . . 1.0 110.365 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 56.43 63.03 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 1.0 112.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.402 ' OG ' ' CG1' ' A' ' 104' ' ' VAL . 80.0 p -96.31 124.3 40.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -117.17 145.05 44.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 1.5 t -108.06 144.15 35.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.713 -1.13 . . . . 1.0 108.618 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--N 1.325 -0.47 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.467 -179.006 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 N--CA 1.491 1.38 0 CA-C-O 120.792 0.247 . . . . 1.0 112.452 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.97 126.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.451 ' HA ' ' H ' ' A' ' 112' ' ' SER . 1.7 p30 -45.68 143.5 3.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.401 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -37.36 -25.92 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.118 2.545 . . . . 1.0 113.649 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.427 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.1 t -53.9 -61.23 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.257 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -69.39 -24.9 63.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.664 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.492 ' CG1' HG13 ' A' ' 106' ' ' VAL . 47.3 t -59.51 -60.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -61.81 -40.25 94.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 1.0 110.353 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -46.75 -39.11 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.06 -45.17 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -57.17 -43.1 82.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 t -63.5 -20.13 65.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 1.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.3 mmm -99.72 -3.45 32.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.093 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.06 78.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.15 141.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 1.0 110.254 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.94 -36.12 3.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.998 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 m -142.01 119.43 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.705 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 168' ' ' SER . 44.4 t -126.79 136.39 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.981 0.419 . . . . 1.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.77 132.36 41.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 t -113.5 129.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.31 -0.556 . . . . 1.0 112.298 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.7 t -136.97 136.39 21.09 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.255 -1.017 . . . . 1.0 108.255 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.82 166.25 1.02 Allowed 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.423 2.082 . . . . 1.0 113.699 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 mt -118.43 114.73 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.419 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 22.0 ptm -142.03 153.91 44.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.457 0.646 . . . . 1.0 112.683 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 43.7 t-80 -129.68 124.19 33.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.903 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.41 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.7 t-80 61.84 -123.73 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.144 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.41 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 95.5 mt-30 -97.56 3.61 50.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.813 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.8 144.75 33.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.736 1.013 . . . . 1.0 113.736 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 39.7 tp -100.69 125.26 47.11 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 87.5 m95 -102.92 -32.95 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.09 -173.31 30.61 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.393 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.2 123.19 21.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.433 -0.383 . . . . 1.0 111.634 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.7 tp -95.29 149.9 20.83 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.1 p -158.01 134.5 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.844 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 151' ' ' SER . 42.2 m -114.94 136.66 52.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.729 -0.669 . . . . 1.0 109.282 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.556 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 32.3 m-70 -112.35 129.6 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -120.03 128.62 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.18 23.91 1.7 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.871 -0.331 . . . . 1.0 110.558 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.72 0.295 . . . . 1.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 1.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.6 tp -56.24 -45.29 80.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.9 -53.66 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.66 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 90.8 t -44.58 -40.1 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.07 -49.03 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -48.68 -33.52 10.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 190' ' ' GLN . 47.2 tp -75.17 -46.19 35.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.039 -0.982 . . . . 1.0 109.064 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.8 tp -54.64 -47.74 73.13 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.41 92.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.595 ' O ' HD13 ' A' ' 193' ' ' ILE . 57.2 t0 -62.28 -39.41 92.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.0 tp60 -64.54 -30.92 71.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 194' ' ' ALA . 51.6 t -77.23 -45.35 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 31.1 p -49.2 -31.64 8.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -73.57 -35.39 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.296 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -66.69 -44.01 82.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.922 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.609 HD12 HH12 ' A' ' 55' ' ' ARG . 25.2 pt -64.97 -27.01 41.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.6 -54.36 6.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.301 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.3 pt20 -66.06 -37.53 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.289 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.415 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.355 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -58.15 -43.72 87.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.204 0.446 . . . . 1.0 112.204 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 47.7 mt -51.94 -30.39 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 95.8 p -44.87 -55.75 5.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.636 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.459 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 66.9 t0 -48.15 -37.1 14.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.694 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -74.7 -51.19 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.838 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 38' ' ' THR . 95.3 mt -55.67 -47.45 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 1.0 110.964 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.489 ' O ' ' OG1' ' A' ' 38' ' ' THR . 24.5 mt -56.9 -30.17 63.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.943 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.507 ' O ' HG12 ' A' ' 39' ' ' VAL . 28.3 ttm180 -65.25 -38.48 90.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.73 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.739 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -69.59 -34.95 74.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.35 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.512 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.7 p -74.12 -25.22 19.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.22 -47.28 18.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.266 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -49.93 67.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.768 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.9 p -52.48 -47.08 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.315 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.593 ' N ' HG13 ' A' ' 42' ' ' VAL . 53.5 ttp180 -49.98 -43.93 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 1.0 110.596 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.52 -40.47 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.36 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.45 -37.29 82.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.804 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -96.64 -17.72 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.695 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 25.26 27.57 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 p -79.6 149.54 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.64 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 28.0 p30 -49.94 -41.94 47.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.64 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 29.7 ptt180 -159.41 146.54 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.584 -0.847 . . . . 1.0 112.788 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 13.4 p -144.02 135.65 22.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.956 -1.02 . . . . 1.0 108.733 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -137.54 149.75 46.97 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.239 -0.584 . . . . 1.0 111.573 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 166' ' ' LEU . 54.7 t -98.09 140.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.501 ' HH ' ' C ' ' A' ' 62' ' ' GLY . 17.8 t80 -129.48 131.3 46.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.482 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -109.89 148.19 32.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 1.0 111.257 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.47 133.91 45.38 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.755 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 61' ' ' HIS . 23.0 m-20 -98.44 152.95 38.17 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -39.43 -50.37 2.97 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.02 2.48 . . . . 1.0 114.516 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -70.11 -6.18 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.35 41.45 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.871 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 57' ' ' ASP . 31.1 m80 -79.69 152.29 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.369 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.501 ' C ' ' HH ' ' A' ' 54' ' ' TYR . . . -139.21 164.65 25.85 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -135.87 157.67 46.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.0 111.525 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 t -92.03 109.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 65' ' ' VAL . 21.6 t -111.32 -1.86 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.54 128.43 9.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' N ' HD21 ' A' ' 78' ' ' LEU . 84.8 tt0 -160.09 140.95 12.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.151 0.501 . . . . 1.0 111.762 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.27 136.53 52.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.499 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 15.1 mtt180 -104.33 134.94 46.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.062 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.636 -0.986 . . . . 1.0 110.636 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.794 0.331 . . . . 1.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -109.5 10.05 25.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.929 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 67' ' ' GLU . 53.5 mt -53.68 127.9 27.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.4 84.56 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.817 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 80' ' ' LEU . 90.2 mt -82.36 148.03 28.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.438 0.619 . . . . 1.0 110.448 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 81' ' ' THR . 14.2 t -106.64 132.72 52.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.614 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.57 107.74 59.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.297 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -43.38 140.35 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.525 2.15 . . . . 1.0 111.464 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -67.16 -26.34 66.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.392 . . . . 1.0 110.471 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.08 -17.57 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ALA . 26.2 p-10 -69.12 -17.2 63.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 1.0 111.035 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.37 133.53 24.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.45 -97.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.616 2.21 . . . . 1.0 111.631 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -163.89 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.932 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -56.39 -41.48 76.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.651 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.81 59.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.695 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 39.9 ttm180 -60.25 -34.45 73.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.797 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -63.44 -33.82 76.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.94 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.81 -34.08 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.513 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.437 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 89.0 m-85 -69.38 -38.94 78.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 14.9 mtm180 -72.35 -33.38 67.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.26 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.11 -36.1 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.45 -16.49 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.664 ' O ' HG13 ' A' ' 100' ' ' VAL . 15.1 mp0 48.72 58.68 5.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.972 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 99' ' ' GLN . 4.9 m -159.61 112.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.92 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -165.02 135.57 3.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.898 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -150.41 157.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.693 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.694 HG12 HG21 ' A' ' 135' ' ' VAL . 3.3 mt -109.43 130.0 63.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.246 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.4 t -83.7 165.16 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' H ' HG12 ' A' ' 104' ' ' VAL . 61.2 m-20 -50.0 116.97 2.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.18 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.8 p -49.92 -21.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.701 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -80.3 -37.4 32.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.837 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.1 -21.66 66.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.119 0.485 . . . . 1.0 110.412 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 57.79 61.43 2.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.523 -0.762 . . . . 1.0 112.9 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.9 m -93.31 125.88 38.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -121.6 146.43 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.431 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -113.86 152.01 31.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.782 -1.099 . . . . 1.0 108.668 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 120.416 -0.514 . . . . 1.0 111.446 -178.091 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 120.803 0.251 . . . . 1.0 112.37 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 103' ' ' ILE . 3.0 t -120.4 129.5 75.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.431 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.5 m-20 -44.53 140.9 2.97 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.708 0.29 . . . . 1.0 111.365 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -38.32 -23.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.064 2.51 . . . . 1.0 113.685 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -53.78 -62.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.23 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.442 ' CD2' HD11 ' A' ' 143' ' ' LEU . 71.7 t60 -71.29 -23.48 61.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.676 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.443 ' CG1' HG23 ' A' ' 106' ' ' VAL . 80.4 t -59.41 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.623 0.601 . . . . 1.0 112.623 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.14 -39.76 95.61 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.37 -37.61 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.442 HD11 ' CD2' ' A' ' 139' ' ' HIS . 61.8 mt -72.99 -42.13 63.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.192 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.81 -42.94 90.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.8 m -62.11 -19.45 63.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.623 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.0 mmm -99.54 0.98 43.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.102 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.76 19.63 75.28 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.473 HG21 HH21 ' A' ' 50' ' ' ARG . 93.4 t -110.48 144.47 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.734 0.302 . . . . 1.0 110.245 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.63 -24.61 5.71 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -152.41 119.57 5.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.76 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.2 p -127.85 139.32 52.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 1.0 111.405 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -99.38 134.47 42.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 t -114.91 128.25 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.294 -0.563 . . . . 1.0 112.337 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 26.5 t -134.3 133.16 21.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.05 161.22 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.415 2.076 . . . . 1.0 113.692 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.4 mt -115.2 116.81 28.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.9 ptm -141.2 156.2 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -133.26 127.46 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.062 -0.972 . . . . 1.0 108.798 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.497 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 2.0 t60 62.89 -125.4 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.16 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.497 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 19.5 pt20 -99.38 2.06 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.839 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.471 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 10.0 pt-20 -108.91 154.33 22.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.68 126.87 52.19 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.471 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 43.5 m95 -101.79 -28.21 12.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.1 -170.26 31.75 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.598 -1.287 . . . . 1.0 112.318 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 90.0 mt -136.31 123.94 22.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.454 -0.373 . . . . 1.0 111.631 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.483 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.0 tp -96.59 149.65 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.0 p -156.3 133.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.139 -0.625 . . . . 1.0 111.912 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.0 p -117.31 133.08 56.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.249 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.512 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 59.8 m80 -101.65 126.19 48.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 -178.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 170' ' ' HIS . 1.9 m80 -116.25 117.75 30.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.09 25.06 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.75 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 . . . . . 0 C--N 1.327 -0.409 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.572 -179.741 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 183' ' ' VAL . 78.6 mm-40 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.599 0.237 . . . . 1.0 111.214 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.8 mt-10 -70.77 -33.7 71.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 1.0 111.015 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.59 -33.29 72.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.644 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.44 -54.82 5.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.915 -0.314 . . . . 1.0 111.609 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 184' ' ' VAL . 31.8 m -46.51 -40.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.597 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 185' ' ' GLN . 30.1 m -71.88 -50.62 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.58 ' N ' HG23 ' A' ' 184' ' ' VAL . 60.8 tt0 -46.46 -32.16 3.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.7 tt -66.86 -48.04 70.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.027 -0.988 . . . . 1.0 109.1 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 184' ' ' VAL . 91.2 mt -52.69 -45.21 66.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.38 90.11 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.71 -38.01 89.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.5 tp60 -64.88 -32.52 74.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.4 t -77.1 -44.7 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.6 m -52.9 -36.5 59.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -67.57 -36.31 75.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.111 -0.95 . . . . 1.0 110.219 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.45 84.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.948 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.07 -29.73 47.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.55 -55.02 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.398 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.4 pt20 -65.38 -40.03 92.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.222 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.39 -32.91 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 1.0 111.434 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.44 -42.87 83.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.6 mp -54.27 -36.4 63.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.945 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.7 t -49.57 -58.21 5.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.631 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.432 179.864 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.338 . . . . 1.0 110.519 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -65.39 -31.11 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -76.07 -48.99 18.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.853 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.54 -49.99 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.072 0.463 . . . . 1.0 110.997 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.562 HD11 ' CD2' ' A' ' 31' ' ' LEU . 55.1 mt -57.45 -31.52 66.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.914 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.421 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.0 ttt180 -63.01 -40.62 98.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.735 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.48 70.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.795 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.747 ' O ' HG23 ' A' ' 42' ' ' VAL . 73.6 p -65.28 -35.99 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.314 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -75.17 -24.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 1.0 112.201 -177.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.65 -49.99 41.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.247 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.25 -37.25 85.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.779 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 38' ' ' THR . 77.4 t -56.06 -54.1 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.345 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 47' ' ' GLY . 53.7 ttt-85 -51.02 -44.39 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 1.0 110.623 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.77 70.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.323 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.732 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.92 -14.96 21.41 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.664 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.92 26.05 25.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.8 p -81.55 152.38 27.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -48.3 -43.9 33.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.623 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 50.9 ptt85 -158.8 147.28 18.37 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.542 -0.863 . . . . 1.0 112.779 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -139.23 133.88 40.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.002 -0.999 . . . . 1.0 108.736 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.439 ' CE ' HH12 ' A' ' 50' ' ' ARG . 46.1 pttt -137.31 146.25 44.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.379 -0.528 . . . . 1.0 111.66 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.9 t -98.06 142.68 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.0 t80 -130.74 132.6 45.42 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.407 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -111.54 150.64 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 1.0 111.159 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -101.81 133.84 45.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.594 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -99.18 153.35 37.83 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -38.36 -51.61 2.09 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.994 2.463 . . . . 1.0 114.492 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.44 -5.56 29.41 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.173 0.435 . . . . 1.0 112.173 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -7.75 43.15 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.964 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 57' ' ' ASP . 6.0 m-70 -78.98 151.94 31.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.365 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.411 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.99 164.3 25.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.5 p -135.88 157.99 45.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 111.487 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 t -88.08 107.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.83 -3.96 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.083 0.401 . . . . 1.0 112.083 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -154.19 128.29 8.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.342 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.5 tt0 -158.09 139.31 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 1.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -117.37 137.92 52.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.572 . . . . 1.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.757 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.819 0.342 . . . . 1.0 111.401 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.569 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 25.2 mt -99.85 12.17 37.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.967 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.8 tp -66.57 133.33 50.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.916 0.709 . . . . 1.0 112.916 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.92 86.51 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.402 -0.817 . . . . 1.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -87.67 153.14 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.347 0.574 . . . . 1.0 110.53 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.8 m -106.86 132.21 53.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.58 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -106.0 147.21 34.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 134.78 12.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.603 2.202 . . . . 1.0 111.473 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.62 -32.9 72.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 1.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 -16.11 0.11 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.7 m-20 -59.07 -10.49 2.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.66 0.267 . . . . 1.0 110.997 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' HE ' ' A' ' 92' ' ' ARG . 1.8 pt -141.15 145.93 40.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.559 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.59 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.502 2.135 . . . . 1.0 111.709 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 93' ' ' ARG . 79.2 tt0 -163.47 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.963 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -71.7 -39.64 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.662 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.644 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.493 ' HE ' HD12 ' A' ' 87' ' ' ILE . 18.3 ttm180 -61.94 -36.79 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 1.0 110.81 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 18.2 mmt85 -61.51 -35.37 77.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.943 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.08 -33.31 75.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.522 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.29 -34.97 77.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 12.0 mtm180 -75.8 -31.1 59.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.251 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.51 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.8 mt -93.78 -38.08 11.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.792 1.034 . . . . 1.0 113.792 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -120.43 -10.54 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.246 1.202 . . . . 1.0 114.246 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.51 HE22 ' C ' ' A' ' 97' ' ' LEU . 5.0 mp0 44.46 63.31 1.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.641 -0.824 . . . . 1.0 109.859 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 100' ' ' VAL . 13.2 p -169.33 117.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.315 -0.554 . . . . 1.0 111.882 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.587 HH22 ' CA ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -173.77 131.14 0.42 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.859 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.54 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 2.5 m -142.42 159.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.657 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.498 HG23 HG11 ' A' ' 135' ' ' VAL . 23.8 mt -111.02 128.29 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.252 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 104' ' ' VAL . 19.2 m -87.89 171.45 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.419 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 56.3 m-20 -52.26 113.2 0.96 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.277 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.736 HG23 ' CG1' ' A' ' 140' ' ' VAL . 10.1 p -47.71 -17.74 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 1.0 110.688 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' N ' ' C ' ' A' ' 105' ' ' ASP . 84.7 tt0 -81.81 -36.68 28.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.806 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.58 -20.21 44.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.105 0.479 . . . . 1.0 110.451 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 56.46 58.94 3.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.819 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -96.71 126.83 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -122.39 143.33 49.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.757 ' HG ' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -111.81 156.73 21.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.746 -1.116 . . . . 1.0 108.63 177.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 C--N 1.326 -0.426 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.462 -178.806 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.51 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 63.7 Cg_endo . . . . . 0 N--CA 1.492 1.413 0 CA-C-O 120.824 0.26 . . . . 1.0 112.413 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.587 ' CA ' HH22 ' A' ' 101' ' ' ARG . 1.9 p -117.17 129.26 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.757 ' N ' ' HG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -44.97 141.18 3.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 1.0 111.294 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -40.54 -32.96 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.08 2.52 . . . . 1.0 113.706 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.52 -63.13 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.746 -0.382 . . . . 1.0 111.215 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -71.54 -22.53 61.75 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.589 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.736 ' CG1' HG23 ' A' ' 106' ' ' VAL . 82.3 t -61.69 -55.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -64.68 -38.83 92.34 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.4 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.443 ' O ' ' OG ' ' A' ' 145' ' ' SER . 88.3 t80 -48.72 -34.74 12.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 58.9 mt -73.53 -42.78 61.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.12 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -58.21 -44.53 88.21 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 87.2 p -62.81 -18.03 62.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.659 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.0 mmm -101.53 -0.71 34.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.137 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.07 18.55 78.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 88.1 t -107.32 142.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 1.0 110.27 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.27 -25.31 6.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.419 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 15.0 m -153.96 120.73 5.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.804 -0.359 . . . . 1.0 110.802 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.7 t -127.66 136.42 51.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.983 0.421 . . . . 1.0 111.38 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -97.97 132.33 43.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.0 t -114.86 132.4 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.268 -0.573 . . . . 1.0 112.212 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.52 133.37 20.28 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.7 161.59 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.361 2.041 . . . . 1.0 113.695 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.8 mt -115.26 116.44 28.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' OG ' ' A' ' 192' ' ' SER . 24.9 ptm -141.19 142.8 33.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -125.23 122.43 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.989 -1.005 . . . . 1.0 108.874 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.412 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 26.0 t-80 71.67 -128.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.223 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.412 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 37.4 tt0 -100.47 4.89 44.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.796 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.49 ' CD ' ' CZ2' ' A' ' 163' ' ' TRP . 5.2 pt-20 -111.28 158.31 19.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.726 1.01 . . . . 1.0 113.726 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.3 tp -101.73 128.96 47.82 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.49 ' CZ2' ' CD ' ' A' ' 161' ' ' GLU . 52.1 m95 -105.44 -37.01 6.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.512 0.93 . . . . 1.0 113.512 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.28 -172.82 24.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.731 -1.223 . . . . 1.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.2 tp -141.25 120.92 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.439 -0.38 . . . . 1.0 111.633 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.77 149.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 167' ' ' VAL . 13.5 p -155.95 133.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.034 -0.666 . . . . 1.0 111.836 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 82.1 p -115.62 136.67 52.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 1.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.623 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 65.7 m-70 -115.44 131.15 57.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -123.11 126.19 46.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.51 -16.61 61.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.774 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--N 1.327 -0.399 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.607 179.712 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.408 ' OE1' ' N ' ' A' ' 179' ' ' GLU . 48.7 mp0 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.601 0.239 . . . . 1.0 111.269 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.545 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.7 mt-10 -65.79 -30.73 71.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 1.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.65 -36.23 78.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.611 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.16 -55.97 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.699 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 184' ' ' VAL . 31.8 m -43.72 -41.02 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.66 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.576 HG23 ' N ' ' A' ' 185' ' ' GLN . 27.8 m -75.26 -48.88 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.576 ' N ' HG23 ' A' ' 184' ' ' VAL . 62.0 tt0 -49.24 -34.4 14.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 190' ' ' GLN . 97.5 mt -76.03 -48.0 22.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.982 -1.008 . . . . 1.0 109.079 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.74 -47.73 67.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.4 89.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.472 -0.936 . . . . 1.0 108.472 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.28 -38.6 91.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 186' ' ' LEU . 78.3 mm-40 -66.72 -31.64 72.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.46 -47.25 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.277 -1.009 . . . . 1.0 108.277 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 157' ' ' MET . 14.4 t -49.17 -32.66 10.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -74.72 -33.4 31.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.205 -0.907 . . . . 1.0 110.28 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.44 77.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.6 pt -62.23 -29.62 47.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -75.85 -51.83 11.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.02 -43.31 96.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.212 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.57 -31.93 73.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 1.0 111.395 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.43 -43.67 84.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.1 mp -51.19 -28.46 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.973 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 98.8 p -49.75 -56.01 11.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.471 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 63.5 t0 -48.14 -36.24 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.684 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.52 -50.65 15.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.826 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.93 -48.71 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.021 0.438 . . . . 1.0 110.913 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.48 ' O ' ' OG1' ' A' ' 38' ' ' THR . 31.0 mt -57.38 -28.8 63.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.961 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.2 ttp180 -67.14 -39.14 86.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.778 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.07 -30.82 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.739 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.6 p -67.0 -36.79 82.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.301 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 36' ' ' ARG . 1.1 p -71.62 -25.39 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.35 -36.02 40.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.239 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.58 -48.52 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.833 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.2 p -57.59 -52.1 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.31 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.646 ' N ' HG13 ' A' ' 42' ' ' VAL . 9.0 ptm180 -51.81 -43.41 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 1.0 110.641 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 43' ' ' ARG . . . -51.95 -39.25 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.296 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -69.49 -32.78 71.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.833 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -97.11 -17.15 20.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.704 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.18 26.15 55.51 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 170' ' ' HIS . 48.0 m -77.79 143.75 37.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -55.57 -40.71 72.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.605 0.594 . . . . 1.0 112.605 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.677 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -149.97 130.77 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.525 -0.87 . . . . 1.0 112.763 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.411 HG22 ' OG ' ' A' ' 168' ' ' SER . 6.4 t -139.19 132.72 38.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.911 -1.04 . . . . 1.0 108.727 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.21 150.0 46.33 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.654 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 166' ' ' LEU . 45.3 t -99.57 141.25 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.525 ' OH ' ' CD1' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -131.34 136.24 47.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.442 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -110.43 148.89 31.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 1.0 111.251 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -99.82 126.66 45.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.71 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -92.0 153.25 43.38 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.19 -50.91 2.69 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.94 2.427 . . . . 1.0 114.523 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -70.12 -7.5 42.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.184 0.438 . . . . 1.0 112.184 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.06 -6.65 40.25 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.753 -0.737 . . . . 1.0 112.014 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -77.19 149.9 35.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.348 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.57 158.82 23.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.811 -0.915 . . . . 1.0 110.811 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 p -131.86 155.63 47.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.467 . . . . 1.0 111.426 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.903 HG11 ' O ' ' A' ' 77' ' ' LEU . 3.7 p -91.02 109.35 20.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' VAL . 23.7 t -114.72 -4.32 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.116 0.413 . . . . 1.0 112.116 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . . . -152.15 127.64 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.291 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 12.3 tm-20 -162.36 142.39 9.76 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.703 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' CB ' ' NE ' ' A' ' 43' ' ' ARG . . . -127.95 135.14 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -103.14 135.1 45.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.362 -0.535 . . . . 1.0 112.035 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.797 0 N-CA-C 110.556 -1.017 . . . . 1.0 110.556 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.839 0.352 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.903 ' O ' HG11 ' A' ' 64' ' ' VAL . 40.2 mt -117.74 22.09 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.932 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 67' ' ' GLU . 64.1 mt -67.29 129.77 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.919 0.711 . . . . 1.0 112.919 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.509 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 84.53 -1.88 88.45 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.782 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.783 ' O ' HG12 ' A' ' 64' ' ' VAL . 84.5 mt -87.43 149.74 24.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.418 0.609 . . . . 1.0 110.46 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 81' ' ' THR . 8.8 t -106.14 133.76 50.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.602 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 54' ' ' TYR . 8.2 m-85 -103.39 144.03 27.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.65 138.05 14.89 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.552 2.168 . . . . 1.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.425 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -61.02 -33.14 72.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.913 0.387 . . . . 1.0 110.449 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.5 -18.77 0.22 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 84' ' ' ALA . 95.1 m-20 -65.4 -20.79 66.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 1.0 110.975 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.25 133.87 25.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.57 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.47 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.589 2.193 . . . . 1.0 111.615 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -163.71 -53.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.927 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -43.84 -43.77 6.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.615 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.64 -34.87 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.701 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.581 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 48.8 mtp85 -65.04 -35.03 79.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.779 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.71 -37.03 82.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.945 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.39 -35.0 76.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.556 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -68.46 -33.77 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.73 HH21 ' H ' ' A' ' 162' ' ' LEU . 22.1 mtp180 -77.01 -28.63 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.154 -0.93 . . . . 1.0 111.337 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.5 mt -96.76 -39.28 9.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.84 -13.01 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.266 1.21 . . . . 1.0 114.266 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.649 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.2 mp0 48.58 58.22 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.674 -0.811 . . . . 1.0 109.899 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.0 m -159.42 112.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.374 -0.53 . . . . 1.0 112.012 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -165.21 134.07 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.833 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.9 p -151.31 156.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.715 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.451 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 97.9 mt -110.92 130.84 63.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.204 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.09 170.03 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.609 0.718 . . . . 1.0 112.892 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -50.14 116.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.248 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.562 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.5 p -50.45 -19.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.691 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -80.08 -37.24 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.81 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.5 -18.77 42.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 56.77 62.88 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.848 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 t -95.66 124.38 39.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -118.53 145.82 45.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.1 t -109.18 145.92 35.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.811 -1.086 . . . . 1.0 108.641 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.475 -178.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.493 1.442 0 CA-C-O 120.796 0.248 . . . . 1.0 112.378 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.6 m -120.24 129.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 138' ' ' CYS . 9.7 p30 -45.81 142.08 3.86 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 1.0 111.34 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -37.34 -19.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.113 2.542 . . . . 1.0 113.675 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 t -60.73 -61.57 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -69.71 -25.75 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.627 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.562 ' CG1' HG23 ' A' ' 106' ' ' VAL . 88.0 t -59.44 -60.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -60.53 -37.46 81.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.372 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -46.42 -37.94 8.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.61 -43.53 63.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -58.99 -42.98 91.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.9 t -63.63 -20.27 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.669 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.5 0.28 42.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.09 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.77 18.37 78.97 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 89.5 t -108.01 143.82 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.681 0.277 . . . . 1.0 110.273 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -24.19 6.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.018 0.377 . . . . 1.0 112.018 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.9 m -154.34 122.38 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.771 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.9 p -128.08 137.16 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 1.0 111.418 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.39 133.08 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.53 129.19 68.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.298 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.85 127.6 20.37 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -90.41 161.72 4.5 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.425 2.083 . . . . 1.0 113.65 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.85 114.35 24.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.4 ptm -141.29 150.7 42.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 84.5 t60 -125.05 124.14 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.929 -1.032 . . . . 1.0 108.836 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.559 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 53.6 t-80 59.05 -120.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.109 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.559 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.3 pp0? -98.79 0.41 44.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.807 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.429 ' HA ' HH21 ' A' ' 96' ' ' ARG . 47.2 tp10 -105.31 145.87 30.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.73 ' H ' HH21 ' A' ' 96' ' ' ARG . 35.9 tp -101.26 124.7 47.37 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.498 -1.297 . . . . 1.0 107.498 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.435 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 71.6 m95 -103.73 -31.67 9.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.563 0.949 . . . . 1.0 113.563 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.57 -168.32 22.32 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.697 -1.239 . . . . 1.0 112.401 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.17 124.07 14.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.418 -0.391 . . . . 1.0 111.658 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.641 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.1 tp -97.18 150.52 20.79 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.0 p -155.63 133.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.11 -0.636 . . . . 1.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.431 ' OG ' HG21 ' A' ' 48' ' ' THR . 4.1 t -115.53 134.31 55.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 25.5 m-70 -108.38 124.89 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 48' ' ' THR . 79.9 m80 -117.88 119.39 34.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.6 -18.06 61.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.775 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 C--N 1.327 -0.411 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.558 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 183' ' ' VAL . 97.3 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.653 0.263 . . . . 1.0 111.254 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.56 -34.87 79.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 1.0 110.932 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 181' ' ' LEU . 3.1 tt -55.36 -59.68 4.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.574 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -59.31 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.713 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 179' ' ' GLU . 92.7 t -45.43 -39.63 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.664 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.59 -50.51 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -49.31 -34.55 15.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 186' ' ' LEU . 36.1 tp -72.55 -48.12 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.033 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.67 -45.51 63.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.86 91.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.07 -39.3 91.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.474 ' HA ' HD12 ' A' ' 193' ' ' ILE . 79.8 mm-40 -66.6 -31.93 72.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.91 -48.09 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.6 p -52.03 -35.25 46.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 190' ' ' GLN . 25.6 mt -66.95 -35.24 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.82 -39.68 79.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.986 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.63 -47.78 78.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -62.91 -48.99 76.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.39 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.32 -46.27 87.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.269 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.43 75.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.397 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -56.65 -41.3 76.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.6 mt -55.15 -32.84 62.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.966 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.6 m -51.37 -57.09 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.656 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.8 mp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.467 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 195' ' ' ILE . 1.4 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.805 0.336 . . . . 1.0 110.503 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.5 p-10 -48.74 -33.78 10.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 51.3 tt0 -76.01 -48.82 19.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 38' ' ' THR . 23.1 mm -56.84 -46.04 83.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 1.0 111.025 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 38' ' ' THR . 40.2 mt -57.95 -29.41 65.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 1.0 112.008 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 39' ' ' VAL . 96.9 mtt180 -69.48 -40.74 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.785 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.14 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.533 ' O ' HG13 ' A' ' 42' ' ' VAL . 50.6 p -67.97 -37.56 81.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.329 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -69.62 -22.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.45 -36.5 38.76 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.267 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -71.0 -44.42 65.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.764 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 43' ' ' ARG . 16.6 m -59.53 -47.23 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.336 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 47' ' ' GLY . 50.4 ttp180 -50.4 -46.08 55.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 1.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.18 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.316 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -63.38 -40.55 97.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.807 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.96 -13.58 22.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.713 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.11 26.43 20.17 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.618 ' HG1' ' CE1' ' A' ' 170' ' ' HIS . 59.7 m -77.13 144.3 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -55.51 -41.02 72.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.522 0.564 . . . . 1.0 112.522 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.471 ' NH2' HD12 ' A' ' 77' ' ' LEU . 71.1 ttt-85 -150.51 132.26 14.99 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.65 -0.82 . . . . 1.0 112.842 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 42' ' ' VAL . 14.6 p -141.95 134.52 28.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.97 -1.013 . . . . 1.0 108.725 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -137.95 151.14 47.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.249 -0.581 . . . . 1.0 111.614 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 48.0 t -97.39 140.88 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.7 t80 -130.57 130.5 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.388 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.432 HH22 HG21 ' A' ' 65' ' ' VAL . 24.6 ttm105 -106.39 145.01 32.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 1.0 111.275 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 57' ' ' ASP . 64.4 t80 -99.56 127.55 45.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.877 -0.602 . . . . 1.0 111.703 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.575 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -98.24 154.41 37.67 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -50.86 -36.25 51.89 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.03 2.487 . . . . 1.0 114.469 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.43 -4.28 55.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.184 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.79 -16.51 47.14 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.859 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.575 ' NE2' ' CB ' ' A' ' 57' ' ' ASP . 36.6 p-80 -78.12 148.74 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.65 160.78 24.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.1 p -133.62 154.79 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 1.0 111.567 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.797 HG11 ' O ' ' A' ' 77' ' ' LEU . 7.1 p -92.71 113.02 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.432 HG21 HH22 ' A' ' 55' ' ' ARG . 2.5 t -114.72 -1.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 1.0 112.041 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.52 129.05 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.279 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 18.1 pt-20 -162.71 142.13 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.472 -0.491 . . . . 1.0 111.678 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.7 146.82 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -134.32 146.52 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.969 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 179.617 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.808 0.337 . . . . 1.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.797 ' O ' HG11 ' A' ' 64' ' ' VAL . 20.5 mt -94.35 10.26 34.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.952 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.4 tp -57.12 129.24 40.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.54 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 85.85 -4.86 85.32 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.863 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.774 ' O ' HG12 ' A' ' 64' ' ' VAL . 88.0 mt -82.21 147.47 28.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.308 0.554 . . . . 1.0 110.392 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.7 m -108.34 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.622 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -105.82 148.12 35.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.208 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.89 137.4 12.48 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.548 2.166 . . . . 1.0 111.428 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.8 -34.75 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.854 0.359 . . . . 1.0 110.439 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.11 -17.77 0.12 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.9 m-20 -58.17 -14.16 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.668 0.271 . . . . 1.0 111.018 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.0 145.62 19.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.513 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.496 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 79.2 Cg_endo -74.52 -88.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.502 2.135 . . . . 1.0 111.691 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 85.1 tt0 -170.15 -36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.16 -39.93 63.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.574 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.51 63.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.515 -0.312 . . . . 1.0 111.733 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.695 HH12 ' NH2' ' A' ' 96' ' ' ARG . 76.6 ttt-85 -61.81 -35.86 79.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.778 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -63.88 -36.89 85.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.937 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD13 ' NH1' ' A' ' 101' ' ' ARG . 7.3 mt -61.55 -37.02 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.524 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -65.88 -34.51 78.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.695 ' NH2' HH12 ' A' ' 92' ' ' ARG . 40.3 ttm180 -76.3 -30.3 57.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.097 -0.956 . . . . 1.0 111.252 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.5 ' C ' HE22 ' A' ' 99' ' ' GLN . 83.6 mt -93.86 -39.93 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.41 -10.7 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.198 1.184 . . . . 1.0 114.198 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.7 mp0 46.72 49.17 14.27 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.688 -0.805 . . . . 1.0 109.904 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 99' ' ' GLN . 17.1 t -152.85 111.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.954 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.499 ' NH1' HD13 ' A' ' 94' ' ' LEU . 5.0 tpt180 -165.86 130.23 2.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.875 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.04 158.01 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.726 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 135' ' ' VAL . 82.2 mt -111.44 128.82 67.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.228 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 104' ' ' VAL . 3.0 m -86.7 170.2 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.976 0.732 . . . . 1.0 112.976 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -48.58 115.01 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.221 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.546 HG13 ' CG1' ' A' ' 140' ' ' VAL . 54.9 t -52.65 -23.07 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.697 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -76.6 -39.01 53.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.781 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.5 -15.51 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.12 0.486 . . . . 1.0 110.436 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.704 HE21 ' NH2' ' A' ' 111' ' ' ARG . 47.6 tt0 56.37 61.85 2.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.465 -0.789 . . . . 1.0 112.885 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 m -96.97 125.23 41.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.808 -1.552 . . . . 1.0 106.808 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.704 ' NH2' HE21 ' A' ' 109' ' ' GLN . 97.2 mtt180 -118.36 146.41 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -109.43 148.51 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.6 178.155 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 113' ' ' ILE . 22.0 pt . . . . . 0 C--N 1.326 -0.446 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.457 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo . . . . . 0 N--CA 1.491 1.335 0 CA-C-O 120.788 0.245 . . . . 1.0 112.391 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.439 HG21 HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -111.44 122.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 138' ' ' CYS . 17.9 t70 -44.82 138.69 4.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.761 0.315 . . . . 1.0 111.356 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -35.93 -20.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.125 2.55 . . . . 1.0 113.603 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.8 t -62.63 -62.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 58.7 t-80 -69.53 -25.48 64.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.69 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.546 ' CG1' HG13 ' A' ' 106' ' ' VAL . 96.7 t -58.76 -59.05 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 14.1 p80 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.346 -0.541 . . . . 1.0 110.341 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.636 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 73.8 t80 -46.99 -38.79 11.3 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.53 -43.61 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -58.06 -43.08 86.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.6 m -62.97 -19.96 64.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.645 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.76 -1.28 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.097 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.57 18.14 78.04 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.49 142.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 1.0 110.277 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -22.45 7.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.981 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 p -155.17 123.16 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.769 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.0 m -129.08 137.41 51.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.416 . . . . 1.0 111.449 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.05 133.07 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.1 t -114.17 130.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.327 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.07 133.1 18.39 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.563 ' HB2' HD11 ' A' ' 162' ' ' LEU . 5.9 Cg_endo -95.32 166.82 1.51 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.412 2.075 . . . . 1.0 113.759 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.44 116.7 27.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.564 ' HB3' HD12 ' A' ' 162' ' ' LEU . 24.4 ptm -142.45 152.97 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 -176.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 39.7 t-80 -131.68 124.15 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.075 -0.966 . . . . 1.0 108.891 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.415 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.0 t-80 64.63 -126.56 0.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.122 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.415 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 98.0 mm-40 -97.05 4.96 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.784 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.528 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -107.53 145.99 32.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.723 1.009 . . . . 1.0 113.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 157' ' ' MET . 20.2 tp -99.54 125.64 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.528 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 72.1 m95 -103.33 -34.25 8.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.31 33.03 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.651 -1.262 . . . . 1.0 112.403 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 78.1 mt -135.66 121.47 19.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.469 -0.365 . . . . 1.0 111.664 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.474 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.6 tp -94.53 150.51 20.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.5 p -156.84 133.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.803 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.1 p -114.13 139.77 49.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.26 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 12.4 m80 -111.21 123.81 50.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.618 ' CE1' ' HG1' ' A' ' 48' ' ' THR . 73.4 m80 -117.87 119.37 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.04 -18.36 62.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.744 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.616 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.646 0.26 . . . . 1.0 111.277 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 184' ' ' VAL . 77.8 mm-40 -67.66 -34.23 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 1.0 110.975 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -65.96 -40.09 90.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.592 -179.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -77.95 -52.15 9.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.66 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.8 t -44.58 -44.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.678 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.629 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.2 p -74.29 -50.58 26.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.629 ' N ' HG13 ' A' ' 184' ' ' VAL . 61.5 tt0 -49.82 -36.05 25.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 190' ' ' GLN . 28.2 tp -71.23 -47.61 56.19 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.016 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 187' ' ' LEU . 53.1 tp -54.04 -45.76 71.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.61 91.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -59.63 -36.6 76.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 186' ' ' LEU . 1.0 OUTLIER -67.32 -31.26 71.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.3 t -77.07 -46.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 157' ' ' MET . 37.8 p -50.93 -32.69 21.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.42 -33.06 32.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.232 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.82 80.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.959 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.409 ' HA ' HD21 ' A' ' 31' ' ' LEU . 25.1 pt -65.86 -26.46 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.44 -54.4 6.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 8.0 pt20 -67.39 -37.87 83.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.12 -33.19 74.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.378 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.04 -43.44 86.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.177 0.436 . . . . 1.0 112.177 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.9 mt -53.28 -35.86 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.99 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.8 t -47.22 -56.12 7.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.611 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.407 179.701 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.786 0.326 . . . . 1.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -49.43 -32.84 12.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.735 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -75.91 -48.29 21.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.778 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 38' ' ' THR . 98.3 mt -55.18 -51.47 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.034 0.445 . . . . 1.0 110.993 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.491 ' O ' ' OG1' ' A' ' 38' ' ' THR . 88.0 mt -55.69 -31.46 62.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.914 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 39' ' ' VAL . 91.0 mtt180 -65.62 -38.77 90.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.392 -0.523 . . . . 1.0 109.743 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.24 -32.22 68.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.783 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 p -66.9 -36.93 83.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.274 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.584 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.9 p -72.46 -24.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.269 0.47 . . . . 1.0 112.269 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -70.66 -44.99 65.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.276 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -69.93 -35.0 74.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.754 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 38' ' ' THR . 77.5 t -59.64 -54.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.296 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.5 ttt-85 -51.52 -44.55 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 1.0 110.746 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.21 -46.35 79.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.295 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.548 ' CE2' ' OE2' ' A' ' 180' ' ' GLU . 63.6 t80 -62.41 -41.45 98.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.815 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.0 mt -96.33 -12.85 23.84 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.706 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 51.68 25.08 13.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.2 t -78.45 148.06 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -51.94 -42.25 62.7 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.538 HH22 ' CG ' ' A' ' 77' ' ' LEU . 77.9 ttt180 -152.95 137.17 16.51 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.647 -0.821 . . . . 1.0 112.808 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 51' ' ' VAL . 11.7 p -142.75 133.15 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.668 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.8 pttm -138.33 151.85 47.94 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.679 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.2 t -97.42 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.8 t80 -130.01 132.86 46.41 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.854 -0.338 . . . . 1.0 110.434 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.82 150.9 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.424 . . . . 1.0 111.215 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.601 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -102.38 132.71 48.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.698 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 61' ' ' HIS . 26.6 m-20 -97.71 154.52 37.85 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -40.14 -50.81 3.4 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.001 2.467 . . . . 1.0 114.479 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.74 -6.77 39.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.3 -7.41 37.23 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.697 -0.764 . . . . 1.0 111.905 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' ASP . 21.5 m80 -79.72 151.91 30.17 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.371 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.71 163.52 25.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -135.07 156.92 48.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.024 0.44 . . . . 1.0 111.483 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.26 109.63 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.33 -4.79 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.28 128.12 9.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.251 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HG3' HH21 ' A' ' 50' ' ' ARG . 0.6 OUTLIER -159.41 141.28 13.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.655 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.82 137.29 52.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 76' ' ' SER . 83.4 mtm-85 -111.5 138.39 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.075 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.501 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.849 0 N-CA-C 110.624 -0.99 . . . . 1.0 110.624 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 12.9 m . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.851 0.358 . . . . 1.0 111.338 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' CG ' HH22 ' A' ' 50' ' ' ARG . 43.3 mt -95.93 11.82 32.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 1.0 109.938 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.1 mt -58.9 131.51 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.85 -3.77 86.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.905 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.29 149.16 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.286 0.543 . . . . 1.0 110.454 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 81' ' ' THR . 12.9 t -105.46 131.14 53.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -105.5 106.1 54.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -42.26 134.07 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.508 2.139 . . . . 1.0 111.528 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -57.94 -30.6 66.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.861 0.363 . . . . 1.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.85 -17.69 0.1 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.4 t0 -67.49 -28.93 68.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 1.0 111.036 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mm -112.01 133.05 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.503 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 97.1 Cg_endo -76.28 -111.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.642 2.228 . . . . 1.0 111.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 90.6 mt-10 -151.57 -51.23 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.905 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.2 -40.59 67.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.633 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.32 -37.89 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.749 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 65.3 ttt180 -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.8 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -64.07 -35.53 81.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.911 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.26 -34.93 77.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.504 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -69.78 -37.64 76.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -77.31 -30.65 54.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.47 -40.39 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -117.04 -11.35 10.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 98' ' ' ALA . 5.3 mp0 44.55 62.98 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.663 -0.815 . . . . 1.0 109.898 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.8 p -168.54 114.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 120.31 -0.556 . . . . 1.0 111.854 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.466 ' HE ' ' CA ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -167.5 137.22 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.911 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.3 p -149.5 156.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.676 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.576 HG23 HG21 ' A' ' 135' ' ' VAL . 3.2 mt -109.57 128.34 65.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.257 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 105' ' ' ASP . 4.0 t -84.65 165.88 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.013 0.745 . . . . 1.0 113.013 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.538 ' N ' HG12 ' A' ' 104' ' ' VAL . 75.8 m-20 -50.32 116.25 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.216 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.428 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.2 p -49.77 -21.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.74 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.28 -38.02 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.797 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.06 -21.19 63.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 1.0 110.399 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.503 HE21 ' CZ ' ' A' ' 111' ' ' ARG . 46.4 tt0 57.97 60.61 2.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.53 -0.759 . . . . 1.0 112.854 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -94.23 125.59 38.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.768 -1.568 . . . . 1.0 106.768 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.503 ' CZ ' HE21 ' A' ' 109' ' ' GLN . 87.0 mtt180 -120.38 144.76 47.73 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -117.03 157.15 26.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.801 -1.09 . . . . 1.0 108.634 177.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.41 HG23 ' C ' ' A' ' 112' ' ' SER . 27.9 pt . . . . . 0 C--N 1.326 -0.455 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.407 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.492 1.401 0 CA-C-O 120.812 0.255 . . . . 1.0 112.396 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 103' ' ' ILE . 3.6 m -118.48 131.22 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -40.9 156.57 0.2 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.669 0.271 . . . . 1.0 111.388 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.33 -26.12 80.76 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.13 2.553 . . . . 1.0 113.584 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -58.47 -56.63 19.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.0 111.21 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.526 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 2.0 t60 -68.46 -27.16 65.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.602 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.448 ' CG2' HG23 ' A' ' 135' ' ' VAL . 78.1 t -65.26 -53.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.37 -40.88 94.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.397 -0.521 . . . . 1.0 110.362 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -47.63 -35.3 9.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.491 HD11 ' CE1' ' A' ' 139' ' ' HIS . 50.9 mt -73.8 -41.61 62.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.193 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -60.25 -43.59 95.98 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.3 t -61.69 -18.18 58.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.632 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.8 mmm -100.95 2.66 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.166 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.79 19.0 78.34 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 144.77 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.752 0.311 . . . . 1.0 110.211 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.58 -25.1 6.54 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.974 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -154.35 122.24 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.749 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -131.2 141.71 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.006 0.432 . . . . 1.0 111.398 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.74 130.45 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 167' ' ' VAL . 28.5 m -117.0 141.3 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.267 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.83 132.41 20.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -86.87 159.67 8.9 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.35 2.034 . . . . 1.0 113.71 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.4 mt -113.51 116.29 29.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.6 ptm -140.85 149.5 42.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.511 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 86.6 t60 -130.42 122.57 28.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.03 -0.986 . . . . 1.0 108.812 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.441 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 51.5 t60 69.73 -126.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.144 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.441 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 93.9 mt-30 -100.91 5.85 43.44 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.781 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.531 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 5.7 pt-20 -111.31 156.72 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 34.4 tp -103.38 127.66 50.69 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.518 -1.29 . . . . 1.0 107.518 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.531 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 32.2 m95 -103.86 -34.98 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.44 -174.52 29.28 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.628 -1.273 . . . . 1.0 112.346 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.3 mt -137.11 122.35 19.27 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.422 -0.389 . . . . 1.0 111.677 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.463 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.8 tp -94.31 148.35 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.505 HG23 HG12 ' A' ' 153' ' ' VAL . 11.0 p -152.48 132.01 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.067 -0.653 . . . . 1.0 111.862 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.7 t -115.02 136.8 52.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.709 -0.678 . . . . 1.0 109.227 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.509 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 12.2 m80 -110.55 124.68 52.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -119.15 121.84 40.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.42 -17.36 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.807 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.591 -179.947 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.741 0.305 . . . . 1.0 111.263 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.548 ' OE2' ' CE2' ' A' ' 45' ' ' PHE . 38.5 tp10 -63.44 -35.94 82.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 1.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -65.82 -37.03 85.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.626 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -78.59 -52.16 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.709 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.1 t -44.28 -43.1 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.621 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 185' ' ' GLN . 6.9 p -75.39 -49.75 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.595 ' N ' HG13 ' A' ' 184' ' ' VAL . 58.1 tt0 -49.78 -34.36 19.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tp -72.7 -48.24 40.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.067 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.95 -45.87 64.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.93 95.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -63.11 -38.67 92.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.83 -31.32 71.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 49.1 t -76.05 -47.41 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.5 p -53.42 -34.33 57.4 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.41 -35.77 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.205 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.92 83.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.932 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.9 mt -56.92 -44.57 82.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.84 -50.51 64.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.386 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -61.85 -44.82 96.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.22 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.88 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.376 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -57.85 -44.06 86.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.1 tp -52.63 -38.39 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.5 t -51.71 -59.3 4.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.445 179.705 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 35' ' ' LEU . 5.5 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.872 0.367 . . . . 1.0 110.49 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 29.9 p-10 -51.84 -32.82 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.724 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.9 tt0 -76.59 -50.0 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.787 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 38' ' ' THR . 96.6 mt -55.18 -51.8 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.041 0.448 . . . . 1.0 110.899 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.488 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.8 mt -56.13 -30.25 61.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.935 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 39' ' ' VAL . 75.9 ttt180 -64.44 -40.25 95.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.407 -0.517 . . . . 1.0 109.661 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.93 -33.45 70.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.721 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 p -64.51 -37.35 87.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.346 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -73.35 -24.59 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.208 0.448 . . . . 1.0 112.208 -178.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -72.04 -40.81 68.11 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.48 -31.33 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.777 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 38' ' ' THR . 66.6 t -64.84 -56.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.339 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -53.55 -43.11 68.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 1.0 110.703 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.39 -43.17 71.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.288 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -65.64 -36.34 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -96.38 -15.02 22.07 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.706 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.77 26.05 53.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.0 p -80.01 147.29 31.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.9 p30 -54.11 -39.35 66.32 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.644 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -153.12 134.69 14.43 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.574 -0.85 . . . . 1.0 112.813 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -139.8 131.83 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.701 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' NZ ' ' CE1' ' A' ' 169' ' ' HIS . 25.2 pttm -138.73 152.86 48.33 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.294 -0.563 . . . . 1.0 111.614 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -98.15 140.91 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -130.8 131.18 44.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.45 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HE ' HG21 ' A' ' 65' ' ' VAL . 71.8 mtm180 -112.64 153.27 27.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.007 0.432 . . . . 1.0 111.217 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.4 136.87 41.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.677 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 61' ' ' HIS . 34.3 m-20 -97.21 150.58 36.97 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -41.94 -21.71 0.17 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.044 2.496 . . . . 1.0 114.528 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -103.04 3.44 36.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.6 -14.03 57.89 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.686 -0.769 . . . . 1.0 111.922 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 57' ' ' ASP . 66.2 m80 -78.86 150.05 32.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.43 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.57 162.11 25.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -134.34 155.78 49.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.034 0.445 . . . . 1.0 111.491 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 t -88.74 109.57 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.403 HG21 ' HE ' ' A' ' 55' ' ' ARG . 9.1 t -110.46 -5.15 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . . . -152.49 126.25 8.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.3 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.619 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 1.1 tm-20 -158.71 139.67 12.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 1.0 111.695 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.34 136.35 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -107.5 136.41 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.094 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.801 0.334 . . . . 1.0 111.372 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' H ' ' NH2' ' A' ' 50' ' ' ARG . 79.2 mt -102.92 15.19 30.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.946 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.6 mt -66.48 131.47 46.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.03 -5.21 72.3 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.818 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.3 154.52 21.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.333 0.566 . . . . 1.0 110.468 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 p -106.23 128.05 53.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.603 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -103.73 150.08 37.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.263 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.24 134.65 9.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.481 2.121 . . . . 1.0 111.46 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -62.56 -30.4 71.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.796 0.332 . . . . 1.0 110.368 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.4 -16.28 0.06 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.196 -0.762 . . . . 1.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' ALA . 55.6 t0 -58.3 -15.97 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.654 0.264 . . . . 1.0 110.99 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.12 143.44 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.468 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.59 -96.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.548 2.165 . . . . 1.0 111.699 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 2.7 pp20? -162.72 -28.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.92 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 22.5 pt-20 -70.55 -39.72 73.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.585 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.791 ' HB1' HH12 ' A' ' 101' ' ' ARG . . . -74.0 -40.34 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.649 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 61.0 ttp180 -63.14 -36.27 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.349 . . . . 1.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -60.82 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.926 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 94' ' ' LEU . 94.5 mt -63.92 -34.17 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 1.0 111.538 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 28.0 mtp180 -73.72 -31.55 63.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.295 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.54 ' C ' HE22 ' A' ' 99' ' ' GLN . 90.2 mt -96.8 -37.26 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.17 -16.84 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.616 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.8 OUTLIER 45.73 52.84 9.24 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.619 -0.832 . . . . 1.0 109.964 -178.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 99' ' ' GLN . 24.8 t -157.33 101.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 120.293 -0.563 . . . . 1.0 111.862 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.791 HH12 ' HB1' ' A' ' 91' ' ' ALA . 5.4 mtt180 -158.46 137.92 11.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.876 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -145.97 158.35 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.71 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.47 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 2.9 mp -108.04 128.23 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.249 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.7 t -82.9 164.63 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.476 ' H ' HG12 ' A' ' 104' ' ' VAL . 64.5 t0 -50.6 118.89 3.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.966 -1.016 . . . . 1.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 140' ' ' VAL . 12.1 p -51.28 -22.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.709 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -78.88 -37.82 39.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.797 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.35 63.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.192 0.52 . . . . 1.0 110.432 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 57.55 62.59 2.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.904 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -94.02 124.39 38.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.19 145.23 46.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -110.68 149.67 30.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.803 -1.09 . . . . 1.0 108.6 177.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.412 -179.281 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.493 1.464 0 CA-C-O 120.841 0.267 . . . . 1.0 112.375 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.7 m -120.27 131.13 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 112' ' ' SER . 19.7 t70 -43.61 137.57 3.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 1.0 111.378 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -36.22 -25.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.047 2.498 . . . . 1.0 113.696 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 136' ' ' ASP . 25.6 t -53.61 -59.72 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.771 -0.372 . . . . 1.0 111.239 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.5 ' CD2' HD11 ' A' ' 143' ' ' LEU . 73.8 t60 -69.62 -23.89 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.634 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 106' ' ' VAL . 61.2 t -59.11 -61.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -62.04 -40.93 97.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.428 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -45.94 -38.92 8.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.5 HD11 ' CD2' ' A' ' 139' ' ' HIS . 69.4 mt -72.92 -42.81 63.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -57.83 -43.51 85.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.6 t -62.55 -19.9 64.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.336 -0.847 . . . . 1.0 109.636 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.4 mmm -99.0 -0.55 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.09 18.93 75.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 99.0 t -109.32 142.97 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.728 0.299 . . . . 1.0 110.25 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -122.22 -26.01 4.76 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 111.997 0.369 . . . . 1.0 111.997 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p -152.5 118.65 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.727 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 p -129.76 142.21 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.004 0.43 . . . . 1.0 111.359 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tp -98.97 135.19 40.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.06 130.12 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.305 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.0 131.43 18.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -93.92 163.19 2.18 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.363 2.042 . . . . 1.0 113.656 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.3 mt -115.8 113.39 23.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.659 -1.237 . . . . 1.0 107.659 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.8 ptm -140.57 149.28 42.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.477 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.3 t60 -120.75 123.62 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.958 -1.019 . . . . 1.0 108.892 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.477 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 42.8 m-70 55.86 -118.08 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.122 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -97.44 0.55 47.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.802 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.516 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.01 142.74 34.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.784 1.031 . . . . 1.0 113.784 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 49.4 tp -99.59 123.57 43.98 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.535 -1.283 . . . . 1.0 107.535 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.516 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.4 m95 -103.33 -33.77 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.576 0.954 . . . . 1.0 113.576 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.14 31.95 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.351 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 54.4 mt -134.54 121.39 20.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.706 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.61 149.77 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.444 ' CG1' ' HZ3' ' A' ' 52' ' ' LYS . 10.8 p -157.19 134.13 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.013 -0.675 . . . . 1.0 111.821 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.5 t -114.23 137.47 51.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.464 ' CE1' ' NZ ' ' A' ' 52' ' ' LYS . 17.0 m80 -110.19 127.46 54.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 4.1 t60 -118.58 120.38 37.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.24 12.77 7.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.83 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.481 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 42.2 mm-40 . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.615 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.639 0.257 . . . . 1.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.42 -27.5 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.974 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -55.02 -49.78 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.665 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.494 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 5.0 pt20 -78.08 -52.14 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.655 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.494 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 80.1 t -44.28 -42.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.649 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.47 -49.3 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -50.42 -33.09 19.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 190' ' ' GLN . 20.6 tp -74.51 -49.4 22.25 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.065 -0.971 . . . . 1.0 109.112 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 187' ' ' LEU . 1.1 tt -52.35 -46.11 65.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.57 86.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -61.13 -38.33 86.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 186' ' ' LEU . 62.1 tt0 -66.53 -32.34 73.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.29 -47.27 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.8 p -51.96 -35.69 46.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 190' ' ' GLN . 27.7 mt -66.32 -35.66 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.212 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.71 78.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.983 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.6 -46.1 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -66.02 -50.29 64.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.374 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.04 -45.8 91.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.269 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.99 73.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.393 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.39 -41.8 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 tp -51.54 -35.72 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.962 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.8 p -57.29 -60.97 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.621 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.3 mp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.005 -0.998 . . . . 1.0 110.446 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD22 HD11 ' A' ' 35' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.576 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -49.63 -32.16 12.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.96 -48.28 25.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.791 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 38' ' ' THR . 26.6 mm -55.02 -49.95 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.046 0.45 . . . . 1.0 110.939 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 HD22 ' A' ' 31' ' ' LEU . 83.2 mt -55.16 -32.95 62.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.935 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 39' ' ' VAL . 33.9 ttm180 -61.93 -42.34 98.98 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.9 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.787 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 34' ' ' ILE . 82.2 p -66.61 -36.66 83.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 1.0 112.242 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.633 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p -71.25 -24.51 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.174 0.435 . . . . 1.0 112.174 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -78.74 -37.19 41.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.311 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -72.52 -43.41 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.78 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 43' ' ' ARG . 33.9 m -60.14 -49.69 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.304 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.602 ' N ' HG23 ' A' ' 42' ' ' VAL . 71.2 ttp85 -53.33 -45.79 69.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.683 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.53 68.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.255 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -65.7 -36.68 84.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.758 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CB ' HG23 ' A' ' 48' ' ' THR . 14.4 mt -96.68 -14.29 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.704 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.84 25.96 38.9 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.616 HG22 ' CE1' ' A' ' 170' ' ' HIS . 69.5 p -79.29 149.24 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.9 m-20 -49.1 -42.6 39.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.635 HH12 ' CG2' ' A' ' 148' ' ' VAL . 14.9 ptt-85 -158.28 145.44 17.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.576 -0.85 . . . . 1.0 112.791 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.7 t -137.75 135.13 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.943 -1.026 . . . . 1.0 108.684 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 67' ' ' GLU . 34.6 mttt -136.01 147.07 47.81 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.265 -0.574 . . . . 1.0 111.651 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 166' ' ' LEU . 46.9 t -98.81 140.18 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.407 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 16.6 t80 -129.67 130.48 45.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.441 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -111.8 151.76 28.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 1.0 111.215 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.7 OUTLIER -101.91 139.05 38.07 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.631 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.8 m-20 -103.54 154.33 37.94 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -39.98 -51.95 2.93 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.045 2.496 . . . . 1.0 114.51 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.93 -5.03 23.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.11 -8.16 44.96 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.763 -0.732 . . . . 1.0 111.939 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ASP . 57.7 m80 -76.42 148.98 36.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.445 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.77 159.05 23.78 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -132.99 156.09 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.015 0.436 . . . . 1.0 111.449 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 80' ' ' LEU . 7.5 p -94.0 112.05 26.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -115.33 0.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.633 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.48 126.08 8.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.341 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 81.9 tt0 -153.75 138.47 17.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 1.0 111.697 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.91 133.39 51.89 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -112.02 138.54 48.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.35 -0.54 . . . . 1.0 112.055 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.775 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.853 0.359 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' O ' HG11 ' A' ' 64' ' ' VAL . 32.0 mt -114.66 10.62 16.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 67' ' ' GLU . 77.8 mt -55.52 130.1 41.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.517 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.99 -2.53 87.11 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.858 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 64' ' ' VAL . 88.7 mt -85.7 144.86 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.31 0.555 . . . . 1.0 110.483 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 p -102.56 131.26 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.59 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -104.39 105.31 49.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.214 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.26 136.31 5.64 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.555 2.17 . . . . 1.0 111.484 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.854 0.359 . . . . 1.0 110.391 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.06 -17.92 0.12 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.9 m-20 -64.74 -18.36 64.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.606 0.241 . . . . 1.0 111.028 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.79 133.54 18.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.539 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.57 -96.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.556 2.171 . . . . 1.0 111.672 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.7 pt-20 -164.19 -42.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.947 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 86.1 tt0 -52.95 -43.31 66.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.596 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.35 70.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.572 ' HE ' HD23 ' A' ' 162' ' ' LEU . 60.8 ttt180 -65.56 -31.61 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.757 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -64.84 -37.93 89.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 101' ' ' ARG . 8.7 mt -59.19 -37.76 78.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.531 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -68.52 -33.88 74.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -77.46 -30.32 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.291 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.6 mt -94.77 -39.53 10.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.0 -11.81 9.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.542 HE22 ' C ' ' A' ' 97' ' ' LEU . 2.9 mp0 46.64 50.53 12.97 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.958 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 99' ' ' GLN . 16.1 t -152.57 111.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.457 HH12 HD13 ' A' ' 94' ' ' LEU . 3.8 tpt180 -164.32 130.13 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.876 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -143.97 156.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.66 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.489 HD12 ' OG ' ' A' ' 151' ' ' SER . 54.7 mt -111.99 127.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.209 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.59 169.65 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.423 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 27.5 m-20 -50.87 115.86 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.305 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.618 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.6 p -50.51 -19.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.661 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -76.28 -40.44 51.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -62.29 -8.18 5.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.132 0.491 . . . . 1.0 110.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 9.7 pt20 45.52 62.5 2.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.751 . . . . 1.0 112.868 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -92.5 127.02 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -118.75 145.17 45.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.623 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -111.04 151.25 28.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.757 -1.11 . . . . 1.0 108.589 178.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.426 -179.673 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.623 ' C ' ' HG ' ' A' ' 112' ' ' SER . 50.9 Cg_endo . . . . . 0 N--CA 1.492 1.401 0 CA-C-O 120.809 0.254 . . . . 1.0 112.402 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -119.78 128.71 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.501 ' HA ' ' H ' ' A' ' 112' ' ' SER . 5.0 t70 -44.86 140.37 3.42 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.802 0.334 . . . . 1.0 111.335 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -36.32 -26.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.198 2.599 . . . . 1.0 113.629 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 136' ' ' ASP . 38.4 t -54.22 -61.45 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.768 -0.373 . . . . 1.0 111.2 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -70.27 -24.92 63.13 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.61 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.618 ' CG1' HG23 ' A' ' 106' ' ' VAL . 59.2 t -60.51 -58.59 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -62.1 -38.88 90.58 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.363 -0.535 . . . . 1.0 110.402 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -47.29 -36.8 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.33 -43.4 60.86 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -58.15 -43.52 87.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.4 t -62.34 -19.28 63.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.687 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.9 mmm -100.15 0.93 41.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.158 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.7 19.46 77.8 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.635 ' CG2' HH12 ' A' ' 50' ' ' ARG . 99.0 t -108.72 144.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.624 0.249 . . . . 1.0 110.369 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.95 -27.44 5.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.423 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 51.1 m -149.71 121.43 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.489 ' OG ' HD12 ' A' ' 103' ' ' ILE . 87.9 p -130.45 141.8 50.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 1.0 111.418 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -103.21 133.74 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.9 t -112.64 129.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.247 -0.581 . . . . 1.0 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.69 132.83 21.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.27 164.52 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.362 2.042 . . . . 1.0 113.738 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 mt -117.05 114.31 23.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.64 -1.245 . . . . 1.0 107.64 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.432 ' H ' ' HB2' ' A' ' 192' ' ' SER . 23.5 ptm -141.47 153.02 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.556 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 58.9 t60 -126.97 126.42 43.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.9 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.556 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 38.8 m80 57.0 -120.87 1.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.157 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -97.8 2.32 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.791 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.58 145.3 31.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.572 HD23 ' HE ' ' A' ' 92' ' ' ARG . 51.7 tp -100.76 124.25 46.13 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 75.3 m95 -102.94 -33.22 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 54' ' ' TYR . . . -162.88 -172.33 30.23 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.598 -1.286 . . . . 1.0 112.3 -177.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.62 122.67 19.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.426 -0.387 . . . . 1.0 111.682 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -95.99 149.35 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.7 p -154.68 133.81 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.981 -0.687 . . . . 1.0 111.836 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 96.4 p -116.17 133.74 55.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.234 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -108.43 128.35 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.616 ' CE1' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.4 123.29 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.269 -1.012 . . . . 1.0 108.269 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.76 -18.94 62.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.774 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.585 0.231 . . . . 1.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.8 mt-10 -68.68 -26.83 65.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 1.0 110.983 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.25 -38.27 88.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.646 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -54.86 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.704 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -44.22 -41.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.652 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 185' ' ' GLN . 23.4 m -74.13 -47.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.586 ' N ' HG23 ' A' ' 184' ' ' VAL . 58.1 tt0 -50.68 -33.08 21.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.3 tt -72.84 -50.03 26.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.074 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.4 -44.61 65.46 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.42 92.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -58.42 -37.37 75.23 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -67.77 -31.3 71.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.61 -47.78 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.432 ' HB2' ' H ' ' A' ' 157' ' ' MET . 44.1 p -50.32 -32.2 16.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -74.98 -33.95 30.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.094 -0.957 . . . . 1.0 110.236 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.9 79.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.98 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 196' ' ' ALA . 22.4 pt -63.14 -28.91 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.05 -52.3 10.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.356 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.23 -41.81 96.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.302 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.61 72.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.409 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.03 -43.89 87.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.57 -35.77 54.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.707 -0.397 . . . . 1.0 111.003 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -51.08 -57.49 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.627 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.413 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.915 0.388 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 30.9 p-10 -50.66 -32.67 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.677 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 52.7 tt0 -75.67 -49.99 16.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.863 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.77 -50.58 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 1.0 110.936 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.468 ' O ' ' OG1' ' A' ' 38' ' ' THR . 65.8 mt -55.82 -31.04 62.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.001 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 39' ' ' VAL . 87.5 mtt180 -67.13 -38.32 85.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.412 -0.515 . . . . 1.0 109.757 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.53 -31.99 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.754 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 42' ' ' VAL . 77.7 p -67.13 -37.77 84.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.553 . . . . 1.0 112.329 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.515 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.5 p -73.57 -22.79 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -73.09 -40.2 65.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.337 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.92 -33.61 59.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.746 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' THR . 79.8 t -62.27 -56.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.349 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -52.91 -42.91 65.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 1.0 110.656 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.78 -45.5 74.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.327 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.29 -36.79 85.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.87 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.74 -16.12 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.715 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.51 24.84 48.25 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 p -79.21 146.94 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -51.62 -42.23 61.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.657 HH22 ' CG ' ' A' ' 77' ' ' LEU . 67.7 ttt180 -153.31 136.45 15.61 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.635 -0.826 . . . . 1.0 112.819 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 8.8 t -139.22 130.67 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.88 -1.055 . . . . 1.0 108.751 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -137.26 150.61 47.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.349 -0.541 . . . . 1.0 111.69 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 166' ' ' LEU . 48.2 t -98.86 140.42 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -129.28 131.99 47.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.488 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -110.9 148.91 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 1.0 111.22 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.8 130.53 48.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.692 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 61' ' ' HIS . 9.9 m-20 -90.53 152.31 45.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -49.5 -18.68 2.56 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.055 2.504 . . . . 1.0 114.466 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.1 4.96 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.137 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 99.79 -15.56 59.48 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.698 -0.763 . . . . 1.0 111.875 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 74.1 m80 -79.86 151.09 30.41 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.88 163.75 25.85 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -135.39 157.55 46.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.973 0.416 . . . . 1.0 111.5 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -90.91 110.6 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 65' ' ' VAL . 15.8 t -111.53 -3.44 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.23 125.89 8.92 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.313 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' OE2' ' CZ ' ' A' ' 50' ' ' ARG . 79.9 tt0 -155.18 138.5 15.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.119 0.485 . . . . 1.0 111.746 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.78 139.89 52.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -131.17 146.03 52.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.031 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.763 0 N-CA-C 110.564 -1.014 . . . . 1.0 110.564 179.663 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.775 0.321 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.657 ' CG ' HH22 ' A' ' 50' ' ' ARG . 26.8 mt -94.08 11.57 29.43 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.421 HD21 ' CB ' ' A' ' 67' ' ' GLU . 86.9 mt -56.48 130.43 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -3.5 87.0 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.369 -0.832 . . . . 1.0 112.854 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.95 146.83 27.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.336 0.568 . . . . 1.0 110.463 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -107.8 138.39 44.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.633 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -110.71 149.76 40.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.193 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.49 133.98 10.9 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.569 2.179 . . . . 1.0 111.44 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -57.22 -31.17 65.22 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.433 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.78 -16.88 0.23 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 30.4 p-10 -66.77 -17.3 64.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.661 0.267 . . . . 1.0 111.029 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.0 mt -137.02 98.41 10.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.506 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 43.7 Cg_exo -39.5 -95.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.507 2.138 . . . . 1.0 111.727 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 82.9 tt0 -163.67 -42.51 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.885 0.374 . . . . 1.0 110.991 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -54.64 -39.68 68.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.571 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.77 -42.01 51.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.741 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.546 HH12 HH11 ' A' ' 96' ' ' ARG . 73.6 ttp85 -61.68 -37.51 84.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.827 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.471 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 91.5 mtt-85 -61.95 -34.86 76.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.001 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.08 -33.69 76.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.5 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -68.39 -33.45 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.546 HH11 HH12 ' A' ' 92' ' ' ARG . 12.7 mtm180 -77.01 -30.74 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.236 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' C ' HE22 ' A' ' 99' ' ' GLN . 97.0 mt -96.03 -38.55 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.71 -14.11 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.188 1.181 . . . . 1.0 114.188 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.644 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.4 mp0 47.82 55.94 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.878 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.7 m -158.95 112.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.949 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.487 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 4.2 tpp180 -168.04 133.96 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.797 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.502 HG23 HD23 ' A' ' 152' ' ' LEU . 2.0 p -144.56 157.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.709 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.64 HG23 HG11 ' A' ' 135' ' ' VAL . 8.2 mt -110.51 129.1 66.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.322 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 105' ' ' ASP . 16.7 t -84.06 165.97 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.615 ' N ' HG12 ' A' ' 104' ' ' VAL . 57.1 t0 -47.9 119.53 2.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.947 -1.024 . . . . 1.0 112.282 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.22 -23.51 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.685 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -82.01 -37.09 27.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.777 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.9 -16.13 6.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.162 0.506 . . . . 1.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 57.35 60.16 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 1.0 112.844 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.5 p -95.12 125.98 40.15 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -120.98 138.63 54.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.667 0.988 . . . . 1.0 113.667 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -111.74 156.26 22.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.742 -1.117 . . . . 1.0 108.642 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.403 HG23 ' C ' ' A' ' 112' ' ' SER . 30.7 pt . . . . . 0 C--N 1.325 -0.495 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.475 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.834 0.264 . . . . 1.0 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.64 HG11 HG23 ' A' ' 103' ' ' ILE . 1.1 p -115.27 130.16 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' N ' ' OG ' ' A' ' 112' ' ' SER . 7.9 t0 -44.96 131.99 5.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 1.0 111.393 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.86 -31.02 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.092 2.528 . . . . 1.0 113.662 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.3 t -47.24 -61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.231 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.582 ' CD2' HD11 ' A' ' 143' ' ' LEU . 43.7 t60 -70.88 -23.14 62.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.698 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.49 -58.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.87 -41.23 97.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.331 -0.547 . . . . 1.0 110.398 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.54 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 66.7 t80 -47.41 -38.32 13.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 139' ' ' HIS . 32.9 mt -72.05 -43.68 64.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.04 -42.75 77.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -35.09 75.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.61 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 63.2 mtp -83.39 -1.54 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.071 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.39 75.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.03 143.48 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.272 . . . . 1.0 110.341 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.16 -43.46 2.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.025 0.38 . . . . 1.0 112.025 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.7 m -134.1 119.84 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.763 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.0 m -132.93 144.11 49.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.931 0.396 . . . . 1.0 111.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 102' ' ' VAL . 14.2 mt -99.02 136.83 38.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.59 105.88 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.337 -0.545 . . . . 1.0 112.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 57.5 t -112.83 128.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.212 -1.032 . . . . 1.0 108.212 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -93.36 162.54 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.369 2.046 . . . . 1.0 113.782 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.49 116.72 28.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.605 -1.258 . . . . 1.0 107.605 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.545 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.7 ptm -141.1 148.23 39.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.9 t60 -126.78 132.46 51.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.016 -0.993 . . . . 1.0 108.832 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 23.3 m-70 56.62 -126.52 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -98.31 3.33 48.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.776 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 12.4 pt-20 -109.78 153.25 24.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.703 1.001 . . . . 1.0 113.703 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.7 tp -103.88 127.39 51.4 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.542 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 43.6 m95 -103.88 -32.41 9.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.543 0.942 . . . . 1.0 113.543 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 -174.13 31.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.403 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -135.58 125.12 25.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.388 . . . . 1.0 111.701 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.569 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.5 tp -96.9 149.92 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.7 p -156.5 133.43 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.046 -0.661 . . . . 1.0 111.784 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 t -114.77 135.49 54.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.259 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -110.92 128.61 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -120.75 130.54 54.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.91 26.56 2.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.775 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.945 -0.302 . . . . 1.0 110.63 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.648 0.261 . . . . 1.0 111.205 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -70.72 -30.67 67.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.521 -0.308 . . . . 1.0 110.947 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.08 -33.68 74.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.584 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -77.84 -54.58 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.922 -0.311 . . . . 1.0 111.704 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.4 t -42.92 -41.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 185' ' ' GLN . 28.8 m -75.42 -47.08 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.538 ' N ' HG23 ' A' ' 184' ' ' VAL . 56.2 tt0 -51.8 -32.88 33.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 190' ' ' GLN . 43.2 tp -75.7 -51.69 12.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.66 -46.4 67.15 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.59 98.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.62 ' O ' HD13 ' A' ' 193' ' ' ILE . 61.7 t0 -63.79 -37.01 85.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 186' ' ' LEU . 51.6 tt0 -68.05 -29.24 68.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -76.36 -46.01 33.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 157' ' ' MET . 8.2 t -50.87 -37.52 43.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.1 mp -64.1 -36.83 78.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.261 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.73 82.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.612 . . . . 1.0 110.903 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.33 -47.52 81.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.457 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -64.82 -49.41 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.712 -0.676 . . . . 1.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.43 -45.63 92.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.175 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.94 71.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.375 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.2 -43.11 82.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.29 -35.64 62.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -55.02 -60.69 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.5 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.407 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 1.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 28.8 p-10 -70.91 -32.36 69.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.723 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 53.3 tt0 -77.45 -48.26 17.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.807 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' THR . 96.6 mt -56.02 -50.34 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.055 0.455 . . . . 1.0 110.964 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.471 ' O ' ' OG1' ' A' ' 38' ' ' THR . 78.2 mt -57.56 -30.73 65.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.942 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 39' ' ' VAL . 90.0 mtt180 -66.73 -38.81 87.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.391 -0.524 . . . . 1.0 109.781 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -30.13 65.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.787 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 34' ' ' ILE . 69.0 p -69.69 -36.42 75.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 1.0 112.314 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -71.63 -25.44 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.52 -31.86 32.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 1.0 111.296 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -76.8 -38.34 54.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.709 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.629 HG23 ' N ' ' A' ' 43' ' ' ARG . 30.4 m -66.53 -52.83 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.304 -177.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.629 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -51.87 -43.3 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 1.0 110.669 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.2 -44.12 71.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.317 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -64.66 -35.79 82.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.842 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.29 -13.01 23.68 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.703 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.03 25.83 47.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 p -80.03 148.82 30.94 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.991 -0.374 . . . . 1.0 109.991 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' GLY . 87.8 m-20 -50.25 -42.66 52.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.643 0.608 . . . . 1.0 112.643 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.556 HH21 ' CG2' ' A' ' 148' ' ' VAL . 18.7 ptt-85 -158.4 149.78 21.0 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.633 -0.827 . . . . 1.0 112.805 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -141.33 136.14 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.962 -1.017 . . . . 1.0 108.743 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' NZ ' ' CE1' ' A' ' 169' ' ' HIS . 29.8 mttp -137.07 145.58 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.624 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.5 t -100.91 142.1 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 20.7 t80 -130.44 133.27 46.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 1.0 110.426 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.444 HH12 ' CG2' ' A' ' 195' ' ' ILE . 78.1 mtp85 -114.44 154.1 28.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.019 0.438 . . . . 1.0 111.14 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.23 138.19 40.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.711 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -97.42 153.64 38.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -45.39 -21.1 0.65 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.012 2.474 . . . . 1.0 114.463 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -102.83 2.97 36.14 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.206 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.32 -13.68 56.96 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.661 -0.781 . . . . 1.0 111.957 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 57' ' ' ASP . 59.1 m80 -78.72 150.13 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.416 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.29 161.6 25.27 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -133.74 155.92 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.473 . . . . 1.0 111.473 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.22 108.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 65' ' ' VAL . 13.0 t -109.0 -4.99 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.12 0.415 . . . . 1.0 112.12 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.04 125.96 8.41 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.329 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB3' HD21 ' A' ' 78' ' ' LEU . 55.0 tt0 -154.89 139.14 16.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.18 0.514 . . . . 1.0 111.739 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.36 131.82 51.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.6 mtm-85 -103.15 135.08 45.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.071 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.755 0.312 . . . . 1.0 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.37 9.96 38.02 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.978 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 67' ' ' GLU . 95.1 mt -61.75 131.54 50.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.13 73.08 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.877 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.05 152.5 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.345 0.572 . . . . 1.0 110.464 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 81' ' ' THR . 9.0 t -107.43 131.23 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.602 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.07 148.79 36.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.273 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.8 129.18 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.489 2.126 . . . . 1.0 111.459 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -56.97 -31.13 64.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.866 0.365 . . . . 1.0 110.463 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.92 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.7 m-20 -63.72 -26.39 68.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.562 0.22 . . . . 1.0 111.02 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.5 mt -122.59 132.99 24.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.555 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.6 -103.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.608 2.205 . . . . 1.0 111.633 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 22.3 pt-20 -159.66 -40.77 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.032 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 87.2 tt0 -60.27 -41.28 92.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.623 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.82 -39.86 63.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.631 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 60.9 ttp180 -63.14 -37.5 87.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 1.0 110.808 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.72 -34.66 74.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.941 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.84 -32.23 73.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.614 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.41 -35.84 78.24 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.3 mtm180 -73.55 -33.63 64.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.215 -0.902 . . . . 1.0 111.262 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.574 ' C ' HE22 ' A' ' 99' ' ' GLN . 86.4 mt -95.54 -37.67 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.782 1.03 . . . . 1.0 113.782 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.16 -15.05 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -175.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.662 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER 47.48 57.45 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.658 -0.817 . . . . 1.0 109.969 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.4 m -159.57 114.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.88 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.475 ' HE ' ' CA ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -168.44 132.46 1.57 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.878 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.64 157.78 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.688 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 135' ' ' VAL . 6.3 mt -109.75 126.98 66.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.266 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.69 169.56 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -49.84 115.21 1.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.952 -1.022 . . . . 1.0 112.292 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 140' ' ' VAL . 55.6 t -51.57 -17.68 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.72 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -81.97 -36.69 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.789 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -60.71 -8.91 3.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.172 0.511 . . . . 1.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.588 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 16.2 pt20 46.8 60.21 3.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.844 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 p -94.43 129.19 41.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -119.69 142.36 48.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.681 0.993 . . . . 1.0 113.681 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.2 p -109.29 149.53 29.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.753 -1.112 . . . . 1.0 108.661 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 113' ' ' ILE . 6.2 mt . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.451 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 120.786 0.244 . . . . 1.0 112.374 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.733 HG21 HG12 ' A' ' 103' ' ' ILE . 4.6 t -118.26 130.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 138' ' ' CYS . 16.9 t70 -45.2 135.9 5.22 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.385 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -36.97 -21.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.07 2.513 . . . . 1.0 113.677 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 136' ' ' ASP . 54.1 t -56.21 -60.17 3.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.758 -0.377 . . . . 1.0 111.237 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -71.26 -25.01 62.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.64 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 106' ' ' VAL . 19.3 t -60.14 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.668 0.618 . . . . 1.0 112.668 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 144' ' ' LYS . 86.1 t60 -63.18 -39.48 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.368 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' O ' ' OG ' ' A' ' 145' ' ' SER . 77.6 t80 -45.77 -36.07 4.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.69 -42.48 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.68 -42.45 92.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 97.4 p -64.16 -20.01 65.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.618 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 25.7 mmm -99.98 1.58 42.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.06 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.89 19.45 77.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.556 ' CG2' HH21 ' A' ' 50' ' ' ARG . 86.4 t -109.38 144.22 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.719 0.295 . . . . 1.0 110.275 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.34 -27.47 6.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.974 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 p -152.0 121.9 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.685 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.7 t -131.04 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 111.474 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.82 132.64 53.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.525 HG12 HG23 ' A' ' 167' ' ' VAL . 31.9 m -117.86 139.49 44.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.336 -0.546 . . . . 1.0 112.323 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.6 t -134.09 134.27 22.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -89.49 159.64 5.41 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.381 2.054 . . . . 1.0 113.718 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.1 mt -114.63 113.59 24.55 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.0 ptm -142.09 153.36 44.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.778 0.658 . . . . 1.0 112.778 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -127.85 122.92 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.872 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 160' ' ' GLN . 17.2 t60 59.65 -118.1 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.133 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.477 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 13.5 pt20 -99.65 1.15 43.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -106.02 143.73 33.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.84 126.42 45.94 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -105.47 -35.37 7.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.3 -173.75 27.12 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.654 -1.26 . . . . 1.0 112.353 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.8 tp -138.07 122.5 18.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.449 -0.375 . . . . 1.0 111.657 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.408 HD12 HG22 ' A' ' 53' ' ' VAL . 11.3 tp -93.76 144.77 25.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 153' ' ' VAL . 8.4 p -151.86 132.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.856 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.9 m -118.36 128.97 55.15 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.435 ' CE1' ' NZ ' ' A' ' 52' ' ' LYS . 48.6 m80 -100.22 126.14 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.647 0.61 . . . . 1.0 112.647 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.8 t60 -119.54 109.98 16.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.37 49.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 32.9 mm-40 . . . . . 0 C--N 1.326 -0.433 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.614 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.628 0.252 . . . . 1.0 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.77 -33.53 72.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.24 -42.7 91.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.626 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -67.28 -52.5 39.89 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.664 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.3 t -42.08 -43.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.63 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.05 -46.19 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -52.13 -32.78 37.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.058 -1.089 . . . . 1.0 108.058 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 190' ' ' GLN . 22.8 tp -74.66 -55.97 5.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.088 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -52.03 -45.86 64.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.98 74.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.53 -37.93 82.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 186' ' ' LEU . 49.1 tp60 -64.96 -33.07 75.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.99 -46.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.2 p -51.99 -35.15 45.63 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 mt -68.94 -35.03 67.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.265 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.57 -41.69 75.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.914 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.444 ' CG2' HH12 ' A' ' 55' ' ' ARG . 65.7 mt -56.71 -45.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.38 58.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.367 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -61.73 -44.31 97.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.266 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.74 70.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 1.0 111.419 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.22 -43.43 82.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.181 0.438 . . . . 1.0 112.181 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.7 mp -52.53 -33.26 44.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.984 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.1 -58.76 5.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.691 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.548 HD23 ' C ' ' A' ' 202' ' ' LEU . 2.7 tt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.459 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.808 0.337 . . . . 1.0 110.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.3 t0 -70.11 -33.2 71.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.55 -48.49 19.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.834 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -54.93 -53.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 1.0 110.924 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.487 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.7 mt -55.72 -31.41 62.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.96 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' O ' HG12 ' A' ' 39' ' ' VAL . 67.0 ttt180 -62.84 -39.54 94.67 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.383 -0.527 . . . . 1.0 109.822 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.08 -32.74 69.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.762 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 42' ' ' VAL . 74.9 p -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.272 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 2.3 p -73.75 -25.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.211 0.448 . . . . 1.0 112.211 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.44 -44.72 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.287 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.91 -37.85 72.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.751 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' THR . 68.2 t -57.11 -54.25 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.596 -0.274 . . . . 1.0 111.394 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 47' ' ' GLY . 69.9 ttt-85 -52.3 -45.56 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 1.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.45 -44.63 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.257 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -65.4 -39.01 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.795 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.92 -14.69 21.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.68 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.71 25.68 22.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.596 -1.001 . . . . 1.0 110.596 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.466 ' OG1' ' CD2' ' A' ' 170' ' ' HIS . 14.2 t -78.87 147.44 33.14 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -52.91 -41.61 64.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.613 ' HE ' ' CD ' ' A' ' 67' ' ' GLU . 65.0 ttt-85 -152.67 133.44 13.95 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.759 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 51' ' ' VAL . 11.2 p -141.45 132.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.912 -1.04 . . . . 1.0 108.648 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -137.82 153.59 49.61 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.682 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 54.4 t -98.33 141.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 11.5 t80 -131.77 133.56 44.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.483 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -113.81 152.56 30.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 1.0 111.166 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.42 134.92 45.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.769 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 61' ' ' HIS . 19.7 m-20 -99.25 154.24 37.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -38.35 -52.19 1.98 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 122.952 2.435 . . . . 1.0 114.549 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' OE2' ' CD2' ' A' ' 61' ' ' HIS . 22.2 pt-20 -70.69 -6.56 38.15 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.71 -6.76 38.31 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.656 -0.783 . . . . 1.0 111.862 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-70 -77.21 149.14 35.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.42 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -135.52 159.54 24.17 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -133.42 155.15 50.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 1.0 111.527 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.19 110.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 65' ' ' VAL . 14.4 t -111.95 -3.99 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.127 0.417 . . . . 1.0 112.127 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.59 124.74 8.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.287 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.613 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 65.3 tt0 -153.29 138.46 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.176 0.512 . . . . 1.0 111.689 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.53 138.13 52.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -133.46 147.34 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.989 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.578 -1.009 . . . . 1.0 110.578 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.864 0.364 . . . . 1.0 111.331 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 HH22 ' A' ' 50' ' ' ARG . 21.3 mt -107.79 9.05 29.06 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.408 HD21 ' CB ' ' A' ' 67' ' ' GLU . 76.8 mt -56.46 131.5 48.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -3.97 86.6 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.88 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.49 147.12 27.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.342 -0.543 . . . . 1.0 110.466 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -104.16 129.83 51.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.54 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -106.17 105.64 54.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.269 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.3 139.35 4.27 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.485 2.123 . . . . 1.0 111.524 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -63.18 -28.21 69.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.817 0.342 . . . . 1.0 110.413 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.91 -17.52 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 24.4 p-10 -68.16 -14.43 62.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.61 0.243 . . . . 1.0 110.996 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.02 133.68 25.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.481 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.16 -102.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.551 2.167 . . . . 1.0 111.639 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -157.84 -43.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.003 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -57.91 -40.34 80.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.636 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -40.65 57.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.679 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 69.3 ttt180 -62.32 -38.35 89.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -62.56 -34.13 76.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.965 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD13 ' NH1' ' A' ' 101' ' ' ARG . 7.9 mt -63.99 -33.37 75.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.593 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -68.92 -33.72 74.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.8 mtm180 -78.07 -30.03 49.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.122 -0.945 . . . . 1.0 111.249 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.435 ' C ' HE22 ' A' ' 99' ' ' GLN . 37.5 mt -95.69 -38.93 10.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.67 -12.6 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.508 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.2 mp0 46.57 49.02 13.97 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 t -152.22 110.86 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 101' ' ' ARG . 0.4 OUTLIER -165.41 138.34 4.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.933 178.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.4 p -154.11 157.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.709 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.569 HG12 HG21 ' A' ' 135' ' ' VAL . 2.9 mp -111.94 129.85 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.203 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 104' ' ' VAL . 1.2 m -87.33 170.84 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.924 0.712 . . . . 1.0 112.924 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -49.21 114.57 1.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.234 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.414 HG13 ' CG1' ' A' ' 140' ' ' VAL . 39.2 t -51.19 -19.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.686 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -81.18 -37.31 28.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -17.48 19.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 1.0 110.414 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.433 HE21 ' NH2' ' A' ' 111' ' ' ARG . 49.5 tt0 56.56 61.16 2.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.829 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 m -95.2 125.75 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.433 ' NH2' HE21 ' A' ' 109' ' ' GLN . 92.4 mtt180 -118.95 143.98 46.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.65 0.981 . . . . 1.0 113.65 -176.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.3 p -110.54 149.4 30.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.641 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 113' ' ' ILE . 6.4 mt . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.437 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.769 0.237 . . . . 1.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.569 HG21 HG12 ' A' ' 103' ' ' ILE . 2.9 t -116.26 127.43 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.546 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -45.27 144.98 2.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.74 0.305 . . . . 1.0 111.347 -178.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -38.28 -18.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.123 2.549 . . . . 1.0 113.658 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 136' ' ' ASP . 34.6 t -56.98 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.259 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.71 -26.01 62.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.659 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG1' HG13 ' A' ' 106' ' ' VAL . 45.3 t -56.43 -63.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 142' ' ' TYR . 12.8 p-80 -66.84 -40.88 88.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.386 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.627 ' N ' ' CD2' ' A' ' 141' ' ' HIS . 71.1 t80 -44.3 -39.46 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.6 -41.69 62.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.185 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.25 -43.38 92.42 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -63.34 -21.35 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.618 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.4 mmm -99.14 0.35 43.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.149 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.22 17.46 79.98 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.599 -1.001 . . . . 1.0 110.599 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.73 145.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 1.0 110.289 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.14 -20.75 7.89 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.055 0.391 . . . . 1.0 112.055 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 120.07 4.76 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.778 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -124.96 132.49 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.915 0.388 . . . . 1.0 111.412 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -98.73 127.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.0 108.49 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.279 -0.568 . . . . 1.0 112.266 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.63 135.18 20.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -92.28 166.05 2.98 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.408 2.072 . . . . 1.0 113.737 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.39 116.48 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 24.0 ptm -141.58 151.83 43.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.621 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 32.7 t-80 -124.1 123.59 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.948 -1.024 . . . . 1.0 108.824 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.621 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 45.0 m-70 56.72 -118.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.12 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -98.06 0.58 46.45 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.848 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.467 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.23 143.25 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -176.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.4 tp -99.23 125.71 44.89 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.542 -1.281 . . . . 1.0 107.542 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.467 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 61.7 m95 -104.96 -35.25 7.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.538 0.94 . . . . 1.0 113.538 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.58 -173.58 25.26 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.401 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.7 tp -139.51 120.96 15.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.473 -0.363 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.7 tp -93.63 150.48 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.4 p -155.73 133.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.028 -0.669 . . . . 1.0 111.869 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -115.03 136.03 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 9.7 m80 -108.73 123.44 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.466 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 54.2 m80 -117.06 125.22 50.98 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.19 -16.63 57.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.817 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--N 1.326 -0.429 0 C-N-CA 120.911 -0.316 . . . . 1.0 110.608 179.889 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 183' ' ' VAL . 78.3 mm-40 . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.713 0.292 . . . . 1.0 111.288 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 184' ' ' VAL . 77.8 mm-40 -71.41 -28.99 64.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.998 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.61 -46.91 86.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.614 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 13.1 pt20 -80.18 -47.07 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.667 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 179' ' ' GLU . 43.1 t -42.86 -45.58 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.644 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 185' ' ' GLN . 34.1 m -74.41 -47.34 40.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.557 ' N ' HG23 ' A' ' 184' ' ' VAL . 40.5 tp60 -49.54 -32.06 11.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.123 -1.066 . . . . 1.0 108.123 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 190' ' ' GLN . 13.8 tp -73.89 -52.11 14.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.034 -0.984 . . . . 1.0 109.098 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.86 -47.51 67.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.62 83.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.429 -0.952 . . . . 1.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.56 ' O ' HD13 ' A' ' 193' ' ' ILE . 65.0 t0 -62.41 -41.73 98.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 186' ' ' LEU . 59.1 tp60 -61.66 -31.3 71.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.84 -44.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.2 p -51.67 -35.8 43.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -66.51 -37.19 79.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.161 -0.927 . . . . 1.0 110.276 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.22 -41.78 80.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.2 mt -56.83 -46.3 83.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -65.94 -49.55 67.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.394 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.46 -45.36 93.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.216 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.19 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.362 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -58.26 -44.13 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.219 0.451 . . . . 1.0 112.219 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.93 -32.85 54.99 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.996 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 m -51.87 -57.03 10.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.614 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.096 -0.954 . . . . 1.0 110.441 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 35' ' ' LEU . 1.2 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.713 0.292 . . . . 1.0 110.484 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -48.93 -35.72 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 26.4 mp0 -74.49 -50.7 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.783 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.28 -50.56 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 1.0 110.94 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 38' ' ' THR . 30.5 mt -54.78 -29.7 54.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.95 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.515 ' O ' HG12 ' A' ' 39' ' ' VAL . 76.6 ttt180 -64.37 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 109.754 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.57 -32.86 68.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.835 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.62 ' O ' HG23 ' A' ' 42' ' ' VAL . 70.5 p -66.46 -36.97 84.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.333 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 2.4 p -73.65 -24.48 20.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -45.99 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.308 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -68.55 -38.62 80.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.739 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 38' ' ' THR . 76.9 t -54.78 -55.14 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.296 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -50.11 -43.87 51.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.693 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.54 77.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.269 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.52 -40.72 97.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.753 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -96.92 -14.8 21.52 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.65 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.62 25.8 22.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 p -79.65 149.43 31.27 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 3.0 p30 -53.6 -38.98 64.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 ttt180 -154.51 135.29 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.609 -0.836 . . . . 1.0 112.891 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.0 p -141.81 132.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.01 -0.995 . . . . 1.0 108.783 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -138.25 153.03 49.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.615 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 43.5 t -98.58 139.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HH ' ' C ' ' A' ' 62' ' ' GLY . 23.7 t80 -128.21 131.0 48.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 1.0 110.391 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -109.68 149.13 30.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.41 . . . . 1.0 111.22 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.88 135.76 42.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 61' ' ' HIS . 24.2 m-20 -101.03 153.55 37.67 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -38.85 -51.02 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.06 2.507 . . . . 1.0 114.514 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.41 -5.74 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.199 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.77 -8.84 43.51 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.661 -0.78 . . . . 1.0 111.946 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.567 ' O ' ' N ' ' A' ' 57' ' ' ASP . 73.6 m80 -78.83 151.64 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' HH ' ' A' ' 54' ' ' TYR . . . -139.34 165.09 25.83 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.1 p -136.95 159.61 41.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 1.0 111.455 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 t -87.8 105.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 65' ' ' VAL . 25.8 t -105.68 -6.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.86 122.6 6.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.278 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 81.7 tt0 -150.47 138.06 19.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.122 0.487 . . . . 1.0 111.686 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.61 132.07 51.35 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 44.6 ptt85 -114.17 142.88 45.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.042 -177.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 178.786 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 111.345 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 21.9 mt -111.23 20.37 17.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.021 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.9 tp -64.8 130.67 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.17 88.11 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.861 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.55 149.57 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.325 0.563 . . . . 1.0 110.484 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.5 m -108.46 136.63 47.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.655 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.78 148.67 39.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.256 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.25 138.49 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.494 2.129 . . . . 1.0 111.474 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.915 0.388 . . . . 1.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.87 -16.27 0.2 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 84' ' ' ALA . 93.0 m-20 -70.35 -20.56 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.596 0.236 . . . . 1.0 111.004 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 88' ' ' PRO . 2.2 mt -125.01 95.65 41.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.516 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.0 Cg_exo -44.77 -114.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.521 2.147 . . . . 1.0 111.694 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 56.5 mp0 -147.11 -58.88 0.27 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.936 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -45.72 -42.71 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.681 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.97 -40.09 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.683 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 70.1 ttp85 -62.24 -34.46 76.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.808 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -62.81 -34.58 77.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.914 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.662 ' CD1' HH22 ' A' ' 101' ' ' ARG . 93.3 mt -63.66 -33.6 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.524 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 76.4 m-85 -67.97 -34.06 75.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 36.1 mtp180 -75.33 -31.8 60.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.262 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.496 ' C ' HE22 ' A' ' 99' ' ' GLN . 91.8 mt -97.79 -36.8 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.753 1.02 . . . . 1.0 113.753 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.31 -17.49 8.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.258 1.207 . . . . 1.0 114.258 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.631 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.7 OUTLIER 48.38 55.72 8.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.98 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 99' ' ' GLN . 20.7 t -153.3 109.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.891 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.662 HH22 ' CD1' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -161.88 131.87 4.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.921 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 103' ' ' ILE . 54.0 t -146.53 155.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.665 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.564 HG12 HG21 ' A' ' 135' ' ' VAL . 57.6 mt -112.47 128.53 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.268 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.09 170.53 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.052 0.76 . . . . 1.0 113.052 -176.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -51.2 115.05 1.38 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.246 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.482 HG23 ' CG1' ' A' ' 140' ' ' VAL . 12.0 p -50.07 -19.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.716 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -81.07 -36.41 30.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.79 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.5 -18.34 28.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.137 0.494 . . . . 1.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 57.44 61.49 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.532 -0.758 . . . . 1.0 112.819 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -94.62 125.7 39.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.762 -1.569 . . . . 1.0 106.762 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -118.75 142.93 47.23 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.679 0.992 . . . . 1.0 113.679 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -111.87 150.91 29.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.73 -1.123 . . . . 1.0 108.616 178.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 113' ' ' ILE . 31.4 pt . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.411 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 120.838 0.266 . . . . 1.0 112.378 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.564 HG21 HG12 ' A' ' 103' ' ' ILE . 22.3 t -122.24 133.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -42.08 157.6 0.21 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.356 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.13 -24.57 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.124 2.549 . . . . 1.0 113.614 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -58.02 -58.46 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.246 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.15 -26.76 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.68 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 136' ' ' ASP . 76.3 t -61.1 -56.18 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -62.26 -38.95 91.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.303 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -47.53 -36.22 10.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.03 -42.93 62.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -58.31 -43.68 88.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -62.21 -19.3 63.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.683 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.5 mmm -99.34 0.02 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.133 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 18.26 77.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 84.3 t -108.75 143.59 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.738 0.304 . . . . 1.0 110.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.94 -25.39 4.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -152.49 118.68 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.756 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 96.3 p -129.23 144.2 51.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.994 0.426 . . . . 1.0 111.398 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 152' ' ' LEU . 8.2 mp -102.69 137.33 41.06 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.76 129.1 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 1.0 112.263 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.3 133.29 20.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.49 162.54 3.58 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.368 2.045 . . . . 1.0 113.736 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.6 mt -117.12 115.03 24.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.414 ' H ' ' HB3' ' A' ' 192' ' ' SER . 22.0 ptm -141.99 154.74 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 55.9 t60 -128.34 124.78 37.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.021 -0.991 . . . . 1.0 108.871 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 46.2 m-70 59.72 -121.21 1.03 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.117 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -97.94 0.57 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.823 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.535 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -105.46 143.56 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.6 tp -99.71 124.54 45.06 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.535 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.3 m95 -102.92 -31.02 10.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.31 -169.82 26.21 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.448 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.7 mp -140.03 121.74 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 1.0 111.637 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.1 tp -94.67 149.66 21.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.7 p -157.56 134.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.075 -0.65 . . . . 1.0 111.861 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -114.52 135.76 53.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.267 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -107.82 126.99 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -117.46 122.81 44.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.33 16.69 5.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.797 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.636 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.675 0.274 . . . . 1.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 184' ' ' VAL . 96.1 mt-10 -78.39 -28.96 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 1.0 110.971 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.65 -39.53 73.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.636 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 11.7 pt20 -80.45 -52.87 7.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.92 -0.312 . . . . 1.0 111.682 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' A' ' 182' ' ' GLN . 9.9 p -44.13 -41.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.645 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.6 p -75.1 -49.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.597 ' N ' HG13 ' A' ' 184' ' ' VAL . 56.8 tt0 -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.6 tp -71.74 -48.61 45.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.053 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 187' ' ' LEU . 62.9 tp -51.42 -44.58 62.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.71 91.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -64.09 -39.32 93.8 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -64.53 -31.41 72.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 53.7 t -77.49 -44.58 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 157' ' ' MET . 2.2 m -51.77 -33.6 35.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.78 -34.61 34.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.56 78.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.98 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.1 pt -62.24 -29.82 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.42 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.5 -53.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.639 -0.71 . . . . 1.0 110.37 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.54 -42.63 98.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.321 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.8 74.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.352 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.86 -43.11 80.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 tp -51.35 -38.12 51.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.959 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.4 t -47.85 -57.54 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.631 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.496 179.894 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 31' ' ' LEU . 11.0 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 1.0 110.517 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -48.07 -36.61 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.764 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -74.09 -50.6 18.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.874 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 38' ' ' THR . 95.7 mt -56.47 -45.53 81.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.145 0.498 . . . . 1.0 110.982 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.44 ' O ' ' OG1' ' A' ' 38' ' ' THR . 29.5 mt -58.07 -28.89 64.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.903 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.502 HH12 HD22 ' A' ' 78' ' ' LEU . 87.4 mtt-85 -68.53 -39.5 81.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.81 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.42 -31.71 69.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.9 p -67.68 -36.93 81.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.371 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -74.59 -23.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.209 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.46 -48.36 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.323 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.34 -35.9 80.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.71 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' THR . 70.6 t -58.1 -53.87 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.613 -0.267 . . . . 1.0 111.313 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 47' ' ' GLY . 65.5 ttt-85 -50.21 -43.73 52.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.942 0.401 . . . . 1.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.03 -43.33 70.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.295 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.65 -37.65 87.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.786 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.84 -14.6 21.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.725 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.47 25.68 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.2 p -81.25 152.52 27.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.3 m-20 -48.83 -43.57 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.599 0.592 . . . . 1.0 112.599 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.432 HH21 HG21 ' A' ' 148' ' ' VAL . 30.1 ptt180 -159.17 146.93 17.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.625 -0.83 . . . . 1.0 112.765 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.13 133.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.703 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 61.3 mttt -135.77 142.83 44.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.665 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 166' ' ' LEU . 59.8 t -102.02 140.94 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.453 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 19.1 m-85 -131.55 136.59 47.96 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.531 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -112.86 153.28 28.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.036 0.446 . . . . 1.0 111.188 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CD1' ' NH2' ' A' ' 92' ' ' ARG . 43.5 m-85 -100.0 141.84 32.28 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -114.2 166.67 11.0 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -41.75 -55.82 2.17 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.055 2.503 . . . . 1.0 114.497 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -67.88 -12.56 60.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.79 0.28 48.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.752 -0.737 . . . . 1.0 111.904 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.509 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 2.4 p80 -74.6 148.79 40.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.466 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.54 144.34 16.98 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -125.12 149.69 47.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.948 0.404 . . . . 1.0 111.57 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 77' ' ' LEU . 4.2 p -90.19 108.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 65' ' ' VAL . 12.1 t -112.34 -4.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.32 128.17 9.54 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.271 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 24.0 tt0 -160.75 141.92 11.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 1.0 111.662 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.75 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -110.73 138.59 46.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.038 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 110.611 -0.995 . . . . 1.0 110.611 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.807 0.337 . . . . 1.0 111.346 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.877 ' O ' HG11 ' A' ' 64' ' ' VAL . 41.1 mt -116.19 15.99 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.946 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.502 HD22 HH12 ' A' ' 36' ' ' ARG . 52.3 mt -60.15 129.18 40.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.564 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.8 -2.35 87.17 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.814 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.813 ' O ' HG12 ' A' ' 64' ' ' VAL . 84.1 mt -86.0 147.39 26.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.358 0.579 . . . . 1.0 110.458 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -106.02 133.35 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -105.54 148.39 36.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.217 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.98 140.12 12.43 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.487 2.125 . . . . 1.0 111.493 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -62.97 -31.37 72.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.799 0.333 . . . . 1.0 110.434 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.12 -17.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.8 m-20 -63.23 -24.91 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.624 0.249 . . . . 1.0 111.023 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.66 132.55 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.507 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.58 -99.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.535 2.157 . . . . 1.0 111.672 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -159.25 -47.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.956 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -52.0 -40.99 61.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.636 ' CB ' HH22 ' A' ' 101' ' ' ARG . . . -74.89 -38.32 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.712 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.46 ' HE ' HD23 ' A' ' 162' ' ' LEU . 72.4 ttt180 -61.08 -32.36 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.798 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.07 -36.43 83.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.933 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.78 -36.27 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.532 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -67.96 -37.1 81.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -75.54 -30.23 59.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.162 -0.927 . . . . 1.0 111.26 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.548 ' C ' HE22 ' A' ' 99' ' ' GLN . 95.9 mt -96.98 -38.63 9.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.94 -14.47 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.564 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.0 mp0 48.8 51.37 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.902 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 99' ' ' GLN . 22.8 t -153.17 109.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.911 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.636 HH22 ' CB ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -164.02 135.91 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.873 178.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -151.58 156.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.684 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 87.7 mt -110.56 130.69 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.265 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 104' ' ' VAL . 1.4 m -85.94 169.66 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.921 0.711 . . . . 1.0 112.921 -177.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.457 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 64.6 m-20 -48.19 116.01 1.4 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.902 -1.044 . . . . 1.0 112.236 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.5 -18.85 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.666 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 109' ' ' GLN . 43.4 tp10 -78.7 -38.83 38.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.821 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.33 -5.91 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.501 . . . . 1.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 11.6 pt20 46.23 63.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 1.0 112.83 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.5 m -91.24 126.96 36.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.77 -1.567 . . . . 1.0 106.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -118.34 144.48 45.84 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -111.71 149.87 31.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.695 -1.139 . . . . 1.0 108.654 178.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 120.435 -0.506 . . . . 1.0 111.418 -179.263 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo . . . . . 0 N--CA 1.491 1.363 0 CA-C-O 120.864 0.277 . . . . 1.0 112.36 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.69 128.92 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 112' ' ' SER . 21.3 t70 -44.2 135.87 4.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.307 . . . . 1.0 111.345 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -37.41 -23.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.132 2.555 . . . . 1.0 113.645 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 136' ' ' ASP . 36.3 t -55.66 -61.3 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.263 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.94 -24.04 61.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.658 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.6 t -57.97 -61.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.551 0.574 . . . . 1.0 112.551 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.592 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 23.2 p80 -60.79 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.391 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.592 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 83.1 t80 -47.44 -39.75 16.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.4 mt -72.06 -43.44 64.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.64 -43.03 79.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.5 m -61.7 -20.12 63.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.709 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.8 mmm -98.48 -1.16 41.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.074 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.53 19.32 76.38 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.432 HG21 HH21 ' A' ' 50' ' ' ARG . 65.7 t -107.56 142.49 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.297 . . . . 1.0 110.242 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.64 -35.17 3.6 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.457 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 22.8 m -143.2 121.17 12.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.766 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 m -129.81 142.11 50.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 1.0 111.378 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -102.76 136.24 42.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.14 128.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.331 -0.548 . . . . 1.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.22 128.97 19.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.255 -1.016 . . . . 1.0 108.255 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -92.6 164.21 2.85 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.4 2.067 . . . . 1.0 113.704 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.9 113.68 22.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.567 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.6 ptm -140.7 152.47 45.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.107 -0.637 . . . . 1.0 112.718 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 53.6 t60 -126.19 123.99 39.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.829 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 56.8 m-70 58.54 -120.73 1.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.182 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -97.42 1.51 49.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.787 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.01 143.44 34.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.46 HD23 ' HE ' ' A' ' 92' ' ' ARG . 39.4 tp -99.31 124.94 44.82 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 66.3 m95 -103.91 -35.31 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -156.87 -174.59 26.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 119.684 -1.246 . . . . 1.0 112.375 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.7 tp -138.42 121.2 16.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.457 HD12 HG22 ' A' ' 53' ' ' VAL . 10.3 tp -93.69 142.57 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.1 p -149.41 131.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.815 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.8 t -116.46 130.66 56.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.197 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -106.21 129.33 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 19.1 t-80 -120.77 117.4 27.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.77 -15.65 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.742 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.419 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 51.1 mm-40 . . . . . 0 C--N 1.326 -0.455 0 C-N-CA 120.894 -0.323 . . . . 1.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.675 0.274 . . . . 1.0 111.318 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -72.1 -36.09 69.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.57 -40.54 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.551 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -67.15 -55.8 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.759 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.3 t -45.73 -40.6 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.626 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.48 -50.76 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -48.43 -36.54 15.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 87.1 mt -71.64 -46.52 58.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.075 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 tp -52.13 -46.33 65.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.939 -0.764 . . . . 1.0 108.939 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.95 91.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.377 -0.971 . . . . 1.0 108.377 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.82 -38.11 89.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 27.2 mt-30 -66.89 -30.6 70.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.72 -45.89 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -52.25 -37.39 55.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 190' ' ' GLN . 31.8 mt -65.47 -34.97 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.162 -0.926 . . . . 1.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.05 78.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.928 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mt -55.24 -50.25 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.96 -50.42 66.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.417 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -61.87 -46.96 87.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.325 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.83 -32.74 74.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.41 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -56.4 -41.63 76.61 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.234 0.457 . . . . 1.0 112.234 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.2 mt -53.77 -34.67 59.78 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.987 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.6 t -44.92 -56.73 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.621 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.418 179.583 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 63.0 t0 -48.82 -34.17 11.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.485 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 22.6 mp0 -76.38 -48.44 19.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.826 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 38' ' ' THR . 25.7 mm -56.56 -50.38 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.065 0.459 . . . . 1.0 110.885 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 38' ' ' THR . 47.9 mt -57.38 -30.24 64.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 1.0 111.934 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.4 ttp85 -65.78 -39.7 91.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.762 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.42 68.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 76.3 p -65.07 -37.85 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.948 -0.569 . . . . 1.0 112.368 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p -71.94 -25.57 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.165 0.432 . . . . 1.0 112.165 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -80.78 -35.12 33.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.298 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -77.15 -42.63 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.76 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.7 p -63.65 -52.4 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.356 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.651 ' N ' HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.22 -42.21 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 1.0 110.697 -179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -53.86 -41.28 67.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.317 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.16 -34.68 78.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.764 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -95.86 -14.83 22.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.8 0.333 . . . . 1.0 111.683 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.92 25.31 45.0 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 p -78.17 145.19 35.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.84 -40.27 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' A' ' 67' ' ' GLU . 44.9 ttt180 -150.47 132.46 15.21 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.511 -0.876 . . . . 1.0 112.762 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 7.1 t -138.69 131.54 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.007 -0.997 . . . . 1.0 108.671 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.598 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.9 pttm -137.17 149.97 47.61 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.722 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 166' ' ' LEU . 61.4 t -98.99 141.35 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 16.0 t80 -131.05 132.31 44.84 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.42 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -113.04 153.56 27.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.012 0.434 . . . . 1.0 111.253 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.79 135.59 44.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.1 m-20 -95.09 150.73 38.12 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -41.45 -21.87 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.012 2.474 . . . . 1.0 114.485 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -103.22 4.6 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.565 -0.454 . . . . 1.0 112.155 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.21 -14.35 59.77 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.671 -0.776 . . . . 1.0 111.897 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 57' ' ' ASP . 39.9 m80 -78.13 150.44 33.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.56 164.0 25.73 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -136.35 158.07 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.034 0.445 . . . . 1.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.2 106.54 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 65' ' ' VAL . 54.7 t -107.92 -5.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.126 0.417 . . . . 1.0 112.126 -177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.19 123.51 7.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.348 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' CD ' HH21 ' A' ' 50' ' ' ARG . 87.1 tt0 -150.87 136.6 18.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 1.0 111.719 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.56 135.85 51.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -119.26 140.06 50.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 1.0 112.044 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.481 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.823 0.344 . . . . 1.0 111.348 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.485 HD12 HH22 ' A' ' 50' ' ' ARG . 15.9 mt -91.69 16.03 11.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.946 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.2 132.68 52.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 -2.94 86.98 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.43 -0.805 . . . . 1.0 112.812 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.5 mt -85.55 150.81 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.372 0.586 . . . . 1.0 110.415 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -109.16 137.63 46.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.622 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -108.99 148.72 38.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.274 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.51 137.02 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.574 2.183 . . . . 1.0 111.442 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.9 -34.75 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.865 0.364 . . . . 1.0 110.445 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.14 -16.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 84' ' ' ALA . 97.5 m-20 -66.39 -22.08 66.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.647 0.261 . . . . 1.0 111.03 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.92 133.36 24.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.529 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.64 -98.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.537 2.158 . . . . 1.0 111.685 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -161.96 -50.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.953 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -46.52 -42.84 16.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.593 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.32 -38.48 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.743 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.57 -32.21 72.29 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.791 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -64.01 -35.31 80.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.915 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.41 -36.04 79.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.534 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 45.3 m-85 -68.25 -35.36 77.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -81.11 -27.77 35.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.166 -0.925 . . . . 1.0 111.269 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.427 ' C ' HE22 ' A' ' 99' ' ' GLN . 97.0 mt -96.95 -42.04 8.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 100' ' ' VAL . . . -119.8 -15.0 8.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.243 1.201 . . . . 1.0 114.243 -174.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.674 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.6 OUTLIER 45.57 54.9 7.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.7 -0.8 . . . . 1.0 109.866 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.9 m -159.68 111.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.857 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.78 ' NE ' ' N ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -170.81 139.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.852 177.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.5 p -146.01 158.36 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.73 -0.668 . . . . 1.0 109.641 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.524 HG23 HG11 ' A' ' 135' ' ' VAL . 49.8 mt -110.62 126.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.217 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 105' ' ' ASP . 10.0 p -86.53 168.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.613 ' N ' HG22 ' A' ' 104' ' ' VAL . 48.7 m-20 -49.0 115.88 1.45 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.283 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.77 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.8 p -51.03 -21.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.675 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -77.94 -38.08 46.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.835 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.58 -16.13 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.185 0.517 . . . . 1.0 110.404 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 56.24 60.93 2.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.482 -0.781 . . . . 1.0 112.824 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.6 m -96.86 126.19 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -117.87 143.92 45.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.519 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -114.45 153.91 29.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.731 -1.122 . . . . 1.0 108.636 177.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 112' ' ' SER . 29.0 pt . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.473 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 120.807 0.253 . . . . 1.0 112.407 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 103' ' ' ILE . 1.4 p -114.95 128.0 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.519 ' HA ' ' H ' ' A' ' 112' ' ' SER . 45.9 p-10 -46.53 138.88 6.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.307 . . . . 1.0 111.315 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -39.21 -28.24 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.145 2.563 . . . . 1.0 113.663 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 t -48.94 -64.42 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.475 ' NE2' HD11 ' A' ' 143' ' ' LEU . 29.6 t60 -71.37 -21.83 61.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.77 ' CG1' HG23 ' A' ' 106' ' ' VAL . 88.5 t -59.34 -58.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -63.1 -40.11 96.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.424 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.517 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 71.2 t80 -47.59 -38.42 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.475 HD11 ' NE2' ' A' ' 139' ' ' HIS . 84.5 mt -71.82 -43.7 65.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.104 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -56.41 -41.98 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.0 m -62.66 -21.36 65.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.692 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.517 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 50.6 mtp -98.31 -0.74 43.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.488 -0.778 . . . . 1.0 111.06 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.05 19.71 76.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.2 t -107.78 143.44 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.679 0.276 . . . . 1.0 110.367 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.56 -26.86 6.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.968 0.359 . . . . 1.0 111.968 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 32.4 m -150.77 120.29 6.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.766 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p -129.76 141.85 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 1.0 111.402 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.3 mp -104.37 130.7 52.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.617 ' O ' ' NE ' ' A' ' 101' ' ' ARG . 10.9 t -113.83 106.36 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.308 -0.557 . . . . 1.0 112.311 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 42.6 t -110.17 135.77 20.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -94.93 167.3 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.299 1.999 . . . . 1.0 113.723 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.1 mt -119.24 116.33 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.7 ptm -141.02 154.78 46.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.408 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 74.8 t60 -127.99 123.39 34.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.942 -1.026 . . . . 1.0 108.865 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.599 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 82.2 t60 60.23 -120.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.363 . . . . 1.0 110.09 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.599 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 28.0 tp60 -98.26 2.03 47.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.816 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.529 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 144.98 31.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.12 123.99 46.13 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.529 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m95 -102.24 -31.65 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.37 -173.73 31.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.453 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.1 mt -135.12 121.44 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 1.0 111.614 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.649 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.5 tp -94.69 150.82 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.431 HG11 ' NZ ' ' A' ' 52' ' ' LYS . 13.0 p -157.33 134.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.859 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.9 t -115.6 132.8 56.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.598 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 21.4 m80 -101.61 122.66 44.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.6 t60 -117.75 108.7 15.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.42 66.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.751 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.495 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 21.2 mt-10 . . . . . 0 C--N 1.327 -0.406 0 C-N-CA 120.942 -0.303 . . . . 1.0 110.569 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.645 0.26 . . . . 1.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 184' ' ' VAL . 97.1 mt-10 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 1.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.83 -35.77 75.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.619 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -81.11 -55.4 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.618 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 184' ' ' VAL . 9.3 p -44.16 -41.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.419 . . . . 1.0 110.659 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.4 p -73.96 -48.39 38.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.591 ' N ' HG13 ' A' ' 184' ' ' VAL . 62.3 tt0 -46.62 -32.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.106 -1.072 . . . . 1.0 108.106 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 190' ' ' GLN . 7.9 tp -68.84 -47.37 66.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.108 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 184' ' ' VAL . 95.5 mt -53.97 -46.43 71.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.88 86.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.541 ' O ' HD13 ' A' ' 193' ' ' ILE . 71.9 m-20 -63.27 -42.35 99.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 186' ' ' LEU . 61.3 tt0 -60.66 -31.3 70.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.43 -44.13 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.5 p -52.42 -36.55 54.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.815 -0.809 . . . . 1.0 108.815 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.4 mp -66.06 -37.78 80.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.197 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.81 83.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.0 mt -55.15 -50.41 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.93 -50.35 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.411 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.6 -47.07 87.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.282 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.21 -32.67 73.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.39 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -56.14 -40.57 74.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 tp -52.5 -35.44 52.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 96.8 p -53.11 -58.71 6.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.615 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.058 -0.973 . . . . 1.0 110.397 179.647 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.82 0.343 . . . . 1.0 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.51 -33.03 68.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -77.51 -48.17 17.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.788 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -56.16 -51.2 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.056 0.455 . . . . 1.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.492 ' O ' ' OG1' ' A' ' 38' ' ' THR . 71.0 mt -58.34 -30.88 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.986 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 39' ' ' VAL . 41.2 mtp180 -67.73 -39.36 84.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.408 -0.517 . . . . 1.0 109.732 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' O ' ' OE1' ' A' ' 41' ' ' GLU . . . -70.39 -33.24 71.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.769 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 42' ' ' VAL . 53.4 p -63.65 -37.15 86.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.305 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.545 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -74.27 -23.34 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.4 -51.71 33.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.341 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 18.1 mp0 -69.7 -34.94 74.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.745 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' THR . 53.5 t -58.74 -55.35 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.337 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.3 tmm_? -53.9 -43.65 69.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.392 . . . . 1.0 110.669 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.63 -43.41 72.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.321 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -65.41 -37.28 86.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.8 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 mt -96.65 -15.06 21.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.763 0.316 . . . . 1.0 111.697 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.85 25.04 35.84 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.505 -1.038 . . . . 1.0 110.505 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 87.6 m -78.36 146.07 34.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.8 m-20 -52.17 -41.98 63.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 67' ' ' GLU . 49.4 ttt180 -152.45 132.29 13.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.549 -0.86 . . . . 1.0 112.802 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 t -136.76 131.64 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 1.0 108.702 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.477 ' HE2' HBB2 ' A' ' 203' ' ' CYC . 16.0 pttp -137.88 151.74 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.628 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.6 t -98.85 140.36 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 13.7 t80 -129.13 132.57 47.38 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.431 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.993 0.425 . . . . 1.0 111.206 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.9 t80 -100.47 128.49 46.52 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.696 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' OD2' ' CD2' ' A' ' 61' ' ' HIS . 40.9 m-20 -97.75 151.97 37.88 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.93 -22.45 30.43 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.029 2.486 . . . . 1.0 114.488 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HB2' ' ND1' ' A' ' 61' ' ' HIS . 96.2 mt-10 -91.16 -3.51 56.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 84' ' ' ALA . . . 106.07 -19.59 37.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.67 -0.776 . . . . 1.0 111.901 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CD2' ' OD2' ' A' ' 57' ' ' ASP . 57.2 p-80 -80.49 151.45 29.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.404 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.45 162.85 26.14 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -134.57 154.99 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.015 0.436 . . . . 1.0 111.504 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 t -90.9 113.42 26.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 108.338 -0.986 . . . . 1.0 108.338 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 65' ' ' VAL . 11.3 t -112.28 -3.33 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -151.92 125.92 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.31 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 50' ' ' ARG . 79.1 tt0 -155.34 138.69 15.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.156 0.503 . . . . 1.0 111.676 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.28 138.95 53.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 74' ' ' LEU . 58.1 mtp180 -113.28 136.48 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.019 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.96 77.62 2.09 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.59 -1.004 . . . . 1.0 110.59 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 38.07 29.51 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 53.6 17.91 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 1.0 110.405 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -57.66 -47.52 82.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.078 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.542 ' O ' ' NE ' ' A' ' 69' ' ' ARG . 8.3 mp -101.87 153.06 38.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.79 157.13 35.29 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.514 2.143 . . . . 1.0 112.208 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t -84.97 116.59 23.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.35 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.492 HD12 HH22 ' A' ' 50' ' ' ARG . 17.6 mt -96.93 10.86 37.89 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.03 -0.532 . . . . 1.0 109.978 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.424 HD21 ' CB ' ' A' ' 67' ' ' GLU . 88.0 mt -55.93 129.16 38.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -4.04 86.54 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.847 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -83.79 147.36 27.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.3 0.55 . . . . 1.0 110.422 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.3 m -107.52 135.81 48.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.611 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.45 112.92 62.31 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.248 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.08 137.95 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.561 2.174 . . . . 1.0 111.464 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' A' ' 60' ' ' GLY . . . -60.52 -37.6 81.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 1.0 110.432 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.06 -16.33 0.47 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' N ' ' C ' ' A' ' 84' ' ' ALA . 86.9 m-20 -71.76 -23.22 61.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.687 0.28 . . . . 1.0 111.049 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' PRO . 44.7 mt -116.83 101.57 53.44 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.542 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 87' ' ' ILE . 76.9 Cg_exo -45.63 -115.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.575 2.183 . . . . 1.0 111.653 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -157.0 -51.68 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.93 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -49.53 -39.97 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.608 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.57 -37.85 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.669 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -63.8 -33.9 76.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.819 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.69 -37.15 86.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.947 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.44 -36.65 83.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.484 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.405 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 83.7 m-85 -66.85 -35.0 79.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -77.24 -31.15 54.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.284 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' C ' HE22 ' A' ' 99' ' ' GLN . 79.1 mt -94.55 -38.99 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -121.58 -13.12 8.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.651 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.4 mp0 47.71 56.7 6.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.669 -0.813 . . . . 1.0 109.926 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.5 m -159.09 112.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.875 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.403 ' NH2' ' O2D' ' A' ' 203' ' ' CYC . 2.9 tpp180 -165.57 133.88 3.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.888 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 103' ' ' ILE . 78.2 t -145.68 156.3 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.703 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.513 ' CD1' ' NE2' ' A' ' 139' ' ' HIS . 62.4 mt -112.5 127.73 69.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.265 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.1 m -86.96 170.62 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -49.53 114.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.906 -1.043 . . . . 1.0 112.249 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG22 HG13 ' A' ' 140' ' ' VAL . 52.9 t -53.25 -21.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.512 -0.767 . . . . 1.0 110.674 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -80.36 -37.86 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.839 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.2 -14.55 2.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.18 0.514 . . . . 1.0 110.453 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 57.32 59.96 3.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.849 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.3 t -94.97 124.94 39.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -119.72 143.73 47.62 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.5 153.74 28.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.764 -1.107 . . . . 1.0 108.668 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 pt -149.55 153.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.468 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.43 ' C ' ' NE2' ' A' ' 115' ' ' GLN . 70.2 m -91.12 172.69 8.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 117' ' ' GLU . 2.1 mp0 -134.63 156.85 78.36 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -36.79 -25.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.601 2.201 . . . . 1.0 112.275 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 115' ' ' GLN . 95.5 mt-10 -110.34 160.76 16.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.606 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -111.74 145.34 39.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.521 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -105.43 148.14 27.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.683 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -145.7 -96.69 0.2 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 121' ' ' LEU . 8.7 mp -61.6 -14.98 34.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 1.0 110.635 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.3 t -51.76 -24.52 6.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.72 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 97' ' ' LEU . . . -57.55 -17.4 13.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.743 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -45.92 -14.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.7 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 123' ' ' ALA . 27.9 m -84.95 139.26 37.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 127' ' ' LEU . 84.0 Cg_endo -80.1 117.72 3.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.338 2.025 . . . . 1.0 111.559 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 100' ' ' VAL . 65.8 mt 39.27 -110.88 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.398 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.12 50.92 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.129 -0.789 . . . . 1.0 111.129 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 130' ' ' PRO . 49.1 mm-40 -133.29 154.81 81.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.523 0.201 . . . . 1.0 110.624 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 132' ' ' GLN . 65.5 Cg_exo -41.65 168.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.423 2.082 . . . . 1.0 112.012 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.407 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 51.7 mt -63.07 11.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.981 -0.554 . . . . 1.0 112.063 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 130' ' ' PRO . 9.9 mm100 -137.6 155.48 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.445 . . . . 1.0 111.484 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -125.59 117.41 24.71 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.554 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.4 142.7 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.658 2.239 . . . . 1.0 112.348 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.477 HG11 HG12 ' A' ' 103' ' ' ILE . 2.4 m -119.81 132.89 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -41.68 160.86 0.15 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.401 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.11 -23.67 45.66 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.159 2.573 . . . . 1.0 113.666 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.576 ' H ' ' CG ' ' A' ' 136' ' ' ASP . 7.3 t -58.89 -58.76 7.22 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.723 -0.391 . . . . 1.0 111.298 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.543 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 2.1 t60 -68.38 -27.23 66.06 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.616 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 136' ' ' ASP . 43.7 t -62.25 -56.95 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.608 0.595 . . . . 1.0 112.608 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -62.23 -38.78 90.49 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.376 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.428 ' O ' ' OG ' ' A' ' 145' ' ' SER . 74.8 t80 -47.9 -36.58 12.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 139' ' ' HIS . 49.9 mt -73.64 -42.73 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -58.24 -44.84 88.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 83.7 p -61.9 -17.73 57.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.319 -0.855 . . . . 1.0 109.687 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.3 mmm -100.48 -0.02 38.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.53 -0.759 . . . . 1.0 111.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.38 18.9 77.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.538 -1.025 . . . . 1.0 110.538 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.29 142.96 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.696 0.284 . . . . 1.0 110.298 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.2 -26.73 5.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.983 0.364 . . . . 1.0 111.983 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 p -153.78 121.35 5.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.701 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.2 m -126.77 138.66 53.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 1.0 111.385 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.99 134.27 39.21 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.1 t -113.96 127.76 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.332 -0.547 . . . . 1.0 112.291 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.65 126.18 17.91 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -90.51 161.42 4.41 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.351 2.034 . . . . 1.0 113.704 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.506 HD23 ' HB1' ' A' ' 188' ' ' ALA . 24.6 mt -114.34 114.78 26.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.618 -1.253 . . . . 1.0 107.618 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.435 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 23.4 ptm -141.9 150.56 41.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.489 ' CE1' ' NE2' ' A' ' 159' ' ' HIS . 9.1 t-80 -125.7 126.29 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.809 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.489 ' NE2' ' CE1' ' A' ' 158' ' ' HIS . 84.0 m-70 58.34 -122.47 1.35 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.105 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.56 2.72 50.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.811 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.527 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.2 tt0 -106.22 145.97 30.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.755 1.02 . . . . 1.0 113.755 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 44.9 tp -101.26 123.8 45.94 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.527 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.7 m95 -101.87 -32.08 10.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -176.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.88 -167.75 22.77 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.719 -1.229 . . . . 1.0 112.398 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -143.7 122.94 12.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.417 -0.392 . . . . 1.0 111.664 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.487 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.4 tp -94.76 150.5 20.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.3 p -156.31 133.92 2.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.091 -0.644 . . . . 1.0 111.822 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 87.9 p -113.24 139.73 48.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.249 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.471 ' O ' ' CG2' ' A' ' 48' ' ' THR . 18.1 m80 -111.92 124.38 52.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -117.44 116.88 28.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.09 -15.33 62.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.395 -0.366 . . . . 1.0 111.747 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -133.22 151.05 76.98 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.611 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -40.44 132.38 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.631 2.221 . . . . 1.0 111.858 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -164.4 80.98 1.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.532 -0.304 . . . . 1.0 110.684 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 156.06 12.18 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.574 2.183 . . . . 1.0 111.459 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -104.69 148.62 26.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 1.0 110.817 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.2 m -89.84 147.24 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.16 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.35 -29.37 69.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.171 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -77.82 -53.1 7.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.241 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.7 -33.57 74.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.937 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.27 -45.57 90.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.633 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.33 -55.31 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.724 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.1 t -45.37 -39.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.724 -0.391 . . . . 1.0 110.638 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -74.56 -49.37 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -48.54 -36.59 15.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 190' ' ' GLN . 21.6 tp -70.69 -46.39 63.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.082 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.05 -46.83 75.38 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.506 ' HB1' HD23 ' A' ' 156' ' ' LEU . . . -58.43 -48.23 81.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.22 -36.66 75.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 186' ' ' LEU . 7.0 tt0 -68.61 -32.41 72.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.47 -48.54 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.342 -0.985 . . . . 1.0 108.342 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.4 p -50.12 -31.6 13.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mt -74.65 -34.9 35.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.125 -0.943 . . . . 1.0 110.27 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -43.71 79.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.95 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 196' ' ' ALA . 31.7 pt -63.17 -30.77 50.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -72.79 -50.12 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.411 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.8 -40.79 95.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.275 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' OG ' ' A' ' 201' ' ' SER . . . -67.51 -31.39 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.385 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -57.78 -43.39 85.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.93 -36.17 48.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.965 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 198' ' ' ALA . 83.1 p -52.17 -57.49 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.647 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.486 179.414 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.543 HMA2 ' NE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.835 0.35 . . . . 1.0 110.546 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 66.6 t0 -48.06 -36.05 12.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -74.4 -49.95 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.808 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' THR . 96.3 mt -56.7 -44.98 82.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.022 0.439 . . . . 1.0 110.92 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.48 ' O ' ' OG1' ' A' ' 38' ' ' THR . 45.2 mt -58.4 -30.7 67.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.599 -0.728 . . . . 1.0 111.98 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 39' ' ' VAL . 54.3 mtp180 -66.81 -38.35 86.3 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.78 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.76 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 42' ' ' VAL . 76.9 p -68.67 -36.65 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 1.0 112.273 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -74.34 -23.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.147 0.425 . . . . 1.0 112.147 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -72.76 -48.48 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.305 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.76 -34.96 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.742 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 38' ' ' THR . 77.7 t -59.98 -54.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.609 -0.269 . . . . 1.0 111.287 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.6 ttp180 -51.45 -43.43 62.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 1.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.17 -42.49 69.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.254 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.4 -37.19 86.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.793 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.2 mt -97.13 -13.93 21.83 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.864 -0.335 . . . . 1.0 111.701 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.65 25.59 22.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.524 -1.03 . . . . 1.0 110.524 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.6 p -81.29 152.21 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -48.71 -42.93 36.64 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.534 HH21 ' CG2' ' A' ' 148' ' ' VAL . 36.1 ptt180 -160.17 146.25 15.52 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.568 -0.853 . . . . 1.0 112.782 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 20.2 t -137.44 133.92 46.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.957 -1.019 . . . . 1.0 108.675 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HZ2' HD12 ' A' ' 77' ' ' LEU . 17.7 mttt -135.91 144.62 45.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.604 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 166' ' ' LEU . 48.9 t -99.43 141.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 18.1 t80 -129.78 130.62 45.6 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.509 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -111.86 154.11 25.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 1.0 111.239 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.66 136.89 40.73 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.661 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -97.17 150.94 37.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -41.54 -22.03 0.15 Allowed 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.962 2.441 . . . . 1.0 114.468 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -103.85 9.0 37.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.185 0.439 . . . . 1.0 112.185 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 96.03 -15.81 62.29 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.598 -0.81 . . . . 1.0 111.966 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.585 ' O ' ' N ' ' A' ' 57' ' ' ASP . 35.6 m80 -77.52 151.27 34.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.78 163.56 25.54 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 p -135.63 158.85 43.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 1.0 111.495 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 104.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.78 -4.75 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -154.0 125.68 7.63 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.652 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 75.1 tt0 -154.45 138.99 16.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.158 0.504 . . . . 1.0 111.684 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.7 131.41 51.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.562 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 34.8 ptt180 -109.03 140.2 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.02 -177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.72 66.71 3.55 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 81.77 163.68 32.17 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -59.94 6.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 1.0 110.343 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.614 ' H ' ' C ' ' A' ' 71' ' ' GLY . 62.4 ttt180 -62.34 -40.63 96.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.992 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.2 144.08 40.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.14 166.17 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.47 2.113 . . . . 1.0 112.264 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.2 p -100.95 139.02 37.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.291 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 35.0 mt -103.98 18.09 22.74 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.968 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 24.5 tp -65.21 131.03 45.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.01 -1.6 88.77 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.843 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.78 151.01 23.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.352 0.576 . . . . 1.0 110.461 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 81' ' ' THR . 14.4 t -104.41 128.99 52.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 5.1 m-85 -106.69 107.3 60.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -43.37 138.89 4.66 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.592 2.195 . . . . 1.0 111.522 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -61.55 -29.29 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.21 -17.71 0.24 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' N ' ' C ' ' A' ' 84' ' ' ALA . 89.2 m-20 -67.52 -16.55 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.665 0.269 . . . . 1.0 111.032 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' PRO . 16.1 mt -134.55 99.47 12.97 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.53 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 40.9 Cg_exo -39.6 -97.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.521 2.147 . . . . 1.0 111.704 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 22.8 pt-20 -165.71 -39.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.272 -0.422 . . . . 1.0 111.003 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -56.97 -43.35 81.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.625 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.12 -35.66 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.466 -0.333 . . . . 1.0 111.686 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -65.01 -32.23 73.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.806 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -64.6 -37.91 89.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.908 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.541 ' CB ' ' NH2' ' A' ' 101' ' ' ARG . 10.0 mt -60.18 -38.31 82.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.546 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -66.56 -32.5 73.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.168 -0.679 . . . . 1.0 109.168 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -79.74 -27.53 40.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.172 -0.922 . . . . 1.0 111.305 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.85 -40.43 8.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -119.08 -11.57 9.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.422 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 4.0 mp0 44.77 64.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.669 -0.812 . . . . 1.0 109.91 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.1 p -168.8 107.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.905 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.542 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -159.15 134.4 8.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.895 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 103' ' ' ILE . 53.7 t -149.01 155.76 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.707 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.552 HD11 HMA2 ' A' ' 203' ' ' CYC . 66.2 mt -111.9 129.14 67.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.238 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -87.28 169.58 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.16 115.79 1.58 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.975 -1.011 . . . . 1.0 112.274 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG23 ' CG1' ' A' ' 140' ' ' VAL . 13.4 p -51.24 -22.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.644 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -76.38 -38.83 55.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.822 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.87 19.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.234 0.54 . . . . 1.0 110.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 56.33 62.79 2.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.838 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 m -95.43 125.59 40.15 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.777 -1.564 . . . . 1.0 106.777 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -117.62 145.36 44.39 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.661 0.985 . . . . 1.0 113.661 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -111.97 148.8 33.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.77 -1.105 . . . . 1.0 108.62 177.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -145.6 149.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.426 -0.51 . . . . 1.0 111.438 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.3 m -87.2 171.88 10.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.09 157.9 37.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 120.638 -0.425 . . . . 1.0 110.887 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 167.08 28.25 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.635 2.224 . . . . 1.0 112.24 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 56.88 102.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.65 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.8 m -151.39 165.17 34.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -152.83 -19.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.717 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' SER . . . 85.34 -169.39 43.5 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 tp 56.9 3.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 1.0 110.644 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' GLY . 66.3 p -68.56 -24.06 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.705 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.632 ' C ' ' H ' ' A' ' 125' ' ' VAL . . . -66.35 -3.34 5.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.793 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -49.33 -3.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 1.0 110.682 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.632 ' H ' ' C ' ' A' ' 123' ' ' ALA . 16.9 m -108.7 148.56 38.02 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.8 142.97 32.73 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.417 2.078 . . . . 1.0 111.558 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.432 ' O ' ' OE2' ' A' ' 129' ' ' GLU . 51.8 mt 50.11 -117.88 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.617 -0.265 . . . . 1.0 110.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.66 5.61 58.72 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' A' ' 129' ' ' GLU . 3.6 pm0 -154.73 153.21 27.29 Favored Pre-proline 0 C--N 1.329 -0.288 0 O-C-N 122.836 -0.214 . . . . 1.0 110.619 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 132' ' ' GLN . 72.0 Cg_exo -42.97 173.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.481 2.12 . . . . 1.0 111.982 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.17 14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 1.0 112.078 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' H ' ' C ' ' A' ' 130' ' ' PRO . 48.4 mm-40 -137.98 159.5 41.85 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.596 -0.442 . . . . 1.0 111.523 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.533 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -127.45 79.09 73.87 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.541 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.56 142.76 6.66 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.644 2.229 . . . . 1.0 112.422 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.63 125.44 71.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.241 -0.652 . . . . 1.0 109.241 178.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.644 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 3.5 p30 -45.67 142.55 3.47 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.752 0.31 . . . . 1.0 111.317 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.8 -20.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.15 2.567 . . . . 1.0 113.634 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.5 t -61.59 -62.78 1.57 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.769 -0.372 . . . . 1.0 111.209 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -70.26 -24.61 63.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.631 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.472 ' CG1' HG23 ' A' ' 106' ' ' VAL . 61.4 t -60.6 -60.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.61 0.596 . . . . 1.0 112.61 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -61.12 -38.4 86.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.351 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -47.23 -36.64 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.9 mt -73.33 -43.65 60.39 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.098 -0.705 . . . . 1.0 109.098 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.22 -44.63 88.28 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.644 -0.873 . . . . 1.0 108.644 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -62.63 -19.0 63.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.691 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 23.2 mmm -101.27 -0.98 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 1.0 111.052 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.6 17.62 79.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.534 ' CG2' HH21 ' A' ' 50' ' ' ARG . 73.0 t -107.29 143.65 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.655 0.264 . . . . 1.0 110.335 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.7 -42.74 2.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.944 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.7 t -136.87 118.16 14.59 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.77 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.3 m -129.12 143.39 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.998 0.428 . . . . 1.0 111.405 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.0 mp -100.45 132.54 45.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.74 107.17 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.304 -0.558 . . . . 1.0 112.258 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.53 132.68 21.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -91.63 163.39 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.386 2.057 . . . . 1.0 113.701 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.5 mt -116.9 113.86 23.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.569 ' N ' ' OG ' ' A' ' 192' ' ' SER . 25.3 ptm -142.69 150.3 39.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 58.1 t-80 -125.66 124.49 41.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.897 -1.047 . . . . 1.0 108.842 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 79.5 t60 60.17 -122.04 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.165 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.618 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 41.3 tt0 -97.85 1.71 48.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.808 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.536 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.8 tt0 -106.43 144.24 33.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 tp -99.31 125.74 45.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.521 -1.288 . . . . 1.0 107.521 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 75.7 m95 -104.37 -34.84 8.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.633 0.975 . . . . 1.0 113.633 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.5 -175.05 31.08 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.717 -1.23 . . . . 1.0 112.417 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.6 mt -137.44 122.02 18.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.471 -0.365 . . . . 1.0 111.644 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 53' ' ' VAL . 47.1 tp -94.95 150.02 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.5 p -156.62 134.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.004 -0.678 . . . . 1.0 111.843 -178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 90.5 p -116.03 132.74 56.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -104.96 126.83 52.44 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.598 ' HE2' ' NH1' ' A' ' 174' ' ' ARG . 5.7 t-80 -118.8 115.35 24.25 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.79 63.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.383 -0.371 . . . . 1.0 111.799 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 21.6 mp0 -134.93 150.7 73.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.87 -0.332 . . . . 1.0 110.535 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -41.83 145.62 0.7 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.637 2.225 . . . . 1.0 111.802 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.598 ' NH1' ' HE2' ' A' ' 170' ' ' HIS . 11.8 tpp85 -172.91 81.62 0.42 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.686 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.16 152.53 24.45 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.538 2.158 . . . . 1.0 111.5 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CE1' HD12 ' A' ' 181' ' ' LEU . 20.5 p90 -105.46 150.45 25.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.362 . . . . 1.0 110.739 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -94.58 152.94 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.213 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -52.7 -38.05 60.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.159 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -73.99 -44.86 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.246 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 184' ' ' VAL . 77.3 mm-40 -66.37 -28.88 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 1.0 110.902 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -69.98 -39.25 76.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.651 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -78.92 -54.19 6.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.953 -0.299 . . . . 1.0 111.618 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 184' ' ' VAL . 9.9 p -43.67 -42.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.669 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 185' ' ' GLN . 34.0 m -75.09 -48.36 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.578 ' N ' HG23 ' A' ' 184' ' ' VAL . 60.9 tt0 -48.26 -36.49 14.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 190' ' ' GLN . 24.1 tp -70.85 -45.72 63.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.023 -0.989 . . . . 1.0 109.088 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.08 -47.67 77.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.8 93.54 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -62.78 -37.12 85.42 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 186' ' ' LEU . 7.0 tt0 -66.89 -31.7 72.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.647 -0.871 . . . . 1.0 108.647 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.62 -46.79 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.569 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -50.8 -32.84 21.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.2 mt -74.73 -34.32 33.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.198 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.94 -43.53 78.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.984 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 196' ' ' ALA . 24.2 pt -63.06 -30.06 48.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.72 -53.47 7.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.392 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.84 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.224 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.05 -34.05 77.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.7 -40.92 73.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.211 0.449 . . . . 1.0 112.211 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.0 tp -51.45 -34.65 36.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.928 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.2 p -48.3 -56.41 8.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.696 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.986 . . . . 1.0 110.482 179.507 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.644 ' HHD' ' OD2' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' CD2' HD11 ' A' ' 35' ' ' LEU . 6.7 tp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.362 . . . . 1.0 110.563 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.2 t0 -51.69 -33.24 33.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.728 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -75.98 -49.44 17.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.779 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 38' ' ' THR . 97.0 mt -55.38 -52.69 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 1.0 110.976 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.7 mt -56.36 -30.94 63.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.988 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.447 ' O ' HG12 ' A' ' 39' ' ' VAL . 67.9 ttp85 -64.6 -38.93 92.7 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.754 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.09 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.844 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 67.2 p -65.8 -37.4 86.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.933 -0.576 . . . . 1.0 112.311 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -74.58 -25.45 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.58 -43.17 23.48 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.283 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -72.24 -43.99 63.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.785 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 43' ' ' ARG . 7.2 p -61.69 -47.63 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.306 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG13 ' A' ' 42' ' ' VAL . 70.7 ttp85 -54.97 -44.21 74.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 1.0 110.689 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.82 60.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.351 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -70.18 -33.59 71.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.813 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.6 mt -97.52 -18.96 18.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.759 0.314 . . . . 1.0 111.695 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.8 25.21 51.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.516 -1.034 . . . . 1.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 170' ' ' HIS . 91.7 m -77.36 144.01 38.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.981 -0.377 . . . . 1.0 109.981 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -52.83 -42.45 65.16 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.635 0.605 . . . . 1.0 112.635 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' HE ' ' CB ' ' A' ' 74' ' ' LEU . 2.9 mtt-85 -149.48 128.35 12.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.507 -0.877 . . . . 1.0 112.797 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 10.9 t -136.7 129.89 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.968 -1.015 . . . . 1.0 108.739 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.875 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 49.8 pttt -137.95 152.39 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.658 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 46.3 t -99.12 141.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.6 t80 -131.85 133.24 44.44 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.468 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -113.66 154.06 27.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 1.0 111.205 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -103.87 137.64 41.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.68 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.3 m-20 -101.75 154.95 36.97 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 109.44 -0.578 . . . . 1.0 109.44 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.54 -52.3 2.04 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 123.001 2.468 . . . . 1.0 114.481 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.12 -6.31 38.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.561 -0.456 . . . . 1.0 112.141 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.1 -7.07 37.42 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.689 -0.767 . . . . 1.0 111.887 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 57' ' ' ASP . 72.8 m80 -77.56 149.29 34.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.826 -0.35 . . . . 1.0 110.342 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.444 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.47 161.06 24.95 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.781 -0.928 . . . . 1.0 110.781 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 155.48 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 1.0 111.559 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.44 108.68 18.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 65' ' ' VAL . 48.5 t -108.89 -4.27 10.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.078 0.399 . . . . 1.0 112.078 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.41 123.44 7.54 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.25 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 85.7 tt0 -151.84 136.62 17.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.155 0.502 . . . . 1.0 111.705 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.82 134.36 50.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.364 -0.534 . . . . 1.0 112.061 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.04 66.91 3.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 84.31 36.48 12.52 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 178.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 57.41 0.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.806 0.336 . . . . 1.0 110.34 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.56 ' H ' ' C ' ' A' ' 71' ' ' GLY . 43.0 mtp180 -46.35 -49.11 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.056 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.55 ' CB ' ' HE ' ' A' ' 50' ' ' ARG . 15.1 mt -102.61 150.57 37.79 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 109.327 -0.619 . . . . 1.0 109.327 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.0 150.03 59.97 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.489 2.126 . . . . 1.0 112.217 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.5 t -81.66 120.34 24.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.284 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 32.6 mt -98.23 14.69 26.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.078 -0.51 . . . . 1.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.484 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.7 tp -64.53 131.79 48.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.61 88.15 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.781 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.81 150.21 24.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.344 0.572 . . . . 1.0 110.479 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 p -108.63 137.17 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.566 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' CE2' HAB2 ' A' ' 203' ' ' CYC . 46.0 m-85 -108.55 149.57 39.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.235 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 78.5 Cg_endo -80.12 136.66 11.7 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.493 2.129 . . . . 1.0 111.507 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.67 -35.05 75.28 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.473 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.81 -14.7 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . 47.7 p-10 -68.71 -19.61 64.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.624 0.249 . . . . 1.0 111.016 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.6 mt -132.97 97.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.538 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 41.3 Cg_exo -39.18 -95.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.565 2.177 . . . . 1.0 111.683 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 41.8 tp10 -162.91 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.969 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -51.03 -40.9 59.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.646 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.48 66.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.726 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -64.7 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.782 0.325 . . . . 1.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -65.21 -38.8 91.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.05 -36.95 75.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.549 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CE2' ' O1A' ' A' ' 203' ' ' CYC . 88.0 m-85 -68.7 -35.37 77.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -76.98 -32.08 56.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.231 -0.895 . . . . 1.0 111.24 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.553 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.7 mt -95.84 -39.24 9.93 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.41 -12.94 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.2 1.185 . . . . 1.0 114.2 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.574 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.8 mp0 47.17 48.12 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.0 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.6 t -149.87 108.45 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.912 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.656 ' HE ' ' CZ ' ' A' ' 133' ' ' ARG . 1.1 tpt180 -160.91 130.9 5.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.84 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.2 p -150.06 155.96 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.683 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 135' ' ' VAL . 95.2 mt -114.32 131.18 67.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.245 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -87.99 171.13 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 113.028 0.751 . . . . 1.0 113.028 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -50.74 115.4 1.48 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 114.932 -1.031 . . . . 1.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.474 HG23 ' CG1' ' A' ' 140' ' ' VAL . 13.0 p -49.66 -19.74 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.642 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -76.76 -38.79 53.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.821 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.78 -8.94 5.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.167 0.508 . . . . 1.0 110.43 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 15.8 pt20 46.17 62.03 2.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.435 -0.802 . . . . 1.0 112.891 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -93.35 126.94 38.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.752 -1.573 . . . . 1.0 106.752 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -119.4 147.01 44.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.666 0.987 . . . . 1.0 113.666 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.634 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -111.44 149.32 31.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.789 -1.096 . . . . 1.0 108.636 178.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 113' ' ' ILE . 7.5 mt -145.82 149.82 16.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.454 -0.498 . . . . 1.0 111.445 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -84.01 164.07 19.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -151.69 159.72 32.79 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.909 -178.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.78 156.87 62.18 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.67 2.247 . . . . 1.0 112.187 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 59.61 84.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.619 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.1 m -69.77 161.9 28.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.502 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -90.0 -169.17 2.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.692 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -128.8 -129.94 3.23 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.0 tp -71.66 35.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.744 0.307 . . . . 1.0 110.569 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 120' ' ' GLY . 65.0 m -60.75 -23.9 65.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.79 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' VAL . . . -49.62 -30.89 9.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.764 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.79 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 1.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.0 t -92.95 131.27 33.76 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.717 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 128' ' ' GLY . 84.7 Cg_endo -76.38 135.03 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.395 2.064 . . . . 1.0 111.537 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.3 mt 59.22 -80.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.381 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 65.18 9.04 39.65 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' PRO . 18.5 pt-20 -153.39 152.98 28.65 Favored Pre-proline 0 C--N 1.33 -0.256 0 O-C-N 122.828 -0.219 . . . . 1.0 110.619 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.612 ' C ' ' H ' ' A' ' 132' ' ' GLN . 55.2 Cg_exo -40.97 167.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.385 2.057 . . . . 1.0 111.995 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -57.84 9.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 1.0 112.039 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.612 ' H ' ' C ' ' A' ' 130' ' ' PRO . 47.8 mm-40 -137.37 166.06 24.73 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.465 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.656 ' CZ ' ' HE ' ' A' ' 101' ' ' ARG . 15.7 ttt-85 -139.76 123.7 10.86 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.509 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.634 ' C ' ' HG ' ' A' ' 112' ' ' SER . 49.6 Cg_endo -84.74 145.39 10.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.647 2.232 . . . . 1.0 112.401 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -117.61 128.17 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.699 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 4.5 p30 -45.03 140.77 3.41 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 1.0 111.376 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -37.91 -17.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 123.053 2.502 . . . . 1.0 113.748 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 136' ' ' ASP . 42.6 t -63.28 -62.21 1.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.267 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.407 ' CE1' ' CD1' ' A' ' 103' ' ' ILE . 51.7 t-80 -71.1 -25.06 62.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.667 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.474 ' CG1' HG23 ' A' ' 106' ' ' VAL . 65.2 t -58.36 -60.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -61.41 -37.45 83.52 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.394 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.598 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 61.1 t80 -46.17 -37.93 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.16 -43.4 64.68 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.36 -41.49 89.39 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.631 -0.878 . . . . 1.0 108.631 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -64.16 -22.18 66.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.441 -0.799 . . . . 1.0 109.642 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.598 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 70.9 mtp -97.97 2.09 48.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.101 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.97 19.44 78.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.6 -1.0 . . . . 1.0 110.6 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 78.9 t -110.19 145.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.679 0.276 . . . . 1.0 110.276 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.3 -23.9 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.027 0.38 . . . . 1.0 112.027 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -152.36 120.21 6.15 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.747 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.3 p -128.17 137.58 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 1.0 111.419 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.0 131.83 46.69 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.4 t -111.95 130.45 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.293 -0.563 . . . . 1.0 112.306 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.95 128.59 18.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.88 166.28 3.23 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.389 2.059 . . . . 1.0 113.733 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.59 115.35 24.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.605 -1.257 . . . . 1.0 107.605 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.448 ' H ' ' HB2' ' A' ' 192' ' ' SER . 23.8 ptm -142.3 151.61 42.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.44 0.638 . . . . 1.0 112.684 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.469 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 48.9 t-80 -128.31 124.56 36.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.913 -1.039 . . . . 1.0 108.899 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.498 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 62.2 t60 61.79 -123.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.107 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.498 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 99.0 mm-40 -97.63 3.55 50.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.86 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.519 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -107.0 144.83 33.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.683 0.994 . . . . 1.0 113.683 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.5 tp -98.78 125.7 44.21 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.519 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 73.9 m95 -105.21 -36.83 7.1 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.599 0.963 . . . . 1.0 113.599 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.44 -173.25 23.91 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.694 -1.241 . . . . 1.0 112.39 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.5 tp -139.57 120.19 14.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.441 -0.379 . . . . 1.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.455 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.8 tp -94.73 149.8 20.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.5 p -156.42 134.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.097 -0.641 . . . . 1.0 111.863 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.5 m -114.45 137.86 51.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.223 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 30.5 m-70 -111.96 124.69 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.663 0.616 . . . . 1.0 112.663 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.506 ' CD2' HG23 ' A' ' 48' ' ' THR . 71.5 m80 -116.42 121.33 41.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.51 13.38 6.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.785 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -156.3 152.02 22.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.579 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -44.52 122.6 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.689 2.259 . . . . 1.0 111.823 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -156.55 106.43 2.0 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.684 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.68 157.73 21.59 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.478 2.119 . . . . 1.0 111.46 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.502 ' OH ' ' CE1' ' A' ' 170' ' ' HIS . 81.9 m-85 -108.85 146.58 33.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.859 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.6 p -88.29 157.81 18.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -58.57 -33.65 70.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.189 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -77.16 -54.16 6.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.299 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 184' ' ' VAL . 50.8 tp10 -61.08 -33.41 73.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.96 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.19 -49.51 75.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.62 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.0 -52.61 8.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.652 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.8 t -44.98 -39.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 187' ' ' LEU . 83.7 t -73.32 -49.82 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -45.99 -32.02 2.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 tp -68.18 -48.15 66.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.119 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 184' ' ' VAL . 92.7 mt -52.1 -46.3 65.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.94 93.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.423 -0.955 . . . . 1.0 108.423 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.77 -38.89 92.79 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -66.19 -31.16 71.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.7 t -76.74 -46.62 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 157' ' ' MET . 42.5 p -51.24 -32.04 22.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.68 -34.59 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.132 -0.94 . . . . 1.0 110.294 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.51 -43.66 80.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.895 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.437 HG13 ' N ' ' A' ' 196' ' ' ALA . 21.0 pt -62.7 -29.57 47.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.437 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -74.92 -52.37 11.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.321 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.69 -42.67 97.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.82 72.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.36 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.02 -43.13 81.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.225 0.454 . . . . 1.0 112.225 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.4 mp -52.44 -33.51 44.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.995 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 16.3 m -54.56 -58.61 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.627 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.398 179.833 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.875 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.838 0.351 . . . . 1.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -48.0 -35.49 11.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -75.14 -49.88 18.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.802 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 38' ' ' THR . 24.4 mm -56.12 -48.54 78.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.141 0.496 . . . . 1.0 110.959 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.501 ' O ' ' OG1' ' A' ' 38' ' ' THR . 32.5 mt -57.42 -29.25 63.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.955 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' HG12 ' A' ' 39' ' ' VAL . 36.4 ttm180 -66.43 -39.82 89.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.447 -0.501 . . . . 1.0 109.739 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.77 -30.04 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.742 -0.663 . . . . 1.0 110.767 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 42' ' ' VAL . 75.1 p -68.48 -36.02 78.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.283 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -72.72 -25.48 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.16 0.429 . . . . 1.0 112.16 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.32 -42.67 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.267 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -68.95 -48.29 63.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.804 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 43' ' ' ARG . 34.4 m -56.44 -49.22 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.352 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG23 ' A' ' 42' ' ' VAL . 70.8 ttp85 -51.01 -43.5 60.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.9 0.381 . . . . 1.0 110.672 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.8 -40.79 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.33 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.59 -35.81 79.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.758 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -96.75 -15.76 21.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 1.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.57 25.23 34.54 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 170' ' ' HIS . 69.9 m -78.63 145.89 34.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.918 -0.401 . . . . 1.0 109.918 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -53.37 -44.46 68.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.445 HH21 ' HB2' ' A' ' 73' ' ' ARG . 11.0 mtt85 -148.28 132.44 17.35 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 119.563 -0.855 . . . . 1.0 112.798 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.4 t -136.49 130.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 114.937 -1.029 . . . . 1.0 108.777 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -136.56 148.32 47.5 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.604 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 47.6 t -98.57 140.72 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.923 -0.769 . . . . 1.0 108.923 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.5 t80 -128.92 133.04 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.464 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -106.62 141.96 37.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.979 0.419 . . . . 1.0 111.234 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.452 ' CE2' ' NH1' ' A' ' 92' ' ' ARG . 64.6 t80 -97.99 124.55 42.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.696 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' HIS . 7.6 t70 -95.22 138.72 21.91 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -40.76 -29.68 0.46 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.931 2.421 . . . . 1.0 114.564 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -84.44 -4.56 58.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.229 0.455 . . . . 1.0 112.229 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 104.8 -17.53 45.38 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.929 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' CB ' ' A' ' 57' ' ' ASP . 75.6 m80 -80.25 149.27 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.376 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -139.1 162.98 26.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.4 p -134.14 156.15 48.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.976 0.417 . . . . 1.0 111.504 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.4 t -88.39 108.56 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.54 -4.93 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.42 124.14 7.25 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.301 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 71.2 tt0 -150.69 138.5 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.195 0.521 . . . . 1.0 111.69 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.08 128.02 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.738 -0.838 . . . . 1.0 108.738 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -102.68 137.41 40.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.296 -0.562 . . . . 1.0 111.991 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -79.07 -143.18 2.48 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -62.58 61.73 0.03 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.065 -0.814 . . . . 1.0 111.065 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 70' ' ' GLY . 3.2 pm0 26.34 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.835 0.35 . . . . 1.0 110.392 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 71' ' ' GLY . 81.6 mtt180 -84.38 -36.0 22.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.0 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 146' ' ' MET . 12.6 tp -124.74 123.6 25.63 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.365 -0.605 . . . . 1.0 109.365 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.7 149.63 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.52 2.147 . . . . 1.0 112.211 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.8 p -66.66 138.04 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.332 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.602 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -108.11 12.95 26.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.991 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.9 tp -64.08 132.04 49.33 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.881 0.697 . . . . 1.0 112.881 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.28 -4.3 84.01 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.42 -0.809 . . . . 1.0 112.873 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.84 151.45 23.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.357 0.579 . . . . 1.0 110.383 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.9 m -108.04 134.81 50.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.635 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -108.52 150.9 41.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.249 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -79.37 140.6 15.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -63.73 -33.86 76.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 1.0 110.463 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.2 -16.67 0.17 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 84' ' ' ALA . 11.8 p-10 -55.65 -11.98 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.671 0.272 . . . . 1.0 111.037 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -151.75 146.45 18.76 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.536 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 93.4 Cg_endo -75.7 -92.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.556 2.17 . . . . 1.0 111.675 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' OE2' ' NH2' ' A' ' 92' ' ' ARG . 46.7 tp10 -167.58 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 20.2 pt-20 -55.23 -41.74 72.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -72.07 -37.64 69.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.76 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 54.0 ttp180 -62.58 -33.06 74.2 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.776 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -64.05 -37.42 87.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.915 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.63 -35.87 77.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.589 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.3 -36.94 77.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -75.43 -30.87 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.255 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.54 -38.86 10.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.804 1.039 . . . . 1.0 113.804 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.92 -13.08 8.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.262 1.208 . . . . 1.0 114.262 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.659 ' O ' HG13 ' A' ' 100' ' ' VAL . 9.0 mp0 47.87 56.92 6.55 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.689 -0.804 . . . . 1.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.3 m -159.41 113.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.913 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -165.99 135.77 3.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.896 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.3 p -148.21 156.44 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.793 -0.639 . . . . 1.0 109.705 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.681 HD11 HMA2 ' A' ' 203' ' ' CYC . 28.2 mt -109.78 128.5 65.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.339 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.4 t -83.84 165.8 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.999 0.74 . . . . 1.0 112.999 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.507 ' H ' HG12 ' A' ' 104' ' ' VAL . 63.1 t0 -51.46 118.63 3.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.291 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.446 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.3 p -51.43 -25.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.656 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -77.18 -38.91 50.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.831 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.1 43.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.129 0.49 . . . . 1.0 110.375 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 57.73 60.26 2.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.549 -0.75 . . . . 1.0 112.858 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t -94.39 124.82 38.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -119.69 143.85 47.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.649 0.981 . . . . 1.0 113.649 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -112.51 152.64 28.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.756 -1.111 . . . . 1.0 108.627 177.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.0 pt -152.72 157.29 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.492 -0.483 . . . . 1.0 111.448 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.5 t -88.8 166.73 13.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 117' ' ' GLU . 6.5 tp-100 -151.2 118.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.401 . . . . 1.0 110.859 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 117' ' ' GLU . 34.4 Cg_exo -37.74 87.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.577 2.185 . . . . 1.0 112.299 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 115' ' ' GLN . 85.0 tt0 44.57 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.653 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.2 t -157.31 0.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.518 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -93.32 144.47 25.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.657 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.97 -177.34 51.77 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 123' ' ' ALA . 40.1 tp -89.27 125.15 34.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.741 0.305 . . . . 1.0 110.645 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.5 m -60.09 -36.1 76.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' H ' ' HG ' ' A' ' 121' ' ' LEU . . . -54.0 -27.2 30.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.774 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -56.15 -59.38 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.694 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 125' ' ' VAL . 8.0 p -142.61 133.4 12.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.623 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.78 167.81 25.55 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.343 2.028 . . . . 1.0 111.529 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 127' ' ' LEU . 8.2 mp 44.68 -107.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.447 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 57.42 37.68 83.08 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.033 -0.827 . . . . 1.0 111.033 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -132.89 151.86 78.79 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.547 0.213 . . . . 1.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 132' ' ' GLN . 55.2 Cg_endo -66.46 158.13 56.96 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.428 2.085 . . . . 1.0 112.026 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.428 ' HB2' HE21 ' A' ' 132' ' ' GLN . 70.4 mt -47.69 -12.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.064 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' PRO . 17.3 mm-40 -133.51 135.26 44.32 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.477 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -111.85 131.09 22.59 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.525 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.05 139.11 10.58 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.597 2.198 . . . . 1.0 112.409 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.594 HG11 HG23 ' A' ' 103' ' ' ILE . 1.4 p -118.17 129.83 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.505 ' N ' ' OG ' ' A' ' 112' ' ' SER . 6.9 t0 -45.99 138.53 5.77 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.729 0.3 . . . . 1.0 111.33 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -39.08 -35.79 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.068 2.512 . . . . 1.0 113.62 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 t -43.53 -63.71 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.261 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.78 -22.49 62.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.678 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.446 ' CG1' HG23 ' A' ' 106' ' ' VAL . 92.9 t -61.67 -55.2 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.562 0.578 . . . . 1.0 112.562 -177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.48 -40.14 96.3 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.378 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.79 -35.57 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.64 -42.79 60.96 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -58.68 -43.73 90.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.1 m -62.42 -19.37 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.653 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.569 ' O ' HD13 ' A' ' 74' ' ' LEU . 24.6 mmm -99.97 0.87 41.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.088 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.06 18.55 78.48 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.519 -1.032 . . . . 1.0 110.519 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.8 144.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.661 0.267 . . . . 1.0 110.351 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.43 -38.57 2.99 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.087 0.403 . . . . 1.0 112.087 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.1 p -138.4 121.26 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.721 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -130.92 141.46 50.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 1.0 111.332 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.66 131.62 55.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.52 HG12 HG23 ' A' ' 167' ' ' VAL . 20.1 m -116.18 140.04 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.264 -0.575 . . . . 1.0 112.239 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.9 t -131.91 132.66 23.33 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -89.92 159.87 4.99 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.326 2.018 . . . . 1.0 113.666 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 34.3 mt -114.89 117.02 29.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.2 ptm -140.33 148.07 40.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.692 0.627 . . . . 1.0 112.692 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 81.5 t60 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.826 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.616 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 22.1 m-70 58.38 -125.44 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.148 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -100.67 6.11 43.94 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.761 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 11.5 pt-20 -111.98 156.32 22.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.728 1.01 . . . . 1.0 113.728 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.6 tp -102.04 128.1 48.63 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.464 -1.31 . . . . 1.0 107.464 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.515 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 29.7 m95 -104.58 -34.74 8.09 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.15 31.06 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.712 -1.232 . . . . 1.0 112.383 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -137.41 123.11 19.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.446 -0.377 . . . . 1.0 111.643 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.65 149.24 21.44 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.633 -0.877 . . . . 1.0 108.633 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.52 HG23 HG12 ' A' ' 153' ' ' VAL . 12.1 p -152.69 131.36 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.1 -0.64 . . . . 1.0 111.899 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 48' ' ' THR . 7.6 t -114.91 135.18 54.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.258 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' ' CG2' ' A' ' 48' ' ' THR . 11.7 m-70 -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.63 ' CD2' HG23 ' A' ' 48' ' ' THR . 72.3 m80 -117.45 119.88 36.42 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.11 24.58 1.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.822 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 1.3 pm0 -160.68 152.98 17.1 Favored Pre-proline 0 C--N 1.326 -0.437 0 C-N-CA 120.956 -0.298 . . . . 1.0 110.627 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.13 124.87 13.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.659 2.24 . . . . 1.0 111.792 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -158.2 93.81 2.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.91 153.76 11.26 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.57 2.18 . . . . 1.0 111.451 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -107.43 152.07 24.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.811 0.339 . . . . 1.0 110.839 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.5 p -94.85 153.99 17.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.201 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -59.48 -34.69 72.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.151 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -71.83 -49.13 41.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.176 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 184' ' ' VAL . 76.6 mm-40 -64.56 -31.86 73.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 1.0 110.953 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.2 tp -63.13 -38.52 91.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.614 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.67 -51.87 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.869 -0.332 . . . . 1.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.9 t -42.23 -42.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.689 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 185' ' ' GLN . 26.9 m -74.47 -45.94 44.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.523 ' N ' HG23 ' A' ' 184' ' ' VAL . 56.0 tt0 -50.53 -32.87 19.6 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.063 -1.088 . . . . 1.0 108.063 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 16.8 tp -73.0 -52.65 13.64 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.089 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.17 -46.01 65.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.19 80.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -61.23 -38.44 86.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 44.5 tt0 -64.9 -33.11 75.23 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.4 -45.74 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.376 -0.972 . . . . 1.0 108.376 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 m -52.46 -36.03 53.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -68.61 -37.0 77.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.17 -0.923 . . . . 1.0 110.272 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.61 -41.01 80.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.0 mt -55.52 -48.43 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.608 -0.516 . . . . 1.0 109.608 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.474 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.363 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.44 -46.54 88.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.264 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.41 -33.08 74.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 1.0 111.398 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -55.97 -41.13 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.242 0.46 . . . . 1.0 112.242 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 26.0 tp -53.18 -37.29 61.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.02 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.8 m -48.94 -57.75 5.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.67 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.7 mp . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.453 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.681 HMA2 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.805 0.336 . . . . 1.0 110.528 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -51.22 -32.4 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.742 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.8 -48.73 20.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.792 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 38' ' ' THR . 25.6 mm -55.1 -53.3 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.467 . . . . 1.0 110.945 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.6 mt -56.44 -30.21 62.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.99 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 39' ' ' VAL . 59.9 ttp180 -64.49 -39.94 94.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.384 -0.526 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -31.12 67.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.774 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.5 p -67.49 -36.46 81.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.314 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.603 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -73.65 -25.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.236 0.458 . . . . 1.0 112.236 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 71.5 mm-40 -79.6 -43.8 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.773 -0.371 . . . . 1.0 111.318 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.88 -44.6 80.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.807 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 43' ' ' ARG . 36.0 m -59.42 -46.56 92.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.323 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 47' ' ' GLY . 6.2 ttm180 -50.76 -45.03 58.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.896 0.379 . . . . 1.0 110.692 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.44 -41.78 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.0 111.254 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -67.95 -37.86 82.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.852 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.37 -18.69 18.96 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.914 -0.314 . . . . 1.0 111.674 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.76 25.49 56.0 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.577 -1.009 . . . . 1.0 110.577 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 169' ' ' HIS . 50.0 m -78.07 143.23 37.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.38 -39.97 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 13.3 mtt85 -148.48 124.19 10.5 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.596 -0.842 . . . . 1.0 112.822 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.5 t -132.63 128.48 57.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.748 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HZ2' HD12 ' A' ' 77' ' ' LEU . 34.9 mttt -136.64 148.78 47.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.616 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.587 HG22 ' CD1' ' A' ' 166' ' ' LEU . 59.9 t -98.39 140.96 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.405 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 20.1 t80 -130.6 132.3 45.42 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.433 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.431 HH12 ' CG2' ' A' ' 195' ' ' ILE . 60.4 ttt85 -110.84 149.84 30.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.035 0.445 . . . . 1.0 111.195 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.14 133.95 46.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.851 -0.613 . . . . 1.0 111.691 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 61' ' ' HIS . 11.6 m-20 -99.26 153.51 37.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -38.68 -51.08 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 122.96 2.44 . . . . 1.0 114.53 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -70.96 -6.43 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 106.84 -8.23 39.27 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.684 -0.77 . . . . 1.0 111.922 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ASP . 70.0 m80 -78.23 151.03 33.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.424 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.59 163.61 25.78 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.81 -0.916 . . . . 1.0 110.81 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -135.87 157.72 46.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.999 0.428 . . . . 1.0 111.528 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.6 107.75 17.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 65' ' ' VAL . 21.6 t -107.77 -5.19 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.71 123.2 7.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.791 -0.364 . . . . 1.0 110.274 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 55.1 tt0 -148.45 136.99 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.152 0.501 . . . . 1.0 111.734 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.62 129.03 48.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' CB ' ' NH2' ' A' ' 50' ' ' ARG . 30.8 ptt-85 -107.01 137.98 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.292 -0.563 . . . . 1.0 112.052 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.13 65.19 4.14 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.584 -1.006 . . . . 1.0 110.584 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 82.52 162.53 31.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.059 -0.816 . . . . 1.0 111.059 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -61.67 11.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 1.0 110.364 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.652 ' H ' ' C ' ' A' ' 71' ' ' GLY . 61.6 mtp180 -62.89 -48.94 76.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.045 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 11.9 mt -116.71 148.31 41.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.47 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 86.5 Cg_endo -76.67 166.37 27.27 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.504 2.136 . . . . 1.0 112.237 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.6 p -101.22 148.13 25.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.342 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.61 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 42.7 mt -110.81 19.43 18.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.0 tp -66.47 130.47 43.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.04 -3.35 87.2 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.41 -0.814 . . . . 1.0 112.858 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.3 149.23 25.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.32 0.56 . . . . 1.0 110.429 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.1 m -106.89 134.62 49.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.589 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' CG ' HBB3 ' A' ' 203' ' ' CYC . 61.5 m-85 -108.78 148.9 38.75 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.215 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.73 136.17 10.6 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.572 2.182 . . . . 1.0 111.502 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -58.28 -30.58 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.817 0.341 . . . . 1.0 110.413 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.61 -16.63 0.06 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.227 -0.749 . . . . 1.0 111.227 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.754 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 51.4 t0 -62.07 -21.84 65.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.701 0.286 . . . . 1.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.0 mt -143.35 104.71 5.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.529 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 47.9 Cg_exo -40.38 -84.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.56 2.173 . . . . 1.0 111.629 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.486 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 46.2 tp10 -172.41 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.936 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -59.53 -43.31 93.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.626 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.64 -36.78 70.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.521 -0.308 . . . . 1.0 111.702 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 65.4 ttp85 -64.6 -32.75 74.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.774 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' NH1' ' CH2' ' A' ' 119' ' ' TRP . 62.6 ttt180 -64.42 -37.19 86.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.857 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.11 -36.7 80.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.532 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' CZ ' HBA1 ' A' ' 203' ' ' CYC . 91.2 m-85 -67.39 -33.98 76.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -74.14 -33.22 63.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.263 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.492 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.2 mt -94.82 -38.11 10.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.82 -13.56 9.07 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 114.228 1.196 . . . . 1.0 114.228 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.575 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 1.4 mp0 47.06 49.7 14.72 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.665 -0.814 . . . . 1.0 109.864 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.4 109.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 120.314 -0.554 . . . . 1.0 111.878 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.02 134.88 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.865 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.446 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.4 p -151.05 156.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.724 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.544 HG12 HG21 ' A' ' 135' ' ' VAL . 27.8 mt -109.96 128.77 65.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.263 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.69 169.34 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 112.972 0.73 . . . . 1.0 112.972 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -49.52 113.73 0.89 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.937 -1.029 . . . . 1.0 112.289 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.482 HG13 ' CG1' ' A' ' 140' ' ' VAL . 52.9 t -51.37 -18.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -77.95 -38.81 44.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.795 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.75 -7.19 3.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.131 0.491 . . . . 1.0 110.384 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 18.2 pt20 45.67 62.77 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.494 -0.776 . . . . 1.0 112.881 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.9 m -93.91 127.83 39.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -119.79 144.73 47.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.708 1.003 . . . . 1.0 113.708 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.655 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -108.84 150.43 27.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.715 -1.129 . . . . 1.0 108.619 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.3 pt -150.61 154.79 8.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.1 t -85.18 163.82 18.49 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 117' ' ' GLU . 62.4 mt-30 -148.17 153.39 41.25 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.866 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -35.81 -27.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.593 2.195 . . . . 1.0 112.272 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 115' ' ' GLN . 94.6 mt-10 -144.58 -128.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.633 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.8 t 60.9 82.43 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.483 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.609 ' CH2' ' NH1' ' A' ' 93' ' ' ARG . 83.6 t90 -156.56 137.07 13.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.761 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.3 31.39 51.86 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 121' ' ' LEU . 8.6 mp -64.62 -37.32 87.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 1.0 110.608 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 m -59.88 -36.34 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.06 79.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -57.61 -61.01 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.69 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.52 156.28 45.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.627 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.552 ' O ' ' N ' ' A' ' 128' ' ' GLY . 50.0 Cg_endo -65.16 126.06 15.73 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.356 2.038 . . . . 1.0 111.551 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.8 mt 56.32 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.549 -0.296 . . . . 1.0 110.4 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 56.29 9.98 3.65 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.086 -0.806 . . . . 1.0 111.086 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -154.52 152.03 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.57 0.224 . . . . 1.0 110.576 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' A' ' 132' ' ' GLN . 66.3 Cg_exo -41.66 141.37 1.55 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.438 2.092 . . . . 1.0 111.995 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.48 12.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.986 -0.552 . . . . 1.0 112.032 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 130' ' ' PRO . 27.4 mt-30 -127.34 134.99 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.457 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -132.57 152.56 80.19 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.553 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.655 ' C ' ' HG ' ' A' ' 112' ' ' SER . 56.1 Cg_endo -84.82 148.32 10.87 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.64 2.226 . . . . 1.0 112.356 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.544 HG21 HG12 ' A' ' 103' ' ' ILE . 89.4 t -112.11 123.87 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.533 ' N ' ' OG ' ' A' ' 112' ' ' SER . 5.6 t70 -44.83 139.23 3.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.749 0.309 . . . . 1.0 111.293 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.67 -25.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.091 2.527 . . . . 1.0 113.632 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.8 t -49.58 -61.97 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.771 -0.371 . . . . 1.0 111.206 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.416 ' HE2' ' CHB' ' A' ' 203' ' ' CYC . 30.9 t-80 -72.94 -23.21 60.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.68 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.482 ' CG1' HG13 ' A' ' 106' ' ' VAL . 72.5 t -55.55 -60.96 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -63.31 -39.46 94.62 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.364 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.588 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 83.1 t80 -48.21 -40.01 22.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.27 -44.8 64.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -56.2 -41.77 76.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -62.65 -22.07 66.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.622 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.588 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 46.1 mtp -97.25 -1.48 44.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.129 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 20.27 73.8 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.17 143.49 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.277 . . . . 1.0 110.344 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.38 -28.2 4.69 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.976 0.362 . . . . 1.0 111.976 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -151.44 120.2 6.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.811 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 72.9 m -128.65 142.46 51.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 1.0 111.46 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tp -100.07 132.43 45.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.91 130.39 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.305 -0.558 . . . . 1.0 112.242 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 19.8 t -135.71 131.35 19.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.247 -1.02 . . . . 1.0 108.247 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.29 163.01 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.389 2.06 . . . . 1.0 113.69 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.2 mt -115.77 113.93 24.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.4 ptm -142.0 152.31 43.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.751 0.649 . . . . 1.0 112.751 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -128.04 123.74 35.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 1.0 108.88 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.451 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 17.6 t-80 61.98 -123.64 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.1 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.451 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 15.3 mm100 -97.39 3.3 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.843 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.4 tt0 -106.56 144.96 32.48 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.75 1.018 . . . . 1.0 113.75 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 48.2 tp -100.18 125.05 46.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.9 m95 -103.76 -33.45 8.92 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.58 0.956 . . . . 1.0 113.58 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.64 -175.99 32.25 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.668 -1.253 . . . . 1.0 112.371 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 mt -135.06 123.12 22.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.447 -0.377 . . . . 1.0 111.617 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.587 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.4 p -155.45 132.67 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.825 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.5 p -114.2 133.69 55.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.678 -0.692 . . . . 1.0 109.174 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.472 ' O ' ' CG2' ' A' ' 48' ' ' THR . 46.4 m80 -106.05 122.7 46.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.593 ' CG ' ' NE ' ' A' ' 174' ' ' ARG . 4.7 t-80 -118.08 121.52 40.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.1 -17.36 62.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.81 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 0.1 OUTLIER -126.26 163.66 38.68 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.618 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.51 141.04 34.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.606 2.204 . . . . 1.0 111.867 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.593 ' NE ' ' CG ' ' A' ' 170' ' ' HIS . 10.9 ptt180 -162.87 94.61 1.16 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.585 -0.279 . . . . 1.0 110.683 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.18 152.63 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.574 2.182 . . . . 1.0 111.473 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -110.17 154.16 23.73 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.809 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.4 p -110.05 150.11 29.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.187 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -56.66 -37.41 70.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.77 -51.86 62.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.219 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -73.18 -37.24 66.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 1.0 110.941 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.6 -43.97 93.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.625 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -64.45 -51.55 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 1.0 111.721 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 83.8 t -44.25 -42.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.669 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 88.0 t -75.09 -50.5 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -49.46 -33.44 14.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 190' ' ' GLN . 6.5 tt -74.55 -48.15 28.53 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.032 -0.985 . . . . 1.0 109.069 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.6 tt -53.43 -46.52 69.86 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.3 80.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -60.58 -38.37 84.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 186' ' ' LEU . 57.4 tp60 -65.85 -33.4 75.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.3 -47.13 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.1 p -52.64 -35.01 54.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.13 -35.47 71.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.12 -0.945 . . . . 1.0 110.326 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.99 -40.2 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.431 ' CG2' HH12 ' A' ' 55' ' ' ARG . 64.3 mt -56.49 -45.5 82.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.6 -49.7 67.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.401 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.54 -46.3 88.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.24 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -32.2 73.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 1.0 111.394 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.82 -43.03 80.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 37.6 tp -53.64 -37.64 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.935 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 32.0 t -54.5 -61.84 2.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.657 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.499 179.728 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.754 ' HHB' ' OD2' ' A' ' 86' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.781 0.325 . . . . 1.0 110.496 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -48.67 -35.1 13.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.753 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -74.74 -50.57 16.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.798 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -56.78 -46.49 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.124 0.488 . . . . 1.0 110.945 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' O ' ' OG1' ' A' ' 38' ' ' THR . 22.3 mt -58.71 -27.38 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.968 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 39' ' ' VAL . 70.9 mtp85 -69.92 -37.73 76.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.42 -0.512 . . . . 1.0 109.807 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -30.1 66.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.751 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 57.2 p -67.98 -37.14 81.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 1.0 112.324 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p -72.08 -24.91 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.83 -43.09 23.01 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.28 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -70.28 -48.34 57.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.78 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 43' ' ' ARG . 14.4 p -57.67 -47.66 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.366 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.591 ' N ' HG13 ' A' ' 42' ' ' VAL . 66.2 ttt-85 -51.79 -44.09 63.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 1.0 110.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.39 -40.81 65.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -66.12 -36.45 83.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.838 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.44 -14.67 21.03 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.722 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 26.06 30.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' ' CE1' ' A' ' 170' ' ' HIS . 49.6 m -76.99 143.66 39.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.989 -0.374 . . . . 1.0 109.989 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.8 p30 -53.84 -41.57 67.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.602 0.593 . . . . 1.0 112.602 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 22.2 ttt-85 -151.31 131.85 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 119.612 -0.835 . . . . 1.0 112.826 -179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 9.0 t -138.66 132.94 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.946 -1.024 . . . . 1.0 108.759 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HE3' HBB2 ' A' ' 203' ' ' CYC . 24.3 pttm -137.13 149.27 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.279 -0.568 . . . . 1.0 111.628 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 56.0 t -96.41 139.18 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.3 t80 -128.36 132.16 48.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.43 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -107.86 143.25 36.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 1.0 111.231 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 64.8 t80 -99.56 125.19 45.3 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.687 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 2.5 m-20 -92.07 152.04 42.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -56.58 -21.43 38.51 Favored 'Trans proline' 0 N--CA 1.501 1.93 0 C-N-CA 123.038 2.492 . . . . 1.0 114.474 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.43 -0.93 57.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.168 0.432 . . . . 1.0 112.168 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.8 -16.58 54.4 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.716 -0.754 . . . . 1.0 111.901 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 74.5 m80 -80.4 148.91 30.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.421 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -137.41 160.04 24.98 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.2 p -133.19 154.2 50.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.99 0.424 . . . . 1.0 111.503 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 t -91.78 113.29 26.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.13 -2.95 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.196 0.443 . . . . 1.0 112.196 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.96 128.33 9.91 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.324 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CB ' HD21 ' A' ' 78' ' ' LEU . 88.7 tt0 -156.14 138.82 15.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.162 0.506 . . . . 1.0 111.722 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.94 140.54 51.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.809 -0.812 . . . . 1.0 108.809 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HE ' ' CB ' ' A' ' 76' ' ' SER . 23.5 mtt85 -116.77 137.5 52.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.352 -0.539 . . . . 1.0 112.104 -177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.5 82.62 1.63 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' C ' ' N ' ' A' ' 73' ' ' ARG . . . 74.64 41.04 36.47 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 49.65 15.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 1.0 110.408 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' N ' ' C ' ' A' ' 71' ' ' GLY . 52.7 ttt85 -55.75 -47.43 76.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.0 109.998 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 mt -102.98 149.01 36.45 Favored Pre-proline 0 C--N 1.332 -0.194 0 N-CA-C 109.273 -0.64 . . . . 1.0 109.273 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.95 160.13 40.68 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.47 2.113 . . . . 1.0 112.191 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.516 ' CB ' ' HE ' ' A' ' 69' ' ' ARG . 4.9 p -85.51 130.81 34.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.336 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.549 HD12 ' NH2' ' A' ' 50' ' ' ARG . 24.0 mt -109.53 9.19 25.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.007 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD21 ' CB ' ' A' ' 67' ' ' GLU . 89.4 mt -56.11 129.04 38.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.21 -6.53 81.41 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.468 -0.787 . . . . 1.0 112.861 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.92 147.24 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.348 0.574 . . . . 1.0 110.482 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.5 m -108.8 137.46 46.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.515 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -108.58 149.58 39.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.213 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.8 136.23 11.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.583 2.189 . . . . 1.0 111.449 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -61.23 -32.06 71.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.818 0.342 . . . . 1.0 110.429 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.08 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.5 m-20 -61.11 -24.96 66.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.72 0.295 . . . . 1.0 111.035 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.474 HG22 ' HD ' ' A' ' 203' ' ' CYC . 7.7 pt -137.32 143.96 43.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.52 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 96.4 Cg_endo -76.39 -89.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.581 2.187 . . . . 1.0 111.608 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.512 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 83.3 tt0 -170.01 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.957 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 19.6 pt-20 -59.26 -40.47 86.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.586 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -73.39 -38.28 65.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.703 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.675 HH12 ' NH2' ' A' ' 96' ' ' ARG . 66.9 ttp85 -61.89 -32.89 73.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 1.0 110.808 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -64.61 -36.77 85.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.938 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -60.91 -36.36 79.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.493 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' CE2' ' O1A' ' A' ' 203' ' ' CYC . 87.2 m-85 -69.55 -38.45 77.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.675 ' NH2' HH12 ' A' ' 92' ' ' ARG . 28.1 ttm180 -74.03 -33.15 63.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.159 -0.928 . . . . 1.0 111.197 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.541 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.0 mt -94.58 -37.73 11.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.789 1.033 . . . . 1.0 113.789 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.12 -12.65 9.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.274 1.213 . . . . 1.0 114.274 -175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.548 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.3 mp0 46.99 47.63 15.75 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.958 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.51 109.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.413 -0.515 . . . . 1.0 111.946 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.466 ' HD2' HBD2 ' A' ' 203' ' ' CYC . 0.1 OUTLIER -166.58 130.72 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.798 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.14 159.05 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 1.0 109.647 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.719 HG12 HG21 ' A' ' 135' ' ' VAL . 4.7 mt -110.37 128.45 66.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.004 0.431 . . . . 1.0 110.257 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.47 HG21 ' OG ' ' A' ' 110' ' ' SER . 5.2 m -86.96 171.39 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.021 0.749 . . . . 1.0 113.021 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -50.32 115.0 1.25 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.999 -1.0 . . . . 1.0 112.192 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.491 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.3 p -52.55 -27.15 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.69 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.08 -40.27 62.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.85 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.15 -15.05 3.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.101 0.477 . . . . 1.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.693 ' NE2' HH21 ' A' ' 111' ' ' ARG . 6.9 tp60 56.81 60.81 2.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.491 -0.777 . . . . 1.0 112.847 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.47 ' OG ' HG21 ' A' ' 104' ' ' VAL . 2.3 m -95.62 125.29 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.693 HH21 ' NE2' ' A' ' 109' ' ' GLN . 87.9 mtt-85 -118.08 144.92 45.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.2 t -109.46 145.46 36.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.767 -1.106 . . . . 1.0 108.646 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.2 mt -146.8 151.78 13.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.441 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -88.53 160.89 17.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.292 -0.633 . . . . 1.0 109.292 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -152.76 132.08 6.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.929 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 117' ' ' GLU . 32.3 Cg_exo -36.64 129.61 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.699 2.266 . . . . 1.0 112.24 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 116' ' ' PRO . 43.0 tp10 58.06 120.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.606 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.3 p -67.58 154.68 40.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.519 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -61.26 -36.36 79.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.731 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.34 -171.35 44.2 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 123' ' ' ALA . 21.4 tp -97.35 138.52 34.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 1.0 110.624 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -53.78 -27.13 27.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.787 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.449 ' H ' ' HG ' ' A' ' 121' ' ' LEU . . . -48.33 -34.28 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.751 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -64.92 -139.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.658 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.12 133.55 95.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 145.11 37.27 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.398 2.065 . . . . 1.0 111.537 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.11 -108.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.413 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.98 48.1 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -135.78 153.28 77.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 121.207 -0.197 . . . . 1.0 110.615 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.576 ' C ' ' H ' ' A' ' 132' ' ' GLN . 68.6 Cg_exo -41.52 167.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.402 2.068 . . . . 1.0 112.04 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.405 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 46.9 mt -59.27 9.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.985 -0.552 . . . . 1.0 112.059 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.576 ' H ' ' C ' ' A' ' 130' ' ' PRO . 46.2 mm-40 -137.28 154.31 50.13 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.616 -0.434 . . . . 1.0 111.471 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -126.88 83.06 66.56 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.65 141.19 27.6 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.657 2.238 . . . . 1.0 112.38 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.779 HG13 HAD2 ' A' ' 203' ' ' CYC . 96.3 t -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -45.03 157.27 0.34 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.401 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.94 -9.92 15.91 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.135 2.557 . . . . 1.0 113.711 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -66.56 -63.16 1.13 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.258 -179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.486 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 41.5 t60 -71.64 -25.41 62.13 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.656 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 136' ' ' ASP . 92.4 t -61.2 -58.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -63.86 -37.9 89.09 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.419 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.438 ' O ' ' OG ' ' A' ' 145' ' ' SER . 80.5 t80 -48.8 -35.28 14.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.445 HD11 ' NE2' ' A' ' 139' ' ' HIS . 49.8 mt -73.45 -43.25 60.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.137 -0.69 . . . . 1.0 109.137 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -58.73 -44.31 90.41 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 96.9 p -62.51 -18.11 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.382 -0.826 . . . . 1.0 109.716 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.8 mmm -100.89 0.57 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.93 19.05 78.13 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.564 -1.015 . . . . 1.0 110.564 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.605 HG21 ' HD1' ' A' ' 169' ' ' HIS . 97.8 t -108.13 143.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.697 0.284 . . . . 1.0 110.292 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -116.78 -32.15 5.23 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.975 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.8 m -143.79 122.45 12.57 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.746 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 p -126.86 131.7 51.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 1.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tp -97.0 131.43 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.95 131.13 64.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.32 -0.552 . . . . 1.0 112.304 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.7 t -135.93 131.36 18.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.199 -1.038 . . . . 1.0 108.199 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -93.78 162.41 2.26 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.424 2.083 . . . . 1.0 113.706 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 30.5 mt -115.55 113.86 24.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 23.3 ptm -140.92 150.19 42.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 71.9 t60 -122.09 123.22 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.933 -1.03 . . . . 1.0 108.878 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.62 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 45.8 m-70 57.4 -118.88 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.12 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -98.12 1.87 48.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.806 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 143.75 33.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.721 1.008 . . . . 1.0 113.721 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.7 tp -99.51 124.43 44.68 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.508 -1.293 . . . . 1.0 107.508 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 65.5 m95 -103.24 -32.18 9.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.575 0.954 . . . . 1.0 113.575 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.81 -173.06 32.05 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 119.701 -1.238 . . . . 1.0 112.39 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.6 mt -136.22 122.81 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.443 -0.379 . . . . 1.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.415 ' CD1' HG22 ' A' ' 53' ' ' VAL . 17.9 tp -95.33 149.35 21.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.652 -0.87 . . . . 1.0 108.652 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.464 HG11 ' NZ ' ' A' ' 52' ' ' LYS . 11.0 p -155.15 134.52 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.867 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.1 m -115.73 139.02 50.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.22 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.605 ' HD1' HG21 ' A' ' 148' ' ' VAL . 18.9 m-70 -110.64 123.97 51.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.542 ' CE1' ' OG1' ' A' ' 48' ' ' THR . 84.8 m-70 -117.97 113.86 22.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.92 -22.71 59.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.777 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -106.17 115.03 61.78 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.553 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -42.9 136.12 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.675 2.25 . . . . 1.0 111.806 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -169.1 138.55 1.74 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.588 -0.278 . . . . 1.0 110.685 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 156.01 31.02 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.545 2.164 . . . . 1.0 111.431 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.99 153.64 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.804 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.1 m -105.57 150.65 25.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.816 ' H ' ' NE2' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -55.76 -37.7 68.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.19 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.7 -47.04 85.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.305 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.52 -32.61 68.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 1.0 110.952 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.96 -35.8 81.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.667 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -78.69 -53.17 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.718 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 76.2 t -41.82 -42.96 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.589 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 185' ' ' GLN . 29.1 m -74.67 -45.85 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.511 ' N ' HG23 ' A' ' 184' ' ' VAL . 53.4 tt0 -52.91 -31.5 40.21 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 190' ' ' GLN . 39.3 tp -75.84 -56.56 4.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.053 -0.976 . . . . 1.0 109.097 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.0 mt -51.04 -45.42 61.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.43 76.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.361 -0.978 . . . . 1.0 108.361 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -61.11 -39.02 88.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 186' ' ' LEU . 46.8 tp60 -64.44 -33.37 75.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.593 -0.892 . . . . 1.0 108.593 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.75 -46.78 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.0 p -53.14 -33.79 53.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.822 -0.807 . . . . 1.0 108.822 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.6 mt -70.41 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.114 -0.948 . . . . 1.0 110.174 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.12 -40.48 82.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.871 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.5 mt -55.74 -48.26 78.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.14 66.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.403 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -62.82 -46.54 87.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.294 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -33.14 75.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 1.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.6 tp -53.07 -38.89 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 35.5 t -47.67 -58.41 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.638 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.955 -1.022 . . . . 1.0 110.426 179.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.779 HAD2 HG13 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.553 ' CD2' HD11 ' A' ' 35' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.755 0.312 . . . . 1.0 110.52 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 2.3 p30 -67.12 -31.09 71.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.707 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 79.9 mt-30 -74.53 -49.06 23.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.754 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.28 -48.01 77.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 1.0 110.954 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 31' ' ' LEU . 62.7 mt -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.984 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 39' ' ' VAL . 78.2 mtm180 -65.32 -39.88 93.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.378 -0.529 . . . . 1.0 109.835 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.47 68.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.768 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.722 ' O ' HG23 ' A' ' 42' ' ' VAL . 73.0 p -67.56 -35.97 80.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 1.0 112.303 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -74.69 -24.69 18.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -178.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.71 -47.25 60.78 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.298 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.31 -32.37 64.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.828 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 38' ' ' THR . 62.0 t -62.99 -55.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.298 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 47' ' ' GLY . 9.6 tmm_? -54.22 -43.77 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 1.0 110.689 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -40.68 66.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.314 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -67.82 -36.08 79.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.826 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.5 mt -96.88 -18.65 19.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.756 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.94 25.19 56.05 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.444 -1.062 . . . . 1.0 110.444 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 p -79.86 147.26 31.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -52.43 -41.48 63.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.708 HH22 ' NE ' ' A' ' 69' ' ' ARG . 84.1 mtt-85 -151.15 128.83 11.52 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 119.55 -0.86 . . . . 1.0 112.818 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 6.2 t -134.35 128.24 51.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.771 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.556 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 20.9 pttm -138.65 153.54 48.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.353 -0.539 . . . . 1.0 111.662 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.481 HG22 ' CD1' ' A' ' 166' ' ' LEU . 48.2 t -98.36 139.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.907 -0.775 . . . . 1.0 108.907 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -127.14 130.23 49.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.609 HH12 HD12 ' A' ' 195' ' ' ILE . 16.6 mmm180 -110.68 149.64 30.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.007 0.432 . . . . 1.0 111.156 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.87 138.97 38.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -104.12 153.35 38.98 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 109.392 -0.596 . . . . 1.0 109.392 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -39.18 -51.61 2.52 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 123.015 2.477 . . . . 1.0 114.473 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.54 -4.76 24.59 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.206 0.447 . . . . 1.0 112.206 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 105.61 -8.5 43.68 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.693 -0.765 . . . . 1.0 111.944 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' A' ' 57' ' ' ASP . 75.3 m80 -76.97 149.2 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.378 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.19 161.78 25.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.4 p -135.9 157.47 46.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.98 0.419 . . . . 1.0 111.524 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 80' ' ' LEU . 4.3 p -96.87 114.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.39 3.13 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.102 0.408 . . . . 1.0 112.102 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.61 127.16 9.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.274 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.524 ' OE2' ' NH1' ' A' ' 50' ' ' ARG . 79.8 tt0 -156.69 138.87 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.194 0.521 . . . . 1.0 111.683 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.57 134.78 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.708 ' NE ' HH22 ' A' ' 50' ' ' ARG . 10.5 mtp180 -104.08 134.57 47.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.34 -0.544 . . . . 1.0 112.05 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.13 -142.51 1.21 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -65.98 53.34 0.17 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 70' ' ' GLY . 97.2 mt-10 37.73 33.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.355 . . . . 1.0 110.409 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' GLY . 14.6 tpp85 -81.62 -40.27 23.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.005 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.453 ' C ' ' HE ' ' A' ' 50' ' ' ARG . 90.7 mt -109.83 148.95 39.27 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.491 ' O ' ' CZ ' ' A' ' 50' ' ' ARG . 97.5 Cg_endo -74.34 159.4 43.59 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.545 2.164 . . . . 1.0 112.264 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -83.36 133.78 34.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.35 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.745 ' O ' HG11 ' A' ' 64' ' ' VAL . 25.5 mt -113.6 17.37 18.31 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.954 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 28.0 tp -66.79 130.72 44.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.585 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 85.56 -1.39 88.29 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.478 -0.783 . . . . 1.0 112.807 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.817 ' O ' HG12 ' A' ' 64' ' ' VAL . 86.0 mt -87.09 149.9 24.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.407 0.604 . . . . 1.0 110.451 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 81' ' ' THR . 13.7 t -104.86 131.15 52.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.629 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CG ' HBB3 ' A' ' 203' ' ' CYC . 79.9 m-85 -106.09 106.35 56.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.303 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -43.34 139.17 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.562 2.175 . . . . 1.0 111.511 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.44 -32.09 69.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.942 0.401 . . . . 1.0 110.503 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.48 -18.01 0.1 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.25 -0.74 . . . . 1.0 111.25 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 60.1 t0 -64.28 -19.2 65.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.624 0.25 . . . . 1.0 111.075 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mt -138.06 133.26 17.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.515 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.71 -94.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.525 2.15 . . . . 1.0 111.643 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.17 -38.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.994 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.48 -42.73 71.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.576 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.926 ' HB2' HBD2 ' A' ' 203' ' ' CYC . . . -71.28 -37.9 71.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.75 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -62.81 -33.43 75.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.747 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -64.15 -38.74 92.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.16 -37.32 79.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 1.0 111.536 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -67.99 -34.65 76.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.77 -28.9 50.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.12 -0.946 . . . . 1.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -94.69 -39.59 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.06 -10.16 8.63 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.234 1.198 . . . . 1.0 114.234 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.419 ' CG ' ' SD ' ' A' ' 157' ' ' MET . 3.7 mp0 45.74 58.93 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.621 -0.832 . . . . 1.0 109.942 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.9 p -163.83 114.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.703 HH22 HH21 ' A' ' 133' ' ' ARG . 7.6 tpt180 -168.38 136.87 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.824 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.3 p -152.08 157.21 5.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.677 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.472 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 71.3 mt -109.77 130.07 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.262 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.601 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.6 p -85.96 168.56 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.601 ' N ' HG22 ' A' ' 104' ' ' VAL . 60.0 m-20 -48.12 114.73 0.99 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.204 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.492 HG13 ' CG1' ' A' ' 140' ' ' VAL . 41.4 t -51.86 -21.38 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.697 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -78.18 -37.91 44.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.34 -16.49 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.17 0.509 . . . . 1.0 110.365 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 56.43 63.03 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.541 -0.754 . . . . 1.0 112.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.402 ' OG ' ' CG1' ' A' ' 104' ' ' VAL . 80.0 p -96.31 124.3 40.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -117.17 145.05 44.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 1.5 t -108.06 144.15 35.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.713 -1.13 . . . . 1.0 108.618 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.71 149.57 16.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.504 -0.478 . . . . 1.0 111.467 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 t -89.93 164.49 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 117' ' ' GLU . 9.7 pt20 -150.31 148.76 25.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.861 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -37.17 -26.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.696 2.264 . . . . 1.0 112.229 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLN . 89.8 mt-10 -98.18 159.7 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.622 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.4 p -143.13 157.29 44.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.499 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -148.07 160.61 42.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.718 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.11 134.26 3.7 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt -90.41 38.56 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 1.0 110.615 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -48.32 -25.13 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.699 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -69.66 -2.79 12.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.787 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 123' ' ' ALA . 36.3 ttm180 51.08 102.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 1.0 110.677 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.3 p -137.11 135.02 19.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.644 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -40.58 158.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.366 2.044 . . . . 1.0 111.587 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.0 mp 46.59 -102.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.396 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.46 -14.26 9.5 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -146.95 152.11 43.18 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.538 0.208 . . . . 1.0 110.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.04 173.28 14.7 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.387 2.058 . . . . 1.0 112.042 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.7 -28.3 65.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 1.0 112.094 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.38 134.79 45.58 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.511 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.703 HH21 HH22 ' A' ' 101' ' ' ARG . 9.5 mmm180 -119.71 147.79 44.7 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.5 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -87.39 143.23 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.65 2.234 . . . . 1.0 112.452 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.97 126.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.678 ' OD2' ' HHD' ' A' ' 203' ' ' CYC . 1.7 p30 -45.68 143.5 3.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.56 -0.291 . . . . 1.0 111.401 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -37.36 -25.92 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.118 2.545 . . . . 1.0 113.649 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.427 ' N ' ' O ' ' A' ' 136' ' ' ASP . 16.1 t -53.9 -61.23 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.257 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.545 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 18.3 t60 -69.39 -24.9 63.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.664 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.492 ' CG1' HG13 ' A' ' 106' ' ' VAL . 47.3 t -59.51 -60.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -61.81 -40.25 94.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.355 -0.538 . . . . 1.0 110.353 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -46.75 -39.11 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.352 -0.61 . . . . 1.0 109.352 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.06 -45.17 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -57.17 -43.1 82.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 t -63.5 -20.13 65.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.362 -0.835 . . . . 1.0 109.659 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.3 mmm -99.72 -3.45 32.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.093 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.06 78.93 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.15 141.69 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.69 0.281 . . . . 1.0 110.254 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.94 -36.12 3.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.998 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.7 m -142.01 119.43 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.705 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 168' ' ' SER . 44.4 t -126.79 136.39 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.981 0.419 . . . . 1.0 111.414 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 tp -95.77 132.36 41.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 t -113.5 129.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.31 -0.556 . . . . 1.0 112.298 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.7 t -136.97 136.39 21.09 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.255 -1.017 . . . . 1.0 108.255 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -96.82 166.25 1.02 Allowed 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.423 2.082 . . . . 1.0 113.699 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 54.6 mt -118.43 114.73 23.34 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.419 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 22.0 ptm -142.03 153.91 44.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.457 0.646 . . . . 1.0 112.683 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 43.7 t-80 -129.68 124.19 33.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.003 -0.999 . . . . 1.0 108.903 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.41 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.7 t-80 61.84 -123.73 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.144 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.41 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 95.5 mt-30 -97.56 3.61 50.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.813 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.51 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.8 144.75 33.0 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.736 1.013 . . . . 1.0 113.736 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 39.7 tp -100.69 125.26 47.11 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.51 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 87.5 m95 -102.92 -32.95 9.51 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 -177.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.09 -173.31 30.61 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.393 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.2 123.19 21.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.433 -0.383 . . . . 1.0 111.634 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.7 tp -95.29 149.9 20.83 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.1 p -158.01 134.5 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.844 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 151' ' ' SER . 42.2 m -114.94 136.66 52.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.729 -0.669 . . . . 1.0 109.282 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.556 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 32.3 m-70 -112.35 129.6 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -120.03 128.62 53.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.18 23.91 1.7 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.763 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -151.5 147.73 20.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 120.871 -0.331 . . . . 1.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.72 112.84 3.6 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.659 2.239 . . . . 1.0 111.75 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -152.42 139.89 12.93 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.685 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.97 152.88 28.61 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.57 2.18 . . . . 1.0 111.451 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -100.21 157.65 16.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.838 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.9 m -92.64 146.45 23.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.221 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -65.63 -25.35 67.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.142 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -72.87 -54.82 7.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.231 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -66.48 -28.58 68.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 1.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.6 tp -56.24 -45.29 80.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.651 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.9 -53.66 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.66 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 90.8 t -44.58 -40.1 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.3 t -75.07 -49.03 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -48.68 -33.52 10.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 190' ' ' GLN . 47.2 tp -75.17 -46.19 35.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.039 -0.982 . . . . 1.0 109.064 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.8 tp -54.64 -47.74 73.13 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.951 -0.759 . . . . 1.0 108.951 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.41 92.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.595 ' O ' HD13 ' A' ' 193' ' ' ILE . 57.2 t0 -62.28 -39.41 92.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.0 tp60 -64.54 -30.92 71.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 194' ' ' ALA . 51.6 t -77.23 -45.35 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 31.1 p -49.2 -31.64 8.92 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -73.57 -35.39 44.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.296 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 191' ' ' VAL . . . -66.69 -44.01 82.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.922 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.609 HD12 HH12 ' A' ' 55' ' ' ARG . 25.2 pt -64.97 -27.01 41.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.6 -54.36 6.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.301 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.415 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.3 pt20 -66.06 -37.53 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.289 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.415 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.355 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -58.15 -43.72 87.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.204 0.446 . . . . 1.0 112.204 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 47.7 mt -51.94 -30.39 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 95.8 p -44.87 -55.75 5.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.636 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.459 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.926 HBD2 ' HB2' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 66.9 t0 -48.15 -37.1 14.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.694 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -74.7 -51.19 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.838 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 38' ' ' THR . 95.3 mt -55.67 -47.45 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.026 0.441 . . . . 1.0 110.964 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.489 ' O ' ' OG1' ' A' ' 38' ' ' THR . 24.5 mt -56.9 -30.17 63.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.583 -0.735 . . . . 1.0 111.943 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.507 ' O ' HG12 ' A' ' 39' ' ' VAL . 28.3 ttm180 -65.25 -38.48 90.47 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.73 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.739 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 73.6 p -69.59 -34.95 74.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.35 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.512 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.7 p -74.12 -25.22 19.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.22 -47.28 18.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.266 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.37 -49.93 67.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.413 . . . . 1.0 111.768 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.9 p -52.48 -47.08 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.315 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.593 ' N ' HG13 ' A' ' 42' ' ' VAL . 53.5 ttp180 -49.98 -43.93 50.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 1.0 110.596 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.52 -40.47 65.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.36 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.45 -37.29 82.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.804 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.3 mt -96.64 -17.72 20.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.695 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 53.57 25.26 27.57 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 p -79.6 149.54 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.01 -0.367 . . . . 1.0 110.01 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.64 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 28.0 p30 -49.94 -41.94 47.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.64 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 29.7 ptt180 -159.41 146.54 16.93 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.584 -0.847 . . . . 1.0 112.788 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 13.4 p -144.02 135.65 22.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.956 -1.02 . . . . 1.0 108.733 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.717 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 48.7 pttt -137.54 149.75 46.97 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.239 -0.584 . . . . 1.0 111.573 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 166' ' ' LEU . 54.7 t -98.09 140.88 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.501 ' HH ' ' C ' ' A' ' 62' ' ' GLY . 17.8 t80 -129.48 131.3 46.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.482 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -109.89 148.19 32.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.958 0.409 . . . . 1.0 111.257 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.47 133.91 45.38 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.823 -0.626 . . . . 1.0 111.755 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 61' ' ' HIS . 23.0 m-20 -98.44 152.95 38.17 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -39.43 -50.37 2.97 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.02 2.48 . . . . 1.0 114.516 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -70.11 -6.18 32.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.35 41.45 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.696 -0.764 . . . . 1.0 111.871 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 57' ' ' ASP . 31.1 m80 -79.69 152.29 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.369 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.501 ' C ' ' HH ' ' A' ' 54' ' ' TYR . . . -139.21 164.65 25.85 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.0 p -135.87 157.67 46.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.0 111.525 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 t -92.03 109.67 21.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 65' ' ' VAL . 21.6 t -111.32 -1.86 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.54 128.43 9.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' N ' HD21 ' A' ' 78' ' ' LEU . 84.8 tt0 -160.09 140.95 12.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.151 0.501 . . . . 1.0 111.762 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.27 136.53 52.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.499 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 15.1 mtt180 -104.33 134.94 46.71 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.062 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.44 72.07 2.72 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.636 -0.986 . . . . 1.0 110.636 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 78.63 46.93 8.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 46.66 16.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 1.0 110.336 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' GLY . 41.9 ttm180 -57.21 -46.72 82.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.069 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.07 127.51 26.46 Favored Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.59 170.67 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.459 2.106 . . . . 1.0 112.252 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.3 p -95.32 145.82 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.26 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.9 mt -109.5 10.05 25.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.929 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 67' ' ' GLU . 53.5 mt -53.68 127.9 27.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -5.4 84.56 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.405 -0.816 . . . . 1.0 112.817 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 80' ' ' LEU . 90.2 mt -82.36 148.03 28.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.438 0.619 . . . . 1.0 110.448 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 81' ' ' THR . 14.2 t -106.64 132.72 52.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.614 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CG ' HAB2 ' A' ' 203' ' ' CYC . 46.2 m-85 -109.57 107.74 59.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -43.38 140.35 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.525 2.15 . . . . 1.0 111.464 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -67.16 -26.34 66.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.392 . . . . 1.0 110.471 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.08 -17.57 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.136 -0.786 . . . . 1.0 111.136 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ALA . 26.2 p-10 -69.12 -17.2 63.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 1.0 111.035 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.37 133.53 24.58 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.45 -97.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.616 2.21 . . . . 1.0 111.631 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -163.89 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.932 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -56.39 -41.48 76.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.651 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.81 59.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.695 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 39.9 ttm180 -60.25 -34.45 73.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.797 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 mtp85 -63.44 -33.82 76.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.94 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.81 -34.08 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.513 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.437 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 89.0 m-85 -69.38 -38.94 78.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 14.9 mtm180 -72.35 -33.38 67.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.26 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.11 -36.1 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.45 -16.49 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.664 ' O ' HG13 ' A' ' 100' ' ' VAL . 15.1 mp0 48.72 58.68 5.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.972 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 99' ' ' GLN . 4.9 m -159.61 112.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.364 -0.534 . . . . 1.0 111.92 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -165.02 135.57 3.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.898 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -150.41 157.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.693 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.694 HG12 HG21 ' A' ' 135' ' ' VAL . 3.3 mt -109.43 130.0 63.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.246 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.4 t -83.7 165.16 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' H ' HG12 ' A' ' 104' ' ' VAL . 61.2 m-20 -50.0 116.97 2.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.95 -1.023 . . . . 1.0 112.18 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.8 p -49.92 -21.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.701 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -80.3 -37.4 32.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.837 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.1 -21.66 66.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.119 0.485 . . . . 1.0 110.412 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 57.79 61.43 2.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.523 -0.762 . . . . 1.0 112.9 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.9 m -93.31 125.88 38.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -121.6 146.43 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.431 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -113.86 152.01 31.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.782 -1.099 . . . . 1.0 108.668 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.8 mt -148.3 154.24 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.416 -0.514 . . . . 1.0 111.446 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 p -83.3 164.01 20.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -153.21 163.97 21.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.88 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -40.37 -13.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.61 2.207 . . . . 1.0 112.335 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 115' ' ' GLN . 85.6 tt0 60.49 -95.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.571 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.3 p 44.21 23.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.471 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.424 ' N ' ' C ' ' A' ' 117' ' ' GLU . 59.2 t-105 -89.78 154.22 20.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.684 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.3 -161.28 5.39 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 121' ' ' LEU . 7.9 mp -80.08 143.53 33.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 1.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 t -59.75 -34.33 72.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.725 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.3 -52.12 17.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.721 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -51.64 -59.15 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.687 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.6 t -109.99 103.67 53.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.659 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.64 146.55 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.397 2.064 . . . . 1.0 111.547 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.46 -117.98 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.57 -0.286 . . . . 1.0 110.457 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.65 38.42 37.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -142.29 157.03 63.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 122.906 -0.173 . . . . 1.0 110.695 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.593 ' C ' ' H ' ' A' ' 132' ' ' GLN . 40.4 Cg_endo -63.2 168.51 10.82 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.425 2.083 . . . . 1.0 111.988 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 51.1 mt -58.36 9.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.094 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.593 ' H ' ' C ' ' A' ' 130' ' ' PRO . 51.1 mm-40 -137.99 154.13 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.481 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -121.73 80.46 40.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.567 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -48.07 142.55 15.62 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.649 2.233 . . . . 1.0 112.37 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 103' ' ' ILE . 3.0 t -120.4 129.5 75.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.494 ' H ' HMD2 ' A' ' 203' ' ' CYC . 1.5 m-20 -44.53 140.9 2.97 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.708 0.29 . . . . 1.0 111.365 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -38.32 -23.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.064 2.51 . . . . 1.0 113.685 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.51 ' SG ' ' HHD' ' A' ' 203' ' ' CYC . 0.0 OUTLIER -53.78 -62.15 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.23 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.442 ' CD2' HD11 ' A' ' 143' ' ' LEU . 71.7 t60 -71.29 -23.48 61.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.676 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.443 ' CG1' HG23 ' A' ' 106' ' ' VAL . 80.4 t -59.41 -60.51 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.623 0.601 . . . . 1.0 112.623 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.14 -39.76 95.61 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.342 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.37 -37.61 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.442 HD11 ' CD2' ' A' ' 139' ' ' HIS . 61.8 mt -72.99 -42.13 63.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.192 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.81 -42.94 90.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.8 m -62.11 -19.45 63.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.357 -0.838 . . . . 1.0 109.623 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.0 mmm -99.54 0.98 43.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.102 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.76 19.63 75.28 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.473 HG21 HH21 ' A' ' 50' ' ' ARG . 93.4 t -110.48 144.47 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.734 0.302 . . . . 1.0 110.245 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -120.63 -24.61 5.71 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.973 0.36 . . . . 1.0 111.973 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.5 t -152.41 119.57 5.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.76 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.2 p -127.85 139.32 52.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.972 0.415 . . . . 1.0 111.405 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 tp -99.38 134.47 42.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 t -114.91 128.25 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.294 -0.563 . . . . 1.0 112.337 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 26.5 t -134.3 133.16 21.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.05 161.22 3.25 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.415 2.076 . . . . 1.0 113.692 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.4 mt -115.2 116.81 28.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.664 -1.235 . . . . 1.0 107.664 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.9 ptm -141.2 156.2 45.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -133.26 127.46 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.062 -0.972 . . . . 1.0 108.798 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.497 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 2.0 t60 62.89 -125.4 0.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.16 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.497 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 19.5 pt20 -99.38 2.06 44.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.839 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.471 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 10.0 pt-20 -108.91 154.33 22.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.68 126.87 52.19 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.471 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 43.5 m95 -101.79 -28.21 12.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.1 -170.26 31.75 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.598 -1.287 . . . . 1.0 112.318 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 90.0 mt -136.31 123.94 22.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.454 -0.373 . . . . 1.0 111.631 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.483 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.0 tp -96.59 149.65 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.0 p -156.3 133.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.139 -0.625 . . . . 1.0 111.912 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.0 p -117.31 133.08 56.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.249 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.512 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 59.8 m80 -101.65 126.19 48.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 -178.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 170' ' ' HIS . 1.9 m80 -116.25 117.75 30.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.09 25.06 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.75 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.91 150.04 29.19 Favored Pre-proline 0 C--N 1.327 -0.409 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.94 119.06 5.24 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.592 2.195 . . . . 1.0 111.882 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -155.55 136.29 8.9 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.39 157.01 29.2 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.531 2.154 . . . . 1.0 111.466 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -110.1 153.84 24.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.829 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.8 m -111.3 148.28 33.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.2 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -56.32 -36.83 69.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.122 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 183' ' ' VAL . 78.6 mm-40 -67.13 -54.6 19.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.429 -0.351 . . . . 1.0 111.214 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.8 mt-10 -70.77 -33.7 71.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 1.0 111.015 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.59 -33.29 72.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.644 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.44 -54.82 5.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.915 -0.314 . . . . 1.0 111.609 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 184' ' ' VAL . 31.8 m -46.51 -40.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.597 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 185' ' ' GLN . 30.1 m -71.88 -50.62 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.58 ' N ' HG23 ' A' ' 184' ' ' VAL . 60.8 tt0 -46.46 -32.16 3.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.7 tt -66.86 -48.04 70.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.027 -0.988 . . . . 1.0 109.1 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 184' ' ' VAL . 91.2 mt -52.69 -45.21 66.75 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.38 90.11 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.71 -38.01 89.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 186' ' ' LEU . 52.5 tp60 -64.88 -32.52 74.26 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.4 t -77.1 -44.7 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.6 m -52.9 -36.5 59.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.768 -0.827 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.6 mt -67.57 -36.31 75.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.111 -0.95 . . . . 1.0 110.219 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.45 84.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.948 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.07 -29.73 47.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.55 -55.02 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.398 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 7.4 pt20 -65.38 -40.03 92.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.222 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.459 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.39 -32.91 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.751 0.31 . . . . 1.0 111.434 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.44 -42.87 83.28 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.6 mp -54.27 -36.4 63.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.945 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.7 t -49.57 -58.21 5.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.631 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.432 179.864 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.717 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.338 . . . . 1.0 110.519 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -65.39 -31.11 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -76.07 -48.99 18.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.853 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.54 -49.99 69.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.072 0.463 . . . . 1.0 110.997 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.562 HD11 ' CD2' ' A' ' 31' ' ' LEU . 55.1 mt -57.45 -31.52 66.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.914 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.0 ttt180 -63.01 -40.62 98.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.735 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.48 70.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.795 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.747 ' O ' HG23 ' A' ' 42' ' ' VAL . 73.6 p -65.28 -35.99 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.314 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -75.17 -24.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 1.0 112.201 -177.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -70.65 -49.99 41.54 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.247 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.25 -37.25 85.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.779 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 38' ' ' THR . 77.4 t -56.06 -54.1 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.345 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 47' ' ' GLY . 53.7 ttt-85 -51.02 -44.39 61.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 1.0 110.623 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.77 70.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.323 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.732 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.92 -14.96 21.41 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.664 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.92 26.05 25.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.558 -1.017 . . . . 1.0 110.558 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.8 p -81.55 152.38 27.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -48.3 -43.9 33.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.623 ' NH2' ' CE1' ' A' ' 169' ' ' HIS . 50.9 ptt85 -158.8 147.28 18.37 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.542 -0.863 . . . . 1.0 112.779 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -139.23 133.88 40.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.002 -0.999 . . . . 1.0 108.736 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' CE ' HH12 ' A' ' 50' ' ' ARG . 46.1 pttt -137.31 146.25 44.39 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.379 -0.528 . . . . 1.0 111.66 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.9 t -98.06 142.68 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.0 t80 -130.74 132.6 45.42 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.407 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -111.54 150.64 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 1.0 111.159 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -101.81 133.84 45.92 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.594 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.8 m-20 -99.18 153.35 37.83 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -38.36 -51.61 2.09 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.994 2.463 . . . . 1.0 114.492 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.44 -5.56 29.41 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.173 0.435 . . . . 1.0 112.173 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -7.75 43.15 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.706 -0.759 . . . . 1.0 111.964 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 57' ' ' ASP . 6.0 m-70 -78.98 151.94 31.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.365 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.411 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.99 164.3 25.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.5 p -135.88 157.99 45.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 111.487 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 t -88.08 107.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.83 -3.96 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.083 0.401 . . . . 1.0 112.083 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -154.19 128.29 8.97 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.342 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.5 tt0 -158.09 139.31 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.231 0.538 . . . . 1.0 111.663 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -117.37 137.92 52.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.269 -0.572 . . . . 1.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.45 87.3 1.56 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.586 -1.006 . . . . 1.0 110.586 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' C ' ' N ' ' A' ' 73' ' ' ARG . . . 68.09 37.43 87.24 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 52.8 12.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 1.0 110.397 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.421 ' N ' ' C ' ' A' ' 71' ' ' GLY . 28.7 ttm180 -49.62 -47.7 49.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.421 HD23 ' HE ' ' A' ' 50' ' ' ARG . 6.5 mp -108.31 156.01 39.27 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 158.47 50.75 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.55 2.167 . . . . 1.0 112.182 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.3 122.71 29.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.569 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 25.2 mt -99.85 12.17 37.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.043 -0.526 . . . . 1.0 109.967 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.8 tp -66.57 133.33 50.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.916 0.709 . . . . 1.0 112.916 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.92 86.51 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.402 -0.817 . . . . 1.0 112.823 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.6 mt -87.67 153.14 21.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.347 0.574 . . . . 1.0 110.53 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.8 m -106.86 132.21 53.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.58 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -106.0 147.21 34.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.214 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 134.78 12.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.603 2.202 . . . . 1.0 111.473 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.62 -32.9 72.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 1.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.6 -16.11 0.11 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.7 m-20 -59.07 -10.49 2.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.66 0.267 . . . . 1.0 110.997 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' HE ' ' A' ' 92' ' ' ARG . 1.8 pt -141.15 145.93 40.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.559 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.59 -98.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.502 2.135 . . . . 1.0 111.709 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.534 ' OE2' ' NH2' ' A' ' 93' ' ' ARG . 79.2 tt0 -163.47 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.963 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -71.7 -39.64 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.662 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.644 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.493 ' HE ' HD12 ' A' ' 87' ' ' ILE . 18.3 ttm180 -61.94 -36.79 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 1.0 110.81 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 18.2 mmt85 -61.51 -35.37 77.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.943 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.08 -33.31 75.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.522 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.29 -34.97 77.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 12.0 mtm180 -75.8 -31.1 59.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.251 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.51 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.8 mt -93.78 -38.08 11.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.792 1.034 . . . . 1.0 113.792 -177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -120.43 -10.54 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.246 1.202 . . . . 1.0 114.246 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.51 HE22 ' C ' ' A' ' 97' ' ' LEU . 5.0 mp0 44.46 63.31 1.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.641 -0.824 . . . . 1.0 109.859 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 100' ' ' VAL . 13.2 p -169.33 117.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.315 -0.554 . . . . 1.0 111.882 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.587 HH22 ' CA ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -173.77 131.14 0.42 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.859 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.54 ' O ' ' NH1' ' A' ' 101' ' ' ARG . 2.5 m -142.42 159.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.657 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.573 HD11 HMA2 ' A' ' 203' ' ' CYC . 23.8 mt -111.02 128.29 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.252 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 104' ' ' VAL . 19.2 m -87.89 171.45 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.419 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 56.3 m-20 -52.26 113.2 0.96 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.277 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.736 HG23 ' CG1' ' A' ' 140' ' ' VAL . 10.1 p -47.71 -17.74 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 1.0 110.688 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' N ' ' C ' ' A' ' 105' ' ' ASP . 84.7 tt0 -81.81 -36.68 28.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.806 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.58 -20.21 44.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.105 0.479 . . . . 1.0 110.451 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 56.46 58.94 3.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.819 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -96.71 126.83 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -122.39 143.33 49.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.757 ' HG ' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -111.81 156.73 21.52 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.746 -1.116 . . . . 1.0 108.63 177.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.6 pt -152.8 156.61 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.462 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.7 p -89.77 172.73 8.71 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -139.35 152.37 69.14 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.893 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.49 -14.15 16.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.648 2.232 . . . . 1.0 112.312 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -57.26 136.54 56.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.634 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.5 t -87.81 -10.01 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.486 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -98.75 145.54 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.669 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 147.06 86.89 0.07 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.18 110.9 21.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.71 0.29 . . . . 1.0 110.604 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.2 t -65.58 -27.82 68.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.745 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -65.84 -5.22 8.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.748 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 125' ' ' VAL . 32.4 ptt180 -58.32 -151.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.74 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.424 ' N ' ' HG3' ' A' ' 124' ' ' ARG . 3.5 m -57.89 151.27 44.65 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.615 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.9 143.16 49.31 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.377 2.052 . . . . 1.0 111.529 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.6 mt 59.6 -112.83 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.405 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 24.95 37.08 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.081 -0.807 . . . . 1.0 111.081 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' A' ' 133' ' ' ARG . 54.7 mt-10 -143.03 154.42 61.67 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.215 -0.194 . . . . 1.0 110.633 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 132' ' ' GLN . 66.2 Cg_exo -41.65 168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.416 2.077 . . . . 1.0 112.029 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.404 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 53.0 mt -62.72 12.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.521 . . . . 1.0 112.074 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.543 ' H ' ' C ' ' A' ' 130' ' ' PRO . 50.9 mm-40 -137.17 157.09 47.45 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.507 -178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 129' ' ' GLU . 17.8 mmm180 -124.22 115.91 27.25 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.567 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.51 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 63.7 Cg_endo -83.51 138.59 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.556 2.17 . . . . 1.0 112.413 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.587 ' CA ' HH22 ' A' ' 101' ' ' ARG . 1.9 p -117.17 129.26 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.757 ' N ' ' HG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -44.97 141.18 3.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 1.0 111.294 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -40.54 -32.96 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.08 2.52 . . . . 1.0 113.706 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.52 -63.13 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.746 -0.382 . . . . 1.0 111.215 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -71.54 -22.53 61.75 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.589 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.736 ' CG1' HG23 ' A' ' 106' ' ' VAL . 82.3 t -61.69 -55.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.587 0.588 . . . . 1.0 112.587 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -64.68 -38.83 92.34 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.4 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.443 ' O ' ' OG ' ' A' ' 145' ' ' SER . 88.3 t80 -48.72 -34.74 12.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 58.9 mt -73.53 -42.78 61.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.12 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -58.21 -44.53 88.21 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 87.2 p -62.81 -18.03 62.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.394 -0.821 . . . . 1.0 109.659 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.0 mmm -101.53 -0.71 34.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.137 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.07 18.55 78.47 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 88.1 t -107.32 142.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.31 . . . . 1.0 110.27 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.27 -25.31 6.63 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.419 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 15.0 m -153.96 120.73 5.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.804 -0.359 . . . . 1.0 110.802 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 45.7 t -127.66 136.42 51.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.983 0.421 . . . . 1.0 111.38 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -97.97 132.33 43.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.131 -0.692 . . . . 1.0 109.131 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.0 t -114.86 132.4 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.268 -0.573 . . . . 1.0 112.212 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.52 133.37 20.28 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.7 161.59 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.361 2.041 . . . . 1.0 113.695 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.8 mt -115.26 116.44 28.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' OG ' ' A' ' 192' ' ' SER . 24.9 ptm -141.19 142.8 33.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -125.23 122.43 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.989 -1.005 . . . . 1.0 108.874 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.412 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 26.0 t-80 71.67 -128.12 0.05 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.223 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.412 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 37.4 tt0 -100.47 4.89 44.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.796 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.49 ' CD ' ' CZ2' ' A' ' 163' ' ' TRP . 5.2 pt-20 -111.28 158.31 19.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.726 1.01 . . . . 1.0 113.726 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.3 tp -101.73 128.96 47.82 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.49 ' CZ2' ' CD ' ' A' ' 161' ' ' GLU . 52.1 m95 -105.44 -37.01 6.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.512 0.93 . . . . 1.0 113.512 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.28 -172.82 24.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.731 -1.223 . . . . 1.0 112.392 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.2 tp -141.25 120.92 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.439 -0.38 . . . . 1.0 111.633 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.77 149.86 20.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 167' ' ' VAL . 13.5 p -155.95 133.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.034 -0.666 . . . . 1.0 111.836 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 82.1 p -115.62 136.67 52.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.736 -0.665 . . . . 1.0 109.209 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.623 ' CE1' ' NH2' ' A' ' 50' ' ' ARG . 65.7 m-70 -115.44 131.15 57.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -123.11 126.19 46.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.51 -16.61 61.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.774 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.9 155.51 75.43 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.607 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.73 133.97 38.72 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.692 2.261 . . . . 1.0 111.796 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -158.18 93.27 2.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.653 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -52.09 152.54 14.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.543 2.162 . . . . 1.0 111.399 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -107.33 152.44 24.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.799 0.333 . . . . 1.0 110.852 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 61.2 m -94.82 154.96 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.221 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -54.18 -35.82 62.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -72.33 -44.68 62.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.269 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.545 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.7 mt-10 -65.79 -30.73 71.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 1.0 110.95 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.65 -36.23 78.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.611 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.16 -55.97 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.699 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 184' ' ' VAL . 31.8 m -43.72 -41.02 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.66 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.576 HG23 ' N ' ' A' ' 185' ' ' GLN . 27.8 m -75.26 -48.88 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.576 ' N ' HG23 ' A' ' 184' ' ' VAL . 62.0 tt0 -49.24 -34.4 14.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 190' ' ' GLN . 97.5 mt -76.03 -48.0 22.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.982 -1.008 . . . . 1.0 109.079 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.74 -47.73 67.2 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.4 89.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.472 -0.936 . . . . 1.0 108.472 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -64.28 -38.6 91.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.481 ' N ' ' O ' ' A' ' 186' ' ' LEU . 78.3 mm-40 -66.72 -31.64 72.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.46 -47.25 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.277 -1.009 . . . . 1.0 108.277 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 157' ' ' MET . 14.4 t -49.17 -32.66 10.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 38.3 mt -74.72 -33.4 31.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.205 -0.907 . . . . 1.0 110.28 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.44 77.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.45 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.6 pt -62.23 -29.62 47.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.45 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -75.85 -51.83 11.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.02 -43.31 96.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.212 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.57 -31.93 73.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 1.0 111.395 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -57.43 -43.67 84.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.1 mp -51.19 -28.46 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.973 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 98.8 p -49.75 -56.01 11.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.471 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.776 HBC2 ' HD ' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' OD1' ' CG1' ' A' ' 65' ' ' VAL . 63.5 t0 -48.14 -36.24 13.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.684 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.52 -50.65 15.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.826 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.93 -48.71 78.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.021 0.438 . . . . 1.0 110.913 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.48 ' O ' ' OG1' ' A' ' 38' ' ' THR . 31.0 mt -57.38 -28.8 63.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.961 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.2 ttp180 -67.14 -39.14 86.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.778 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.07 -30.82 67.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.683 -0.69 . . . . 1.0 110.739 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.6 p -67.0 -36.79 82.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.301 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 36' ' ' ARG . 1.1 p -71.62 -25.39 24.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -79.35 -36.02 40.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.239 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.58 -48.52 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.833 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.2 p -57.59 -52.1 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.31 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.646 ' N ' HG13 ' A' ' 42' ' ' VAL . 9.0 ptm180 -51.81 -43.41 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 1.0 110.641 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 43' ' ' ARG . . . -51.95 -39.25 58.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.296 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -69.49 -32.78 71.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.833 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -97.11 -17.15 20.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.704 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 57.18 26.15 55.51 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.537 -1.025 . . . . 1.0 110.537 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 170' ' ' HIS . 48.0 m -77.79 143.75 37.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -55.57 -40.71 72.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.605 0.594 . . . . 1.0 112.605 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.677 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -149.97 130.77 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.525 -0.87 . . . . 1.0 112.763 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.411 HG22 ' OG ' ' A' ' 168' ' ' SER . 6.4 t -139.19 132.72 38.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.911 -1.04 . . . . 1.0 108.727 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 49.8 pttt -138.21 150.0 46.33 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.654 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG22 ' CD1' ' A' ' 166' ' ' LEU . 45.3 t -99.57 141.25 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.886 ' CZ ' HBB1 ' A' ' 203' ' ' CYC . 0.3 OUTLIER -131.34 136.24 47.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.442 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -110.43 148.89 31.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 1.0 111.251 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -99.82 126.66 45.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.71 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -92.0 153.25 43.38 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.19 -50.91 2.69 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.94 2.427 . . . . 1.0 114.523 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -70.12 -7.5 42.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.184 0.438 . . . . 1.0 112.184 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.06 -6.65 40.25 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.753 -0.737 . . . . 1.0 112.014 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -77.19 149.9 35.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.348 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.57 158.82 23.42 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.811 -0.915 . . . . 1.0 110.811 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 p -131.86 155.63 47.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.467 . . . . 1.0 111.426 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.903 HG11 ' O ' ' A' ' 77' ' ' LEU . 3.7 p -91.02 109.35 20.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 65' ' ' VAL . 23.7 t -114.72 -4.32 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.116 0.413 . . . . 1.0 112.116 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . . . -152.15 127.64 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.291 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 12.3 tm-20 -162.36 142.39 9.76 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.703 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' CB ' ' NE ' ' A' ' 43' ' ' ARG . . . -127.95 135.14 49.54 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -103.14 135.1 45.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.362 -0.535 . . . . 1.0 112.035 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -77.17 -140.13 1.18 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.556 -1.017 . . . . 1.0 110.556 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' GLU . . . -64.91 53.62 0.1 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' GLY . 96.3 mt-10 37.27 35.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -83.09 -36.19 25.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.003 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.3 mt -111.67 146.29 34.4 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 91.7 Cg_endo -75.44 157.95 40.7 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.462 2.108 . . . . 1.0 112.307 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 m -82.01 137.54 35.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.331 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.903 ' O ' HG11 ' A' ' 64' ' ' VAL . 40.2 mt -117.74 22.09 12.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.932 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 67' ' ' GLU . 64.1 mt -67.29 129.77 40.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.919 0.711 . . . . 1.0 112.919 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.509 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 84.53 -1.88 88.45 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.782 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.783 ' O ' HG12 ' A' ' 64' ' ' VAL . 84.5 mt -87.43 149.74 24.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.418 0.609 . . . . 1.0 110.46 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 81' ' ' THR . 8.8 t -106.14 133.76 50.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.602 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.665 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 8.2 m-85 -103.39 144.03 27.82 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.65 138.05 14.89 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.552 2.168 . . . . 1.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.425 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -61.02 -33.14 72.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.913 0.387 . . . . 1.0 110.449 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.5 -18.77 0.22 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.192 -0.763 . . . . 1.0 111.192 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' N ' ' C ' ' A' ' 84' ' ' ALA . 95.1 m-20 -65.4 -20.79 66.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.674 0.273 . . . . 1.0 110.975 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mt -130.25 133.87 25.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.57 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.47 -100.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.589 2.193 . . . . 1.0 111.615 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -163.71 -53.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.927 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' OE2' ' CE3' ' A' ' 119' ' ' TRP . 26.6 tp10 -43.84 -43.77 6.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.615 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.64 -34.87 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.701 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.581 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 48.8 mtp85 -65.04 -35.03 79.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.779 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.71 -37.03 82.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.945 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -61.39 -35.0 76.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.556 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -68.46 -33.77 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.73 HH21 ' H ' ' A' ' 162' ' ' LEU . 22.1 mtp180 -77.01 -28.63 55.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.154 -0.93 . . . . 1.0 111.337 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' C ' HE22 ' A' ' 99' ' ' GLN . 96.5 mt -96.76 -39.28 9.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.84 -13.01 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.266 1.21 . . . . 1.0 114.266 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.649 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.2 mp0 48.58 58.22 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.674 -0.811 . . . . 1.0 109.899 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.0 m -159.42 112.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.374 -0.53 . . . . 1.0 112.012 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -165.21 134.07 3.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.833 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.9 p -151.31 156.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.715 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.451 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 97.9 mt -110.92 130.84 63.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.204 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.09 170.03 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.609 0.718 . . . . 1.0 112.892 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -50.14 116.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.248 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.562 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.5 p -50.45 -19.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.691 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -80.08 -37.24 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.81 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.5 -18.77 42.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.51 . . . . 1.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 56.77 62.88 2.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 112.848 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.1 t -95.66 124.38 39.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -118.53 145.82 45.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.1 t -109.18 145.92 35.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.811 -1.086 . . . . 1.0 108.641 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.6 mt -145.88 150.53 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.475 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.6 p -86.07 162.51 18.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -143.57 153.53 58.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.89 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.97 -3.62 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.598 2.199 . . . . 1.0 112.217 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.77 -85.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.667 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 t -158.14 173.45 16.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.542 ' CE3' ' O ' ' A' ' 120' ' ' GLY . 12.7 p-90 -87.74 -174.14 4.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.667 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.542 ' O ' ' CE3' ' A' ' 119' ' ' TRP . . . -49.38 161.65 0.75 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.2 mt -116.82 48.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 1.0 110.574 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 m -58.64 -42.72 88.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.72 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.69 74.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -65.39 -59.2 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.717 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -149.8 120.54 3.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.646 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -43.42 144.17 2.08 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.364 2.043 . . . . 1.0 111.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.4 tp 59.03 -105.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.531 -0.304 . . . . 1.0 110.425 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.81 35.28 36.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.111 -0.796 . . . . 1.0 111.111 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 130' ' ' PRO . 57.4 mt-10 -146.46 153.84 48.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.545 0.212 . . . . 1.0 110.641 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' C ' ' H ' ' A' ' 132' ' ' GLN . 61.9 Cg_exo -41.28 166.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.476 2.117 . . . . 1.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 3.3 tp -59.71 10.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.973 -0.558 . . . . 1.0 112.038 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.587 ' H ' ' C ' ' A' ' 130' ' ' PRO . 46.6 mm-40 -138.4 158.88 43.41 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.568 -0.453 . . . . 1.0 111.476 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -125.56 115.77 25.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.529 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.67 141.86 10.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.683 2.256 . . . . 1.0 112.378 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.679 HG12 HAD2 ' A' ' 203' ' ' CYC . 2.6 m -120.24 129.54 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 138' ' ' CYS . 9.7 p30 -45.81 142.08 3.86 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.769 0.319 . . . . 1.0 111.34 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -37.34 -19.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.113 2.542 . . . . 1.0 113.675 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 136' ' ' ASP . 32.4 t -60.73 -61.57 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -69.71 -25.75 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.448 -0.342 . . . . 1.0 111.627 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.562 ' CG1' HG23 ' A' ' 106' ' ' VAL . 88.0 t -59.44 -60.92 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -60.53 -37.46 81.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.372 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -46.42 -37.94 8.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.61 -43.53 63.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.125 -0.695 . . . . 1.0 109.125 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -58.99 -42.98 91.36 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.9 t -63.63 -20.27 65.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.393 -0.821 . . . . 1.0 109.669 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.5 0.28 42.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.09 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.77 18.37 78.97 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.546 -1.022 . . . . 1.0 110.546 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 89.5 t -108.01 143.82 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.681 0.277 . . . . 1.0 110.273 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -24.19 6.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.018 0.377 . . . . 1.0 112.018 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.9 m -154.34 122.38 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.771 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.9 p -128.08 137.16 52.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 1.0 111.418 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.39 133.08 44.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.53 129.19 68.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.298 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.85 127.6 20.37 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -90.41 161.72 4.5 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.425 2.083 . . . . 1.0 113.65 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.85 114.35 24.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.4 ptm -141.29 150.7 42.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 84.5 t60 -125.05 124.14 41.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.929 -1.032 . . . . 1.0 108.836 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.559 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 53.6 t-80 59.05 -120.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.109 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.559 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.3 pp0? -98.79 0.41 44.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.807 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.429 ' HA ' HH21 ' A' ' 96' ' ' ARG . 47.2 tp10 -105.31 145.87 30.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.73 ' H ' HH21 ' A' ' 96' ' ' ARG . 35.9 tp -101.26 124.7 47.37 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.498 -1.297 . . . . 1.0 107.498 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.435 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 71.6 m95 -103.73 -31.67 9.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.563 0.949 . . . . 1.0 113.563 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.57 -168.32 22.32 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.697 -1.239 . . . . 1.0 112.401 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.666 ' CD1' HBA2 ' A' ' 203' ' ' CYC . 8.1 tt -143.17 124.07 14.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.418 -0.391 . . . . 1.0 111.658 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.641 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.1 tp -97.18 150.52 20.79 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.0 p -155.63 133.82 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.11 -0.636 . . . . 1.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.431 ' OG ' HG21 ' A' ' 48' ' ' THR . 4.1 t -115.53 134.31 55.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 25.5 m-70 -108.38 124.89 51.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 48' ' ' THR . 79.9 m80 -117.88 119.39 34.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.6 -18.06 61.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.775 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.42 150.32 60.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.558 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.36 128.15 17.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.662 2.242 . . . . 1.0 111.875 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -154.58 98.53 2.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.632 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.75 151.35 11.05 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.534 2.156 . . . . 1.0 111.449 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -103.45 153.73 20.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 1.0 110.846 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.9 t -90.26 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.181 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -54.47 -29.59 50.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.189 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 183' ' ' VAL . 97.3 mt-10 -76.82 -52.23 9.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.254 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.56 -34.87 79.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 1.0 110.932 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 181' ' ' LEU . 3.1 tt -55.36 -59.68 4.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.574 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -59.31 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.713 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 179' ' ' GLU . 92.7 t -45.43 -39.63 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.664 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.59 -50.51 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -49.31 -34.55 15.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 186' ' ' LEU . 36.1 tp -72.55 -48.12 42.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.033 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.67 -45.51 63.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.86 91.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.379 -0.971 . . . . 1.0 108.379 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -62.07 -39.3 91.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.474 ' HA ' HD12 ' A' ' 193' ' ' ILE . 79.8 mm-40 -66.6 -31.93 72.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.91 -48.09 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.6 p -52.03 -35.25 46.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 190' ' ' GLN . 25.6 mt -66.95 -35.24 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.82 -39.68 79.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.986 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.63 -47.78 78.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -62.91 -48.99 76.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.39 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.32 -46.27 87.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.269 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.43 75.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.397 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -56.65 -41.3 76.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.6 mt -55.15 -32.84 62.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.646 -0.422 . . . . 1.0 110.966 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.6 m -51.37 -57.09 9.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.656 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.8 mp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.467 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.886 HBB1 ' CZ ' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 195' ' ' ILE . 1.4 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.805 0.336 . . . . 1.0 110.503 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.5 p-10 -48.74 -33.78 10.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 51.3 tt0 -76.01 -48.82 19.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 38' ' ' THR . 23.1 mm -56.84 -46.04 83.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 1.0 111.025 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 38' ' ' THR . 40.2 mt -57.95 -29.41 65.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.529 -0.759 . . . . 1.0 112.008 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 39' ' ' VAL . 96.9 mtt180 -69.48 -40.74 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.785 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.14 69.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.749 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.533 ' O ' HG13 ' A' ' 42' ' ' VAL . 50.6 p -67.97 -37.56 81.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.329 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -69.62 -22.48 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.45 -36.5 38.76 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.267 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -71.0 -44.42 65.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.764 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 43' ' ' ARG . 16.6 m -59.53 -47.23 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.336 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 47' ' ' GLY . 50.4 ttp180 -50.4 -46.08 55.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 1.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.18 75.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.316 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -63.38 -40.55 97.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.807 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.96 -13.58 22.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.713 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.11 26.43 20.17 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.618 ' HG1' ' CE1' ' A' ' 170' ' ' HIS . 59.7 m -77.13 144.3 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.484 ' CG ' ' NH2' ' A' ' 73' ' ' ARG . 89.3 m-20 -55.51 -41.02 72.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.522 0.564 . . . . 1.0 112.522 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.471 ' NH2' HD12 ' A' ' 77' ' ' LEU . 71.1 ttt-85 -150.51 132.26 14.99 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 119.65 -0.82 . . . . 1.0 112.842 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 42' ' ' VAL . 14.6 p -141.95 134.52 28.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.97 -1.013 . . . . 1.0 108.725 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.624 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 56.5 pttt -137.95 151.14 47.67 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.249 -0.581 . . . . 1.0 111.614 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 48.0 t -97.39 140.88 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' OH ' ' C ' ' A' ' 62' ' ' GLY . 12.7 t80 -130.57 130.5 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.844 -0.342 . . . . 1.0 110.388 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.432 HH22 HG21 ' A' ' 65' ' ' VAL . 24.6 ttm105 -106.39 145.01 32.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 1.0 111.275 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 57' ' ' ASP . 64.4 t80 -99.56 127.55 45.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.877 -0.602 . . . . 1.0 111.703 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.575 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -98.24 154.41 37.67 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -50.86 -36.25 51.89 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.03 2.487 . . . . 1.0 114.469 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.43 -4.28 55.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.184 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.79 -16.51 47.14 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.657 -0.782 . . . . 1.0 111.859 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' NE2' ' CB ' ' A' ' 57' ' ' ASP . 36.6 p-80 -78.12 148.74 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.48 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OH ' ' A' ' 54' ' ' TYR . . . -136.65 160.78 24.92 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.1 p -133.62 154.79 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 1.0 111.567 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.797 HG11 ' O ' ' A' ' 77' ' ' LEU . 7.1 p -92.71 113.02 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.432 HG21 HH22 ' A' ' 55' ' ' ARG . 2.5 t -114.72 -1.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 1.0 112.041 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.52 129.05 9.96 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.279 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 18.1 pt-20 -162.71 142.13 9.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.472 -0.491 . . . . 1.0 111.678 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.7 146.82 51.45 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -134.32 146.52 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.309 -0.556 . . . . 1.0 111.969 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -102.11 141.43 15.27 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 37.77 31.35 0.08 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 70' ' ' GLY . 40.8 tt0 47.74 13.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 1.0 110.36 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.484 ' NH2' ' CG ' ' A' ' 49' ' ' ASP . 19.1 ttp180 -49.9 -38.21 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.959 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.8 mt -110.86 145.08 31.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.91 157.09 39.08 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.432 2.088 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 m -80.74 115.94 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.359 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.797 ' O ' HG11 ' A' ' 64' ' ' VAL . 20.5 mt -94.35 10.26 34.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.045 -0.525 . . . . 1.0 109.952 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 23.4 tp -57.12 129.24 40.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.54 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 85.85 -4.86 85.32 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.433 -0.803 . . . . 1.0 112.863 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.774 ' O ' HG12 ' A' ' 64' ' ' VAL . 88.0 mt -82.21 147.47 28.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.308 0.554 . . . . 1.0 110.392 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.7 m -108.34 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.622 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -105.82 148.12 35.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.208 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.89 137.4 12.48 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.548 2.166 . . . . 1.0 111.428 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.8 -34.75 74.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.854 0.359 . . . . 1.0 110.439 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.11 -17.77 0.12 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 96.9 m-20 -58.17 -14.16 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.668 0.271 . . . . 1.0 111.018 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.7 pt -150.0 145.62 19.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.513 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.496 ' HG2' ' H ' ' A' ' 89' ' ' GLU . 79.2 Cg_endo -74.52 -88.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.502 2.135 . . . . 1.0 111.691 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' H ' ' HG2' ' A' ' 88' ' ' PRO . 85.1 tt0 -170.15 -36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -53.16 -39.93 63.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.574 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.459 ' CB ' HAD2 ' A' ' 203' ' ' CYC . . . -73.83 -40.51 63.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.515 -0.312 . . . . 1.0 111.733 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.695 HH12 ' NH2' ' A' ' 96' ' ' ARG . 76.6 ttt-85 -61.81 -35.86 79.42 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.778 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -63.88 -36.89 85.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.937 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD13 ' NH1' ' A' ' 101' ' ' ARG . 7.3 mt -61.55 -37.02 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.524 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.412 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 84.1 m-85 -65.88 -34.51 78.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.695 ' NH2' HH12 ' A' ' 92' ' ' ARG . 40.3 ttm180 -76.3 -30.3 57.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.097 -0.956 . . . . 1.0 111.252 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.5 ' C ' HE22 ' A' ' 99' ' ' GLN . 83.6 mt -93.86 -39.93 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.41 -10.7 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.198 1.184 . . . . 1.0 114.198 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.7 mp0 46.72 49.17 14.27 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.688 -0.805 . . . . 1.0 109.904 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 99' ' ' GLN . 17.1 t -152.85 111.41 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.954 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.716 ' NH2' ' HE ' ' A' ' 133' ' ' ARG . 5.0 tpt180 -165.86 130.23 2.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.875 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.04 158.01 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.726 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 135' ' ' VAL . 82.2 mt -111.44 128.82 67.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.228 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 104' ' ' VAL . 3.0 m -86.7 170.2 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.976 0.732 . . . . 1.0 112.976 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -48.58 115.01 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.221 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.546 HG13 ' CG1' ' A' ' 140' ' ' VAL . 54.9 t -52.65 -23.07 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.697 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -76.6 -39.01 53.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.781 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.5 -15.51 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.12 0.486 . . . . 1.0 110.436 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.704 HE21 ' NH2' ' A' ' 111' ' ' ARG . 47.6 tt0 56.37 61.85 2.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.465 -0.789 . . . . 1.0 112.885 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 m -96.97 125.23 41.25 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.808 -1.552 . . . . 1.0 106.808 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.704 ' NH2' HE21 ' A' ' 109' ' ' GLN . 97.2 mtt180 -118.36 146.41 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -109.43 148.51 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.6 178.155 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 113' ' ' ILE . 22.0 pt -148.99 152.59 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.457 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.0 p -87.27 165.25 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -144.22 152.89 55.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -37.39 -46.34 1.67 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.719 2.279 . . . . 1.0 112.257 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 118' ' ' SER . 96.0 mt-10 -117.19 -165.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.599 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.9 p 79.72 115.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.543 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -170.04 97.05 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.659 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.5 53.83 5.33 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.53 -4.13 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.666 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.5 m -57.51 -33.7 68.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.763 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.53 29.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.768 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -61.75 -60.24 3.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.633 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.14 154.44 42.68 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 128' ' ' GLY . 62.8 Cg_endo -69.98 134.65 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.359 2.039 . . . . 1.0 111.468 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 129' ' ' GLU . 15.4 mt 59.0 -77.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.366 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 58.91 0.61 0.68 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.138 -0.785 . . . . 1.0 111.138 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 127' ' ' LEU . 52.2 mm-40 -145.65 155.5 52.73 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.584 0.231 . . . . 1.0 110.592 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.565 ' C ' ' H ' ' A' ' 132' ' ' GLN . 58.7 Cg_exo -40.69 144.98 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.444 2.096 . . . . 1.0 111.987 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.4 mt -61.06 13.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.098 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' A' ' 130' ' ' PRO . 35.4 mt-30 -128.11 136.23 50.89 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.512 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.716 ' HE ' ' NH2' ' A' ' 101' ' ' ARG . 12.8 mmm180 -126.72 101.96 26.17 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 115.912 -0.585 . . . . 1.0 110.529 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -45.08 147.87 1.93 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.693 2.262 . . . . 1.0 112.391 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.439 HG21 HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -111.44 122.52 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 138' ' ' CYS . 17.9 t70 -44.82 138.69 4.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.761 0.315 . . . . 1.0 111.356 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -35.93 -20.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.125 2.55 . . . . 1.0 113.603 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.573 ' N ' ' O ' ' A' ' 136' ' ' ASP . 10.8 t -62.63 -62.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.774 -0.37 . . . . 1.0 111.219 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.404 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 58.7 t-80 -69.53 -25.48 64.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.69 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.546 ' CG1' HG13 ' A' ' 106' ' ' VAL . 96.7 t -58.76 -59.05 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.636 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 14.1 p80 -61.55 -37.23 83.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.346 -0.541 . . . . 1.0 110.341 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.636 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 73.8 t80 -46.99 -38.79 11.3 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.295 -0.632 . . . . 1.0 109.295 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.53 -43.61 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -58.06 -43.08 86.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.6 m -62.97 -19.96 64.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.645 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 31.8 mmm -99.76 -1.28 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.097 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.57 18.14 78.04 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.49 142.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.771 0.32 . . . . 1.0 110.277 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.54 -22.45 7.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.981 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.9 p -155.17 123.16 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.769 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.0 m -129.08 137.41 51.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.416 . . . . 1.0 111.449 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.05 133.07 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.442 HG11 HBA2 ' A' ' 203' ' ' CYC . 8.1 t -114.17 130.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.327 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.07 133.1 18.39 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.563 ' HB2' HD11 ' A' ' 162' ' ' LEU . 5.9 Cg_endo -95.32 166.82 1.51 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.412 2.075 . . . . 1.0 113.759 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.44 116.7 27.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.564 ' HB3' HD12 ' A' ' 162' ' ' LEU . 24.4 ptm -142.45 152.97 43.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 -176.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 39.7 t-80 -131.68 124.15 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.075 -0.966 . . . . 1.0 108.891 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.415 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.0 t-80 64.63 -126.56 0.41 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.122 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.415 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 98.0 mm-40 -97.05 4.96 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.784 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.528 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -107.53 145.99 32.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.723 1.009 . . . . 1.0 113.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 157' ' ' MET . 20.2 tp -99.54 125.64 45.36 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.528 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 72.1 m95 -103.33 -34.25 8.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.14 -175.31 33.03 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.651 -1.262 . . . . 1.0 112.403 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 78.1 mt -135.66 121.47 19.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.469 -0.365 . . . . 1.0 111.664 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.6 tp -94.53 150.51 20.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.5 p -156.84 133.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.803 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 54.1 p -114.13 139.77 49.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.77 -0.65 . . . . 1.0 109.26 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 48' ' ' THR . 12.4 m80 -111.21 123.81 50.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.618 ' CE1' ' HG1' ' A' ' 48' ' ' THR . 73.4 m80 -117.87 119.37 34.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.287 -1.005 . . . . 1.0 108.287 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.04 -18.36 62.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.744 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -132.07 151.45 78.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.616 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -41.77 141.8 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.649 2.233 . . . . 1.0 111.867 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -165.48 78.32 1.26 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.929 -0.309 . . . . 1.0 110.655 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.22 153.31 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.571 2.181 . . . . 1.0 111.489 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.582 ' CE1' HD12 ' A' ' 181' ' ' LEU . 12.9 p90 -106.63 148.09 28.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.823 0.344 . . . . 1.0 110.803 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.8 m -94.42 157.12 16.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.173 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.567 ' CD ' ' H ' ' A' ' 178' ' ' GLN . 8.7 mp0 -53.03 -37.62 61.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.123 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -77.01 -42.85 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.277 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 184' ' ' VAL . 77.8 mm-40 -67.66 -34.23 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 1.0 110.975 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -65.96 -40.09 90.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.592 -179.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -77.95 -52.15 9.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.96 -0.296 . . . . 1.0 111.66 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.8 t -44.58 -44.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.678 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.629 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.2 p -74.29 -50.58 26.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.629 ' N ' HG13 ' A' ' 184' ' ' VAL . 61.5 tt0 -49.82 -36.05 25.17 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 190' ' ' GLN . 28.2 tp -71.23 -47.61 56.19 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.046 -0.979 . . . . 1.0 109.016 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 187' ' ' LEU . 53.1 tp -54.04 -45.76 71.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.61 91.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.45 -0.944 . . . . 1.0 108.45 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -59.63 -36.6 76.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 186' ' ' LEU . 1.0 OUTLIER -67.32 -31.26 71.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.3 t -77.07 -46.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.407 -0.96 . . . . 1.0 108.407 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 157' ' ' MET . 37.8 p -50.93 -32.69 21.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.42 -33.06 32.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.108 -0.951 . . . . 1.0 110.232 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.82 80.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.959 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.409 ' HA ' HD21 ' A' ' 31' ' ' LEU . 25.1 pt -65.86 -26.46 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.44 -54.4 6.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 8.0 pt20 -67.39 -37.87 83.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 197' ' ' GLN . . . -68.12 -33.19 74.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.378 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.04 -43.44 86.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.177 0.436 . . . . 1.0 112.177 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.9 mt -53.28 -35.86 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.99 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.8 t -47.22 -56.12 7.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.611 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.407 179.701 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.624 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 50.6 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.786 0.326 . . . . 1.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -49.43 -32.84 12.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.735 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -75.91 -48.29 21.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.778 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 38' ' ' THR . 98.3 mt -55.18 -51.47 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.034 0.445 . . . . 1.0 110.993 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.491 ' O ' ' OG1' ' A' ' 38' ' ' THR . 88.0 mt -55.69 -31.46 62.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.914 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 39' ' ' VAL . 91.0 mtt180 -65.62 -38.77 90.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.392 -0.523 . . . . 1.0 109.743 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.24 -32.22 68.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.783 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 p -66.9 -36.93 83.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.966 -0.561 . . . . 1.0 112.274 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.584 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.9 p -72.46 -24.54 22.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.269 0.47 . . . . 1.0 112.269 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -70.66 -44.99 65.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.276 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -69.93 -35.0 74.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.754 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 38' ' ' THR . 77.5 t -59.64 -54.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.296 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 47' ' ' GLY . 51.5 ttt-85 -51.52 -44.55 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 1.0 110.746 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.21 -46.35 79.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.295 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.548 ' CE2' ' OE2' ' A' ' 180' ' ' GLU . 63.6 t80 -62.41 -41.45 98.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.815 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.0 mt -96.33 -12.85 23.84 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.978 -0.289 . . . . 1.0 111.706 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 51.68 25.08 13.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.513 -1.035 . . . . 1.0 110.513 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.2 t -78.45 148.06 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.889 -0.412 . . . . 1.0 109.889 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 73' ' ' ARG . 94.7 m-20 -51.94 -42.25 62.7 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.638 0.607 . . . . 1.0 112.638 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.554 ' NH1' ' O ' ' A' ' 75' ' ' PRO . 77.9 ttt180 -152.95 137.17 16.51 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 119.647 -0.821 . . . . 1.0 112.808 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 51' ' ' VAL . 11.7 p -142.75 133.15 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.668 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.8 pttm -138.33 151.85 47.94 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.679 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 59.2 t -97.42 139.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 17.8 t80 -130.01 132.86 46.41 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.854 -0.338 . . . . 1.0 110.434 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.82 150.9 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.424 . . . . 1.0 111.215 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.601 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -102.38 132.71 48.2 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.698 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 61' ' ' HIS . 26.6 m-20 -97.71 154.52 37.85 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -40.14 -50.81 3.4 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.001 2.467 . . . . 1.0 114.479 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.74 -6.77 39.97 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.247 0.462 . . . . 1.0 112.247 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.3 -7.41 37.23 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.697 -0.764 . . . . 1.0 111.905 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 57' ' ' ASP . 21.5 m80 -79.72 151.91 30.17 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.371 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.71 163.52 25.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -135.07 156.92 48.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.024 0.44 . . . . 1.0 111.483 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.26 109.63 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.33 -4.79 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.095 0.406 . . . . 1.0 112.095 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.28 128.12 9.53 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.251 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HG3' HH21 ' A' ' 50' ' ' ARG . 0.6 OUTLIER -159.41 141.28 13.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.475 -0.49 . . . . 1.0 111.655 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.82 137.29 52.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 76' ' ' SER . 83.4 mtm-85 -111.5 138.39 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.075 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.501 ' CA ' HH21 ' A' ' 43' ' ' ARG . . . -86.81 76.11 2.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.624 -0.99 . . . . 1.0 110.624 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.07 30.44 42.37 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 61.71 16.03 7.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 1.0 110.354 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 35.3 ttm180 -56.5 -44.69 80.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.067 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.9 mt -107.21 121.76 43.58 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.554 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 90.5 Cg_exo -49.56 157.39 2.33 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.505 2.136 . . . . 1.0 112.268 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 12.9 m -83.15 117.38 22.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.338 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' CG ' HH22 ' A' ' 50' ' ' ARG . 43.3 mt -95.93 11.82 32.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.022 -0.535 . . . . 1.0 109.938 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.1 mt -58.9 131.51 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.933 0.716 . . . . 1.0 112.933 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.85 -3.77 86.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.45 -0.796 . . . . 1.0 112.905 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.1 mt -85.29 149.16 25.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.286 0.543 . . . . 1.0 110.454 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 81' ' ' THR . 12.9 t -105.46 131.14 53.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -105.5 106.1 54.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -42.26 134.07 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.508 2.139 . . . . 1.0 111.528 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -57.94 -30.6 66.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.861 0.363 . . . . 1.0 110.461 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.85 -17.69 0.1 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.4 t0 -67.49 -28.93 68.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.697 0.284 . . . . 1.0 111.036 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.3 mm -112.01 133.05 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.503 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 97.1 Cg_endo -76.28 -111.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.642 2.228 . . . . 1.0 111.638 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 90.6 mt-10 -151.57 -51.23 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.905 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.2 -40.59 67.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.633 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.32 -37.89 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.749 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.601 ' NH2' ' CD2' ' A' ' 56' ' ' PHE . 65.3 ttt180 -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.8 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -64.07 -35.53 81.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.911 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.26 -34.93 77.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.504 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CE1' ' O2A' ' A' ' 203' ' ' CYC . 80.1 m-85 -69.78 -37.64 76.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -77.31 -30.65 54.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.153 -0.93 . . . . 1.0 111.264 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.47 -40.39 9.5 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -117.04 -11.35 10.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 98' ' ' ALA . 5.3 mp0 44.55 62.98 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.663 -0.815 . . . . 1.0 109.898 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.8 p -168.54 114.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 120.31 -0.556 . . . . 1.0 111.854 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.549 ' HG2' HBD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -167.5 137.22 2.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.911 177.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.3 p -149.5 156.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.676 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.576 HG23 HG21 ' A' ' 135' ' ' VAL . 3.2 mt -109.57 128.34 65.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.257 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 105' ' ' ASP . 4.0 t -84.65 165.88 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.013 0.745 . . . . 1.0 113.013 -176.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.538 ' N ' HG12 ' A' ' 104' ' ' VAL . 75.8 m-20 -50.32 116.25 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.036 -0.984 . . . . 1.0 112.216 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.428 HG23 ' CG1' ' A' ' 140' ' ' VAL . 11.2 p -49.77 -21.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.74 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.28 -38.02 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.797 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.06 -21.19 63.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 1.0 110.399 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.503 HE21 ' CZ ' ' A' ' 111' ' ' ARG . 46.4 tt0 57.97 60.61 2.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.53 -0.759 . . . . 1.0 112.854 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -94.23 125.59 38.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.768 -1.568 . . . . 1.0 106.768 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.503 ' CZ ' HE21 ' A' ' 109' ' ' GLN . 87.0 mtt180 -120.38 144.76 47.73 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.661 0.986 . . . . 1.0 113.661 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -117.03 157.15 26.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.801 -1.09 . . . . 1.0 108.634 177.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.41 HG23 ' C ' ' A' ' 112' ' ' SER . 27.9 pt -154.7 158.79 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.407 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.1 m -86.29 167.22 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 116' ' ' PRO . 54.6 mt-30 -151.02 152.61 31.77 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.686 -0.405 . . . . 1.0 110.912 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 117' ' ' GLU . 31.4 Cg_exo -34.41 -62.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.584 2.189 . . . . 1.0 112.281 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' PRO . 84.5 tt0 58.78 141.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.629 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 t -86.06 -85.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.516 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.573 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 73.5 t-105 -157.74 174.65 15.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.698 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.573 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 88.28 111.51 1.1 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.907 -0.877 . . . . 1.0 110.907 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.0 mt -136.11 -45.73 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 1.0 110.625 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -55.28 -31.01 61.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.773 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' ARG . . . -67.19 -38.31 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.74 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 123' ' ' ALA . 56.2 mmt-85 -35.74 119.02 0.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.656 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.0 158.95 51.14 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.592 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 62.7 Cg_endo -70.12 111.09 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.352 2.034 . . . . 1.0 111.567 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 126' ' ' PRO . 45.2 tp 167.58 131.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.419 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.92 39.27 13.66 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.106 -0.797 . . . . 1.0 111.106 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -121.54 147.28 47.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.559 0.219 . . . . 1.0 110.629 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.19 173.66 14.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.395 2.064 . . . . 1.0 111.955 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.7 tp -72.08 -9.17 58.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.974 -0.557 . . . . 1.0 112.085 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -134.56 138.34 44.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.529 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -113.98 90.98 20.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.49 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -46.92 141.54 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.583 2.188 . . . . 1.0 112.396 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.783 HG12 HAD2 ' A' ' 203' ' ' CYC . 3.6 m -118.48 131.22 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.4 OUTLIER -40.9 156.57 0.2 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.669 0.271 . . . . 1.0 111.388 179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.33 -26.12 80.76 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.13 2.553 . . . . 1.0 113.584 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -58.47 -56.63 19.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.784 -0.367 . . . . 1.0 111.21 -179.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.549 ' NE2' HMA2 ' A' ' 203' ' ' CYC . 2.0 t60 -68.46 -27.16 65.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.602 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.448 ' CG2' HG23 ' A' ' 135' ' ' VAL . 78.1 t -65.26 -53.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -65.37 -40.88 94.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.397 -0.521 . . . . 1.0 110.362 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -47.63 -35.3 9.14 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.491 HD11 ' CE1' ' A' ' 139' ' ' HIS . 50.9 mt -73.8 -41.61 62.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.617 -0.72 . . . . 1.0 109.193 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -60.25 -43.59 95.98 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.3 t -61.69 -18.18 58.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.632 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.8 mmm -100.95 2.66 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.166 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.79 19.0 78.34 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.526 -1.03 . . . . 1.0 110.526 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.79 144.77 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.752 0.311 . . . . 1.0 110.211 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.58 -25.1 6.54 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.974 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -154.35 122.24 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.749 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 55.5 m -131.2 141.71 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.006 0.432 . . . . 1.0 111.398 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.74 130.45 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 167' ' ' VAL . 28.5 m -117.0 141.3 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.281 -0.568 . . . . 1.0 112.267 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.83 132.41 20.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -86.87 159.67 8.9 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.35 2.034 . . . . 1.0 113.71 -177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.4 mt -113.51 116.29 29.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.6 ptm -140.85 149.5 42.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.511 ' CG ' ' HB2' ' A' ' 196' ' ' ALA . 86.6 t60 -130.42 122.57 28.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.03 -0.986 . . . . 1.0 108.812 177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.441 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 51.5 t60 69.73 -126.7 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.144 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.441 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 93.9 mt-30 -100.91 5.85 43.44 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.781 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.531 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 5.7 pt-20 -111.31 156.72 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 34.4 tp -103.38 127.66 50.69 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.518 -1.29 . . . . 1.0 107.518 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.531 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 32.2 m95 -103.86 -34.98 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.44 -174.52 29.28 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.628 -1.273 . . . . 1.0 112.346 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.3 mt -137.11 122.35 19.27 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.422 -0.389 . . . . 1.0 111.677 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.463 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.8 tp -94.31 148.35 22.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.639 -0.874 . . . . 1.0 108.639 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.505 HG23 HG12 ' A' ' 153' ' ' VAL . 11.0 p -152.48 132.01 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.067 -0.653 . . . . 1.0 111.862 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.7 t -115.02 136.8 52.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.709 -0.678 . . . . 1.0 109.227 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.509 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 12.2 m80 -110.55 124.68 52.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.569 0.581 . . . . 1.0 112.569 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -119.15 121.84 40.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.42 -17.36 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.807 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -133.32 152.59 79.64 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.591 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -41.32 142.46 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.602 2.201 . . . . 1.0 111.882 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.83 78.2 1.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.555 -0.293 . . . . 1.0 110.693 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -54.68 153.65 23.32 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.481 2.12 . . . . 1.0 111.457 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -108.35 147.74 31.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 1.0 110.819 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 66.9 m -95.29 158.11 15.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.212 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -53.86 -39.24 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.151 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.44 -47.75 22.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.263 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.548 ' OE2' ' CE2' ' A' ' 45' ' ' PHE . 38.5 tp10 -63.44 -35.94 82.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 1.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -65.82 -37.03 85.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.626 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -78.59 -52.16 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.709 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 75.1 t -44.28 -43.1 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.621 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 185' ' ' GLN . 6.9 p -75.39 -49.75 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.595 ' N ' HG13 ' A' ' 184' ' ' VAL . 58.1 tt0 -49.78 -34.36 19.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tp -72.7 -48.24 40.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.067 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.8 tp -51.95 -45.87 64.53 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.93 95.08 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -63.11 -38.67 92.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.83 -31.32 71.87 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 49.1 t -76.05 -47.41 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.5 p -53.42 -34.33 57.4 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.41 -35.77 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.205 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.92 83.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.932 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.9 mt -56.92 -44.57 82.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -65.84 -50.51 64.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.386 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -61.85 -44.82 96.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.22 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.88 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.376 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -57.85 -44.06 86.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.1 tp -52.63 -38.39 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.922 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.5 t -51.71 -59.3 4.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.635 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.445 179.705 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.783 HAD2 HG12 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' CD2' HD11 ' A' ' 35' ' ' LEU . 5.5 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.872 0.367 . . . . 1.0 110.49 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 29.9 p-10 -51.84 -32.82 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.724 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 62.9 tt0 -76.59 -50.0 14.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.787 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 38' ' ' THR . 96.6 mt -55.18 -51.8 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.041 0.448 . . . . 1.0 110.899 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.488 ' O ' ' OG1' ' A' ' 38' ' ' THR . 63.8 mt -56.13 -30.25 61.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.732 . . . . 1.0 111.935 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 39' ' ' VAL . 75.9 ttt180 -64.44 -40.25 95.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.407 -0.517 . . . . 1.0 109.661 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.93 -33.45 70.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.721 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 p -64.51 -37.35 87.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 1.0 112.346 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.498 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -73.35 -24.59 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.208 0.448 . . . . 1.0 112.208 -178.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -72.04 -40.81 68.11 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.48 -31.33 57.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.777 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 38' ' ' THR . 66.6 t -64.84 -56.87 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.339 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -53.55 -43.11 68.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 1.0 110.703 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.39 -43.17 71.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.288 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -65.64 -36.34 83.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.1 mt -96.38 -15.02 22.07 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.706 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.77 26.05 53.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.493 -1.043 . . . . 1.0 110.493 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.0 p -80.01 147.29 31.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 2.9 p30 -54.11 -39.35 66.32 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.644 ' NH2' ' H ' ' A' ' 77' ' ' LEU . 63.7 ttt180 -153.12 134.69 14.43 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.574 -0.85 . . . . 1.0 112.813 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -139.8 131.83 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 114.925 -1.034 . . . . 1.0 108.701 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' NZ ' ' CE1' ' A' ' 169' ' ' HIS . 25.2 pttm -138.73 152.86 48.33 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.294 -0.563 . . . . 1.0 111.614 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 60.8 t -98.15 140.91 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -130.8 131.18 44.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.45 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' HE ' HG21 ' A' ' 65' ' ' VAL . 71.8 mtm180 -112.64 153.27 27.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.007 0.432 . . . . 1.0 111.217 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.4 136.87 41.46 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.783 -0.644 . . . . 1.0 111.677 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 61' ' ' HIS . 34.3 m-20 -97.21 150.58 36.97 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -41.94 -21.71 0.17 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.044 2.496 . . . . 1.0 114.528 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -103.04 3.44 36.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.195 0.443 . . . . 1.0 112.195 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.6 -14.03 57.89 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.686 -0.769 . . . . 1.0 111.922 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 57' ' ' ASP . 66.2 m80 -78.86 150.05 32.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.43 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.57 162.11 25.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -134.34 155.78 49.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.034 0.445 . . . . 1.0 111.491 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.7 t -88.74 109.57 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.403 HG21 ' HE ' ' A' ' 55' ' ' ARG . 9.1 t -110.46 -5.15 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.073 0.398 . . . . 1.0 112.073 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . . . -152.49 126.25 8.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.3 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.619 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 1.1 tm-20 -158.71 139.67 12.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 1.0 111.695 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.34 136.35 51.78 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -107.5 136.41 47.33 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.094 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.26 68.16 3.61 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.04 42.5 7.56 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 50.44 20.59 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 1.0 110.337 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' C ' HD12 ' A' ' 74' ' ' LEU . 74.0 ttt-85 -61.62 -46.92 87.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.971 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 73' ' ' ARG . 8.3 mp -109.11 129.62 23.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.527 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 80.5 Cg_exo -51.06 165.86 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.48 2.12 . . . . 1.0 112.226 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 t -93.59 129.31 39.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.372 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' H ' ' NH2' ' A' ' 50' ' ' ARG . 79.2 mt -102.92 15.19 30.08 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.995 -0.548 . . . . 1.0 109.946 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.6 mt -66.48 131.47 46.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.03 -5.21 72.3 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.44 -0.8 . . . . 1.0 112.818 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.3 154.52 21.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.333 0.566 . . . . 1.0 110.468 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 p -106.23 128.05 53.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.603 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -103.73 150.08 37.78 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.263 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.24 134.65 9.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.481 2.121 . . . . 1.0 111.46 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -62.56 -30.4 71.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.796 0.332 . . . . 1.0 110.368 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.4 -16.28 0.06 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.196 -0.762 . . . . 1.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.555 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 55.6 t0 -58.3 -15.97 12.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.654 0.264 . . . . 1.0 110.99 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.12 143.44 33.9 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.468 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.59 -96.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.548 2.165 . . . . 1.0 111.699 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 2.7 pp20? -162.72 -28.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.92 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 22.5 pt-20 -70.55 -39.72 73.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.585 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.791 ' HB1' HH12 ' A' ' 101' ' ' ARG . . . -74.0 -40.34 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.649 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 61.0 ttp180 -63.14 -36.27 83.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.349 . . . . 1.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -60.82 -35.75 77.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.926 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 94' ' ' LEU . 94.5 mt -63.92 -34.17 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.586 . . . . 1.0 111.538 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CE1' HBA1 ' A' ' 203' ' ' CYC . 68.6 m-85 -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.261 -0.644 . . . . 1.0 109.261 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 28.0 mtp180 -73.72 -31.55 63.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.295 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.54 ' C ' HE22 ' A' ' 99' ' ' GLN . 90.2 mt -96.8 -37.26 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.17 -16.84 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.616 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.8 OUTLIER 45.73 52.84 9.24 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.619 -0.832 . . . . 1.0 109.964 -178.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 99' ' ' GLN . 24.8 t -157.33 101.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 120.293 -0.563 . . . . 1.0 111.862 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.791 HH12 ' HB1' ' A' ' 91' ' ' ALA . 5.4 mtt180 -158.46 137.92 11.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.876 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.487 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 2.1 p -145.97 158.35 11.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.71 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.47 ' N ' ' CG2' ' A' ' 102' ' ' VAL . 2.9 mp -108.04 128.23 63.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.249 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 105' ' ' ASP . 2.7 t -82.9 164.63 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.476 ' H ' HG12 ' A' ' 104' ' ' VAL . 64.5 t0 -50.6 118.89 3.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.966 -1.016 . . . . 1.0 112.237 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 140' ' ' VAL . 12.1 p -51.28 -22.69 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.709 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -78.88 -37.82 39.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.797 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.35 63.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.192 0.52 . . . . 1.0 110.432 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 57.55 62.59 2.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.528 -0.76 . . . . 1.0 112.904 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -94.02 124.39 38.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.19 145.23 46.2 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.468 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -110.68 149.67 30.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.803 -1.09 . . . . 1.0 108.6 177.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 pt -149.91 154.03 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.412 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.0 t -88.89 165.98 14.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 117' ' ' GLU . 41.1 tt0 -152.87 123.44 3.5 Favored Pre-proline 0 C--N 1.326 -0.425 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.964 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -36.87 88.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.67 2.247 . . . . 1.0 112.221 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 115' ' ' GLN . 84.8 tt0 -161.59 -82.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.659 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.1 m 42.34 47.41 4.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.494 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 73.6 t-105 -136.56 158.12 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.701 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 91.28 164.86 39.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -99.95 132.85 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 1.0 110.634 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.7 t -63.72 -32.83 74.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -48.59 -45.92 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -39.18 -72.31 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.683 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.41 107.73 46.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.631 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -84.48 144.6 10.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.377 2.051 . . . . 1.0 111.494 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 tp 60.83 -116.16 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.355 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.08 39.51 96.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.467 ' CD ' ' NH2' ' A' ' 133' ' ' ARG . 74.3 mt-10 -135.14 152.04 76.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.551 0.215 . . . . 1.0 110.576 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.563 ' C ' ' H ' ' A' ' 132' ' ' GLN . 59.0 Cg_endo -67.68 167.21 21.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.403 2.069 . . . . 1.0 112.052 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 35.9 mt -57.99 6.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 1.0 112.03 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.563 ' H ' ' C ' ' A' ' 130' ' ' PRO . 26.0 mt-30 -140.81 161.28 38.18 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.444 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.487 ' HB3' ' H ' ' A' ' 102' ' ' VAL . 9.1 tpp180 -129.03 103.76 18.49 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.595 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 133' ' ' ARG . 72.4 Cg_endo -71.47 143.11 42.08 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.59 2.193 . . . . 1.0 112.375 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.54 ' CG1' HAD2 ' A' ' 203' ' ' CYC . 25.7 m -120.27 131.13 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 112' ' ' SER . 19.7 t70 -43.61 137.57 3.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 1.0 111.378 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -36.22 -25.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 123.047 2.498 . . . . 1.0 113.696 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 136' ' ' ASP . 25.6 t -53.61 -59.72 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.771 -0.372 . . . . 1.0 111.239 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.5 ' CD2' HD11 ' A' ' 143' ' ' LEU . 73.8 t60 -69.62 -23.89 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.634 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 106' ' ' VAL . 61.2 t -59.11 -61.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.64 0.608 . . . . 1.0 112.64 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -62.04 -40.93 97.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.428 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -45.94 -38.92 8.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.5 HD11 ' CD2' ' A' ' 139' ' ' HIS . 69.4 mt -72.92 -42.81 63.11 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -57.83 -43.51 85.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.6 t -62.55 -19.9 64.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.336 -0.847 . . . . 1.0 109.636 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.4 mmm -99.0 -0.55 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.082 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.09 18.93 75.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 99.0 t -109.32 142.97 20.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.728 0.299 . . . . 1.0 110.25 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -122.22 -26.01 4.76 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 111.997 0.369 . . . . 1.0 111.997 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.2 p -152.5 118.65 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.727 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 p -129.76 142.21 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.004 0.43 . . . . 1.0 111.359 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tp -98.97 135.19 40.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.06 130.12 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.305 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.0 131.43 18.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -93.92 163.19 2.18 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.363 2.042 . . . . 1.0 113.656 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 39.3 mt -115.8 113.39 23.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.659 -1.237 . . . . 1.0 107.659 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.8 ptm -140.57 149.28 42.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.477 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.3 t60 -120.75 123.62 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.958 -1.019 . . . . 1.0 108.892 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.477 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 42.8 m-70 55.86 -118.08 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.122 -178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -97.44 0.55 47.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.802 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.516 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.01 142.74 34.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.784 1.031 . . . . 1.0 113.784 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 49.4 tp -99.59 123.57 43.98 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.535 -1.283 . . . . 1.0 107.535 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.516 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 63.4 m95 -103.33 -33.77 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.576 0.954 . . . . 1.0 113.576 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.19 -176.14 31.95 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.687 -1.244 . . . . 1.0 112.351 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 54.4 mt -134.54 121.39 20.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.706 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -94.61 149.77 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.625 -0.88 . . . . 1.0 108.625 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.444 ' CG1' ' HZ3' ' A' ' 52' ' ' LYS . 10.8 p -157.19 134.13 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.013 -0.675 . . . . 1.0 111.821 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.5 t -114.23 137.47 51.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.464 ' CE1' ' NZ ' ' A' ' 52' ' ' LYS . 17.0 m80 -110.19 127.46 54.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.557 0.577 . . . . 1.0 112.557 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 4.1 t60 -118.58 120.38 37.3 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.281 -1.007 . . . . 1.0 108.281 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.24 12.77 7.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.83 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.481 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 42.2 mm-40 -143.26 152.02 56.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.615 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.65 132.19 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.676 2.25 . . . . 1.0 111.826 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -172.93 127.38 0.51 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.708 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.08 153.69 32.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.517 2.145 . . . . 1.0 111.451 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -103.67 155.58 18.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.768 0.318 . . . . 1.0 110.846 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 51.1 m -92.21 151.39 20.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.206 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.15 -27.38 68.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.158 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.39 -50.91 57.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.236 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.42 -27.5 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.974 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.5 tp -55.02 -49.78 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 1.0 111.665 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.494 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 5.0 pt20 -78.08 -52.14 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.655 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.494 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 80.1 t -44.28 -42.46 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.649 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -74.47 -49.3 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -50.42 -33.09 19.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 190' ' ' GLN . 20.6 tp -74.51 -49.4 22.25 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.065 -0.971 . . . . 1.0 109.112 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 187' ' ' LEU . 1.1 tt -52.35 -46.11 65.99 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.57 86.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -61.13 -38.33 86.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.582 -0.896 . . . . 1.0 108.582 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 186' ' ' LEU . 62.1 tt0 -66.53 -32.34 73.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.29 -47.27 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.8 p -51.96 -35.69 46.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 190' ' ' GLN . 27.7 mt -66.32 -35.66 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.212 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.71 78.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.983 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.6 -46.1 82.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -66.02 -50.29 64.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.374 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -62.04 -45.8 91.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.269 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.99 73.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.393 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.39 -41.8 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 tp -51.54 -35.72 42.01 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.962 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.8 p -57.29 -60.97 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.621 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.3 mp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.005 -0.998 . . . . 1.0 110.446 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.555 ' HHB' ' OD2' ' A' ' 86' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD22 HD11 ' A' ' 35' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.576 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -49.63 -32.16 12.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.96 -48.28 25.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.791 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 38' ' ' THR . 26.6 mm -55.02 -49.95 67.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.046 0.45 . . . . 1.0 110.939 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 HD22 ' A' ' 31' ' ' LEU . 83.2 mt -55.16 -32.95 62.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.935 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 39' ' ' VAL . 33.9 ttm180 -61.93 -42.34 98.98 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.744 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.9 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.787 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 34' ' ' ILE . 82.2 p -66.61 -36.66 83.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 1.0 112.242 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.633 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p -71.25 -24.51 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.174 0.435 . . . . 1.0 112.174 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -78.74 -37.19 41.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.311 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -72.52 -43.41 63.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.78 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 43' ' ' ARG . 33.9 m -60.14 -49.69 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.304 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.602 ' N ' HG23 ' A' ' 42' ' ' VAL . 71.2 ttp85 -53.33 -45.79 69.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 1.0 110.683 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.53 68.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.255 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -65.7 -36.68 84.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.758 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CB ' HG23 ' A' ' 48' ' ' THR . 14.4 mt -96.68 -14.29 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.704 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 54.84 25.96 38.9 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.616 HG22 ' CE1' ' A' ' 170' ' ' HIS . 69.5 p -79.29 149.24 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.9 m-20 -49.1 -42.6 39.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.635 HH12 ' CG2' ' A' ' 148' ' ' VAL . 14.9 ptt-85 -158.28 145.44 17.88 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.576 -0.85 . . . . 1.0 112.791 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 16.7 t -137.75 135.13 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.943 -1.026 . . . . 1.0 108.684 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 67' ' ' GLU . 34.6 mttt -136.01 147.07 47.81 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.265 -0.574 . . . . 1.0 111.651 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 166' ' ' LEU . 46.9 t -98.81 140.18 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.929 -0.767 . . . . 1.0 108.929 177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.407 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 16.6 t80 -129.67 130.48 45.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.441 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -111.8 151.76 28.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 1.0 111.215 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CD2' ' NH2' ' A' ' 92' ' ' ARG . 0.7 OUTLIER -101.91 139.05 38.07 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.631 -179.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.8 m-20 -103.54 154.33 37.94 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -39.98 -51.95 2.93 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 123.045 2.496 . . . . 1.0 114.51 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.93 -5.03 23.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.227 0.454 . . . . 1.0 112.227 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.11 -8.16 44.96 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.763 -0.732 . . . . 1.0 111.939 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' ASP . 57.7 m80 -76.42 148.98 36.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.445 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.77 159.05 23.78 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -132.99 156.09 47.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.015 0.436 . . . . 1.0 111.449 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 80' ' ' LEU . 7.5 p -94.0 112.05 26.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -115.33 0.36 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.633 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.48 126.08 8.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.341 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 81.9 tt0 -153.75 138.47 17.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 1.0 111.697 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.91 133.39 51.89 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -112.02 138.54 48.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.35 -0.54 . . . . 1.0 112.055 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.34 67.04 3.7 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 84.98 163.91 37.73 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.69 11.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 1.0 110.327 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.635 ' H ' ' C ' ' A' ' 71' ' ' GLY . 40.6 ttm180 -66.11 -40.11 90.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.014 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.1 mt -116.71 142.22 29.35 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.19 168.08 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.484 2.122 . . . . 1.0 112.255 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.9 m -95.78 144.61 26.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.34 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' O ' HG11 ' A' ' 64' ' ' VAL . 32.0 mt -114.66 10.62 16.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 67' ' ' GLU . 77.8 mt -55.52 130.1 41.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.99 -2.53 87.11 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.858 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 64' ' ' VAL . 88.7 mt -85.7 144.86 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.31 0.555 . . . . 1.0 110.483 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 p -102.56 131.26 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.59 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -104.39 105.31 49.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.214 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.26 136.31 5.64 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.555 2.17 . . . . 1.0 111.484 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.0 -30.39 67.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.854 0.359 . . . . 1.0 110.391 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.06 -17.92 0.12 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.184 -0.766 . . . . 1.0 111.184 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.9 m-20 -64.74 -18.36 64.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.606 0.241 . . . . 1.0 111.028 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 mt -136.79 133.54 18.91 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.539 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.57 -96.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.556 2.171 . . . . 1.0 111.672 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.7 pt-20 -164.19 -42.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.947 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 86.1 tt0 -52.95 -43.31 66.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.596 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.43 -35.35 70.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.66 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.572 ' HE ' HD23 ' A' ' 162' ' ' LEU . 60.8 ttt180 -65.56 -31.61 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.757 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -64.84 -37.93 89.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD22 HH11 ' A' ' 124' ' ' ARG . 8.7 mt -59.19 -37.76 78.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 1.0 111.531 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -68.52 -33.88 74.9 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -77.46 -30.32 53.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.145 -0.934 . . . . 1.0 111.291 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' C ' HE22 ' A' ' 99' ' ' GLN . 94.6 mt -94.77 -39.53 10.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 -178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.0 -11.81 9.23 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.542 HE22 ' C ' ' A' ' 97' ' ' LEU . 2.9 mp0 46.64 50.53 12.97 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.958 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 99' ' ' GLN . 16.1 t -152.57 111.09 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.371 -0.532 . . . . 1.0 111.882 -178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.457 HH12 HD13 ' A' ' 94' ' ' LEU . 3.8 tpt180 -164.32 130.13 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.876 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 2.1 p -143.97 156.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.66 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.571 HD11 HMA2 ' A' ' 203' ' ' CYC . 54.7 mt -111.99 127.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.209 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.59 169.65 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.414 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 27.5 m-20 -50.87 115.86 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 114.935 -1.03 . . . . 1.0 112.305 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.618 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.6 p -50.51 -19.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.661 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -76.28 -40.44 51.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.768 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -62.29 -8.18 5.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.132 0.491 . . . . 1.0 110.406 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 9.7 pt20 45.52 62.5 2.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.549 -0.751 . . . . 1.0 112.868 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -92.5 127.02 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.762 -1.57 . . . . 1.0 106.762 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -118.75 145.17 45.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.623 ' HG ' ' C ' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -111.04 151.25 28.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.757 -1.11 . . . . 1.0 108.589 178.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 pt -148.02 151.71 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.426 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.7 t -85.82 168.55 14.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 116' ' ' PRO . 67.1 mt-30 -148.38 155.48 42.55 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.884 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 115' ' ' GLN . 37.4 Cg_exo -35.23 156.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.704 2.269 . . . . 1.0 112.232 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 119' ' ' TRP . 82.9 tt0 -45.29 -42.14 9.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.566 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.9 m 41.16 20.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.545 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' GLU . 93.6 m95 42.31 50.56 4.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.82 148.61 51.17 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.9 mt -95.12 136.13 35.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 1.0 110.627 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.414 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 60.4 m -61.45 -37.02 82.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.05 -28.7 65.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.81 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.485 HH11 HD22 ' A' ' 94' ' ' LEU . 45.5 mtp180 61.02 -143.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.682 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.21 154.54 61.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.619 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.43 118.5 5.71 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.331 2.021 . . . . 1.0 111.524 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.453 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 5.2 tp 53.75 -132.87 1.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.59 -0.277 . . . . 1.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.453 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . 69.53 39.11 79.5 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.497 ' OE1' ' NH2' ' A' ' 133' ' ' ARG . 43.0 mt-10 -130.93 151.3 78.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.53 0.205 . . . . 1.0 110.583 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.6 169.02 23.48 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.485 2.123 . . . . 1.0 112.04 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.418 ' HB2' HE21 ' A' ' 132' ' ' GLN . 52.4 mt -63.52 -3.17 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.096 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.418 HE21 ' HB2' ' A' ' 131' ' ' LEU . 20.9 mm-40 -134.6 168.28 19.27 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.488 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.497 ' NH2' ' OE1' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -141.16 124.89 10.14 Favored Pre-proline 0 N--CA 1.462 0.168 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.501 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.623 ' C ' ' HG ' ' A' ' 112' ' ' SER . 50.9 Cg_endo -84.32 143.97 10.23 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.679 2.252 . . . . 1.0 112.402 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CA ' ' OG ' ' A' ' 112' ' ' SER . 0.2 OUTLIER -119.78 128.71 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.501 ' HA ' ' H ' ' A' ' 112' ' ' SER . 5.0 t70 -44.86 140.37 3.42 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.802 0.334 . . . . 1.0 111.335 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -36.32 -26.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.198 2.599 . . . . 1.0 113.629 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 136' ' ' ASP . 38.4 t -54.22 -61.45 2.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.768 -0.373 . . . . 1.0 111.2 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -70.27 -24.92 63.13 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.61 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.618 ' CG1' HG23 ' A' ' 106' ' ' VAL . 59.2 t -60.51 -58.59 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -62.1 -38.88 90.58 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.363 -0.535 . . . . 1.0 110.402 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -47.29 -36.8 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.271 -0.641 . . . . 1.0 109.271 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.33 -43.4 60.86 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.117 -0.698 . . . . 1.0 109.117 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -58.15 -43.52 87.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.4 t -62.34 -19.28 63.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.687 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.9 mmm -100.15 0.93 41.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.158 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.7 19.46 77.8 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.635 ' CG2' HH12 ' A' ' 50' ' ' ARG . 99.0 t -108.72 144.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.624 0.249 . . . . 1.0 110.369 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.95 -27.44 5.76 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.032 0.382 . . . . 1.0 112.032 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.414 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 51.1 m -149.71 121.43 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.801 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.489 ' OG ' HD12 ' A' ' 103' ' ' ILE . 87.9 p -130.45 141.8 50.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 1.0 111.418 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.3 tt -103.21 133.74 47.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.9 t -112.64 129.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.247 -0.581 . . . . 1.0 112.284 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.69 132.83 21.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -94.27 164.52 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.362 2.042 . . . . 1.0 113.738 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.7 mt -117.05 114.31 23.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.64 -1.245 . . . . 1.0 107.64 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.432 ' H ' ' HB2' ' A' ' 192' ' ' SER . 23.5 ptm -141.47 153.02 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.556 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 58.9 t60 -126.97 126.42 43.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.9 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.556 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 38.8 m80 57.0 -120.87 1.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.157 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -97.8 2.32 49.28 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.791 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.7 tt0 -105.58 145.3 31.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.699 1.0 . . . . 1.0 113.699 -176.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.572 HD23 ' HE ' ' A' ' 92' ' ' ARG . 51.7 tp -100.76 124.25 46.13 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 75.3 m95 -102.94 -33.22 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 54' ' ' TYR . . . -162.88 -172.33 30.23 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.598 -1.286 . . . . 1.0 112.3 -177.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.7 mt -137.62 122.67 19.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.426 -0.387 . . . . 1.0 111.682 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.2 tp -95.99 149.35 21.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 167' ' ' VAL . 9.7 p -154.68 133.81 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.981 -0.687 . . . . 1.0 111.836 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 96.4 p -116.17 133.74 55.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.234 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -108.43 128.35 54.71 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.64 0.607 . . . . 1.0 112.64 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.616 ' CE1' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -120.4 123.29 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.269 -1.012 . . . . 1.0 108.269 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.76 -18.94 62.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.774 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -119.01 160.52 40.55 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.555 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.62 -80.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.599 2.199 . . . . 1.0 111.866 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 46.97 90.86 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.662 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.78 159.65 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.514 2.143 . . . . 1.0 111.466 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.68 106.49 14.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.787 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -47.42 146.52 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.266 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.2 -25.77 65.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 1.0 111.12 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -68.89 -47.6 65.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.25 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 184' ' ' VAL . 97.8 mt-10 -68.68 -26.83 65.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 1.0 110.983 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.25 -38.27 88.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.646 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -54.86 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.704 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -44.22 -41.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.652 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 185' ' ' GLN . 23.4 m -74.13 -47.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.586 ' N ' HG23 ' A' ' 184' ' ' VAL . 58.1 tt0 -50.68 -33.08 21.23 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 186' ' ' LEU . 1.3 tt -72.84 -50.03 26.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.062 -0.972 . . . . 1.0 109.074 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.4 -44.61 65.46 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.42 92.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.469 -0.937 . . . . 1.0 108.469 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -58.42 -37.37 75.23 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -67.77 -31.3 71.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.61 -47.78 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.432 ' HB2' ' H ' ' A' ' 157' ' ' MET . 44.1 p -50.32 -32.2 16.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.823 -0.806 . . . . 1.0 108.823 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -74.98 -33.95 30.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.094 -0.957 . . . . 1.0 110.236 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.9 79.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.98 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 196' ' ' ALA . 22.4 pt -63.14 -28.91 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.05 -52.3 10.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.356 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.23 -41.81 96.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.302 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.54 -31.61 72.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.409 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.03 -43.89 87.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 1.0 112.166 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 41.0 tp -52.57 -35.77 54.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.707 -0.397 . . . . 1.0 111.003 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.7 m -51.08 -57.49 8.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.627 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.413 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.571 HMA2 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.915 0.388 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 30.9 p-10 -50.66 -32.67 19.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.677 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 52.7 tt0 -75.67 -49.99 16.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.863 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 38' ' ' THR . 96.1 mt -55.77 -50.58 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 1.0 110.936 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.468 ' O ' ' OG1' ' A' ' 38' ' ' THR . 65.8 mt -55.82 -31.04 62.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.001 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 39' ' ' VAL . 87.5 mtt180 -67.13 -38.32 85.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.412 -0.515 . . . . 1.0 109.757 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.53 -31.99 67.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.754 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 42' ' ' VAL . 77.7 p -67.13 -37.77 84.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.553 . . . . 1.0 112.329 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.515 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.5 p -73.57 -22.79 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -73.09 -40.2 65.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.337 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.92 -33.61 59.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.746 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 38' ' ' THR . 79.8 t -62.27 -56.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.349 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -52.91 -42.91 65.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 1.0 110.656 -179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.78 -45.5 74.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.327 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.29 -36.79 85.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.87 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.74 -16.12 21.03 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.715 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.51 24.84 48.25 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.2 p -79.21 146.94 32.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.899 -0.408 . . . . 1.0 109.899 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -51.62 -42.23 61.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.657 HH22 ' CG ' ' A' ' 77' ' ' LEU . 67.7 ttt180 -153.31 136.45 15.61 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.635 -0.826 . . . . 1.0 112.819 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 8.8 t -139.22 130.67 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 114.88 -1.055 . . . . 1.0 108.751 176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.681 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 58.0 pttt -137.26 150.61 47.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.349 -0.541 . . . . 1.0 111.69 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 166' ' ' LEU . 48.2 t -98.86 140.42 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -129.28 131.99 47.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.488 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -110.9 148.91 31.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 1.0 111.22 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.8 130.53 48.25 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.692 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 61' ' ' HIS . 9.9 m-20 -90.53 152.31 45.09 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -49.5 -18.68 2.56 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.055 2.504 . . . . 1.0 114.466 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.1 4.96 42.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.537 -0.465 . . . . 1.0 112.137 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 99.79 -15.56 59.48 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.698 -0.763 . . . . 1.0 111.875 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 74.1 m80 -79.86 151.09 30.41 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.88 163.75 25.85 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -135.39 157.55 46.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.973 0.416 . . . . 1.0 111.5 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.4 t -90.91 110.6 22.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 65' ' ' VAL . 15.8 t -111.53 -3.44 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.23 125.89 8.92 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.313 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' OE2' ' CZ ' ' A' ' 50' ' ' ARG . 79.9 tt0 -155.18 138.5 15.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.119 0.485 . . . . 1.0 111.746 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.78 139.89 52.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -131.17 146.03 52.18 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.3 -0.56 . . . . 1.0 112.031 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.59 134.58 11.86 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.564 -1.014 . . . . 1.0 110.564 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 40.63 38.35 1.5 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 42.58 20.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 1.0 110.415 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 71' ' ' GLY . 43.9 ttm180 -54.75 -42.21 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.061 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.4 mt -108.25 146.45 33.59 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.67 161.94 33.33 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.411 2.074 . . . . 1.0 112.24 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p -89.16 115.76 26.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.657 ' CG ' HH22 ' A' ' 50' ' ' ARG . 26.8 mt -94.08 11.57 29.43 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.066 -0.516 . . . . 1.0 109.95 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.421 HD21 ' CB ' ' A' ' 67' ' ' GLU . 86.9 mt -56.48 130.43 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.942 0.719 . . . . 1.0 112.942 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.38 -3.5 87.0 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.369 -0.832 . . . . 1.0 112.854 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.95 146.83 27.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.336 0.568 . . . . 1.0 110.463 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -107.8 138.39 44.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.633 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -110.71 149.76 40.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.193 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.49 133.98 10.9 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.569 2.179 . . . . 1.0 111.44 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -57.22 -31.17 65.22 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.844 -0.343 . . . . 1.0 110.433 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.78 -16.88 0.23 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 30.4 p-10 -66.77 -17.3 64.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.661 0.267 . . . . 1.0 111.029 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.0 mt -137.02 98.41 10.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.506 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 43.7 Cg_exo -39.5 -95.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.507 2.138 . . . . 1.0 111.727 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 82.9 tt0 -163.67 -42.51 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.885 0.374 . . . . 1.0 110.991 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -54.64 -39.68 68.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.571 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.77 -42.01 51.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.741 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.546 HH12 HH11 ' A' ' 96' ' ' ARG . 73.6 ttp85 -61.68 -37.51 84.38 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.827 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.471 ' NH2' ' OE2' ' A' ' 89' ' ' GLU . 91.5 mtt-85 -61.95 -34.86 76.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.001 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.08 -33.69 76.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.5 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -68.39 -33.45 74.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.546 HH11 HH12 ' A' ' 92' ' ' ARG . 12.7 mtm180 -77.01 -30.74 56.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.236 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' C ' HE22 ' A' ' 99' ' ' GLN . 97.0 mt -96.03 -38.55 10.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.816 1.043 . . . . 1.0 113.816 -177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.71 -14.11 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.188 1.181 . . . . 1.0 114.188 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.644 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.4 mp0 47.82 55.94 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.878 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.7 m -158.95 112.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.949 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.591 ' NH1' ' NH1' ' A' ' 133' ' ' ARG . 4.2 tpp180 -168.04 133.96 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.797 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.502 HG23 HD23 ' A' ' 152' ' ' LEU . 2.0 p -144.56 157.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.709 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.64 HG23 HG11 ' A' ' 135' ' ' VAL . 8.2 mt -110.51 129.1 66.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.322 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 105' ' ' ASP . 16.7 t -84.06 165.97 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.615 ' N ' HG12 ' A' ' 104' ' ' VAL . 57.1 t0 -47.9 119.53 2.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.947 -1.024 . . . . 1.0 112.282 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.22 -23.51 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.685 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -82.01 -37.09 27.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.777 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -56.9 -16.13 6.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.162 0.506 . . . . 1.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tp60 57.35 60.16 3.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.497 -0.774 . . . . 1.0 112.844 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.5 p -95.12 125.98 40.15 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.797 -1.557 . . . . 1.0 106.797 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -120.98 138.63 54.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.667 0.988 . . . . 1.0 113.667 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER -111.74 156.26 22.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.742 -1.117 . . . . 1.0 108.642 178.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.403 HG23 ' C ' ' A' ' 112' ' ' SER . 30.7 pt -154.06 158.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.505 -0.478 . . . . 1.0 111.475 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.6 p -87.55 170.36 11.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.268 -0.642 . . . . 1.0 109.268 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -143.14 153.94 60.66 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.865 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.49 -26.39 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.642 2.228 . . . . 1.0 112.302 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.97 139.96 57.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.1 m -69.06 151.26 46.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -146.43 148.14 31.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.624 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.59 -168.91 41.78 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 mt 57.57 46.03 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 1.0 110.654 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.9 m -60.46 -32.1 71.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.719 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 125' ' ' VAL . . . -55.32 -44.46 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -68.69 4.33 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.694 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 123' ' ' ALA . 13.4 t -146.6 99.03 4.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.685 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -88.02 130.34 2.54 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.443 2.095 . . . . 1.0 111.502 178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 127' ' ' LEU . 9.8 mp 54.72 -109.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.449 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.53 36.82 62.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.111 -0.796 . . . . 1.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -142.48 153.94 62.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 121.228 -0.189 . . . . 1.0 110.642 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 132' ' ' GLN . 43.7 Cg_endo -63.9 163.03 26.59 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.401 2.067 . . . . 1.0 111.998 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.426 ' HB2' HE21 ' A' ' 132' ' ' GLN . 69.5 mt -49.35 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.006 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 130' ' ' PRO . 31.5 mm-40 -134.29 138.82 45.27 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.603 -0.439 . . . . 1.0 111.477 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.591 ' NH1' ' NH1' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -116.82 128.1 26.26 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.458 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.58 140.32 11.78 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.701 2.267 . . . . 1.0 112.338 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.64 HG11 HG23 ' A' ' 103' ' ' ILE . 1.1 p -115.27 130.16 70.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' N ' ' OG ' ' A' ' 112' ' ' SER . 7.9 t0 -44.96 131.99 5.3 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 1.0 111.393 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -37.86 -31.02 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.092 2.528 . . . . 1.0 113.662 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.3 t -47.24 -61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.231 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.582 ' CD2' HD11 ' A' ' 143' ' ' LEU . 43.7 t60 -70.88 -23.14 62.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.698 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.49 -58.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -63.87 -41.23 97.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.331 -0.547 . . . . 1.0 110.398 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.54 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 66.7 t80 -47.41 -38.32 13.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 139' ' ' HIS . 32.9 mt -72.05 -43.68 64.54 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.04 -42.75 77.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 m -60.98 -35.09 75.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.345 -0.843 . . . . 1.0 109.61 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.54 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 63.2 mtp -83.39 -1.54 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.071 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.39 75.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.03 143.48 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.272 . . . . 1.0 110.341 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.16 -43.46 2.43 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.025 0.38 . . . . 1.0 112.025 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.7 m -134.1 119.84 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.763 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.0 m -132.93 144.11 49.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.931 0.396 . . . . 1.0 111.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 102' ' ' VAL . 14.2 mt -99.02 136.83 38.43 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.59 105.88 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.337 -0.545 . . . . 1.0 112.272 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 57.5 t -112.83 128.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.212 -1.032 . . . . 1.0 108.212 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -93.36 162.54 2.45 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.369 2.046 . . . . 1.0 113.782 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.49 116.72 28.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.605 -1.258 . . . . 1.0 107.605 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.545 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.7 ptm -141.1 148.23 39.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 80.9 t60 -126.78 132.46 51.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.016 -0.993 . . . . 1.0 108.832 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 23.3 m-70 56.62 -126.52 1.93 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.164 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -98.31 3.33 48.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.776 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE2' ' NE1' ' A' ' 163' ' ' TRP . 12.4 pt-20 -109.78 153.25 24.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.703 1.001 . . . . 1.0 113.703 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.7 tp -103.88 127.39 51.4 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.542 ' NE1' ' OE2' ' A' ' 161' ' ' GLU . 43.6 m95 -103.88 -32.41 9.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.543 0.942 . . . . 1.0 113.543 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 -174.13 31.88 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.403 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.474 HD22 ' O2A' ' A' ' 203' ' ' CYC . 80.8 mt -135.58 125.12 25.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.388 . . . . 1.0 111.701 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.569 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.5 tp -96.9 149.92 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.7 p -156.5 133.43 2.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.046 -0.661 . . . . 1.0 111.784 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 t -114.77 135.49 54.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.259 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -110.92 128.61 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -120.75 130.54 54.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.274 -1.009 . . . . 1.0 108.274 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.91 26.56 2.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.775 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -148.65 146.12 21.54 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 120.945 -0.302 . . . . 1.0 110.63 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -80.77 137.97 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.63 2.22 . . . . 1.0 111.85 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -178.76 149.41 0.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.973 -0.291 . . . . 1.0 110.647 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -78.13 150.02 25.8 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.579 2.186 . . . . 1.0 111.478 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.485 ' CZ ' HD21 ' A' ' 152' ' ' LEU . 70.5 m-85 -106.12 162.19 13.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.35 . . . . 1.0 110.833 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.9 m -114.29 143.09 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.182 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -58.39 -34.22 70.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.106 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -56.39 -55.4 34.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.205 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -70.72 -30.67 67.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.521 -0.308 . . . . 1.0 110.947 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.08 -33.68 74.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.584 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -77.84 -54.58 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.922 -0.311 . . . . 1.0 111.704 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.4 t -42.92 -41.94 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.622 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 185' ' ' GLN . 28.8 m -75.42 -47.08 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.538 ' N ' HG23 ' A' ' 184' ' ' VAL . 56.2 tt0 -51.8 -32.88 33.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 190' ' ' GLN . 43.2 tp -75.7 -51.69 12.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.66 -46.4 67.15 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.941 -0.762 . . . . 1.0 108.941 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.59 98.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.62 ' O ' HD13 ' A' ' 193' ' ' ILE . 61.7 t0 -63.79 -37.01 85.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 186' ' ' LEU . 51.6 tt0 -68.05 -29.24 68.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.5 t -76.36 -46.01 33.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 157' ' ' MET . 8.2 t -50.87 -37.52 43.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.1 mp -64.1 -36.83 78.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.261 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.73 82.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.855 -0.612 . . . . 1.0 110.903 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.33 -47.52 81.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.457 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -64.82 -49.41 70.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.712 -0.676 . . . . 1.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -62.43 -45.63 92.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.175 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.94 71.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.375 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.2 -43.11 82.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.29 -35.64 62.83 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.2 t -55.02 -60.69 3.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.5 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.407 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.681 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.78 0.324 . . . . 1.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 28.8 p-10 -70.91 -32.36 69.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.723 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 53.3 tt0 -77.45 -48.26 17.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.807 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' THR . 96.6 mt -56.02 -50.34 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.055 0.455 . . . . 1.0 110.964 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.471 ' O ' ' OG1' ' A' ' 38' ' ' THR . 78.2 mt -57.56 -30.73 65.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 1.0 111.942 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.476 ' O ' HG12 ' A' ' 39' ' ' VAL . 90.0 mtt180 -66.73 -38.81 87.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.391 -0.524 . . . . 1.0 109.781 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.42 -30.13 65.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.787 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 34' ' ' ILE . 69.0 p -69.69 -36.42 75.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 1.0 112.314 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.4 p -71.63 -25.44 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.168 0.433 . . . . 1.0 112.168 -177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.52 -31.86 32.6 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 1.0 111.296 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -76.8 -38.34 54.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.709 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.629 HG23 ' N ' ' A' ' 43' ' ' ARG . 30.4 m -66.53 -52.83 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.304 -177.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.629 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -51.87 -43.3 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.384 . . . . 1.0 110.669 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -54.2 -44.12 71.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.317 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -64.66 -35.79 82.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.842 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.29 -13.01 23.68 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.703 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 56.03 25.83 47.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.3 p -80.03 148.82 30.94 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.991 -0.374 . . . . 1.0 109.991 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' GLY . 87.8 m-20 -50.25 -42.66 52.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.643 0.608 . . . . 1.0 112.643 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.556 HH21 ' CG2' ' A' ' 148' ' ' VAL . 18.7 ptt-85 -158.4 149.78 21.0 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 119.633 -0.827 . . . . 1.0 112.805 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 21.3 t -141.33 136.14 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.962 -1.017 . . . . 1.0 108.743 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' NZ ' ' CE1' ' A' ' 169' ' ' HIS . 29.8 mttp -137.07 145.58 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.243 -0.583 . . . . 1.0 111.624 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 57.5 t -100.91 142.1 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.953 -0.758 . . . . 1.0 108.953 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 20.7 t80 -130.44 133.27 46.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 1.0 110.426 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.444 HH12 ' CG2' ' A' ' 195' ' ' ILE . 78.1 mtp85 -114.44 154.1 28.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.019 0.438 . . . . 1.0 111.14 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.23 138.19 40.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.711 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.5 m-20 -97.42 153.64 38.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -45.39 -21.1 0.65 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.012 2.474 . . . . 1.0 114.463 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -102.83 2.97 36.14 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.206 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.32 -13.68 56.96 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.661 -0.781 . . . . 1.0 111.957 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' A' ' 57' ' ' ASP . 59.1 m80 -78.72 150.13 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.416 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.29 161.6 25.27 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.7 p -133.74 155.92 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.094 0.473 . . . . 1.0 111.473 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 t -87.22 108.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 65' ' ' VAL . 13.0 t -109.0 -4.99 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.12 0.415 . . . . 1.0 112.12 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.04 125.96 8.41 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.884 -0.327 . . . . 1.0 110.329 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB3' HD21 ' A' ' 78' ' ' LEU . 55.0 tt0 -154.89 139.14 16.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.18 0.514 . . . . 1.0 111.739 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.36 131.82 51.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.6 mtm-85 -103.15 135.08 45.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.071 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -79.1 74.65 2.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.85 38.75 30.31 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 54.55 21.73 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.791 0.329 . . . . 1.0 110.3 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -57.58 -43.19 84.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.972 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.539 HD22 ' NE ' ' A' ' 50' ' ' ARG . 2.9 mp -114.51 159.91 35.11 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 177.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.56 147.61 19.97 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.514 2.142 . . . . 1.0 112.223 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -67.33 124.24 22.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.355 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.37 9.96 38.02 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.978 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 67' ' ' GLU . 95.1 mt -61.75 131.54 50.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.13 73.08 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.877 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.05 152.5 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.345 0.572 . . . . 1.0 110.464 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 81' ' ' THR . 9.0 t -107.43 131.23 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.602 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.07 148.79 36.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.273 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.8 129.18 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.489 2.126 . . . . 1.0 111.459 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -56.97 -31.13 64.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.866 0.365 . . . . 1.0 110.463 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.92 0.06 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.7 m-20 -63.72 -26.39 68.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.562 0.22 . . . . 1.0 111.02 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.449 HG23 ' HHA' ' A' ' 203' ' ' CYC . 9.5 mt -122.59 132.99 24.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.555 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.6 -103.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.608 2.205 . . . . 1.0 111.633 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 22.3 pt-20 -159.66 -40.77 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.032 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 87.2 tt0 -60.27 -41.28 92.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.623 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.82 -39.86 63.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.631 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 60.9 ttp180 -63.14 -37.5 87.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 1.0 110.808 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -60.72 -34.66 74.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.941 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.84 -32.23 73.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.614 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.41 -35.84 78.24 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.3 mtm180 -73.55 -33.63 64.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.215 -0.902 . . . . 1.0 111.262 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.574 ' C ' HE22 ' A' ' 99' ' ' GLN . 86.4 mt -95.54 -37.67 10.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.782 1.03 . . . . 1.0 113.782 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.16 -15.05 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -175.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.662 ' O ' HG13 ' A' ' 100' ' ' VAL . 1.0 OUTLIER 47.48 57.45 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.658 -0.817 . . . . 1.0 109.969 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.4 m -159.57 114.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.88 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.594 ' NH1' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -168.44 132.46 1.57 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.878 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.64 157.78 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.688 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 135' ' ' VAL . 6.3 mt -109.75 126.98 66.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.266 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.69 169.56 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.973 0.731 . . . . 1.0 112.973 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -49.84 115.21 1.29 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.952 -1.022 . . . . 1.0 112.292 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 140' ' ' VAL . 55.6 t -51.57 -17.68 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.505 -0.77 . . . . 1.0 110.72 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -81.97 -36.69 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.789 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' O ' ' CG ' ' A' ' 109' ' ' GLN . . . -60.71 -8.91 3.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.172 0.511 . . . . 1.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.588 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 16.2 pt20 46.8 60.21 3.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.459 -0.791 . . . . 1.0 112.844 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 p -94.43 129.19 41.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -119.69 142.36 48.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.681 0.993 . . . . 1.0 113.681 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.2 p -109.29 149.53 29.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.753 -1.112 . . . . 1.0 108.661 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 113' ' ' ILE . 6.2 mt -147.15 152.56 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.451 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 m -85.31 169.13 14.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -151.81 132.54 7.51 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.887 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.74 14.87 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.259 . . . . 1.0 112.223 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.56 143.09 26.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.648 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -55.29 96.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.498 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -61.07 -31.45 71.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.667 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.27 -173.63 34.5 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.681 HD12 ' N ' ' A' ' 121' ' ' LEU . 8.3 mp -92.58 125.18 37.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 1.0 110.622 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.427 ' OG ' ' CD1' ' A' ' 97' ' ' LEU . 85.3 p -67.16 -27.16 67.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.72 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.99 -11.09 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.84 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -50.56 -60.01 3.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.7 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.24 133.86 16.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.567 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 165.66 31.34 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.376 2.05 . . . . 1.0 111.605 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.6 mt 44.79 -118.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.362 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 56.34 38.63 79.75 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -119.06 150.49 48.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.513 0.197 . . . . 1.0 110.592 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.44 154.44 40.47 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.41 2.073 . . . . 1.0 111.991 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.5 mt -54.39 -27.16 34.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.943 -0.572 . . . . 1.0 112.068 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -132.43 135.14 45.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.567 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.594 ' HE ' ' NH1' ' A' ' 101' ' ' ARG . 12.3 mmm180 -123.94 147.95 55.51 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.578 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -85.77 144.04 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.631 2.221 . . . . 1.0 112.374 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.733 HG21 HG12 ' A' ' 103' ' ' ILE . 4.6 t -118.26 130.52 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.207 -0.664 . . . . 1.0 109.207 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 138' ' ' CYS . 16.9 t70 -45.2 135.9 5.22 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.385 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -36.97 -21.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.07 2.513 . . . . 1.0 113.677 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.506 ' N ' ' O ' ' A' ' 136' ' ' ASP . 54.1 t -56.21 -60.17 3.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.758 -0.377 . . . . 1.0 111.237 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -71.26 -25.01 62.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.64 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 106' ' ' VAL . 19.3 t -60.14 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.668 0.618 . . . . 1.0 112.668 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 144' ' ' LYS . 86.1 t60 -63.18 -39.48 94.76 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.368 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' O ' ' OG ' ' A' ' 145' ' ' SER . 77.6 t80 -45.77 -36.07 4.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.69 -42.48 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.68 -42.45 92.96 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 142' ' ' TYR . 97.4 p -64.16 -20.01 65.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.618 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 25.7 mmm -99.98 1.58 42.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.556 -0.747 . . . . 1.0 111.06 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.89 19.45 77.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.556 ' CG2' HH21 ' A' ' 50' ' ' ARG . 86.4 t -109.38 144.22 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.719 0.295 . . . . 1.0 110.275 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.34 -27.47 6.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.974 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 p -152.0 121.9 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.685 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.7 t -131.04 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.0 111.474 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.7 tt -109.82 132.64 53.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.525 HG12 HG23 ' A' ' 167' ' ' VAL . 31.9 m -117.86 139.49 44.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.336 -0.546 . . . . 1.0 112.323 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.6 t -134.09 134.27 22.79 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -89.49 159.64 5.41 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.381 2.054 . . . . 1.0 113.718 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.1 mt -114.63 113.59 24.55 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.603 -1.258 . . . . 1.0 107.603 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.0 ptm -142.09 153.36 44.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.778 0.658 . . . . 1.0 112.778 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -127.85 122.92 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -1.0 . . . . 1.0 108.872 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 160' ' ' GLN . 17.2 t60 59.65 -118.1 0.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.133 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.477 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 13.5 pt20 -99.65 1.15 43.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.877 0.325 . . . . 1.0 111.877 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -106.02 143.73 33.75 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.84 126.42 45.94 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -105.47 -35.37 7.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.514 0.931 . . . . 1.0 113.514 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -158.3 -173.75 27.12 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.654 -1.26 . . . . 1.0 112.353 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.517 HD23 HMB2 ' A' ' 203' ' ' CYC . 4.8 tp -138.07 122.5 18.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.449 -0.375 . . . . 1.0 111.657 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.408 HD12 HG22 ' A' ' 53' ' ' VAL . 11.3 tp -93.76 144.77 25.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 153' ' ' VAL . 8.4 p -151.86 132.03 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.072 -0.651 . . . . 1.0 111.856 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.9 m -118.36 128.97 55.15 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.435 ' CE1' ' NZ ' ' A' ' 52' ' ' LYS . 48.6 m80 -100.22 126.14 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.647 0.61 . . . . 1.0 112.647 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.8 t60 -119.54 109.98 16.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.37 49.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.454 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 32.9 mm-40 -108.84 155.66 40.35 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.614 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' ARG . 35.9 Cg_endo -61.44 -92.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.657 2.238 . . . . 1.0 111.8 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 173' ' ' PRO . 11.2 tpp180 58.76 124.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.57 -0.286 . . . . 1.0 110.684 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.58 163.98 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.512 2.141 . . . . 1.0 111.436 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -108.54 152.71 24.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 1.0 110.849 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.1 m -112.45 147.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.18 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -55.15 -37.04 66.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.164 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.28 -54.28 48.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.26 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.77 -33.53 72.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.24 -42.7 91.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.626 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -67.28 -52.5 39.89 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.664 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.3 t -42.08 -43.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.63 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.05 -46.19 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -52.13 -32.78 37.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.058 -1.089 . . . . 1.0 108.058 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 190' ' ' GLN . 22.8 tp -74.66 -55.97 5.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.012 -0.995 . . . . 1.0 109.088 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -52.03 -45.86 64.78 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.11 -49.98 74.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.53 -37.93 82.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.606 -0.887 . . . . 1.0 108.606 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 186' ' ' LEU . 49.1 tp60 -64.96 -33.07 75.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.99 -46.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 25.2 p -51.99 -35.15 45.63 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 mt -68.94 -35.03 67.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.162 -0.927 . . . . 1.0 110.265 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.57 -41.69 75.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.914 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.444 ' CG2' HH12 ' A' ' 55' ' ' ARG . 65.7 mt -56.71 -45.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.53 -50.38 58.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.367 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -61.73 -44.31 97.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.266 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.74 70.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 1.0 111.419 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.22 -43.43 82.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.181 0.438 . . . . 1.0 112.181 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.7 mp -52.53 -33.26 44.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.737 -0.385 . . . . 1.0 110.984 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -53.1 -58.76 5.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.691 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.548 HD23 ' C ' ' A' ' 202' ' ' LEU . 2.7 tt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.459 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.534 HAD2 HG13 ' A' ' 135' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.808 0.337 . . . . 1.0 110.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 67.3 t0 -70.11 -33.2 71.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.55 -48.49 19.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.834 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 38' ' ' THR . 96.0 mt -54.93 -53.83 29.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 1.0 110.924 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.487 ' O ' ' OG1' ' A' ' 38' ' ' THR . 59.7 mt -55.72 -31.41 62.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.626 -0.715 . . . . 1.0 111.96 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' O ' HG12 ' A' ' 39' ' ' VAL . 67.0 ttt180 -62.84 -39.54 94.67 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.383 -0.527 . . . . 1.0 109.822 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.08 -32.74 69.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.762 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 42' ' ' VAL . 74.9 p -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.272 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 2.3 p -73.75 -25.42 20.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.211 0.448 . . . . 1.0 112.211 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.44 -44.72 64.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.287 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.91 -37.85 72.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.751 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' THR . 68.2 t -57.11 -54.25 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.596 -0.274 . . . . 1.0 111.394 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 47' ' ' GLY . 69.9 ttt-85 -52.3 -45.56 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 1.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.45 -44.63 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.257 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -65.4 -39.01 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.795 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.92 -14.69 21.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.916 -0.314 . . . . 1.0 111.68 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.71 25.68 22.71 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.596 -1.001 . . . . 1.0 110.596 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.466 ' OG1' ' CD2' ' A' ' 170' ' ' HIS . 14.2 t -78.87 147.44 33.14 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.016 -0.364 . . . . 1.0 110.016 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -52.91 -41.61 64.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.561 0.578 . . . . 1.0 112.561 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.613 ' HE ' ' CD ' ' A' ' 67' ' ' GLU . 65.0 ttt-85 -152.67 133.44 13.95 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.536 -0.866 . . . . 1.0 112.759 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 51' ' ' VAL . 11.2 p -141.45 132.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.912 -1.04 . . . . 1.0 108.648 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.88 ' NZ ' HBB2 ' A' ' 203' ' ' CYC . 41.5 pttt -137.82 153.59 49.61 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.271 -0.571 . . . . 1.0 111.682 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 54.4 t -98.33 141.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 11.5 t80 -131.77 133.56 44.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.483 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -113.81 152.56 30.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 1.0 111.166 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.42 134.92 45.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.769 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 61' ' ' HIS . 19.7 m-20 -99.25 154.24 37.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -38.35 -52.19 1.98 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 122.952 2.435 . . . . 1.0 114.549 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' OE2' ' CD2' ' A' ' 61' ' ' HIS . 22.2 pt-20 -70.69 -6.56 38.15 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.71 -6.76 38.31 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.656 -0.783 . . . . 1.0 111.862 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-70 -77.21 149.14 35.53 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.42 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -135.52 159.54 24.17 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -133.42 155.15 50.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 1.0 111.527 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.19 110.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 65' ' ' VAL . 14.4 t -111.95 -3.99 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.127 0.417 . . . . 1.0 112.127 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.59 124.74 8.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.287 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.613 ' CD ' ' HE ' ' A' ' 50' ' ' ARG . 65.3 tt0 -153.29 138.46 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.176 0.512 . . . . 1.0 111.689 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.53 138.13 52.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.816 -0.809 . . . . 1.0 108.816 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -133.46 147.34 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.989 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . -105.98 140.83 15.29 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.578 -1.009 . . . . 1.0 110.578 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 73' ' ' ARG . . . 36.08 36.84 0.15 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 42.64 19.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 1.0 110.353 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 71' ' ' GLY . 31.9 ttm180 -55.36 -40.13 70.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.036 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 73' ' ' ARG . 7.7 mp -110.71 113.71 55.26 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -49.38 161.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.518 2.146 . . . . 1.0 112.148 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.8 p -84.69 129.53 34.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.331 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 HH22 ' A' ' 50' ' ' ARG . 21.3 mt -107.79 9.05 29.06 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.408 HD21 ' CB ' ' A' ' 67' ' ' GLU . 76.8 mt -56.46 131.5 48.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.889 0.7 . . . . 1.0 112.889 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.67 -3.97 86.6 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.88 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.49 147.12 27.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.342 -0.543 . . . . 1.0 110.466 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -104.16 129.83 51.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.54 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.803 ' CD1' HAB2 ' A' ' 203' ' ' CYC . 30.5 m-85 -106.17 105.64 54.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.269 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.3 139.35 4.27 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.485 2.123 . . . . 1.0 111.524 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -63.18 -28.21 69.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.817 0.342 . . . . 1.0 110.413 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.91 -17.52 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 24.4 p-10 -68.16 -14.43 62.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.61 0.243 . . . . 1.0 110.996 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.02 133.68 25.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.481 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HD ' ' A' ' 203' ' ' CYC . 94.8 Cg_endo -74.16 -102.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.551 2.167 . . . . 1.0 111.639 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -157.84 -43.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.003 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -57.91 -40.34 80.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.636 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -40.65 57.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.679 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 69.3 ttt180 -62.32 -38.35 89.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.869 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -62.56 -34.13 76.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.965 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD13 ' NH1' ' A' ' 101' ' ' ARG . 7.9 mt -63.99 -33.37 75.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.593 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -68.92 -33.72 74.2 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 13.8 mtm180 -78.07 -30.03 49.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.122 -0.945 . . . . 1.0 111.249 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 123' ' ' ALA . 37.5 mt -95.69 -38.93 10.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.67 -12.6 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.508 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.2 mp0 46.57 49.02 13.97 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.642 -0.823 . . . . 1.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 t -152.22 110.86 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.313 -0.555 . . . . 1.0 111.862 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 101' ' ' ARG . 0.4 OUTLIER -165.41 138.34 4.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.933 178.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.4 p -154.11 157.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.709 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.569 HG12 HG21 ' A' ' 135' ' ' VAL . 2.9 mp -111.94 129.85 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.203 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 104' ' ' VAL . 1.2 m -87.33 170.84 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.924 0.712 . . . . 1.0 112.924 -176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -49.21 114.57 1.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.234 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.414 HG13 ' CG1' ' A' ' 140' ' ' VAL . 39.2 t -51.19 -19.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.686 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -81.18 -37.31 28.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.23 -17.48 19.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 1.0 110.414 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.433 HE21 ' NH2' ' A' ' 111' ' ' ARG . 49.5 tt0 56.56 61.16 2.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 1.0 112.829 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 m -95.2 125.75 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.433 ' NH2' HE21 ' A' ' 109' ' ' GLN . 92.4 mtt180 -118.95 143.98 46.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.65 0.981 . . . . 1.0 113.65 -176.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 1.3 p -110.54 149.4 30.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.78 -1.1 . . . . 1.0 108.641 177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 113' ' ' ILE . 6.4 mt -146.9 150.88 14.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.443 -0.503 . . . . 1.0 111.437 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.1 m -89.86 171.9 9.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -119.32 147.64 43.6 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.889 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -35.87 -54.97 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.657 2.238 . . . . 1.0 112.237 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -79.11 146.98 32.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.62 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.4 t -134.83 142.36 46.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.501 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.442 ' CD1' ' N ' ' A' ' 120' ' ' GLY . 2.2 t90 -155.34 -139.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.706 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 122' ' ' SER . . . -161.47 -171.87 28.08 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 121' ' ' LEU . 10.0 mp 54.93 4.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 1.0 110.608 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 120' ' ' GLY . 19.6 t -66.75 -27.52 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.748 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' A' ' 97' ' ' LEU . . . -68.63 -21.49 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.75 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -46.75 -19.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.714 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 125' ' ' VAL . 8.0 p -62.69 131.14 94.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.612 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.26 120.07 3.99 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.469 2.113 . . . . 1.0 111.563 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 tp 43.57 -123.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.015 -0.274 . . . . 1.0 110.391 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.85 36.78 52.05 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.094 -0.802 . . . . 1.0 111.094 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -143.46 157.24 59.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.504 0.193 . . . . 1.0 110.608 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 132' ' ' GLN . 60.9 Cg_endo -69.27 170.14 16.66 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.443 2.095 . . . . 1.0 112.019 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.89 3.06 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 1.0 112.014 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 130' ' ' PRO . 41.2 mm-40 -136.78 164.97 27.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.508 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -136.38 122.44 13.67 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.491 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.7 139.24 8.69 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.635 2.223 . . . . 1.0 112.365 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.677 ' CG1' HAD2 ' A' ' 203' ' ' CYC . 2.9 t -116.26 127.43 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.773 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.8 OUTLIER -45.27 144.98 2.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.74 0.305 . . . . 1.0 111.347 -178.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -38.28 -18.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.123 2.549 . . . . 1.0 113.658 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 136' ' ' ASP . 34.6 t -56.98 -58.73 6.87 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.259 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.667 ' CG ' HAA2 ' A' ' 203' ' ' CYC . 0.8 OUTLIER -71.71 -26.01 62.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.659 179.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG1' HG13 ' A' ' 106' ' ' VAL . 45.3 t -56.43 -63.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 142' ' ' TYR . 12.8 p-80 -66.84 -40.88 88.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.386 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.627 ' N ' ' CD2' ' A' ' 141' ' ' HIS . 71.1 t80 -44.3 -39.46 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.6 -41.69 62.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.185 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' HIS . 84.5 tttt -59.25 -43.38 92.42 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 m -63.34 -21.35 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.618 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 33.4 mmm -99.14 0.35 43.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.609 -0.723 . . . . 1.0 111.149 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.22 17.46 79.98 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.599 -1.001 . . . . 1.0 110.599 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.73 145.19 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.728 0.299 . . . . 1.0 110.289 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.14 -20.75 7.89 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.055 0.391 . . . . 1.0 112.055 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -155.38 120.07 4.76 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.778 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -124.96 132.49 53.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.915 0.388 . . . . 1.0 111.412 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -98.73 127.77 44.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.0 108.49 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.279 -0.568 . . . . 1.0 112.266 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.63 135.18 20.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -92.28 166.05 2.98 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.408 2.072 . . . . 1.0 113.737 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.7 mt -119.39 116.48 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 99' ' ' GLN . 24.0 ptm -141.58 151.83 43.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.621 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 32.7 t-80 -124.1 123.59 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.948 -1.024 . . . . 1.0 108.824 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.621 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 45.0 m-70 56.72 -118.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.12 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -98.06 0.58 46.45 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.848 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.467 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.23 143.25 33.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -176.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 24.4 tp -99.23 125.71 44.89 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.542 -1.281 . . . . 1.0 107.542 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.467 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 61.7 m95 -104.96 -35.25 7.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.538 0.94 . . . . 1.0 113.538 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.58 -173.58 25.26 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.675 -1.25 . . . . 1.0 112.401 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.7 tp -139.51 120.96 15.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.473 -0.363 . . . . 1.0 111.612 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.7 tp -93.63 150.48 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 167' ' ' VAL . 12.4 p -155.73 133.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.028 -0.669 . . . . 1.0 111.869 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -115.03 136.03 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 9.7 m80 -108.73 123.44 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.667 0.617 . . . . 1.0 112.667 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.466 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 54.2 m80 -117.06 125.22 50.98 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.317 -0.994 . . . . 1.0 108.317 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.19 -16.63 57.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.817 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -134.54 152.37 77.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.911 -0.316 . . . . 1.0 110.608 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -42.79 127.51 4.74 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.646 2.231 . . . . 1.0 111.88 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -149.81 77.52 8.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.932 -0.307 . . . . 1.0 110.67 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.97 151.65 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.495 2.13 . . . . 1.0 111.416 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -105.57 148.14 27.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.869 -0.333 . . . . 1.0 110.803 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.1 t -92.97 157.72 16.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.151 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -53.61 -37.36 62.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.14 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 183' ' ' VAL . 78.3 mm-40 -73.43 -43.12 61.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.288 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 184' ' ' VAL . 77.8 mm-40 -71.41 -28.99 64.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.998 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.61 -46.91 86.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.614 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.436 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 13.1 pt20 -80.18 -47.07 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.667 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 179' ' ' GLU . 43.1 t -42.86 -45.58 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.644 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.557 HG23 ' N ' ' A' ' 185' ' ' GLN . 34.1 m -74.41 -47.34 40.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.557 ' N ' HG23 ' A' ' 184' ' ' VAL . 40.5 tp60 -49.54 -32.06 11.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.123 -1.066 . . . . 1.0 108.123 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 190' ' ' GLN . 13.8 tp -73.89 -52.11 14.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.034 -0.984 . . . . 1.0 109.098 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.86 -47.51 67.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.57 -46.62 83.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.429 -0.952 . . . . 1.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.56 ' O ' HD13 ' A' ' 193' ' ' ILE . 65.0 t0 -62.41 -41.73 98.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 186' ' ' LEU . 59.1 tp60 -61.66 -31.3 71.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.636 -0.876 . . . . 1.0 108.636 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.84 -44.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.2 p -51.67 -35.8 43.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.3 mp -66.51 -37.19 79.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.161 -0.927 . . . . 1.0 110.276 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.22 -41.78 80.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.2 mt -56.83 -46.3 83.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -65.94 -49.55 67.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.394 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.46 -45.36 93.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.216 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.19 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.362 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -58.26 -44.13 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.219 0.451 . . . . 1.0 112.219 -177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 52.3 mt -53.93 -32.85 54.99 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.996 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.5 m -51.87 -57.03 10.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.614 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 202' ' ' LEU . 9.9 mp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.096 -0.954 . . . . 1.0 110.441 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.88 HBB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 35' ' ' LEU . 1.2 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.713 0.292 . . . . 1.0 110.484 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -48.93 -35.72 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.735 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 26.4 mp0 -74.49 -50.7 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.783 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.28 -50.56 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 1.0 110.94 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 38' ' ' THR . 30.5 mt -54.78 -29.7 54.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.95 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.515 ' O ' HG12 ' A' ' 39' ' ' VAL . 76.6 ttt180 -64.37 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 109.754 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.57 -32.86 68.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.835 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.62 ' O ' HG23 ' A' ' 42' ' ' VAL . 70.5 p -66.46 -36.97 84.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.333 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 2.4 p -73.65 -24.48 20.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.89 -45.99 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 1.0 111.308 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -68.55 -38.62 80.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.739 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 38' ' ' THR . 76.9 t -54.78 -55.14 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.296 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 47' ' ' GLY . 60.9 ttp180 -50.11 -43.87 51.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.693 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.54 77.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.269 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -63.52 -40.72 97.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.753 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -96.92 -14.8 21.52 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.65 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.62 25.8 22.38 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.478 -1.049 . . . . 1.0 110.478 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 57.6 p -79.65 149.43 31.27 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 50' ' ' ARG . 3.0 p30 -53.6 -38.98 64.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 ttt180 -154.51 135.29 13.65 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.609 -0.836 . . . . 1.0 112.891 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.0 p -141.81 132.35 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.01 -0.995 . . . . 1.0 108.783 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' CE ' HAB1 ' A' ' 203' ' ' CYC . 13.5 pttp -138.25 153.03 49.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.615 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 43.5 t -98.58 139.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.928 -0.767 . . . . 1.0 108.928 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HH ' ' C ' ' A' ' 62' ' ' GLY . 23.7 t80 -128.21 131.0 48.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.795 0.331 . . . . 1.0 110.391 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -109.68 149.13 30.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.41 . . . . 1.0 111.22 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.88 135.76 42.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.791 -0.64 . . . . 1.0 111.708 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 61' ' ' HIS . 24.2 m-20 -101.03 153.55 37.67 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -38.85 -51.02 2.45 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.06 2.507 . . . . 1.0 114.514 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.41 -5.74 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.199 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.77 -8.84 43.51 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.661 -0.78 . . . . 1.0 111.946 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.567 ' O ' ' N ' ' A' ' 57' ' ' ASP . 73.6 m80 -78.83 151.64 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' C ' ' HH ' ' A' ' 54' ' ' TYR . . . -139.34 165.09 25.83 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.1 p -136.95 159.61 41.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 1.0 111.455 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 t -87.8 105.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 65' ' ' VAL . 25.8 t -105.68 -6.25 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.039 0.385 . . . . 1.0 112.039 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.86 122.6 6.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.278 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' OE2' ' NE ' ' A' ' 50' ' ' ARG . 81.7 tt0 -150.47 138.06 19.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.122 0.487 . . . . 1.0 111.686 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.61 132.07 51.35 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 44.6 ptt85 -114.17 142.88 45.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.042 -177.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.06 67.13 2.09 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.625 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 83.77 161.11 31.5 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.033 -0.827 . . . . 1.0 111.033 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.86 4.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.87 0.367 . . . . 1.0 110.323 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 71' ' ' GLY . 8.6 tpm_? -62.0 -42.07 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.068 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.52 108.86 33.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.66 167.34 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.132 . . . . 1.0 112.24 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 m -105.1 149.58 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.345 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 21.9 mt -111.23 20.37 17.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.021 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 21.9 tp -64.8 130.67 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -177.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.48 -2.17 88.11 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.861 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.55 149.57 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.325 0.563 . . . . 1.0 110.484 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.5 m -108.46 136.63 47.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.655 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.78 148.67 39.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.256 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.25 138.49 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.494 2.129 . . . . 1.0 111.474 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' C ' ' N ' ' A' ' 86' ' ' ASP . . . -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.915 0.388 . . . . 1.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.87 -16.27 0.2 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 84' ' ' ALA . 93.0 m-20 -70.35 -20.56 62.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.596 0.236 . . . . 1.0 111.004 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 88' ' ' PRO . 2.2 mt -125.01 95.65 41.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.516 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.0 Cg_exo -44.77 -114.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.521 2.147 . . . . 1.0 111.694 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 56.5 mp0 -147.11 -58.88 0.27 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.936 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -45.72 -42.71 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.681 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.97 -40.09 60.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.683 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 70.1 ttp85 -62.24 -34.46 76.55 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.808 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -62.81 -34.58 77.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.914 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.662 ' CD1' HH22 ' A' ' 101' ' ' ARG . 93.3 mt -63.66 -33.6 76.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.524 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.496 ' CZ ' HBA2 ' A' ' 203' ' ' CYC . 76.4 m-85 -67.97 -34.06 75.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 92' ' ' ARG . 36.1 mtp180 -75.33 -31.8 60.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.132 -0.94 . . . . 1.0 111.262 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.496 ' C ' HE22 ' A' ' 99' ' ' GLN . 91.8 mt -97.79 -36.8 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.753 1.02 . . . . 1.0 113.753 -177.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.31 -17.49 8.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 114.258 1.207 . . . . 1.0 114.258 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.631 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 0.7 OUTLIER 48.38 55.72 8.49 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.618 -0.833 . . . . 1.0 109.98 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 99' ' ' GLN . 20.7 t -153.3 109.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.891 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.662 HH22 ' CD1' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -161.88 131.87 4.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.921 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 103' ' ' ILE . 54.0 t -146.53 155.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.665 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.564 HG12 HG21 ' A' ' 135' ' ' VAL . 57.6 mt -112.47 128.53 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.268 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.09 170.53 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.052 0.76 . . . . 1.0 113.052 -176.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -51.2 115.05 1.38 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.987 -1.006 . . . . 1.0 112.246 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.482 HG23 ' CG1' ' A' ' 140' ' ' VAL . 12.0 p -50.07 -19.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.716 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -81.07 -36.41 30.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.79 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.5 -18.34 28.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.137 0.494 . . . . 1.0 110.409 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 57.44 61.49 2.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.532 -0.758 . . . . 1.0 112.819 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -94.62 125.7 39.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.762 -1.569 . . . . 1.0 106.762 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -118.75 142.93 47.23 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.679 0.992 . . . . 1.0 113.679 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -111.87 150.91 29.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.73 -1.123 . . . . 1.0 108.616 178.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 113' ' ' ILE . 31.4 pt -150.83 155.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.411 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.0 p -84.76 163.63 19.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -150.88 158.52 35.0 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.896 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.22 -13.52 20.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.687 2.258 . . . . 1.0 112.286 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.23 -34.54 77.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 p 62.98 125.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.514 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -98.27 145.63 26.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.675 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -168.73 -175.11 37.95 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.8 mt 46.72 50.4 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 1.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.2 m -60.06 -31.41 69.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.71 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.71 -48.22 58.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.4 mmm-85 -49.93 -56.19 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.759 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.2 109.5 10.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.684 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 128' ' ' GLY . 63.8 Cg_endo -83.04 164.94 15.23 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 122.356 2.037 . . . . 1.0 111.505 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 127' ' ' LEU . 11.2 mp 44.75 -92.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.458 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' PRO . . . 57.36 35.54 72.13 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -139.42 154.06 71.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 1.0 110.639 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 132' ' ' GLN . 65.6 Cg_exo -41.54 165.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.398 2.066 . . . . 1.0 112.048 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.423 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 3.6 tp -59.92 12.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.036 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.591 ' H ' ' C ' ' A' ' 130' ' ' PRO . 50.7 mm-40 -138.11 156.18 48.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.511 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.581 HH21 ' CZ ' ' A' ' 101' ' ' ARG . 21.0 mmm180 -122.42 113.81 30.6 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.587 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -84.65 142.92 9.43 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.641 2.227 . . . . 1.0 112.378 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.564 HG21 HG12 ' A' ' 103' ' ' ILE . 22.3 t -122.24 133.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -42.08 157.6 0.21 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.356 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.13 -24.57 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.124 2.549 . . . . 1.0 113.614 -178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.589 ' SG ' ' HHD' ' A' ' 203' ' ' CYC . 0.8 OUTLIER -58.02 -58.46 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.246 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.876 ' CG ' ' HD ' ' A' ' 203' ' ' CYC . 0.4 OUTLIER -71.15 -26.76 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.68 -178.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 136' ' ' ASP . 76.3 t -61.1 -56.18 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -62.26 -38.95 91.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.303 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -47.53 -36.22 10.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.03 -42.93 62.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -58.31 -43.68 88.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -62.21 -19.3 63.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.39 -0.823 . . . . 1.0 109.683 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.5 mmm -99.34 0.02 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.133 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.86 18.26 77.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.52 -1.032 . . . . 1.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 84.3 t -108.75 143.59 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.738 0.304 . . . . 1.0 110.3 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.94 -25.39 4.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.031 0.382 . . . . 1.0 112.031 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -152.49 118.68 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.756 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 96.3 p -129.23 144.2 51.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.994 0.426 . . . . 1.0 111.398 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 152' ' ' LEU . 8.2 mp -102.69 137.33 41.06 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.76 129.1 74.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 1.0 112.263 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.3 133.29 20.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 108.186 -1.042 . . . . 1.0 108.186 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.49 162.54 3.58 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.368 2.045 . . . . 1.0 113.736 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 37.6 mt -117.12 115.03 24.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.414 ' H ' ' HB3' ' A' ' 192' ' ' SER . 22.0 ptm -141.99 154.74 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 55.9 t60 -128.34 124.78 37.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.021 -0.991 . . . . 1.0 108.871 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.619 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 46.2 m-70 59.72 -121.21 1.03 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.117 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -97.94 0.57 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.344 . . . . 1.0 111.823 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.535 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 87.9 tt0 -105.46 143.56 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.6 tp -99.71 124.54 45.06 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.535 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 86.3 m95 -102.92 -31.02 10.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.31 -169.82 26.21 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.448 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.7 mp -140.03 121.74 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 1.0 111.637 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' A' ' 53' ' ' VAL . 5.1 tp -94.67 149.66 21.01 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 177.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.7 p -157.56 134.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.075 -0.65 . . . . 1.0 111.861 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.9 t -114.52 135.76 53.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.267 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -107.82 126.99 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -117.46 122.81 44.77 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.33 16.69 5.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.797 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -159.21 143.79 11.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.636 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -42.77 139.13 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.668 2.245 . . . . 1.0 111.816 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -173.19 114.16 0.36 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.653 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.05 153.33 21.98 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.56 2.173 . . . . 1.0 111.45 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -108.01 151.32 25.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.876 0.37 . . . . 1.0 110.812 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 91.4 p -104.12 156.69 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.237 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -54.25 -40.72 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.159 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.35 -43.7 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.249 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 184' ' ' VAL . 96.1 mt-10 -78.39 -28.96 47.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 1.0 110.971 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.65 -39.53 73.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.636 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 183' ' ' VAL . 11.7 pt20 -80.45 -52.87 7.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.92 -0.312 . . . . 1.0 111.682 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' A' ' 182' ' ' GLN . 9.9 p -44.13 -41.74 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.645 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.6 p -75.1 -49.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.144 -0.688 . . . . 1.0 109.144 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.597 ' N ' HG13 ' A' ' 184' ' ' VAL . 56.8 tt0 -50.05 -35.28 24.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 15.6 tp -71.74 -48.61 45.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.053 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 187' ' ' LEU . 62.9 tp -51.42 -44.58 62.3 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.71 91.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -64.09 -39.32 93.8 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -64.53 -31.41 72.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 53.7 t -77.49 -44.58 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 157' ' ' MET . 2.2 m -51.77 -33.6 35.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.78 -34.61 34.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.56 78.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.98 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 196' ' ' ALA . 20.1 pt -62.24 -29.82 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.42 ' N ' HG13 ' A' ' 195' ' ' ILE . . . -76.5 -53.5 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.639 -0.71 . . . . 1.0 110.37 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.54 -42.63 98.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.321 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.8 74.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.352 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.86 -43.11 80.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 tp -51.35 -38.12 51.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.959 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 34.4 t -47.85 -57.54 5.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.631 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.496 179.894 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.876 ' HD ' ' CG ' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 31' ' ' LEU . 11.0 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 1.0 110.517 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -48.07 -36.61 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.764 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -74.09 -50.6 18.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.874 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 38' ' ' THR . 95.7 mt -56.47 -45.53 81.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.145 0.498 . . . . 1.0 110.982 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.44 ' O ' ' OG1' ' A' ' 38' ' ' THR . 29.5 mt -58.07 -28.89 64.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.903 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.502 HH12 HD22 ' A' ' 78' ' ' LEU . 87.4 mtt-85 -68.53 -39.5 81.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.416 -0.514 . . . . 1.0 109.81 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.42 -31.71 69.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.9 p -67.68 -36.93 81.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 1.0 112.371 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -74.59 -23.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 -178.209 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.46 -48.36 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.323 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.34 -35.9 80.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.71 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 38' ' ' THR . 70.6 t -58.1 -53.87 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.613 -0.267 . . . . 1.0 111.313 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 47' ' ' GLY . 65.5 ttt-85 -50.21 -43.73 52.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.942 0.401 . . . . 1.0 110.664 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.03 -43.33 70.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.295 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.65 -37.65 87.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.786 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mt -96.84 -14.6 21.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.725 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 52.47 25.68 20.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.2 p -81.25 152.52 27.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.9 -0.408 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.3 m-20 -48.83 -43.57 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.599 0.592 . . . . 1.0 112.599 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.432 HH21 HG21 ' A' ' 148' ' ' VAL . 30.1 ptt180 -159.17 146.93 17.56 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.625 -0.83 . . . . 1.0 112.765 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.13 133.43 50.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.703 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 61.3 mttt -135.77 142.83 44.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.665 -177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 166' ' ' LEU . 59.8 t -102.02 140.94 19.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.748 ' CE2' HBB1 ' A' ' 203' ' ' CYC . 19.1 m-85 -131.55 136.59 47.96 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.531 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -112.86 153.28 28.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.036 0.446 . . . . 1.0 111.188 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CD1' ' NH2' ' A' ' 92' ' ' ARG . 43.5 m-85 -100.0 141.84 32.28 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' CB ' ' NE2' ' A' ' 61' ' ' HIS . 0.1 OUTLIER -114.2 166.67 11.0 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -41.75 -55.82 2.17 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.055 2.503 . . . . 1.0 114.497 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -67.88 -12.56 60.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 84' ' ' ALA . . . 102.79 0.28 48.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.752 -0.737 . . . . 1.0 111.904 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.509 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 2.4 p80 -74.6 148.79 40.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.707 -0.397 . . . . 1.0 110.466 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.54 144.34 16.98 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -125.12 149.69 47.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.948 0.404 . . . . 1.0 111.57 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 77' ' ' LEU . 4.2 p -90.19 108.97 20.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 65' ' ' VAL . 12.1 t -112.34 -4.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -153.32 128.17 9.54 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.271 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 52' ' ' LYS . 24.0 tt0 -160.75 141.92 11.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.205 0.526 . . . . 1.0 111.662 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.75 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -110.73 138.59 46.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.382 -0.527 . . . . 1.0 112.038 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.02 67.33 3.73 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.611 -0.995 . . . . 1.0 110.611 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' A' ' 73' ' ' ARG . . . 82.82 162.42 32.02 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.43 3.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.33 . . . . 1.0 110.328 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.585 ' H ' ' C ' ' A' ' 71' ' ' GLY . 8.9 tpm_? -59.14 -42.59 91.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.971 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt -117.63 143.08 31.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.63 167.9 23.41 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.475 2.117 . . . . 1.0 112.28 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p -98.42 149.7 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.346 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.877 ' O ' HG11 ' A' ' 64' ' ' VAL . 41.1 mt -116.19 15.99 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.952 -0.567 . . . . 1.0 109.946 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.502 HD22 HH12 ' A' ' 36' ' ' ARG . 52.3 mt -60.15 129.18 40.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.564 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 86.8 -2.35 87.17 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.814 177.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.813 ' O ' HG12 ' A' ' 64' ' ' VAL . 84.1 mt -86.0 147.39 26.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.358 0.579 . . . . 1.0 110.458 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.6 m -106.02 133.35 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -105.54 148.39 36.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.217 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.98 140.12 12.43 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.487 2.125 . . . . 1.0 111.493 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 60' ' ' GLY . . . -62.97 -31.37 72.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.799 0.333 . . . . 1.0 110.434 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.12 -17.03 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.8 m-20 -63.23 -24.91 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.624 0.249 . . . . 1.0 111.023 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.66 132.55 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.507 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.58 -99.42 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.535 2.157 . . . . 1.0 111.672 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -159.25 -47.58 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.956 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -52.0 -40.99 61.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.674 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.636 ' CB ' HH22 ' A' ' 101' ' ' ARG . . . -74.89 -38.32 61.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.712 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.46 ' HE ' HD23 ' A' ' 162' ' ' LEU . 72.4 ttt180 -61.08 -32.36 72.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.798 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.07 -36.43 83.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.933 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.78 -36.27 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.532 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -67.96 -37.1 81.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -75.54 -30.23 59.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.162 -0.927 . . . . 1.0 111.26 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.548 ' C ' HE22 ' A' ' 99' ' ' GLN . 95.9 mt -96.98 -38.63 9.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -120.94 -14.47 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.564 ' NE2' ' N ' ' A' ' 99' ' ' GLN . 2.0 mp0 48.8 51.37 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.902 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 99' ' ' GLN . 22.8 t -153.17 109.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.911 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.636 HH22 ' CB ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -164.02 135.91 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.873 178.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 103' ' ' ILE . 1.5 p -151.58 156.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.684 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.798 HD11 HAA1 ' A' ' 203' ' ' CYC . 87.7 mt -110.56 130.69 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.265 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 104' ' ' VAL . 1.4 m -85.94 169.66 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.921 0.711 . . . . 1.0 112.921 -177.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.457 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 64.6 m-20 -48.19 116.01 1.4 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.902 -1.044 . . . . 1.0 112.236 -178.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.5 -18.85 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.666 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 109' ' ' GLN . 43.4 tp10 -78.7 -38.83 38.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.821 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 109' ' ' GLN . . . -61.33 -5.91 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.501 . . . . 1.0 110.454 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 108' ' ' ALA . 11.6 pt20 46.23 63.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 1.0 112.83 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.5 m -91.24 126.96 36.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.77 -1.567 . . . . 1.0 106.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -118.34 144.48 45.84 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 0.5 OUTLIER -111.71 149.87 31.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.695 -1.139 . . . . 1.0 108.654 178.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.9 pt -150.52 154.61 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.435 -0.506 . . . . 1.0 111.418 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -87.16 167.21 14.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.306 -0.628 . . . . 1.0 109.306 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -147.52 153.26 43.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.968 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.12 -5.04 15.47 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.69 2.26 . . . . 1.0 112.208 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.1 160.82 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.633 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 52.8 p -51.7 166.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.562 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -58.42 146.06 36.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.685 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -55.91 -27.07 49.72 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.5 tp 57.93 71.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 1.0 110.653 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.5 m -59.75 -29.85 68.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.73 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.1 -33.25 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.779 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HE ' ' H ' ' A' ' 125' ' ' VAL . 18.0 ttp180 -64.67 -143.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.68 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' H ' ' HE ' ' A' ' 124' ' ' ARG . 22.0 t -60.05 133.84 90.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.619 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.82 141.76 37.92 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.359 2.039 . . . . 1.0 111.569 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.7 -112.71 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.419 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.52 30.0 57.15 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.144 -0.783 . . . . 1.0 111.144 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -131.31 150.61 76.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 O-C-N 122.828 -0.219 . . . . 1.0 110.639 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.577 ' C ' ' H ' ' A' ' 132' ' ' GLN . 71.0 Cg_exo -42.62 162.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.421 2.081 . . . . 1.0 111.985 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.41 ' O ' ' CD ' ' A' ' 132' ' ' GLN . 55.9 mt -54.59 3.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 1.0 112.086 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.577 ' H ' ' C ' ' A' ' 130' ' ' PRO . 38.9 mm-40 -137.49 143.36 41.69 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.56 -0.456 . . . . 1.0 111.467 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -117.83 82.77 17.21 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.538 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -43.81 142.64 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.704 2.269 . . . . 1.0 112.36 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.69 128.92 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 112' ' ' SER . 21.3 t70 -44.2 135.87 4.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.744 0.307 . . . . 1.0 111.345 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -37.41 -23.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.132 2.555 . . . . 1.0 113.645 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 136' ' ' ASP . 36.3 t -55.66 -61.3 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.263 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.758 ' CE1' ' HD ' ' A' ' 203' ' ' CYC . 0.4 OUTLIER -71.94 -24.04 61.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.658 -178.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 69.6 t -57.97 -61.75 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.551 0.574 . . . . 1.0 112.551 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.592 ' ND1' ' N ' ' A' ' 142' ' ' TYR . 23.2 p80 -60.79 -39.23 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.391 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.592 ' N ' ' ND1' ' A' ' 141' ' ' HIS . 83.1 t80 -47.44 -39.75 16.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 38.4 mt -72.06 -43.44 64.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.64 -43.03 79.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.782 -0.822 . . . . 1.0 108.782 176.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.5 m -61.7 -20.12 63.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.709 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.8 mmm -98.48 -1.16 41.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.503 -0.771 . . . . 1.0 111.074 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.53 19.32 76.38 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.559 -1.016 . . . . 1.0 110.559 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.432 HG21 HH21 ' A' ' 50' ' ' ARG . 65.7 t -107.56 142.49 20.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.297 . . . . 1.0 110.242 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -119.64 -35.17 3.6 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.457 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 22.8 m -143.2 121.17 12.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.766 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 m -129.81 142.11 50.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.003 0.43 . . . . 1.0 111.378 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 tp -102.76 136.24 42.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.176 -0.675 . . . . 1.0 109.176 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.1 t -113.14 128.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.331 -0.548 . . . . 1.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.22 128.97 19.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.255 -1.016 . . . . 1.0 108.255 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -92.6 164.21 2.85 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.4 2.067 . . . . 1.0 113.704 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.0 mt -117.9 113.68 22.1 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.567 ' N ' ' OG ' ' A' ' 192' ' ' SER . 23.6 ptm -140.7 152.47 45.35 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.107 -0.637 . . . . 1.0 112.718 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 53.6 t60 -126.19 123.99 39.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.932 -1.031 . . . . 1.0 108.829 178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.608 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 56.8 m-70 58.54 -120.73 1.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.182 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -97.42 1.51 49.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.787 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -106.01 143.44 34.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.46 HD23 ' HE ' ' A' ' 92' ' ' ARG . 39.4 tp -99.31 124.94 44.82 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 66.3 m95 -103.91 -35.31 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.562 0.949 . . . . 1.0 113.562 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -156.87 -174.59 26.78 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 119.684 -1.246 . . . . 1.0 112.375 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.7 tp -138.42 121.2 16.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.399 -0.401 . . . . 1.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.457 HD12 HG22 ' A' ' 53' ' ' VAL . 10.3 tp -93.69 142.57 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.1 p -149.41 131.92 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.098 -0.641 . . . . 1.0 111.815 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.8 t -116.46 130.66 56.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 1.0 109.197 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -106.21 129.33 54.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 172' ' ' GLU . 19.1 t-80 -120.77 117.4 27.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.77 -15.65 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.742 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.419 ' O ' ' ND1' ' A' ' 170' ' ' HIS . 51.1 mm-40 -131.27 141.64 42.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 120.894 -0.323 . . . . 1.0 110.553 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -41.74 150.07 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.67 2.247 . . . . 1.0 111.896 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -173.38 88.33 0.38 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.712 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.81 153.71 14.3 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.497 2.132 . . . . 1.0 111.433 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -110.98 151.55 27.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.846 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.3 t -110.29 146.95 34.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.239 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -53.61 -39.28 64.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.124 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.38 -55.83 27.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.42 -0.355 . . . . 1.0 111.318 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -72.1 -36.09 69.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.941 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.57 -40.54 97.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.551 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -67.15 -55.8 12.63 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.945 -0.302 . . . . 1.0 111.759 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.3 t -45.73 -40.6 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.626 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.48 -50.76 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.103 -0.703 . . . . 1.0 109.103 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -48.43 -36.54 15.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 190' ' ' GLN . 87.1 mt -71.64 -46.52 58.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.075 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 tp -52.13 -46.33 65.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.939 -0.764 . . . . 1.0 108.939 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.95 91.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.377 -0.971 . . . . 1.0 108.377 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -64.82 -38.11 89.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 186' ' ' LEU . 27.2 mt-30 -66.89 -30.6 70.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.72 -45.89 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.384 -0.969 . . . . 1.0 108.384 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' A' ' 157' ' ' MET . 9.5 t -52.25 -37.39 55.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 190' ' ' GLN . 31.8 mt -65.47 -34.97 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.162 -0.926 . . . . 1.0 110.291 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.05 78.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.928 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.7 mt -55.24 -50.25 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.96 -50.42 66.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.417 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -61.87 -46.96 87.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.325 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.83 -32.74 74.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.41 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -56.4 -41.63 76.61 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.234 0.457 . . . . 1.0 112.234 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.2 mt -53.77 -34.67 59.78 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.987 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.6 t -44.92 -56.73 4.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.621 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.418 179.583 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.798 HAA1 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 63.0 t0 -48.82 -34.17 11.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.705 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.485 ' H ' ' CD ' ' A' ' 33' ' ' GLN . 22.6 mp0 -76.38 -48.44 19.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.826 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 38' ' ' THR . 25.7 mm -56.56 -50.38 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.065 0.459 . . . . 1.0 110.885 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 38' ' ' THR . 47.9 mt -57.38 -30.24 64.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 1.0 111.934 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.4 ttp85 -65.78 -39.7 91.23 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.762 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.17 -32.42 68.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.831 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 76.3 p -65.07 -37.85 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.948 -0.569 . . . . 1.0 112.368 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p -71.94 -25.57 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.165 0.432 . . . . 1.0 112.165 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -80.78 -35.12 33.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.819 -0.352 . . . . 1.0 111.298 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -77.15 -42.63 37.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.76 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.7 p -63.65 -52.4 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.356 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.651 ' N ' HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.22 -42.21 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 1.0 110.697 -179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 43' ' ' ARG . . . -53.86 -41.28 67.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.317 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.16 -34.68 78.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.764 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -95.86 -14.83 22.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.8 0.333 . . . . 1.0 111.683 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 55.92 25.31 45.0 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.494 -1.042 . . . . 1.0 110.494 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 p -78.17 145.19 35.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -54.84 -40.27 69.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.618 0.599 . . . . 1.0 112.618 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' A' ' 67' ' ' GLU . 44.9 ttt180 -150.47 132.46 15.21 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 119.511 -0.876 . . . . 1.0 112.762 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 7.1 t -138.69 131.54 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.007 -0.997 . . . . 1.0 108.671 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.598 ' NZ ' ' NE2' ' A' ' 169' ' ' HIS . 24.9 pttm -137.17 149.97 47.61 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.722 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 166' ' ' LEU . 61.4 t -98.99 141.35 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' A' ' 62' ' ' GLY . 16.0 t80 -131.05 132.31 44.84 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.42 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -113.04 153.56 27.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.012 0.434 . . . . 1.0 111.253 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.79 135.59 44.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.664 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' HIS . 1.1 m-20 -95.09 150.73 38.12 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -41.45 -21.87 0.14 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.012 2.474 . . . . 1.0 114.485 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -103.22 4.6 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.565 -0.454 . . . . 1.0 112.155 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.21 -14.35 59.77 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.671 -0.776 . . . . 1.0 111.897 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 57' ' ' ASP . 39.9 m80 -78.13 150.44 33.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' OH ' ' A' ' 54' ' ' TYR . . . -138.56 164.0 25.73 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -136.35 158.07 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.034 0.445 . . . . 1.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.2 106.54 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.308 -0.997 . . . . 1.0 108.308 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 65' ' ' VAL . 54.7 t -107.92 -5.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.126 0.417 . . . . 1.0 112.126 -177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.604 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -152.19 123.51 7.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.348 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' CD ' HH21 ' A' ' 50' ' ' ARG . 87.1 tt0 -150.87 136.6 18.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 1.0 111.719 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.56 135.85 51.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.733 -0.84 . . . . 1.0 108.733 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -119.26 140.06 50.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 1.0 112.044 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.13 113.85 4.55 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.634 -0.986 . . . . 1.0 110.634 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.413 ' C ' ' N ' ' A' ' 73' ' ' ARG . . . 49.52 36.06 23.39 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.049 -0.821 . . . . 1.0 111.049 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 50.32 16.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.825 0.345 . . . . 1.0 110.385 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' N ' ' C ' ' A' ' 71' ' ' GLY . 14.5 tpp85 -55.91 -46.4 78.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.009 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.03 150.19 37.23 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.304 -0.628 . . . . 1.0 109.304 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.32 151.18 42.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.454 2.102 . . . . 1.0 112.267 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.9 m -84.35 110.88 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.348 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.485 HD12 HH22 ' A' ' 50' ' ' ARG . 15.9 mt -91.69 16.03 11.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.023 -0.535 . . . . 1.0 109.946 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.2 132.68 52.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.98 -2.94 86.98 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.43 -0.805 . . . . 1.0 112.812 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.5 mt -85.55 150.81 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.372 0.586 . . . . 1.0 110.415 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -109.16 137.63 46.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.622 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -108.99 148.72 38.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.274 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.51 137.02 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.574 2.183 . . . . 1.0 111.442 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.9 -34.75 73.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.865 0.364 . . . . 1.0 110.445 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.14 -16.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 84' ' ' ALA . 97.5 m-20 -66.39 -22.08 66.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.647 0.261 . . . . 1.0 111.03 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.92 133.36 24.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.529 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.64 -98.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.537 2.158 . . . . 1.0 111.685 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -161.96 -50.72 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.953 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -46.52 -42.84 16.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.593 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.32 -38.48 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.743 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.57 -32.21 72.29 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.791 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -64.01 -35.31 80.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.915 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.41 -36.04 79.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.534 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 45.3 m-85 -68.25 -35.36 77.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -81.11 -27.77 35.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.166 -0.925 . . . . 1.0 111.269 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.427 ' C ' HE22 ' A' ' 99' ' ' GLN . 97.0 mt -96.95 -42.04 8.11 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 100' ' ' VAL . . . -119.8 -15.0 8.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.243 1.201 . . . . 1.0 114.243 -174.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.674 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.6 OUTLIER 45.57 54.9 7.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.7 -0.8 . . . . 1.0 109.866 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 99' ' ' GLN . 5.9 m -159.68 111.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 120.298 -0.561 . . . . 1.0 111.857 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.78 ' NE ' ' N ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -170.81 139.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.498 . . . . 1.0 110.852 177.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 103' ' ' ILE . 2.5 p -146.01 158.36 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.73 -0.668 . . . . 1.0 109.641 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.524 HG23 HG11 ' A' ' 135' ' ' VAL . 49.8 mt -110.62 126.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.217 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 105' ' ' ASP . 10.0 p -86.53 168.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 112.995 0.739 . . . . 1.0 112.995 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.613 ' N ' HG22 ' A' ' 104' ' ' VAL . 48.7 m-20 -49.0 115.88 1.45 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.938 -1.028 . . . . 1.0 112.283 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.77 HG23 ' CG1' ' A' ' 140' ' ' VAL . 14.8 p -51.03 -21.61 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.675 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -77.94 -38.08 46.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.835 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.58 -16.13 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.185 0.517 . . . . 1.0 110.404 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 56.24 60.93 2.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.482 -0.781 . . . . 1.0 112.824 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.6 m -96.86 126.19 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -117.87 143.92 45.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.519 ' H ' ' HA ' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -114.45 153.91 29.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.731 -1.122 . . . . 1.0 108.636 177.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 112' ' ' SER . 29.0 pt -154.23 158.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.473 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -94.08 173.26 7.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -149.7 151.36 32.71 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.921 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.0 -22.36 10.12 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.603 2.202 . . . . 1.0 112.262 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.31 154.64 19.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.6 m -58.04 156.39 9.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.502 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -139.65 164.71 29.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.648 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.65 115.41 6.73 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.2 mt -89.03 148.82 23.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 1.0 110.553 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.415 ' OG ' HD13 ' A' ' 97' ' ' LEU . 88.8 p -59.56 -27.7 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.687 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.02 -35.31 73.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.742 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -55.46 -60.54 3.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.785 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.94 153.31 60.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.629 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.44 145.78 43.37 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.324 2.016 . . . . 1.0 111.533 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 127' ' ' LEU . 10.3 mp 51.26 -107.01 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.447 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.23 36.02 92.7 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -134.32 153.86 79.59 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.541 0.21 . . . . 1.0 110.624 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 132' ' ' GLN . 56.0 Cg_endo -66.26 159.89 47.75 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.403 2.069 . . . . 1.0 111.965 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.432 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 70.3 mt -47.45 -8.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.932 -0.577 . . . . 1.0 112.092 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 130' ' ' PRO . 5.9 mm100 -131.2 167.38 19.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.524 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -143.98 91.3 6.59 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.514 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.91 137.84 21.67 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.619 2.213 . . . . 1.0 112.407 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 103' ' ' ILE . 1.4 p -114.95 128.0 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.7 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 45.9 p-10 -46.53 138.88 6.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.746 0.307 . . . . 1.0 111.315 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -39.21 -28.24 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.145 2.563 . . . . 1.0 113.663 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 5.7 t -48.94 -64.42 0.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.269 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.475 ' NE2' HD11 ' A' ' 143' ' ' LEU . 29.6 t60 -71.37 -21.83 61.97 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.77 ' CG1' HG23 ' A' ' 106' ' ' VAL . 88.5 t -59.34 -58.1 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -63.1 -40.11 96.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.424 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.517 ' CE2' ' SD ' ' A' ' 146' ' ' MET . 71.2 t80 -47.59 -38.42 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.475 HD11 ' NE2' ' A' ' 139' ' ' HIS . 84.5 mt -71.82 -43.7 65.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.104 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -56.41 -41.98 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.0 m -62.66 -21.36 65.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.692 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.517 ' SD ' ' CE2' ' A' ' 142' ' ' TYR . 50.6 mtp -98.31 -0.74 43.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.488 -0.778 . . . . 1.0 111.06 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.05 19.71 76.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.591 -1.004 . . . . 1.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.2 t -107.78 143.44 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.679 0.276 . . . . 1.0 110.367 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -118.56 -26.86 6.06 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.968 0.359 . . . . 1.0 111.968 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' A' ' 105' ' ' ASP . 32.4 m -150.77 120.29 6.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.766 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p -129.76 141.85 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 1.0 111.402 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 152' ' ' LEU . 9.3 mp -104.37 130.7 52.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.617 ' O ' ' NE ' ' A' ' 101' ' ' ARG . 10.9 t -113.83 106.36 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.308 -0.557 . . . . 1.0 112.311 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 42.6 t -110.17 135.77 20.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -94.93 167.3 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.299 1.999 . . . . 1.0 113.723 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 36.1 mt -119.24 116.33 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.7 ptm -141.02 154.78 46.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.408 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 74.8 t60 -127.99 123.39 34.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.942 -1.026 . . . . 1.0 108.865 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.599 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 82.2 t60 60.23 -120.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.363 . . . . 1.0 110.09 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.599 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 28.0 tp60 -98.26 2.03 47.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.816 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.529 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 88.0 tt0 -105.7 144.98 31.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.68 0.993 . . . . 1.0 113.68 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.12 123.99 46.13 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.529 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 74.6 m95 -102.24 -31.65 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.37 -173.73 31.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 119.77 -1.205 . . . . 1.0 112.453 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.1 mt -135.12 121.44 20.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 1.0 111.614 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.649 ' CD1' HG22 ' A' ' 53' ' ' VAL . 4.5 tp -94.69 150.82 19.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.431 HG11 ' NZ ' ' A' ' 52' ' ' LYS . 13.0 p -157.33 134.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.859 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.9 t -115.6 132.8 56.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.598 ' NE2' ' NZ ' ' A' ' 52' ' ' LYS . 21.4 m80 -101.61 122.66 44.27 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.495 ' CD2' ' O ' ' A' ' 172' ' ' GLU . 7.6 t60 -117.75 108.7 15.7 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.42 66.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.751 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.495 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 21.2 mt-10 -104.77 157.82 33.35 Favored Pre-proline 0 C--N 1.327 -0.406 0 C-N-CA 120.942 -0.303 . . . . 1.0 110.569 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.48 ' O ' ' O ' ' A' ' 174' ' ' ARG . 59.1 Cg_endo -69.08 -97.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.695 2.264 . . . . 1.0 111.845 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 173' ' ' PRO . 59.9 ttp85 58.71 131.38 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.572 -0.286 . . . . 1.0 110.609 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.47 160.59 28.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.514 2.143 . . . . 1.0 111.416 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 181' ' ' LEU . 37.2 p90 -109.3 157.77 18.54 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.886 -0.326 . . . . 1.0 110.862 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 96.0 p -110.27 147.4 33.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.16 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.19 -34.69 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.122 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.89 -47.76 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.441 -0.345 . . . . 1.0 111.209 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 184' ' ' VAL . 97.1 mt-10 -73.16 -31.18 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 1.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 176' ' ' TYR . 42.5 tp -69.83 -35.77 75.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.619 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -81.11 -55.4 4.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.618 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 184' ' ' VAL . 9.3 p -44.16 -41.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.654 -0.419 . . . . 1.0 110.659 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 185' ' ' GLN . 7.4 p -73.96 -48.39 38.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.591 ' N ' HG13 ' A' ' 184' ' ' VAL . 62.3 tt0 -46.62 -32.9 3.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.106 -1.072 . . . . 1.0 108.106 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 190' ' ' GLN . 7.9 tp -68.84 -47.37 66.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.961 -1.018 . . . . 1.0 109.108 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 184' ' ' VAL . 95.5 mt -53.97 -46.43 71.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.88 86.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.541 ' O ' HD13 ' A' ' 193' ' ' ILE . 71.9 m-20 -63.27 -42.35 99.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 186' ' ' LEU . 61.3 tt0 -60.66 -31.3 70.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.43 -44.13 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.5 p -52.42 -36.55 54.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.815 -0.809 . . . . 1.0 108.815 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 189' ' ' ASP . 1.4 mp -66.06 -37.78 80.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.197 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.81 83.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.917 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.0 mt -55.15 -50.41 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.93 -50.35 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.411 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.6 -47.07 87.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.282 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.21 -32.67 73.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.39 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -56.14 -40.57 74.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 tp -52.5 -35.44 52.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.952 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 96.8 p -53.11 -58.71 6.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.615 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.058 -0.973 . . . . 1.0 110.397 179.647 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.831 HBC2 ' HD ' ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_